<SEC-DOCUMENT>0001333493-21-000167.txt : 20211108
<SEC-HEADER>0001333493-21-000167.hdr.sgml : 20211108
<ACCEPTANCE-DATETIME>20211108172917
ACCESSION NUMBER:		0001333493-21-000167
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		83
CONFORMED PERIOD OF REPORT:	20210930
FILED AS OF DATE:		20211108
DATE AS OF CHANGE:		20211108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			eHealth, Inc.
		CENTRAL INDEX KEY:			0001333493
		STANDARD INDUSTRIAL CLASSIFICATION:	INSURANCE AGENTS BROKERS & SERVICES [6411]
		IRS NUMBER:				770470789
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33071
		FILM NUMBER:		211389052

	BUSINESS ADDRESS:	
		STREET 1:		2625 AUGUSTINE DRIVE, SECOND FLOOR
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95054
		BUSINESS PHONE:		650-584-2700

	MAIL ADDRESS:	
		STREET 1:		2625 AUGUSTINE DRIVE, SECOND FLOOR
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95054
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ehth-20210930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:001ee10b-2bdc-4177-8047-00c9b0c2bbeb,g:3e9ca025-a681-404c-b475-c1976cd6b86b,d:a6d7e8bb0f4f45f88f677d6cf06c1b8f--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ehth="http://www.ehealthinsurance.com/20210930" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ehth-20210930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" format="ixt:fixed-false" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80L2ZyYWc6MTk2YjBiNjJlYzIyNGZhYzliMWFjM2NhZTJkMGVjYjcvdGFibGU6NTY0MTkzMjA5NTUxNDg0MmFhNjE2ZGY2ZTIxYzY0YzMvdGFibGVyYW5nZTo1NjQxOTMyMDk1NTE0ODQyYWE2MTZkZjZlMjFjNjRjM18zLTEtMS0xLTA_805ed3b1-3a7c-47f8-bbb1-db94377043a2">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80L2ZyYWc6MTk2YjBiNjJlYzIyNGZhYzliMWFjM2NhZTJkMGVjYjcvdGFibGU6NTY0MTkzMjA5NTUxNDg0MmFhNjE2ZGY2ZTIxYzY0YzMvdGFibGVyYW5nZTo1NjQxOTMyMDk1NTE0ODQyYWE2MTZkZjZlMjFjNjRjM181LTEtMS0xLTA_7e488d10-41bb-4b13-9f2d-e89f91e865ee">2021</ix:nonNumeric><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80L2ZyYWc6MTk2YjBiNjJlYzIyNGZhYzliMWFjM2NhZTJkMGVjYjcvdGFibGU6NTY0MTkzMjA5NTUxNDg0MmFhNjE2ZGY2ZTIxYzY0YzMvdGFibGVyYW5nZTo1NjQxOTMyMDk1NTE0ODQyYWE2MTZkZjZlMjFjNjRjM182LTEtMS0xLTA_3ce42fb0-87b9-44d5-bf55-bd69365396c1">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80L2ZyYWc6MTk2YjBiNjJlYzIyNGZhYzliMWFjM2NhZTJkMGVjYjcvdGFibGU6NTY0MTkzMjA5NTUxNDg0MmFhNjE2ZGY2ZTIxYzY0YzMvdGFibGVyYW5nZTo1NjQxOTMyMDk1NTE0ODQyYWE2MTZkZjZlMjFjNjRjM185LTEtMS0xLTA_bdfa1ce4-3ba1-4a9a-87e4-0a52c0f7872c">0001333493</ix:nonNumeric><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80L2ZyYWc6MTk2YjBiNjJlYzIyNGZhYzliMWFjM2NhZTJkMGVjYjcvdGFibGU6NTY0MTkzMjA5NTUxNDg0MmFhNjE2ZGY2ZTIxYzY0YzMvdGFibGVyYW5nZTo1NjQxOTMyMDk1NTE0ODQyYWE2MTZkZjZlMjFjNjRjM18xMC0xLTEtMS0w_07e47616-1d08-4562-ae9a-d2b2fde2ecd6">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i3aca269a6c854fa48018d8b33d96f58f_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNC0wLTEtMS0w_60f9a9ee-3a38-457d-b1c8-5c6bce90da25">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ehth-20210930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="icf7a643bd0844ee692d39d0f7d9dd31b_I20211101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i942081d424f34699add16e658f851ed1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i759d5300c26749239484a4f23e10ce0a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0273079a37b24f93bde9cf3de6f118a8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b864a8e10634cc386d2e4b1b66f73c9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb2628c9d51a46139995f5f56f04eb1b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5334a64f425448d4aa5dd0966023fad5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc76aa4ecb8a42b3bb83ea9ae9209b0f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f614f83f3b14aceb5dddc72972dc625_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c18bac640fb4358b74a9021f64f8f09_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i079a9bbf2d8444019d86c147c114b59f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i1e357e366d8f4c42ad7a50b0355c2477_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26c4eb4348de4a19a5f72c79a61f308d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f613da7232e4dffaa5665383fbfb47b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f721d7c0f874c25b09289e676fdcbac_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61a6496ebf1f45f38f971210c3817264_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4897b9072b44635b238daed55d2a37a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i370978c8564c4fcdadb9f1ea0c93f92a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i877f626f60a8448690bb833acb808b17_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebbf9ee7e6494e258504f10868840783_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecb1fedd8d124030a82eedac5b7a9e86_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a48fdb953934f5bb836534b0414bbb6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22fd73312a7c407e9083c80dffa106ff_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic86196f7d0f9445781c8ca4767d942db_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i531b3484676346ac94040d2dc4065a31_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibabacd5b0f804aabada2cd5365f24498_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33e718004b6a4f5aa57db218524b5773_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifefede64050246d08daebbf50765bb4f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d5eb3c604944f028aede8e47b8499b7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia86272a5d3aa4258b2f07ea45b88ff59_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i391fe734bef14823a887a006994653ec_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bd8ce3993854b8e97b6b76978a4d09c_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7fbdf6185ab4c1da95b8b7ef4dd0e03_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98ccd6154a98467786e1d4ef694bc1b1_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dde38ab27e34c2389470563ce4f40dd_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7ebb4122db248399d55925e46f33a97_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i150bf8ca70274905a045d294be04c55f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40d62c8d4357468a811e6df8b3eb306f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c86001988504201bc82e067924ed6cf_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9def4cfc83f54b30addf32c96889fca4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90037718d9204b0384103fade0d6cc45_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8de5a03a387f4e069c2641fc24a40166_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66989f5e965f4615937f019de6f617c4_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3afb9956061e4743b8afadadf5214bfe_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ccdcb106e384ddeb87a904ee03a58ec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i556e4d2503564d02a306ef205e40b6e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie21f15744a034c72bc7d41e0bf1b76f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2012813b7e7f4d55b5f995c8c974f514_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9da432b99fc042a88112d75776ee1823_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ae5a20475f543a7a5f9fde45d7bc4b1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadf2c5122ad64d28a8d34ec6b3182521_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2df0c24aa97b454985d49591cb833558_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i280b8878146141b5a2280971a470a37e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib088409742214844b1196f2379e1f6ab_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia776a591bb4d4eabab7db24eecef27c1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94afe3fa9f0f4d32bdfb8049be90c448_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eb5bda82ad94139a7613a0c425e11c0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibda03bb57f0b4466a93ac7974d90a217_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5df02cc0922640229ea054a72d8338e3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i023ad41593504141a87219e927134521_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3aca269a6c854fa48018d8b33d96f58f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib87b2fd6b0e94d1194ca2219f67dbe72_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i952e9678a9584f75a5d6851f6e9eeb1b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d26bc89cf9d42679d5552c59c55cdbf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd8aecbec0954165b87a5ec97df1d4e2_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83756e9e70664bbb9d9ce121c6030638_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ee387271fcb47c8ae521d21b67a6519_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id84eb822e5c644a4a6c213ee899e2d4e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="insurance_carrier"><xbrli:measure>ehth:insurance_carrier</xbrli:measure></xbrli:unit><xbrli:unit id="state"><xbrli:measure>ehth:state</xbrli:measure></xbrli:unit><xbrli:context id="i53205ea49e0b458292f697b7a5c56a93_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">ehth:UnderRecognitionOfStockBasedCompensationExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i373a791d3cae4ac8ac03bd94922adf11_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">ehth:OverRecognitionOfLicensingCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f1209faee954d01bec8ebffed7361b4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">ehth:OutOfPeriodAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0659c47707f64baa904993c672f45c27_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">ehth:OutOfPeriodAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8d44d8be1ff4d9ba8d66ea2c112a2de_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8e13b0d1c22425ca8ca7bebe6811adf_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cd73075ac5746c1ac3c693924ea8745_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79a3575bc66645c4873d69cd381d6522_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb69f48720624bd2ba3990d45781b58b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareSupplementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90eeed6c273749e88dabae5495cf6c9d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareSupplementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e3aa4585c2a420aac2dbbcd2a763c5e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareSupplementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if58e722068de4216be2a26dc1df27ada_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareSupplementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifab10f50711a46a8b9bdcbee99dfed11_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicarePartDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a03b84610f148308bee0aedeeeeded4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicarePartDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if432dd7d445c47b68e3465e50a0cce99_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicarePartDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae4bbc252a254aca8e08652db1ae75f4_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicarePartDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bf2b0808d5d4b95ad14fb56678b89df_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64b14a1e7cf747b5bdd0af47f7efa4bf_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i288de29276794a4b98de7093838e980b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b2f0942dcca4e079dc5dd9bcd2a7f2b_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07e75d14864c4f86befd75db7d14b2be_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:NonQualifiedHealthPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36c47733c755462195bb2209eb595273_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:NonQualifiedHealthPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fa14ebfc4094081974d71ef4e246a62_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:NonQualifiedHealthPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48aa029a268b4ec2b76e22c7b495a170_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:NonQualifiedHealthPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i851cd6431ca8482eb6cf6148f01f3118_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:QualifiedHealthPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc8fa77be2f04de88bb71b5c8d8a8e8c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:QualifiedHealthPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1430539e8454dec87d06cc7d906f6c3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:QualifiedHealthPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cfe3cb32fd14c69820a09d8cf0a7ec5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:QualifiedHealthPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i865072ee20694d9a916202d1277bb59a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8d71827a12044b98aca58d93cc8b447_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12b7def10b7c4144a3529c00d81371ea_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic140144201d545bb89a26e563ea54efc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibccfac65e89e46b0a4779b6a9f5a1595_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:ShorttermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb2e1ef01a8a49be95e5633382fff52e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:ShorttermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb08ebace2994766abfc06f5a7ca01e0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:ShorttermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib04f6ab9257d4c3c82133b0ebf9ec119_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:ShorttermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b84638a44674aae820620c1ad281b03_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:DentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f329a84a77c4b40a18c88baac1fa79e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:DentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib265edd981cb4329b96667e22174e69a_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:DentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9226a70837c94f539c18e81cea08edff_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:DentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if35afead23854a98ba1ae85afef88254_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if334ca37e8184c3bb05e9970b42f9537_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia15e62c7d2ac4d8783c355c63461fb13_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9ba1db851374ea0bdc62b19987a5f2d_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5794689700d84cc19cd5b25cb7e1a896_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75a8cb208fd74edb96d789382c6d519f_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f0cf3d15ecd4e02aba71ef693d79134_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4e89f067c984a58aee8388d3f4e26f6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie938c6c5a4b344bb9a1e717ea937a556_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0717ef9e88ca45c68fd977740d8d5fbb_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if45ec5bca96d4cffba4e82a71f5a9909_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic33a9cc99b61453181708c8ac5a2aa97_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77dc76304d9f4dc794d414ab98cc2411_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:SmallBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdb8cd80cf0c4da9853fa98df8f7fd37_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:SmallBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i411334780a0440f9b3aa7d1cd64fd42e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:SmallBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id66e7ebb7d4e493789cd440c77019454_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:SmallBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4787e3cd9c774e0486d6813affce59e3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionBonusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e50511dfd494fd4b8f5a928e5ead478_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionBonusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieed01c48dc4640938d300839252fb560_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionBonusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cfcd2d5b5b040a09df39b1ff8138e51_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionBonusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c3369cffbd74e249a3e3bcbd0df3054_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:SponsorshipAndAdvertisingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice58cf46aa33484b9c94c1f20980a068_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:SponsorshipAndAdvertisingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c4ce1d15f494a5996713fb811a2066e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:SponsorshipAndAdvertisingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c7bf84cecf545a7a3974f7c1cfe3799_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:SponsorshipAndAdvertisingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0336634f72994ba8b44ad3381f004b4e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:MiscellaneousOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc891b5b3b9c469f8a49e2e7a57facb8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:MiscellaneousOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b1f428af2a34ebd8d75cfdee0ffd03b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:MiscellaneousOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6053607ddf734936ad39bb851ebfddc8_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:MiscellaneousOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60f7bd4ed2c54782bc3f2260952e6258_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71df5a32a01545eca393c3d91f915fec_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i351266363f7a4e1b8813c1836650f960_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20e9c547df0148a987469593fc0dd987_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icde2beb0631d4a4287783b69cf7d4e1d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb0006a549d140b98d5bf1d2830e36e6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a16931904664e00b694766bb038e051_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i828454e449d849978e8c318cd2776b04_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i911f48697817404ab0c1d37ff5c70eb3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie30b009d33834b2784f9f5fde66749b8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ddb689a8fbc45558ae1921f6350e8fd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fb878914bf0422e994e7b471e4529cb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7afaf2016ac0443f80caca194735e56e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0d09f83aa5a4ea2a65c601a78f12257_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48026c37588241f584802f09d54f9ecf_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2733db6c0ea4360b6296e5e62c73ccb_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b76269dbb014c83960a5587af0692a7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b68547b7b4546788f2a85f5b220c5e4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7da352e8a9c40eb9cbd7fb732779cfe_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89f5b05319a44a1cad8dcf843dfca2f6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1947f932e9cd407bb62d56755087564a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2908788ec3a452c97c238d92d2d6035_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacc349161dd6466bbcd492c1b35bd633_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c979359de9d4404ab9ede567f6f6ece_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ef44b438b8345fb9a5e4685fa068d53_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib56fc804e10645e19884d6bf939a1e47_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if141fe6636bb4186bf1303c83e6e12ae_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f9533cbf4c24f3584970b6fd8bf789e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1758dd3c120e4914bdef33946facb083_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic84a9e32128947c58eaef205f493a0c8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88f0ca026fd6441dacb2cb5e02eaa395_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8aa4da10fcd0440f893af9317b139b55_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf89006ab2ec48268296871b08a85218_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc92029c098b4a3f9121ab760ccd9f11_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc72c1bed1c841499706dc72a9f006a6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife96baa989854bd5b161f91c7ee2b238_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c18eadfc0c5443f8b7c31b736463ad6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f03cec81030405695e2198510c5675c_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e56edcaffd445c099ce1763d8e2bac1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ee271f47aa44a19bcbb4c37143a41fc_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6e1b062da104b6c93845164602f2f2c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i359b7b468f5540df8ade4326d6c36a90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib46a8ba9e5024efe8bf5aba81c5b9600_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e3e7808533446fa841efe0261464aab_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1845a379344d4ba7b78716155f0ecf21_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7485ea45ef6d477b95fa116525c62450_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i799a45e99b484907806a69b59e333c89_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b25b5471f2842f191c5c90038a9fce3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib803d8adedf24fbdbcb6cc7f5c5f99e9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd6a2b2a5d6143c983bec97ffe0e0bd6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f376e41d3214a4a8692048243ef8566_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55279fea227b4f7992ca05764db25cfe_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic38fa4c27d674faaa2153103268bc6f2_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07543f61382c4935bdeec18bab41cc0e_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i523d407abcc34388915c073912053b35_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="id2046c7d044743ceaad71b60d4431854_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i352b2ea156634799b87eb09859219c43_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29e568455e4e48e0a5ef2ebf86b689a0_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fc6666241c84c42af5630376e4ae6d3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a7cfd923d224bb6b7fe901abc5d9385_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i850ab8c5df8746729fb79a1ced686481_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86f303cf73634348bebc5dab18fff7f4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaab6d0a0d8545a186157b9fcb246894_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47719e7e84e544339538a6b07e7b4dff_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib53890909b2842a6922819e1edeaa771_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa1c7c5fa3884882909610f165c0d007_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5610009dd37b4384bc33a616a6aab127_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50134f65952c447c8536c4c509d440b0_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e7212367a01499c93d6d4b809f9ed9c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad309707646240918be65ddd93e7dcf8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5d5ade3741d4a9185c2b653a4af9ecb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6f15061ad6e471cbda9021bf8810571_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie38b6c1b1c9c45fdba0d48aa1ce710c2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2deb8ce979e4e7ebc3e73924fdf8984_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4abea0af5374b2ea1c4c1f3394ae378_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20249488a86d4517ad2ce8519062fb47_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1196177b8cd4b4889d59fe382f0884a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6f25d09031048a4ad52c1658b5f4ec4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i336d38756e4c40b1ba67a778fec1c8b7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24ead09862b2413a86a888c37af9278b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d257f4867664e9e9883a4c86aab2afc_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id70b3e6e37f5474eac6b0c1c37de4585_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85a1662f85774554ac4dd94f6a4bd607_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d97d81f0af64632a38c7998284dd90c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bb1b3fedcf14b3d9257f06b935d3e4a_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70979db466f8423f9755a5fb92cb03ae_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7fa9733a3384f39b6dcfeb1f1ee2a6f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7fcfcdb20334394afbf1256cc0e0662_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcd9ed25d2764e9db6588f766c6ceb7c_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i491b5e834621498ca113938980a0be07_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id423dd6355054bb288a4cc0434f373bf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic58f49a9465c47028f47e4656f464863_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i129ac8211d8e4c0ba7a255b8dab26a32_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bcd9764a5744c69a32ac980ad18308e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4e09372bd664c3ab1b9f51f41199eb8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd42b9bb33c044dbb1de60bee9c42876_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec3221d11bf648bfb054e3fc5ae908f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd4b24a0a2e341d199c0c81e18f6fe7a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i717e94aee1cb438cabdc9a27ae11551f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ef7c7b9f546496b9cfa4c224aed630e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i506a76e2d8ca425cbdb5ae11dd6cd259_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i746a758123914e1d937d531d3b4f1360_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5847226e38d1465db0569a5ceb228ff4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i002e42fc0f9446dea52b4be056b82628_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f22b60783114271b6d18262ae59b3e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i723227d94b364d578aed1bb6c4c7d173_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbd22cf0dccc41498bd9e877ebc39f93_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i980493d2590e4651b3a1f828bf64d0e6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae0c078eeb4f4e9eb08d1321632981e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id40bd3241bac4466a336bb6f5771fbef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dd7aca5034144ce9adb12f61bcad4b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f3ecf18721d481caad5f826b596a46f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dba4eac468c476b9642c00c8d545983_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b68294e77e84233b3a350690a075beb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i007949f0ecbd4d28a3fc49a2fbb4899d_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia88748e076ec49309ce124b0255894ee_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81970b5cc22849c79344d636832e6166_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62c9f97d16144d79b7c6fc675d93c63f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>ehth:security</xbrli:measure></xbrli:unit><xbrli:context id="ie5b86e4a17824c849cfbd6758868c90c_I20210922"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i772c44978dc24667b2c627577234e585_D20211001-20211108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-11-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35c1fdbec1c54ee8a4e0d47f73f57d02_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ehth:PreviousRepurchaseProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c6e47a0194e4a0d80cb752cc22efef5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13884cc2d99e4cdca2c6d705a5357058_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff865bc5ba294fe1a8f363fa0a398bae_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if870e8c7cb0242ba8a5c2b4b20121f1f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27e01cc9738244978808f5a333f4fb54_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i460c059f80ca40628e4e5afaff80cc5e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58966c27927746fab2aa950798c6ed8e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cead6ea1a294d599363076673911adf_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife779febc9214b9d9f667dc5dce85356_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecda63b246a6400e9b5384de30aae603_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4fedf3dee684a9698a7fa96f6d62fd4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideb486a863af4417a98de87d059c62b5_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5734b0b91d441278f565d646dc3d8b0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8edbc452bd9741e797e8dbd8b3399e72_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice545f8f5bdb4b2fbe3864ed0eea00e2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90df302f532b402fa538eed1092beab9_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a5df46f99ab4327bcb5856e5d342696_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:CustomerCareAndEnrollmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic776873fdaff4484b896e658fb1dacfc_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:CustomerCareAndEnrollmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f1064a52d154cec94e9b6c3036d94f7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:CustomerCareAndEnrollmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5086b187a3b4d09a240002bc9755ba1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:CustomerCareAndEnrollmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibad2aa3a8cc44b218b307dfd6f4d7625_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:TechnologyAndContentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bd41afc910548ce9002b75544cdf8b6_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:TechnologyAndContentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61ff6162f5f44a859043de58c54befec_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:TechnologyAndContentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98ea343e414e4f2daab5caa63d2dd869_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:TechnologyAndContentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i154a3a36dc224680b714cc68444215d8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb4e953743a04c219eeb943727baf738_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9890280d5b954508a226b55c81aeaf25_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c5deda3fcee4a46bf2d57a2cb6c387e_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i538a335bee9d4605ac36f25f4181afa7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05a980eb0e6b4490bb82b24144c3b3c8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-30</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26a73d8f5e7749d9aa6a2add8248dab7_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2066383d954548c7a2a439ea4837e924_D20230630-20230630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-30</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10b063ee9a3341c08e50e129ebfdff8a_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i411da4d1faed43bea99e5a09b88c09cb_I20270430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2027-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>ehth:day</xbrli:measure></xbrli:unit><xbrli:context id="id4e0a9ea40624a0c8ff143de3025b216_I20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ehth:EchelonHealthSPCLPHIGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i745ac50b018842c299fbdeda74cca4fd_D20240430-20240430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-30</xbrli:startDate><xbrli:endDate>2024-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb998d550c844cf9af4331570da45fc4_I20210217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ehth:EchelonHealthSPCLPHIGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e6cbb434882488fb8c40546664dd72a_I20210217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43de0639e96543369be5664fcb0fb527_I20230817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6156a60f5d5a4f659313e014d9aa6e94_I20210217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee6fe712df744b2590f8f3fc4983ca39_I20210217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a83bcf547574a6b95583d2323256a2f_D20210430-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-30</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if073c25e8f81417c919277ea8f455b19_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d6d24f666c04e62a06ca4c5cf46e773_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5e0e7005d3f4062a071addcafc27c06_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e30025f0e894023bc09a663cf9f1b11_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia579f87161bd4c4bbfb8854b3b172133_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbfdeb0605ef4c5f870e8f2f7cd707a4_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i229764ec8611404cb78a18d3f3ea7742_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebe8f8a1f6c74de99d0800095353e8d6_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib307fc5e33fc48b29073be7772a66cf6_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1be182ab19bb49e5ad85243990d16da7_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic43e48e719fb4602912e4b0b7aa5e097_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecb19833c8e8461f9982c3ef70588776_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i340227a27cb64be1b3a57692746b5bbe_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b044301e060489699b1d5da2e923272_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic70c39ada9ec49e5a840c9102e12c415_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fba14fb6ba94783a410123eed9f78a3_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>ehth:claim</xbrli:measure></xbrli:unit><xbrli:context id="if22877f27abe4b9e9bcea617938a333a_D20200408-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-08</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d162a37afc94df8a25268308d382345_D20200707-20201013"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-07</xbrli:startDate><xbrli:endDate>2020-10-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plaintiff"><xbrli:measure>ehth:plaintiff</xbrli:measure></xbrli:unit><xbrli:context id="i21698a317c0745a9b39abd2f8c067af4_D20190701-20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ehth:LeViasCompliantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>ehth:segment</xbrli:measure></xbrli:unit><xbrli:context id="i78acf1a81a984826bfe2cedc7f25d60d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i599f7c7be93c4814890c266b5ec47df8_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ef09b5449f84c8ead10851320de6c76_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a6293eb4d8349d9a31d1b1a2fd3ed11_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5da3c7f6d5d4610954eeac8d16c4dbe_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a41b5baa43d4ed18e1b54843fc57273_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i467949b0884e43b0a011bdf4fadde010_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i039e32b3c64041e49cb0878ecaabafd1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91c81e16d0784d4d958fe95d1f894a24_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaef638b0fa1046eb9911d6d4747f5df0_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ad8d3eeb32049fe90a788e0eda6b25d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23411f69f39b432f81bcc3da7c590e76_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8a334e29b924ce49cd96becafc4d8fb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d37c58f9574acc85052b984bfa332e_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaae702e195164e63ba0beb670c74dde5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22910efbde7440648884b8f7e2613f28_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d576e424126448ab8ccca7322a38757_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90ca3570cf7d49f6a8e32f5b5cb816e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9c3527283ec406d936905c741fd644e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i807a2c2c69384b17a0895525b7e3edd3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaaefcb4864c42c9977406372dae345d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia99590146c5a4c1da65f6789c51d6d45_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0361883d6d844e64919f623c50758d9f_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifed085705a1141f7b66607c7f088c4f7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedb3906c92b9439bb9f00fb896ef8c19_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c33a4818d8a4dd1b84a8c1a8ef5eda5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eb35f5535224b48aab5f6959f231bec_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic37891f447e942e58713991d7596b9e8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6e791641d474976aa090740b18829e9_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f2574a154db4f12910857916c1fb936_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b3c828fd9844044b536167585b76ad7_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aee3ac4c576453099eae47761de55e3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c33c1733414490c92126731233e4e66_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie78c1d1beb9648dfa9a878f03a582e82_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ccf79aa1d6a4dc9a005e080c3858ac1_D20200101-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fd910c49a244d5c84e732a5b01119c4_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f4d4b8270d044b59fee38b2066bc5db_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="employee"><xbrli:measure>ehth:employee</xbrli:measure></xbrli:unit><xbrli:context id="i2ce9e77371e64f6a8892196a9e45088f_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic22af0ed9d5a46f7a09827528922c14b_D20210201-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8e43307bfae4745be61c3650614ae16_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b88d930749840dda7fc079ab96c882a_I20180917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i157113a553d840878f52e68b6c57d78d_I20180917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa14883525614cf79dab683249f898ec_I20191220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8887c4dc48dd49678b387048f0530ba7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ehth:BorrowingBasePercentageAxis">ehth:EligibleCommissionsReceivablesPrecedingThreeMonthsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ec55043cfb045c2aa1b9f8dd9a631ce_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:BorrowingBasePercentageAxis">ehth:EligibleCommissionsReceivablesSucceedingThreeMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieca95dd280a443e393ddf3ccbcca1f92_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ehth:BorrowingBasePercentageAxis">ehth:EligibleCommissionsReceivablesSucceedingSixMonthsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i724149df6b244d9cb6760b3d59438694_D20180917-20180917"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-17</xbrli:startDate><xbrli:endDate>2018-09-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea337c22bd714443919d49600be45338_D20191220-20191220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-20</xbrli:startDate><xbrli:endDate>2019-12-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica1b5f7280934d02b7e7917401872662_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ehth:CreditAgreementAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8ba51940194417ebfd20f82ded0000b_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ehth:CreditAgreementAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35b23d73e2ba484d8591b732fcc5f47c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ehth:CreditAgreementAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTItMy0xLTEtMA_adf0cfc9-05b4-4267-8b84-5052befdd4dd id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzEtMy0xLTEtMA_f2c82846-1978-4782-ab46-14ced2a76dcd id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDEtMy0xLTEtMA_518524af-b08d-469d-a46b-ad21ff86b3e8 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOC0zLTEtMS0w_a4ef4595-7fda-42b2-a40a-60640a12be13 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzktMy0xLTEtMA_23659aac-e96b-4ca6-9b5a-3e0277e23a69 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNi0zLTEtMS0w_b0c470d1-5569-4b38-ba4c-549e9f2c8ba1 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNy0zLTEtMS0w_06f2a0e0-4c0f-4c3a-bd07-1da910ffb435 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzItMy0xLTEtMA_da23f0db-05c5-4d01-a973-6d1630dbc55b id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTYtMy0xLTEtMA_badf2027-c006-488e-a6d5-6961ba416881 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzUtMy0xLTEtMA_c1ed0323-1ba4-463e-8f80-6a886a540a12 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjEtMy0xLTEtMA_93ce37c2-5e41-4572-ae76-22f89096d113 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDAtMy0xLTEtMA_a7d99179-ef04-42e8-812f-d02c653646e7 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTctMy0xLTEtMA_d4569728-416a-47a6-9953-462068b66f5c id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjktMy0xLTEtMA_8dd10fb0-60d3-4cd0-8e67-50c5e4edd50e id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjgtMy0xLTEtMA_c0b94042-c45c-4332-b7ce-89ffa7e675c5 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjAtMy0xLTEtMA_d97efac3-28eb-4ea2-9676-9133521a2c9b id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzMtMy0xLTEtMA_b7c1e801-3c04-4559-b6f4-b080c391953e id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTAtMy0xLTEtMA_07cb5ec8-79d1-418e-8f4d-63364b505854 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzYtMy0xLTEtMA_effeaa50-9e6e-4471-87b2-c397dfb10fde id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjYtMy0xLTEtMA_d9730304-e7ad-477a-a47f-77fb5f54d0a2 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzgtMy0xLTEtMA_e0767b25-f544-4f1a-ba74-87b6dadf7af4 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOS0zLTEtMS0w_f9e8d5fc-5f1a-4394-a3ba-3b83620cc224 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTMtMy0xLTEtMA_771b9f87-82e8-4711-9fb8-a744d7d9c306 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjItMy0xLTEtMA_8a61d91c-006a-4d3f-aafe-517efebf3aec id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTQtMy0xLTEtMA_fb23a37a-2ca0-4833-b6c8-b309f76b307c id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNS0zLTEtMS0w_c7f0cd2d-e5b7-4572-8091-5f90beb9e305 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjQtMy0xLTEtMA_294efc7c-77df-4766-84ab-0e37f25faaaf id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjctMy0xLTEtMA_fc64627f-a1a3-4c25-9756-78e60e35dfff id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjUtMy0xLTEtMA_8c1e456e-b4ff-4909-b9c0-d5ef37d91249 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMy0zLTEtMS0w_ac4a11bb-e4d7-486f-851d-d6c471a89fee id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzAtMy0xLTEtMA_895d489e-e29f-400b-a15e-e0bc1ac39f76 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNC0zLTEtMS0w_973cd248-37a9-408f-998f-7395871cea8e id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzctMy0xLTEtMA_e5e15142-ba25-4497-9ae7-ec708f2f9259 id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTUtMy0xLTEtMA_3964d77d-fea3-4afe-8421-55c3cc3cde1b" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d" order="1"></ix:relationship></ix:resources></ix:header></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMzA3_29b01eb4-299a-4b34-8d5c-0d93e4777e6c">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMzA0_fa564492-40b5-42d1-9a02-47aa05aa16bd">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE&#160;SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMTE_d7554414-7154-4ec8-ac53-27d772c738d5">September 30, 2021</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">OR</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMzAy_1f11b6fb-c383-4938-833c-39452020cf28">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE&#160;SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the transition period from     to</span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commission File Number: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMjk4_ef2ed3ad-a802-4afd-b080-0f9e8ee21384">001-33071</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMzAz_5ef1ee40-eeed-42cd-bb6b-6a94fd5f6e60">EHEALTH, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6Njc0OWE2ZTQyNjgzNGNmZjlmYjc3MDYxMDRjMTAxMDAvdGFibGVyYW5nZTo2NzQ5YTZlNDI2ODM0Y2ZmOWZiNzcwNjEwNGMxMDEwMF8wLTAtMS0xLTA_71864b57-7dea-4f51-a09c-3b7576962262">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6Njc0OWE2ZTQyNjgzNGNmZjlmYjc3MDYxMDRjMTAxMDAvdGFibGVyYW5nZTo2NzQ5YTZlNDI2ODM0Y2ZmOWZiNzcwNjEwNGMxMDEwMF8wLTItMS0xLTA_784d443e-e42a-4099-9e08-72b1c1930c4f">56-2357876</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(I.R.S Employer Identification No)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMjk5_2ff7a770-2237-48a5-8ae4-d140b8a63c99">2625 AUGUSTINE DRIVE, SECOND FLOOR</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMzA2_02b476e3-4d9f-459b-9ac9-d4410de61d22">SANTA CLARA</ix:nonNumeric>, <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMjk0_72cd8b9c-4250-4ad5-ab30-bb4c57095a52">CA</ix:nonNumeric> <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMjk1_673c95fe-628e-4a8b-8526-29a4aa7b6b27">95054</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMjk2_38a10899-62f2-4221-88fd-5ad46ced3560">650</ix:nonNumeric>) <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF82NTM_357c900c-1f54-4902-9ba6-a7bdbea091c2">584-2700</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.065%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6ZmExZWU0NTBmZTA2NDhlMjg1ZDkzZDNmNDAxNzI5MDQvdGFibGVyYW5nZTpmYTFlZTQ1MGZlMDY0OGUyODVkOTNkM2Y0MDE3MjkwNF8xLTAtMS0xLTA_5b1b176f-7e12-4ca5-8b76-70525e2bd837">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6ZmExZWU0NTBmZTA2NDhlMjg1ZDkzZDNmNDAxNzI5MDQvdGFibGVyYW5nZTpmYTFlZTQ1MGZlMDY0OGUyODVkOTNkM2Y0MDE3MjkwNF8xLTEtMS0xLTA_73fb98cf-6d1c-4c6b-9449-10e1586dad9c">EHTH</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6ZmExZWU0NTBmZTA2NDhlMjg1ZDkzZDNmNDAxNzI5MDQvdGFibGVyYW5nZTpmYTFlZTQ1MGZlMDY0OGUyODVkOTNkM2Y0MDE3MjkwNF8xLTItMS0xLTA_630c6594-3acd-422f-9f19-296ae86f6638">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMjk3_b8dfe5e9-615b-41a0-b058-daa13ed8e5e2">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulations S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMzAw_885cc04b-aada-4efe-b9b5-c9452fac549c">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221;&#160;&#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.359%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6MjA2MWJiNzFkMDFkNGUyMDg2YWI3MjgxNDVmMWYzODAvdGFibGVyYW5nZToyMDYxYmI3MWQwMWQ0ZTIwODZhYjcyODE0NWYxZjM4MF8wLTAtMS0xLTA_44aa684f-cfda-4a79-bf66-6a8698835820">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6MjA2MWJiNzFkMDFkNGUyMDg2YWI3MjgxNDVmMWYzODAvdGFibGVyYW5nZToyMDYxYmI3MWQwMWQ0ZTIwODZhYjcyODE0NWYxZjM4MF8xLTQtMS0xLTA_fec0075e-40c8-4150-9abb-41baf9872382">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6MjA2MWJiNzFkMDFkNGUyMDg2YWI3MjgxNDVmMWYzODAvdGFibGVyYW5nZToyMDYxYmI3MWQwMWQ0ZTIwODZhYjcyODE0NWYxZjM4MF8yLTQtMS0xLTA_9b9c6dc1-4574-48ed-ad98-2b05c823cc96">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMzAx_03f4ec84-4c9b-454b-9810-ae0fbabbfb45">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s common stock, par value $0.001 per share, outstanding as of November&#160;1, 2021 was&#160;<ix:nonFraction unitRef="shares" contextRef="icf7a643bd0844ee692d39d0f7d9dd31b_I20211101" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMjgy_6592956b-c272-45b3-96be-d023f6b1142c">26,388,112</ix:nonFraction> shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EHEALTH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PAGE</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Summary of Risk Factors</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_13">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_13">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_16">Condensed Consolidated Balance Sheets as of </a>September 30, 2021<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_16"> and </a>December 31, 2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_16">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_19">Condensed Consolidated Statements of Comprehensive </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_19">Loss</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_19"> for the </a>Three and Nine Months<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_19"> Ended </a>September 30, 2021<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_19"> and </a>2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_19">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_25">Condensed Consolidated Statements of Stockholders' Equity for the </a>Three and Nine Months<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_25"> Ended </a>September 30, 2021<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_28"> and </a>2020</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_25">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_28">Condensed Consolidated Statements of Cash Flows for the </a>Nine Months<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_28"> Ended </a>September 30, 2021<a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_28"> and </a>2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_28">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_31">8</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_79">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_79">28</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_109">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_109">53</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_112">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_112">54</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INFORMATION</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_118">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_118">55</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_121">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_121">55</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_124">Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_124">80</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_127">Signatures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ia6d7e8bb0f4f45f88f677d6cf06c1b8f_127">81</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_1199"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Risk Factors</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following is a summary of the principal risks we face, any of which could adversely affect our business, operating results, financial condition or prospects:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our ability to enroll individuals during enrollment periods is impeded or if investments we make in enrollment periods do not result in the returns we expected when making those investments, our business, operating results and financial condition would be harmed.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unsuccessful in competing effectively against current and future competitors, including government-run health insurance exchanges.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business may be harmed if we lose our relationship with health insurance carriers or our relationship with health insurance carriers is modified.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our financial results will be adversely impacted if our membership does not grow or if member retention does not improve and plan terminations do not decline.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are not able to maintain and enhance our brand, our business and operating results will be harmed.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The ongoing COVID-19 pandemic and public health crises, illness, epidemics or pandemics could adversely impact our business, operating results and financial condition.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business may be harmed if we are not successful in executing on our strategic investments and initiatives, including our growth strategy and retention initiatives.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The success of our customer care center operations depends upon our ability to timely hire, train, retain and ensure the productivity of our licensed health insurance agents.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are not successful in cost-effectively converting visitors to our website&#160;and customers who call into our call centers&#160;into members for whom we receive commissions, our business and operating results would be harmed.&#160;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We depend upon Internet search engines and social media platforms to attract a significant portion of the consumers who visit our website, and if we are unable to effectively advertise on search engines or social media platforms on a cost-effective basis, our business and operating results would be harmed.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely significantly on marketing partners and our business and operating results would be harmed if we are unable to maintain effective relationships with our existing marketing partners or if we do not establish successful relationships with new marketing partners.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our future operating results are likely to fluctuate and could fall short of expectations.&#160;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The marketing and sale of Medicare plans are subject to numerous, complex and frequently changing laws, regulations and guidelines, and non-compliance with or changes in laws, regulations and guidelines could harm our business, operating results and financial condition.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes and developments in the health insurance industry or system as a result of health care reform could harm our business, operating results and financial condition.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our success in selling health insurance is dependent in part on the actions of federal and state governments. Changes in the laws and regulations governing the offer, sale and purchase of health insurance could harm our business and operating results.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business is subject to security risks and, if we experience a successful cyberattack, a security breach or are otherwise unable to safeguard the confidentiality and integrity of the data we hold, including sensitive personal information, our business will be harmed.  Our business is also subject to emerging privacy laws being passed at the state level that create unique compliance challenges.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our operating results will be impacted by factors that impact our estimate of the constrained lifetime value, or LTV, of commissions per approved member.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating and growing our business may require additional capital, and if capital is not available to us, our business, operating results and financial condition may suffer.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I.&#160;&#160;&#160;&#160;FINANCIAL INFORMATION</span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_13"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL STATEMENTS</span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_16"></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, unaudited) </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2020 *</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMy0xLTEtMS0w_3109826f-773c-417c-acc6-33c3f80a8443">157,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMy0zLTEtMS0w_ac4a11bb-e4d7-486f-851d-d6c471a89fee">43,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNC0xLTEtMS0w_12cb0125-c0bd-4aa4-8343-c0a621b37d51">70,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNC0zLTEtMS0w_973cd248-37a9-408f-998f-7395871cea8e">49,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNS0xLTEtMS0w_afb70e4b-5c57-4083-9169-edec942225ca">1,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNS0zLTEtMS0w_c7f0cd2d-e5b7-4572-8091-5f90beb9e305">1,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract assets &#8211; commissions receivable &#8211; current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNi0xLTEtMS0w_c3ccab4a-412c-4f89-843d-db75b009d1ae">194,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNi0zLTEtMS0w_b0c470d1-5569-4b38-ba4c-549e9f2c8ba1">219,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNy0xLTEtMS0w_9a012dde-dc74-46a5-824a-74f35ad437c5">36,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNy0zLTEtMS0w_06f2a0e0-4c0f-4c3a-bd07-1da910ffb435">16,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOC0xLTEtMS0w_c6c695cb-07cb-479d-bd54-579786acd07a">459,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOC0zLTEtMS0w_a4ef4595-7fda-42b2-a40a-60640a12be13">330,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract assets &#8211; commissions receivable &#8211; non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNetNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOS0xLTEtMS0w_d3392f06-25ed-4e55-b582-1f7ae6e0ca72">563,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNetNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOS0zLTEtMS0w_f9e8d5fc-5f1a-4394-a3ba-3b83620cc224">573,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTAtMS0xLTEtMA_6f97af61-8882-4695-98b6-7f02d0765d05">13,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTAtMy0xLTEtMA_07cb5ec8-79d1-418e-8f4d-63364b505854">14,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTItMS0xLTEtMA_92035fae-d71a-411e-8d30-a3a8cb9ca30f">38,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTItMy0xLTEtMA_adf0cfc9-05b4-4267-8b84-5052befdd4dd">42,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTMtMS0xLTEtMA_a3d23428-fd9a-4dce-93c8-9e526b66ea5e">3,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTMtMy0xLTEtMA_771b9f87-82e8-4711-9fb8-a744d7d9c306">3,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTQtMS0xLTEtMA_3e65f51f-84d8-4f66-a33c-a0aa391eeb8f">8,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTQtMy0xLTEtMA_fb23a37a-2ca0-4833-b6c8-b309f76b307c">8,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTUtMS0xLTEtMA_aa0e0069-8b04-4983-9014-26103445f3d7">40,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTUtMy0xLTEtMA_3964d77d-fea3-4afe-8421-55c3cc3cde1b">40,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTYtMS0xLTEtMA_619656c4-f743-4aba-9e05-42f5e58f5864">32,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTYtMy0xLTEtMA_badf2027-c006-488e-a6d5-6961ba416881">26,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTctMS0xLTEtMA_d2df6bc6-66eb-4185-b9c8-20a08a2c5f69">1,159,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTctMy0xLTEtMA_d4569728-416a-47a6-9953-462068b66f5c">1,040,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities, convertible preferred stock,  and stockholders&#8217; equity</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjAtMS0xLTEtMA_5a98efc5-1437-4bc7-b7a6-a160fb68c45d">10,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjAtMy0xLTEtMA_d97efac3-28eb-4ea2-9676-9133521a2c9b">36,921</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjEtMS0xLTEtMA_a4ebc50e-fb26-4ae7-a79c-fa2a1574755c">20,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjEtMy0xLTEtMA_93ce37c2-5e41-4572-ae76-22f89096d113">20,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:AccruedMarketingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjItMS0xLTEtMA_5e81b6e6-7ab5-4e95-8dd4-0fa0365d69f8">11,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="ehth:AccruedMarketingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjItMy0xLTEtMA_8a61d91c-006a-4d3f-aafe-517efebf3aec">17,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liabilities &#8211; current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjQtMS0xLTEtMA_fa0b57da-c1eb-4a6e-a34f-acf227c62f25">5,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjQtMy0xLTEtMA_294efc7c-77df-4766-84ab-0e37f25faaaf">5,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjUtMS0xLTEtMA_225c40cc-9686-4279-bcd2-557d50733961">10,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjUtMy0xLTEtMA_8c1e456e-b4ff-4909-b9c0-d5ef37d91249">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjYtMS0xLTEtMA_0dfc378c-846b-4248-80fa-6ecd0006ad6f">4,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjYtMy0xLTEtMA_d9730304-e7ad-477a-a47f-77fb5f54d0a2">3,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjctMS0xLTEtMA_f2a6f78b-b922-47e3-a8e3-81afed6da6dc">62,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjctMy0xLTEtMA_fc64627f-a1a3-4c25-9756-78e60e35dfff">84,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes &#8211; non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjgtMS0xLTEtMA_e5c9150e-a8c2-4b53-82c8-abd2d36116cb">52,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjgtMy0xLTEtMA_c0b94042-c45c-4332-b7ce-89ffa7e675c5">72,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lease liabilities &#8211; non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjktMS0xLTEtMA_ce2a3e68-cfbb-41c5-b245-fa8327ea2d49">37,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjktMy0xLTEtMA_8dd10fb0-60d3-4cd0-8e67-50c5e4edd50e">41,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzAtMS0xLTEtMA_37ce7a80-88a1-4768-8064-6644e361e4e4">4,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzAtMy0xLTEtMA_895d489e-e29f-400b-a15e-e0bc1ac39f76">4,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzEtMS0xLTEtMA_21901118-736e-46e2-97f3-59a93173e8b4">156,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzEtMy0xLTEtMA_f2c82846-1978-4782-ab46-14ced2a76dcd">202,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzItMS0xLTEtMA_27de52b2-d690-4e3c-8794-6ee46e0b04be"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzItMy0xLTEtMA_da23f0db-05c5-4d01-a973-6d1630dbc55b"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzMtMS0xLTEtMA_93d60651-88d3-43c0-8ccc-ba722c009b70">225,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzMtMy0xLTEtMA_b7c1e801-3c04-4559-b6f4-b080c391953e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzUtMS0xLTEtMA_67f4ff3a-faee-43a3-8ad8-6e1a21bc39ea">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzUtMy0xLTEtMA_c1ed0323-1ba4-463e-8f80-6a886a540a12">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzYtMS0xLTEtMA_aa65a59b-82ae-424b-b8ab-368ad9a6c421">744,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzYtMy0xLTEtMA_effeaa50-9e6e-4471-87b2-c397dfb10fde">721,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock, at cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzctMS0xLTEtMA_2acbfa4e-50cb-4391-af59-6040c0cc07c9">199,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzctMy0xLTEtMA_e5e15142-ba25-4497-9ae7-ec708f2f9259">199,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzgtMS0xLTEtMA_bb44507d-572a-498d-a121-938031966d00">232,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzgtMy0xLTEtMA_e0767b25-f544-4f1a-ba74-87b6dadf7af4">316,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzktMS0xLTEtMA_5efb177b-e65e-4d0e-b9c1-8fe4cf5d33e4">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzktMy0xLTEtMA_23659aac-e96b-4ca6-9b5a-3e0277e23a69">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDAtMS0xLTEtMA_3adfcfc7-13b4-4669-9407-67c67238defc">777,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDAtMy0xLTEtMA_a7d99179-ef04-42e8-812f-d02c653646e7">837,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities, convertible preferred stock, and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDEtMS0xLTEtMA_baf273b0-d469-449d-b433-55e8e967a1da">1,159,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDEtMy0xLTEtMA_518524af-b08d-469d-a46b-ad21ff86b3e8">1,040,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">_______</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">*<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d" footnoteRole="http://www.xbrl.org/2003/role/footnote">See Note 1 &#8211; Summary of Business and Significant Accounting Policies</ix:footnote></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></div><div style="margin-bottom:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts, unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commission</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0273079a37b24f93bde9cf3de6f118a8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMy0xLTEtMS0w_09a6b808-0534-43b5-ab8c-f8f98444b327">59,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b864a8e10634cc386d2e4b1b66f73c9_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMy0zLTEtMS0w_173b81ec-2060-4dd8-b239-bc36a8c08056">73,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb2628c9d51a46139995f5f56f04eb1b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMy01LTEtMS0w_d0707883-6241-4d16-8411-98f15101f52c">276,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5334a64f425448d4aa5dd0966023fad5_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMy03LTEtMS0w_3e361a9b-2139-47d0-9d68-28b07048e0ee">253,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc76aa4ecb8a42b3bb83ea9ae9209b0f_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNC0xLTEtMS0w_3d929bb9-a91e-4942-8530-0ab79f341237">4,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f614f83f3b14aceb5dddc72972dc625_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNC0zLTEtMS0w_8f038a66-38ea-4a74-827b-6ce2f569de7e">20,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c18bac640fb4358b74a9021f64f8f09_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNC01LTEtMS0w_e16d5e99-aa74-40fb-81a1-773acc0a212e">18,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i079a9bbf2d8444019d86c147c114b59f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNC03LTEtMS0w_aab9f496-0fd6-4b01-93c1-5a4987f95a2d">35,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNS0xLTEtMS0w_2c95bea2-929d-4d21-b203-05205ec2e9a9">63,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNS0zLTEtMS0w_88404364-a2f2-4e89-82cf-cca2a20eb08a">94,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNS01LTEtMS0w_2bf53919-0625-4918-af77-e8bf66a8cbe9">294,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNS03LTEtMS0w_3b684586-57ea-4642-8e39-5a3148db2210">289,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNy0xLTEtMS0w_da12d8d9-e232-4bf0-8761-7836f0e4e7c6">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNy0zLTEtMS0w_39e07cd7-3ee5-4f44-bac7-460d33621268">482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNy01LTEtMS0w_7fc000b3-cbf3-48fe-a7c7-59ac30f2e6dd">1,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNy03LTEtMS0w_5cec756f-f21a-417b-9a28-678a5ff87b34">2,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketing and advertising</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOC0xLTEtMS0w_22edba6b-9b7a-4d91-bbe3-f4bb3820a916">43,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOC0zLTEtMS0w_7ac08d89-1139-47c4-b775-58d2ac9e458c">33,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOC01LTEtMS0w_c79fef99-b6f3-4263-943d-1ef3e094b059">138,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOC03LTEtMS0w_2df02ff2-6717-4b61-9595-2ea8ce44eef4">104,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer care and enrollment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:CustomerCareAndEnrollmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOS0xLTEtMS0w_35b83c25-bbc2-4be4-861a-6f64d30ee57f">48,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:CustomerCareAndEnrollmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOS0zLTEtMS0w_50b64929-d202-4509-994d-31f4cd459c71">43,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:CustomerCareAndEnrollmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOS01LTEtMS0w_c2781a69-c8f2-4699-91eb-b26837dc9e71">121,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:CustomerCareAndEnrollmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOS03LTEtMS0w_e8f7df14-4e18-426e-bd7f-e1c088147764">101,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology and content</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:TechnologyAndContentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTAtMS0xLTEtMA_92661424-d8c7-4aa4-9490-191ce2a0c2db">20,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:TechnologyAndContentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTAtMy0xLTEtMA_f1655439-9430-4fe6-bc20-ee623e9aab5d">17,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:TechnologyAndContentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTAtNS0xLTEtMA_1dbbfcfb-328d-44af-9528-3636421b6fce">63,996</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:TechnologyAndContentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTAtNy0xLTEtMA_a0ae7666-612c-483a-937f-0c5289dad7f6">46,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTEtMS0xLTEtMA_cab6a7bb-96f5-4251-8f0b-da7ce732691d">16,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTEtMy0xLTEtMA_5539d169-c8d7-4348-8932-708fd2887d91">19,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTEtNS0xLTEtMA_0bb1c6c3-e691-4d85-99aa-23e41e122b82">57,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTEtNy0xLTEtMA_5a414351-6fee-4292-9665-e7cf17fd1c1e">60,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTItMS0xLTEtMA_715f15c6-0a9c-4f75-bb98-c1ccad7b2e84">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTItMy0xLTEtMA_91e75712-1599-4b2f-adde-016a62c1033f">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTItNS0xLTEtMA_77653940-5e17-41b3-b87d-0bd758a71bb8">416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTItNy0xLTEtMA_250b1325-346d-42b3-82d2-f79c8cc73f24">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring and reorganization charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTQtMS0xLTEtMA_e16ce87e-6afc-43e0-9d75-49fc863f1df5">573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTQtMy0xLTEtMA_705a5505-f2f7-48ea-9b00-ca401662234c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTQtNS0xLTEtMA_b8815212-c584-4f12-8798-7bba12dc9a26">3,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTQtNy0xLTEtMA_f6757721-4a96-4822-ba17-f97a0e63b39e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTYtMS0xLTEtMA_5eb5ffdb-41b8-43c8-9629-18afd75c7a10">129,951</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTYtMy0xLTEtMA_38a73804-aaa4-40dd-84bb-2f81c475998e">115,131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTYtNS0xLTEtMA_f130bde8-9718-4f89-8701-00df98f2bde0">386,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTYtNy0xLTEtMA_1c40b59e-7473-49b9-bff4-e0da32cacb51">315,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTctMS0xLTEtMA_b3d5517e-ccb3-4c25-8c12-683dd2feeb65">66,037</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTctMy0xLTEtMA_a5e2cdfa-94e8-4358-b683-9e0382e45bfd">20,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTctNS0xLTEtMA_f250d806-605b-40f8-baf7-c3207661013f">92,012</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTctNy0xLTEtMA_5fb8fec5-06e4-451d-b353-16b03f582d7b">26,070</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTgtMS0xLTEtMA_5c9ec167-8b8b-4e7e-8b74-332cdeb55665">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTgtMy0xLTEtMA_6235bd63-8661-4471-aefc-6f46d833bf13">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTgtNS0xLTEtMA_0c831089-d314-4df6-8a12-b0293f93bb21">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTgtNy0xLTEtMA_10a7caaa-62d7-446b-8810-341fb37ac10d">724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss before benefit from income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTktMS0xLTEtMA_b03dde15-b925-481f-93e9-ec81cdeb0bd9">65,848</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTktMy0xLTEtMA_a4b70b88-3677-4046-94c3-b2afef607529">20,948</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTktNS0xLTEtMA_ca8ef228-0713-4b42-8725-2c1848a82e2c">91,501</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTktNy0xLTEtMA_96827cb4-c1de-40c6-b76f-a9325d30a529">25,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjAtMS0xLTEtMA_67561739-f919-44d2-8204-f71c3524f98e">12,834</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjAtMy0xLTEtMA_cbfb2cce-08e4-4da6-aa56-733b2eace4f5">6,443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjAtNS0xLTEtMA_f793fe67-d2c5-46b1-990b-b49f170e3681">19,278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjAtNy0xLTEtMA_3e85c0ed-3773-452a-8677-075751ad36a9">10,923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjEtMS0xLTEtMA_fefcf39e-ecf6-42f9-bd5e-b9b896b6eb2a">53,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjEtMy0xLTEtMA_0c55ceda-8458-4b10-8c0b-36b0bc3cedb3">14,505</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjEtNS0xLTEtMA_6d976586-e8f5-4c2e-8e9f-25e938fff4d8">72,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjEtNy0xLTEtMA_e48c06c5-3022-4035-9937-40860a9fc1a5">14,423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Paid-in-kind dividends for preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityDividendsAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjMtMS0xLTEtMA_9d0a0e5a-6590-4fd0-9d6d-88b692d0cb3a">4,561</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityDividendsAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjMtMy0xLTEtMA_4234da59-7e19-4423-bc88-2393286cdb8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityDividendsAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjMtNS0xLTEtMA_a3f4c5d8-0f65-4275-bde5-76a9f8d7645f">7,643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityDividendsAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjMtNy0xLTEtMA_3f317fda-9f45-404d-b907-e796a8cb4f01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in preferred stock redemption value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjQtMS0xLTEtMA_13627e4d-98e8-421e-9f46-2901359a96dc">2,373</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjQtMy0xLTEtMA_59e7bf88-98a7-48cd-a556-42459a9f71ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjQtNS0xLTEtMA_6ef6b9a8-58e1-410d-baf5-508b70b3906d">3,770</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjQtNy0xLTEtMA_fd10eaed-5db3-44a5-985f-e51696f08eb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjYtMS0xLTEtMA_0fb08296-acda-43ba-9f0a-24e55c827cb0">59,948</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjYtMy0xLTEtMA_a9a3366a-8fef-4f9c-a894-6507d60ec014">14,505</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjYtNS0xLTEtMA_87f52b20-d730-449f-97bb-c860bfcc899f">83,636</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjYtNy0xLTEtMA_6f645f09-f53c-4639-b38a-af7ea956c6ae">14,423</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net loss per share attributable to common stockholders:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjktMS0xLTEtMA_651e1436-f62f-4241-9302-ca76de3e77e2">2.24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjktMy0xLTEtMA_15053ff6-5d62-4223-bb81-87c2a1319264">0.55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjktNS0xLTEtMA_e78c9129-e444-41d5-a15f-8e57b30e1523">3.13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjktNy0xLTEtMA_b64b6945-fb83-4694-8b84-c77d502e98b5">0.56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzAtMS0xLTEtMA_07a2c3a0-0635-4eb4-a5b2-70cfa04f3142">2.24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzAtMy0xLTEtMA_fa08ca0c-95a8-4d0d-a29d-36e740529d9d">0.55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzAtNS0xLTEtMA_ad35b797-fffa-4141-abe4-58fc00eef9ad">3.13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzAtNy0xLTEtMA_cec049fe-0d71-402e-95de-e50fd04ef223">0.56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-average number of shares used in per share amounts:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItMS0xLTEtMA_4185176e-9475-48ed-a43c-2680052cab85"><ix:nonFraction unitRef="shares" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItMS0xLTEtMA_4c2ec322-9466-4ac3-94f2-cde4951f3f3c">26,786</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItMy0xLTEtMA_bcd6144a-62c1-47a2-951a-3ad4dd5e2c54"><ix:nonFraction unitRef="shares" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItMy0xLTEtMA_fbea499e-36f1-4c03-a1c1-3e846734b2d1">26,487</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItNS0xLTEtMA_3d7f67e6-6fd3-4cb1-9750-e64941e26489"><ix:nonFraction unitRef="shares" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItNS0xLTEtMA_e36bd231-6e84-46f7-a91c-0f0937cc0aee">26,688</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItNy0xLTEtMA_68b68290-411e-489f-9fb5-ebb9492ab146"><ix:nonFraction unitRef="shares" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItNy0xLTEtMA_f61202bc-d07e-4c76-bb9e-6eb76deb7a02">25,838</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive loss:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzUtMS0xLTEtMA_7e366031-452c-49af-8c55-4e4d2909e97f">53,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzUtMy0xLTEtMA_b3c3395a-0201-436a-be21-9107c401abb3">14,505</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzUtNS0xLTEtMA_dbe4c1f4-7d42-4bbd-9c0d-10959efc3c49">72,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzUtNy0xLTEtMA_dc60aac0-8aab-44af-bf25-76d26d87f7a2">14,423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized holding gain (loss) for available for sales debt securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzYtMS0xLTEtMA_1fc150f5-87e8-4066-8999-13b609f7d327">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzYtMy0xLTEtMA_539c4009-d20c-4e1b-b87e-fe600b926a4c">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzYtNS0xLTEtMA_6a323464-93ba-4897-88f7-bbf141ff7fd1">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzYtNy0xLTEtMA_87491eff-a484-4607-816d-bc005b955625">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzctMS0xLTEtMA_a519fc64-5b3c-4eef-b50b-9f9410cdf21f">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzctMy0xLTEtMA_b5fa596d-fe35-4661-b6e4-400b6bdde9fe">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzctNS0xLTEtMA_c6e7fa75-e035-418a-b2b2-69ea6002aa79">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzctNy0xLTEtMA_878dbd1e-fc90-4b2d-bd13-9dc17dea10ed">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzgtMS0xLTEtMA_46cbd76c-9454-4206-8617-55e37df25fdc">53,037</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzgtMy0xLTEtMA_c946ac4f-b875-47fa-aa0c-58d6d11e5227">14,498</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzgtNS0xLTEtMA_4302e1fd-84cc-4687-bdd3-4473d6416b58">72,255</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzgtNy0xLTEtMA_5fa8cf31-02e1-4183-bf26-71dba41d06f7">14,279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.891%"><tr><td style="width:1.0%"></td><td style="width:33.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e357e366d8f4c42ad7a50b0355c2477_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy0xLTEtMS0w_867b7dd8-5ec7-424b-a7dc-7cb83000d9be">38,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e357e366d8f4c42ad7a50b0355c2477_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy0zLTEtMS0w_35f00569-ed28-42a9-88ea-fb89d340778d">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c4eb4348de4a19a5f72c79a61f308d_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy01LTEtMS0w_0e3d6d61-3cff-4e46-88fd-981e7d887f89">738,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f613da7232e4dffaa5665383fbfb47b_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy03LTEtMS0w_7256aa9a-5452-4cc8-b4b5-27f59a08d70f">11,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f613da7232e4dffaa5665383fbfb47b_I20210630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy05LTEtMS0w_3b01419c-f149-4240-ae61-3dbae52d34b1">199,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f721d7c0f874c25b09289e676fdcbac_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy0xMS0xLTEtMA_421e57fd-9eff-41b8-93a9-81a9606dd919">292,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61a6496ebf1f45f38f971210c3817264_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy0xMy0xLTEtMA_2e344695-a9a6-4073-a985-cc583fde6669">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4897b9072b44635b238daed55d2a37a_I20210630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy0xNS0xLTEtMA_1e981603-13ef-4a64-b98e-67c028722ab2">831,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in connection with equity incentive plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i370978c8564c4fcdadb9f1ea0c93f92a_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNC0xLTEtMS0w_852aa0f8-5d85-492b-86ff-2bdc1f5a1861">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877f626f60a8448690bb833acb808b17_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNC01LTEtMS0w_2453fbdd-9d96-44fe-a0f7-522a097ae2db">1,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNC0xNS0xLTEtMA_f611645e-d21a-4e8c-9306-4f9ef33b1add">1,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of shares to satisfy employee tax withholding obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i877f626f60a8448690bb833acb808b17_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNS01LTEtMS0w_9cf733cb-54e7-4807-88b4-3a48716cd914">2,061</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebbf9ee7e6494e258504f10868840783_D20210701-20210930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNS03LTEtMS0w_dd53c07c-b84e-46d3-8ba3-7a5b562ca0c1">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNS0xNS0xLTEtMA_290c266f-41c6-46b2-ae03-704f5007f6e5">2,061</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Paid-in-kind dividend and accretion related to convertible preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb1fedd8d124030a82eedac5b7a9e86_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNi0xMS0xLTEtMA_c76d26cc-57e0-4015-b4c0-32403b85c579">6,934</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNi0xNS0xLTEtMA_e66075ce-2427-4ed9-817e-e52ff7b0acb9">6,934</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877f626f60a8448690bb833acb808b17_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfOC01LTEtMS0w_5246cef3-ff17-48ad-93d2-80eebca10100">6,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfOC0xNS0xLTEtMA_74293d5b-633e-4919-adb0-e074592e14fb">6,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a48fdb953934f5bb836534b0414bbb6_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfOS0xMy0xLTEtMA_0af7871c-4658-4180-8c59-689b0c75728f">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfOS0xNS0xLTEtMA_92ed64ee-4d94-4955-ae47-3804a6164769">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb1fedd8d124030a82eedac5b7a9e86_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTAtMTEtMS0xLTA_3c82c022-02cf-4334-a418-dc0ae525add6">53,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTAtMTUtMS0xLTA_b7e38522-1afc-4bb1-94d2-dc20a0436969">53,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of September 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22fd73312a7c407e9083c80dffa106ff_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtMS0xLTEtMA_7b8e8835-c157-4c4a-8b2f-80ff031ad2b9">38,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22fd73312a7c407e9083c80dffa106ff_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtMy0xLTEtMA_121051fd-85aa-489c-8214-4b7becdcc6ec">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic86196f7d0f9445781c8ca4767d942db_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtNS0xLTEtMA_dea35dd8-7a28-427a-9ab9-631d7353673f">744,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i531b3484676346ac94040d2dc4065a31_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtNy0xLTEtMA_3d9a168a-ef84-467d-84e4-90d5689d695e">11,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i531b3484676346ac94040d2dc4065a31_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtOS0xLTEtMA_d900bc42-7e95-45b3-b39c-aad0fe33d137">199,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibabacd5b0f804aabada2cd5365f24498_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtMTEtMS0xLTA_9ed6a9c1-4f5c-466a-ae7d-86e62ca2e998">232,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e718004b6a4f5aa57db218524b5773_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtMTMtMS0xLTA_1538459a-0f97-4392-80fd-c6c4f9cb864d">318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtMTUtMS0xLTA_c2213e41-95a0-4783-9d65-cea575030ba0">777,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.891%"><tr><td style="width:1.0%"></td><td style="width:33.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2020</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifefede64050246d08daebbf50765bb4f_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy0xLTEtMS0w_d20d0ca6-5334-4043-9730-e8fec131e5d3">37,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifefede64050246d08daebbf50765bb4f_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy0zLTEtMS0w_b8096761-d045-4bc1-9f9f-f9392edcbf70">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d5eb3c604944f028aede8e47b8499b7_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy01LTEtMS0w_9a0f7dbf-eaa3-4109-b512-a344f9ec2dc0">720,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia86272a5d3aa4258b2f07ea45b88ff59_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy03LTEtMS0w_e1ea8ce4-c895-42b6-b828-77ba35c6fdd8">11,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia86272a5d3aa4258b2f07ea45b88ff59_I20200630" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy05LTEtMS0w_8b4ff494-e030-46ad-9fd6-aa4919f7c9ba">199,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i391fe734bef14823a887a006994653ec_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy0xMS0xLTEtMA_e0c1c01f-b267-49e3-85d2-1be616f4f255">270,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bd8ce3993854b8e97b6b76978a4d09c_I20200630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy0xMy0xLTEtMA_180bbff3-7b17-4cf0-b903-fb1073d22019">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7fbdf6185ab4c1da95b8b7ef4dd0e03_I20200630" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy0xNS0xLTEtMA_b96ea82f-f118-4d6a-893e-6b0ffbc85d6d">792,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in connection with equity incentive plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98ccd6154a98467786e1d4ef694bc1b1_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfNS0xLTEtMS0w_96b28bba-5efa-470d-8143-225e42755b5e">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98ccd6154a98467786e1d4ef694bc1b1_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfNS0zLTEtMS0w_e60d706c-9856-4dec-9f7d-0eae7696dd6c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dde38ab27e34c2389470563ce4f40dd_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfNS01LTEtMS0w_bd2c1ace-aa72-449d-8265-3ef0503df868">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfNS0xNS0xLTEtMA_ec8175bb-39d5-4c24-8395-e514ecc6a54c">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of shares to satisfy employee tax withholding obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dde38ab27e34c2389470563ce4f40dd_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfNi01LTEtMS0w_6cc4b426-680a-4115-b85f-3f83d4c7a019">9,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7ebb4122db248399d55925e46f33a97_D20200701-20200930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfNi03LTEtMS0w_e562a2ba-fd1a-4cbb-b522-da4a3a84b042">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfNi0xNS0xLTEtMA_4cd07b27-60d5-4ae2-b030-6086293c8861">9,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dde38ab27e34c2389470563ce4f40dd_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfOS01LTEtMS0w_e56a7a58-6601-4bb0-a7c9-7558fdde2182">6,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfOS0xNS0xLTEtMA_85116cad-46ac-407e-ad8f-9d4c8396a20e">6,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150bf8ca70274905a045d294be04c55f_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTAtMTMtMS0xLTA_d9003b4c-22a3-467d-9a7e-41fe981eb926">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTAtMTUtMS0xLTA_ef72d8f9-6dbb-46b2-b918-8326aeaca74a">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40d62c8d4357468a811e6df8b3eb306f_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTEtMTEtMS0xLTA_21637352-1f1b-4431-a1d9-7726e3a12085">14,505</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTEtMTUtMS0xLTA_a3d92c80-66b0-4446-acbd-f3980ece0d9f">14,505</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c86001988504201bc82e067924ed6cf_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItMS0xLTEtMA_008c3426-7b46-4a81-bdf1-484e929d7d11">37,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c86001988504201bc82e067924ed6cf_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItMy0xLTEtMA_0ea8d81b-7aef-4d3b-8abd-184934c19006">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9def4cfc83f54b30addf32c96889fca4_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItNS0xLTEtMA_d3f9d0eb-4b08-40b8-bca9-78d46f4d3691">719,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i90037718d9204b0384103fade0d6cc45_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItNy0xLTEtMA_32efafa9-3422-431d-9ad9-89e045f91277">11,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90037718d9204b0384103fade0d6cc45_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItOS0xLTEtMA_0881f458-ee11-47af-8de9-d1ce3a29bef1">199,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8de5a03a387f4e069c2641fc24a40166_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItMTEtMS0xLTA_9eac98a8-a2f0-4a8b-8877-a3c9cce3acf5">256,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66989f5e965f4615937f019de6f617c4_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItMTMtMS0xLTA_14acb93f-c72e-461a-ad24-3927e39c1d68">260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3afb9956061e4743b8afadadf5214bfe_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItMTUtMS0xLTA_1cd99fe0-3461-4331-bb5b-5893a7966bab">775,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.891%"><tr><td style="width:1.0%"></td><td style="width:33.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ccdcb106e384ddeb87a904ee03a58ec_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy0xLTEtMS0w_558f9251-33c9-4980-988d-ff4505784ac6">37,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ccdcb106e384ddeb87a904ee03a58ec_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy0zLTEtMS0w_210c6858-450e-435e-854e-c66df533e94f">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i556e4d2503564d02a306ef205e40b6e7_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy01LTEtMS0w_45f39890-6988-4abe-a3d3-eac63232f65c">721,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie21f15744a034c72bc7d41e0bf1b76f6_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy03LTEtMS0w_91970227-b5fa-4238-9681-b5de3b480d2f">11,831</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie21f15744a034c72bc7d41e0bf1b76f6_I20201231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy05LTEtMS0w_53443c32-8cc6-412c-93ff-4320d76047b7">199,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2012813b7e7f4d55b5f995c8c974f514_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy0xMS0xLTEtMA_913ac367-4242-490c-abf5-7619a238107a">316,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da432b99fc042a88112d75776ee1823_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy0xMy0xLTEtMA_46efca2b-459c-40b6-945f-9f54d1038717">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy0xNS0xLTEtMA_610a4dd5-910d-4e86-9939-b224eae7ec96">837,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in connection with equity incentive plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ae5a20475f543a7a5f9fde45d7bc4b1_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNC0xLTEtMS0w_3c52b3eb-8ea9-40c3-b559-35eecacac89c">532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf2c5122ad64d28a8d34ec6b3182521_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNC01LTEtMS0w_a7611e03-c89f-426d-99ef-586f86947cc7">2,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNC0xNS0xLTEtMA_e5701fbf-19b3-4be9-b2d4-a733c44c25cd">2,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of shares to satisfy employee tax withholding obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadf2c5122ad64d28a8d34ec6b3182521_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNS01LTEtMS0w_b9501279-2926-4d99-9d5e-fbde15699cd3">7,968</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2df0c24aa97b454985d49591cb833558_D20210101-20210930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNS03LTEtMS0w_f4f2acba-5779-490d-8a5d-9ea3dfbc2fb2">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNS0xNS0xLTEtMA_6ea41d1a-a4c8-4252-a467-4b6d3a05ba2b">7,968</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Paid-in-kind dividend and accretion related to convertible preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i280b8878146141b5a2280971a470a37e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNi0xMS0xLTEtMA_938e20fe-87f0-42b1-a616-d9fc0a43c548">11,413</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNi0xNS0xLTEtMA_3f5c5887-1aaf-4740-b095-24c1cdafc49d">11,413</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock for employee stock purchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1ae5a20475f543a7a5f9fde45d7bc4b1_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNy0xLTEtMS0w_a4f24de9-c46e-4c85-90b7-b0279d38cdd6">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf2c5122ad64d28a8d34ec6b3182521_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNy01LTEtMS0w_12f75d12-b691-4ae2-8168-378edca6c3f4">2,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNy0xNS0xLTEtMA_cdcfcc27-4988-4a6d-9429-c25323fc0d49">2,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf2c5122ad64d28a8d34ec6b3182521_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfOC01LTEtMS0w_2efbd46b-8db7-4929-b581-f63d67890888">26,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfOC0xNS0xLTEtMA_dd8c3793-c6c7-403f-9600-e7c4f4dc2e9c">26,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib088409742214844b1196f2379e1f6ab_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfOS0xMy0xLTEtMA_6e56cc44-297e-40af-bd26-72840d37a8f3">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfOS0xNS0xLTEtMA_880ff9f5-8048-4dbe-80dd-aae5cc08b87b">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i280b8878146141b5a2280971a470a37e_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTAtMTEtMS0xLTA_69fbcc3d-ca0b-475d-96a4-55812ab95be9">72,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTAtMTUtMS0xLTA_dffb040e-c977-4318-aba7-9c64245c4ce7">72,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22fd73312a7c407e9083c80dffa106ff_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtMS0xLTEtMA_cbaa68cc-9242-4fef-a98b-cfd2a42ff4ae">38,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22fd73312a7c407e9083c80dffa106ff_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtMy0xLTEtMA_b874a4e4-79b6-4305-a7c7-167a79fa459e">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic86196f7d0f9445781c8ca4767d942db_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtNS0xLTEtMA_9211b4bf-da03-4502-be21-9c19a0d1ea75">744,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i531b3484676346ac94040d2dc4065a31_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtNy0xLTEtMA_7619b431-50c5-45c7-be51-4f841911e5d9">11,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i531b3484676346ac94040d2dc4065a31_I20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtOS0xLTEtMA_0e1757a1-1d27-42b8-84d5-7edd8c4a0501">199,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibabacd5b0f804aabada2cd5365f24498_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtMTEtMS0xLTA_19ba269b-19eb-4023-a56c-a78d59ba8495">232,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e718004b6a4f5aa57db218524b5773_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtMTMtMS0xLTA_a6b5132e-a41e-4830-b88e-1cf5b1abc060">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtMTUtMS0xLTA_82ceae9a-5be4-4392-a0c9-f5add16ffc81">777,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.783%"><tr><td style="width:1.0%"></td><td style="width:33.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.383%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia776a591bb4d4eabab7db24eecef27c1_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy0xLTEtMS0w_082e83e0-5178-4bb6-a9e2-fef5a7be2b3d">34,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia776a591bb4d4eabab7db24eecef27c1_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy0zLTEtMS0w_d30254df-b0ef-4525-a452-02d7b6f03c1e">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94afe3fa9f0f4d32bdfb8049be90c448_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy01LTEtMS0w_7631307b-4c19-46e5-af69-014803756e9b">455,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3eb5bda82ad94139a7613a0c425e11c0_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy03LTEtMS0w_06630ed8-3615-4f9e-b893-fbee01a3d208">11,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3eb5bda82ad94139a7613a0c425e11c0_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy05LTEtMS0w_4f79b1d3-5f5a-4cd7-baa7-a1723679745c">199,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda03bb57f0b4466a93ac7974d90a217_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy0xMS0xLTEtMA_883e1d0f-dfd1-4bf3-8271-0292e6e384c6">271,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df02cc0922640229ea054a72d8338e3_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy0xMy0xLTEtMA_7f114412-d523-4346-b625-cdc9cafb7d3d">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i023ad41593504141a87219e927134521_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy0xNS0xLTEtMA_11be6491-cba4-42ca-9c61-4f90239e954b">527,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNC0wLTEtMS0w_60f9a9ee-3a38-457d-b1c8-5c6bce90da25">Cumulative effect from the adoption of ASU 2016-13</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib87b2fd6b0e94d1194ca2219f67dbe72_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNC0xMS0xLTEtMA_cec07249-88fc-4ac3-8479-51a229687570">1,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i952e9678a9584f75a5d6851f6e9eeb1b_I20191231" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNC0xNS0xLTEtMA_a7e9d216-0289-4211-ae06-c22ab63fb67d">1,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock in connection with equity incentive plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d26bc89cf9d42679d5552c59c55cdbf_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNS0xLTEtMS0w_f8c4ed9d-c867-49f9-8955-ec5b5afacb02">531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d26bc89cf9d42679d5552c59c55cdbf_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNS0zLTEtMS0w_ee8c5916-160c-409d-ba1f-77aaef8037ed">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd8aecbec0954165b87a5ec97df1d4e2_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNS01LTEtMS0w_185b1b1e-b5b8-4b3a-ab51-88ea2f2e9a2d">1,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNS0xNS0xLTEtMA_4575ace6-02ea-431c-addc-cd51f5d24fee">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of shares to satisfy employee tax withholding obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd8aecbec0954165b87a5ec97df1d4e2_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNi01LTEtMS0w_eb936155-6c12-4462-be57-8406e68c9940">17,174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i83756e9e70664bbb9d9ce121c6030638_D20200101-20200930" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNi03LTEtMS0w_9c32f7e3-3a23-455a-a184-5f081a401b73">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNi0xNS0xLTEtMA_7e9092ad-0d1a-465e-8891-9015aba0f3a8">17,174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares issued in equity offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d26bc89cf9d42679d5552c59c55cdbf_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNy0xLTEtMS0w_0a731dad-ab1b-45fd-be50-ca8b4ab26101">2,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d26bc89cf9d42679d5552c59c55cdbf_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNy0zLTEtMS0w_ed3b424e-f550-4de7-96fd-8882ff6308fa">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd8aecbec0954165b87a5ec97df1d4e2_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNy01LTEtMS0w_6a13ced2-6932-4802-a5a5-b58ca81e078d">228,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNy0xNS0xLTEtMA_5fac66fe-b398-4927-9828-f6a79ee5b700">228,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Settlement of earnout liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d26bc89cf9d42679d5552c59c55cdbf_D20200101-20200930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfOC0xLTEtMS0w_d5dff5d9-5d85-4398-a0f1-dbe7f163006b">295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd8aecbec0954165b87a5ec97df1d4e2_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfOC01LTEtMS0w_fd86b890-45e0-401d-b97f-0ee8dd65db39">28,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfOC0xNS0xLTEtMA_30bc9a7e-6080-4055-9f6d-0cf366e7f473">28,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd8aecbec0954165b87a5ec97df1d4e2_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfOS01LTEtMS0w_382b3414-cf58-4aef-af2f-8de6004326c6">23,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfOS0xNS0xLTEtMA_fa374163-2c09-495f-84d2-97cd86eb18cd">23,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ee387271fcb47c8ae521d21b67a6519_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTAtMTMtMS0xLTA_9e6e0697-416a-4fd8-be0f-1a6cfa67d0fd">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTAtMTUtMS0xLTA_dcd4937c-49c9-4919-95b6-b64e81657e20">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id84eb822e5c644a4a6c213ee899e2d4e_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTEtMTEtMS0xLTA_db2a72b4-7002-45ef-8fa3-1cad03107d2e">14,423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTEtMTUtMS0xLTA_578bff87-a6a3-47e8-aa34-0cc466f1cded">14,423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of September 30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c86001988504201bc82e067924ed6cf_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItMS0xLTEtMA_71a14dde-03a8-45b3-9b62-7f547c4cc93a">37,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c86001988504201bc82e067924ed6cf_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItMy0xLTEtMA_c9365de0-2900-49e2-9b0d-8b1205b4ea85">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9def4cfc83f54b30addf32c96889fca4_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItNS0xLTEtMA_4400a07d-3403-4569-aa90-ee6ba239a107">719,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i90037718d9204b0384103fade0d6cc45_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItNy0xLTEtMA_4bd99289-2a4b-4727-9e10-3a0a5a697361">11,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90037718d9204b0384103fade0d6cc45_I20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItOS0xLTEtMA_b0ebb642-7637-4072-b44c-e55937e49747">199,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8de5a03a387f4e069c2641fc24a40166_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItMTEtMS0xLTA_d274af5a-5613-48f3-aa8c-b0d344948e62">256,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66989f5e965f4615937f019de6f617c4_I20200930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItMTMtMS0xLTA_1c876bd1-aad9-42b7-b964-5afc7ce3ce46">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3afb9956061e4743b8afadadf5214bfe_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItMTUtMS0xLTA_a76d344a-7e1f-4a1b-acc4-e72a2798c3f6">775,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMy0xLTEtMS0w_c42e1ca1-31f5-4bcd-acfe-6dc90ac3f80b">72,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMy0zLTEtMS0w_102b4b84-d4ea-4f7f-8e58-d0ab3907b1a8">14,423</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNS0xLTEtMS0w_dd71a0f3-9b8c-4043-ad4e-7a7bc22c96d1">3,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNS0zLTEtMS0w_6a5ed80f-3eb4-4651-ba2a-f02860c77df9">2,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of internally developed software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNi0xLTEtMS0w_20377929-95bd-47ea-8338-d631bad56c83">9,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNi0zLTEtMS0w_2e552495-b232-4aa9-9eb0-0493bb6da456">5,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNy0xLTEtMS0w_2767afb0-52c2-42c3-b693-e926816767ba">416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNy0zLTEtMS0w_62d5bb44-0b4c-48f4-9884-879b5954a3e8">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfOC0xLTEtMS0w_f2d9a6d2-f9d3-4d5b-8370-848c0dec0a09">24,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfOC0zLTEtMS0w_0da54035-6525-4f1d-ae5e-a267a9ed5ac9">21,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfOS0xLTEtMS0w_23543c3d-bc9e-46c1-8122-1f90c2f5e83f">20,134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfOS0zLTEtMS0w_a14fc96f-c68f-4f0f-8833-97e211caf404">10,982</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTItMS0xLTEtMA_ae61e99c-9516-431b-b1f9-867f9fa5390a">908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTItMy0xLTEtMA_7dd2bf65-f015-4ae1-a78f-dab344dd6c91">421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTQtMS0xLTEtMA_9ec6ec29-f636-4e15-897a-0c427e8344ac">493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTQtMy0xLTEtMA_06d7aa1f-29c7-4f32-a6ef-5cbd644a76ae">1,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets &#8211; commissions receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:IncreaseDecreaseInCommissionsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTUtMS0xLTEtMA_c3af405d-7d2f-4392-8ac3-8e46340e5da9">35,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="ehth:IncreaseDecreaseInCommissionsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTUtMy0xLTEtMA_e5f6a4ca-ec62-4f48-866b-cf36723a9498">16,772</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTYtMS0xLTEtMA_c66e9d01-e088-4d45-88c6-75d87f6323f5">20,790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTYtMy0xLTEtMA_8cc85d80-711b-4625-8ae0-4c2c05eada08">9,398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTctMS0xLTEtMA_138315ae-38e4-46a0-9918-02710792394b">26,913</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTctMy0xLTEtMA_7474cb1f-b3e8-4ead-a08c-7778f6e07cec">3,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTgtMS0xLTEtMA_72b667b2-6e67-45b5-b514-2d35c60a124e">118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTgtMy0xLTEtMA_303643d6-2e52-40d6-8df0-bfcf92f9272f">7,438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued marketing expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="ehth:IncreaseDecreaseInAccruedMarketingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTktMS0xLTEtMA_d757be99-2f30-4f74-830e-8a4b87e68466">6,525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="ehth:IncreaseDecreaseInAccruedMarketingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTktMy0xLTEtMA_560ab3d3-8690-428b-b927-41f7c22b42c2">5,449</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjAtMS0xLTEtMA_39d89aef-6694-470c-9a3f-3ec2eae477af">10,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjAtMy0xLTEtMA_b8ce12f7-6e01-458c-8456-5f55d5407dae">23,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjEtMS0xLTEtMA_2a6d6ade-f0b2-4b31-944e-ea9525851b9d">1,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjEtMy0xLTEtMA_cd64dc47-5bd5-444f-aced-a9ca3f61cb1e">3,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjItMS0xLTEtMA_9fa5ca08-7023-4555-9450-5e113f5b32bd">60,321</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjItMy0xLTEtMA_5a3c2257-39c9-4d2d-b4c5-10bd7c4b346c">10,959</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized internal-use software and website development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToDevelopSoftware" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjQtMS0xLTEtMA_f2d589fd-35aa-48b5-b9b9-96579a7ac504">12,589</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToDevelopSoftware" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjQtMy0xLTEtMA_b610fb2d-be63-4a6b-bc70-fbfd9f9df8b7">12,082</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjUtMS0xLTEtMA_dc5eb367-0226-4dcd-a007-a5cfef125b57">3,554</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjUtMy0xLTEtMA_ca0c6f88-b0e1-4015-8fb2-edd34cac0c61">6,454</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjYtMS0xLTEtMA_26b13fde-dd19-4d63-a7df-f332da29b3ce">88,967</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjYtMy0xLTEtMA_388cf309-db17-44a9-9536-9367b7b942d2">180,505</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from redemption and maturities of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjctMS0xLTEtMA_fc00a161-fcb3-4ec4-91c0-0b75e3fc343c">68,288</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjctMy0xLTEtMA_95d05db4-10ec-41b0-a8c4-6f91defc92cb">70,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzAtMS0xLTEtMA_f3ca7ee2-1565-447c-b80b-34e509272f92">36,822</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzAtMy0xLTEtMA_e3f43051-a4e3-44ca-9a83-10d2db878542">128,291</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of preferred stock, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzItMS0xLTEtMA_c0cf61b7-2919-4359-8edc-715a1a52dd7b">214,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzItMy0xLTEtMA_27ff6ffa-1710-45cd-98e7-09ee105b0a12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzMtMS0xLTEtMA_334dee4f-83a3-452c-a7d1-2f3cc4ebd573">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzMtMy0xLTEtMA_30be7d91-47b6-47a4-b8e6-d70730d53a0f">228,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net proceeds from exercise of common stock options and employee stock purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzQtMS0xLTEtMA_8250774e-c8af-4a05-bacd-56c858264a8e">4,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzQtMy0xLTEtMA_9069d909-fc9a-4508-93f3-59a7393d6570">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of shares to satisfy employee tax withholding obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzUtMS0xLTEtMA_84d4ce77-69ab-47a1-b1de-78a43bd62db2">7,968</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzUtMy0xLTEtMA_61493c57-9b44-4ea2-9691-e99634d00287">17,174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition-related contingent payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzktMS0xLTEtMA_f39e7a2f-a318-4726-a571-e3c1b53036e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzktMy0xLTEtMA_b5d1077e-e3a2-40d0-87c5-d26c8848299f">8,751</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal payments in connection with leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDAtMS0xLTEtMA_0bb451b9-91b6-4c0d-82a4-7ad0ecf4494e">126</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDAtMy0xLTEtMA_4727ce92-4413-4ef4-9ad8-00c434d3843e">121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDEtMS0xLTEtMA_f37f5961-6184-4513-a9bb-fe72542e3d11">210,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDEtMy0xLTEtMA_7e59c48f-6fb8-4148-a91e-9a7ad9c03cea">203,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDItMS0xLTEtMA_497d5b29-2a5b-405b-9eef-33e8cac9d007">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDItMy0xLTEtMA_4047117b-9bac-47ba-bce9-908a92329139">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDMtMS0xLTEtMA_ea26f4b4-742f-43ac-b327-ed40b5453c07">113,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDMtMy0xLTEtMA_38404e58-4dd8-4125-a772-550911d046b5">64,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDQtMS0xLTEtMA_5ff4354b-0eb9-4361-9ac5-6fecddcf46fa">47,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i023ad41593504141a87219e927134521_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDQtMy0xLTEtMA_6160fcf2-79ac-4712-808c-266aafeaa606">26,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDUtMS0xLTEtMA_7bdd48c8-d7d3-481f-8299-23638aa88ebd">160,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3afb9956061e4743b8afadadf5214bfe_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDUtMy0xLTEtMA_136a0ee7-859d-4f18-ba2e-c6b5bf7c6899">91,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_31"></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><div><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfODk2Mw_bec94f25-5fea-446e-8895-a02dd4e70c53" continuedAt="i2d6b78bd8c064f1f895095c1ba00dbc4" escape="true">Summary of Business and Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2d6b78bd8c064f1f895095c1ba00dbc4" continuedAt="i94bfd037485549d6985fa790de52ce06"><div style="text-indent:36pt"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="ehth:DescriptionOfBusinessPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfODk3MA_584f6af1-cd07-4820-a7b8-791f27eece2f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eHealth, Inc. (the &#8220;Company,&#8221; &#8220;eHealth,&#8221; &#8220;we&#8221; or &#8220;us&#8221;) is a leading health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Our mission is to connect every person with the highest quality, most affordable health insurance and Medicare plans for their life circumstances. Our platform integrates proprietary and third-party developed educational content regarding health insurance plans with decision support tools to aid consumers in what has traditionally been a confusing and opaque health insurance purchasing process, and to help them obtain the health insurance products that meet their individual health and economic needs. Our omnichannel consumer engagement platform enables consumers to use our services online, through interactive chat, or by telephone with a licensed insurance agent. We have created a marketplace that offers consumers a broad choice of insurance products that includes thousands of Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business and other ancillary health insurance products from over <ix:nonFraction unitRef="insurance_carrier" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="INF" name="ehth:NumberOfHealthInsuranceCarriers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfMTIyMg_8860382b-d9f0-455f-ae40-2d2ce6212812">200</ix:nonFraction> health insurance carriers across all <ix:nonFraction unitRef="state" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfStatesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfMTI2Mg_efc97489-1d8c-4682-be80-3b2e3ab7bd0a">fifty</ix:nonFraction> states and the District of Columbia.</span></ix:nonNumeric></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfODk2MA_34eb88fd-723b-4e04-a843-c7c611523f37" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Basis of Presentation &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The accompanying condensed consolidated balance sheet as of September 30, 2021, the condensed consolidated statements of comprehensive loss and stockholders&#8217; equity for the three and nine months ended September 30, 2021 and 2020, and the condensed consolidated statements of cash flows for the nine months ended September 30, 2021 and 2020 are unaudited. The condensed consolidated balance sheet data as of December 31, 2020 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission on February 26, 2021 and amended on April 29, 2021. The accompanying financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and reflect all normal recurring adjustments that are necessary to present fairly the results for the interim periods presented. The condensed consolidated financial statements include the accounts of eHealth, Inc. and its direct and indirect wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with those rules and regulations. Certain prior period amounts have been reclassified to conform with our current period presentation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020 and include all adjustments necessary for the fair presentation of our financial position as of September 30, 2021 and December 31, 2020, and our results of operations for the periods presented. The results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for any subsequent period or for the year ending December 31, 2021 and therefore should not be relied upon as an indicator of future results.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the issuance of our consolidated financial statements for the year ended December 31, 2020, we identified certain errors, including a $<ix:nonFraction unitRef="usd" contextRef="i53205ea49e0b458292f697b7a5c56a93_D20200101-20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfMzcwMg_d0b16cda-bca3-4813-84ec-e0ac6914d880">3.0</ix:nonFraction>&#160;million under-recognition of stock-based compensation expense and a $<ix:nonFraction unitRef="usd" contextRef="i373a791d3cae4ac8ac03bd94922adf11_D20200101-20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfMzc2NQ_a81f6694-3ce3-4632-af1c-a96f8839fdba">1.5</ix:nonFraction>&#160;million over-recognition of licensing costs for the year ended December 31, 2020. We adjusted for these items in the first quarter of 2021 and the adjustments reduced our net loss by approximately $<ix:nonFraction unitRef="usd" contextRef="i7f1209faee954d01bec8ebffed7361b4_D20210101-20210331" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfMzk1Nw_789f17f8-eff4-45d7-b7a0-54f5cb54c0e1">1.5</ix:nonFraction>&#160;million, or $<ix:nonFraction unitRef="usdPerShare" contextRef="i7f1209faee954d01bec8ebffed7361b4_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfMzk2NA_07d3d055-d22d-408c-bdbc-e232fe987246"><ix:nonFraction unitRef="usdPerShare" contextRef="i7f1209faee954d01bec8ebffed7361b4_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfMzk2NA_cdfcc80d-ce29-4363-96e8-321111f0b478">0.06</ix:nonFraction></ix:nonFraction> per basic and diluted share in our Condensed Consolidated Statement of Comprehensive Loss for the three months ended March 31, 2021. These items also reduced our net loss by approximately $<ix:nonFraction unitRef="usd" contextRef="i0659c47707f64baa904993c672f45c27_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfNDE2NA_8d81e599-363c-4aa0-994b-6a1f2d2df6ab">1.5</ix:nonFraction>&#160;million, or $<ix:nonFraction unitRef="usdPerShare" contextRef="i0659c47707f64baa904993c672f45c27_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfNDE3MQ_9cbbc716-14eb-4d99-8fe7-0c406d6ca590"><ix:nonFraction unitRef="usdPerShare" contextRef="i0659c47707f64baa904993c672f45c27_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfNDE3MQ_c75718f0-eb7e-43a2-b2b1-ba77baf2a664">0.06</ix:nonFraction></ix:nonFraction> per basic and diluted share, on our Condensed Consolidated Statement of Comprehensive Loss for the nine months ended September 30, 2021. We evaluated the effects of these out-of-period adjustments, both qualitatively and quantitatively, and concluded that the errors and the correction thereof were immaterial both individually and in the aggregate to the current reporting period and the periods in which they originated, including quarterly reporting.</span></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i94bfd037485549d6985fa790de52ce06"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfODk3MQ_bd369a30-0d62-4f9c-8d91-0bffe239e56f" continuedAt="i316a6963dca34dc19ab37bc3858b13dc" escape="true">Significant Accounting Policies, Estimates and Judgments &#8211; </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i316a6963dca34dc19ab37bc3858b13dc">The preparation of condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates, including those related to, but not limited to, the useful lives of intangible assets, fair value of investments, recoverability of intangible assets, the commissions we expect to collect for each approved member cohort, valuation allowance for deferred income taxes, provision (benefit) for income taxes and the assumptions used in determining stock-based compensation. We base our estimates of the carrying value of certain assets and liabilities on historical experience and on various other assumptions that we believe to be reasonable. Actual results may differ from these estimates.</ix:continuation> There have been no material changes to our significant accounting policies discussed in our Annual Report on Form 10-K for the year ended December 31, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="ehth:SeasonalityPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfODk3Mg_ec63f06f-f489-42d5-af67-ecfdf270b4c1" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Seasonality &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Open enrollment periods drive the seasonality of our business. A greater number of our Medicare-related health insurance plans are sold in our fourth quarter during the Medicare annual enrollment period when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, our Medicare plan-related commission revenue is highest in our fourth quarter. Our Medicare plan-related commission revenue is also elevated in the first quarter compared to the second and third quarters as a result of the reintroduction of the Medicare Advantage open enrollment period in the first quarter of 2019. Any changes to or adoption of open enrollment or special enrollment periods may change the seasonality of our business.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The majority of our individual and family health insurance plans is sold in the fourth quarter during the annual open enrollment period as defined under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act. In the states where the Federally Facilitated marketplace operates as the state health insurance exchange, individuals and families generally are not able to purchase individual and family health insurance outside of the annual enrollment period, unless they qualify for a special enrollment period as a result of certain qualifying events, such as losing employer-sponsored health insurance or moving to another state. Extended open enrollment or special enrollment periods may change the seasonality of our individual and family health insurance business.  For example, the COVID-related special enrollment period which ended on August 15, 2021 has caused increased commission revenue from the sale of individual and family health insurance plans outside of the open enrollment period. In addition, we may experience changes in seasonality due to the extension of the 2022 open enrollment period to January 15, 2022 for most states.</span></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfODk2Ng_68fde2a5-faa0-4425-805d-da66efd53046" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Income Taxes (Topic 740) &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2019, the Financial Accounting Standard Board (&#8220;FASB&#8221;) issued ASU No. 2019-12, Income Tax, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, which aims to simplify the accounting for income taxes. We adopted this guidance in the first quarter of 2021, and it did not have a material impact on our condensed consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">. ASU 2020-10 is intended to facilitate codification updates for technical corrections, such as conforming amendments, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements. It contains amendments that improve the consistency of the codification by including all disclosure guidance in the appropriate disclosure section and other updates that vary in nature. We adopted this guidance in the first quarter of 2021 with no material impact on our condensed consolidated financial statements and disclosures.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Debt with Conversion and Other Options (Topic 470) and Contracts in Entity's Own Equity (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> &#8211; In June 2020, the FASB issued ASU No. 2020-06 to simplify the accounting for convertible instruments and improve the usefulness and relevance of information regarding convertible instruments. This ASU reduces the number of accounting models for converting debt instruments and convertible preferred stock. ASU No. 2020-06 is effective for us in 2022, with early adoption permitted. We early adopted this guidance in the first quarter of 2021, and it did not have a material impact on our condensed consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_37"></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjQ5Mw_22090a29-915a-435c-8179-915e8f5b9ac3" continuedAt="ife0a016eb96d4dfa97c85e1871c9c908" escape="true">Revenue</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ife0a016eb96d4dfa97c85e1871c9c908" continuedAt="if1b18206b6894bc39637972d5c5a4b3a"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjQ5NA_e73c9a89-215b-4778-b1e3-c3b06188a778" continuedAt="i382a961ca5fb485384536fc4a4dfd4f7" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below depicts the disaggregation of revenue by product and is consistent with how we evaluate our financial performance (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d44d8be1ff4d9ba8d66ea2c112a2de_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMy0xLTEtMS0w_69978ede-baf6-4172-a4f6-cfa472250082">36,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8e13b0d1c22425ca8ca7bebe6811adf_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMy0zLTEtMS0w_5713fdfd-6f14-4f21-8bb7-fc07f0233581">41,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cd73075ac5746c1ac3c693924ea8745_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMy01LTEtMS0w_0a9b2bde-8b62-4785-9b8f-b87da358c462">209,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79a3575bc66645c4873d69cd381d6522_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMy03LTEtMS0w_a8d2c716-03c6-48f4-8789-0b439a78420d">168,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb69f48720624bd2ba3990d45781b58b_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNC0xLTEtMS0w_0016e0c9-474a-4f21-8c18-9db79ddbf2ec">3,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90eeed6c273749e88dabae5495cf6c9d_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNC0zLTEtMS0w_acaa8c57-4194-413a-8122-53ef4e677eef">7,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e3aa4585c2a420aac2dbbcd2a763c5e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNC01LTEtMS0w_d6df5dc7-bbf2-41a2-a270-044969616a7a">15,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if58e722068de4216be2a26dc1df27ada_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNC03LTEtMS0w_b1b3f04a-de88-4083-ad88-054567b06521">32,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifab10f50711a46a8b9bdcbee99dfed11_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNS0xLTEtMS0w_5747b3f8-b92a-448a-9093-f4d5ad3553b2">1,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a03b84610f148308bee0aedeeeeded4_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNS0zLTEtMS0w_dc6f34cf-0d62-44d8-baf0-bcf4c87204e0">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if432dd7d445c47b68e3465e50a0cce99_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNS01LTEtMS0w_7f65b91f-8443-4e7d-a451-3c57d7458c46">2,953</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae4bbc252a254aca8e08652db1ae75f4_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNS03LTEtMS0w_b8cf0b7d-03b9-41b1-8dd7-fdc2cd31328c">7,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bf2b0808d5d4b95ad14fb56678b89df_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNi0xLTEtMS0w_cfc3524c-d512-46d7-9296-8cafd3d7ab2f">41,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64b14a1e7cf747b5bdd0af47f7efa4bf_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNi0zLTEtMS0w_fac2a22b-2e6d-4f12-8988-4ee1887113d3">49,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i288de29276794a4b98de7093838e980b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNi01LTEtMS0w_73a465bd-eb6f-47eb-9f29-5cd2d24d7d51">221,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b2f0942dcca4e079dc5dd9bcd2a7f2b_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNi03LTEtMS0w_7b2e1df5-c5cd-4c2e-aef9-c64d9630faef">208,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Individual and Family </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Qualified Health Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07e75d14864c4f86befd75db7d14b2be_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOC0xLTEtMS0w_3a4d1c04-4e03-4cf6-90a1-d4486e3e649e">5,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36c47733c755462195bb2209eb595273_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOC0zLTEtMS0w_7edee2b7-cc76-44fd-8786-34cd34d18083">9,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa14ebfc4094081974d71ef4e246a62_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOC01LTEtMS0w_4177eeff-8bbc-424c-997d-733fa9594ddb">20,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48aa029a268b4ec2b76e22c7b495a170_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOC03LTEtMS0w_599bfe07-5a45-4831-8fe9-ec99558a158a">12,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qualified Health Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i851cd6431ca8482eb6cf6148f01f3118_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOS0xLTEtMS0w_a5c7b901-ffd6-446e-abf1-79d8ee1c30aa">2,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc8fa77be2f04de88bb71b5c8d8a8e8c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOS0zLTEtMS0w_665c2c11-2fb3-443a-8d81-fb83906f6e9a">1,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1430539e8454dec87d06cc7d906f6c3_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOS01LTEtMS0w_e06ea226-fdcd-4b3a-91d5-7d25ce0ab30e">7,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cfe3cb32fd14c69820a09d8cf0a7ec5_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOS03LTEtMS0w_4005cf0a-c797-483b-91d0-2561eace2fec">3,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Individual and Family</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i865072ee20694d9a916202d1277bb59a_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTAtMS0xLTEtMA_7f16393d-b70d-43d3-9b49-c92e930dbb3b">8,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d71827a12044b98aca58d93cc8b447_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTAtMy0xLTEtMA_22944c37-ab10-4578-8d8d-a255fae74a1a">11,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b7def10b7c4144a3529c00d81371ea_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTAtNS0xLTEtMA_8ae6f534-e4f2-458e-822c-99e28ef29827">27,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic140144201d545bb89a26e563ea54efc_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTAtNy0xLTEtMA_4fcc5d26-3ec1-4b24-9ab3-2fb05f79c4ec">16,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ancillary</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibccfac65e89e46b0a4779b6a9f5a1595_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTItMS0xLTEtMA_d7ee8e11-a523-44f8-b727-37a13b0f31dc">1,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb2e1ef01a8a49be95e5633382fff52e_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTItMy0xLTEtMA_4a865147-1bfe-47bc-96e1-a9ac128e79bb">2,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb08ebace2994766abfc06f5a7ca01e0_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTItNS0xLTEtMA_c3c8a889-21c7-4cf5-8d3a-c376a1a428f6">4,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04f6ab9257d4c3c82133b0ebf9ec119_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTItNy0xLTEtMA_4898958f-f16b-469d-8fff-5fd53c5970ce">6,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b84638a44674aae820620c1ad281b03_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTMtMS0xLTEtMA_0954bd5b-6f31-4e62-8252-4646937e4c1b">3,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f329a84a77c4b40a18c88baac1fa79e_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTMtMy0xLTEtMA_41f50381-ee9c-4ea9-b620-262e4da72614">4,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib265edd981cb4329b96667e22174e69a_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTMtNS0xLTEtMA_7dd0e204-d3d5-4e20-9f2a-fbad32f71bc5">9,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9226a70837c94f539c18e81cea08edff_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTMtNy0xLTEtMA_4a7bb788-9a69-4664-bdd1-35006d0f56ce">5,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if35afead23854a98ba1ae85afef88254_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTQtMS0xLTEtMA_aaeb666d-a816-4600-8a1b-39c79df0a32a">642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if334ca37e8184c3bb05e9970b42f9537_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTQtMy0xLTEtMA_19db8b63-4dff-46b7-8623-4089b5f6d896">1,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15e62c7d2ac4d8783c355c63461fb13_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTQtNS0xLTEtMA_05ec7b6a-6442-4101-934b-576ada008d87">1,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9ba1db851374ea0bdc62b19987a5f2d_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTQtNy0xLTEtMA_90a64d91-1863-4116-9b30-7edc1e531f57">2,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5794689700d84cc19cd5b25cb7e1a896_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTUtMS0xLTEtMA_e33e1509-efa6-4bb7-b304-6757451e4d25">845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a8cb208fd74edb96d789382c6d519f_D20200701-20200930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTUtMy0xLTEtMA_08789488-0c8b-45f5-8f6c-ab5024ed7279">847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0cf3d15ecd4e02aba71ef693d79134_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTUtNS0xLTEtMA_da160765-92d6-447c-94b9-8de4e37030f7">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4e89f067c984a58aee8388d3f4e26f6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTUtNy0xLTEtMA_db05a3d0-7946-42dc-9923-313756ed198f">2,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Ancillary</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie938c6c5a4b344bb9a1e717ea937a556_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTYtMS0xLTEtMA_e6bf78dc-3325-491f-968e-3ff1376d5bdf">6,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0717ef9e88ca45c68fd977740d8d5fbb_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTYtMy0xLTEtMA_10fa469e-1267-4861-90e1-544ea14a66f0">9,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45ec5bca96d4cffba4e82a71f5a9909_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTYtNS0xLTEtMA_6647c462-1a2b-4eb0-bef9-87005b10d455">17,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic33a9cc99b61453181708c8ac5a2aa97_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTYtNy0xLTEtMA_a85ce5d7-89ad-4e02-ab15-2253dafb14ae">17,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Small Business</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77dc76304d9f4dc794d414ab98cc2411_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTctMS0xLTEtMA_a9ce4292-59a2-4b50-afcc-f3e2264da58a">2,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdb8cd80cf0c4da9853fa98df8f7fd37_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTctMy0xLTEtMA_b66ffa33-7c89-4701-b153-b1636c99be30">1,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i411334780a0440f9b3aa7d1cd64fd42e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTctNS0xLTEtMA_276b42d3-dc94-435b-88b3-e948a2352cc7">7,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id66e7ebb7d4e493789cd440c77019454_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTctNy0xLTEtMA_4de3b522-3646-4529-866c-279597886d6c">6,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commission Bonus and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4787e3cd9c774e0486d6813affce59e3_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTgtMS0xLTEtMA_1243ee7e-a9a4-4985-907f-0efeda9c5731">922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e50511dfd494fd4b8f5a928e5ead478_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTgtMy0xLTEtMA_05495262-52cb-477b-b311-2d103b561921">1,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieed01c48dc4640938d300839252fb560_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTgtNS0xLTEtMA_1d97bac6-aa91-4a3f-aca4-b9aec409dc1c">1,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cfcd2d5b5b040a09df39b1ff8138e51_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTgtNy0xLTEtMA_3cfc30c2-09da-4275-a672-c18248d7a38a">5,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Commission Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0273079a37b24f93bde9cf3de6f118a8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTktMS0xLTEtMA_59bdf115-e7df-472a-95e9-7eebf25a9fd4">59,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b864a8e10634cc386d2e4b1b66f73c9_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTktMy0xLTEtMA_2cfd6b67-4d8c-4f53-83ea-df307bc10d2f">73,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb2628c9d51a46139995f5f56f04eb1b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTktNS0xLTEtMA_8842e3b7-85ee-421b-9392-f271a0d0ed4a">276,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5334a64f425448d4aa5dd0966023fad5_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTktNy0xLTEtMA_b2d8aa9e-ec41-4856-9fa7-f714dc972d1d">253,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsorship and Advertising Revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c3369cffbd74e249a3e3bcbd0df3054_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjEtMS0xLTEtMA_970c96ce-7db7-4619-bada-2b3c0eb82d15">4,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice58cf46aa33484b9c94c1f20980a068_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjEtMy0xLTEtMA_d5af26e3-bf81-4e08-ad2c-b872f6ad700a">18,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4ce1d15f494a5996713fb811a2066e_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjEtNS0xLTEtMA_5f43e0f8-eb4f-49dc-9d91-92faa8469572">16,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7bf84cecf545a7a3974f7c1cfe3799_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjEtNy0xLTEtMA_be4c9f10-e227-4cde-a41e-42649c9f51a2">32,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0336634f72994ba8b44ad3381f004b4e_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjItMS0xLTEtMA_8a6dd826-b85e-430f-b93a-bd610730e532">558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc891b5b3b9c469f8a49e2e7a57facb8_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjItMy0xLTEtMA_f3580f80-938d-490f-8bec-9edc0f716fe3">1,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b1f428af2a34ebd8d75cfdee0ffd03b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjItNS0xLTEtMA_828921e2-7bdd-4424-a68e-9db3dd189a8d">2,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6053607ddf734936ad39bb851ebfddc8_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjItNy0xLTEtMA_0a4140c7-273d-436c-83a6-a011cf2a829f">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc76aa4ecb8a42b3bb83ea9ae9209b0f_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjMtMS0xLTEtMA_6a41de8f-d005-49be-ac39-00f002d37822">4,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f614f83f3b14aceb5dddc72972dc625_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjMtMy0xLTEtMA_04176bb2-d6e4-4c91-8e69-52e16ab1605b">20,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c18bac640fb4358b74a9021f64f8f09_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjMtNS0xLTEtMA_90a77647-8057-4f16-9d39-b35e3728224f">18,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i079a9bbf2d8444019d86c147c114b59f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjMtNy0xLTEtMA_91495d8d-f349-45f6-8cdc-21f57c6eb4af">35,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjQtMS0xLTEtMA_d9a5e167-b138-4170-96e7-cb71f1868818">63,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjQtMy0xLTEtMA_509d62a3-4813-49f1-b4db-bf9a9bd35d46">94,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjQtNS0xLTEtMA_6c650add-9406-4176-99db-734aca82a17a">294,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjQtNy0xLTEtMA_25745ef6-ea6a-48c0-a71f-5c8a56ee4702">289,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:11.65pt">We define our Individual and Family plan offerings as major medical individual and family health insurance plans, which does not include Medicare-related, small business or ancillary plans. Individual and family health insurance plans include both qualified and non-qualified plans. Qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are offered through the government-run health insurance exchange in the relevant jurisdiction. Non-qualified health plans are Individual and Family plans that meet the requirements of the Affordable Care Act and are not offered through the exchange in the relevant jurisdiction. Individuals that purchase non-qualified health plans cannot receive a subsidy in connection with the purchase of those plans.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:18pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="if1b18206b6894bc39637972d5c5a4b3a"><ix:continuation id="i382a961ca5fb485384536fc4a4dfd4f7"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commission revenue by segment is presented in the table below (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Members Approved During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60f7bd4ed2c54782bc3f2260952e6258_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMy0xLTEtMS0w_569725b2-3a18-4df2-82da-5b92a5661a8c">42,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71df5a32a01545eca393c3d91f915fec_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMy0zLTEtMS0w_e34bf98f-ec7b-49e9-bbba-5d01b281a6bb">52,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i351266363f7a4e1b8813c1836650f960_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMy01LTEtMS0w_949180ea-ac84-4310-9ac2-53f5174c9742">235,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20e9c547df0148a987469593fc0dd987_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMy03LTEtMS0w_bdb3bd67-4836-4e9e-9a86-df2158104d7f">205,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Commission Revenue from Members Approved in Prior Periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icde2beb0631d4a4287783b69cf7d4e1d_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNC0xLTEtMS0w_21234fd1-0a6c-4ba9-bdb5-5b39312d68ec">171</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb0006a549d140b98d5bf1d2830e36e6_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNC0zLTEtMS0w_31c0c53e-6142-443d-8eb8-c3dd5305b654">698</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a16931904664e00b694766bb038e051_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNC01LTEtMS0w_e522922a-b736-4aef-8e7b-eb13aefebc00">11,700</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i828454e449d849978e8c318cd2776b04_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNC03LTEtMS0w_eded4b9a-8df5-4da8-8ff6-8127564e3664">8,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare Segment Commission Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i911f48697817404ab0c1d37ff5c70eb3_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNS0xLTEtMS0w_56d786cf-e865-4a4a-bbf0-72617b1f1307">42,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie30b009d33834b2784f9f5fde66749b8_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNS0zLTEtMS0w_f2e39a0e-a69d-4e25-b496-1b842e048bd8">51,342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ddb689a8fbc45558ae1921f6350e8fd_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNS01LTEtMS0w_695e8c5c-6e64-411c-a8ba-8cb0e91e4678">224,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fb878914bf0422e994e7b471e4529cb_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNS03LTEtMS0w_b94d3677-4a43-4d82-bb87-abb4c88b0375">214,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Individual, Family and Small Business</span></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Members Approved During the Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7afaf2016ac0443f80caca194735e56e_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNy0xLTEtMS0w_0d9efa07-c4de-488d-b230-b2874fa12e5d">4,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0d09f83aa5a4ea2a65c601a78f12257_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNy0zLTEtMS0w_af5a1f27-1e12-4082-a02a-7ba9cc7d7756">4,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48026c37588241f584802f09d54f9ecf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNy01LTEtMS0w_163ab5d3-4193-4435-babf-92f3e5afeaa7">16,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2733db6c0ea4360b6296e5e62c73ccb_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNy03LTEtMS0w_9fb8e468-431b-4ccb-a098-15ffe49f53b9">14,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Renewals of Small Business Members During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b76269dbb014c83960a5587af0692a7_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOC0xLTEtMS0w_94c5572f-8a31-4a12-82a3-5338f542f9fa">1,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b68547b7b4546788f2a85f5b220c5e4_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOC0zLTEtMS0w_9f202601-833f-46eb-a430-2d45c3c5740c">1,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7da352e8a9c40eb9cbd7fb732779cfe_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOC01LTEtMS0w_cf7db437-258e-440b-8f2e-3892e3c93e70">6,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89f5b05319a44a1cad8dcf843dfca2f6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOC03LTEtMS0w_3f1acb9b-4782-460d-b0c6-882697094a6d">5,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Commission Revenue from Members Approved in Prior Periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1947f932e9cd407bb62d56755087564a_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOS0xLTEtMS0w_ee2067c5-41e3-4db3-ba49-df48f6d17dc6">10,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2908788ec3a452c97c238d92d2d6035_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOS0zLTEtMS0w_4fdd1937-cae0-42e5-a66c-f157f64945f4">17,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacc349161dd6466bbcd492c1b35bd633_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOS01LTEtMS0w_212f59ad-36b4-426f-9676-cc233591ec26">29,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c979359de9d4404ab9ede567f6f6ece_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOS03LTEtMS0w_6254724a-9547-46c7-929d-d69c1b89f700">20,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total IFP/SMB Segment Commission Revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ef44b438b8345fb9a5e4685fa068d53_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTAtMS0xLTEtMA_74d80582-ba67-42a6-9330-156bbb059837">16,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib56fc804e10645e19884d6bf939a1e47_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTAtMy0xLTEtMA_36390b71-b0d7-4a2d-b7fe-7b63b7a3c2a9">22,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if141fe6636bb4186bf1303c83e6e12ae_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTAtNS0xLTEtMA_3c2da1e5-fa1c-46d9-8864-598c65bd4a95">51,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9533cbf4c24f3584970b6fd8bf789e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTAtNy0xLTEtMA_054132ea-4f94-4265-a304-1eeae5222465">39,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Commission Revenue from Members Approved During the Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1758dd3c120e4914bdef33946facb083_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTItMS0xLTEtMA_a2eba4a0-fa27-41c4-90dc-6b59bcd8a556">47,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84a9e32128947c58eaef205f493a0c8_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTItMy0xLTEtMA_1400eb4b-c7b4-4909-bd5b-dca862c289e3">56,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88f0ca026fd6441dacb2cb5e02eaa395_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTItNS0xLTEtMA_b9d24017-f357-4993-8864-1e833ee375f1">252,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa4da10fcd0440f893af9317b139b55_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTItNy0xLTEtMA_33209c0a-b167-4ad8-a11b-34ad8ee119fe">219,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Renewals of Small Business Members During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf89006ab2ec48268296871b08a85218_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTMtMS0xLTEtMA_f5c2c32b-51cf-406b-9965-5ed1e0bb75fb">1,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc92029c098b4a3f9121ab760ccd9f11_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTMtMy0xLTEtMA_67ffd8da-df05-4d93-b214-38fe871ca352">1,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc72c1bed1c841499706dc72a9f006a6_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTMtNS0xLTEtMA_06fe4779-60ae-410e-8968-11f0a4ad5c05">6,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife96baa989854bd5b161f91c7ee2b238_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTMtNy0xLTEtMA_ec74f418-b485-44a1-a67a-e0d652f4032a">5,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net Commission Revenue from Members Approved in Prior Periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c18eadfc0c5443f8b7c31b736463ad6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTQtMS0xLTEtMA_02f5ca1b-486f-48e3-8bcc-367eeeb7c443">9,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f03cec81030405695e2198510c5675c_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTQtMy0xLTEtMA_682006cd-96c6-4256-bdfd-6ffe874eb24a">16,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e56edcaffd445c099ce1763d8e2bac1_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTQtNS0xLTEtMA_31cc04d0-6c5a-4d00-83f2-a87f7ff48326">17,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee271f47aa44a19bcbb4c37143a41fc_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTQtNy0xLTEtMA_b64ebe5d-da1e-413d-bfd6-dd09e33ab74d">29,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Commission Revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0273079a37b24f93bde9cf3de6f118a8_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTUtMS0xLTEtMA_6ee577c4-30eb-43a0-bb4f-3112de5e6b44">59,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b864a8e10634cc386d2e4b1b66f73c9_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTUtMy0xLTEtMA_582fc1e2-a258-4360-a750-805cd97dea8a">73,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb2628c9d51a46139995f5f56f04eb1b_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTUtNS0xLTEtMA_d2dfda49-99f8-4703-b496-eb4871ed370a">276,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5334a64f425448d4aa5dd0966023fad5_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTUtNy0xLTEtMA_e77d6d6a-8495-41f5-a043-16475ec47035">253,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These amounts include commission bonus revenue.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These amounts reflect our revised estimates of cash collections for certain members approved prior to the relevant reporting period that are recognized as adjustments to revenue within the relevant reporting period. The net adjustment revenue includes both increases in revenue for certain prior period cohorts as well as reductions in revenue for certain prior period cohorts. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, beginning in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">The impacts of total net commission revenue from members approved in prior periods were $<ix:nonFraction unitRef="usdPerShare" contextRef="i7c18eadfc0c5443f8b7c31b736463ad6_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjAzMw_09b40c27-d694-4f75-a23e-4b8b259826f1"><ix:nonFraction unitRef="usdPerShare" contextRef="i7c18eadfc0c5443f8b7c31b736463ad6_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjAzMw_7662be22-10e3-42c5-b21f-13cca31b8fda">0.37</ix:nonFraction></ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i5f03cec81030405695e2198510c5675c_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjA0MA_85a00039-ed08-4579-9259-e72209403c99"><ix:nonFraction unitRef="usdPerShare" contextRef="i5f03cec81030405695e2198510c5675c_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjA0MA_bc3ec806-802c-46b8-871c-f335f2d2b26c">0.62</ix:nonFraction></ix:nonFraction> per basic and diluted share for the three months ended September 30, 2021 and 2020, respectively. The impacts of total net commission revenue from members approved in prior periods were $<ix:nonFraction unitRef="usdPerShare" contextRef="i5e56edcaffd445c099ce1763d8e2bac1_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjE4NA_48cd7dc8-f9eb-4eef-a0ae-e23d7f67dc73"><ix:nonFraction unitRef="usdPerShare" contextRef="i5e56edcaffd445c099ce1763d8e2bac1_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjE4NA_48dba395-783e-4457-b118-23eec42ccda0">0.65</ix:nonFraction></ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i3ee271f47aa44a19bcbb4c37143a41fc_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjE5MQ_8373f003-784d-4e3f-9bcc-a24cbfa71c13"><ix:nonFraction unitRef="usdPerShare" contextRef="i3ee271f47aa44a19bcbb4c37143a41fc_D20200101-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjE5MQ_d3e2edbc-aebb-4f16-adef-af6a1609f7e2">1.14</ix:nonFraction></ix:nonFraction> per basic and diluted share, for the nine months ended September 30, 2021 and 2020, respectively. </span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The total reductions to revenue from members approved in prior periods were $<ix:nonFraction unitRef="usd" contextRef="i7c18eadfc0c5443f8b7c31b736463ad6_D20210701-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjM0NQ_8ddda1a0-cf43-4552-9f74-8c04d5290ac7">3.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5f03cec81030405695e2198510c5675c_D20200701-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjM1Mg_d1a4d4d8-e47f-4c54-b401-2731dd9d3c96">3.7</ix:nonFraction> million for the three months ended September 30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i5e56edcaffd445c099ce1763d8e2bac1_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjM4NA_9dc4e668-c996-45f4-8192-ee3aa1344e42">22.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3ee271f47aa44a19bcbb4c37143a41fc_D20200101-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjM5MQ_5edce167-86e3-4628-9140-eb0d457890bb">5.3</ix:nonFraction> million for the nine months ended September 30, 2021 and 2020, respectively. These reductions to revenue primarily related to the Medicare segment.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNDIyOA_b5b53aec-8fae-4bd6-bca9-be22d8df6c5d" continuedAt="ib2d722758e0a472f880a63aefeb0752f" escape="true">Supplemental Financial Statement Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib2d722758e0a472f880a63aefeb0752f" continuedAt="i551ca6295218485bbbf294ba5210877d"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all investments with an original maturity of 90 days or less from the date of purchase to be cash equivalents. Cash and cash equivalents are stated at fair value. We also invest in marketable securities that are measured and recorded at fair value. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion about our marketable securities. </span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i551ca6295218485bbbf294ba5210877d" continuedAt="if55dc1e4c227415ea270bdeb97ca5b75"><div style="text-indent:36pt"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNDIyMQ_16383e09-994b-4276-80af-f6c6c207dbbc" escape="true"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNDIzMQ_65c0ebc8-a0a7-4c43-bb4c-1ffd0f05ae83" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalent and restricted cash balances are summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:65.078%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfMS0xLTEtMS0w_a7e7eb2d-c45c-48e5-b931-ed6e505db631">37,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfMS0zLTEtMS0w_dd2b4eb5-dc3c-4a94-8aae-ee2e4a791d5e">39,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfMi0xLTEtMS0w_ad6bd7b3-e022-44cd-9556-6be30f676940">119,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfMi0zLTEtMS0w_edea9e42-a40f-4abf-a564-972830b466bd">4,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfMy0xLTEtMS0w_14ea1ac5-a4f4-4892-9e03-779b0db39987">157,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfMy0zLTEtMS0w_4238fb76-5c3c-442d-a9a4-c7e91f43ed96">43,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfNC0xLTEtMS0w_319d145c-5a55-426a-b897-7ebb954f413d">3,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfNC0zLTEtMS0w_13389649-98b5-4419-836b-ae680e5beb84">3,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfNS0xLTEtMS0w_6950c83c-144e-4194-b3b9-09e3a449c1c0">160,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfNS0zLTEtMS0w_3a2db234-80b9-456d-98df-caf85719d9c8">47,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021 and December 31, 2020, we had $<ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNTEz_060864d4-787b-40da-bd8f-8214f356961a"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNTEz_4d15d5a7-a857-4c63-8960-2a916834cf56">3.4</ix:nonFraction></ix:nonFraction> million of restricted cash which was classified as a non-current asset on our Condensed Consolidated Balance Sheets. This amount collateralizes letters of credit related to certain lease commitments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets and Accounts Receivable</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not require collateral or other security for our contract assets and accounts receivable. We believe the potential for collection issues with any of our customers was minimal as of September 30, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We estimate an allowance for credit losses using relevant available information from internal and external sources, related to past events, current conditions, and reasonable and supportable forecasts. Specifically, for the purpose of measuring the probability of default parameters, we utilize Capital IQ&#8217;s, Standard &amp; Poor&#8217;s and Moody&#8217;s analytics. Our estimates of loss given default are determined by using our historical collections data as well as historical information obtained through our research and review of other insurance related companies. Our estimated exposure at default is determined by applying these internal and external data sources to our commission receivable balances. As such, we apply an immediate reversion method and revert to historical loss information when computing our credit loss exposure. Credit loss expenses are assessed quarterly and included in general and administrative expense on our Condensed Consolidated Statement of Comprehensive Loss. There were <ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossWriteoff" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfMTk0Nw_0a4c49e0-8045-48ee-867e-2b4f29b96054"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossWriteoff" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfMTk0Nw_d4c41c18-77db-44a2-92ea-8be8fce92b45"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossWriteoff" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfMTk0Nw_df72cb80-98b0-4913-b4ea-d918638a0cd7"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossWriteoff" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfMTk0Nw_eff0ca74-3700-4846-ac9c-faa76618374d">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> write-offs during any of the three or nine month periods ended September 30, 2021 and 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We considered the impact of recent events and global economic conditions when evaluating the appropriate adjustments to our allowance for credit losses as of September 30, 2021. We also considered the current and expected future economic and market conditions surrounding the COVID-19 pandemic.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNDIzMw_9314a8f0-dab7-4a60-a7fd-e8451293288b" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the allowance for credit losses for the nine months ended September 30, 2021 is summarized as follows (in thousands):&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.485%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjJhM2FlNzVlOTc5OTQ2YzE5ZGZiZjg3NjA5OTM1NjI3L3RhYmxlcmFuZ2U6MmEzYWU3NWU5Nzk5NDZjMTlkZmJmODc2MDk5MzU2MjdfMS0xLTEtMS0w_793ee4c9-708e-430b-9087-194a11127bc5">2,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjJhM2FlNzVlOTc5OTQ2YzE5ZGZiZjg3NjA5OTM1NjI3L3RhYmxlcmFuZ2U6MmEzYWU3NWU5Nzk5NDZjMTlkZmJmODc2MDk5MzU2MjdfMi0xLTEtMS0w_a61f0cd2-2c12-40ff-a2f4-6e8c73eb33ef">207</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjJhM2FlNzVlOTc5OTQ2YzE5ZGZiZjg3NjA5OTM1NjI3L3RhYmxlcmFuZ2U6MmEzYWU3NWU5Nzk5NDZjMTlkZmJmODc2MDk5MzU2MjdfMy0xLTEtMS0w_95ac9106-61fd-4301-872e-62cf2b50a631">1,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="if55dc1e4c227415ea270bdeb97ca5b75" continuedAt="i21f5c7a09f66423ab3253586a171e762"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNDI0MA_cc95bab0-0e13-445d-834b-a181dd289858" continuedAt="i4a4c6f072c3a4f959b5ab740d77f2412" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract assets &#8211; commission receivable activities, net of credit loss allowances&#160;are summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.037%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFP/SMB Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6e1b062da104b6c93845164602f2f2c_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfMi0xLTEtMS0w_f82dd35b-ffe2-4846-a3fa-b037844c841f">739,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i359b7b468f5540df8ade4326d6c36a90_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfMi0zLTEtMS0w_d68ab950-6721-486a-8891-796ce9c98b81">52,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfMi01LTEtMS0w_64de4c31-d31e-429d-995c-d370a8e2b079">792,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from members approved during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i351266363f7a4e1b8813c1836650f960_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfMy0xLTEtMS0w_b376bc4c-9b28-4fbb-902b-455223dc2c6d">235,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48026c37588241f584802f09d54f9ecf_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfMy0zLTEtMS0w_7c64db7e-022f-4515-8786-b8866bd097b5">16,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88f0ca026fd6441dacb2cb5e02eaa395_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfMy01LTEtMS0w_1110cb61-f045-493d-b8f2-b585d4f7c7db">252,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from renewals of small business members during the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib46a8ba9e5024efe8bf5aba81c5b9600_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNC0xLTEtMS0w_91abe160-d9d0-46d5-bddf-171b774255a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7da352e8a9c40eb9cbd7fb732779cfe_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNC0zLTEtMS0w_9c18847d-e017-4623-aabb-e01547ed7c28">6,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc72c1bed1c841499706dc72a9f006a6_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNC01LTEtMS0w_73f46167-8f0b-4360-a6a9-b2558c4817d0">6,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net commission revenue from members approved in prior periods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a16931904664e00b694766bb038e051_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNS0xLTEtMS0w_3a59c245-4efa-4e55-ac38-23816e6f03f9">11,700</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacc349161dd6466bbcd492c1b35bd633_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNS0zLTEtMS0w_a047b3fe-f18c-49bd-b66a-bb43fea8bcea">29,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e56edcaffd445c099ce1763d8e2bac1_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNS01LTEtMS0w_fd5ed4c1-2f4a-436e-b7c2-5b3c084f8696">17,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e3e7808533446fa841efe0261464aab_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromCommissionsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNi0xLTEtMS0w_3ba589b9-6915-42d4-af50-02cd79d555f6">276,825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1845a379344d4ba7b78716155f0ecf21_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromCommissionsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNi0zLTEtMS0w_87a5a1f3-5ad8-48b2-80fe-aee33951409d">34,485</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromCommissionsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNi01LTEtMS0w_ef5bd9bd-95fa-4715-8738-bd389849de7b">311,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in credit loss allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e3e7808533446fa841efe0261464aab_D20210101-20210930" decimals="-3" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNy0xLTEtMS0w_bd0abe1c-57f2-42e9-811c-aa8abd10e2e3">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1845a379344d4ba7b78716155f0ecf21_D20210101-20210930" decimals="-3" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNy0zLTEtMS0w_fcd0c535-b501-4506-b85f-b7d33591b2ea">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNy01LTEtMS0w_75ca1a31-a7b1-40ee-a3d0-d746bfaf1d9e">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7485ea45ef6d477b95fa116525c62450_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfOC0xLTEtMS0w_c602e175-41af-47fc-9daf-3512496be5ce">687,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i799a45e99b484907806a69b59e333c89_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfOC0zLTEtMS0w_83fe779f-fbae-4a81-91c4-b29c014394c9">70,094</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfOC01LTEtMS0w_c9caa734-9c12-47ad-8e4e-edffebb858b6">757,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.037%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFP/SMB Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b25b5471f2842f191c5c90038a9fce3_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfMi0xLTEtMS0w_141346c9-10ea-443b-bc5a-99778a4930a2">550,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib803d8adedf24fbdbcb6cc7f5c5f99e9_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfMi0zLTEtMS0w_e4b2e620-aa61-49d1-acbd-b50dcd1a62a7">38,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i023ad41593504141a87219e927134521_I20191231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfMi01LTEtMS0w_e78a21a7-c07d-4ecf-ae23-048310a5afc4">589,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from members approved during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20e9c547df0148a987469593fc0dd987_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfMy0xLTEtMS0w_d0fa458a-bf44-4238-a6c0-87cda76a9dcd">205,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2733db6c0ea4360b6296e5e62c73ccb_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfMy0zLTEtMS0w_28947ab6-7dba-4c94-8537-e51a719fd304">14,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa4da10fcd0440f893af9317b139b55_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfMy01LTEtMS0w_14720dc1-1ffc-40fe-84fa-5b893bf1484a">219,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from renewals of small business members during the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd6a2b2a5d6143c983bec97ffe0e0bd6_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNC0xLTEtMS0w_e520bb59-a313-4a2e-8850-449c12ad59b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89f5b05319a44a1cad8dcf843dfca2f6_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNC0zLTEtMS0w_1ce0e92d-a28a-4aff-bb66-301c1a1f7b54">5,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife96baa989854bd5b161f91c7ee2b238_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNC01LTEtMS0w_bcbe0871-1871-4073-9603-59ee75ba1b4a">5,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net commission revenue from members approved in prior periods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i828454e449d849978e8c318cd2776b04_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNS0xLTEtMS0w_a4194635-7728-4038-9c4c-123f959b211f">8,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c979359de9d4404ab9ede567f6f6ece_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNS0zLTEtMS0w_3a99e481-cc11-4ebb-85ee-29d7a9556cca">20,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ee271f47aa44a19bcbb4c37143a41fc_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNS01LTEtMS0w_97b51512-b2e7-4d84-8e01-3000d3e07295">29,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f376e41d3214a4a8692048243ef8566_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromCommissionsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNi0xLTEtMS0w_ff7f6e2a-fef9-41ca-939d-cdf9da4527e0">201,256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55279fea227b4f7992ca05764db25cfe_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromCommissionsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNi0zLTEtMS0w_705ad6a3-68f8-43ce-a980-7962543cd059">35,957</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromCommissionsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNi01LTEtMS0w_b1fb39a4-57fc-41bc-a510-145c4188826a">237,213</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in credit loss allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f376e41d3214a4a8692048243ef8566_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNy0xLTEtMS0w_7e27cad8-f46a-45ed-9be3-00b6ea3678c4">1,536</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55279fea227b4f7992ca05764db25cfe_D20200101-20200930" decimals="-3" sign="-" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNy0zLTEtMS0w_95f9f4c2-8474-48a2-afc3-4d2d03f371c4">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNy01LTEtMS0w_0f3485a2-b412-42d5-ab5e-d38210fe45ca">1,650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic38fa4c27d674faaa2153103268bc6f2_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfOC0xLTEtMS0w_0c545d41-e79d-4c33-9e2f-a165b61f844b">562,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07543f61382c4935bdeec18bab41cc0e_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfOC0zLTEtMS0w_dfdf0af8-1e7b-400c-ab1c-40bb750e8d8b">41,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3afb9956061e4743b8afadadf5214bfe_I20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfOC01LTEtMS0w_66f582cc-2a47-410a-8f22-251b27b47f31">604,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div></ix:nonNumeric><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"><ix:continuation id="i4a4c6f072c3a4f959b5ab740d77f2412" continuedAt="ibc8c323bf5e84c1b8f5caa92cb0db7e6">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"><ix:continuation id="ibc8c323bf5e84c1b8f5caa92cb0db7e6">Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item.</ix:continuation> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments that are exposed to concentrations of credit risk principally consist of cash, cash equivalents, marketable securities, contract assets &#8211; commissions receivable, and accounts receivable. We invest our cash and cash equivalents with major banks and financial institutions and such investments are in excess of federally insured limits. We also have deposits with major banks in China that are denominated in both U.S. dollars and Chinese Yuan Renminbi and are not insured by the U.S. federal government. The deposits in China were $<ix:nonFraction unitRef="usd" contextRef="i523d407abcc34388915c073912053b35_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:Deposits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfMzQ3Nw_af58861b-c51e-4e2e-becc-f0a3cb4e478f">3.8</ix:nonFraction>&#160;million as of September 30, 2021. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information regarding our marketable securities.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i21f5c7a09f66423ab3253586a171e762"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not require collateral or other security for either our contract assets or accounts receivable. <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNDIzNA_366fae82-ba0a-4bd0-a565-284ae9e5220c" continuedAt="ide7759efb63742b7b682129f86fcbd29" escape="true">Carriers that represented 10% or more of our total contract assets and accounts receivable balance are summarized as of the dates presented below:</ix:nonNumeric></span><ix:continuation id="ide7759efb63742b7b682129f86fcbd29" continuedAt="iee4de4636e744608a470f5c0fb86792f"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id2046c7d044743ceaad71b60d4431854_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfMS0xLTEtMS0w_138e395f-10b7-418d-bef2-e2b27ca0c10e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i352b2ea156634799b87eb09859219c43_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfMS0zLTEtMS0w_553ac249-7b76-410d-b5e9-94cee2e7ea4f">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthCare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i29e568455e4e48e0a5ef2ebf86b689a0_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfMi0xLTEtMS0w_674c8937-39c2-48b8-8647-e60930d9822d">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7fc6666241c84c42af5630376e4ae6d3_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfMi0zLTEtMS0w_92aea5e0-ba73-45af-91e6-b2c72031cd40">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aetna</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a7cfd923d224bb6b7fe901abc5d9385_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfMy0xLTEtMS0w_bb5a4321-3fa2-4f21-948f-40cd28f0ecb1">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i850ab8c5df8746729fb79a1ced686481_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfMy0zLTEtMS0w_964e142e-c38b-4211-b0d3-a26a4b50a053">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86f303cf73634348bebc5dab18fff7f4_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfNC0xLTEtMS0w_25814a18-e161-40ec-b1fe-b3b09bbb8c09">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibaab6d0a0d8545a186157b9fcb246894_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfNC0zLTEtMS0w_1a7d2579-4381-40d0-9683-97244dac35e3">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><ix:continuation id="iee4de4636e744608a470f5c0fb86792f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Percentages include the carriers' subsidiaries.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the contract assets and accounts receivable of WellCare are included in the percentage calculation for September 30, 2021 and December 31, 2020.</span></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid Expenses and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets &#8211; </span><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNDI0MQ_f980755e-3b58-4aa7-a484-f46c7c56eb23" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our prepaid expenses and other current assets are summarized as of the periods presented as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.276%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid maintenance contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:PrepaidMaintenanceContractsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfMS0xLTEtMS0w_0a78b057-3287-4e67-a2b4-cbf3a29baa3f">8,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="ehth:PrepaidMaintenanceContractsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfMS0zLTEtMS0w_8bb3a347-8792-491e-b976-b37976b4d0e3">7,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:PrepaidLicenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfMi0xLTEtMS0w_816f199c-b876-4813-aee7-4d962ca9a8e6">3,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:fixed-zero" name="ehth:PrepaidLicenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfMi0zLTEtMS0w_26d616dd-ccfa-4707-97d5-84573aabda9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfMy0xLTEtMS0w_59ae1d75-b193-4010-b6e7-550fc6c02102">23,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfMy0zLTEtMS0w_7991bcd8-7a78-4fd8-876a-fd008cf386c1">6,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfNC0xLTEtMS0w_56a0004c-a19d-4ebc-b9c6-1b481412378d">672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidInsurance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfNC0zLTEtMS0w_12e39c1c-d329-41a1-877a-faaf9d7566b2">1,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfNi0xLTEtMS0w_51b18a37-725f-499a-b8d4-cfba7961db53">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfNi0zLTEtMS0w_b6c964c3-2212-46a8-a6d8-1e36c72ce3de">646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfNy0xLTEtMS0w_97a7fb5f-8ad3-41d9-9126-6c6983145421">36,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfNy0zLTEtMS0w_889e4157-509a-4d40-91a2-654171c81c73">16,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RleHRyZWdpb246YzJhNTRiYWY4YjkxNDJhNTg1MDliZjc2NmZmNWEyYTZfMjQ2NQ_2db5619b-40aa-4a42-8200-e2f77ecf1897" continuedAt="i50de30f8960b43d4891d26b06f81f8d1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i50de30f8960b43d4891d26b06f81f8d1" continuedAt="if5b898773c9b40418740ced6af809ebe"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define fair value as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques we use to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RleHRyZWdpb246YzJhNTRiYWY4YjkxNDJhNTg1MDliZjc2NmZmNWEyYTZfMjQ3Mw_317891ca-63bc-4802-8800-cdc3aaef1fb0" continuedAt="i22dfd1d1e1db4165a95aa788e73b00bd" escape="true">We classify the inputs used to measure fair value into the following hierarchy:</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div><ix:continuation id="i22dfd1d1e1db4165a95aa788e73b00bd"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.129%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unadjusted quoted prices in active markets for identical assets or liabilities.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs for the asset or liability.</span></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="if5b898773c9b40418740ced6af809ebe" continuedAt="i399723c139734ac38648545e536c00d2"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RleHRyZWdpb246YzJhNTRiYWY4YjkxNDJhNTg1MDliZjc2NmZmNWEyYTZfMjQ2Nw_f882c011-8891-44ca-884d-3be3f19669b7" continuedAt="i711a512b540d49da8d5a877d0b56fecf" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial assets measured at fair value on a recurring basis are summarized below by their classification within the fair value hierarchy as of the dates presented below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.969%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47719e7e84e544339538a6b07e7b4dff_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNC0xLTEtMS0w_8c3cc523-c80a-4494-a1f0-bf1679738634"><ix:nonFraction unitRef="usd" contextRef="i47719e7e84e544339538a6b07e7b4dff_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNC0xLTEtMS0w_e3c83499-acf1-4230-bc1a-a88380225bf9">19,371</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib53890909b2842a6922819e1edeaa771_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNC0zLTEtMS0w_139853a5-ddf5-471d-8f77-6c492256de9b">19,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa1c7c5fa3884882909610f165c0d007_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNC01LTEtMS0w_26643c56-3c90-43a1-a272-aafed4d44844">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5610009dd37b4384bc33a616a6aab127_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNC03LTEtMS0w_4119d34c-e6b5-4291-91d3-70d758464c3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50134f65952c447c8536c4c509d440b0_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNC05LTEtMS0w_2da19d0b-90f8-4611-ae1e-589c248aca20">19,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e7212367a01499c93d6d4b809f9ed9c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNS0xLTEtMS0w_91c27bde-2731-4b2e-8d0c-6de16b83352b">100,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad309707646240918be65ddd93e7dcf8_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNS0zLTEtMS0w_1b6ab3cf-8fc0-40df-9315-34ce87a505f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5d5ade3741d4a9185c2b653a4af9ecb_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNS01LTEtMS0w_d0e34237-6729-4114-acb5-87039fda36a6">100,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f15061ad6e471cbda9021bf8810571_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNS03LTEtMS0w_907dfb85-a865-4478-921f-07b3361d768d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie38b6c1b1c9c45fdba0d48aa1ce710c2_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNS05LTEtMS0w_a0277e36-efff-4245-ad6d-bd5555466819">100,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2deb8ce979e4e7ebc3e73924fdf8984_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOC0xLTEtMS0w_5fc9ceb6-45d6-4785-adec-56bdad18fa19">1,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4abea0af5374b2ea1c4c1f3394ae378_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOC0zLTEtMS0w_9136d07d-2569-4a53-b6d2-cbfb2b449500">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20249488a86d4517ad2ce8519062fb47_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOC01LTEtMS0w_2545d599-8f0f-4553-8a47-b331081b30be">1,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1196177b8cd4b4889d59fe382f0884a_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOC03LTEtMS0w_55b7dce2-78c2-40c4-a722-aa8d4d5f43e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6f25d09031048a4ad52c1658b5f4ec4_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOC05LTEtMS0w_a6106d31-97e1-4111-9a4e-e80c45ba67ad">1,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336d38756e4c40b1ba67a778fec1c8b7_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOS0xLTEtMS0w_60f3064a-c9c5-4cce-90bd-1c382336e3ec">66,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24ead09862b2413a86a888c37af9278b_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOS0zLTEtMS0w_43bf04be-7f81-45cf-b6be-1da2eafdf25f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d257f4867664e9e9883a4c86aab2afc_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOS01LTEtMS0w_40714407-f7d9-476d-a6a2-d09f1b305096">66,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id70b3e6e37f5474eac6b0c1c37de4585_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOS03LTEtMS0w_112c8713-bf9a-4578-a825-12f03d7b53d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85a1662f85774554ac4dd94f6a4bd607_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOS05LTEtMS0w_9fd25e9e-c66a-48c8-a417-86a21da4fbee">66,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bond</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d97d81f0af64632a38c7998284dd90c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTEtMS0xLTEtMA_fd092baa-9a35-42c4-b3a3-28c63829d65e">2,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bb1b3fedcf14b3d9257f06b935d3e4a_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTEtMy0xLTEtMA_5e06c2d8-e6af-4181-9f08-14b75dc128bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70979db466f8423f9755a5fb92cb03ae_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTEtNS0xLTEtMA_f179278d-4bef-402f-ad2f-3a2c088fe188">2,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7fa9733a3384f39b6dcfeb1f1ee2a6f_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTEtNy0xLTEtMA_95ad2f0d-5434-4d24-94b6-b7e8cc2423c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7fcfcdb20334394afbf1256cc0e0662_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTEtOS0xLTEtMA_fb5a6ea2-0c89-4f56-8f42-83337d767451">2,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcd9ed25d2764e9db6588f766c6ceb7c_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTQtMS0xLTEtMA_a2c9f289-4949-4eb5-9a69-d68d992e6845">189,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i491b5e834621498ca113938980a0be07_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTQtMy0xLTEtMA_1c945384-b4fc-4593-9114-8aa3de8c77ac">19,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id423dd6355054bb288a4cc0434f373bf_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTQtNS0xLTEtMA_8f0854b2-1870-4e8f-910e-91ff3ddc42be">170,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic58f49a9465c47028f47e4656f464863_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTQtNy0xLTEtMA_ade39669-66b3-4b71-8fb3-99e23daac2af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i129ac8211d8e4c0ba7a255b8dab26a32_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTQtOS0xLTEtMA_1101848a-c224-4cc4-aaf9-b80b8c0aaef8">189,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:50.366%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bcd9764a5744c69a32ac980ad18308e_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNC0xLTEtMS0w_e06d6202-b81c-4b96-a5d7-bae343786fce">4,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e09372bd664c3ab1b9f51f41199eb8_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNC0zLTEtMS0w_3603e990-6d4b-4725-87f8-92840a10bb10">4,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd42b9bb33c044dbb1de60bee9c42876_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNC01LTEtMS0w_ceaf35f4-fddd-4f0c-9e6f-a180b6932f2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec3221d11bf648bfb054e3fc5ae908f2_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNC03LTEtMS0w_707bb74a-8708-4ead-a98b-37710bf83648">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd4b24a0a2e341d199c0c81e18f6fe7a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNC05LTEtMS0w_7161224f-42e7-4a4a-8e4f-05a05f76a4dd">4,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i717e94aee1cb438cabdc9a27ae11551f_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNi0xLTEtMS0w_d73fda8f-82a6-4675-bfe5-ea0fc7b5a1fe">35,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef7c7b9f546496b9cfa4c224aed630e_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNi0zLTEtMS0w_0212dfce-7690-43ca-b8a8-da5b36f7b77e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506a76e2d8ca425cbdb5ae11dd6cd259_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNi01LTEtMS0w_d5dae0a1-c18b-4a40-81a3-caddda5042fd">35,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i746a758123914e1d937d531d3b4f1360_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNi03LTEtMS0w_a3ac61dd-ced8-45bc-9384-2e298ee9fcba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5847226e38d1465db0569a5ceb228ff4_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNi05LTEtMS0w_0a87ff3f-05d5-4967-b95a-3847649edda0">35,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i002e42fc0f9446dea52b4be056b82628_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNy0xLTEtMS0w_35087fef-281d-4705-beb0-76bf0882eba2">14,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f22b60783114271b6d18262ae59b3e5_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNy0zLTEtMS0w_d1e9cb8d-8551-4238-b968-cdfdc2a8f44b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i723227d94b364d578aed1bb6c4c7d173_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNy01LTEtMS0w_06c31b95-826b-4a63-9594-ee14c2b73165">14,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd22cf0dccc41498bd9e877ebc39f93_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNy03LTEtMS0w_d003e7e1-18ea-41e2-93b0-ff0326cbd744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i980493d2590e4651b3a1f828bf64d0e6_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNy05LTEtMS0w_d829ac3f-088c-41d6-b687-63ac3ec38fa0">14,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae0c078eeb4f4e9eb08d1321632981e8_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfOC0xLTEtMS0w_e02209d6-c147-4f69-a895-0e3fc6a6379f">53,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40bd3241bac4466a336bb6f5771fbef_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfOC0zLTEtMS0w_57b4c4c9-a0fb-4b09-8580-01bd8777d6cf">4,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dd7aca5034144ce9adb12f61bcad4b2_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfOC01LTEtMS0w_faad7800-2110-4f79-b454-b46f64b7fef7">49,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f3ecf18721d481caad5f826b596a46f_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfOC03LTEtMS0w_1cb04f62-22f9-4bb3-be96-1c11702a4bb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dba4eac468c476b9642c00c8d545983_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfOC05LTEtMS0w_3d5c76e2-8cc2-448c-bf95-f5893e271526">53,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i711a512b540d49da8d5a877d0b56fecf">As of September 30, 2021, o</ix:continuation>ur cash equivalents consisted of money market funds and commercial paper with original maturity of 90 days or less were classified as Level 1 and 2, respectively. We endeavor to utilize the best available information in measuring fair value. We used observable prices in active markets in determining the classification of our money market funds as Level 1. Our Level 2 assets consisted of available for sale marketable securities, which included commercial paper, agency bonds, and a corporate bond with maturities of less than one year. We classify our marketable debt securities within Level 2 in the fair value hierarchy, because we use quoted market prices to the extent available or alternative pricing sources and models utilizing market observable inputs to determine fair value. Our portfolio primarily consisted of financial instruments with a credit rating of AA or equivalent by S&amp;P Rating and Moody's Investor Services. There were no transfers between the hierarchy levels during either the nine months ended September 30, 2021 or the year ended December 31, 2020. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RleHRyZWdpb246YzJhNTRiYWY4YjkxNDJhNTg1MDliZjc2NmZmNWEyYTZfMjQ3Mg_7ae960f4-0c38-4ea1-ad73-e590293313e7" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash equivalents and available-for-sale debt securities by contractual maturity (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjJlZTRmYzBlYzljNzQxZTRiMThlYTUxN2E1OGM3ZGRlL3RhYmxlcmFuZ2U6MmVlNGZjMGVjOWM3NDFlNGIxOGVhNTE3YTU4YzdkZGVfMi0xLTEtMS0w_4f3960b1-fe84-4e4d-9daf-366ac4376be0">189,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjJlZTRmYzBlYzljNzQxZTRiMThlYTUxN2E1OGM3ZGRlL3RhYmxlcmFuZ2U6MmVlNGZjMGVjOWM3NDFlNGIxOGVhNTE3YTU4YzdkZGVfMi0zLTEtMS0w_b21e82f2-0d6f-4321-b51a-74a1b3c91357">189,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i399723c139734ac38648545e536c00d2" continuedAt="if0fe1780c2154a82b7f6721cc73b4b62"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RleHRyZWdpb246YzJhNTRiYWY4YjkxNDJhNTg1MDliZjc2NmZmNWEyYTZfMjQ2NA_16bdfc95-d159-4473-bd11-e5d35dd33b4e" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gains and losses on available-for-sale debt securities that are not credit related are included in accumulated other comprehensive income and summarized as follows as of September 30, 2021 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b68294e77e84233b3a350690a075beb_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMi0xLTEtMS0w_b18087aa-c2c9-4f86-ab50-d7640b870e22">19,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b68294e77e84233b3a350690a075beb_I20210930" decimals="-3" format="ixt:fixed-zero" name="ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMi0zLTEtMS0w_25be5938-46a4-446b-af60-96083d2252c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b68294e77e84233b3a350690a075beb_I20210930" decimals="-3" format="ixt:fixed-zero" name="ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMi01LTEtMS0w_28a49f21-556f-4798-9d61-eb3db1dc3791">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b68294e77e84233b3a350690a075beb_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMi03LTEtMS0w_aa1ab839-c595-496f-be66-c1f2d9e2b8f5">19,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007949f0ecbd4d28a3fc49a2fbb4899d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMy0xLTEtMS0w_91596cc5-b0bb-4d66-a4b8-b8e05524ca56">100,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007949f0ecbd4d28a3fc49a2fbb4899d_I20210930" decimals="-3" format="ixt:fixed-zero" name="ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMy0zLTEtMS0w_5f7225b6-6670-43b1-95c1-a6f912f1f038">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i007949f0ecbd4d28a3fc49a2fbb4899d_I20210930" decimals="-3" name="ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMy01LTEtMS0w_ece2cee4-c88d-41e3-8296-7ff1773a1348">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007949f0ecbd4d28a3fc49a2fbb4899d_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMy03LTEtMS0w_5f13473d-6759-42fd-94fd-84072f10f390">100,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88748e076ec49309ce124b0255894ee_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNi0xLTEtMS0w_df01d1a4-807b-48ba-a7e4-7c27f69ff1c9">1,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88748e076ec49309ce124b0255894ee_I20210930" decimals="-3" format="ixt:fixed-zero" name="ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNi0zLTEtMS0w_f7691255-481b-4764-8d44-484098846355">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88748e076ec49309ce124b0255894ee_I20210930" decimals="-3" format="ixt:fixed-zero" name="ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNi01LTEtMS0w_da816915-5f43-415b-97b3-465324485c6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia88748e076ec49309ce124b0255894ee_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNi03LTEtMS0w_d193f0d5-1a5a-41be-bda6-5de2afddc67e">1,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81970b5cc22849c79344d636832e6166_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNy0xLTEtMS0w_0a794fcc-3238-46b1-a0bb-4d5d056d4e23">66,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81970b5cc22849c79344d636832e6166_I20210930" decimals="-3" name="ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNy0zLTEtMS0w_69cd2caf-3743-4a15-bcce-c6138db453da">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81970b5cc22849c79344d636832e6166_I20210930" decimals="-3" name="ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNy01LTEtMS0w_f377fb9b-d21c-4ef4-a5bb-2f24f9d89ede">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81970b5cc22849c79344d636832e6166_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNy03LTEtMS0w_16d49b23-e59e-4932-b2a6-2c9b8b08c5cb">66,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bond</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c9f97d16144d79b7c6fc675d93c63f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfOC0xLTEtMS0w_3b88de48-4cde-4900-8811-351a0d9d1a2f">2,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c9f97d16144d79b7c6fc675d93c63f_I20210930" decimals="-3" format="ixt:fixed-zero" name="ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfOC0zLTEtMS0w_a38635c5-a35a-4b26-83d1-02dc51406fb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c9f97d16144d79b7c6fc675d93c63f_I20210930" decimals="-3" format="ixt:fixed-zero" name="ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfOC01LTEtMS0w_9e1bcacd-7e9d-480a-b092-32340eb0cd2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62c9f97d16144d79b7c6fc675d93c63f_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfOC03LTEtMS0w_9975e96a-0729-4766-a2bd-563313b2aae0">2,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMTEtMS0xLTEtMA_c1ee966d-6abd-4572-9761-9486ce6c6474">189,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" name="ehth:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMTEtMy0xLTEtMA_cdcd3dc2-b561-42dd-83d9-c0e493742644">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" name="ehth:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMTEtNS0xLTEtMA_0558f0c2-7314-491f-88c0-b57aee4ada59">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:CashCashEquivalentsAndAvailableForSaleDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMTEtNy0xLTEtMA_df8b00c9-0f1f-4d34-b476-ea5bafa66be0">189,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if0fe1780c2154a82b7f6721cc73b4b62">As of September 30, 2021, we had <ix:nonFraction unitRef="security" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RleHRyZWdpb246YzJhNTRiYWY4YjkxNDJhNTg1MDliZjc2NmZmNWEyYTZfMjA4Mg_f02bbf4e-884b-4a76-80cb-457bb902f031">forty-one</ix:nonFraction> securities in net loss positions and their unrealized losses were immaterial individually and in aggregate. We did not record any credit losses regarding our available-for-sales debt securities during the nine months ended September 30, 2021. We do not intend to sell these securities and it is more likely than not that we will not be required to sell these securities before the recovery of their amortized cost basis.</ix:continuation> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMTAzMQ_909debda-5a9a-4e81-a51c-d1934f9137a6" continuedAt="iecf48b7187b3468790cd2ac23b81b1f5" escape="true">Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iecf48b7187b3468790cd2ac23b81b1f5" continuedAt="i4e301bbdc95442c7a05e7f6d0fc4f462"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Inducement Plan &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 22, 2021, the Company adopted an inducement plan (the &#8220;2021 Inducement Plan&#8221;), pursuant to which the Company reserved <ix:nonFraction unitRef="shares" contextRef="ie5b86e4a17824c849cfbd6758868c90c_I20210922" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMjc0ODc3OTA3MzIzNA_6aff4547-8851-490f-8f8f-ea17539c9513">410,000</ix:nonFraction> shares of its common stock (subject to customary adjustments in the event of a change in capital structure of the Company) to be used exclusively for grants of awards to individuals who were not previously employees or directors of the Company, other than following a bona fide period of non-employment, as an inducement material to the individual's entry into employment with the Company within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules (&#8220;Nasdaq Rules&#8221;). The Inducement Plan was approved by the Company's board of directors (the &#8220;Board&#8221;) without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Rules, and the terms and conditions of the Inducement Plan and awards to be granted thereunder are substantially similar to the Company's stockholder-approved Amended and Restated 2014 Equity Incentive Plan.  As of September 30, 2021, <ix:nonFraction unitRef="shares" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMjc0ODc3OTA3MzQ4Ng_2bb787c9-72d7-436e-b5e9-05c60cb824bf">no</ix:nonFraction> shares were issued under the 2021 Inducement Plan. Subsequently, <ix:nonFraction unitRef="shares" contextRef="i772c44978dc24667b2c627577234e585_D20211001-20211108" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMjc0ODc3OTA3NDU1MQ_ec7c8aa9-b264-4200-83ca-e1a1c5e8793e">390,584</ix:nonFraction> shares were issued under the 2021 Inducement Plan in October 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Programs &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="shares" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfNDk_177a2203-bdb7-4090-b036-f1461836cf21"><ix:nonFraction unitRef="shares" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:TreasuryStockSharesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfNDk_7d5afe05-1061-422b-85fe-0191407ff0a4">no</ix:nonFraction></ix:nonFraction> stock repurchase activity during the three and nine months ended September 30, 2021. In addition to <ix:nonFraction unitRef="shares" contextRef="i35c1fdbec1c54ee8a4e0d47f73f57d02_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfOTc_a550bd49-bd56-4f46-a0c5-93a41f250da1">10.7</ix:nonFraction> million shares repurchased under our previous repurchase programs, we have in treasury <ix:nonFraction unitRef="shares" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="ehth:TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMTc5_7d1903d3-7ca3-4778-a321-39ad4731b708">1.3</ix:nonFraction> million shares as of September 30, 2021 that were previously surrendered by employees to satisfy tax withholding due in connection with the vesting of certain restricted stock units. As of September 30, 2021 and December 31, 2020, we had a total of <ix:nonFraction unitRef="shares" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMzc2_89d71a65-9c06-4d34-a94d-390cef948683">12.0</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMzkw_05483b54-f3de-49ff-b18b-9b537712ee28">11.8</ix:nonFraction> million shares, respectively, held in treasury. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For accounting purposes, common stock repurchased under our stock repurchase programs is recorded based upon the settlement date of the applicable trade. Such repurchased shares are held in treasury and are presented using the cost method.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i4e301bbdc95442c7a05e7f6d0fc4f462"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="ehth:ScheduleOfStockBasedCompensationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMTAyOQ_48893d6f-ad86-4995-b858-315a789e7025" continuedAt="i659178da01224448a6a1402e05cc126a" escape="true">Our stock-based compensation expense is summarized as follows by award types (in thousands):</ix:nonNumeric></span></div><ix:continuation id="i659178da01224448a6a1402e05cc126a"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c6e47a0194e4a0d80cb752cc22efef5_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMi0xLTEtMS0w_17438b96-bc6d-486f-8301-30adf7403c43">4,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13884cc2d99e4cdca2c6d705a5357058_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMi0zLTEtMS0w_4b88a39f-4ce7-41ed-b499-d409fbd04325">6,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff865bc5ba294fe1a8f363fa0a398bae_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMi01LTEtMS0w_96f7b525-cee2-4d82-93a8-a6e741511488">23,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if870e8c7cb0242ba8a5c2b4b20121f1f_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMi03LTEtMS0w_8d3a1ae1-2d6e-4a2f-9904-bced1ac5868a">20,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27e01cc9738244978808f5a333f4fb54_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMy0xLTEtMS0w_ef6e8912-e7ef-4489-bc43-1243a3d1788b">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i460c059f80ca40628e4e5afaff80cc5e_D20200701-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMy0zLTEtMS0w_2870a32f-5393-40c6-b054-ba42eb5f3dda">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58966c27927746fab2aa950798c6ed8e_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMy01LTEtMS0w_b4a8af3c-1286-4b87-88d7-2e1a3d9f730f">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cead6ea1a294d599363076673911adf_D20200101-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMy03LTEtMS0w_40b4e7cf-70a3-4f16-9025-a1ff0b175699">867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife779febc9214b9d9f667dc5dce85356_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNC0xLTEtMS0w_581256bd-d9cf-41c0-ac9d-053919176b10">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecda63b246a6400e9b5384de30aae603_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNC0zLTEtMS0w_4eb5b7ce-4b71-449a-ac0e-090f545968f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4fedf3dee684a9698a7fa96f6d62fd4_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNC01LTEtMS0w_6f684abb-3543-45f4-b0bb-b695520c9646">1,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb486a863af4417a98de87d059c62b5_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNC03LTEtMS0w_9a029512-a7d5-47f6-b39a-c04afb2d83dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNS0xLTEtMS0w_0146ff14-0dad-4373-8fbc-775e67e20c9f">5,234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNS0zLTEtMS0w_a2b55fc4-2750-4e86-99a7-92d10b27b760">6,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNS01LTEtMS0w_3bad2193-39a7-46ba-9a07-48f49077f4d1">24,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNS03LTEtMS0w_023d1cf6-51d1-4067-8faa-8645ec23298a">21,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Amounts include market-based and performance-based restricted stock units.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="ehth:ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMTAyMQ_499ecddc-4336-4963-979e-280604554a65" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense by operating function for the periods presented below&#160;(in thousands):&#160;</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"></td><td style="width:39.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.207%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.207%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.207%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.209%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing and advertising</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5734b0b91d441278f565d646dc3d8b0_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMi0xLTEtMS0w_28cb2f6a-9cc1-4c01-97c7-c0b9fe4ca972">2,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8edbc452bd9741e797e8dbd8b3399e72_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMi0zLTEtMS0w_a584bd75-54ce-42ef-8832-444ccb7103a8">1,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice545f8f5bdb4b2fbe3864ed0eea00e2_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMi01LTEtMS0w_48ed3516-6b28-4378-b74d-03306e162854">6,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90df302f532b402fa538eed1092beab9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMi03LTEtMS0w_e143af2d-8316-49cd-94ff-e8a2422f3a94">5,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer care and enrollment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a5df46f99ab4327bcb5856e5d342696_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMy0xLTEtMS0w_b0bdef97-256a-410c-a4c7-5cb92f9bbef2">740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic776873fdaff4484b896e658fb1dacfc_D20200701-20200930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMy0zLTEtMS0w_6c68752d-1d62-4e87-9b6b-ffcb4285ce8c">527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f1064a52d154cec94e9b6c3036d94f7_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMy01LTEtMS0w_f20d0586-84e6-404f-9c9b-b71791a9831e">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5086b187a3b4d09a240002bc9755ba1_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMy03LTEtMS0w_4ce5dc15-8331-41ac-8d99-e0d31cfc9793">1,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology and content</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibad2aa3a8cc44b218b307dfd6f4d7625_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNC0xLTEtMS0w_cb9606ca-79e4-449d-b93f-4a32c1026a2a">2,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bd41afc910548ce9002b75544cdf8b6_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNC0zLTEtMS0w_83134c62-ac1e-49cc-8f04-bdf4afcd9517">1,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61ff6162f5f44a859043de58c54befec_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNC01LTEtMS0w_bbaafff1-9aff-4a09-b630-3dd77679a23f">7,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98ea343e414e4f2daab5caa63d2dd869_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNC03LTEtMS0w_2d21ba05-dc95-4082-8556-563d016c1d2a">2,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i154a3a36dc224680b714cc68444215d8_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNS0xLTEtMS0w_522fd74d-a64e-448b-a3f8-d472c905128b">183</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb4e953743a04c219eeb943727baf738_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNS0zLTEtMS0w_c9b2cf6e-1010-443a-b661-fc81cecee19b">2,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9890280d5b954508a226b55c81aeaf25_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNS01LTEtMS0w_cce9718d-f683-4960-a39c-80c6d2864f4f">8,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c5deda3fcee4a46bf2d57a2cb6c387e_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNS03LTEtMS0w_d58e2fbd-eb29-40e4-8d02-49ef23b2388d">11,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNy0xLTEtMS0w_51fc82b6-bd6a-4895-ad7c-284618fdc903">5,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNy0zLTEtMS0w_95ae30d8-e733-40de-a553-66ef7f471018">6,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNy01LTEtMS0w_90b0c5d9-fa76-492d-9c7e-f7f7b3c24b6d">24,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNy03LTEtMS0w_3b41b7e4-0aa8-4103-86b8-97002304854f">21,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount capitalized in internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOC0xLTEtMS0w_08e5b362-c4fe-4646-8000-4d1f5709330a">772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOC0zLTEtMS0w_f24e365f-3b67-45c9-8fe6-a547f7eaeda6">548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOC01LTEtMS0w_99de9a82-bbd7-4039-af0e-7a4bc10712f7">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOC03LTEtMS0w_0cfcbe80-9483-47ac-a3c8-51375ca65f76">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOS0xLTEtMS0w_19748f36-c814-4675-a704-06218203649c">6,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOS0zLTEtMS0w_9632c59d-8447-44e1-9c29-3cbd16dd6ef7">6,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOS01LTEtMS0w_28253f2e-297e-4465-b8c2-64baa8d22edd">26,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOS03LTEtMS0w_30efbe4e-3575-40f6-a824-181b5935c364">23,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Stock-based compensation expense for both three and nine months ended September 30, 2021 was impacted by a $<ix:nonFraction unitRef="usd" contextRef="i538a335bee9d4605ac36f25f4181afa7_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMTA5OTUxMTYzMjI5Nw_7726ef97-c3e8-483d-b723-efcd82f92d10"><ix:nonFraction unitRef="usd" contextRef="i05a980eb0e6b4490bb82b24144c3b3c8_D20210701-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMTA5OTUxMTYzMjI5Nw_bc3308b7-e9d9-41e2-8bbf-ce40158b1a2c">4.1</ix:nonFraction></ix:nonFraction>&#160;million credit related to forfeited equity awards due to our chief executive officer's separation.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6 &#8212; <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:PreferredStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfOTUyOA_dcdc669b-ec11-4bea-b4ef-cc121517e7a2" continuedAt="icfa103ac0e7e4753937219c1076f4bf4" escape="true">Convertible Preferred Stock</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="icfa103ac0e7e4753937219c1076f4bf4" continuedAt="i1e62616d05214e5ca06a9239764f3798"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2021 (the &#8220;Closing Date&#8221;), we issued and sold to Echelon Health SPV, LP (&#8220;H.I.G.&#8221;), an investment vehicle of H.I.G. Capital, in a private placement, <ix:nonFraction unitRef="shares" contextRef="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMTY0_86e95a49-4fdf-4051-95d0-b1f4e4af4248">2,250,000</ix:nonFraction> shares of our newly designated Series A convertible preferred stock (the &#8220;Series A preferred stock&#8221;), par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i26a73d8f5e7749d9aa6a2add8248dab7_I20210430" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMjc5_6c9b2735-1eb7-4d8e-a870-30dd3403e926">0.001</ix:nonFraction> per share, at an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430" decimals="-5" format="ixt:num-dot-decimal" name="ehth:SaleOfStockConsiderationReceivedOnTransactionGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMzI3_d930209a-6102-453a-9ee4-f33562874f4a">225.0</ix:nonFraction>&#160;million. We received $<ix:nonFraction unitRef="usd" contextRef="i26a73d8f5e7749d9aa6a2add8248dab7_I20210430" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMzQz_ba64ff5c-4e3b-4dbf-b0d6-af34bb0608e0">214.0</ix:nonFraction>&#160;million in net proceeds from the private placement with H.I.G., net of sales commissions and certain transaction fees totaling $<ix:nonFraction unitRef="usd" contextRef="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNDY1_7fae3db9-e63c-4392-91f8-27896adfa5c6">11.0</ix:nonFraction> million. The Series A preferred stock ranks senior to all other equity securities of the Company with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Dividends initially accrue on the Series A preferred stock daily at <ix:nonFraction unitRef="number" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="INF" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfODEz_9d0db2d5-5fbc-417d-a2f2-47029f401cf5">8</ix:nonFraction>% per annum on the stated value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="INF" name="ehth:PreferredStockConvertibleStatedValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfODQ5_57b6d49e-d9aa-478f-9dd7-97eb0c003ee4">100</ix:nonFraction> per share (&#8220;Stated Value&#8221;) and compound semiannually, payable in kind (&#8220;PIK&#8221;) until the second anniversary of the Closing Date on June 30 and December 31 of each year (each, a &#8220;Dividend Payment Date&#8221;), beginning on June 30, 2021, and thereafter <ix:nonFraction unitRef="number" contextRef="i2066383d954548c7a2a439ea4837e924_D20230630-20230630" decimals="INF" name="ehth:PreferredStockDividendRatePayableInKindPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMTA5Nw_1861b1e0-703b-45c3-ad38-4c4e9d973d66">6</ix:nonFraction>% PIK and <ix:nonFraction unitRef="number" contextRef="i2066383d954548c7a2a439ea4837e924_D20230630-20230630" decimals="INF" name="ehth:PreferredStockDividendRateCashPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMTEwOA_fd2078ae-f195-4384-8fca-cfc49f316e95">2</ix:nonFraction>% payable in cash in arrears on June 30 and December 31 of each year, beginning on June 30, 2023. PIK dividends are cumulative and are added to the Accrued Value (as defined below). &#8220;Accrued Value&#8221; means, as of any date, with respect to any share of Series A preferred stock, the sum of the Stated Value per share plus, on each Dividend Payment Date, on a cumulative basis, all accrued PIK dividends on such share that have not previously compounded and been added to the Accrued Value. The Series A preferred stock participates, on an as-converted basis in all dividends paid to the holders of our common stock.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="i1e62616d05214e5ca06a9239764f3798" continuedAt="id76d7c877751410e853f4fe1270717f6"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Conversion Rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211; The Series A preferred stock is convertible at any time into common stock at a conversion rate equal to (i) the Accrued Value plus accrued PIK dividends that have not yet been added to the Accrued Value, (ii) divided by the conversion price as of the applicable conversion date (the &#8220;Conversion Price&#8221;). As of the date of this report, the Conversion Price is equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="i10b063ee9a3341c08e50e129ebfdff8a_I20210531" decimals="4" name="us-gaap:PreferredStockConvertibleConversionPrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMjIwNw_97aa2126-8b44-4a7f-9b44-28e5b5bc0505">79.5861</ix:nonFraction> per share. This Conversion Price is subject to further adjustment and the number of shares of common stock issuable upon conversion of the Series A preferred stock is subject to certain limitations, each as set forth in the Certificate of Designations of Series A preferred stock, as filed with the Secretary of State of the State of Delaware on April 30, 2021 (the &#8220;Certificate of Designations&#8221;).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption Put Right </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; At any time on or after the sixth anniversary of the Closing Date, holders of the Series A preferred stock will have the right to cause the Company to redeem all or any portion of the Series A preferred stock in cash at an amount equal to the greater of (i) <ix:nonFraction unitRef="number" contextRef="i411da4d1faed43bea99e5a09b88c09cb_I20270430" decimals="2" name="ehth:ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMjg5MA_5d271ed0-e760-4b9a-b299-1b2db52de9b7">135</ix:nonFraction>% of the Accrued Value per share as of the redemption date, plus accrued PIK dividends that have not yet been added to the Accrued Value and (ii) the amount per share that would be payable on an as-converted basis on such Series A preferred stock at the then-current Accrued Value, plus accrued PIK dividends that have not yet been added to the Accrued Value, and in either case of (i) or (ii) plus any unpaid cash dividends that would have otherwise been settled in cash in connection with such conversion (the greater of (i) and (ii), the &#8220;Redemption Price&#8221;).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption Call Right </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; At any time on or after the sixth anniversary of the Closing Date, the Company will have the right (but not the obligation) to redeem out of legally available funds and for cash consideration all (but not less than all) of the Series A preferred stock upon at least <ix:nonFraction unitRef="day" contextRef="i411da4d1faed43bea99e5a09b88c09cb_I20270430" decimals="INF" name="ehth:ConvertiblePreferredStockRedemptionCallRightWrittenNotice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMzc0NQ_5fad303d-4874-4102-bea6-1382a74d004c">30</ix:nonFraction> days prior written notice at an amount equal to the Redemption Price.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Board Nomination Rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211; H.I.G. is entitled to nominate <ix:nonFraction unitRef="state" contextRef="id4e0a9ea40624a0c8ff143de3025b216_I20210430" decimals="INF" format="ixt-sec:numwordsen" name="ehth:ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMzg3Ng_6dc9cc9a-d37e-41f5-959a-f4ef850b4070">one</ix:nonFraction> individual for election to the the Board so long as it continues to own at least <ix:nonFraction unitRef="number" contextRef="id4e0a9ea40624a0c8ff143de3025b216_I20210430" decimals="2" name="ehth:CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMzk5Mw_d4392431-8172-4c1d-bf25-8790b409847c">30</ix:nonFraction>% of the common stock issuable or issued upon conversion of the Series A preferred stock originally issued to it in the private placement. H.I.G. also has the right to nominate an additional individual to the Board if the Company fails to maintain certain levels of commissions receivable and liquidity.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Voting Rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211; The Series A preferred stock will vote together with the common stock as a single class on all matters submitted to a vote of the holders of the common stock (subject to certain voting limitations set forth in, and the terms and conditions of, the Certificate of Designations). Each holder of Series A preferred stock shall be entitled to the number of votes, rounded down to the nearest whole number, equal to the product of (i) the aggregate Accrued Value of the issued and outstanding shares of Series A preferred stock divided by the Minimum Price (as defined below), multiplied by (ii) a fraction, the numerator of which is the number of shares of Series A preferred stock held by such holder and the denominator of which is the aggregate number of issued and outstanding shares of Series A preferred stock. &#8220;Minimum Price&#8221; means the lower of: (i) the Nasdaq Official Closing Price per share of common stock on the Closing Date; or (ii) the average Nasdaq Official Closing Price per share of common stock for the five trading days immediately prior to the Closing Date. Holders of Series A preferred stock will have <ix:nonFraction unitRef="state" contextRef="i26a73d8f5e7749d9aa6a2add8248dab7_I20210430" decimals="INF" format="ixt-sec:numwordsen" name="ehth:ConvertiblePreferredStockVotesPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNTUzMQ_d38cd55b-3a26-4778-baeb-5089cfe9c801">one</ix:nonFraction> vote per share on any matter on which the holders of the Series A preferred stock are entitled to vote separately as a class (subject to certain voting limitations set forth in, and the terms and conditions of, the Certificate of Designations).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Mandatory Conversion of the Series A Preferred Stock  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211; At any time on or after the third anniversary of the Closing Date, if the volume-weighted average price per share of our common stock is greater than <ix:nonFraction unitRef="number" contextRef="i745ac50b018842c299fbdeda74cca4fd_D20240430-20240430" decimals="3" name="ehth:ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNTk4Ng_2ae0b084-6369-4348-af63-405c0d3bc987">167.5</ix:nonFraction>% of the then-current Conversion Price for <ix:nonFraction unitRef="day" contextRef="i745ac50b018842c299fbdeda74cca4fd_D20240430-20240430" decimals="INF" name="ehth:ConvertiblePreferredStockThresholdConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNjAzMA_e7f5c184-4277-479f-8963-024b4d36aba4">20</ix:nonFraction> consecutive trading days in a <ix:nonFraction unitRef="day" contextRef="i745ac50b018842c299fbdeda74cca4fd_D20240430-20240430" decimals="INF" name="ehth:ConvertiblePreferredStockThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNjA2Mw_656cf688-d6bb-4a5f-a3e0-351d9403099e">30</ix:nonFraction>-day trading day period, the Company will have the right to convert all, but not less than all, of the Series A preferred stock into common stock at a conversion rate with respect to each share of Series A preferred stock of (i) the Accrued Value plus accrued PIK dividends that have not yet been added to the Accrued Value, (ii) divided by the then applicable Conversion Price.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Covenants and Liquidity Requirements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211; As long as H.I.G. continues to own at least <ix:nonFraction unitRef="number" contextRef="icb998d550c844cf9af4331570da45fc4_I20210217" decimals="2" name="ehth:ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNjUyOA_54841ddd-9bdb-470f-9ff3-d77f0b9d5ff3">30</ix:nonFraction>% of the Series A preferred stock originally issued to it in the private placement, the consent of H.I.G. will be required for the Company to incur certain indebtedness and to take certain other corporate actions as set forth in the Company's investment agreement with H.I.G. entered into on February 17, 2021 (the &#8220;Investment Agreement&#8221;).  In addition, the Company is required to maintain an asset coverage ratio (as defined in the Investment Agreement) of at least <ix:nonFraction unitRef="number" contextRef="i0e6cbb434882488fb8c40546664dd72a_I20210217" decimals="INF" name="ehth:ConvertiblePreferredStockCovenantAssetCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNjk5Ng_6152b23d-ba80-4c35-a52e-ba7c8a60155c">2</ix:nonFraction>x, which increases to <ix:nonFraction unitRef="number" contextRef="i43de0639e96543369be5664fcb0fb527_I20230817" decimals="INF" name="ehth:ConvertiblePreferredStockCovenantAssetCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNzAyMA_0899e486-623a-458b-b780-aa8019d91641">2.5</ix:nonFraction>x thirty months after the date of the Investment Agreement.  Additionally, the Investment Agreement requires the Company to maintain a minimum liquidity amount (as defined in the Investment Agreement) for certain periods that ranges from $<ix:nonFraction unitRef="usd" contextRef="i6156a60f5d5a4f659313e014d9aa6e94_I20210217" decimals="-6" format="ixt:num-dot-decimal" name="ehth:ConvertiblePreferredStockCovenantLiquidity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNzI2MA_c0eec618-7fb6-4113-af3e-323c39972321">65</ix:nonFraction>&#160;million to $<ix:nonFraction unitRef="usd" contextRef="iee6fe712df744b2590f8f3fc4983ca39_I20210217" decimals="-6" format="ixt:num-dot-decimal" name="ehth:ConvertiblePreferredStockCovenantLiquidity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNzI2Ng_a8d729f6-8c3d-4461-89b2-94c42996c954">125</ix:nonFraction>&#160;million. If the Company fails to maintain the minimum asset coverage ratio or minimum liquidity amount as of a certain date or for a certain time period required by the Investment Agreement and H.I.G continues to own at least <ix:nonFraction unitRef="number" contextRef="icb998d550c844cf9af4331570da45fc4_I20210217" decimals="2" name="ehth:ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNzQ4Nw_508bb041-8144-4b09-bb46-1d26af1b9348">30</ix:nonFraction>% of the Series A preferred stock originally issued to it in the private placement, H.I.G will have the right to nominate an additional director to the Board, and the consent of H.I.G. will be required to approve the Company's annual budget, hire or terminate certain key executives, and incur </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="id76d7c877751410e853f4fe1270717f6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">certain indebtedness as outlined in the Investment Agreement. H.I.G. will no longer have these additional board nomination and consent rights if the Company is able to satisfy the minimum liquidity amount requirements in the Investment Agreement for any subsequent 12 consecutive months.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Series A preferred stock is considered temporary equity in our condensed consolidated financial statements. We have determined there are no material embedded features that require recognition as a derivative asset or liability. We recognized the Series A preferred stock at its stated amount less issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfODM5MA_7fae3db9-e63c-4392-91f8-27896adfa5c6">11.0</ix:nonFraction> million, or $<ix:nonFraction unitRef="usd" contextRef="i26a73d8f5e7749d9aa6a2add8248dab7_I20210430" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfODM5Nw_ba64ff5c-4e3b-4dbf-b0d6-af34bb0608e0">214.0</ix:nonFraction> million.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, the estimated Series A preferred stock redemption value equals <ix:nonFraction unitRef="number" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="2" name="ehth:ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfODQ4Ng_8fba2664-7908-460d-8383-4bad6277e087">135</ix:nonFraction>% of the Accrued Value per share as of the redemption date, plus any accrued and unpaid dividends, which is significantly in excess of the fair value of the common stock into which the Series A preferred stock is convertible as of September 30, 2021. We have elected to apply the accretion method to adjust the carrying value of the Series A preferred stock to its redemption value at the earliest date of redemption, April 30, 2027. Amounts recognized to accrete the Series A preferred stock to its estimated redemption value are treated as a deemed dividend and are recorded as a reduction to retained earnings. The estimated redemption value will vary in subsequent periods due to the redemption put right described above and we have elected to recognize such changes prospectively.  <ix:nonFraction unitRef="shares" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:ConversionOfStockSharesConverted1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfOTI3MA_71867a1e-45b9-4f4f-bfc2-70daa8f7ea0c">No</ix:nonFraction> shares of Series A preferred stock have been converted and the Series A preferred stock was convertible into <ix:nonFraction unitRef="shares" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="ehth:ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfOTM4Mw_914e95ca-bbf4-4fe9-acac-8eaf0f736ce8">2.9</ix:nonFraction>&#160;million shares of common stock as of September 30, 2021. </span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:TemporaryEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfOTUzMA_f408ba6e-9ca4-46c1-a9b6-ef522c415a6a" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the proceeds and changes to our Series A preferred stock (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430" decimals="-3" format="ixt:num-dot-decimal" name="ehth:SaleOfStockConsiderationReceivedOnTransactionGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RhYmxlOjM1M2FkNDlmMjU2OTRhZWQ4OTllNjdmMTI2NDk4YTA0L3RhYmxlcmFuZ2U6MzUzYWQ0OWYyNTY5NGFlZDg5OWU2N2YxMjY0OThhMDRfMC0yLTEtMS0w_fd03dff4-bea8-481c-81bd-af0587b93d75">225,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RhYmxlOjM1M2FkNDlmMjU2OTRhZWQ4OTllNjdmMTI2NDk4YTA0L3RhYmxlcmFuZ2U6MzUzYWQ0OWYyNTY5NGFlZDg5OWU2N2YxMjY0OThhMDRfMS0yLTEtMS0w_81152123-039e-4b11-8851-78e0ec9b1fa3">10,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RhYmxlOjM1M2FkNDlmMjU2OTRhZWQ4OTllNjdmMTI2NDk4YTA0L3RhYmxlcmFuZ2U6MzUzYWQ0OWYyNTY5NGFlZDg5OWU2N2YxMjY0OThhMDRfMi0yLTEtMS0w_2fd2b0df-6fbc-4c78-9f16-65414a297ec9">214,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of Closing Date</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26a73d8f5e7749d9aa6a2add8248dab7_I20210430" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RhYmxlOjM1M2FkNDlmMjU2OTRhZWQ4OTllNjdmMTI2NDk4YTA0L3RhYmxlcmFuZ2U6MzUzYWQ0OWYyNTY5NGFlZDg5OWU2N2YxMjY0OThhMDRfNC0yLTEtMS0w_b03de381-8cf6-4240-8f81-f5069daf57aa">214,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued paid-in-kind dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a83bcf547574a6b95583d2323256a2f_D20210430-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAccretionOfDividends" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RhYmxlOjM1M2FkNDlmMjU2OTRhZWQ4OTllNjdmMTI2NDk4YTA0L3RhYmxlcmFuZ2U6MzUzYWQ0OWYyNTY5NGFlZDg5OWU2N2YxMjY0OThhMDRfNS0yLTEtMS0w_c820e7a3-3008-4b53-a358-7710501720f0">7,643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in preferred stock redemption value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a83bcf547574a6b95583d2323256a2f_D20210430-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RhYmxlOjM1M2FkNDlmMjU2OTRhZWQ4OTllNjdmMTI2NDk4YTA0L3RhYmxlcmFuZ2U6MzUzYWQ0OWYyNTY5NGFlZDg5OWU2N2YxMjY0OThhMDRfNi0yLTEtMS0w_9e1dfc74-1767-490e-8691-3dce8ebf49eb">3,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RhYmxlOjM1M2FkNDlmMjU2OTRhZWQ4OTllNjdmMTI2NDk4YTA0L3RhYmxlcmFuZ2U6MzUzYWQ0OWYyNTY5NGFlZDg5OWU2N2YxMjY0OThhMDRfNy0yLTEtMS0w_8562b03f-ab5a-49d8-ab8a-1f7e509d494a">225,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RleHRyZWdpb246N2NmNWZiZjViNDEwNDlmOWI2OGIzOWViMDdjNzMxYTFfMjA2Ng_cb4c6061-6ae1-45fc-9b50-ef921064a4eb" continuedAt="ifc75abbe7b9b4de3bce69f8a7154947d" escape="true">Net Loss Per Share Attributable to Common Stockholders</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ifc75abbe7b9b4de3bce69f8a7154947d" continuedAt="ia3b321cbd73641879b929104d150fef0"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Series A preferred stock is considered a participating security which requires the use of two-class method for the computation of basic and diluted per share amounts. Under the two-class method, earnings available to common stockholders for the period are allocated between common stockholders and participating securities according to dividends accumulated and participation rights in undistributed earnings. Net loss attributable to common stockholders is not allocated to the convertible preferred stock as the holder of the Series A preferred stock does not have a contractual obligation to share in losses. Basic net loss attributable to common stockholders per share is computed by dividing net loss available to common stockholders by the weighted-average number of shares of common stock outstanding for the period. Diluted net loss attributable to common stockholders per share is computed by dividing the net loss available to common stockholders for the period by the weighted average number of common and common equivalent shares outstanding during the period. Diluted net loss attributable to common stockholders per share reflects all potential dilutive common stock equivalent shares, including conversion of preferred stock, stock options, restricted stock units and shares to be issued under our employee stock purchase program (&#8220;ESPP&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="ia3b321cbd73641879b929104d150fef0"><div style="text-indent:36pt"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RleHRyZWdpb246N2NmNWZiZjViNDEwNDlmOWI2OGIzOWViMDdjNzMxYTFfMjA2Mw_e790ad04-93e6-4489-a0c2-c1b02390493e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss attributable to common stockholders per share (in thousands, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfMy0xLTEtMS0w_35c1f391-5294-4ce0-a3f3-d21a71efa85e">59,948</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfMy0zLTEtMS0w_ca618b2d-e2ab-4b7d-afff-f591875ba4ab">14,505</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfMy01LTEtMS0w_0bfdadcd-8819-431c-a037-dd3c64d12254">83,636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfMy03LTEtMS0w_d3809256-d886-45a8-8b6a-30bc34727b62">14,423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculation &#8211; basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNS0xLTEtMS0w_9d3b9790-7281-4f7e-9835-7b838abd922c">26,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNS0zLTEtMS0w_8f7f5dd1-ff24-4657-bae1-1809d5bc38a5">26,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNS01LTEtMS0w_6de6b208-fb84-45cb-9f17-c9815405429a">26,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNS03LTEtMS0w_b9c4cf2a-0249-416f-9f7b-28b649e4ae82">25,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:fixed-zero" name="ehth:IncrementalCommonSharesAttributableToOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNi0xLTEtMS0w_77d9fadd-16a4-412a-b21e-400b0942904b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="ehth:IncrementalCommonSharesAttributableToOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNi0zLTEtMS0w_d3f1f7db-805f-43bd-bb1a-6defea499eed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:fixed-zero" name="ehth:IncrementalCommonSharesAttributableToOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNi01LTEtMS0w_90f536f8-41fb-491b-8517-18e2a2a4328b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="ehth:IncrementalCommonSharesAttributableToOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNi03LTEtMS0w_54ebf7cf-0f3c-4ad4-8ec1-bc9f1aaef914">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in diluted share calculation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNy0xLTEtMS0w_3be13faa-5ff2-4f1b-95b4-7fd0b5a0ee2b">26,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNy0zLTEtMS0w_280abca7-4137-415c-b6c3-ee7acd850011">26,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNy01LTEtMS0w_824ad166-d17e-469f-a11b-b4059162ea9d">26,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNy03LTEtMS0w_21c54e28-1caf-4d9d-8a3e-48dd162b0426">25,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders per share &#8211; basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS0xLTEtMS0w_302f5217-72d9-462d-a64d-b015a1c6f5e7"><ix:nonFraction unitRef="usdPerShare" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS0xLTEtMS0w_f3cd95ac-4d50-4d7c-95d5-100cb3a9e7ce">2.24</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS0zLTEtMS0w_8b4e6b4b-03b2-43d6-ba17-cb8f89acd427"><ix:nonFraction unitRef="usdPerShare" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS0zLTEtMS0w_e5a756f5-0a36-4b16-b987-bcce92c07f35">0.55</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS01LTEtMS0w_5cc71833-db27-4f5d-8fe2-14a69932e254"><ix:nonFraction unitRef="usdPerShare" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS01LTEtMS0w_c185eb37-2994-44b6-8ace-35e2c3271d37">3.13</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS03LTEtMS0w_e80c6ed1-0472-42db-9167-cb9a1c74d810"><ix:nonFraction unitRef="usdPerShare" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS03LTEtMS0w_fa71f2bf-dfc5-4855-a2b9-b31f03bb22c4">0.56</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each of the three and nine months ended September 30, 2021 and 2020, we had securities outstanding that could potentially dilute per share amounts, but the shares from the assumed conversion or exercise of these securities were excluded in the computation of diluted net loss per share as their effect would have been anti-dilutive. <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RleHRyZWdpb246N2NmNWZiZjViNDEwNDlmOWI2OGIzOWViMDdjNzMxYTFfMjA2NQ_db0c174e-d17c-4ffe-add6-971eeaf3992e" continuedAt="i56a31e6176dc4b8c8c8d54681eee99a4" escape="true">The number of outstanding anti-dilutive shares that were excluded from the computation of diluted net income (loss) per share consisted of the following (in thousands):</ix:nonNumeric></span><ix:continuation id="i56a31e6176dc4b8c8c8d54681eee99a4"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if073c25e8f81417c919277ea8f455b19_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMi0xLTEtMS0w_4009b581-802f-4459-9cba-654ad32c682c">2,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5d6d24f666c04e62a06ca4c5cf46e773_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMi0zLTEtMS0w_da6b6f93-5aa5-40f1-b5dd-7b2d6a63dd0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia5e0e7005d3f4062a071addcafc27c06_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMi01LTEtMS0w_67aff4e1-c810-45d7-9e5e-1a20da1857a4">1,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e30025f0e894023bc09a663cf9f1b11_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMi03LTEtMS0w_38702861-9d20-449a-adca-d7b98b01324d">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia579f87161bd4c4bbfb8854b3b172133_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMy0xLTEtMS0w_e631a274-2acf-4e20-9145-63bdf5545021">1,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icbfdeb0605ef4c5f870e8f2f7cd707a4_D20200701-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMy0zLTEtMS0w_aee83f7a-ec02-40be-939c-de81aa257087">599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i229764ec8611404cb78a18d3f3ea7742_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMy01LTEtMS0w_5c511f74-c872-47b7-9e2d-e4ebd05af9d7">1,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iebe8f8a1f6c74de99d0800095353e8d6_D20200101-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMy03LTEtMS0w_927e9bd6-94fe-4527-ba8f-072193fff188">748</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib307fc5e33fc48b29073be7772a66cf6_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNC0xLTEtMS0w_5aa8d338-4bc5-4b5b-b554-5c4498b985d5">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1be182ab19bb49e5ad85243990d16da7_D20200701-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNC0zLTEtMS0w_9941e55a-130f-4442-8b80-8d8da5ab9647">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic43e48e719fb4602912e4b0b7aa5e097_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNC01LTEtMS0w_d807bc4b-86cf-476c-b04e-c6a80d042681">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iecb19833c8e8461f9982c3ef70588776_D20200101-20200930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNC03LTEtMS0w_d13b13c0-57e5-4c2b-a24a-6d34ca4e1bb2">453</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i340227a27cb64be1b3a57692746b5bbe_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNS0xLTEtMS0w_fc855527-fe0f-460f-9694-747f6344cb63">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b044301e060489699b1d5da2e923272_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNS0zLTEtMS0w_cab29a76-6ddf-4981-92fb-1362a18061a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic70c39ada9ec49e5a840c9102e12c415_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNS01LTEtMS0w_2e536f4f-8efe-47d3-91df-41254a0106d6">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9fba14fb6ba94783a410123eed9f78a3_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNS03LTEtMS0w_9ead96aa-d610-40a7-90ee-436d7a52e75b">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNi0xLTEtMS0w_406a251f-1267-4f27-b75e-e5fed5283869">4,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNi0zLTEtMS0w_d97ac120-a712-4354-804c-13911e8744dc">1,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNi01LTEtMS0w_533d14dd-b36f-4946-bdcb-13464e9ca0ab">2,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNi03LTEtMS0w_b16da1dc-4f37-4cf3-a348-4d9dc0669d7e">1,201</ix:nonFraction></span></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RleHRyZWdpb246YzVhNzQxMGFmZjczNGE5YmJmMTYxMTUyNmMxZmRhNjlfNjE1Ng_ff331933-f79d-4d8d-8357-45fb33912d87" continuedAt="i610eee28c6114931a5c10cb36bc9210b" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i610eee28c6114931a5c10cb36bc9210b" continuedAt="if62f90197e3a4c8cb45bc8d37087edda"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service and Licensing Obligations</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into service and licensing agreements with third party vendors to provide various services, including network access, equipment maintenance, and software licensing. As the benefits of these agreements are experienced uniformly over the applicable contractual periods, we record the related service and licensing expenses on a straight-line basis, although actual cash payment obligations under certain of these agreements fluctuate over the terms of the agreements. </span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="if62f90197e3a4c8cb45bc8d37087edda" continuedAt="i733ce665a01c43b7941eeb766859be29"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RleHRyZWdpb246YzVhNzQxMGFmZjczNGE5YmJmMTYxMTUyNmMxZmRhNjlfNjE1Nw_e8f56709-b8c7-4b31-b9fc-7e82d08da05a" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future minimum payments under non-cancellable contractual service and licensing obligations as of September 30, 2021 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.444%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">For the Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RhYmxlOjIyMGYzOWEwZDYwMzQwNjQ5YjBjZDQ2Y2QyNzYxNDk1L3RhYmxlcmFuZ2U6MjIwZjM5YTBkNjAzNDA2NDliMGNkNDZjZDI3NjE0OTVfMS0xLTEtMS0w_71be8867-13fb-4675-b210-0f9c60e984f0">2,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractualObligationDueInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RhYmxlOjIyMGYzOWEwZDYwMzQwNjQ5YjBjZDQ2Y2QyNzYxNDk1L3RhYmxlcmFuZ2U6MjIwZjM5YTBkNjAzNDA2NDliMGNkNDZjZDI3NjE0OTVfMi0xLTEtMS0w_1aff71c6-73ff-4c06-92e1-ffa7a1285817">10,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractualObligationDueInSecondYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RhYmxlOjIyMGYzOWEwZDYwMzQwNjQ5YjBjZDQ2Y2QyNzYxNDk1L3RhYmxlcmFuZ2U6MjIwZjM5YTBkNjAzNDA2NDliMGNkNDZjZDI3NjE0OTVfMy0xLTEtMS0w_bc0097a2-a217-4a9c-9905-3cb4a000028e">8,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractualObligationDueInThirdYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RhYmxlOjIyMGYzOWEwZDYwMzQwNjQ5YjBjZDQ2Y2QyNzYxNDk1L3RhYmxlcmFuZ2U6MjIwZjM5YTBkNjAzNDA2NDliMGNkNDZjZDI3NjE0OTVfNC0xLTEtMS0w_b66bdb71-e7fa-41cf-a8e7-c2703dec72c5">2,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:ContractualObligationDueInFourthYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RhYmxlOjIyMGYzOWEwZDYwMzQwNjQ5YjBjZDQ2Y2QyNzYxNDk1L3RhYmxlcmFuZ2U6MjIwZjM5YTBkNjAzNDA2NDliMGNkNDZjZDI3NjE0OTVfNS0xLTEtMS0w_f038c1b4-2e1e-47e8-8ca0-3a276c754db0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:fixed-zero" name="ehth:ContractualObligationToBePaidAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RhYmxlOjIyMGYzOWEwZDYwMzQwNjQ5YjBjZDQ2Y2QyNzYxNDk1L3RhYmxlcmFuZ2U6MjIwZjM5YTBkNjAzNDA2NDliMGNkNDZjZDI3NjE0OTVfNi0xLTEtMS0w_4945701e-1635-4ea2-9859-693f5847f3aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractualObligation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RhYmxlOjIyMGYzOWEwZDYwMzQwNjQ5YjBjZDQ2Y2QyNzYxNDk1L3RhYmxlcmFuZ2U6MjIwZjM5YTBkNjAzNDA2NDliMGNkNDZjZDI3NjE0OTVfNy0xLTEtMS0w_0409bd70-67e0-4dc1-94b9-9f108afdf861">23,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for commitments related to our operating leases.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, we receive inquiries from governmental bodies and also may be subject to various legal proceedings and claims arising in the ordinary course of business. We assess contingencies to determine the degree of probability and range of possible loss for potential accrual in our condensed consolidated financial statements. An estimated loss contingency is accrued in the condensed consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. There was no material litigation-related accrual during the three and nine months ended September 30, 2021. Legal proceedings or other contingencies could result in material costs, even if we ultimately prevail.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Securities Class Action </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211; On April 8, 2020 and April 30, 2020, <ix:nonFraction unitRef="claim" contextRef="if22877f27abe4b9e9bcea617938a333a_D20200408-20200430" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RleHRyZWdpb246YzVhNzQxMGFmZjczNGE5YmJmMTYxMTUyNmMxZmRhNjlfMTUzNQ_b67ae687-737a-40ff-957a-c2e4e8bcbe1a">two</ix:nonFraction> purported class action lawsuits were filed against us, our then-chief executive officer, Scott N. Flanders, our then-chief financial officer, Derek N. Yung, and our then-chief operating officer, David K. Francis (collectively, the &#8220;Defendants&#8221;), in the United States District Court for the Northern District of California. The cases are captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Patel v. eHealth, Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">., Case No. 5:20-cv-02395 (N.D. Cal.) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Bertrand v. eHealth, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Case No. 4:20-cv-02967 (N.D. Cal.). The complaints allege, among other things, that we and Messrs. Flanders, Yung and Francis made materially false and misleading statements and/or failed to disclose material information regarding our accounting and modeling assumptions, rate of member churn and our profitability during the alleged class period of March 19, 2018 to April 7, 2020. The complaints allege that we and Messrs. Flanders, Yung and Francis violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The complaints seek compensatory and (in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Patel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> lawsuit) punitive damages, attorneys&#8217; fees and costs, and such other relief as the court deems proper. On June 24, 2020, the court consolidated the above-referenced matters under the caption</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> In re eHealth Securities Litig.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Master File No. 4:20-cv-02395-JST (N.D. Cal.). The court also appointed a lead plaintiff and lead counsel for the consolidated matter. The lead plaintiff filed an amended complaint on August 25, 2020, which the Defendants moved to dismiss on October 23, 2020. The Defendants&#8217; motion, which the plaintiff opposed, was granted in part and denied in part on August 12, 2021.  The court dismissed the plaintiff's claims to the extent premised upon alleged misrepresentations or omissions relating to churn, but denied the Defendants motion with respect to alleged misstatements regarding purported operating costs.  On October 1, 2021, the Company filed an answer denying in part and admitting in part the remaining allegations, and denying any wrongdoing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Derivative Actions &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 7, 2020 and October 13, 2020, <ix:nonFraction unitRef="claim" contextRef="i4d162a37afc94df8a25268308d382345_D20200707-20201013" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RleHRyZWdpb246YzVhNzQxMGFmZjczNGE5YmJmMTYxMTUyNmMxZmRhNjlfMzEzMw_fc582cdd-3f2c-4ad9-b903-291c3d00a3d4">two</ix:nonFraction> derivative lawsuits were filed against our then-chief executive officer, Mr. Flanders, our then-chief financial officer, Mr. Yung, our then-chief operating officer, Mr. Francis, and the members of our Board  at the time of filing of the complaints (collectively, the &#8220;Individual Defendants&#8221;), in the United States District Court for the Northern District of California and the Superior Court of California, County of Santa Clara. The cases are captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet v. Flanders et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">., Case No. 3:20-cv-04477-SK (N.D. Cal.), and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire Police Pension Fund v. Flanders et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Case No. 20CV371555 (Cal. Super. Ct.), and also name the Company as a nominal defendant. A third derivative lawsuit was filed against the same defendants on October 5, 2021 in the United States District Court for the Northern District of California, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Badwal v. Flanders et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">., Case No. 4:21-cv-07795 (N.D. Cal.). The complaints allege, among </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><div><ix:continuation id="i733ce665a01c43b7941eeb766859be29" continuedAt="i7b717dcec0eb40e0b04408c2599f00b6"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">other things, that beginning on March 19, 2018, the Individual Defendants made or caused the Company to make materially false and misleading statements and/or failed to disclose material information regarding our accounting and modeling assumptions, rate of member churn, profitability, and internal controls. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> complaints purport to assert claims for breach of fiduciary duty, unjust enrichment and waste of corporate assets. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> lawsuit also alleges that the Individual Defendants violated Sections 14(a), 10(b), and 20(a) of the Securities Exchange Act of 1934, and asserts claims for abuse of control and gross mismanagement. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Badwal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> complaint purports to assert a claim for breach of fiduciary duty, an insider trading claim, and violations of Section 14(a), 10(b) and 20D of the Securities Exchange Act of 1934.  The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> complaints seek damages, restitution, attorneys&#8217; fees and costs, and certain measures with respect to our corporate governance and internal procedures, and (in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> lawsuit) equitable and/or injunctive relief. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Badwal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> complaint seeks damages, declaratory relief, corporate governance measures, equitable and injunctive relief, restitution and disgorgement, and attorneys' fees and costs.  On August 10, 2020, the parties filed a Stipulation and Proposed Order in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> matter to stay the action until and through the resolution of the Defendants' anticipated motion to dismiss the consolidated securities class action, and filed a similar stipulation in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> matter on December 11, 2020.  The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> stipulation was granted by the court on August 12, 2020 and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> stipulation on December 11, 2020. The agreed-upon stays terminated with the filing of an answer in the securities class action and the parties are engaged in discussions regarding further proceedings. </span></ix:continuation></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><ix:continuation id="i7b717dcec0eb40e0b04408c2599f00b6" continuedAt="i5fa0a2bb81364044b0c193fb917c8011"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The Gonzalez and Le</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Vias Complaints</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="i5fa0a2bb81364044b0c193fb917c8011"> &#8211; On April 6, 2018, a former employee, Lupita Gonzalez, filed a complaint against us in the Superior Court of the State of California for the County of Sacramento (the &#8220;Gonzalez Complaint&#8221;). On July 1, 2019, <ix:nonFraction unitRef="plaintiff" contextRef="i21698a317c0745a9b39abd2f8c067af4_D20190701-20190701" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RleHRyZWdpb246YzVhNzQxMGFmZjczNGE5YmJmMTYxMTUyNmMxZmRhNjlfNTE0MQ_318974f3-3b7e-4809-9eca-828d4bfc74fc">two</ix:nonFraction> other current or former employees, Michael Le&#8217;Vias and Ramona Meadows, filed a related complaint against us and eHealth Ins. Serv. Co., in the Superior Court of the State of California for the County of Santa Clara (the &#8220;Le&#8217;Vias Complaint&#8221;). Both complaints asserted claims under the California Private Attorney General Act on behalf of all current and former hourly-paid or non-exempt employees who work or have worked for us in California, based on alleged failures to comply with California wage and hour laws. The parties have entered into a court-approved settlement agreement that resolves both matters related to the Gonzalez and Le'Vias Complaints, and both the Gonzalez and Le'Vias Complaints have been dismissed with prejudice.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMjI4MA_4297cf9a-b0f4-415d-8ad0-280746449eae" continuedAt="i6ca9cf9a77514d13a25a6034386c8d1a" escape="true">Segment and Geographic Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6ca9cf9a77514d13a25a6034386c8d1a" continuedAt="ieeeb33c91922492cabe45b523f33a703"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Segments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report segment information based on how our chief executive officer, who is our chief operating decision maker ("CODM"), regularly reviews our operating results, allocates resources and makes decisions regarding our business operations. The performance measures of our segments include total revenue and profit. Our business structure is comprised of&#160;<ix:nonFraction unitRef="segment" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMzg4_54c4d7ea-1858-4f83-b45c-8701d91107d3">two</ix:nonFraction>&#160;operating segments: Medicare and Individual, Family and Small Business. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Business and Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Part II, Item 8 of the Annual Report on Form 10-K for the year ended December 31, 2020 for our accounting policies relating to operating segments.</span></div></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="ieeeb33c91922492cabe45b523f33a703" continuedAt="iefc742eba0ec42dbaa2e4378964a8756"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMjI3NQ_df7f4e20-aad7-44eb-9ab1-8d7ec4fe9784" continuedAt="ia8b6b85f496d447b869a0b35dd7d6b39" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of our operating segments are summarized for the periods presented below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78acf1a81a984826bfe2cedc7f25d60d_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMy0xLTEtMS0w_e11330df-9f00-493c-80fb-7dc31a5ffab2">46,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i599f7c7be93c4814890c266b5ec47df8_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMy0zLTEtMS0w_61d5a716-7cdd-4672-af1b-4fcc0347d790">70,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ef09b5449f84c8ead10851320de6c76_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMy01LTEtMS0w_b97e0a8c-4e71-4942-a17d-ac9b3bf449ea">240,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6293eb4d8349d9a31d1b1a2fd3ed11_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMy03LTEtMS0w_003021bb-bb12-4698-b2ee-db8077123d29">246,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual, Family and Small Business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5da3c7f6d5d4610954eeac8d16c4dbe_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNC0xLTEtMS0w_62b78901-0768-470d-ab5a-78726df36a06">17,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a41b5baa43d4ed18e1b54843fc57273_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNC0zLTEtMS0w_bbf8d34e-db5a-40f6-9ce3-8f4dea67592b">23,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467949b0884e43b0a011bdf4fadde010_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNC01LTEtMS0w_81dd316c-293c-4e55-83a5-4820f9532efa">54,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i039e32b3c64041e49cb0878ecaabafd1_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNC03LTEtMS0w_1a07dd71-54fc-436b-ae7b-03b91a58d8e8">42,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91c81e16d0784d4d958fe95d1f894a24_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNS0xLTEtMS0w_9887d40d-245d-45c2-b662-c40a8106ed38">63,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaef638b0fa1046eb9911d6d4747f5df0_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNS0zLTEtMS0w_c5d3b279-180e-4858-8698-48ecfe99800f">94,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ad8d3eeb32049fe90a788e0eda6b25d_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNS01LTEtMS0w_b1eceefe-bf8e-4086-99d4-7f4774d420ca">294,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23411f69f39b432f81bcc3da7c590e76_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNS03LTEtMS0w_41f61397-385c-4ab5-a45d-ce88d3320854">289,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment profit (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare segment profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78acf1a81a984826bfe2cedc7f25d60d_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOC0xLTEtMS0w_56a5f2d8-bb9c-4ef9-add6-202dec7c87cc">52,882</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i599f7c7be93c4814890c266b5ec47df8_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOC0zLTEtMS0w_449f90aa-453e-4582-bc87-fd1d8a0d36bf">14,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ef09b5449f84c8ead10851320de6c76_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOC01LTEtMS0w_0e9310cf-6613-4e7d-8f03-6ef9b8b9b333">46,141</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6293eb4d8349d9a31d1b1a2fd3ed11_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOC03LTEtMS0w_29eb7a22-7a50-4b84-9ccb-cdeec83792be">23,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual, Family and Small Business segment profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5da3c7f6d5d4610954eeac8d16c4dbe_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOS0xLTEtMS0w_bfb402fb-9510-4dda-b302-26c7ff9fd59b">12,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a41b5baa43d4ed18e1b54843fc57273_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOS0zLTEtMS0w_c03fc242-aec6-4c3b-bf74-b3d2e85fb377">18,487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i467949b0884e43b0a011bdf4fadde010_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOS01LTEtMS0w_12252427-4bcd-4875-b46f-bde0a1af66d6">38,476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i039e32b3c64041e49cb0878ecaabafd1_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOS03LTEtMS0w_9ad658b6-b107-49db-826e-b82e9608e33b">24,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total segment profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91c81e16d0784d4d958fe95d1f894a24_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTAtMS0xLTEtMA_33a04c53-55b3-458e-be0c-676d42ff404e">40,383</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaef638b0fa1046eb9911d6d4747f5df0_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTAtMy0xLTEtMA_414c8709-7032-496a-b401-c5c89d1600cb">4,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ad8d3eeb32049fe90a788e0eda6b25d_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTAtNS0xLTEtMA_5628a9b4-13a5-474d-9f57-dff449252769">7,665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23411f69f39b432f81bcc3da7c590e76_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTAtNy0xLTEtMA_e795aa5b-7b19-4d9c-a3ce-91e3d7605e33">48,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8a334e29b924ce49cd96becafc4d8fb_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTEtMS0xLTEtMA_ce3abb36-46d9-4a5a-aaf0-54a43a1b5c24">14,827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74d37c58f9574acc85052b984bfa332e_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTEtMy0xLTEtMA_9f3fdc59-38e8-469f-8bda-d12ef151ce29">15,581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaae702e195164e63ba0beb670c74dde5_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTEtNS0xLTEtMA_fdf161fa-facc-4093-8e28-cc7fcdf3acb4">43,206</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22910efbde7440648884b8f7e2613f28_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="ehth:SegmentOperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTEtNy0xLTEtMA_b5749eca-aee0-4748-b55b-cbacf89a77ff">43,376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTItMS0xLTEtMA_952ceb23-6da1-480c-8b87-da246fa4f355">5,234</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTItMy0xLTEtMA_db8e7ba9-dd8d-4119-b5e4-5d28200fd434">6,332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTItNS0xLTEtMA_2c5a29b1-3824-4a21-b996-e35af829751c">24,881</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTItNy0xLTEtMA_1a6cfd62-9fe5-4c9a-80dc-224173708253">21,722</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTQtMS0xLTEtMA_2b2cd089-84ba-4dd7-b88c-5d178aa4a1d6">4,899</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTQtMy0xLTEtMA_eb4d1529-a57f-494f-a4a0-917ee31f0587">2,995</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTQtNS0xLTEtMA_32bb5412-4014-40b3-9771-3f0b195cd73b">12,840</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTQtNy0xLTEtMA_e14de518-02c1-4906-8bf4-0ecc8f884d7b">7,911</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTUtMS0xLTEtMA_2e556781-f98b-430d-8fa3-23e104f31c00">121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTUtMy0xLTEtMA_858f0b8a-9aeb-4a87-9773-c2644bd679f0">287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTUtNS0xLTEtMA_09960910-2880-405f-a1e7-c92c0069b798">416</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTUtNy0xLTEtMA_fa04b52a-4b6b-4ac3-86b5-d0dbd6171743">1,207</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and reorganization charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTctMS0xLTEtMA_fa065998-cee5-4bfc-bf7c-f99f7e839938">573</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTctMy0xLTEtMA_73f81cff-de9b-46e5-ba3c-8dcc91f0907b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTctNS0xLTEtMA_a2b8ed7f-83d2-4cd0-9167-6e3ab7e26c0f">3,004</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTctNy0xLTEtMA_18d666b1-3bc7-4143-bd2d-00aeb40a00fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTgtMS0xLTEtMA_9dc7c228-3cee-49f2-8ef1-695cfd6aa549">189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTgtMy0xLTEtMA_c147e370-5132-4479-a114-f08d77ac6705">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTgtNS0xLTEtMA_847ec8fa-dc3e-4d26-9c17-f4f0ffd1090e">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTgtNy0xLTEtMA_62685d50-8a89-45ea-998d-cfbd1de458d4">724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before benefit from income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTktMS0xLTEtMA_77dec6b2-1b60-4db2-8c03-02cf84badbd5">65,848</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTktMy0xLTEtMA_cec1d475-0c95-4e39-8acc-7b3441d8ba47">20,948</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTktNS0xLTEtMA_37bc2a53-5b7b-4ea1-8400-d7c64886ba4d">91,501</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTktNy0xLTEtMA_d2a58c0c-4175-496e-a83d-eeb7b5d7df54">25,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">During the first quarter of 2021, we revised the calculation of segment profit by excluding amortization of capitalized software development costs to enhance comparability of our financial metrics with peer companies. The amortization of capitalized software development costs were $<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMTA3NA_07973a90-b01d-4203-9eb1-2d2e68c1d7a8">3.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMTA4MQ_991d3d48-fabc-468e-be67-0b88a584f6d2">2.1</ix:nonFraction> million for the three months ended September 30, 2021 and 2020, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMTEyMQ_2ea6ffeb-74bd-4e73-99fb-fc20c33fbd92">9.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMTEyOA_e9d70401-33c6-4780-91bf-f3251420772b">5.3</ix:nonFraction> million for the nine months ended September 30, 2021 and 2020, respectively.</span></div></ix:nonNumeric><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"><ix:continuation id="ia8b6b85f496d447b869a0b35dd7d6b39" continuedAt="i65052d737a434af4bde92d0273d61c3a">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"><ix:continuation id="i65052d737a434af4bde92d0273d61c3a">Depreciation and amortization has been adjusted to include amortization of software development costs.</ix:continuation> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no inter-segment revenue transactions for the periods presented. With the exception of contract assets &#8211; commissions receivable, which is presented by segment in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Financial Statement Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our CODM does not separately evaluate assets by segment, and therefore, assets by segment are not presented. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Information</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-lived assets primarily consist of property and equipment and internally-developed software. Our long-lived assets are attributed to the geographic location in which they are located. <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="ehth:ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMjI4Ng_240f480e-8ebf-40d5-a4d8-3b0fafb08621" continuedAt="if6398a3ffe7f4032ba45115e549e9f55" escape="true">Long-lived assets by geographical area are summarized as follows (in thousands):</ix:nonNumeric></span></div><div><ix:continuation id="if6398a3ffe7f4032ba45115e549e9f55"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d576e424126448ab8ccca7322a38757_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjM3OGNmMTg0YjNmODRhODhiNGNhNGFlN2QzZmE3NmE3L3RhYmxlcmFuZ2U6Mzc4Y2YxODRiM2Y4NGE4OGI0Y2E0YWU3ZDNmYTc2YTdfMS0xLTEtMS0w_dbbaba14-5078-4201-a685-bfeae81becf0">45,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ca3570cf7d49f6a8e32f5b5cb816e8_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjM3OGNmMTg0YjNmODRhODhiNGNhNGFlN2QzZmE3NmE3L3RhYmxlcmFuZ2U6Mzc4Y2YxODRiM2Y4NGE4OGI0Y2E0YWU3ZDNmYTc2YTdfMS0zLTEtMS0w_5fc5c066-fcd3-45e2-b8a7-7240af7e8022">40,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i523d407abcc34388915c073912053b35_I20210930" decimals="-3" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjM3OGNmMTg0YjNmODRhODhiNGNhNGFlN2QzZmE3NmE3L3RhYmxlcmFuZ2U6Mzc4Y2YxODRiM2Y4NGE4OGI0Y2E0YWU3ZDNmYTc2YTdfMi0xLTEtMS0w_cb6e06d2-11a9-447f-b73d-4ab36a6fdefd">637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9c3527283ec406d936905c741fd644e_I20201231" decimals="-3" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjM3OGNmMTg0YjNmODRhODhiNGNhNGFlN2QzZmE3NmE3L3RhYmxlcmFuZ2U6Mzc4Y2YxODRiM2Y4NGE4OGI0Y2E0YWU3ZDNmYTc2YTdfMi0zLTEtMS0w_fa3f7ede-73b6-4b98-adcb-7c6823a5cee8">565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjM3OGNmMTg0YjNmODRhODhiNGNhNGFlN2QzZmE3NmE3L3RhYmxlcmFuZ2U6Mzc4Y2YxODRiM2Y4NGE4OGI0Y2E0YWU3ZDNmYTc2YTdfMy0xLTEtMS0w_b22911ff-ce67-4afe-9bb4-45aedaf98467">46,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjM3OGNmMTg0YjNmODRhODhiNGNhNGFlN2QzZmE3NmE3L3RhYmxlcmFuZ2U6Mzc4Y2YxODRiM2Y4NGE4OGI0Y2E0YWU3ZDNmYTc2YTdfMy0zLTEtMS0w_fc4bfb62-c507-4d91-bb1a-a37e7081752b">41,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="iefc742eba0ec42dbaa2e4378964a8756"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Customers</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all revenue for the three and nine months ended September 30, 2021 and 2020&#160;was generated from customers located in the United States. <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMjI3OA_9646ce5b-5e6e-441e-9505-c66a86bbbf35" continuedAt="i61616df62576497bbe07906ab06f30ce" escape="true">Carriers representing 10% or more of our total revenue are summarized as follows:&#160;</ix:nonNumeric></span><ix:continuation id="i61616df62576497bbe07906ab06f30ce" continuedAt="i91748b86adb34b83833b43161c370417"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthCare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i807a2c2c69384b17a0895525b7e3edd3_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi0xLTEtMS0zMjkyNQ_b3259d58-5139-4533-b03d-3f4afcdbdcbe">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icaaefcb4864c42c9977406372dae345d_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi0zLTEtMS0zMjkyNQ_eb757e02-1cfa-4adb-a70e-55d8c6b2dfb6">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia99590146c5a4c1da65f6789c51d6d45_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi01LTEtMS0zMjkyNQ_da7e0920-bafb-4f77-ace8-c51107903cc2">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0361883d6d844e64919f623c50758d9f_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi03LTEtMS0zMjkyNQ_792fa8be-b43e-4ffb-8d44-b1855f0c6af1">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aetna </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifed085705a1141f7b66607c7f088c4f7_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi0xLTEtMS0w_9e73071a-db2e-43b5-9824-a2bb6b297365">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iedb3906c92b9439bb9f00fb896ef8c19_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi0zLTEtMS0w_c29ada72-c867-4d91-8f04-a71005b40b30">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c33a4818d8a4dd1b84a8c1a8ef5eda5_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi01LTEtMS0w_942da05e-0aae-416d-aee3-9fd68798715b">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4eb35f5535224b48aab5f6959f231bec_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi03LTEtMS0w_e169bac4-c9c7-4932-86c5-e45ae9a5ca56">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic37891f447e942e58713991d7596b9e8_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNC0xLTEtMS0w_f674956c-2fd4-4190-891b-83594052b94b">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic6e791641d474976aa090740b18829e9_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNC0zLTEtMS0w_8ce5893d-4447-4061-a3d4-e3d5fc4e4dd3">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f2574a154db4f12910857916c1fb936_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNC01LTEtMS0w_44e2631f-2a5c-4b93-a6af-ae3cbba99c20">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b3c828fd9844044b536167585b76ad7_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNC03LTEtMS0w_b0d1d0c2-e881-4e48-b89c-f49480f405fb">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7aee3ac4c576453099eae47761de55e3_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNS0xLTEtMS0w_3faa129a-ffd6-42ea-8e8e-39e617d4afc9">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4c33c1733414490c92126731233e4e66_D20200701-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNS0zLTEtMS0w_2d60be9a-fce5-46b1-9d72-07ebff160f6f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie78c1d1beb9648dfa9a878f03a582e82_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNS01LTEtMS0w_96ea85da-2662-4a4d-8826-b9cd786b8457">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ccf79aa1d6a4dc9a005e080c3858ac1_D20200101-20200930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNS03LTEtMS0w_ee49983d-ed76-481e-99c0-8b0daf41996f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><ix:continuation id="i91748b86adb34b83833b43161c370417"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Percentages include the carriers' subsidiaries.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the revenue of WellCare is included in the percentage calculation for the three and nine months ended September 30, 2021 and 2020.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfMTEwMQ_0bd93761-2c0a-4234-a91e-fe04c9f16e51" continuedAt="id64f337f5fdc43acab4ef709fe368f2e" escape="true">Leases</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="id64f337f5fdc43acab4ef709fe368f2e" continuedAt="ifbb341b42cf24e4bacfdec7ddf66d840"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases have remaining lease terms of <ix:nonNumeric contextRef="i1fd910c49a244d5c84e732a5b01119c4_I20210930" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfNTU_4948ce53-25dc-44d0-8463-c374a13a3088">2</ix:nonNumeric> to <ix:nonNumeric contextRef="i3f4d4b8270d044b59fee38b2066bc5db_I20210930" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfNjE_7f94cb83-ec95-496e-9820-372dcbfd54fd">8</ix:nonNumeric> years. Certain of these leases have free or escalating rent payment provisions. We recognize lease expense on a straight-line basis over the terms of the leases, although actual cash payment obligations under certain of these agreements fluctuate over the terms of the agreements. Most leases include options to renew, and the exercise of these options is at our discretion.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease expenses were $<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfNDcw_24c457b3-f96f-4c13-87dd-6d7759ba1432">1.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfNDc3_edd3cd8a-d8f9-40ce-9bec-42e6f1bb27ba">2.1</ix:nonFraction> million for the three months ended September 30, 2021 and 2020, and $<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfNDkx_1b3553cd-e857-4940-aec7-9cc9b2924415">5.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfNDk4_de7d5448-bea0-4d26-b7fc-4a2b866c4ab1">6.4</ix:nonFraction> million for the nine months ended September 30, 2021 and 2020, respectively and sublease income was immaterial for both periods.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfMTEwNQ_d054e1fe-e216-463c-af64-8e0224e29564" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases are as follows (dollars in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term of operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i942081d424f34699add16e658f851ed1_I20210930" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfMS0xLTEtMS0w_e634a838-edaf-45ab-8d22-a22653c62ef2">6.6</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfMS0zLTEtMS0w_5a49c346-dfd5-4959-89a1-8a931a653e13">7.2</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate used to recognize operating lease right-of-use-assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfMi0xLTEtMS0w_cc4e1c5f-5a90-4ec6-9eca-c72d21e8102c">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfMi0zLTEtMS0w_475e91b4-a8ef-4864-9edb-fd29b5c99c85">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfNS0xLTEtMS0w_2ba35eb8-ad90-4561-94f2-faf88d295b28">5,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfNS0zLTEtMS0w_b6dac049-5585-4e30-829a-608c46de1d84">6,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash outflows related to operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfNi0xLTEtMS0w_37e8d443-dd9f-4ba2-811c-03babc3bb521">5,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfNi0zLTEtMS0w_30ebc1d7-0e55-4f4a-b5da-38f86cd34940">5,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><ix:continuation id="ifbb341b42cf24e4bacfdec7ddf66d840"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfMTEwOA_ccb36018-edb0-46a8-9553-a0dc77445f55" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, maturities of operating lease liabilities are as follows (in thousands):</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfMS0xLTEtMS0w_719fd2b7-e102-4cd5-becc-7a3d584076a5">1,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfMi0xLTEtMS0w_1f8dca16-bc79-4cdd-a3b9-d0b3e022ba81">7,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfMy0xLTEtMS0w_f7b884e3-a1a4-4a69-a855-9c173e537876">8,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfNC0xLTEtMS0w_b9ab929d-4cdc-4586-bc57-5c3c21fb5eaa">7,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfNS0xLTEtMS0w_3f3c0fb6-5bb3-4485-a2a7-6b71c61dfb54">8,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="ehth:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfNi0xLTEtMS0w_29336ce6-e4ee-4fa7-ab14-7f271d7efe44">19,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfNy0xLTEtMS0w_8aad0b5f-3fbc-47b2-94fc-ef381a0f206c">52,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfOC0xLTEtMS0w_45f7bfe9-8b0f-4ab6-ac7e-bf6106e3da47">10,200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfOS0xLTEtMS0w_4336206c-d3df-45b5-80a3-87bb77e735a9">42,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Noncancellable sublease income for the remainder of 2021 and years ending December 31, 2022 and 2023 of $<ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfMTAzNA_5e5fd28f-4a00-45df-83db-a2dfef6f3a94">0.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfMTAzOA_6d2da63a-5533-4f8f-9305-66189011f177">0.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfMTA0Ng_e39e83a7-7f6f-44ef-bb59-b035186f2923">0.4</ix:nonFraction> million, respectively, is not included in the table above.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 &#8212; <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfNjI3_107c8d28-c877-4109-9aa5-331df915a7cd" continuedAt="i146c553863c04769987fc63953a70b2e" escape="true">Restructuring and Reorganization</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i146c553863c04769987fc63953a70b2e"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our restructuring and reorganization costs and liabilities consist primarily of severance, transition and other related costs. <ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfMjc0ODc3OTA3NTMxMw_8402f2d3-e1ab-4e61-b5c0-b44c26122119" continuedAt="ie66fe1856c3c4f6885487d8d9b33be9c" escape="true">The following table summarizes the cash-based restructuring and reorganization related liabilities (in thousands):</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div><ix:continuation id="ie66fe1856c3c4f6885487d8d9b33be9c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231" decimals="-3" format="ixt:fixed-zero" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RhYmxlOjM3N2IyZTRhY2I0NzQ3Njk5MjVlYzJjZTRiMjk0NDQwL3RhYmxlcmFuZ2U6Mzc3YjJlNGFjYjQ3NDc2OTkyNWVjMmNlNGIyOTQ0NDBfMS0xLTEtMS0yOTc5NQ_024b440d-0ca7-41ab-bf89-822eb575bd39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and reorganization charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RhYmxlOjM3N2IyZTRhY2I0NzQ3Njk5MjVlYzJjZTRiMjk0NDQwL3RhYmxlcmFuZ2U6Mzc3YjJlNGFjYjQ3NDc2OTkyNWVjMmNlNGIyOTQ0NDBfMi0xLTEtMS0yOTc5NQ_bf481f5f-38d7-41e2-b8c6-3537c51c903c">3,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RhYmxlOjM3N2IyZTRhY2I0NzQ3Njk5MjVlYzJjZTRiMjk0NDQwL3RhYmxlcmFuZ2U6Mzc3YjJlNGFjYjQ3NDc2OTkyNWVjMmNlNGIyOTQ0NDBfMy0xLTEtMS0yOTc5NQ_a206b536-76d9-4afc-9dc6-cecce96404c6">2,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RhYmxlOjM3N2IyZTRhY2I0NzQ3Njk5MjVlYzJjZTRiMjk0NDQwL3RhYmxlcmFuZ2U6Mzc3YjJlNGFjYjQ3NDc2OTkyNWVjMmNlNGIyOTQ0NDBfNC0xLTEtMS0yOTc5NQ_3c581d09-a7d8-4913-9ba6-395d99a73bf0">538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, we eliminated approximately <ix:nonFraction unitRef="employee" contextRef="i2ce9e77371e64f6a8892196a9e45088f_D20210201-20210228" decimals="0" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfNjE_e44a279f-5296-4231-b365-8461a977afa9">89</ix:nonFraction> full-time positions, primarily in the United States, representing approximately <ix:nonFraction unitRef="number" contextRef="i2ce9e77371e64f6a8892196a9e45088f_D20210201-20210228" decimals="2" name="ehth:RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfMTQ0_e564f005-0271-481a-85b5-f9e2f824568e">5</ix:nonFraction>% of our workforce, primarily within our customer care and enrollment group, and to a lesser extent, in our marketing and advertising, technology and content, and general and administrative groups. Total pre-tax restructuring charges  were $<ix:nonFraction unitRef="usd" contextRef="ic22af0ed9d5a46f7a09827528922c14b_D20210201-20210331" decimals="-5" format="ixt:num-dot-decimal" name="ehth:RestructuringChargesPreTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfNTQ5NzU1ODEzOTUzOA_89153e0f-1d21-4194-aab8-9f15a74c451e">2.4</ix:nonFraction>&#160;million for the nine months ended September 30, 2021, which primarily related to employee termination benefits. Substantially all of the restructuring charges resulted in cash expenditures. The restructuring activities were completed by March&#160;31, 2021. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, we announced the transition of our chief executive officer. Mr. Scott Flanders resigned as a member of our Board and chief executive officer, effective October 31, 2021. We recognized $<ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfMTA5OTUxMTYzMDM0Mg_0bb31582-f709-4f11-8f32-dd98c66b0f4e">0.5</ix:nonFraction>&#160;million in severance costs related to his separation in September 2021 and we expect to recognize an additional $<ix:nonFraction unitRef="usd" contextRef="ib8e43307bfae4745be61c3650614ae16_I20211231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfMTA5OTUxMTYzMzI3NQ_d38ec248-dc10-4244-80ce-a367551f41e0">1.9</ix:nonFraction>&#160;million in the fourth quarter of 2021. Stock-based compensation expense for both three and nine months ended September 30, 2021 was impacted by a $<ix:nonFraction unitRef="usd" contextRef="i538a335bee9d4605ac36f25f4181afa7_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfMTA5OTUxMTYzMzc2MA_7726ef97-c3e8-483d-b723-efcd82f92d10"><ix:nonFraction unitRef="usd" contextRef="i05a980eb0e6b4490bb82b24144c3b3c8_D20210701-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfMTA5OTUxMTYzMzc2MA_bc3308b7-e9d9-41e2-8bbf-ce40158b1a2c">4.1</ix:nonFraction></ix:nonFraction>&#160;million credit related to forfeited equity awards due to Mr. Flanders' separation, which was included in general and administrative expenses on our Condensed Consolidated Statement of Comprehensive Loss.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_70"></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMzkxMw_74aeaa12-042c-4eac-88d2-340e905eff5f" continuedAt="i13130ce4235b414f82352e0802ba65de" escape="true">Debt</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i13130ce4235b414f82352e0802ba65de" continuedAt="i04e15f34d0eb4b63bb20be501400153c"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 17, 2018, we entered into a Credit Agreement with Royal Bank of Canada (&#8220;RBC&#8221;), as administrative agent and collateral agent (the &#8220;Credit Agreement&#8221;). The Credit Agreement provides for a $<ix:nonFraction unitRef="usd" contextRef="i1b88d930749840dda7fc079ab96c882a_I20180917" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjE0_0e766f7e-90e3-4d30-9805-faaa9865f0b0">40.0</ix:nonFraction> million secured asset-backed revolving credit facility with a $<ix:nonFraction unitRef="usd" contextRef="i157113a553d840878f52e68b6c57d78d_I20180917" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjcx_71e29f00-74ee-40d7-b1ce-001f47b3cc9d">5.0</ix:nonFraction> million letter of credit sub-facility. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2019, we amended our revolving credit facility agreement with RBC (the &#8220;Amendment&#8221;) and increased the borrowing amount from $<ix:nonFraction unitRef="usd" contextRef="i1b88d930749840dda7fc079ab96c882a_I20180917" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfNDQ3_128654c6-2770-4902-8bc2-acc425c81b2d">40.0</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="ifa14883525614cf79dab683249f898ec_I20191220" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfNDUz_2679f9f1-6acb-4ef5-801f-28b42b64c674">75.0</ix:nonFraction>&#160;million. The maturity date has been extended to December 20, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowing base under the Credit Agreement is comprised of an amount equal to (a) the lesser of (i) eighty percent (<ix:nonFraction unitRef="number" contextRef="i8887c4dc48dd49678b387048f0530ba7_D20210101-20210930" decimals="INF" name="ehth:LineOfCreditFacilityBorrowingBasePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfNjM1_590a00c7-a6d5-4d3b-a771-1651593d38ee">80</ix:nonFraction>%) of Eligible Commissions Receivables (as defined in the Credit Agreement) we actually collected during the immediately preceding period of three months or (ii) eighty percent (<ix:nonFraction unitRef="number" contextRef="i8ec55043cfb045c2aa1b9f8dd9a631ce_D20210101-20210930" decimals="INF" name="ehth:LineOfCreditFacilityBorrowingBasePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfODE0_9ff01baa-02fb-4470-98fd-06a7168e662e">80</ix:nonFraction>%) of our Eligible Commission Receivables for the immediately succeeding period of three months, plus (b) fifty percent (<ix:nonFraction unitRef="number" contextRef="ieca95dd280a443e393ddf3ccbcca1f92_D20210101-20210930" decimals="INF" name="ehth:LineOfCreditFacilityBorrowingBasePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfOTM2_95da6b4d-5d34-412c-a4bc-2aed85506085">50</ix:nonFraction>%) of our Eligible Commission Receivables for the immediately succeeding period of six months (excluding the immediately succeeding period of three months), in each case subject to reserves established by RBC (the &#8220;Borrowing Base&#8221;). The proceeds of the loans under the Credit Agreement may be used for working capital and general corporate purposes. The borrowers have the right to prepay the loans under the Credit Agreement in whole or in part at any time without penalty. Subject to availability under the Borrowing Base, amounts repaid may be reborrowed. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts not borrowed under the Credit Agreement will be subject to a commitment fee of <ix:nonFraction unitRef="number" contextRef="i724149df6b244d9cb6760b3d59438694_D20180917-20180917" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMTU4NQ_1926be87-6f79-4715-83ce-56977e252dcb">0.5</ix:nonFraction>% per annum on the daily unused portion of the credit facility, to be paid in arrears on the first business day of each calendar quarter. At the closing of the Credit Agreement, we paid a one-time facility fee of <ix:nonFraction unitRef="number" contextRef="i724149df6b244d9cb6760b3d59438694_D20180917-20180917" decimals="INF" name="ehth:LineOfCreditFacilityFacilityFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMTc5OQ_a80845df-68ce-40a2-b713-f5bc5b97951c">1.75</ix:nonFraction>% of the total commitments of $<ix:nonFraction unitRef="usd" contextRef="i1b88d930749840dda7fc079ab96c882a_I20180917" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMTgzMA_db375c42-5b4f-44be-bc97-93130eb426c3">40.0</ix:nonFraction>&#160;million. We also paid a one-time closing fee of <ix:nonFraction unitRef="number" contextRef="iea337c22bd714443919d49600be45338_D20191220-20191220" decimals="INF" name="ehth:LineOfCreditFacilityFacilityFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMTg3Mw_c393b9ac-dbcd-4982-9763-ef13b1a1a78c">0.5</ix:nonFraction>% of the new commitment of $<ix:nonFraction unitRef="usd" contextRef="ifa14883525614cf79dab683249f898ec_I20191220" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMTkwMQ_d4603485-b7d5-43f5-a6c8-b8504de1c24b">75.0</ix:nonFraction>&#160;million in connection with the Amendment. The Company is also obligated to pay other customary administration fees for a credit facility of this size and type. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability under the credit facility was up to the lesser of $<ix:nonFraction unitRef="usd" contextRef="i1b88d930749840dda7fc079ab96c882a_I20180917" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjEyNQ_dcb1fcd4-bbf1-46fd-82a4-eec94611ca11">40.0</ix:nonFraction> million or the Borrowing Base in the original credit agreement. The Amendment increased the availability up to the lesser of $<ix:nonFraction unitRef="usd" contextRef="ifa14883525614cf79dab683249f898ec_I20191220" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjI0NQ_1126ca19-7ccd-4c62-8558-3b4be088cd7c">75.0</ix:nonFraction> million or the Borrowing Base, which may be reduced from time to time pursuant to the Credit Agreement.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial covenants in the original Credit Agreement required that we maintain Excess Availability (as defined in the Credit Agreement) at or above $<ix:nonFraction unitRef="usd" contextRef="i1b88d930749840dda7fc079ab96c882a_I20180917" decimals="-5" format="ixt:num-dot-decimal" name="ehth:LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjQ5Mw_c7d1af62-2120-4227-b899-701cd4aeb168">6.0</ix:nonFraction> million at any time. The Amendment also changed the financial covenants to require us to maintain at least $<ix:nonFraction unitRef="usd" contextRef="ifa14883525614cf79dab683249f898ec_I20191220" decimals="-5" format="ixt:num-dot-decimal" name="ehth:LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjU5NQ_e5586ea8-3f1f-4179-b50c-84f977f421fb">6.0</ix:nonFraction>&#160;million of Excess Availability at all times or, if greater, up to $<ix:nonFraction unitRef="usd" contextRef="ifa14883525614cf79dab683249f898ec_I20191220" decimals="-5" format="ixt:num-dot-decimal" name="ehth:LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjY1Ng_3981d935-da2f-4258-89b7-55117aa606cf">11.3</ix:nonFraction>&#160;million depending on our Borrowing Base as determined by eligible past and future commissions receivable. In addition, the Amendment also included changes in the payment conditions to, among other things, require us to have at least $<ix:nonFraction unitRef="usd" contextRef="ifa14883525614cf79dab683249f898ec_I20191220" decimals="-5" format="ixt:num-dot-decimal" name="ehth:LineOfCreditFacilityCovenantMinimumLiquidity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjg4NA_744997be-8a7c-4a33-8aec-b401ecfb0c2d">10.0</ix:nonFraction>&#160;million of liquidity or, if greater, up to $<ix:nonFraction unitRef="usd" contextRef="ifa14883525614cf79dab683249f898ec_I20191220" decimals="-5" format="ixt:num-dot-decimal" name="ehth:LineOfCreditFacilityCovenantMaximumLiquidity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjkyMg_247ebc29-1bbe-4903-b184-3686595111e8">18.8</ix:nonFraction>&#160;million depending on the Borrowing Base as determined by eligible past and future commissions receivable, in order for us to make certain permitted acquisitions, investments, distributions and payments of indebtedness. The Amendment also stated the seasonal amount thresholds used in connection with the cash dominion and field examination covenants in the Credit Agreement. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred $<ix:nonFraction unitRef="usd" contextRef="i1b88d930749840dda7fc079ab96c882a_I20180917" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMzMwNg_f2835f44-012c-4fd6-9094-53e1e2ad4b5e">1.2</ix:nonFraction> million of issuance costs in connection with the Credit Agreement, which were capitalized as part of other assets on our Consolidated Balance Sheet in the period we entered into the Credit Agreement. The Amendment did not change the interest rate. In connection with the Amendment, we incurred closing costs totaling $<ix:nonFraction unitRef="usd" contextRef="ica1b5f7280934d02b7e7917401872662_I20191231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMzYxOA_df2f79ee-9740-436a-8039-8deb3e37f641">0.5</ix:nonFraction>&#160;million, which were capitalized and recorded as other assets on our Consolidated Balance Sheet as of December 31, 2019. The remaining balance of unamortized issuance costs was $<ix:nonFraction unitRef="usd" contextRef="id8ba51940194417ebfd20f82ded0000b_I20210930" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMzc4OQ_4f9b23b2-9b6f-44c2-ac5b-dbd68a8ef6e3">0.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i35b23d73e2ba484d8591b732fcc5f47c_I20201231" decimals="-5" format="ixt:num-dot-decimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMzc5Ng_7ac5d196-caea-4f3c-94ca-97ff570d5ac8">0.7</ix:nonFraction>&#160;million as of September 30, 2021 and December 31, 2020, respectively. </span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i04e15f34d0eb4b63bb20be501400153c">As of September 30, 2021, we had <ix:nonFraction unitRef="usd" contextRef="i942081d424f34699add16e658f851ed1_I20210930" decimals="INF" format="ixt:fixed-zero" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMzg0OQ_f127a321-b09e-442c-b86f-96b6cea3e93f">no</ix:nonFraction> outstanding borrowings under our revolving credit facility.</ix:continuation> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_73"></div><hr style="page-break-after:always"/><div style="min-height:99pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EHEALTH, INC.&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfMTg1Mw_49d415aa-d90a-4c4a-afee-6e22d879da0a" continuedAt="i08988bfbc85b4a7b8f1963a117bc40b1" escape="true">Income Taxes </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i08988bfbc85b4a7b8f1963a117bc40b1"><div style="text-indent:36pt"><ix:nonNumeric contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfMTg2Mw_2734ec25-93f5-464e-9cde-bd6fd3302f5e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes our benefit from income taxes and our effective tax rates for the periods presented below (in thousands, except effective tax rate):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before benefit from income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMi0xLTEtMS0w_542eea80-8b7c-489c-af04-5aecfc9e10fe">65,848</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMi0zLTEtMS0w_19752c18-a642-4ae0-bd72-02e835763bd2">20,948</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMi01LTEtMS0w_5c86eac6-0e07-414c-bfa0-ce11662fe818">91,501</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMi03LTEtMS0w_86d26888-1f2b-4d1e-b34e-843d499700af">25,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMy0xLTEtMS0w_1136af01-ddfd-4a1f-965c-16c440ee8d3c">12,834</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMy0zLTEtMS0w_b4506e28-7765-4eff-bbe8-687893eba8d4">6,443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMy01LTEtMS0w_7a4592c1-3669-4035-ad7e-d07376c63453">19,278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-3" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMy03LTEtMS0w_20047725-20a4-428e-854c-66b18436e4e4">10,923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfNC0xLTEtMS0w_18fcdef3-c708-4e22-be11-f91f5a644645">19.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfNC0zLTEtMS0w_09c3034f-3ed5-4774-b879-aea37f9e47ed">30.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfNC01LTEtMS0w_866b3145-e05f-4009-a68b-cfb1b09a91c5">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfNC03LTEtMS0w_edc8aa60-6df2-458a-b78e-3e47d741722e">43.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2021, we recognized a benefit from income taxes of $<ix:nonFraction unitRef="usd" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfMjIw_0be0bea4-0a40-41f2-9272-10e03cdf1736">12.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfMjI3_3382f98a-8c15-4321-93e2-e76a5df31bc3">19.3</ix:nonFraction>&#160;million, representing an effective tax rate of <ix:nonFraction unitRef="number" contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfMjY5_18fcdef3-c708-4e22-be11-f91f5a644645">19.5</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfMjc2_866b3145-e05f-4009-a68b-cfb1b09a91c5">21.1</ix:nonFraction>%, respectively. These effective tax rates are higher than the statutory federal tax rate due primarily to stock-based compensation adjustments, non-deductible lobbying expenses and state taxes, partially offset by research and development credits. For the three and nine months ended September 30, 2020, we recognized benefits from income taxes of $<ix:nonFraction unitRef="usd" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfNTQ5NzU1ODE0MDc3MA_903e542a-d1a3-4bff-97f1-36258dc8065a">6.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="-5" sign="-" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfNTgx_6da43a04-3c2d-493f-94dd-8a5b304e5a9d">10.9</ix:nonFraction>&#160;million, representing an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfNTQ5NzU1ODE0MDc4OA_09c3034f-3ed5-4774-b879-aea37f9e47ed">30.8</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfNjMw_edc8aa60-6df2-458a-b78e-3e47d741722e">43.1</ix:nonFraction>%, respectively, which were higher than the statutory federal tax rate due primarily to stock-based compensation adjustments, non-deductible lobbying expenses and state taxes, partially offset by research and development credits.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assessing the realizability of our deferred tax assets is dependent upon several factors, including the likelihood and amount, if any, of future taxable income in relevant jurisdictions during the periods in which those temporary differences become deductible. We forecast taxable income by considering all available positive and negative evidence, including our history of operating income and losses and our financial plans and estimates that we use to manage the business. These assumptions require significant judgment about future taxable income. As a result, the amount of deferred tax assets considered realizable is subject to adjustment in future periods if estimates of future taxable income change. We continue to recognize our deferred tax assets as of September 30, 2021, as we believe it is more likely than not that the net deferred tax assets will be realized, with the exception of certain net operating losses and credits that are expected to expire unutilized which have a valuation allowance.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_79"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In addition to historical information, this Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The words &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;target,&#8221; &#8220;goal,&#8221; &#8220;project,&#8221; &#8220;hope,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;seek,&#8221; &#8220;continue,&#8221; &#8220;may,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;might,&#8221; &#8220;forecast,&#8221; and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements include, among other things, statements regarding our expectations relating to approved members, new paying members and estimated membership; our estimates regarding the constrained lifetime value of commissions; our expectations relating to revenue, operating costs, cash flows and profitability; our expectations regarding our strategy and investments, including investments in our e-commerce and call center capabilities, technology, agent training and quality assurance efforts; our expectations regarding our Medicare business, including market opportunity, consumer demand and our competitive advantage; our expectations regarding our individual and family business, including anticipated trends and our ability to enroll individuals and families into qualified health plans; the impact of future and existing laws and regulations on our business; the expected impact of the COVID-19 pandemic on our business; our expectations regarding commission rates, payment rates, conversion rates, plan termination rates and duration, membership retention rates and membership acquisition costs; our expectations regarding health insurance agents licensing and productivity; our expectations regarding beneficiary complaints, customer experience and enrollment quality; our expectations relating to the seasonality of our business; expected competition from government-run health insurance exchanges and other sources; our expectations relating to marketing and advertising expense and expected contributions from our marketing and strategic partnership channels; the timing of our receipt of commission and other payments; our critical accounting policies and related estimates; liquidity and capital needs; political, legislative, regulatory and legal challenges; the merits or potential impact of any lawsuits filed against us; as well as other statements regarding our future operations, financial condition, prospects and business strategies. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">We have based these forward-looking statements on our current expectations about future events. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Our actual results may differ materially from those suggested by these forward-looking statements for various reasons, including our ability to retain existing members and enroll new members during the annual healthcare open enrollment period, the Medicare annual enrollment period and other special enrollment period; changes in laws, regulations and guidelines, including in connection with healthcare reform or with respect to the marketing and sale of Medicare plans; competition, including competition from government-run health insurance exchanges and other sources; the seasonality of our business and the fluctuation of our operating results; our ability to accurately estimate membership, lifetime value of commissions and commissions receivable; changes in product offerings among carriers on our ecommerce platform and the resulting impact on our commission revenue; our ability to execute on our growth strategy in the Medicare market; the continued impact of the COVID-19 pandemic on our operations, business, financial condition and growth prospects, as well as on the general economy; changes in our management and key employees; exposure to security risks and our ability to safeguard the security and privacy of confidential data; our relationships with health insurance carriers; customer concentration and consolidation of the health insurance industry; our success in marketing and selling health insurance plans and our unit cost of acquisition; our ability to hire, train, retain and ensure the productivity of licensed health insurance agents and other employees; the need for health insurance carrier and regulatory approvals in connection with the marketing of Medicare-related insurance products; changes in the market for private health insurance; consumer satisfaction of our service and actions we take to improve the quality of enrollments; changes in member conversion rates; changes in commission rates; our ability to sell qualified health insurance plans to subsidy-eligible individuals and to enroll subsidy-eligible individuals through government-run health insurance exchanges; our ability to maintain and enhance our brand identity; our ability to derive desired benefits from investments in our business, including membership growth and retention initiatives; reliance on marketing partners; the impact of our direct-to-consumer email, telephone and television marketing efforts; timing of receipt and accuracy of commission reports; payment practices of health insurance carriers; dependence on our operations in China; the restrictions in our debt obligations; the restrictions in our investment agreement with H.I.G; compliance with insurance and other laws and regulations; the outcome of litigation in which we are involved; the performance, reliability and availability of our information technology systems, ecommerce platform and underlying network infrastructure; and those identified under the heading &#8220;Risk Factors&#8221; in Part II, Item 1A. of this report and those discussed in our other Securities and Exchange Commission filings. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included in this report are made only as of the date hereof. Except as required by applicable law, we do not undertake, and specifically decline, any obligation to update any of these statements or to publicly announce the results of any revisions to any forward-looking statements, whether as a result of new information, future events, changes in assumptions or otherwise. The following discussion should be read in conjunction with our Annual Report on Form 10-K as filed with the </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Securities and Exchange Commission in February 2021 and amended in April 2021, and the audited consolidated financial statements and related notes contained therein.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are a leading private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Our mission is to connect every person with the highest quality, most affordable health insurance and Medicare plans for their life circumstances. Our platform integrates proprietary and third-party developed educational content regarding health insurance plans with decision support tools to aid consumers in what has traditionally been a confusing and opaque health insurance purchasing process, and to help them obtain the health insurance products that meet their individual health and economic needs. Our omnichannel consumer engagement platform enables consumers to use our services online, through interactive chat, or by telephone with a licensed insurance agent. We have created a marketplace that offers consumers a broad choice of insurance products that includes thousands of Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business and other ancillary health insurance products from over 200 health insurance carriers across all fifty states and the District of Columbia.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Updates on Business Initiatives</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, we made a number of changes to our telesales and online capabilities with a focus on driving performance and improving enrollment quality in preparation for the annual enrollment period in the fourth quarter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we shifted the mix of our telesales capacity towards full-time internal agents and away from third party vendor agents. In October 2021, we entered the Medicare annual enrollment period with internal agents comprising over 95% of our total agents, the largest number of full-time employed agents in our history and compared to approximately 50% at the same time in 2020. We also made other important changes across our call centers to improve the effectiveness of our agents and further enhance consumer experience. These changes include the migration of our call center technology to a cloud-based contact center and upgraded lead scoring and routing tools. We believe these improvements and new tools provide better support to our agents in their interactions with consumers as we enter into the most critical selling season of the year.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enrollment quality has been our focus since the launch of our retention program over a year ago, which is ensuring that eHealth presents Medicare beneficiaries with choices that best align with their eligibility status, lifestyle, health conditions and economic means with the goal of minimal disruption in existing provider relationships. We have been seeking additional ways to improve our customer experience, enhance accuracy of plan recommendations and reduce disenrollment. In the third quarter of 2021, we introduced additional mandatory training for our agents, added a new customer care function to verify certain Medicare enrollments prior to submission to the carrier, and expanded other quality assurance efforts. We restructured agent compensation incentives to place more focus on addressing the longer-term coverage needs of customers. As part of the recent migration of our call center technology to a cloud-based contact center, we also implemented a new cloud-based agent monitoring system, which is expected to provide new robust capabilities to train agents and monitor their performance in real time. While we expect these initiatives will enhance the quality of our enrollments generally, the introduction of these efforts to date has resulted in lower conversion rates and longer average talk times for telephonic enrollments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We continuously look for ways to improve the user experience of our online tools. Ahead of the annual enrollment period, we enhanced our online capabilities by launching an updated recommendation engine. This engine is designed to improve the accuracy of personalized plan-matching. It has machine-learning capabilities and leverages data from online customer interactions to provide recommendations, which we believe improves the online shopping experience and helps Medicare eligible consumers navigate increasingly broad and complex plan choices. Our online Customer Center continues to strengthen and support our relationships with consumers and to help retain their business when it's time to review their plan coverage choices. The Customer Center enables members to create a secure personal profile that stores their prescription drug regimen, preferred doctors and pharmacies, current coverage, and other relevant data, and makes this data available to the member and our licensed agents that they contact. The accessibility of the information facilities plan selection for our agents and members with accounts and also incentivizes members to return to us when their needs change.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the investments in our telesales operations, technology and enrollment quality assurance have negatively impacted our third quarter financial results, we believe that they will create long-term competitive advantages for us as carriers place an increasing value on enrollment quality and reduction in beneficiary complaints.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Senior Management</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, we announced the appointment of Christine Janofsky as our senior vice president, chief financial officer, effective September 2021. We also announced the resignation of Scott Flanders from his positions as a member of our board of directors and chief executive officer, effective October 31, 2021, and the appointment of Fran Soistman as a member of our board of directors and our chief executive officer, effective November 1, 2021. Mr. Flanders has agreed to provide consulting services to us through December 31, 2021 to assist with the transition of his duties and responsibilities. These executive changes resulted in lower general and administrative expenses in the third quarter of 2021, primarily due to the reversal of stock-based compensation expense related to Mr. Flanders' forfeited equity awards. Severance and other personnel costs related to Mr. Flanders' separation are included in restructuring and reorganization charges on our Condensed Consolidated Statement of Comprehensive Loss in the third quarter of 2021. Part of these severance and other personnel costs will be recognized during his remaining service period in the fourth quarter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Impact Updates </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, all of our offices remained open at reduced capacity and with additional safety and social distancing measures as a result of the COVID-19 pandemic. eHealth currently plans to operate with a combination of remote and in-office work in the United States at least through the end of 2021. We plan to increase the number of in-office employees next year depending upon the COVID-19 vaccination status of our employees as we intend to have only vaccinated employees in the office to promote the health and safety of our employees. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent of the impact of the COVID-19 pandemic on our operational and financial performance will depend on future developments, including the duration, spread and severity of the pandemic, the availability, effectiveness and uptake of vaccines for COVID-19, the emergence of new variants of COVID-19 and whether existing vaccines are effective with respect to such variants, the actions to contain the disease or mitigate its impact, and the duration, timing and severity of the impact on consumer behavior, including any recession resulting from the pandemic, all of which are unpredictable. Due to the surge of COVID-19 cases caused by the COVID-19 Delta variant, employees in our California offices are still required by county order to wear masks while in our offices regardless of vaccination status. The emergence of Delta and other variants could cause us to alter our operations and plans for in-office and remote work. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Part II, Item 1A of this Quarterly Report on Form 10-Q for a discussion of risks related to the COVID-19 pandemic.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Selected Metrics</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely upon certain metrics to estimate and recognize commission revenue, evaluate our business performance and facilitate strategic planning. Our commission revenue is influenced by a number of factors including but not limited to:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of individuals on applications for Medicare-related, individual and family, small business and ancillary health insurance plans that are approved by the relevant health insurance carriers;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of approved members for Medicare-related, individual and family, small business and ancillary health insurance plans from whom we have received an initial commission payment; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the constrained lifetime value (&#8220;LTV&#8221;), of approved members for Medicare-related, individual and family and ancillary health insurance plans we sell, as well as the estimated annual value of approved members for small business plans we sell.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Approved Members</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approved members represent the number of individuals on submitted applications that were approved by the relevant insurance carrier for the identified product during the current period. The applications may be submitted in either the current period or prior periods. Not all approved members ultimately become paying members.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows approved members by product for&#160;the period presented:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,999&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">222,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,940&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261,136&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">221,516&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual and Family</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Qualified Health Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Qualified Health Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Individual and Family</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,019&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ancillary</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dental</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Ancillary</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Small Business</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,320&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,473&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,856&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,194&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Approved Members</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,420&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,502&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371,654&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">333,026&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Three Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Medicare approved members decreased 22% in the three months ended September 30, 2021 compared to the same period in 2020. The decrease in total Medicare approved members was primarily attributable to a decline in telesales conversion rate which was primarily driven by additional quality initiatives we introduced during the third quarter of 2021, partially offset by the growth of our online applications.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual and family plan approved members grew 88% in the three months ended September 30, 2021 compared to the same period in 2020 due to the favorable market environment. The individual and family health insurance market is benefiting from the passage of the American Rescue Plan Act in March 2021. This legislation expanded access to premium credits making individual and family major medical plans more affordable, which allows a larger population to get the coverage that our major medical plans offer.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ancillary plan approved members decreased 14% in the three months ended September 30, 2021 compared to the same period in 2020 primarily due to decreases in approved members for short-term health insurance plans, dental and other ancillary insurance, partially offset by an increase in approved members for vision insurance. Small business group health insurance approved members declined 33% in the three months ended September 30, 2021 compared to the same period in 2020 mainly due to the shift of our focus away from the sale of small business products.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Nine Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Medicare approved members increased 18% in the nine months ended September 30, 2021 compared to the same period in 2020. The increase in total Medicare approved members was primarily attributable to an increase in Medicare Advantage plan members, partially offset by decreases in Medicare Supplement plan members and Medicare Part D prescription drug plan members during the nine months ended September 30, 2021 compared to the same period in 2020. The increase in approved Medicare Advantage members was primarily driven by strong consumer demand, online enrollment growth, and an increase in our internal agent productivity during the Medicare Advantage open enrollment period in the first quarter of 2021, partially offset by a decline in telesales conversion rate during the third quarter of 2021, as described above. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual and family plan approved members grew 52% in the nine months ended September 30, 2021 compared to the same period in 2020 partially due to the favorable market environment resulting from the passage of the American Rescue Plan Act mentioned above. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ancillary plan approved members declined 10% in the nine months ended September 30, 2021 compared to the same period in 2020 primarily due to declines in approved members for short-term health insurance plans and other ancillary plans, partially offset by an increase in approved members for dental and vision insurance. Small business group health insurance approved members declined 23% in the nine months ended September 30, 2021 compared to the same period in 2020 mainly due to the shift of our focus away from the sale of small business products.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Paying Members</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New Paying Members consist of approved members from the period presented and any periods prior to the period presented from whom we have received an initial commission payment during the period presented. The following table shows our new paying members by product for&#160;the periods presented below:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.656%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,626&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">293,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual and Family</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Qualified Health Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Qualified Health Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Individual and Family</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,098&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,961&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,520&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ancillary</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dental</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Ancillary</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,356&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Small Business</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,230&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total New Paying Members</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,850&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">440,728&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414,965&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Three Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Medicare total new paying members declined 19% in the three months ended September 30, 2021 compared to the same period in 2020, attributable to a decline in telesales conversion rate, partially offset by the growth of our online applications</span><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Individual and family plan new paying members grew 99% in the three months ended September 30, 2021 compared to the same period in 2020 primarily driven by an increase in approved members for qualified health plans. Ancillary new paying members declined 10% in the three months ended September 30, 2021 compared to the same period in 2020 primarily due to a decline in approved members for short-term, dental and other ancillary insurance plans, partially offset by an increase in approved members for vision insurance plans. Small business new paying members declined 37% in the three months ended September 30, 2021 compared to the same period in 2020 primarily due to a decrease in approved members for small business plans</span><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Nine Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Medicare total new paying members grew 8% in the nine months ended September 30, 2021 compared to the same period in 2020, primarily driven by an increase in Medicare Advantage plan approved members, partially offset by decreases in Medicare Part D prescription drug plan and Medicare Supplement plan approved members</span><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Individual and family plan new paying members grew 32% in the nine months ended September 30, 2021 compared to the same period in 2020 primarily driven by increases in approved members for non-qualified  and qualified plans. Ancillary new paying members declined 5% in the nine months ended September 30, 2021 compared to the same period in 2020 primarily due to a decrease in approved members for short-term and other ancillary plans. Small business new paying members declined 26% in the nine months ended September 30, 2021 compared to the same period in 2020 primarily due to a decrease in approved members for small business plans</span><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Estimated Constrained Lifetime Value of Commissions Per Approved Member</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table shows our estimated constrained LTV of commissions per approved member by product for&#160;the periods presented below:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.539%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Advantage </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Supplement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Part D </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual and Family</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Qualified Health Plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Qualified Health Plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ancillary</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dental </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vision </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Small Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Constrained LTV of commissions per approved member represents commissions estimated to be collected over the estimated life of an approved member&#8217;s plan after applying constraints in accordance with our revenue recognition policy. The estimate is driven by multiple factors, including but not limited to, contracted commission rates, carrier mix, estimated average plan duration, the regulatory environment, and cancellations of insurance plans offered by health insurance carriers with which we have a relationship. These factors may result in varying values from period to period. For additional information on constrained LTV, see Critical Accounting Policies and Estimates in our Annual Report on Form 10-K for the year ended December 31, 2020.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">For small business, the amount represents the estimated commissions we expect to collect from the plan over the following twelve months. The estimate is driven by multiple factors, including but not limited to, contracted commission rates, carrier mix, estimated average plan duration, the regulatory environment, and cancellations of insurance plans offered by health insurance carriers with which we have a relationship and applied constraints. These factors may result in varying values from period to period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Medicare </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The constrained LTV of commissions per approved member for Medicare Advantage plans grew by 9%, and declined by 11% and 7%, respectively, for Medicare Supplement and Medicare Part D prescription drug plans during the three months ended September 30, 2021 compared to the same period in 2020. The increase in constrained LTV of Medicare Advantage plans was due to higher commission rates. The decline in constrained LTV of commissions per approved member for Medicare Supplement and Medicare Part D prescription drug plans was due to shorter average plan durations for both products.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Individual and Family and Ancillary </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The constrained LTV of commissions per non-qualified health plan approved member and qualified health plan approved member increased 35% and 21%, respectively, during the three months ended September 30, 2021 compared with the same period in 2020 mostly due to increased estimates of average plan duration and a lower constraint for non-qualified health insurance plans. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The constrained LTV of commissions per approved member for short-term health insurance, dental, vision, and small business insurance plans increased by 5%, 17%, 11%, and 31%, respectively, during the three months ended September 30, 2021 compared with the same period in 2020 primarily due to an increase in estimated average plan duration.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The constraints applied to the total estimated lifetime commissions we expect to receive for selling the plan after the carrier approves an application in order to derive the constrained LTV of commissions for approved members recognized for the periods presented below are summarized as follows: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual and Family</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Qualified Health Plans </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Qualified Health Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ancillary</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dental</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Small Business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The constraints for Medicare Supplement and Medicare Part D prescription drug plans increased during the three months ended September 30, 2021, as compared to the same period in the prior year, due to declining LTV trends for these products. The constraints for non-qualified health plans decreased during the three months ended September 30, 2021, as compared to the same period in the prior year, due to stabilization of market conditions and increases in LTV values. The constraints for dental plans decreased during the three months ended September 30, 2021, as compared to the same period in the prior year, due to improved LTV trends.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Estimated Membership</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated membership represents the estimated number of members active as of the date indicated based on the estimation methodology below. The following table shows estimated membership by product for the periods presented below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.652%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">875,439&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">734,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual and Family</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Qualified Health Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,054&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Qualified Health Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Individual and Family</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,126&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112,834&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ancillary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dental</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Ancillary</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">241,366&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">245,053&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Small Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,424&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Estimated Membership</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,270,628&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,136,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">To estimate the number of members on Medicare-related health insurance plans, we take the sum of (i) the number of members for whom we have received or applied a commission payment for a month that may be up to three months prior to the date of estimation (after reducing that number using historical experience for assumed member cancellations over the period being estimated); and (ii) the number of approved members over that period (after reducing that number using historical experience for an assumed number of members who do not accept their approved policy and for estimated member cancellations through the date of the estimate). To the extent we determine through confirmations from a health insurance carrier that a commission payment is delayed or is inaccurate as of the date of estimation, we adjust the estimated membership to also reflect the number of members for whom we expect to receive or to refund a commission payment.  Further, to the extent we have received substantially all of the commission payments related to a given month during the period being estimated, we will take the number of members for whom we have received or applied a commission payment during the month of estimation.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">To estimate the number of members on Individual and Family health insurance plans (&#8220;IFP&#8221;), we take the sum of (i) the number of IFP members for whom we have received or applied a commission payment for a month that may be up to three months prior to the date of estimation (after reducing that number using historical experience for assumed member cancellations over the period being estimated); and (ii) the number of approved members over that period (after reducing that number using historical experience for an assumed number of members who do not accept their approved policy and for estimated member cancellations through the date of the estimate). To the extent we determine we have received substantially all of the commission payments related to a given month during the period being estimated, we will take the number of members for whom we have received or applied a commission payment during the month of estimation.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">To estimate the number of members on ancillary health insurance plans (such as short-term, dental and vision insurance), we take the sum of (i) the number of members for whom we have received or applied a commission payment for a month that may be up to three months prior to the date of estimation (after reducing that number using historical experience for assumed member cancellations over the period being estimated); and (ii) the number of approved members over that period (after reducing that number using historical experience for an assumed number of members who do not accept their approved policy and for estimated member cancellations through the date of the estimate). To the extent we determine we have received substantially all of the commission payments related to a given month during the period being estimated, we will take the number of members for whom we have received or applied a commission payment during the month of estimation. The one to three-month period varies by insurance product and is largely dependent upon the timeliness of commission payment and related reporting from the related carriers.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">To estimate the number of members on small business health insurance plans, we use the number of initial members at the time the group was approved, and we update this number for changes in membership if such changes are reported to us by the group or carrier. However, groups generally notify the carrier directly of policy cancellations and increases or decreases in group size without informing us. Health insurance carriers often do not communicate policy cancellation information or group size changes to us. We often are made aware of policy cancellations and group size changes at the time of annual renewal and update our membership statistics accordingly in the period they are reported.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A member who purchases and is active on multiple standalone insurance plans will be counted as a member more than once. For example, a member who is active on both an individual and family health insurance plan and a standalone dental plan will be counted as two continuing members.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health insurance carriers bill and collect insurance premiums paid by our members. The carriers do not report to us the number of members that we have as of a given date. The majority of our members who terminate their plans do so by discontinuing their premium payments to the carrier or notifying the carrier directly and do not inform us of the cancellation. Also, some of our members pay their premiums less frequently than monthly. Given the number of months required to observe non-payment of commissions in order to confirm cancellations, we estimate the number of members who are active on insurance policies as of a specified date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After we have estimated membership for a period, we may receive information from health insurance carriers that would have impacted the estimate if we had received the information prior to the date of estimation. We may receive commission payments or other information that indicates that a member who was not included in our estimates for a prior period was in fact an active member at that time, or that a member who was included in our estimates was in fact not an active member of ours. For instance, we reconcile information carriers provide to us and may determine that we were not historically paid commissions owed to us, which would cause us to have underestimated membership. Conversely, carriers may require us to return commission payments paid in a prior period due to policy cancellations for members we previously estimated as being active. We do not update our estimated membership numbers reported in previous periods. Instead, we reflect updated information regarding our historical membership in the membership estimate for the current period. If we experience a significant variance in historical membership as compared to our initial estimates, we keep the prior period data consistent with previously reported amounts, while we may provide the updated information in other communications or disclosures. As a result of the delay in our receipt of information from insurance carriers, actual trends in our membership are most discernible over periods longer than from one quarter to the next. As a result of the delay we experience in receiving information about our membership, it is difficult for us to determine with any certainty the impact of current conditions on our membership retention. Various circumstances could cause the assumptions and estimates that we make in connection with estimating our membership to be inaccurate, which would cause our membership estimates to be inaccurate. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, our membership estimates in a particular quarter have not been significantly different when compared to membership data received from carriers in a subsequent quarter. However, we experienced a larger deviation in the actual Medicare Advantage membership, which was lower than our initial estimate, for the first quarter of 2020. This deviation was primarily due to the time delay in our receiving information from carriers and a higher level of plan cancellations than expected. The difference between our estimates and carrier data have returned to our historical ranges since that time.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare-related plan estimated membership as of September 30, 2021 grew 19% compared to estimated membership as of September 30, 2020 due to a 33% growth in Medicare Advantage estimated membership and a 3% growth in Medicare Supplement plan estimated membership. The overall growth in Medicare estimated membership was due to increased sales of Medicare Advantage plans. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual and family plan estimated membership as of September 30, 2021 declined 4% compared to estimated membership as of September 30, 2020 due to overall market conditions in the individual and family plan market, despite the recent stabilization and improvement, and the shift of our investment towards Medicare. Ancillary plan estimated membership as of September 30, 2021 declined 2% compared to estimated membership as of September 30, 2020 primarily as a result of the decline in short-term health plans estimated membership.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Member Acquisition</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Marketing initiatives are an important component of our strategy to increase revenue and are primarily designed to encourage consumers to complete an application for health insurance. Variable marketing cost represents direct costs incurred in member acquisition from our direct, marketing partners and online advertising channels. In addition, we incur customer care and enrollment (&#8220;CC&amp;E&#8221;) expenses in assisting applicants during the enrollment process. Variable marketing costs exclude fixed overhead costs, such as personnel related costs, consulting expenses, facilities and other operating costs allocated to the marketing and advertising department.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the estimated variable marketing cost per approved member and the estimated customer care and enrollment expense per approved member metrics for&#160;the periods presented below. The numerator used to calculate each metric is the portion of the respective operating expenses for marketing and advertising and customer care and enrollment that is directly related to member acquisition for our sale of Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans (collectively, &#8220;Medicare Plans&#8221;) and for all individual and family major medical plans and short-term health insurance (collectively, &#8220;IFP Plans&#8221;), respectively. The denominator used to calculate each metric is based on a derived metric that represents the relative value of the new members acquired. For Medicare Plans, we call this derived metric Medicare Advantage (&#8220;MA&#8221;)-equivalent members, and for IFP Plans, we call this derived metric IFP-equivalent members. The calculations for MA-equivalent members and for IFP-equivalent members are based on the weighted number of approved members for Medicare Plans and IFP Plans during the period, with the number of approved members adjusted based on the relative LTV of the product they are purchasing. Since the LTV for any product fluctuates from period to period, the weight given to each product was determined based on their relative LTVs at the time of our adoption of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Standards Codification 606 &#8211; Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 606").</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.652%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated CC&amp;E cost per approved MA-equivalent approved member </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated variable marketing cost per MA-equivalent approved member</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Medicare estimated cost per approved member</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual and Family Plan</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated CC&amp;E cost per IFP-equivalent approved member</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (2)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Estimated variable marketing cost per IFP-equivalent approved member</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total IFP estimated cost per approved member</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">MA-equivalent approved members is a derived metric with a Medicare Part D approved member being weighted at 25% of a Medicare Advantage member and a Medicare Supplement member based on their relative LTVs at the time of our adoption of ASC 606. We calculate the number of approved MA-equivalent members by adding the total number of approved Medicare Advantage and Medicare Supplement members and 25% of the total number of approved Medicare Part D members during the period presented.</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">IFP-equivalent approved members is a derived metric with a short-term approved member being weighted at 33% of a major medical individual and family health insurance plan member based on their relative LTVs at the time of our adoption of ASC 606. We calculate the number of approved IFP-equivalent members by adding the total number of approved qualified and non-qualified health plan members and 33% of the total number of short-term approved members during the period presented.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Estimated CC&amp;E cost per approved MA-equivalent member increased 45%&#160;in the three months ended September 30, 2021&#160;compared to the same period in 2020 due to lower enrollment volume resulting from enrollment quality initiatives, a decline in our telesales conversion rate and an earlier start to our staffing increase for the Medicare annual enrollment period this year. In October 2021, we entered this annual enrollment period with over 95% of our sales force consisting of internal agents. We believe that this investment in internal telesales capacity will strengthen our telesales organization and improve enrollment quality going forward. Estimated variable marketing cost per MA-equivalent member increased 84% primarily due to lower enrollment volume as a result of lower conversion rates from our telephonic leads. In addition, a greater focus on our online advertising channel also contributed to the increase as it carries higher per enrollment marketing costs but lower customer care and enrollment costs.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated CC&amp;E cost per approved IFP-equivalent member decreased 13% in the three months ended September 30, 2021&#160;compared to the same period in 2020&#160;due primarily to an increase in agent productivity. Estimated variable marketing cost per IFP-equivalent member decreased 18% in the three months ended September 30, 2021 compared to the same period in 2020 due to an extended special open enrollment period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="text-indent:40.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements and related disclosures in conformity with U.S. generally accepted accounting principles requires us to make judgments, assumptions, and estimates that affect the amounts reported in the consolidated financial statements and the accompanying notes. These estimates and assumptions are based on current facts, historical experience, and various other factors that we believe are reasonable under the circumstances to determine reported amounts of assets, liabilities, revenue and expenses that are not readily apparent from other sources. To the extent there are material differences between our estimates and the actual results, our future consolidated results of comprehensive income may be affected.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An accounting policy is considered to be critical if the nature of the estimates or assumptions is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change, and the effect of the estimates and assumptions on financial condition or operating performance. The accounting policies we believe to reflect our more significant estimates, judgments and assumptions and are most critical to understanding and evaluating our reported financial results are as follows:&#160;</span></div><div style="text-indent:40.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue Recognition and contract assets - commission receivable;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Stock-Based Compensation; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Accounting for Income Taxes.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes to our critical accounting policies and estimates described in our Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on February 26, 2021 and amended on April 29, 2021, that have had a significant impact on our condensed consolidated financial statements and related notes. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contained in Part II, Item&#160;7 of our Annual Report on Form 10-K for the year ended December 31, 2020, for a complete discussion of our other critical accounting policies and estimates. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_91"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating results and related percentage of total revenue are summarized below for the periods presented (dollars in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commission</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,284&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294,685&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">289,458&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating costs and expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketing and advertising</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer care and enrollment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology and content</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,996&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring and reorganization charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,951&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">386,697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66,037)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,847)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(92,012)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,070)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss before benefit from income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,848)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,948)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(91,501)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,346)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,834)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,443)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,923)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53,014)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,505)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,223)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,423)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:29.2pt">Operating costs and expenses include the following amounts of stock-based compensation expense (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.642%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.648%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketing and advertising</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Customer care and enrollment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Technology and content</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,234&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,332&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,881&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,722&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commission revenue, other revenue and total revenue are summarized as (dollars in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Commission</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,353)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276,066&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">253,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,017)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,853)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,914&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,284&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,370)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294,685&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">289,458&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Three Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Commission revenue decreased $14.4 million, or 20%, during the three months ended September 30, 2021 compared to the same period in 2020 due to an $8.8 million decrease in commission revenue from the Medicare segment and a $5.5 million decrease in commission revenue from the Individual, Family and Small Business segment. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The decrease in commission revenue from the Medicare segment during the three months ended September 30, 2021 compared to the same period in 2020 was due to a 22% decline in approved members primarily attributable to an 18% decline of approved members for Medicare Advantage plans, partially offset by a 9% increase in Medicare Advantage LTVs. The decrease in commission revenue from the Individual, Family and Small Business segment was due primarily to a $7.0 million decrease in net adjustment revenue from members enrolled in prior periods, partially offset by an 88% increase in approved individual and family plan members due to a favorable market environment, and higher lifetime values for individual and family plan and certain ancillary products.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue declined $16.0 million, or 77%, during the three months ended September 30, 2021 compared to the same period in 2020 due primarily to a decrease in Medicare sponsorship and advertising revenue driven by reduced sponsorship activity, a decline in Medicare enrollment volumes year-over-year, and timing, with certain advertising arrangements commencing in the fourth quarter as compared to the third quarter in 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Nine Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Commission revenue increased $22.1 million, or 9%, during the nine months ended September 30, 2021 compared to the same period in 2020 due to a $12.1 million increase in commission revenue from the Individual, Family and Small Business segment and a $10.0 million increase in commission revenue from the Medicare segment. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The increase in commission revenue from the Medicare segment was driven by an 18% increase in Medicare plan approved members, driven primarily by a 30% growth in Medicare Advantage plan approved members compared to 2020, partially offset by a decrease in net commission revenue from Medicare members approved in prior periods which was primarily attributable to Medicare Supplement and Medicare Part D prescription drug plans. The increase in commission revenue from the Individual, Family and Small Business segment was primarily driven by a $8.6 million increase in net adjustment revenue, 52% increase in individual and family major medical plan approved members, 11% increase in dental plan approved members, and 16% increase in vision plan approved members. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Segment Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> below for further discussion.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue decreased $16.9 million, or 48%, during the nine months ended September 30, 2021 compared to the same period in 2020 due to a decrease in Medicare sponsorship and advertising revenue also related to timing as mentioned above.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the nature of our sponsorship arrangements with carriers will evolve and be driven by the quality of broker enrollments to a greater extent compared to the prior arrangements which were more focused on volume.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists of payments related to health insurance plans sold to members who were referred to our website by marketing partners with whom we have revenue-sharing arrangements. In order to enter into a revenue-sharing arrangement, marketing partners must be licensed to sell health insurance in the state where the policy is sold. Costs related to revenue-sharing arrangements are expensed as the related revenue is recognized.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, cost of revenue includes the amortization of consideration we paid to certain broker partners in connection with the transfer of their health insurance members to us as the new broker of record on the underlying plans. These transfers include primarily Medicare plan members. Consideration for all book-of-business transfers is being amortized to cost of revenue as we recognize commission revenue related to the transferred members.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cost of revenue is summarized as follows (dollars in thousands):&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(507)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(943)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Three Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Cost of revenue decreased by $0.5 million during the three months ended September 30, 2021, compared to the same period in 2020, primarily due to decreased activity from our revenue sharing arrangements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Nine Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Cost of revenue decreased by $0.9 million during the three months ended September 30, 2021, compared to the same period in 2020, primarily due to decreased activity from our revenue sharing arrangements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketing and Advertising</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing and advertising expenses consist primarily of member acquisition expenses associated with our direct, marketing partner and online advertising member acquisition channels, in addition to compensation and other expenses related to marketing, business development, partner management, public relations and carrier relations personnel who support our offerings.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketing and advertising expenses are summarized as follows (dollars in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketing and advertising</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,912&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138,772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,042&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Three Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Marketing and advertising expenses increased $9.9 million, or 30%, during the three months ended September 30, 2021 compared to the same period in 2020, primarily driven by a $10.2 million increase in Medicare plan related variable advertising, $0.4 million in stock-based compensation expenses and $0.4 million in facilities and other costs, partially offset by decreases of $0.6 million in consulting expenses and $0.6 million in personnel and compensation costs. The increase in variable advertising expense was due to an increase in our advertising expense per approved Medicare member, partially offset by a decline in the number of approved members during the quarter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Nine Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Marketing and advertising expenses increased $34.7 million, or 33%, during the nine months ended September 30, 2021 compared to the same period in 2020, primarily driven by a $36.1 million increase in Medicare plan related variable advertising and $1.8 million in stock-based compensation expenses, partially offset by decreases of $2.2 million in consulting expenses and $1.8 million in personnel and compensation costs. The increase in variable advertising expenses was due to an increase in our advertising expense through our partner and online channels.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Customer Care and Enrollment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer care and enrollment expenses primarily consist of compensation, benefits, and licensing costs for personnel engaged in assistance to applicants who call our customer care center and for enrollment personnel who assist applicants during the enrollment process. Our customer care and enrollment expenses also include third-party call center costs. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customer care and enrollment expenses are summarized as follows (dollars in thousands):&#160;</span></div><div style="text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Customer care and enrollment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,956&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,614&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,025&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Three Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Customer care and enrollment expenses increased $5.6 million, or 13%, during the three months ended September 30, 2021 compared to the same period in 2020, primarily due to increases of $15.1 million in personnel costs reflecting our investment in earlier onboarding of our internal telesales team and strengthening our resources in advance of the Medicare annual enrollment period as noted below and $1.9 million in facilities and other costs as well as a decline in telephonic conversion rates, partially offset by decreases of $8.4 million in external agents and consulting expenses, and $3.2 million in licensing costs. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Nine Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Customer care and enrollment expenses increased $20.5 million, or 20%, during the nine months ended September 30, 2021 compared to the same period in 2020, primarily due to increases of $28.7 million in personnel costs reflecting our investment in earlier onboarding of our internal telesales team and strengthening our resources in advance of the Medicare annual enrollment period as noted below and $2.4 million in facilities and other costs, partially offset by decreases of $7.0 million in consulting expenses and $4.4 million in licensing costs. The decrease in licensing costs was primarily due to previously over-recognized licensing costs that were adjusted during the first quarter of 2021. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have shifted to a predominantly internal agent model and intend to employ and maintain the majority of our health insurance agent force year-round. In 2021, we started internal agent hiring and training earlier in the year compared to 2020, with the largest headcount increase in the second and third quarters. During the three months ended September 30, 2021, we made progress expanding and enhancing our telesales organization and continued to scale our digital business. In October 2021, we entered the annual enrollment period with over 95% of our sales force consisting of internal agents, the largest number of full-time agents in our company's history. We also incurred more spending on agent training and the expansion of our customer service team in the third and fourth quarters, including the addition of a new customer care role to verify Medicare enrollments prior to submission and expanding our quality assurance efforts. Over time, we expect for these initiatives to result in improved enrollment quality, higher LTVs, as well as stronger consumer awareness of our choice platform. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technology and Content</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Technology and content expenses consist primarily of compensation and benefits costs for personnel associated with developing and enhancing our website technology as well as maintaining our website. A portion of our technology and content group is located at our wholly-owned subsidiary in China, where technology development costs are generally lower than in the United States.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology and content expenses are summarized as follows (dollars in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Technology and content</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,369&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,996&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Three Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Technology and content expenses increased $2.7 million, or 15%, during the three months ended September 30, 2021 compared to the same period in 2020 primarily driven by increases of $1.7 million in depreciation and amortization expenses, $1.0 million in stock-based compensation expense and $0.9 million in personnel and compensation costs due to higher headcount, partially offset by $0.6 million decrease in facilities and other operating costs and $0.3 million in consulting expenses.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Nine Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Technology and content expenses increased $17.2 million, or 37%, during the nine months ended September 30, 2021 compared to the same period in 2020 primarily driven by increases of $6.8 million in personnel and compensation costs due to higher headcount, $4.5 million in stock-based compensation expense, $4.3 million in depreciation and amortization expenses, and $1.2 million in facilities and other operating costs.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">General and Administrative</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses include compensation and benefits costs for personnel working in our executive, finance, investor relations, government affairs, legal, human resources, internal audit, facilities and internal information technology departments. These expenses also include fees paid for outside professional services, including audit, tax, legal, government affairs and information technology fees. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative expenses are summarized as follows (dollars in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,640&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,302)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,496)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Three Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; General and administrative expenses decreased $3.3 million, or 17%, during the three months ended September 30, 2021 compared to the same period in 2020, primarily driven by decreases of $2.7 million in stock-based compensation expenses, $1.8 million in personnel and compensation costs, and $0.5 million in consulting expenses, partially offset by an increase of $1.3 million in other professional fees. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Nine Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; General and administrative expenses decreased $2.5 million, or 4%, during the nine months ended September 30, 2021 compared to the same period in 2020, primarily driven by decreases of $3.3 million in stock-based compensation expenses, $2.4 million in personnel and compensation costs and $1.1 million in consulting expenses, partially offset by an increase of $2.7 million in other professional fees, $0.8 million in facilities and other operating costs and $0.5 million in depreciation and amortization expenses. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The decrease in stock-based compensation expenses for both three and nine months ended September 30, 2021 compared to the same periods in the prior year was primarily attributable to a $4.1 million credit related to forfeited equity awards due to our chief executive officer's separation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our intangible asset amortization expense is summarized as follows (dollars in thousands):&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortization of intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(791)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization expense was primarily related to intangible assets purchased through our acquisitions. Amortization expense decreased during the three and nine months ended September 30, 2021 compared to the same periods in 2020 due to certain intangible assets being fully amortized during the three and nine months ended September 30, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring and Reorganization Charges</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our restructuring and reorganization charges consist primarily of severance, transition and other related costs. Our restructuring and reorganization charges are summarized as follows (dollars in thousands):&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restructuring and reorganization charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,004&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,004&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* &#160;&#160;&#160;&#160;Percentage calculated is not meaningful.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Three Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Restructuring and reorganization charges for the three months ended September 30, 2021 consisted of the severance and other personnel related cost related to the separation arrangement with our chief executive officer in September 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Nine Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Restructuring and reorganization costs for the nine months ended September 30, 2021 primarily consisted of the severance and other personnel related cost related to the restructuring that took place in the first quarter of 2021. In February 2021, our board of directors approved a plan to terminate the employment of certain employees in certain locations. As part of this plan, we eliminated approximately 89 full-time positions, representing approximately 5% of our workforce, primarily in the United States within the customer care and enrollment groups, and to a lesser extent, in our marketing and advertising and general and administrative groups. In addition, we recognized severance and other personnel related costs related to our chief executive officer's separation as described above. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), Net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net, primarily consisted of interest income, sublease income and margin earned on commissions received from Medicare plan members transferred to us in 2010 through 2012 by a broker partner, partially offset by interest expense on finance leases and debt and other bank fees.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our other income (expense), net is summarized as follows (dollars in thousands):&#160; </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">% of total revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#929292;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Three Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Other income (expense), net increased $0.3 million during the three months ended September 30, 2021 compared to the same period in 2020 due to multiple individually immaterial items.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Nine Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Other income (expense), net decreased $0.2 million during the nine months ended September 30, 2021 compared to the same period in 2020 due primarily to a decrease in interest income.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Benefit from Income Taxes&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our benefit from income taxes are summarized as follows (dollars in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Benefit from income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,834)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,443)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,391)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19,278)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,923)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8,355)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Three Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Our effective tax rate of 19.5% for the three months ended September 30, 2021 was lower compared to 30.8% for the three months ended September 30, 2020 primarily due to a decrease in excess tax benefits associated with stock-based compensation. Our effective tax rate for the three months ended September 30, 2021 and 2020 were higher than the statutory federal tax rate due primarily to stock-based compensation adjustments, and non-deductible lobbying expenses and state taxes, partially offset by research and development credits. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Nine Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Our effective tax rate of 21.1% for the nine months ended September 30, 2021 was lower compared to 43.1% for the nine months ended September 30, 2020 primarily due to a decrease in excess tax benefits associated with stock-based compensation. Our effective tax rate for the nine months ended September 30, 2021 and 2020 were higher than the statutory federal tax rate due primarily to stock-based compensation adjustments, and non-deductible lobbying expenses and state taxes, partially offset by research and development credits.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_94"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Information</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report segment information based on how our chief executive officer, who is our CODM, regularly reviews our operating results, allocates resources and makes decisions regarding our business operations. The performance measures of our segments include total revenue and profit (loss). Our business structure is comprised of&#160;two&#160;operating segments:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare; and</span></div><div style="padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Individual, Family and Small Business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CODM does not separately evaluate assets by segment, with the exception of commissions receivable, and therefore assets by segment are not presented.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicare segment consists primarily of commissions earned from our sale of Medicare-related health insurance plans, including Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans, and to a lesser extent, ancillary products sold to our Medicare-eligible applicants, including but not limited to, dental and vision plans, as well as our advertising program that allows Medicare-related carriers to purchase advertising on a separate website developed, hosted and maintained by us and to purchase other marketing and advertising services, as well as our delivery and sale to third parties of Medicare-related health insurance leads generated by our ecommerce platforms and our marketing activities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Individual, Family and Small Business segment consists primarily of commissions earned from our sale of individual, family and small business health insurance plans and ancillary products sold to our non-Medicare-eligible applicants, including but not limited to, dental, vision, and short-term health insurance. To a lesser extent, the Individual, Family and Small Business segment consists of amounts earned from our online sponsorship program that allows carriers to purchase advertising space in specific markets in a sponsorship area on our website, our licensing to third parties the use of our health insurance ecommerce technology, and our delivery and sale to third parties of individual and family health insurance leads generated by our ecommerce platforms and our marketing activities. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing and advertising, customer care and enrollment, technology and content, and general and administrative operating expenses that are directly attributable to a segment are reported within the applicable segment. Indirect marketing and advertising, customer care and enrollment, and technology and content operating expenses are allocated to each segment based on usage. Other indirect general and administrative operating expenses are managed in a corporate shared services environment and, since they are not the responsibility of segment operating management, are not allocated to the operating segments and instead reported within Corporate. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment profit (loss) is calculated as total revenue for the applicable segment less direct and allocated marketing and advertising, customer care and enrollment, technology and content, and general and administrative operating expenses, excluding stock-based compensation expense, depreciation and amortization expense, amortization of intangible assets, and restructuring and reorganization charges. During the first quarter of 2021, we modified the calculation of segment profit to exclude the amortization of capitalized software development cost to enhance comparability of our financial metrics with peer companies.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating segment revenue and profit (loss) are summarized as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:21.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.934%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,980)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240,633&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">246,891&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Individual, Family and Small Business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,390)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,485&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,370)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">294,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">289,458&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Segment profit (loss):</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare segment profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,882)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,139)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38,743)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46,141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,134)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Individual, Family and Small Business segment profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total segment profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40,383)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,029)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,665)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48,146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,811)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(14,827)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,581)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,206)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,376)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,234)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,332)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,098&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,881)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21,722)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,899)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,995)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,904)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,911)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(416)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,207)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restructuring and reorganization charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,004)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,004)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Loss before benefit from income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,848)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,948)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(44,900)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(91,501)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,346)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66,155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* &#160;&#160;&#160;&#160;Percentage calculated is not meaningful.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">During the first quarter of 2021, we revised the calculation of segment profit by excluding amortization of capitalized software development costs to enhance comparability of our financial metrics with peer companies. The amortization of capitalized software development costs were $3.4 million and $2.1 million for the three months ended September 30, 2021 and 2020, respectively, and were $9.1 million and $5.3 million for the nine months ended September 30, 2021 and 2020, respectively. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Depreciation and amortization has been adjusted to include amortization of software development costs.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Three Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Revenue from our Medicare segment declined $24.0 million, or 34%, during the three months ended September 30, 2021 compared to the same period in 2020, primary attributable to a $15.2 million decrease in sponsorship and advertising revenue and an $8.8 million decrease in commission revenue.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from our Individual, Family and Small Business segment declined $6.4 million, or 27%, during the three months ended September 30, 2021 compared to the same period in 2020, primarily attributable to a $7.0 million decrease in net adjustment revenue. Despite the extension of the COVID-related special enrollment period through August 15, 2021 and an increase in subsidies to certain individuals who purchase qualified health plans, we continued to observe stronger member retention rates in our LTV assessments for the majority of the earlier period cohorts of certain products in our Individual, Family and Small Business segment. Based on our evaluation of the updated LTV models and retention trends, we recognized $10.0 million in net adjustment revenue during the three months ended September 30, 2021, compared to $17.1 million recognized in the same period in 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Nine Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Revenue from our Medicare segment declined $6.3 million, or 3%, during the nine months ended September 30, 2021 compared to the same period in 2020, primary attributable to a $16.2 million decrease in sponsorship and advertising revenue, partially offset by a $10.0 million increase in commission revenue. The increase in Medicare segment commission revenue is primarily driven by an increase in Medicare Advantage plan related commission revenue of $40.4 million, partially offset by a $20.7 million decrease in net adjustment revenue which was largely attributable to our Medicare Part D prescription drug plans and a decline in the LTV of Medicare Supplement and Medicare Part D prescription drug plans. The increase in Medicare Advantage commission revenue was driven by 30% growth in Medicare Advantage plan approved members.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from our Individual, Family and Small Business segment grew $11.5 million, or 27%, during the nine months ended September 30, 2021 compared to the same period in 2020, primarily attributable to a $12.1 million increase in commission revenue. Despite the extension of the COVID-related special enrollment period through August 15, 2021 and an increase in subsidies to certain individuals who purchase qualified health plans, we continued to observe stronger member retention rates in our LTV assessments for the majority of the earlier period cohorts of certain products in our Individual, Family and Small Business segment. Based on our evaluation of the updated LTV models and retention trends, we recognized $29.1 million in net adjustment revenue, an increase of $8.6 million during the nine months ended September 30, 2021 compared to the same period in 2020. Our Individual, Family and Small Business segment is benefiting from the passage of the American Rescue Plan Act in March 2021. This legislation expanded access to premium credits making individual and family health plans more affordable, which allows a larger population to get quality coverage that our major medical plans offer.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Profit (Loss)</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Three Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Our Medicare segment loss was $52.9 million during the three months ended September 30, 2021, an increase of $38.7 million, or 274%, compared to segment loss of $14.1 million for the same period in 2020. This was primarily due to a $24.0 million decrease in revenue and a $14.8 million increase in operating expenses, excluding stock-based compensation expense, depreciation and amortization expenses, amortization of intangible assets, and restructuring and reorganization charges. The increase in operating expenses was mostly attributable to increases in marketing costs and customer care and enrollment costs as we continued to invest in telesales capacity, internal agent counts, agent productivity tools and incentives, customer engagement and retention, enrollment quality initiatives, and enhancements to our technology platform. These investments were made in preparation for the annual enrollment period in the fourth quarter.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Individual, Family and Small Business segment profit was $12.5 million during the three months ended September 30, 2021, a decrease of $6.0 million, or 32% compared to the same period in 2020. The decrease was primarily driven by a $6.4 million decrease in revenue and a $0.4 million decrease in operating expenses, excluding stock-based compensation expense, depreciation and amortization expenses, amortization of intangible assets, and restructuring and reorganization charges.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Nine Months Ended September 30, 2021 and 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> &#8211; Our Medicare segment loss was $46.1 million during the nine months ended September 30, 2021, a decrease of $70.1 million, or 292%, compared to segment profit of $24.0 million for the same period in 2020. This was primarily due to a $63.9 million increase in operating expenses, excluding stock-based compensation expense, depreciation and amortization expenses, amortization of intangible assets, and restructuring and reorganization charges, as well as a $6.3 million decrease in revenue. The increase in operating expenses was mostly attributable to our enrollment quality initiatives and our investments in preparation for the annual enrollment period in the fourth quarter.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Individual, Family and Small Business segment profit was $38.5 million during the nine months ended September 30, 2021, an increase of $14.3 million, or 59% compared to the same period in 2020. The increase was primarily driven by a $11.5 million increase in revenue and a $2.8 million decrease in operating expenses, excluding stock-based compensation expense, depreciation and amortization expenses, amortization of intangible assets, and restructuring and reorganization charges.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_97"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents, and short-term marketable securities are summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.323%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash, cash equivalents, and short-term marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227,742&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,379&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our current cash and cash equivalents, credit facility and expected cash collections will be sufficient to fund our operations for at least twelve&#160;months after the filing date of this Quarterly Report on Form 10-Q. Our future capital requirements will depend on many factors, including our enrollment volume, membership, retention rates, telesales conversion rates and our level of investment in technology, marketing and advertising, customer care and other initiatives. In addition, our cash position could be impacted by further acquisitions and the level of investments we make to pursue our strategy. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we recognize constrained LTV as revenue at the time applications are approved, our collection of the cash commissions resulting from approved applications generally occurs over a number of years. The expense associated with approved applications, however, is generally incurred at the time of enrollment. As a result, the net cash flow resulting from approved applications is generally negative in the period of revenue recognition and generally becomes positive over the lifetime of the member. In periods of membership growth, cash receipts associated with new and continuing members may be less than the cash outlays to acquire new members. We expect a reduction in cash and cash equivalents in the future resulting from our continued investments to grow our business. To the extent that available funds are insufficient to fund</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our future activities or to execute our financial strategy, we may raise additional capital through bank debt, or public or private equity or debt financing to the extent such funding sources are available. Alternatively, we may decide to reduce marketing and advertising, customer care and enrollment, technology and content, or other expenses in order to manage liquidity.  These reductions could adversely impact our rate of membership and revenue growth.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, our cash and cash equivalents totaled $157.5 million. Cash equivalents,&#160;which are comprised of financial instruments with an original maturity of 90 days or less from the date of purchase, primarily consist of money market funds and commercial paper. The increase in cash and cash equivalents reflects $210.9 million of net cash provided by financing activities, partially offset by $60.3 million of net cash used in operating activities and $36.8 million of net cash used in investing activities. We also maintained $3.4 million in restricted cash as of September 30, 2021 and December 31, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a summary of our cash flows for the nine months ended September 30, 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.323%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,321)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,959)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128,291)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:58.5pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities primarily consists of net loss, adjusted for certain non-cash items, including, deferred income taxes, stock-based compensation expense, depreciation and amortization, amortization of intangible assets and internally developed software, other non-cash items, and the effect of changes in working capital and other activities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collection of commissions receivable depends upon the timing of our receipt of commission payments and associated commission reports from health insurance carriers. If we were to experience a delay in receiving a commission payment from a health insurance carrier within a quarter, our operating cash flows for that quarter could be adversely impacted. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our marketing and advertising expense is driven by the number of health insurance applications submitted on our ecommerce platforms. Since our marketing and advertising costs are expensed and generally paid as incurred, and since commission revenue is recognized upon approval of a member but commission payments are paid to us over time, our operating cash flows could be adversely impacted by a substantial increase in the volume of applications submitted during a quarter or positively impacted by a substantial decline in the volume of applications submitted during a quarter. During the Medicare annual enrollment period that takes place during the last quarter of each year and the reintroduced Medicare Advantage open enrollment period in the first quarter of the year, we experience an increase in the number of submitted Medicare-related health insurance applications and marketing and advertising expenses compared to outside of these enrollment periods. Similarly, during the open enrollment period for individual and family health insurance plans which typically takes place during the fourth quarter of each year, we experience an increase in the number of submitted individual and family plan health insurance applications and marketing and advertising expenses compared to outside of open enrollment periods. The timing of enrollment periods for individual and family health insurance plans, the Medicare annual enrollment period and the open enrollment period for Medicare-related health insurance can positively or negatively affect our cash flows during each quarter. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September 30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash used in operating activities was $60.3 million during the nine months ended September 30, 2021, primarily driven by net loss of $72.2 million and changes in net operating assets and liabilities of $7.0 million, partially offset by adjustments for non-cash items of $18.9 million. Adjustments for non-cash items primarily consisted of $24.9 million of stock-based compensation expense, $9.6 million of amortization of intangible assets and internally-developed software, and $3.7 million of depreciation and amortization, partially offset by a $20.1 million decrease due to the change in deferred income taxes. Cash used from changes in net operating assets and liabilities during the nine months ended September 30, 2021 primarily consisted of decreases of $26.9 million in accounts payable, $6.5 million in accrued marketing expense, increases of $20.8 million in prepaid expenses and other current asset, and decreases in $0.1 million in accrued compensation and benefits, partially offset by decreases of $35.2 million in contract assets &#8211; commissions receivable, increases of $10.2 million in deferred revenue and $1.4 million in accrued expenses and other liabilities.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September 30, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash used in operating activities was $11.0 million during the nine months ended September 30, 2020, primarily driven by changes in net operating assets and liabilities of $16.8 million and a net loss of $14.4 million, partially offset by adjustments for non-cash items totaling $20.3 million. Adjustments for non-cash items primarily consisted of $21.7 million of stock-based compensation expense, $6.5 million of amortization of intangible assets and internally developed software, and $2.6 million of depreciation and amortization, partially offset by an $11.0 million change in deferred income taxes. Cash used from changes in net operating assets and liabilities during the nine months ended September 30, 2020 primarily consisted of increases of $16.8 million in contract assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> commissions receivable, $9.4 million in prepaid expenses and other current assets and $1.5 million in accounts receivable, decreases of $7.4 million in accrued compensation and benefits, $5.4 million in accrued marketing expenses, and $3.2 million in accounts payable, partially offset by increases of $23.9 million in deferred revenue and $3.1 million in accrued expenses and other liabilities.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investing activities primarily consist of purchases, maturities, and redemptions of marketable securities as well as purchases of computer hardware and software to enhance our website and customer care operations, leasehold improvements related to facilities expansion, capitalized internal-use software and website development costs and security deposit payments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September 30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash used in investing activities of $36.8 million for the nine months ended September 30, 2021 mainly consisted of $89.0 million used to purchase marketable securities, $12.6 million in capitalized internal-use software and website development costs and $3.6 million used to purchase property and equipment and other assets, partially offset by $68.3 million proceeds from the maturities and redemptions of marketable securities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September 30, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash used in investing activities of $128.3 million for the nine months ended September 30, 2020 was due to $180.5 million in purchases of marketable securities, $12.1 million in capitalized internal-use software and website development costs and $6.5 million used to purchase property and equipment and other assets, partially offset by $70.8 million proceeds from the maturities and redemptions of marketable securities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September 30, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash provided by financing activities of $210.9 million for the nine months ended September 30, 2021 was primarily due to $214.0 million net proceeds from issuance of convertible preferred stock and $5.0 million net proceeds from exercise of common stock options, partially offset by $8.0 million in repurchases of shares to satisfy employee tax withholding obligations.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September 30, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash provided by financing activities of $203.6 million for the nine months ended September 30, 2020 was primarily due to $228.0 million net proceeds from the issuance of common stock in a public equity offering and $1.6 million of net proceeds from the exercise of common stock options, partially offset by $17.2 million in repurchases of shares to satisfy employee tax withholding obligations and $8.8 million of acquisition-related contingent payments. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Preferred Stock </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 30, 2021 (the &#8220;Closing Date&#8221;), we issued and sold 2,250,000 shares of our newly designated Series A convertible preferred stock (&#8220;Series A preferred stock&#8221;) at an aggregate purchase price of $225.0 million, at a price of $100 (the &#8220;Stated Value&#8221; per share of Series A preferred stock) per share. We received $214.0 million net proceeds from the private placement with Echelon Health SPV, LP ("H.I.G."), net of sales commissions and certain transaction fees.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Dividends on our outstanding shares of Series A preferred stock accrue daily at 8% per annum on the Stated Value per share and compound semiannually, payable in kind until April 30, 2023, which is the second anniversary of the Closing Date, on June 30 and December 31 of each year, beginning on June 30, 2021, and will thereafter become 6% payable in kind and 2% payable in cash in arrears on June 30 and December 31 of each year, beginning on June 30, 2023 (each, a &#8220;Cash Dividend Payment Date&#8221;). Dividends payable in kind will be cumulative. The Series A preferred stock also participates, on an as-converted basis (without regard to conversion limitations) in all dividends paid to the holders of our common stock. If we fail to declare and pay full cash dividend payments as required by the certificate of designations for the Series A preferred stock for two consecutive Cash Dividend Payment Dates, the cash dividend rate then in effect shall increase one time by 2%, retroactive to the first day of the semiannual period immediately preceding the first Cash Dividend Payment Date at which we failed to pay such accrued cash dividends, until such failure to pay full cash dividends is cured (at which time the dividend rate shall return to the rate prior to such increase). The dividend rights of the Series A preferred stock are senior to all of our other equity securities.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning on April 30, 2027, which is the sixth anniversary of the Closing Date, each holder of Series A preferred stock will have the right to require us to redeem all or any portion of the Series A preferred stock for cash at a price calculated as set forth in the certificate of designations. In addition, upon certain change of control events, holders of Series A preferred stock can require us, subject to certain exceptions, to repurchase any or all of their Series A preferred stock.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of September 30, 2021, no shares of the Series A preferred stock have been converted and the balance of our Series A preferred stock was $225.4 million, including a change in the redemption value of $3.8 million and the accrued paid-in-kind dividends of $7.6 million, which was equivalent to 2.9&#160;million shares of common stock on an as-converted basis. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Note 6 &#8211; Convertible Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Notes to Condensed Consolidated Financial Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">included in this Quarterly Report on Form 10-Q for additional information.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into a credit agreement with Royal Bank of Canada (&#8220;RBC&#8221;) as administrative agent and collateral agent, (the &#8220;Credit Agreement&#8221;) in September 2018. The Credit Agreement provides for a $40.0 million secured asset-backed revolving credit facility with a $5.0 million letter of credit sub-facility. On December 20, 2019, we amended our revolving credit facility agreement with RBC (the &#8220;Amendment&#8221;) and increased the maximum borrowing amount to $75.0 million and extended the expiration to December 20, 2022. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowing base under the Credit Agreement is comprised of an amount equal to (a) the lesser of (i) eighty percent (80%) of Eligible Commissions Receivables (as defined in the Credit Agreement) we actually collected during the immediately </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preceding period of three months or (ii) eighty percent (80%) of our Eligible Commission Receivables for the immediately succeeding period of three months, plus (b) fifty percent (50%) of our Eligible Commission Receivables for the immediately succeeding period of six months (excluding the immediately succeeding period of three months), in each case subject to reserves established by RBC (the &#8220;Borrowing Base&#8221;). The proceeds of the loans under the Credit Agreement may be used for working capital and general corporate purposes. We have the right to prepay the loans under the Credit Agreement in whole or in part at any time without penalty. Subject to availability under the Borrowing Base, amounts repaid may be reborrowed. Amounts not borrowed under the Credit Agreement are subject to a commitment fee of&#160;0.5%&#160;per annum on the daily unused portion of the credit facility, to be paid in arrears on the first business day of each calendar quarter. At closing of the Credit Agreement, we paid a one-time facility fee of&#160;1.75%&#160;of the total commitments of $40 million. We also paid a one-time closing fee of 0.5% of the new commitment of $75.0 million in connection with the Amendment. We are also obligated to pay other customary administration fees for a credit facility of this size and type.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, we had no outstanding principal amount under our revolving credit facility. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Notes to Condensed Consolidated Financial Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">included in this Quarterly Report on Form 10-Q for additional information regarding this credit agreement and subsequent amendment.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Issuance</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to an effective registration statement that was filed on December 17, 2018, and amended on January 22, 2019 and March 2, 2020, we entered into an underwriting agreement in March 2020 to issue a total of 2,070,000 shares of common stock, which included the exercise in full of the underwriters&#8217; option to purchase 270,000 additional shares of common stock, at a price to the public of&#160;$115.00&#160;per share. Net proceeds from the offering were approximately&#160;$228.0 million&#160;after deducting underwriting discounts, commissions and expenses of the offering. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our material contractual obligation generally include operating lease liabilities and non-cancellable contractual service and licensing obligations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for information about our operating lease obligations. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the information about our non-cancellable contractual service and licensing obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues, or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_106"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-indent:40.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Business and Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Quarterly Report on Form 10-Q for recently issued accounting standards that could have an effect on us.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_109"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. &#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit and Interest Rate Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments that are exposed to concentrations of credit risk principally consist of cash and cash equivalents, marketable securities, accounts receivable, and contract assets &#8211; commission receivable. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents, short-term marketable securities, and restricted cash are summarized as follows (in thousands):&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.468%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) (2)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">157,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term marketable securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash, cash equivalents, short-term marketable securities, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,096&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,733&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">We deposit our cash and cash equivalents in accounts with major banks and financial institutions and such deposits are in excess of federally insured limits. We also have deposits with major banks in China that are denominated in both U.S. dollars and Chinese Yuan Renminbi and are not insured by the U.S. federal government.&#160;</span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%;padding-left:11.94pt">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"> in our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">Notes to Condensed Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"> for more information on our cash and cash equivalents and marketable securities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio of available-for-sale debt securities is exposed to credit and interest rate risk. As of September 30, 2021, we invested $70.2 million in marketable securities primarily consisting of commercial paper, agency bonds, and a corporate bond with credit rating of AA or equivalent by S&amp;P Rating and Moody's Investor Services. The maturity of these securities were less than one year. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Fair Value Measurements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Notes to Condensed Consolidated Financial Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further discussion on our available-for-sale debt securities.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, our net contract assets &#8211; commissions receivable balance was $757.4 million. Our contracts with carriers expose us to credit risk that a financial loss could be incurred if the counterparty does not fulfill its financial obligation. While we are exposed to credit losses due to the non-performance of our counterparties, we consider the risk of this remote. We estimate our maximum credit risk in determining the contract assets &#8211; commissions receivable balance recognized  on the balance sheet. We had a $1.8 million allowance for credit losses for our commissions receivable balance as of September 30, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total contract assets and accounts receivable as of September 30, 2021&#160;and December 31, 2020 are summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:65.029%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.468%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets &#8211; commissions receivable &#8211; current</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">194,197&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">219,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract assets &#8211; commissions receivable &#8211; non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">573,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,799&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total contract assets and accounts receivable</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">758,673&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">794,204&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, substantially all of our revenue has been derived from transactions denominated in United States Dollars. We have exposure to adverse changes in exchange rates associated with operating expenses of our foreign operations, which are denominated in Chinese Yuan Renminbi. Foreign currency fluctuations have not had a material impact historically on our results of operations; however, they may in the future. We have not engaged in any foreign currency hedging or other derivative transactions to date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_112"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div style="text-indent:40.5pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Our Disclosure Controls and Procedures</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our chief executive officer and chief accounting officer, evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this Quarterly Report on Form 10-Q.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on management&#8217;s evaluation, our chief executive officer and chief accounting officer concluded that our disclosure controls and procedures are effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief accounting officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There were no changes in our internal control over financial reporting that occurred during the nine months ended September 30, 2021&#160;that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inherent Limitations on Effectiveness of Controls</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our chief executive officer and chief accounting officer, believes that our disclosure controls and our internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_115"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">PART II.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_118"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we have received and may continue to receive inquiries from state and federal regulators relating to various matters. We have become, and may in the future become, involved in litigation in the ordinary course of our business. If we are found to have violated laws or regulations in any jurisdiction, we could be subject to various fines and penalties, including revocation of our license to sell insurance in those states, and our business, operating results and financial condition would be harmed. Revocation of any of our licenses or penalties in one jurisdiction could cause our license to be revoked or for us to face penalties in other jurisdictions. In addition, without a health insurance license in a jurisdiction, carriers would not pay us commissions for the products we sold in that jurisdiction, and we would not be able to sell new health insurance products in that jurisdiction. We could also be harmed to the extent that related publicity damages our reputation as a trusted source of objective information relating to health insurance and its affordability. It could also be costly to defend ourselves regardless of the outcome. Our material legal proceedings are described in Part I, Item I of this Quarterly Report on Form 10-Q in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes to Condensed Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In addition to other information in this Quarterly Report on Form 10-Q and in other filings we make with the Securities and Exchange Commission, the following risk factors should be carefully considered in evaluating our business as they may have a significant impact on our business, operating results and financial condition. If any of the following risks actually occurs, our business, financial condition, results of operations and future prospects could be materially and adversely affected. Because of the following factors, as well as other variables affecting our operating results, past financial performance should not be considered as a reliable indicator of future performance and investors should not use historical trends to anticipate results or trends in future periods.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our ability to enroll individuals during enrollment periods is impeded or if investments we make in enrollment periods do not result in the returns we expected when making those investments, our business, operating results and financial condition would be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In an attempt to attract and enroll a large number of individuals during the Medicare annual enrollment period and to a lesser extent, the Medicare Advantage open enrollment period and the health care reform open enrollment period under the Affordable Care Act, we may invest in areas of our business, including technology and content, customer care and enrollment, and marketing and advertising. We have in the past made investments in areas of our business in advance of enrollment periods that have not yielded the results we expected when making those investments. Any investment we make in any enrollment period may not result in a significant number of approved and paying members or may not be as cost-effective as we anticipated. If it does not, or is not, our business, operating results and financial condition would be harmed. If our ability to market and sell Medicare-related health insurance and individual and family health insurance is constrained during an enrollment period for any reason, such as technology failures, interruptions in the operation of our e-commerce or telephony platforms, reduced allocation of resources, any inability to timely employ, license, train, certify and retain our employees and our outsourced call centers and their health insurance agents to sell health insurance, we could acquire fewer members, suffer a reduction in our membership, and our business, operating results and financial condition could be harmed. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unsuccessful in competing effectively against current and future competitors, including government-run health insurance exchanges.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The market for selling health insurance plans is highly competitive. We compete with government-run health insurance exchanges, among others, with respect to our sale of Medicare-related and individual and family health insurance. The federal government operates a website where Medicare beneficiaries can purchase Medicare Advantage and Medicare Part D prescription drug plans or be referred to carriers to purchase Medicare Supplement plans. We also compete with the original Medicare program. The Affordable Care Act exchanges have websites where individuals and small businesses can purchase </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">health insurance, and they also have offline customer support and enrollment capabilities. Our competitors also include local insurance agents across the United States who sell health insurance plans in their communities, companies that advertise primarily through television, and companies that operate websites that provide quote information or the opportunity to purchase health insurance online, including lead aggregator services. Many health insurance carriers also directly market and sell their plans to consumers through call centers, Internet advertising and their own websites. Although we offer health insurance plans for many of these carriers, they also compete with us by offering their plans directly to consumers. In recent years, we also have seen increased competition from national telesales insurance brokers.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To remain competitive against our current and future competitors, we will need to market our services effectively and continue to improve the online shopping experience and functionalities of our website and other platforms that our current and future customers may access to purchase health insurance products from us.&#160;If we cannot predict, develop and deliver the right shopping experience and functionality in a timely and cost-effective manner, or if we are not effective in cost-effectively driving a substantial number of consumers interested in purchasing health insurance to our website and customer care centers, we may not be able to compete successfully against our current or future competitors and our business, operating results and financial condition may be adversely affected.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our current and potential competitors have longer operating histories, larger customer bases, greater brand recognition and significantly greater financial, technical, marketing and other resources than we do. As compared to us, our current and future competitors may be able to undertake more extensive marketing campaigns for their brands and services, devote more resources to website and systems development, negotiate more favorable commission rates and commission override payments, and make more attractive offers to potential employees, marketing partners and third-party service providers.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitive pressures from government-run health insurance exchanges and other competitors may result in our experiencing increased marketing costs, especially during the Medicare annual enrollment period, decreased demand and loss of market share, increased health insurance plan termination and member turnover, reduction in our membership or revenue and may otherwise harm our business, operating results and financial condition.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business may be harmed if we lose our relationship with health insurance carriers or our relationship with health insurance carriers is modified.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically enter into contractual relationships with health insurance carriers that are non-exclusive and terminable on short notice by either party for any reason.&#160;In many cases, health insurance carriers also may amend the terms of our agreements unilaterally, including commission rates, on short notice. Health insurance carriers may decide to reduce our commissions, rely on their own internal distribution channels to sell their own plans, determine not to sell their plans or otherwise limit or prohibit us from selling their plans. Carriers may also amend our agreements with them for a variety of reasons, including for competitive or regulatory reasons, dissatisfaction with the economics of the members that we place with them or because they do not want to be associated with our brand. The termination of our relationship with a health insurance carrier, the reduction of commission rates, or the amendment of or change in our relationship with a carrier has in the past, and may in the future, reduce the variety, quality and affordability of health insurance plans we offer, cause a loss of commission payments, including commissions for past and/or future sales, cause a reduction in the estimated constrained lifetime values, or LTVs we use for revenue recognition purposes, result in a loss of existing and potential members, adversely impact our profitability or have other adverse impacts, which could harm our business, operating results and financial condition. Health insurance carriers may also determine to exit certain states or increase premiums to a significant degree, which could cause our members&#8217; health insurance to be terminated or our members to purchase new health insurance or determine not to pay for health insurance at all. If we lose these members, our business, operating results and financial condition could be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medicare plan-related revenue is concentrated in a small number of health insurance carriers. The success of our Medicare-related health insurance business depends upon our ability to enter into new and maintain existing relationships with health insurance carriers on favorable economic terms. We expect that a small number of health insurance carriers will account for a significant portion of our revenue for the foreseeable future and any impairment of our relationship with, or the material financial impairment of, these health insurance carriers could adversely affect our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We may also temporarily or permanently lose the ability to market and sell Medicare plans for one or more of our Medicare plan carriers.&#160;The regulations applicable to the business of selling Medicare-related health insurance are complex and </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">frequently change. If we or our health insurance agents violate any of the requirements imposed by the Centers for Medicare and Medicaid Services, or CMS, state laws or regulations, a health insurance carrier may terminate our relationship or CMS may penalize a health insurance carrier by suspending or terminating the carrier's ability to market and sell Medicare plans. Health insurance carriers may also terminate their relationship with us or require us to take corrective action if our Medicare product sales or marketing give rise to too many complaints. Given the concentration of our Medicare plan sales in a small number of carriers, if we lose a relationship with a health insurance carrier to market their Medicare plans, even temporarily, or if the health insurance carrier loses its Medicare product membership, our business, operating results and financial condition would be harmed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our financial results will be adversely impacted if our membership does not grow or if member retention does not improve and plan terminations do not decline.  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We receive commissions from health insurance carriers for health insurance plans sold through us. When one of these plans is canceled, or if we otherwise do not remain the agent on the plan, we no longer receive the related commission payment. Our members and/or health insurance carriers may choose to discontinue their health insurance plans for a variety of reasons. Consumers may also purchase individual and family and Medicare-related health insurance plans directly from other sources, such as our competitors, and we would not remain the agent on the policy and receive the related commission. Medicare Advantage plan and Medicare Part D prescription drug plan enrollees may select another plan during the Medicare annual enrollment period that occurs in the fourth quarter every year. Medicare Advantage plan enrollees may also select another plan during the Medicare Advantage open enrollment period that occurs in the first quarter of the year. In addition, certain individuals are permitted to enroll, disenroll or change their Medicare Advantage or Medicare Part D prescription drug plans during special enrollment periods. We experienced an increased plan termination rate in our Medicare membership in 2020 and 2021 above historical levels prior to 2020. While we have implemented measures to improve enrollment quality and member retention, if our Medicare Advantage and other health insurance plan termination rates do not decline in subsequent quarters, our business, operating results and financial condition would be harmed. In addition, enrollment periods could cause us to further experience increased termination rates in the future, which could adversely impact our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any decrease in the amount of time we retain our members on the health insurance plans that they purchased through us could adversely impact the estimated constrained LTVs we use for purposes of recognizing revenue, which would harm our business, operating results and financial condition. For example, our Medicare Advantage plan and Medicare Part D prescription drug plan LTVs have been negatively impacted by increased plan termination rates. While we have recently placed a stronger operational focus on member retention, there are no assurances that investments we make to pursue retention initiatives will result in a decline in health insurance plan termination rate and/or improvement in our constrained LTVs in the future. We have taken and may take additional actions with the goal to improve customer experience, enhance accuracy of plan recommendations, reduce rapid disenrollment and beneficiary complaints, and improve the quality of our enrollments. For example, in the third quarter of 2021, we introduced mandatory additional training for our agents and added a new customer care role to verify certain Medicare enrollments prior to submission. While our focus on enrollment quality could improve retention rates and increase LTVs of our Medicare products, it has led to lower call conversion rates and longer average talk times for telephonic enrollments, resulting in a reduction in enrollments and increased cost of acquisition that has negatively impacted our business, operating results and financial condition. If agent productivity and member retention do not improve, our business, operating results and financial condition would be further harmed. If we experience higher health insurance plan termination rates than we estimated when we recognized commission revenue, we may not collect all of the related commissions receivable, which could result in a reduction in LTV and a write-off of contract assets - commissions receivable, which would harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, the growth of our membership is highly dependent upon our success in attracting new members during the Medicare annual enrollment period and to a lesser extent, the Medicare Advantage open enrollment period and the health care reform open enrollment period. The Medicare-related commission rates that we receive may be higher in the first calendar year of a plan if the plan is the first Medicare-related plan issued to the member. Similarly, the individual and family plan commission rates that we receive are typically higher in the first twelve months of a policy. After the first twelve months, the commission rates generally decline significantly. As a result, if we do not add a sufficient number of members to new plans, our business, operating results and financial condition would be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">If we are not able to maintain and enhance our brand, our business and operating results will be harmed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that maintaining and enhancing our brand identity is critical to our relationships with existing members, marketing partners and health insurance carriers and to our ability to attract new members, marketing partners and health insurance carriers. The promotion of our brand in these and other ways may require us to make substantial investments and we anticipate that, as our market becomes increasingly competitive, these branding initiatives may become increasingly difficult and expensive. Our brand promotion activities may not be successful or yield increased revenue, and to the extent that these activities yield increased revenue, the increased revenue may not offset the expenses we incur and our operating results could be harmed.&#160;If we do not successfully maintain and enhance our brand, our business may not grow and we could lose our relationships with health insurance carriers, marketing partners and/or members, which would harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The ongoing COVID-19 pandemic and public health crises, illness, epidemics or pandemics could adversely impact our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">COVID-19 and public health crises, illness, epidemics or pandemics, in general, and any associated disruption to our call center and service operations, in particular, could materially impact our business, operations and financial condition. In an effort to mitigate the spread of COVID-19, and to comply with applicable government directives, we currently operate with a combination of remote and in-office work in the United States and have implemented new business protocols for employees who have resumed work in our offices. As we begin to reopen our offices at higher capacity, we may implement additional safety measures for our employees. A potential COVID-19 infection of any of our employees could adversely impact our operations, including resulting in the sudden closure of any of our offices. Our business operations may be disrupted if key personnel or significant portions of our employees are unable to work effectively, especially if such disruption occurs during or in our preparation for the Medicare annual enrollment period. We have had to adjust our business operations, including onboarding and training new health insurance agents remotely. In addition, much of our workforce continues to work remotely.  These circumstances could cause operational difficulties, reduce the effectiveness of our agents in selling health insurance and impair our ability to manage our business. An increased number of employees in a remote work environment may also exacerbate certain risks to our business, including an increased demand for information technology resources, increased risk of phishing and other cybersecurity attacks, and increased risk of unauthorized dissemination of sensitive personal information or proprietary or confidential information about us or our customers or other third-parties. Our business operations and recruitment efforts could be impacted if government offices, including CMS and state departments of insurance, are adversely impacted by COVID-19 given that our marketing materials require CMS approval and health insurance agent licensing and licensing renewals are dependent on state department of insurance processing. Our product development initiatives could also be negatively impacted by our current combination of remote and in-office work and could be further impacted by potential extended office closures in the future. Furthermore, if any of our health insurance carriers, business partners or vendors increase the prices of or become unable to continue to provide their products or services as a result of COVID-19, or if health insurance carriers reduce our commission rates or the amount they pay us, our business, operating results and financial condition would be harmed. The impact of COVID-19 to our Individual, Family and Small Business segment could be impacted by potential increases in unemployment rates, potential delays in customer premium payments and/or health insurance carrier commission payments, the extension of the open enrollment period, and changes to qualified health plans subsidies, among others. COVID-19 presents uncertainties and risks with respect to the demand for and pricing of health insurance plans, which could negatively impact our business, operating results and financial condition. The extent of the impact of the COVID-19 pandemic on our operational and financial performance will depend on future developments, including the duration, spread and severity of the pandemic, the availability, effectiveness and uptake of vaccines for COVID-19, the emergence of new variants of COVID-19 and whether existing vaccines are effective with respect to such variants, the actions to contain the disease or mitigate its impact, and the duration, timing and severity of the impact on consumer behavior, including any recession resulting from the pandemic, all of which are unpredictable.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Changes in our management and key employees could affect our business and financial results.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success is dependent upon the performance of our senior management and our ability to attract and retain qualified personnel for all areas of our organization. We may not be successful in attracting and retaining personnel on a timely basis, on competitive terms or at all. If we are unable to attract and retain the necessary personnel, our business would be harmed. Our executive officers and employees can terminate their employment at any time. For example, our former chief executive officer's employment terminated in October 2021, and we appointed Fran Soistman as our new chief executive officer effective November 1, 2021.  In addition, our former chief financial officer's employment terminated in June 2021, and our new chief financial officer Christine Janofsky began her service with us in September 2021.&#160;This transition in senior management could adversely impact our business, operating results and financial condition as it will take time for our new chief executive officer </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and chief financial officer to integrate into our business.  The transition and the departure of members of our senior management could result in attrition in our senior management and key personnel and any significant change in leadership over a short period of time could harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The loss of the services of any of our executive officers or key employees could harm our business. For example, we are required to appoint a single designated writing agent with each insurance carrier. A small number of our employees act as writing agent and each employee that acts as writing agent does so for a number of carriers. When an employee that acts as writing agent terminates their employment with us, we need to replace such writing agent with another employee who has health insurance licenses. Due to our national reach and the large number of carriers whose plans are purchased by our members, the process of changing writing agents has in the past taken and could take a significant period of time to complete. If the transition is not successful, our ability to sell health insurance plans may be interrupted, our agency relationship with particular insurance carriers may be terminated, our commission payments could be discontinued or delayed and, as a result, our business, operating results and financial condition would be harmed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business may be harmed if we are not successful in executing on our strategic investments and initiatives, including our growth strategy and retention initiatives.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our strategy, we have invested in initiatives to accelerate growth in our Medicare product sales, to enhance post-enrollment consumer engagement and increase customer retention, to increase online enrollment and enhance operating leverage, to expand our strategic partner relationships, improve our technology platform to optimize the consumer experience and relationship, and to utilize data analytics to increase the productivity of our customer care employees. Pursuing and investing in these and other initiatives we develop has required and will in the future  require significant investments in marketing and advertising, technology and product offerings, and customer care and enrollment, among others, and involves risks and uncertainties described elsewhere in this Risk Factors section, including the initiatives not achieving our retention, growth or profitability targets, inadequate return of capital on our investments, legal and regulatory compliance risks, potential changes in laws and regulations and other issues that could cause us to fail to realize the anticipated benefits of our investments and incur unanticipated liabilities. Our pursuit of these strategic initiatives may not be successful. Our cash flow from operations is expected to be negative in the year ending December 31, 2021 and was negative in each of the years ended December 31, 2020, 2019 and 2018. If we are not successful in executing on our business strategy, our business, operating results and financial condition would be harmed. </span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Seasonality may cause fluctuations in our financial results.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Open enrollment periods drive the seasonality of our business. The Medicare annual enrollment period occurs from October 15 to December 7 each year and the individual and family health insurance open enrollment period historically occurred  from November 1 through December 15 each year. However, for the 2022 plan year, the individual and family health insurance open enrollment period is scheduled to run from November 1, 2021 through January 15, 2022 for most states. In addition, the Medicare Advantage open enrollment period, where Medicare-eligible individuals who enrolled in a Medicare Advantage plan can switch to the original Medicare program or switch to a different Medicare Advantage plan, runs from January 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> through March 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of each year. We experience an increase in the number of submitted Medicare-related applications and approved members during the fourth quarter and, to a lesser extent, in the first quarter, and an increase in Medicare plan related expense during the third and fourth quarters in connection with the open enrollment periods. In addition, we typically experience the highest plan termination rates from our Medicare Advantage plan members in the first year following the effective date of plan enrollment. If we experience significant growth in Medicare Advantage approved members resulting in an increased number of first year members as a percentage of our total estimated membership, we may also experience increased health insurance plan terminations in the year following such periods of growth.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The seasonality of our business could change in the future due to other factors, including as a result of changes in timing of the Medicare or individual and family health plan enrollment periods, adoption of new enrollment periods such as the COVID-related special enrollment period that was adopted in the second quarter of 2020 for Medicare Advantage and Medicare Part D prescription drug plans, changes in eligibility and subsidies applicable to the purchase of health insurance, and changes in the laws and regulations that govern the sale of health insurance. We may not be able to timely adjust to changes in customer demand and the seasonality of our business. If we are not successful in responding to changes in the seasonality of our business, our business, operating results and financial condition could be harmed.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The success of our customer care center operations depends upon our ability to timely hire, train, retain and ensure the productivity of our licensed health insurance agents.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition to our websites, we rely upon our customer care centers to sell Medicare plans. The success of our customer care center operations is largely dependent on licensed health insurance agents and other employees.&#160;In order to sell Medicare-related health insurance plans, our health insurance agent employees and employees of outsourced call centers must be licensed by the states in which they are selling plans and certified and appointed with the health insurance carrier that offers the plans in each applicable state. We depend upon our employees, state departments of insurance, government exchanges and health insurance carriers for the licensing, certification and appointment of our health insurance agents. We may experience difficulties hiring a sufficient number of additional licensed agents and retaining existing licensed agents for the Medicare annual enrollment period. If we are not successful in these regards, our ability to sell Medicare-related health insurance plans will be impaired during the Medicare annual enrollment period, which would harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Even if we are successful in hiring licensed health insurance agents, our success depends on the productivity of these health insurance agents. Health insurance agents may not perform to the standard we expect of them, which could result in lower than expected conversion rates and revenue, higher costs of acquisition per member and higher plan termination rates. Historically, our health insurance agent employees have generally been more productive than the employees of our outsourced call centers and that experienced health insurance agents have generally been more productive than less-tenured health insurance agents. During the Medicare annual enrollment period that occurred in the fourth quarter of 2020, we experienced reduced conversion rates from health insurance agents that work for outsourced call centers, which impacted our revenue and cost of acquisition. As a result, in preparation for the 2021 Medicare annual enrollment period, we have increased the number of our health insurance agent employees to a much more significant degree, and we also began hiring, onboarding and training our health insurance agent employees earlier than we have in the past. We have incurred increased expenses in agent onboarding and training in preparation for the 2021 Medicare annual enrollment period. Despite our investments in hiring and training a significantly larger number of our health insurance agent employees in 2021, the conversion rates of our health insurance agents have been lower than our expectations since the third quarter of 2021. In addition, our increased focus on enrollment quality that began in the third quarter of 2021 has negatively impacted the conversion rates of our health insurance agents.  If our health insurance agents do not perform to the standards we expect of them or if we do not generate sufficient call volumes for our health insurance agents to remain productive, our conversion and retention rates could be impacted, and our business, operating results and financial condition would be harmed.  Failure to retain, train and ensure the productivity of our health insurance agents would harm our business, operating results and financial condition. If investments we make in our call center operations do not result in the returns we expected when making those investments, we could acquire fewer members, suffer a reduction in our membership, and our business, operating results and financial condition would be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not successful in cost-effectively converting visitors to our website</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and customers who call into our call centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">into members for whom we receive commissions, our business and operating results would be harmed.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth depends in large part upon growth in approved members in a given period. The rate at which consumers visiting our ecommerce platforms and customer care centers seeking to purchase health insurance are converted into approved members directly impacts our revenue. In addition, the rate at which consumers who are approved become paying members impacts the constrained LTV of our approved members, which impacts the revenue that we are able to recognize. A number of factors have influenced, and could in the future influence, these conversion rates for any given period, some of which are outside of our control. These factors include, but are not limited to:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in consumer shopping behavior due to circumstances outside of our control, such as economic conditions, the COVID-19 pandemic, consumers&#8217; ability or willingness to pay for health insurance, adverse weather conditions or natural disasters, availability of unemployment benefits or proposed or enacted legislative or regulatory changes impacting our business, including health care reform; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the quality of and changes to the consumer experience on our ecommerce platforms or with our customer care centers; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory requirements, including those that make the experience on our ecommerce platforms cumbersome or difficult to navigate or reduce the ability of consumers to purchase plans outside of enrollment periods; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the variety, competitiveness, quality and affordability of the health insurance plans that we offer; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">system failures or interruptions in the operation of our ecommerce platform or call center operations; </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the mix of consumers who are referred to us through our direct, marketing partner and online advertising member acquisition channels, including the quality of sales leads;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">health insurance carrier guidelines applicable to applications submitted by consumers, the degree to which our technology is integrated with health insurance carriers, the amount of time a carrier takes to make a decision on that application and the percentage of submitted applications approved by health insurance carriers; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effectiveness of health insurance agents in assisting consumers, including the tenure of the health insurance agent ; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to enroll subsidy-eligible individuals in qualified health plans through government-run health insurance exchanges and the efficacy of the process we are required to use to do so.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our conversion rates can be impacted by changes in the mix of consumers referred to us through our member acquisition channels</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">and whether they interact with a more seasoned health insurance agent or a health insurance agent that works with an outsourced call center. We may make changes to our ecommerce platforms, telephonic operations, marketing material or enrollment process in response to regulatory or health insurance carrier requirements or undertake other initiatives in an attempt to improve consumer experience, increase retention or for other reasons. These changes have in the past, and may in the future have the unintended consequence of adversely impacting our conversion rates. A decline in the percentage of consumers who submit health insurance applications on our ecommerce platforms or telephonically via our customer care centers and are converted into approved and paying members could cause an increase in our cost of acquiring members on a per member basis and impact our revenue in any given period. To the extent the rate at which we convert consumers visiting our ecommerce platforms or telephonically via our customer care centers into members suffers, our membership may decline, which would harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend upon Internet search engines and social media platforms to attract a significant portion of the consumers who visit our website, and if we are unable to effectively advertise on search engines or social media platforms on a cost-effective basis, our business and operating results would be harmed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a significant portion of our website traffic from consumers who search for health insurance through Internet search engines, such as Google, Bing and Yahoo!, and through social media platforms, such as Facebook. A critical factor in attracting consumers to our website is whether we are prominently displayed in response to an Internet search relating to health insurance or on a social media platform. Search engines typically provide two types of search results, algorithmic listings and paid advertisements. We rely on both to attract consumers to our websites and otherwise generate demand for our services.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Algorithmic search result listings are determined and displayed in accordance with a set of formulas or algorithms developed by the particular Internet search engine. The algorithms determine the order of the listing of results in response to the consumer&#8217;s Internet search. From time to time, search engines revise these algorithms. In some instances, these modifications have caused our website to be listed less prominently in algorithmic search results, which has resulted in decreased traffic to our website. We may also be listed less prominently as a result of other factors, such as new websites, changes we make to our website or technical issues with the search engine itself. For example, government health insurance exchange websites appear prominently in algorithmic search results. In addition, search engines have deemed the practices of some companies to be inconsistent with search engine guidelines and decided not to list their website in search result listings at all. If we are listed less prominently in, or removed altogether from, search result listings for any reason, the traffic to our websites would decline and we may not be able to replace this traffic, which would harm our business, operating results and financial condition. If we decide to attempt to replace this traffic, we may be required to increase our marketing expenditures, which would also increase our cost of member acquisition and harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We purchase paid advertisements on search engines and social media platforms in order to attract consumers to our platforms. We typically pay a search engine for prominent placement of our website when particular health insurance-related terms are searched for on the search engine, regardless of the algorithmic search result listings. The prominence of the placement of our advertisement is determined by a combination of factors, including the amount we are willing to pay and algorithms designed to determine the relevance of our paid advertisement to a particular search term. As with algorithmic search result listings, search engines may revise the algorithms relevant to paid advertisements, and websites other than our ecommerce platform may become more optimized for the algorithms. These changes may result in our having to pay increased amounts to maintain our paid advertisement placement in response to a particular search term. We could also have to pay increased amounts should the market share of major search engines continue to become more concentrated with a single search </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">engine. Additionally, we bid against our competitors, insurance carriers, government health insurance exchanges and others for the display of these paid search engine or social media platform advertisements. We have experienced increased competition for both algorithmic search result listings and for paid advertisements, and that competition increases substantially during the enrollment periods for Medicare related health insurance and for individual and family health insurance. The competition has increased the cost of paid internet search advertising and has increased our marketing and advertising expenses. If paid search advertising costs increase or become cost prohibitive, whether as a result of competition, algorithm changes or otherwise, our advertising expenses could rise significantly or we could reduce or discontinue our paid search advertisements, either of which would harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely significantly on marketing partners and our business and operating results would be harmed if we are unable to maintain effective relationships with our existing marketing partners or if we do not establish successful relationships with new marketing partners.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We frequently enter into contractual marketing relationships with partners that drive consumers to our ecommerce platform and call centers. These marketing partners include financial and online services companies, affiliate organizations, online advertisers and content providers, and other marketing vendors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also have relationships with strategic marketing partners, including hospitals and pharmacy chains that promote our Medicare platforms to their customers as well as pharmacy service providers and other affinity groups. We compensate many of our marketing partners for their referrals on a submitted health insurance application basis and, if they are licensed to sell health insurance, may share a percentage of the commission we earn from the health insurance carrier for each member referred by the marketing partner. The success of our relationship is dependent on a number of factors, including but not limited to the continued positive market presence, reputation and growth of the marketing partner, the effectiveness of the marketing partner in marketing our website and services, the compliance of each marketing partner with applicable laws, regulations and guidelines, and the contractual terms we negotiate with our marketing partners, including the marketing fees we agree to pay.  We depend on our marketing partners for a large number of quality referrals to keep our health insurance agents productive.  If our marketing partners fail to deliver effective and/or timely marketing campaigns, especially during the Medicare annual enrollment period, our business and financial condition could be harmed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have relationships with a large number of marketing partners, we depend upon referrals from a limited number of marketing partners for a significant portion of the submitted applications we receive from our marketing partner customer acquisition channel. Given our reliance on our marketing partners, our business operating results and financial condition would be harmed if we are unable to maintain successful relationships with these companies, if we fail to establish successful relationships with new marketing partners, if we experience competition in our receipt of referrals from high volume marketing partners, or if we are required to pay increased amounts to our marketing partners.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Competition for referrals from our marketing partners has increased particularly during the enrollment periods for Medicare-related health insurance and individual and family health insurance. We may lose marketing partner referrals if our competitors pay marketing partners more than we do or be forced to pay increased fees to our marketing partners, which could harm our business, operating results and financial condition. If we lose marketing partner referrals during the Medicare or individual and family health insurance enrollment periods, the adverse impact on our business would be particularly pronounced. In addition, the promulgation of laws, regulations or guidelines, or the interpretation of existing laws, regulations and guidelines, by state departments of insurance or by CMS, could cause our relationships with our marketing partners to be in non-compliance with those laws, regulations and guidelines. We are required to file marketing partner marketing materials relating to Medicare Advantage and Medicare Part D prescription drug plans with CMS, and health insurance carriers must review and approve the marketing materials. Recent changes to the CMS marketing guidelines have resulted in a more complicated and time-consuming process for marketing material filing and the need to file a significantly greater number of marketing partners' marketing materials with CMS. If our marketing partners' marketing materials do not comply with the CMS marketing guidelines or other Medicare program related laws, rules and regulations, such non-compliance could result in our losing the ability to receive referrals of individuals interested in purchasing Medicare-related plans from that marketing material or being delayed in doing so.  In the event that CMS or a health insurance carrier requires changes to, disapproves or delays approval of these materials, we could lose a significant source of Medicare plan demand and the operations of our Medicare business could be adversely affected. We also have relationships with hospital systems and pharmacy chains that utilize aspects of our platform and tools.&#160;Our relationships with these hospital systems and pharmacy chains result in the referral of a significant number of individuals to us who are interested in purchasing Medicare-related health insurance plans.&#160;If CMS or state departments of insurance were to change existing laws, regulations or guidelines, or interpret existing laws, regulations or guidelines, to prohibit these arrangements, or if hospital systems or pharmacy partners otherwise decided to no longer utilize aspects of our platform and tools, we could experience a significant decline in the number of Medicare-eligible individuals who </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">are referred to our platforms and customer care centers, which would harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future operating results are likely to fluctuate and could fall short of expectations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating results are likely to fluctuate as a result of a variety of factors, including the factors described elsewhere in this Risk Factors section, many of which are outside of our control. For example and among these factors, the assumptions underlying our estimates of commission revenue as required by ASC 606&#160;may vary significantly over time. As a result, comparing our operating results on a period-to-period basis may not be meaningful and you should not rely on our past results as an indication of our future performance, particularly in light of the fact that our business and industry are undergoing substantial change as a result of health care reform, competition, shifts in carrier and regulator priorities and initiatives we determine to pursue. If our revenue or operating results differ from our guidance or fall below the expectations of investors or securities analysts, the price of our common stock could decline substantially. In the past, when our revenue and operating results differed from our guidance and the expectations of investors or securities analysts, the price of our common stock was impacted.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If commission reports we receive from carriers are inaccurate or not sent to us in a timely manner, our business and operating results could be harmed and we may not recognize trends in our membership.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on health insurance carriers to timely and accurately report the amount of commissions earned by us, and we calculate our commission revenue, prepare our financial reports, projections and budgets and direct our marketing and other operating efforts based on the reports we receive from health insurance carriers. There have been instances where we have determined that plan cancellation data reported to us by a health insurance carrier has not been accurate. The extent to which health insurance carriers are inaccurate in their reporting of plan cancellations could cause us to change our cancellation estimates, which could adversely impact our revenue. We have designed controls to assess the completeness and accuracy of the data received, whereby we apply judgment and make estimates based on historical data and current trends to independently determine whether or not carriers are accurately reporting commissions due to us. We also operate procedures with carriers on an ongoing basis whereby potential under or over reporting is reconciled and discrepancies are resolved. For instance, we reconcile information health insurance carriers provide to us and may determine that we were not historically paid commissions owed to us, which would cause us to have underestimated our membership. Conversely, health insurance carriers may require us to return commission payments paid in a prior period due to plan cancellations for members we previously estimated as being active. To the extent that health insurance carriers understate or fail to accurately report the amount of commissions due to us in a timely manner or at all, our estimates of constrained LTV may be adversely impacted, which would harm our business, operating results and financial condition. In addition, any inaccuracies in the reporting from and reconciliations with insurance carriers may also impact our estimates of constrained LTV or our estimates of commission revenue for future periods which is based on historical trends, including trends relating to contracted commission rates and expected health insurance plan cancellation.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not receive information about membership cancellations from our health insurance carriers directly, which makes it difficult for us to determine the impact of current conditions on our membership retention and to accurately estimate membership as of a specific date.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on health insurance carriers and others for data related to our membership. For instance, with respect to health insurance plans other than small business health insurance, health insurance carriers do not directly report member cancellations to us, resulting in the need for us to determine cancellations using payment data that carriers provide. We infer cancellations from this payment data by analyzing whether payments from members have ceased for a period of time, and we may not learn of a cancellation for several months. The majority of our members who terminate their plans do so by discontinuing their insurance premium payments to the health insurance carrier and do not inform us of the cancellation. With respect to our small business membership, many groups notify the carrier directly with respect to increases or decreases in group size and policy cancellations. Our insurance carrier partners often do not communicate this information to us, and it often takes a significant amount of time for us to learn about small business group cancellations and changes in our membership within the group itself. We often are not made aware of policy cancellations until the time of the group&#8217;s annual renewal.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Given the number of months required to observe non-payment of commissions in order to confirm cancellations, we estimate the number of members who are active on health insurance plans as of a specified date. After we have estimated </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">membership for a period, we may receive information from health insurance carriers that would have impacted the estimate if we had received the information prior to the date of estimation. We may receive commission payments or other information that indicates that a member who was not included in our estimates for a prior period was in fact an active member at that time, or that a member who was included in our estimates was in fact not an active member of ours. As a result of the Medicare annual enrollment and other open enrollment periods, we may not receive information from our carriers on as timely a basis due to the significant increase in health insurance transaction volume and for other reasons, which could impair the accuracy of our membership estimates. For these and other reasons, including if current trends in membership cancellation are inconsistent with past cancellation trends that we use to estimate our membership or if carriers subsequently report changes to the commission payments that they previously reported to us, our actual membership could be different from our estimates, perhaps materially. If our actual membership is different from our estimates, the constrained LTV component of our revenue recognition could also be inaccurate, including as a result of an inaccurate estimate of the average amount of time our members maintain their health insurance plans. As a result of the delay we experience in receiving information about our membership, it is difficult for us to determine with any certainty the impact of current conditions on our membership retention. For example, our estimated membership reported as of March 31, 2020 was higher than our actual membership, because we experienced increased membership cancellation compared to the historical cancellation rates we used to estimate our membership as of March 31, 2020. We were not able to observe the increased membership cancellations that occurred during the first quarter of 2020 until after we reported our estimated membership for the period. Various circumstances, including market-related factors such as changes in timing of enrollment periods and other factors specific to our business, could cause the assumptions and estimates that we make in connection with estimating our membership and constrained LTV to be inaccurate, which would harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our carrier advertising and sponsorship business may not be successful.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, host and maintain carrier dedicated Medicare plan websites and may undertake other marketing and advertising initiatives through our Medicare plan advertising program. We also allow health insurance carriers to purchase advertising space for non-Medicare products on our website through our sponsorship program. To the extent that economic conditions, health care reform or other factors impact the amount health insurance carriers are willing to pay for advertising, our advertising and sponsorship program will be adversely impacted. In addition, since we maintain relationships with a limited number of health insurance carriers to sell their Medicare plans, our Medicare plan-related advertising revenue is concentrated in a small number of health insurance carriers and our ability to generate Medicare plan-related advertising revenue would be harmed by the termination or non-renewal of any of these relationships as well as by a reduction in the amount a health insurance carrier is willing to pay for these services. Moreover, in light of the regulations applicable to the marketing and sale of Medicare plans, and given that these regulations are often unclear, change frequently and are subject to changing interpretations, we may in the future not be permitted to sell Medicare plan-related advertising services. If we are not successful in these areas or these factors are unfavorable to us, our business, operating results and financial condition could be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our sponsorship and advertising program depends on a number of factors, including the amount health insurance carriers are willing to pay for advertising services, the effectiveness of the sponsorship and advertising program as a cost-effective method for carriers to obtain additional members, consumer demand for the health insurance carrier&#8217;s product, our ability to attract consumers to our ecommerce platform, our call centers or the dedicated Medicare plan websites and convert those consumers into members, and the cost, benefit and brand recognition of the health insurance plan that is the subject of the advertising, among others. In addition, increased carrier focus on the quality of enrollments and reduction in member complaints could adversely impact our ability to successfully negotiate and operate our sponsorship and advertising programs. If we are not successful in these areas or these factors are unfavorable to us, our business, operating results and financial condition could be harmed.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our business may be harmed if we do not enroll subsidy-eligible individuals through government-run health insurance exchanges efficiently.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to offer the qualified health plans that individuals and families must purchase to receive Affordable Care Act subsidies, agents and brokers must meet certain conditions, such as receiving permission to do so from the applicable government health insurance exchange, entering into or maintaining an agreement with the health insurance exchange or a partner of the exchange, ensuring that the enrollment and subsidy application is completed through the health insurance exchange and complying with privacy, security and other standards. In the event Internet-based agents and brokers such as us use the Internet for&#160;completion of qualified health plan selection purposes, their websites may be required to meet certain additional requirements. To the extent we enroll individuals and families into qualified health plans, we do so predominantly </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">through the Federally Facilitated Marketplace, or FFM, which runs all or part of the health insurance exchange in 33 states, using a third-party partnership. We may experience difficulty in satisfying the conditions and requirements to offer qualified health plans to our existing members and new potential members, and in getting them enrolled through the FFM.&#160;If we are not able to satisfy these conditions and requirements, or if we are not able to successfully adopt and maintain solutions that allow us to enroll large numbers of individuals and families in qualified plans over the Internet both during and outside of open enrollment periods, we will lose existing members and new members, and may incur additional expense, which would harm our business, operating results and financial condition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in the open enrollment period that occurred in the fourth quarter of 2018, CMS adopted a new enhanced direct enrollment pathway for CMS-approved partners to enroll individuals into qualified health plans through the FFM and complete all steps in the eligibility and enrollment process on a single website. Before enhanced direct enrollment partners are approved, extensive security and privacy reviews are conducted by an independent third-party auditor and CMS reviews the audit results to ensure the entity satisfies numerous additional privacy and security standards. We entered into an agreement to outsource certain aspects of the enrollment process for qualified health plans to a third party in light of the expense and burden associated with the additional requirements. However, if we do not develop the ability to satisfy the requirements to use the improved qualified health plan enrollment process in the future, or if we are unsuccessful in entering into or maintaining a relationship with a third party who is approved to use the process, we may not be able to enroll individuals into qualified health plans through the FFM or could be required to use an inferior process to do so, which could cause a reduction in our individual and family health insurance plan membership and commission revenue. In addition, if we are not able to adopt or contract with and maintain solutions to integrate with government-run health insurance exchanges or if the health insurance exchange websites and other processes are unstable or not consumer friendly, efficient and compatible with the process we have adopted for enrolling individuals and families into qualified health plans through the exchanges, we would not be successful in retaining and acquiring members, and our business, operating results and financial condition would be harmed. The FFM may at any time cease allowing us, or our third-party partner, to enroll individuals in qualified health plans or change the requirements for doing so, or relevant government regulations or agencies may prevent us from efficiently working with our third-party partner, including timely receiving and using data from our third-party partner. If the FFM ceases allowing us or our third-party partner to enroll individuals, if the FFM platform does not function properly or if we are prevented from efficiently working with our third-party partner, our ability to retain existing members and add new members could be negatively impacted, which would harm our business, operating results and financial condition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">There are many risks associated with our operations in China.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of our operations is conducted by our subsidiary in China. Among other things, we use employees in China to maintain and update our ecommerce platform and perform certain tasks within our finance and customer care and enrollment functions. We rely on the Internet to communicate with our subsidiary in China. Our business would be harmed if our ability to communicate over the Internet with these employees failed, and we were prevented from promptly updating our software or implementing other changes to our database and systems, among other things. From time-to-time we receive inquiries from health insurance carriers relating to our operations in China and the security measures we have implemented to protect data that our employees in China may be able to access. As a part of these inquiries, we have implemented additional security measures relating to our operations in China.&#160;We may be required to implement further security measures to continue aspects of our operations in China or health insurance carriers may require us to bring aspects of our operations in China back to the United States, which could be time consuming and expensive and harm our operating results and financial condition.&#160;Health insurance carriers may also terminate our relationship due to concerns surrounding protection of data that our employees in China are able to access, which would harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations in China also expose us to different and unfamiliar laws, rules and regulations, including different intellectual property laws, which are not as protective of our intellectual property as the laws in the United States. United States and Chinese trade laws may also impose restrictions on the importation of programming or technology to or from the United States. We are also subject to anti-bribery and anti-corruption laws, privacy and data security laws, labor laws, tax laws, foreign exchange controls and cash repatriation restrictions in China. In recent years, China has adopted laws regulating cybersecurity and data protection. The cybersecurity law adopted on June 1, 2017, along with its implementing regulations, applies to the establishment, operation, maintenance and usage of networks within China and the supervision and management of cybersecurity. Under the law, network operators are required to comply with certain tiered security obligations based on the networks&#8217; relative impact on national security, social order, public interest and individuals&#8217; privacy rights. Pursuant to the draft regulations, we may be required to perform self-assessments, obtain third party certifications, report cybersecurity incidents and </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">make filings with public security authorities. We could also be subject to security inspections and evaluations by public security authorities and be restricted to use only network products and services that meet certain standards based on the level of risk applicable to us. In addition, a new data security law became effective on September 1, 2021. The new data security law applies to the usage, collection and protection of data within China and imposes data security obligations and restrictions on transfers of certain data outside of China, including prohibition on providing any data stored in China to law enforcement authorities or judicial bodies outside of China without prior Chinese government approval. There remains considerable uncertainty as to how both the cybersecurity law and data security law will be applied, and the regulatory environment continues to evolve. Such laws, regulations and standards are complex, ambiguous and subject to change or interpretation, which create uncertainty regarding compliance. Compliance with these laws and regulations could cause us to incur substantial costs or require us to change our business operations in China. Violation of applicable laws and regulations could adversely affect our brand, affect our relationship with our health insurance carriers, and could result in regulatory enforcement actions and the imposition of civil or criminal penalties and fines, which would harm our business, operating results and financial condition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business may be adversely impacted by changes in China&#8217;s economic or political condition. We have experienced greater competition for qualified personnel in China, which has raised market salaries and increased our compensation costs related to employees in China. If competition for personnel increases further, our compensation expenses could rise considerably or, if we determine to not increase compensation levels, our ability to attract and retain qualified personnel in China may be impaired, which could harm our business, operating results and financial condition. These risks could cause us to incur increased expenses and could harm our ability to effectively and successfully manage our operations in China. Moreover, any significant or prolonged deterioration in the relationship between United States and China could adversely affect our operations in China. Certain risks and uncertainties of doing business in China are solely within the control of the Chinese government, and Chinese law regulates the scope of our foreign investments and business conducted within China. The escalation of trade tensions has increased the risk associated with our operations in China. Either the United States or the Chinese government may sever our ability to communicate with our China operations or may take actions that force us to close our operations in China. We employ a large number of our technology and content employees in China, and we have other employees in China that support our business. Any sudden disruption of our operations in China would adversely impact our business. If we are required to move aspects of our operations from China to our offices in the United States as a result of political instability, changes in laws, inquiries from health insurance carriers or for other reasons, we could incur increased expenses, and our business, operating results and financial condition could be harmed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We cannot predict the impact that changing climate conditions, including legal, regulatory and social responses thereto, may have on our business.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global climate change has added, and will continue to add, to the unpredictability, frequency and severity of natural disasters, including but not limited to hurricanes, tornadoes, freezes, droughts, other storms and fires in certain parts of the world. In response, a number of legal and regulatory measures and social initiatives have been introduced in an effort to reduce greenhouse gas and other carbon emissions that are chief contributors to global climate change. We cannot predict the impact that changing climate conditions will have on our business, though extreme weather events could impact our facilities, technological assets, business continuity and reputation. The legal, regulatory and social responses to climate change could also adversely affect our results of business, operating results and financial conditions.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success in selling Medicare-related health insurance will depend upon a number of factors some of which are outside of our control.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success in selling Medicare-related health insurance is dependent upon a number of factors, including:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to continue to adapt our ecommerce platforms to market Medicare plans, including our development or acquisition of marketing tools and features important in the sale of Medicare plans online and the effective modification of our user experience; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our success in marketing to Medicare-eligible individuals, including television advertising, online marketing and direct mail marketing, and in entering into and maintaining marketing partner relationships to drive Medicare-eligible individuals to our ecommerce platforms or customer care centers on a cost-effective basis; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to hire and retain additional employees with experience in Medicare, including our ability to develop Medicare sales expertise in our customer care centers; </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to implement and maintain an effective information technology infrastructure for the sale of Medicare plans, including the infrastructure and systems that support our websites, call centers and call recording; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to leverage technology in order to sell, and otherwise become more efficient at selling, Medicare-related plans over the telephone;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with the numerous, complex and changing laws, regulations, guidelines and policies of the federal and state government, including CMS guidelines and policies relating to the marketing and sale of Medicare plans and health care reform; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effectiveness with which our competitors market the availability of Medicare plans from sources other than our ecommerce platforms.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of these and other factors, we may prove unsuccessful in marketing Medicare plans and acting as a health insurance agent in connection with their sale, which would harm our business, operating results and financial condition. In addition, if our efforts to market Medicare plans during enrollment periods were impeded due to lack of timely health insurance carrier or CMS approval, or for other reasons, the impact on our business, operating results and financial condition would be significantly greater given the seasonality of our Medicare-related revenue, membership acquisition and expenses and the fact that much of the sales of Medicare plans occur during this period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Laws and Regulations</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The marketing and sale of Medicare plans are subject to numerous, complex and frequently changing laws, regulations and guidelines, and non-compliance with or changes in laws, regulations and guidelines could harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The marketing and sale of Medicare plans are subject to numerous laws, regulations and guidelines at the federal and state level. The marketing and sale of Medicare Advantage and Medicare Part D prescription drug plans are principally regulated by the CMS but are also subject to state laws. The marketing and sale of Medicare Supplement plans are principally regulated on a state-by-state basis by state departments of insurance. The laws and regulations applicable to the marketing and sale of Medicare plans are numerous, ambiguous and complex, and, particularly with respect to regulations and guidance issued by CMS for Medicare Advantage and Medicare Part D prescription drug plans, change frequently.&#160;We have altered, and likely will have to continue to alter, our marketing and sales process to comply with these laws, regulations and guidelines. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Health insurance carriers whose Medicare plans we sell approve our websites, our call center scripts and some of our marketing material. We must receive these approvals in order for us market and sell Medicare plans to Medicare-eligible individuals as a health insurance agent. We are also required to file many of these materials on a regular basis with CMS.&#160;In addition, certain aspects of our Medicare plan marketing partner relationships have been in the past, and will be in the future, subjected to CMS and health insurance carrier review.&#160;CMS, state departments of insurance or health insurance carriers may determine to object to or not to approve aspects of our online platforms, sales function or marketing material and processes and may determine that certain existing aspects of our Medicare-related business are not in compliance with legal requirements. CMS scrutinizes health insurance carriers whose Medicare plans we sell and those health insurance carriers may be held responsible for actions that we and our agents take. Based on our recent conversations with health insurance carriers, we expect that health insurance carriers will be increasingly evaluating broker performance based on quality of their enrollments, including complaints, retention rates, customer satisfaction and volumes. As a result, health insurance carriers may terminate their relationship with us or require us to take other corrective action if our Medicare product sales, marketing and operations are not in compliance or give rise to too many complaints. The termination of or change in our relationship with health insurance carriers for this reason could reduce the products we are able to offer, could result in the loss of commissions for past and future sales and could otherwise harm our business, operating results and financial condition. Changes to the laws, regulations and guidelines relating to the sale of Medicare plans, their interpretation or the manner in which they are enforced could impact the manner in which we conduct our Medicare business, our ecommerce platforms or our sale of Medicare plans, or we could be prevented from operating aspects of our Medicare revenue generating activities altogether, which would harm our business, operating results and financial condition. We have received, and may in the future receive, inquiries from CMS or state departments of insurance regarding our marketing and business practices and compliance with laws and regulations. Inquiries and proceedings initiated by the government could adversely impact our health insurance licenses, require us to pay </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">fines, require us to modify marketing and business practices, result in litigation and otherwise harm our business, operating results or financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2021, CMS changed its process for the submission and approval of marketing materials related to Medicare Advantage and Medicare Part D prescription drug plans. The practical application of the previous process allowed for a lead carrier to handle most of the review and filing of Medicare plan marketing materials with CMS. The new process requires each carrier to approve of each filed marketing material and has resulted in a more complicated and time consuming process to get our marketing material filed with CMS and through the process with carriers.  In October 2021, CMS issued new guidance that significantly broadens the types of marketing materials that we are required to file with CMS, including the requirement to file certain generic marketing materials that refer to the benefits or costs of Medicare Advantage or Medicare Part D prescription drug plans but that do not specifically mention a health insurance carrier's name or a specific plan.  As a result, we now submit to each Medicare Advantage and Medicare Part D prescription drug plan carrier with which we have a relationship a significantly larger number of marketing materials than we have in the past. We may not be able to use certain of our marketing materials and implement our marketing programs effectively if CMS or a health insurance carrier has comments or disapproves of our marketing materials.   If we do not timely file the additional marketing materials with CMS or if health insurance carriers do not adapt to the new CMS requirements or increase the efficiency with which they review our marketing material, it could harm our sales and also harm our ability to efficiently change and implement new or existing marketing material, including call center scripts and our websites, which could harm our business, operating results and financial condition.  If we or our marketing partners are not successful in timely receiving health insurance carrier or CMS approval of our marketing materials, we could be prevented from implementing our Medicare marketing and sales initiatives, which could harm our business, operating results and financial conditions, particularly if such delay or non-compliance occurs during the Medicare annual enrollment period or the Medicare Advantage open enrollment period.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes and developments in the health insurance industry or system could harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States health insurance system, including the Medicare program, is subject to a changing regulatory environment. The future financial performance of our business will depend in part on our ability to adapt to regulatory developments. For example, the federal Patient Protection and Affordable Care Act of 2010 and related regulatory reforms have and will continue to change the industry in which we operate in substantial ways.&#160;The implementation of health care reform has increased, and could further increase, our competition in the individual and family health insurance market, reduce demand for the health insurance for individuals and families that we sell, decrease the number of health insurance plans that we sell as well as the number of health insurance carriers offering them,&#160;cause carriers to increase premiums or reduce commissions and other amounts they pay for our services, any of which could materially harm our business, operating results and financial condition.&#160;Legislative or regulatory changes to the Medicare program could have similar impacts on our Medicare business. The impacts of health care reform on our business included a significant decline in our individual and family plan revenue and membership and other changes in the future could have a similar impact on our Medicare related health insurance business. Our business, operating results, financial condition and prospects may be materially and adversely affected if we are unable to adapt to developments in healthcare reform in the United States.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business depends upon the private sector of the United States health insurance system, which is subject to a changing environment. Changes and developments in the health insurance system and Medicare program in the United States could reduce demand for our services and harm our business. Ongoing healthcare reform efforts and measures may expand the role of government-sponsored coverage, including single payer or so called &#8220;Medicare-for-All&#8221; proposals, which could have far-reaching implications for the health insurance industry if enacted. Some proposals would seek to eliminate the private marketplace, while others would expand a government-sponsored option to a larger population. We are unable to predict the full impact of healthcare reform initiatives or other regulatory changes on our operations in light of the uncertainty of whether initiatives will be successful and the uncertainty regarding the terms and timing of any provisions enacted and the impact of any of those provisions on various healthcare and insurance industry participants. Changes to the Medicare program or the broader health insurance system as a result of the change in the balance of power in Congress or as a result of the Biden administration could harm our business, operating results and financial condition. In the event that laws, regulations or rules that eliminate or reduce private sources of health insurance or Medicare are adopted, the demand for our products could be adversely impacted and our business, operating results and financial condition would be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">From time to time we are subject to various legal proceedings which could adversely affect our business.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are, and may in the future become, involved in various legal proceedings and governmental inquiries, including labor and employment-related claims, claims relating to our marketing or sale of health insurance, intellectual property claims and claims relating to our compliance with securities laws. Any claims asserted against us, with or without merit, could be time-consuming, expensive to settle or litigate and divert management&#8217;s attention and other resources. These claims also could subject us to significant liability for damages and harm our reputation. Our insurance and indemnities may not cover all claims that may be asserted against us. If we are unsuccessful in our defense in these legal proceedings, we may be forced to pay damages or fines, enter into consent decrees, stop offering our services or change our business practices, any of which would harm our business, operating results or financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success in selling health insurance is dependent in part on the actions of federal and state governments. Changes in the laws and regulations governing the offer, sale and purchase of health insurance could harm our business and operating results.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and regulations governing the offer, sale and purchase of health insurance are complex and subject to change, and future changes may be adverse to our business. For example, a long-standing provision in most applicable state laws that we believe is&#160;advantageous to our business is that once health insurance premiums are set by the carrier and approved by state regulators, they are fixed and not generally subject to negotiation or discounting by insurance companies or agents. Additionally, state regulations generally prohibit carriers, agents and brokers from providing financial incentives, such as rebates, to their members in connection with the sale of health insurance. As a result, we do not currently compete with carriers or other agents and brokers on the price of the health insurance plans offered on our website. If these regulations change, we could be forced to reduce prices or provide rebates or other incentives for the health insurance plans sold through our ecommerce platform, which would harm our business, operating results and financial condition. In addition, a federal law was recently passed that requires disclosure of commissions paid to us to the purchaser of small business, major medical individual and family and short-term health insurance plans. The provisions of the law have not gone into effect. It is unclear what impact the law will have when it goes into effect, but it could cause health insurance carriers to lower our commission rates, which could reduce our revenue. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States and federal governments may adopt laws and regulations that are adverse to our business, including laws and regulations that impact the types of health insurance coverage available to consumers, the product features and benefits, our marketing and selling of plans and the role and compensation of agents and brokers in the sale of health insurance.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to the rules and regulations that apply to our sale of Medicare related health insurance are more likely given that the Biden administration recently took office. CMS may change the rules and regulations applicable to us in connection with our Medicare plan business, and those changes could harm our business, operating results and financial condition. The Biden administration has also indicated that it is in support of changes to the Affordable Care Act. It is difficult to predict what changes the Biden administration may make in the rules and regulations relating to our sale of the products that we sell, but the changes could harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with the numerous&#160;state</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">laws and regulations that are applicable to the sale of health insurance, our business and operating results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">could be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to maintain a valid license in each state in which we transact health insurance business and to adhere to sales, documentation and administration practices specific to that state. We must maintain our health insurance licenses to continue selling plans and to continue to receive commissions from health insurance carriers. In addition, each employee who transacts health insurance business on our behalf must maintain a valid license in one or more states. Because we do business in all 50 states and the District of Columbia, compliance with health insurance-related laws, rules and regulations is difficult and imposes significant costs on our business. Each jurisdiction&#8217;s insurance department typically has the power, among other things, to:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">grant, limit, suspend and revoke licenses to transact insurance business; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conduct inquiries into the insurance-related activities and conduct of agents and agencies; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require and regulate disclosure in connection with the sale and solicitation of health insurance; </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorize how, by which personnel and under what circumstances insurance premiums can be quoted and published and an insurance policy sold; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approve which entities can be paid commissions from carriers and the circumstances under which they may be paid; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulate the content of insurance-related advertisements, including web pages, and other marketing practices; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approve policy forms, require specific benefits and benefit levels and regulate premium rates; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impose fines and other penalties; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impose continuing education requirements.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the complexity, periodic modification and differing interpretations of state insurance laws and regulations, we may not have always been, and we may not always be, in compliance with them. New state insurance laws, regulations and guidelines also may not be compatible with the sale of health insurance over the Internet or with various aspects of our platform or manner of marketing or selling health insurance plans. Failure to comply with insurance laws, regulations and guidelines or other laws and regulations applicable to our business could result in significant liability, additional department of insurance licensing requirements, required modification of our advertising and business practices, changes to our existing technology or platforms, the limitation, suspension and/or revocation of our licenses in a particular jurisdiction, termination of our relationship with health insurance carriers or loss of commissions and/or our inability to sell health insurance plans, which would harm our business, operating results and financial condition.&#160;Moreover, an adverse regulatory action in one jurisdiction could result in penalties and adversely affect our license status, business or reputation in other jurisdictions due to the requirement that adverse regulatory actions in one jurisdiction be reported to other jurisdictions. Even if the allegations in any regulatory or other action against us are proven false, any surrounding negative publicity could harm consumer, marketing partner or health insurance carrier confidence in us, which could significantly damage our brand.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is subject to security risks and, if we experience a successful cyberattack, a security breach or are otherwise unable to safeguard the confidentiality and integrity of the data we hold, including sensitive personal information, our business will be harmed. Our business is also subject to emerging privacy laws being passed at the state level that create unique compliance challenges.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our services involve the collection and storage of confidential and personally identifiable information of consumers and the transmission of certain personal information to their chosen health insurance carriers and to the government. For example, we collect names, addresses, credit card and social security numbers and health information such as information regarding consumers' prescription drugs and providers. As a result, we are subject to various state and federal laws and contractual requirements regarding the access, use and disclosure of personal information. We also hold a significant amount of personal information relating to our current and former employees. Despite our taking precautions, we cannot guarantee that our facilities and systems, and those of our third-party service providers, will be free of security breaches, cyberattacks, acts of vandalism, computer viruses, malware, misplaced or lost data, programming and/or human errors or other similar events. Compliance with state and federal privacy-related laws, particularly new state legislation such as the California Consumer Privacy Act, and increasingly robust industry standard security frameworks will result in cost increases due to  an increased need for privacy compliance, oversight and monitoring, and the development of new processes to effectuate and demonstrate compliance. The effects of potential non-compliance by us or third party service providers, and enforcement actions, may result in increased costs to our business and reputational harm.  The privacy legislation landscape is rapidly evolving on a state-by-state basis that creates challenges for businesses to comply with the new legal obligations in a systematic fashion. For example, Virginia, Colorado and California have new privacy legislation that will come into effect in 2022; however, these laws have differing consumer rights and business obligations, differing obligations on data controllers and differing enforcement mechanisms. These new legal operations may change the way we conduct our business and may harm our results of operations and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to expend significant amounts and other resources to protect against privacy and security breaches or to mitigate and remediate problems caused by privacy or security breaches. Techniques used to obtain unauthorized access or to sabotage systems change frequently. As a result, we may be unable to anticipate these techniques or to implement adequate preventative measures preemptively. Additionally, our third party service providers may cause security breaches for which we are&#160;responsible.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Any compromise or perceived compromise of our security or the security of one of our vendors could damage our reputation, cause the termination of relationships with government-run health insurance exchanges and our members, marketing partners and health insurance carriers, reduce demand for our services and subject us to significant liability and expense as well as regulatory action and lawsuits, which would harm our business, operating results and financial condition. The COVID-19 pandemic generally is increasing the attack surface available to criminals, as more companies and individuals work remotely and otherwise work online.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Consequently, the risk of a cybersecurity incident has increased. We cannot provide assurances that our preventative efforts, or those of our vendors or service providers, will be successful. In the event that additional data privacy or security laws are implemented, or our health insurance carrier or other partners determine to impose requirements on us relating to data privacy security, we may not be able to timely comply with such requirements or such requirements may not be compatible with our current processes. Changing our processes could be time consuming and expensive, and failure to timely implement required changes could result in our inability to sell health insurance plans in a particular jurisdiction or for a particular health insurance carrier or subject us to liability for non-compliance, any of which would damage our business, operating results and financial condition.&#160;For instance, health insurance carriers may require us to be compliant with additional security standards in order to accept credit card information from consumers or require us to comply with additional privacy and security standards to do business with us at all. Compliance with privacy and security standards is regularly assessed, and we may not always be compliant with the standards. If we are not in compliance, we may not be able to accept credit card information from consumers, and our relationship with health insurance carriers could be adversely impacted or terminated, which would harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Any legal liability, regulatory penalties, complaints or negative publicity for the information on our website or that we otherwise provide could harm our business and operating results.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We provide information on our website, through our customer care centers, in our marketing materials and in other ways regarding health insurance in general and the health insurance plans we market and sell, including information relating to insurance premiums, coverage, benefits, provider networks, exclusions, limitations, availability, plan comparisons and insurance company ratings. A significant amount of both automated and manual effort is required to maintain the considerable amount of insurance plan information on our website. We also use the information provided on our website and otherwise collected by us to publish reports designed to educate consumers, facilitate public debate, and facilitate reform at the state and federal level. If the information we provide on our website, through our customer care centers, in our marketing materials or otherwise is not accurate or is construed as misleading, or if we do not properly assist individuals and businesses in purchasing health insurance, members, health insurance carriers and others could attempt to hold us liable for damages or require us to take corrective actions, our relationships with health insurance carriers could be terminated or impaired and regulators could attempt to subject us to penalties, force us to stop using our websites, marketing material or certain aspects of them, revoke our licenses to transact health insurance business in a particular jurisdiction, and/or compromise the status of our licenses to transact health insurance business in other jurisdictions, which could result in our loss of our commission revenue and harm our business, operating results and financial condition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the ordinary course of operating our business, we and our health insurance carrier partners have received complaints that the information we provided was not accurate or was misleading. We have received, and may in the future receive, inquiries from health insurance carriers, CMS or state departments of insurance regarding our marketing and business practices and compliance with laws and regulations. We have experienced an increased rate of complaints filed directly with CMS from Medicare beneficiaries enrolled by us and have taken actions to address the quality of our enrollments and to improve our customer experience.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the actions we take do not effectively reduce the rate of complaints and improve our retention rates, our relationship with health insurance carriers could be modified or terminated, our Medicare commission and advertising revenue could decline, and we may incur significant expenses without realizing the value of our investment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Even if we are successful in reducing the rate of complaints, any initiatives we take to address retention could reduce our number of enrollments and conversion rates, which could harm our business, operating results and financial condition. Also, our sales of short-term health insurance plans that lack the same benefits as major medical health insurance plans may increase the risk that we receive complaints regarding our marketing and business practices due to the potential for consumer confusion between short-term health insurance and major medical health insurance. In addition, these types of claims could be time-consuming and expensive to defend, could divert our management&#8217;s attention and other resources, and could cause a loss of confidence in our services. As a result, whether or not we are able to successfully resolve these claims, they could harm our business, operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our business could be harmed if we are unable to contact our consumers or market the availability of our products through specific channels.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use email and telephone, among other channels, to market our services to potential members and as the primary means of communicating with our existing members. The laws and regulations governing the use of email and telephone calls for marketing purposes continue to evolve, and changes in technology, the marketplace or consumer preferences may lead to the adoption of additional laws or regulations or changes in interpretation of existing laws or regulations. If new laws or regulations are adopted, or existing laws and regulations are interpreted or enforced, to impose additional restrictions on our ability to send email or telephone messages to our members or potential members, we may not be able to communicate with them in a cost-effective manner. In addition to legal restrictions on the use of email, Internet service providers, e-mail service providers and others attempt to block the transmission of unsolicited email, commonly known as &#8220;spam.&#8221; Many Internet and e-mail service providers have relationships with organizations whose purpose it is to detect and notify the Internet and e-mail service providers of entities that the organization believes is sending unsolicited e-mail.&#160;If an Internet or e-mail service provider identifies email from us as &#8220;spam&#8221; as a result of reports from these organizations or otherwise, we can be placed on a restricted list that will block our email to members or potential members. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use telephones to communicate with customers and prospective customers and some of these communications may be subject to the Telephone Consumer Protection Act, or TCPA, and other telemarketing laws. The TCPA and other laws, including state laws, relating to telemarketing restrict our ability to market using the telephone in certain respects. For instance, the TCPA prohibits us from using an automatic telephone dialing system to make certain telephone calls to consumers without prior express consent. We have policies in place to comply with the TCPA and other telemarketing laws. However, we have in the past and may in the future become subject to claims that we have violated the TCPA. The TCPA provides for statutory damages of $500 for each violation and $1,500 for each willful violation. In the event that we were found to have violated the TCPA, our business, operating results and financial condition could be harmed. In addition, telephone carriers may block or put consumer warnings on calls originating from call centers. Consumers increasingly screen their incoming emails and telephone calls, including by using screening tools and warnings, and therefore our members or potential members may not reliably receive our emails or telephone messages. If we are unable to communicate effectively by email or telephone with our members and potential members as a result of legislation, blockage, screening technologies or otherwise, our business, operating results and financial condition would be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Risks Related to Finance, Accounting and Tax Matters</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Our operating results will be impacted by factors that impact our estimate of the constrained LTV of commissions per approved member.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective January 1, 2018, we adopted Accounting Standards Update 2014-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Revenue from Contracts with Customers (ASC 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">. As a result of the adoption of ASC 606, we recognize revenue for plans approved during the period by applying the latest estimated constrained LTVs for that product. Constrained LTVs are estimates and are based on a number of assumptions, which include, but are not limited to, estimates of the conversion rates of approved members into paying members, forecasted average plan duration and forecasted commission rates we expect to receive per approved member's plan. These assumptions are based on historical trends and require significant judgment by our management in interpreting those trends and in applying the constraints. Changes in our historical trends will result in changes to our constrained LTV estimates in future periods and therefore could adversely affect our revenue and financial results in those future periods. As a result, negative changes in the factors upon which we estimate constrained LTVs, such as reduced conversion of approved members to paying members, increased health insurance plan terminations or a reduction in the lifetime commission amounts we expect to receive for selling the plan to a member or other changes could harm our business, operating results and financial condition. Changes in LTV may result in an increase or a decrease to revenue and a corresponding increase or decrease to commission receivables. In addition, if we ultimately receive commission payments that are less than the amount we estimated when we recognized commission revenue, we would need to write off the remaining commission receivable balance, which would adversely impact our business, operating results, and financial condition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rate at which approved members become paying members is a significant factor in our estimation of constrained LTVs. To the extent we experience a decline in the rate at which approved members turn into our paying members, our business, operating results, and financial condition would be harmed.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The forecasted average plan duration is another important factor in our estimation of constrained LTV. We receive commissions from health insurance carriers for health insurance plans sold through us. When one of these plans is canceled, or </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">if we otherwise do not remain the agent on the policy, we no longer receive the related commission payment. Our forecasted average plan duration and health insurance plan termination rate are calculated based on our historical data by plan type.&#160;As a result, a reduction in our forecasted average plan duration or an inability to produce accurate forecasted average plan duration may adversely impact our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission rates are also a significant factor in our estimation of constrained LTVs. The commission rates we receive are impacted by a variety of factors, including the particular health insurance plans chosen by our members, the carriers offering those plans, our members&#8217; states of residence, the laws and regulations in those jurisdictions, the average premiums of plans purchased through us and health care reform. Our commission revenue per member has in the past decreased, and could in the future decrease, as a result of reductions in contractual commission rates, a change in the mix of carriers whose products we sell during a given period, and increased health insurance plan termination rates, all of which are beyond our control and may occur on short notice. To the extent these and other factors cause our commission revenue per member to decline, our revenue may decline and our business, operating results and financial condition would be harmed. Given that Medicare-related and individual and family health insurance purchasing is concentrated during enrollment periods, we may experience a shift in the mix of Medicare-related and individual and family health insurance products selected by our members over a short period of time. Any reduction in our average commission revenue per member caused by such a shift or otherwise would harm our business, operating results and financial condition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of constraints is also a factor that requires significant management judgment. Constraints are applied to LTVs for revenue recognition purposes and help ensure that the total estimated lifetime commissions expected to be collected from an approved member's plan are recognized as revenue only to the extent that is probable that a significant reversal in the amount of cumulative revenue recognized will not occur when the uncertainty associated with future commissions receivable from the plan is subsequently resolved. We determine the constraint for each product by comparing prior calculations of LTV to actual cash received and review the reasons for any variations. We then apply judgment in assessing whether the difference between historical cash collections and LTV is representative of differences that can be expected in future periods. We also analyze whether circumstances have changed and consider any known or potential modifications to the inputs into LTV in light of the factors that can impact the amount of cash expected to be collected in future periods including but not limited to commission rates, carrier mix, plan duration, changes in laws and regulations, and cancellations of insurance plans offered by health insurance carriers with which we have a relationship. We evaluate the appropriateness of our constraints on an ongoing basis, and we update our assumptions when we observe a sufficient amount of evidence that would suggest that the long-term expectation underlying the assumptions has changed. If we underestimate the initial constraint applied to LTVs, we might be required to increase the constraint or record an impairment in a future period which would harm our business, operating results and financial condition. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our debt obligations contain restrictions that impact our business and expose us to risks that could materially adversely affect our liquidity and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are party to a credit agreement with Royal Bank of Canada and other lenders that enables us to borrow up to $75 million pursuant to a revolving credit facility. The actual amount we may borrow is limited to a borrowing base determined based on certain eligible commissions receivable as defined in the credit agreement, which amount could be significantly less than $75 million. If our eligible commissions receivable decline, our access to the revolving credit facility could be limited. The credit agreement also imposes certain covenants and restrictions on our business and our ability to obtain additional financing. As of September 30, 2021, we had no outstanding debt under our revolving credit facility. The credit agreement expires in December 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The credit agreement contains customary affirmative covenants, including covenants regarding the payment of taxes and other obligations, maintenance of insurance, reporting requirements and compliance with applicable laws and regulations. The credit agreement also contains restrictions that, subject to certain exceptions, limit our ability to merge or consolidate, sell or transfer assets outside the ordinary course of business, make certain types of investments and restricted payments, pay dividends, incur additional indebtedness, grant liens, or enter into transactions with affiliates without the lender&#8217;s consent. Further, the credit agreement contains a financial covenant requiring the Company to maintain a minimum level of excess availability at any time. The facility contains events of default, including, among others, non-payment defaults, inaccuracy of representations and warranties, covenant defaults, cross-defaults to other indebtedness, judgment defaults, collateral defaults, bankruptcy and insolvency defaults and a change of control default. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">If we experience a decline in cash flow due to any of the factors described in this &#8220;Risk Factors&#8221; section or otherwise, we could have difficulty paying interest and principal amounts due on our indebtedness and meeting the financial covenants set forth in our loan facility. If we are unable to generate sufficient cash flow or otherwise obtain the funds necessary to make required payments under the credit facility, or if we fail to comply with the requirements of our indebtedness, we could default under our credit facility. Any default that is not cured or waived could result in the acceleration of the obligations under the credit facility, an increase in the applicable interest rate under the credit facility, and would permit our lender to exercise rights and remedies with respect to all of the collateral that is securing the credit facility, which includes substantially all of our assets. Any such default could materially adversely affect our liquidity and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Even if we comply with all of the applicable covenants, the restrictions on the conduct of our business could materially adversely affect our business by, among other things, limiting our ability to take advantage of financings, mergers, acquisitions and other corporate opportunities that may be beneficial to the business. Even if the credit facility were terminated, additional debt we could incur in the future may subject us to similar or additional covenants, which could place restrictions on the operation of our business. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Operating and growing our business may require additional capital, and if capital is not available to us, our business, operating results and financial condition may suffer.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating and growing our business is expected to require further investments in our business. We have generated negative cash from operating activities and may continue to generate negative cash from operating activities in the future. We may decide to raise additional capital through debt or equity financing, or we may decide to reduce marketing and advertising, customer care and enrollment, technology and content, or other expenses in order to manage liquidity. We may be presented with opportunities that we want to pursue, and business or other challenges may present themselves, any of which could cause us to require additional capital.  If we seek to raise funds through debt or equity financing, those funds may prove to be unavailable, may only be available on terms that are not acceptable to us or may result in significant dilution to our stockholders or higher levels of leverage.  Our credit agreement with the Royal Bank of Canada and our investment agreement with H.I.G have restrictions that may limit our ability to incur additional indebtedness, make certain types of investments or obtain additional financing. If we are unable to obtain adequate financing or financing on terms satisfactory to us, when we require it, our ability to continue to pursue our business objectives and to respond to business opportunities or challenges could be harmed, and our business, operating results and financial condition could be materially and adversely affected. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements could be impaired, which could adversely affect our operating results, our ability to operate our business and our stock price.</span></div><div style="text-indent:56.25pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a complex business organization. Ensuring that we have adequate internal financial and accounting controls and procedures in place to help ensure that we can produce accurate financial statements on a timely basis is a costly and time-consuming effort that needs to be re-evaluated frequently and is complicated by the expansion of our business operations and changing accounting requirements. Our management, including our chief executive officer and chief accounting officer, does not expect that our internal control over financial reporting will prevent all errors or all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system&#8217;s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. Over time, controls may become inadequate because changes in conditions or deterioration in the degree of compliance with policies or procedures may occur. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. We cannot assure that significant deficiencies or material weaknesses in our internal control over financial reporting will not be identified in the future. Any failure to maintain or implement required new or improved controls, or any difficulties we encounter in their implementation, could result in significant deficiencies or material weaknesses, cause us to fail to timely meet our periodic reporting obligations, or result in material misstatements in our financial statements. Any such failure could also adversely affect the results of periodic management evaluations and annual auditor attestation reports regarding disclosure controls and the effectiveness of our internal control over financial reporting required under Section&#160;404 of the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder. The existence of a material weakness could result in errors in our financial statements that could result in a restatement of financial statements, cause us to fail to timely meet our reporting obligations and cause investors to lose confidence in our reported financial information, leading to a decline in our stock price and potential lawsuits against us.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in our provision for income taxes or adverse outcomes resulting from examination of our income or other tax returns or changes in tax legislation could adversely affect our results.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes is subject to volatility and could be adversely affected by earnings differing materially from our projections, changes in the valuation of our deferred tax assets and liabilities, tax effects of stock-based compensation, outcomes as a result of tax examinations or by changes in tax laws, regulations, accounting principles, including accounting for uncertain tax positions, or interpretations thereof.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that our provision for income taxes is subject to volatility or adverse outcomes as a result of tax examinations, our operating results could be harmed. Significant judgment is required to determine the recognition and measurement attribute prescribed in U.S. generally accepted accounting principles relating to accounting for income taxes. In addition, we are subject to examinations of our income tax returns by the Internal Revenue Service and other tax authorities. We assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. There may be exposure that the outcomes from these examinations will have an adverse effect on our operating results and financial condition.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use net operating losses to offset future taxable income may be subject to certain limitations. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have net operating loss carryforwards for federal and state income tax purposes to offset future taxable income. Our federal and state net operating loss carryforwards begin expiring in 2034 and 2021, respectively. A lack of future taxable income would adversely affect our ability to utilize these net operating loss carryforwards. In addition, utilization of the net operating loss carryforwards may be subject to a substantial annual limitation due to ownership changes that may have occurred or that could occur in the future, as required by Section 382 of the Internal Revenue Code of 1986, as amended, or the Code, and similar state provisions. These ownership change limitations may limit the amount of net operating loss carryforwards and other tax attributes that can be utilized annually to offset future taxable income and tax, respectively. In general, an &#8220;ownership change&#8221; as defined by Section 382 of the Code results from a transaction or series of transactions over a three-year period resulting in an ownership change of more than 50 percentage points (by value) of the outstanding stock of a company by certain stockholders. Our ability to use the remaining net operating loss carryforwards may be further limited if we experience a Section 382 ownership change as a result of future changes in our stock ownership.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Technology</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to sell Medicare-related health insurance plans as a health insurance agent depends upon maintenance of functioning information technology systems.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The success of our Medicare plan customer care center operations is dependent upon information technology systems.&#160;Many of our Medicare plan members utilize our customer care center in connection with their purchase of a Medicare plan.&#160;CMS rules require that our health insurance agent employees utilize CMS-approved scripts in connection with the sale of Medicare plans and that we record and maintain the recording of telephonic interactions relating to the sale of Medicare plans.&#160;We rely on telephone, call recording, customer relationship management and other systems and technology in our Medicare customer care center operations, and we are dependent upon third parties for some of them, including our telephone and call recording systems.&#160;These systems have failed temporarily in the past and may experience additional disruption due to systems upgrades, power outages, an increase in remote work or other impacts as a result of the COVID-19 pandemic. The effectiveness and stability of our Medicare customer care center systems and technology are critical to our ability to sell Medicare plans, particularly during the Medicare enrollment periods, and the failure or interruption of any of these systems and technology or any inability to handle increased volume would harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">System failures or capacity constraints could harm our business and operating results.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The performance, reliability and availability of our ecommerce platform, cloud contact center and underlying network infrastructures are critical to our financial results, brand, and relationship with members, marketing partners and health insurance carriers. Although we regularly attempt to enhance our platforms and system infrastructure, system failures and interruptions may occur if we are unable to accurately project the rate or timing of increases in our website or call center traffic or for other reasons, some of which are completely outside our control. We could experience significant failures and </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">interruptions, which would harm our business, operating results and financial condition. If these failures or interruptions occurred during the Medicare annual enrollment period, the Medicare Advantage open enrollment period or during the open enrollment period under health care reform, the negative impact on us would be particularly pronounced.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely in part upon third-party vendors, including cloud infrastructure and bandwidth providers, to operate our ecommerce platform and contact center. We cannot predict whether additional network capacity will be available from these vendors as we need it, and our network or our suppliers&#8217; networks might be unable to achieve or maintain a sufficiently high capacity of data transmission. Any system failure that causes an interruption in or decreases the responsiveness of our services would impair our revenue-generating capabilities and harm our business and operating results and damage our reputation. In addition, any loss of data could result in loss of customers and subject us to potential liability. Our facilities and our database and systems are vulnerable to damage or interruption from human error, fire, floods, power loss, telecommunications failures, physical or electronic break-ins, computer viruses, acts of terrorism, other attempts to harm our systems and similar events. In addition, our operations are vulnerable to earthquakes, fire, severe weather conditions, including those brought about by climate change, and other natural disasters in the San Francisco Bay Area and elsewhere in Northern California, China, and as well as in other parts of the U.S. where we or our outsourced health insurance agents maintain offices.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">We may not be able to adequately protect our intellectual property, which could harm our business and operating results.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our intellectual property is an essential asset of our business and that our technology currently gives us a competitive advantage in the distribution of Medicare-related, individual and family and small business health insurance. We rely on a combination of copyright, trademark and trade secret laws as well as confidentiality procedures and contractual provisions to establish and protect our intellectual property rights in the United States. The efforts we have taken to protect our intellectual property may not be sufficient or effective, and our trademarks may be held invalid or unenforceable. Moreover, the law relating to intellectual property is not as developed in China, and our intellectual property rights may not be as respected in China as they are in the United States. We may not be effective in policing unauthorized use of our intellectual property, trade secrets and other confidential information, and even if we do detect violations, litigation may be necessary to enforce our intellectual property rights. Any enforcement efforts we undertake, including litigation, could be time-consuming and expensive, could divert our management&#8217;s attention and may result in a court determining that our intellectual property or other rights are unenforceable. If we are not successful in cost-effectively protecting our intellectual property rights, trade secrets and confidential information, our business, operating results and financial condition could be harmed.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consumers depend upon third-party service providers to access our website and services, and our business and operating results could be harmed as a result of technical difficulties experienced by these service providers.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumers using our website and accessing our services depend upon Internet, online and other service providers for access to our website and services. Many of these service providers have experienced significant outages, delays and other difficulties in the past and could experience them in the future. Any significant interruption in access to our call centers or our website or increase in our website&#8217;s response time as a result of these difficulties could damage our relationship with insurance carriers, marketing partners and existing and potential members and could harm our business, operating results and financial condition.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of Our Common Stock</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our actual operating results may differ significantly from our guidance.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, we have released, and may continue to release guidance in earnings conference calls, earnings releases, or otherwise, regarding our future performance that represents our management's estimates as of the date of release. This guidance, which includes forward-looking statements, has been and will be based on projections prepared by our management. Guidance is necessarily speculative in nature, and it can be expected that some or all of the assumptions underlying the guidance furnished by us will not materialize or will vary significantly from actual results. Accordingly, our guidance is only an estimate of what management believes is realizable as of the date of release. Our actual results have, and may in the future, vary from our guidance and the variations may be material. In light of the foregoing, investors are urged not to rely upon our guidance in making an investment decision regarding our common stock.</span></div><div style="text-indent:20.25pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Projections are based upon a number of assumptions and estimates that, while presented with numerical specificity, are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control and are based upon specific assumptions with respect to future business decisions, some of which will change. Among these factors, the assumptions underlying our estimates of commission revenue as required by ASC 606</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">,&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">may vary significantly over time. We may state possible outcomes as high and low ranges. Any range we provide is not intended to imply that actual results could not fall outside of the suggested ranges. Any failure to successfully implement our operating strategy or the occurrence of any of the events or circumstances set forth in this &#8220;Risk Factors&#8221; section could result in the actual operating results being different from our guidance, and the differences may be adverse and material. The principal reason that we release guidance is to provide a basis for our management to discuss our business outlook with analysts and investors and we may decide to suspend guidance at any time. We do not accept any responsibility for any projections or reports published by any such third parties.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The price of our common stock has been and may continue to be volatile, and the value of your investment could decline.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our common stock has been volatile and is likely to continue to fluctuate substantially. For the quarter ended September 30, 2021, the closing price of our common stock fluctuated from $36.30 to $59.49 per share. The trading price of our common stock depends on a number of factors, including those described in this &#8220;Risk Factors&#8221; section, many of which are beyond our control and may not be related to our operating performance. These fluctuations could cause you to lose all or part of your investment in our common stock since you might be unable to sell your shares at or above the price you paid. Factors that could cause fluctuations in the trading price of our common stock include the following:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">price and volume fluctuations in the overall stock market from time to time, including as a result of the COVID-19 pandemic;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">volatility in the market prices and trading volumes of our competitors' shares, including high technology stocks, which have historically experienced high levels of volatility;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new laws or regulations or new interpretations of existing laws or regulations applicable to our business, including developments relating to the health care industry and the marketing and sale of Medicare plans;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated changes in our operating results or the growth rate of our business;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in operating performance and stock market valuations of other technology companies generally, and of our competitors;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of securities analysts to maintain coverage of us, changes in financial estimates by any securities analysts who follow our company, or our failure to meet these estimates or the expectations of investors;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of shares of our common stock by us or our stockholders;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of new products or services;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the public reaction to our press releases, other public announcements, and filings with the SEC;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">rumors and market speculation involving us or other companies in our industry;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">negative publicity about us, including accurate and inaccurate third-party commentary or reports regarding us;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated developments in our business, our competitors' businesses, or the competitive landscape generally;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to control costs, including our operating expenses;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation involving us, our industry or both, or investigations by regulators into our operations or those of our competitors;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments or disputes concerning our intellectual property or other proprietary rights;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announced or completed acquisitions of businesses or technologies by us or our competitors;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in accounting standards, policies, guidelines, interpretations, or principles;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any significant change in our management; and</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic conditions and slow or negative growth of our markets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of such factors on the trading market for our stock may be enhanced by the lack of a large and established trading market for our stock. In addition, the stock market in general, and the market for technology companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. Broad market and industry factors may seriously affect the market price of our common stock, regardless of our actual operating performance. Additionally, as a public company, we face the risk of shareholder lawsuits, particularly if we experience declines in the price of our common stock. In the past, following periods of volatility in the overall market and the market prices of a particular company's securities, securities class action lawsuits have often been instituted against affected companies. We have been, and may in the future be, subject to such legal actions.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The issuance of shares of common stock underlying our Series A preferred stock would dilute the ownership and relative voting power of holders of our common stock and may adversely affect the market price of our common stock.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Series A preferred stock is convertible at the option of the holders at any time into shares of common stock based on the then applicable conversion rate as determined in the certificate of designations for the Series A preferred stock, which conversion would dilute the ownership interest of existing holders of our common stock. In addition, because holders of our Series A preferred stock are entitled to vote, on an as-converted basis (subject to certain voting limitations and conversion calculations set forth in the certificate of designations for the Series A preferred stock), together with holders of our common stock on all matters submitted to a vote of the holders of our common stock, the issuance of the Series A preferred stock effectively reduces the relative voting power of the holders of our common stock.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any sales in the public market of the common stock issuable upon conversion of the Series A preferred stock could adversely affect prevailing market prices of our common stock. Pursuant to the investment agreement, holders of our Series A preferred stock will receive customary resale registration rights for common stock issued upon conversion of the Series A preferred stock upon closing.  Any resale of our common stock would increase the number of shares of our common stock available for public trading. Sales by our Series A preferred stockholder of a substantial number of shares of our common stock in the public market, or the perception that such sales might occur, could have a material adverse effect on the price of our common stock.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Series A preferred stock has rights, preferences and privileges that are not held by, and are preferential to, the rights of our common stockholders, which could adversely affect our liquidity and financial condition, result in the interests of holders of our Series A preferred stock differing from those of our common stockholders and make an acquisition of us more difficult.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of our Series A preferred stock have (i) a liquidation preference (ii) rights to dividends, which are senior to all of our other equity securities, (iii) redemption rights beginning on April 30, 2027, (iv) the right to require us to repurchase any or all of their Series A preferred stock in connection with certain change of control events, and (v) conversion price adjustments in connection with certain corporate transactions, each subject to the terms, conditions and exceptions contained in the certificate of designations for the Series A preferred stock.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These dividend and share repurchase and redemption obligations could impact our liquidity and reduce the amount of cash flows available for working capital, capital expenditures, growth opportunities, acquisitions, and other general corporate purposes. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of our investment agreement with Echelon Health SPV, LP, or H.I.G., the initial purchaser of our Series A Preferred Stock, could also limit our ability to obtain additional financing or increase our borrowing costs, which could have an adverse effect on our financial condition. The preferential rights could also result in divergent interests between H.I.G. and holders of our common stock. Furthermore, a sale of our company, as a change of control event, may require us to repurchase Series A preferred stock, which could have the effect of making an acquisition of our company more expensive and potentially deterring proposed transactions that may otherwise be beneficial to our stockholders.</span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">H.I.G. may exercise influence over us, including through its ability to designate up to two directors on our board of directors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment agreement with H.I.G. contains certain negative operating covenants that will remain in effect for so long as H.I.G. continues to own at least 30% of the shares of Series A preferred stock originally issued to it. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Further, the investment agreement entitles H.I.G. to nominate one individual for election to our board of directors for so long as it continues to own at least 30% of the common stock issuable or issued upon conversion of the Series A preferred stock originally issued to it. The director designated by H.I.G. will also be entitled to serve on committees of our board of directors, subject to applicable law and stock exchange rules. Notwithstanding the fact that all directors will be subject to fiduciary duties to us and to applicable law, the interests of the director designated by H.I.G. of our Series A preferred stock may differ from the interests of our security holders as a whole or of our other directors. H.I.G. nominated Aaron C. Tolson to our board of directors. Mr. Tolson was appointed to our board of directors as a Class I director on August 30, 2021, and as of the date of this report serves as the chairperson of the compensation committee and as a member of the equity incentive committee, strategy committee and government and regulatory affairs committee of the board of directors. In addition, if we fail to maintain certain levels of commissions receivable and liquidity, H.I.G. will be entitled to nominate one additional director, and the consent of H.I.G. will be required to approve our annual budget, hire or terminate certain key executives and incur certain indebtedness as outlined in the investment agreement. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Anti-takeover provisions contained in our certificate of incorporation and bylaws, as well as provisions of Delaware law, could impair a takeover attempt.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation, bylaws, and Delaware law contain provisions which could have the effect of rendering more difficult, delaying, or preventing an acquisition deemed undesirable by our board of directors. Our corporate governance documents include provisions:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">creating a classified board of directors whose members serve staggered three-year terms</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorizing undesignated preferred stock, which could be issued by our board of directors without stockholder approval and may contain voting, liquidation, dividend, and other rights superior to our common stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting the liability of, and providing indemnification to, our directors and officers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting the ability of our stockholders to call and bring business before special meetings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requiring advance notice of stockholder proposals for business to be conducted at meetings of our stockholders and for nominations of candidates for election to our board of directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">controlling the procedures for the conduct and scheduling of board of directors and stockholder meetings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">providing our board of directors with the express power to postpone previously scheduled annual meetings and to cancel previously scheduled special meetings.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our management.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a Delaware corporation, we are also subject to provisions of Delaware law, including Section 203 of the Delaware General Corporation law, which prevents some stockholders holding more than 15% of our outstanding common stock from engaging in certain business combinations without approval of the holders of substantially all of our outstanding common stock. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any provision of our certificate of incorporation, bylaws or Delaware law that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the price that some investors are willing to pay for our common stock.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_124"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;EXHIBITS </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;Exhibits</span></div><div style="margin-bottom:16pt;margin-top:9pt;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as so indicated in Exhibits 32.1 and 32.2, the following exhibits are filed as part of, or incorporated by reference into, this&#160;Quarterly Report on Form 10-Q.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:5.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.518%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporation by Reference Herein</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description of Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/0001333493/000133349321000144/ehealthinducementplan.htm">2021 Inducement Plan</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current Report on Form 8-K (File No. 001-33071)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 23, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/0001333493/000133349321000144/inducementplan-noticeofsto.htm">Form of Notice of Stock Option Grant and Stock Option Agreement under the 2021 Inducement Plan</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current Report on Form 8-K (File No. 001-33071)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 23, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/0001333493/000133349321000144/inducementplan-formofperfoa.htm">Form of Notice of Stock Option Grant and Stock Option Agreement (Performance-Based Vesting) under the 2021 Inducement Plan</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current Report on Form 8-K (File No. 001-33071)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 23, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/0001333493/000133349321000144/inducementplan-noticeofstoa.htm">Form of Notice of Stock Unit Grant and Stock Unit Agreement under the 2021 Inducement Plan</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current Report on Form 8-K (File No. 001-33071)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 23, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/0001333493/000133349321000144/inducementplan-formofperfo.htm">Form of Notice of Stock Unit Grant and Stock Unit Agreement (Performance-Based Vesting) under the 2021 Inducement Plan</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current Report on Form 8-K (File No. 001-33071)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 23, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="exhibit106fransoistmanexec.htm">Terms of Executive Employment Agreement, dated September 22, 2021, between Fran Soistman and eHealth, Inc.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="exhibit107scottflanderssep.htm">Separation and Consulting Agreement, dated September 22, 2021, between Scott N. Flanders and eHealth, Inc.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="exhibit108christinejanofsk.htm">Severance Agreement, dated September 19, 2021, between Christine Janofsky and eHealth, Inc.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="exhibit109johnpierantonise.htm">Severance Agreement, dated June 5, 2020, between John Pierantoni and eHealth, Inc.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="a2021q3ex311.htm">Certification of Fran Soistman, Chief Executive Officer of eHealth, Inc., pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="a2021q3ex312.htm">Certification of Christine Janofsky, Chief Financial Officer of eHealth, Inc., pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8225;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="a2021q3ex321.htm">Certification of Fran Soistman, Chief Executive Officer of eHealth, Inc., pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8225;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:none" href="a2021q3ex322.htm">Certification of Christine Janofsky, Chief Financial Officer of eHealth, Inc., pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">The cover page from the Company&#8217;s Quarterly Report on Form 10-Q for the three months ended September  30, 2021, formatted in Inline XBRL and contained in Exhibit 101</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Filed herewith.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:174%">&#8225;&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:174%">*&#160;&#160;&#160;&#160;Indicates a management contract or compensatory plan or arrangement.</span></div><div style="padding-left:13.5pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="ia6d7e8bb0f4f45f88f677d6cf06c1b8f_127"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EHEALTH, INC.<br/></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Francis Soistman</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Francis Soistman<br/>Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Christine Janofsky</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Janofsky<br/>Chief Financial Officer<br/>(Principal Financial Officer)</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>2
<FILENAME>exhibit106fransoistmanexec.htm
<DESCRIPTION>EX-10.6
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ibfa539047f21453493f12d6ebe321acd_1"></div><div style="min-height:93.6pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Terms of Executive Employment Agreement</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The following term sheet (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Term Sheet</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) sets forth the terms for the employment of Fran Soistman (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) as the Chief Executive Officer of eHealth, Inc. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">eHealth&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">).  Following the execution of the Term Sheet, which shall initially govern the employment relationship between the Executive and eHealth, they will thereafter enter into good faith negotiations with respect to an employment agreement reflecting these terms, which employment agreement shall then supersede this Term Sheet. Accordingly, the parties hereto agree as follows&#58;</font></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.691%"><tr><td style="width:1.0%"></td><td style="width:10.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.571%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Position&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Chief Executive Officer reporting to the Board of Directors (the &#8220;Board&#8221;).</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Start Date&#47;Relocation&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Start date as an employee is September 22, 2021 (the date Executive actually first commences employment, the &#8220;Start Date&#8221;), with a transition to the Chief Executive Officer role as of November 1, 2021. Relocation will not be required, and Executive will travel as reasonably needed, as mutually determined by Executive and the Board.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Board of Directors&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Executive will initially be appointed to the Board after becoming Chief Executive Officer. </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Term of Employment&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">At-will&#59; Executive or eHealth may terminate employment, at any time, with or without notice or cause.  Severance payable, as described below.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Base Salary&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$750,000 per year, subject to subsequent increases as determined by the Compensation Committee in accordance with annual review process.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">6.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Target Bonus&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Target annual bonus of 110% (with a maximum bonus of 175%) of Base Salary as then in effect payable upon achievement of performance goals set forth as part of eHealth&#8217;s performance bonus plan for the applicable year and approved in the sole discretion of the Compensation Committee after consultation with Executive, subject to continued employment through the date bonuses are paid to eHealth executives generally.  Guaranteed on a pro-rated basis for 2021 calculated based on the target percentage of 110% and the time of service as Chief Executive Officer during 2021.  Compensation Committee to review with respect to 2023 and future years.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">7.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Start Bonus&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Cash starting bonus of $200,000 to be paid within 30 days following commencement of employment.</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:180pt;text-align:justify;text-indent:-162pt"><font><br></font></div><div style="height:58.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:180pt;text-align:justify;text-indent:-162pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.271%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">8.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Initial Equity Grants&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(A) Two options to purchase a number of shares of eHealth&#8217;s outstanding common stock with an exercise price per share equal to the fair market value per share on the date of grant (the &#8220;Options&#8221;).  </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The first Option will cover 100,000 shares of common stock and will vest as to 25% of the shares subject to the Option on the one-year anniversary of the Start Date and as to the remainder of the shares subject to the Option each month thereafter in equal installments on the same day of the month as the Start Date through the fourth anniversary of the Start Date, subject to Executive&#8217;s continued service to eHealth or its subsidiaries through each such date. For the avoidance of doubt, the Option will be fully vested 48 months after the Start Date, assuming such continued service. </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The second Option will cover 100,000 shares of common stock and will vest based on achievement of certain stock price goals (as discussed below).</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(B) In addition to the stock options set forth above, three restricted stock unit awards (the &#8220;RSU Awards&#8221;)&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The first RSU Award will cover 60,000 shares of common stock and will vest as to 25% of the shares subject to the RSU Award on the one-year anniversary of the Start Date and in equal quarterly installments thereafter on the same day of the month as the Start Date through the fourth anniversary of the Start Date, subject to Executive&#8217;s continued service to eHealth or its subsidiaries through each such date. For the avoidance of doubt, the RSU Award will be fully vested 48 months after the Start Date, assuming such continued service. </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The second RSU Award will cover 70,000 shares of common stock and will vest based on achievement of stock price goals (as discussed below).</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The third RSU Award (the &#8220;Starting RSUs&#8221;) will cover 12,500 shares, which will vest with respect to 1&#47;16 of the shares subject to the award on the date of grant, and in 15 equal quarterly installments thereafter, subject to Executive&#8217;s continued service to eHealth or its subsidiaries through each such date. </font></td></tr></table></div><div style="height:58.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:6pt;padding-left:180pt;text-align:justify;text-indent:-162pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.845%"><tr><td style="width:1.0%"></td><td style="width:10.491%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.491%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The Options and RSUs are intended to serve as a material inducement to the Executive to become an employee of the Company and will be granted under, and be subject to the terms and conditions of an equity plan of  eHealth and the applicable form of award agreement thereunder. All grants of equity awards are subject to the approval of the Compensation Committee, Executive being employed by eHealth on the date of grant and, if required by law, a Form S-8 being filed and effective as of the date of grant. The Options will be presented to the Compensation Committee for approval on the Start Date, with a grant date that is ten business days following the date of approval. The RSU Awards will be presented to the Compensation Committee for approval as soon as practicable after the Start Date, but no later than the first regularly scheduled Compensation Committee meeting following the Start Date, with a grant date that is no more than ten business days following the date of approval. Details as to the Options and RSU Awards that are subject to performance goals are set forth on Exhibit A.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Executive will be eligible to receive awards of stock options, restricted stock units or other equity awards pursuant to any plans or arrangements eHealth may have in effect from time to time.  The Compensation Committee will determine in its discretion whether Executive will be granted any such equity awards and the terms of any such award&#59; provided, however, that (except (a) as otherwise determined by the Compensation Committee due to performance issues, and (b) in the case of non-ordinary course (e.g. retention or new hire) grants), Executive shall receive awards on a basis no less favorable than other senior executives of the Company.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">9.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Benefits&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Executive will be eligible to participate in eHealth&#8217;s employee benefit plans, policies and arrangements applicable to other executive officers.  </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">10.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Regular Severance&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">In the event that outside the Change of Control Period eHealth terminates Executive&#8217;s employment for reasons other than &#8220;Cause,&#8221; or in the event Executive resigns as a result of &#8220;Good Reason,&#8221; Executive will receive&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(i)</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Lump sum payment equal to 24 months&#8217; Base Salary&#59;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:58.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:0.12pt;padding-left:180pt;text-align:justify;text-indent:-162pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.537%"><tr><td style="width:1.0%"></td><td style="width:10.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(ii)</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">A pro-rated target bonus for the year in which the termination occurs (and, if actual performance for the year exceeds target and the date of termination is July 1 or later, the remainder of the target bonus for such year, paid when bonuses are paid to other executives)&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(iii)</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Any unpaid bonus with respect to the prior year, based on actual performance&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(iv)</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">COBRA reimbursement for Executive and Executive&#8217;s eligible dependents for 18 months following such termination (if eHealth cannot provide the benefit without violating Section 2716 of the Public Health Service Act, eHealth will, in lieu continuing benefits, provide Executive a taxable monthly payment in an amount equal to the monthly COBRA premium that Executive would be required to pay to continue his group health coverage in effect on the last date of employment with eHealth, which will be made regardless of whether Executive elects COBRA continuation coverage)&#59;</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(v)</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Executive will be granted 12 additional months of vesting credit, with respect to any time based Options and&#47;or RSU Awards that are not subject to performance conditions (with such vesting being calculated as if the award had been subject to monthly vesting)&#59; provided, however, that the Starting RSUs will vest in full.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(vi)</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Any performance Options or RSU Awards that have satisfied the stock price goal, but for which the service-based vesting had not yet been satisfied, will vest, and the remainder of the performance awards that have not satisfied the stock price goals will terminate and be cancelled for no consideration, except as set forth on Exhibit A.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Change of Control  Severance&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">In the event that within the Change of Control Period eHealth, or its successor company, terminates Executive&#8217;s employment for reasons other than &#8220;Cause,&#8221; or in the event Executive resigns as a result of &#8220;Good Reason,&#8221; Executive will receive&#58; </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:58.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:0.12pt;padding-left:180pt;text-align:justify;text-indent:-162pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.537%"><tr><td style="width:1.0%"></td><td style="width:10.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.527%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.903%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(i)</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">a lump-sum equal to the sum of (A) 24 months of Base Salary and (B) two times Executive&#8217;s then-current target bonus&#59; </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(ii)</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Any unpaid bonus with respect to the prior year, based on actual performance&#59;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(iii)</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">COBRA reimbursement for Executive and Executive&#8217;s eligible dependents for 18 months following such termination (if eHealth cannot provide the benefit without violating Section 2716 of the Public Health Service Act, eHealth will, in lieu continuing benefits, provide Executive a taxable monthly payment in an amount equal to the monthly COBRA premium that Executive would be required to pay to continue his group health coverage in effect on the last date of employment with eHealth, which will be made regardless of whether Executive elects COBRA continuation coverage), and </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(iv)</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">one hundred percent (100%) of Executive&#8217;s then-outstanding and unvested time-based equity awards will become vested in full.  Any performance Options or RSU Awards that have satisfied the stock price goal (including in connection with the Change in Control), but for which the service-based vesting had not yet been satisfied will also vest and the remainder of the performance awards that have not satisfied the stock price goals will terminate and be cancelled for no consideration.     </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Conditions to <br>Receipt of Severance&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The severance will be subject to Executive executing a release of claims in a form reasonably acceptable to eHealth and Executive that becomes effective no later than 60 days following termination.  </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Definitions&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; will mean (i) Executive&#8217;s commission of any act of fraud, embezzlement or dishonesty, (ii) Executive&#8217;s conviction of, or plea of nolo contendere to, a felony under the laws of the United States or any state thereof, (iii) Executive&#8217;s continued failure to perform lawfully assigned duties for 30 days after receiving written notification from the  Board, (iv) Executive&#8217;s unauthorized use or disclosure of </font></div></td></tr></table></div><div style="height:58.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">-5-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.271%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">confidential information or trade secrets of the Company, (v) Executive&#8217;s material breach of any material agreement with the Company or (vi) any other intentional misconduct by Executive that adversely affects the business of the Company in a material manner, after having been provided with written notice and (other than in the case of clause (ii)) a 14-day opportunity to cure (if the Board determines a cure to be possible) and to be heard by the Board with Executive&#8217;s counsel present.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; will mean the occurrence of any of the following events&#58;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(i)</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company&#8217;s then outstanding voting securities&#59; or</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(ii)</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation&#59; or</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(iii)</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The consummation of the sale, lease or other disposition by the Company of all or substantially all the Company&#8217;s assets.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Change of Control Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; will mean the period beginning on the date four (4) months prior to, and ending on the date that is twelve (12) months following, a Change of Control.</font></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:0.36pt"><font><br></font></div><div style="margin-top:12pt;padding-left:216pt;text-align:justify"><font><br></font></div><div style="height:58.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">-6-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; will mean that Executive resigns his employment within 120 days after any of the following is undertaken by the Company (or its acquirer) without Executive&#8217;s express written consent&#58; (i) a reduction in Executive&#8217;s title, (ii) a material reduction of Executive&#8217;s duties, authority or responsibilities, (including but not limited to a material reduction in duties, authority or responsibilities solely by virtue of the Company being acquired and made part of a larger entity such that Executive is no longer the Chief Executive Officer of a publicly-traded company)&#59; (iii) any material (at least 10%) reduction of Executive&#8217;s Base Salary and potential bonus (other than a proportionate reduction in Executive&#8217;s Base Salary that affects all senior management of the Company)&#59; (iii) failure of a successor to the Company to assume this agreement&#59; (iv) any material breach by the Company of any material agreement with Executive&#59; or (v) prior to a Change of Control (and, following a Change of Control if the Company&#8217;s Board exists following such Change of Control) Executive&#8217;s position as a member of the Board terminates as a result of the Board&#8217;s failing to nominate him for election or re-election thereto&#59; provided, however, that Good Reason shall not exist unless Executive has provided written notice to the Board of the purported grounds for the Good Reason within 90 days of its initial existence and the Company has been provided at least 30 days to remedy the condition.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Other Termination </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">of Employment&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">In the event eHealth terminates Executive&#8217;s employment with eHealth for &#8220;Cause&#8221; or Executive terminates such employment without &#8220;Good Reason,&#8221; Executive will receive (i) all Base Salary accrued up to the effective date of termination, (ii) all benefits or compensation accrued prior to termination, as provided under the terms of any employee benefit and compensation agreements or plans applicable to Executive, and (iii) all business expenses required to be reimbursed under eHealth&#8217;s expense reimbursement policy to Executive with respect to reasonable business expenses incurred prior to termination.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Death and Disability&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">In the event Executive&#8217;s employment with eHealth terminates due to Executive&#8217;s death or disability, Executive will receive payments in accordance with </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt;padding-left:216pt;text-align:justify"><font><br></font></div><div style="height:58.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">-7-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.271%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">eHealth&#8217;s standard plans, programs, and practices, as well as (a) a pro rata bonus for the year of termination, payable when other bonuses are paid, and only to the extent performance goals are actually met&#59; and (b) any unpaid bonus with respect to the prior year, based on actual performance.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Golden Parachute Tax&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Executive will either receive the full payments and benefits due to him or a lesser amount so that Executive will not be subject to the Golden Parachute Excise Tax under the U.S. Internal Revenue Code, whichever results in Executive receiving more on an after-tax basis.  </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Indemnification&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Subject to applicable law, Executive will be provided indemnification to the maximum extent permitted by eHealth&#8217;s Articles of Incorporation or Bylaws, including, if applicable, any directors and officers insurance policies, with such indemnification to be on terms determined by the Board or any of its committees, but on terms no less favorable than provided to any other Company executive officer or director and subject to the terms of any separate written indemnification agreement.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Other Agreements&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Executive will execute eHealth&#8217;s standard forms of Proprietary Information and Inventions Agreement and Arbitration Agreement.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Attorneys&#8217; Fees&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">eHealth will reimburse Executive up to $20,000 for reasonable attorneys&#8217; fees incurred in the negotiation, preparation, and execution of this term sheet, an employment agreement reflecting this term sheet, and related ancillary documents. </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Enforcement Costs&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">If any civil action or other legal proceeding, including arbitration, is brought for the enforcement of this or any other material agreement between the parties hereto, and&#47;or because of an alleged dispute, breach, default or misrepresentation in connection with any provision of such agreements, the successful or prevailing party or parties shall be entitled to recover reasonable attorneys&#8217; fees, court costs and all expenses.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Governing Law&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Delaware.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Successors and Assigns&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The employment agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors (including any direct or indirect successor by purchase, merger, </font></td></tr></table></div><div style="height:58.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">-8-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:0.12pt;text-align:justify;text-indent:0.36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.271%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">consolidation or otherwise to all or substantially all of the business and&#47;or assets of the Company), assigns, spouses, heirs and personal and legal representatives.  The employment agreement shall also provide that the Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially all, or a substantial part, of the business and&#47;or assets of the Company, by written agreement in form and substance satisfactory to Executive, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place.  </font></td></tr></table></div><div style="margin-top:6pt;text-align:center"><font><br></font></div><div style="height:58.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">-9-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">EXHIBIT A</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Options and RSU Awards that are subject to stock price goals will contain the following stock price hurdles&#58; 25% vested at $58.00&#59; an additional 15% vested at $64.00&#59; an additional 15% vested at $70.00&#59; an additional 15% vested at $76.00&#59; an additional 15% vested at $82.00&#59; and an additional 15% vested at $105.00.  A stock price hurdle will be treated as having been met if the 90 trading day VWAP equals or exceeds such hurdle during the four-year period starting on the date of grant (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;). If a stock price hurdle has been met, the portion of Options or RSU Awards subject to that hurdle will vest on the earlier of (a) the one-year anniversary of the date that the hurdle was met or (b) the fourth anniversary of the date of grant, so long as Executive remains in continuous service to the Company through such earlier date (subject to the severance provisions of the employment agreement).</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">If, during the Performance Period, a Change in Control (as defined in the equity plan pursuant to which the award is granted) occurs, then the Performance Period will be shortened such that the Performance Period will end as of the Change in Control and, to the extent that any of the Performance Goals are achieved based on the value of the per-share consideration received by the Company&#8217;s stockholders in connection with the Change in Control (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Per-Share Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) (and, for the avoidance of doubt, in lieu of and without regard to any ninety (90) trading day VWAP otherwise required with respect to determining the achievement of Performance Goals not in connection with a Change in Control), such Performance Goal will be deemed achieved, as determined by the Compensation Committee in its sole discretion, and the applicable shares subject to the award as a result of such performance goal achievement will become eligible to vest. The unvested portion of the award will be forfeited automatically. Any eligible shares resulting from the Change in Control will be scheduled to vest on the first anniversary of the Change in Control, provided that Executive remains in continuous service through that vesting date (subject to the severance provisions of the employment agreement).   </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Upon a termination of service by the Company without Cause or by Executive for Good Reason in circumstances in which there is no Change in Control and Per-Share Consideration, if the initial $58.00 hurdle has been previously achieved, then the 90 trading day VWAP as of the date of termination will, to the extent it exceeds the highest previously-achieved hurdle and is less than the next-highest hurdle, be used to calculate pro rata vesting of the tranche that would have vested at the next highest hurdle, based on linear interpolation above such highest previously-achieved hurdle and below such next-highest hurdle, as calculated and determined in the sole discretion of the Compensation Committee.  For example, if the $58.00 hurdle has been previously achieved as of the date of termination, and the 90 trading day VWAP as of the date of termination is $61.00 (i.e., halfway between $58.00 and $64.00), then half of the 15% of the RSU Award that would have vested upon the achievement of the $64.00 hurdle (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">i.e.,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> 7.5%) will vest.</font></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="height:58.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">-10-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-bottom:24pt;margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below.</font></div><div style="margin-bottom:36pt;margin-top:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">FRAN SOISTMAN, an individual</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Dated&#58;  9&#47;22&#47;21&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;&#47;s&#47; Fran Soistman&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Fran Soistman</font></div><div style="margin-bottom:36pt;margin-top:12pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">EHEALTH, INC.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Dated&#58;  9&#47;22&#47;21&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">&#47;s&#47; Scott Giesler&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Scott Giesler&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">SVP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-top:6pt"><font><br></font></div><div style="height:58.69pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">-11-</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>3
<FILENAME>exhibit107scottflanderssep.htm
<DESCRIPTION>EX-10.7
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5c11a8b6e5b54ef3b24f757153ebe13c_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">SEPARATION AGREEMENT AND RELEASE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">This Separation Agreement and Release (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) is made by and between </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Scott N. Flanders </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">eHealth, Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) (collectively referred to as the &#8220;Parties&#8221; or individually referred to as a &#8220;Party&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, Executive is employed by the Company as its Chief Executive Officer and serves as a member of its Board of Directors&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, the Executive&#8217;s employment with the Company will terminate effective on October 31, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), and through such date Executive shall continue to serve as its Chief Executive Officer and a member of its Board of Directors, subject to the terms and conditions set forth herein&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, the Company desires to retain Executive as an independent contractor to perform services for a certain period (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Consulting Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) following the Termination Date, and Executive is willing to perform such services, on the terms described in the Consulting Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Consulting Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions, and demands that the Executive may have against the Company and any of the Releasees as defined below, including, but not limited to, any and all claims arising out of or in any way related to Executive&#8217;s employment with or separation from the Company&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">NOW, THEREFORE, in consideration of the mutual promises made herein, the Company and Executive hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27pt;text-decoration:underline">Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Through the Termination Date, Executive shall continue to serve as Chief Executive Officer and to receive such compensation and benefits as he is eligible to receive as of the date hereof.  Upon completion of such period of continuous service as Chief Executive Officer, and subject to Executive&#8217;s execution (and non-revocation) of the release attached hereto as Exhibit A (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) on the Termination Date, the Company will pay Executive the following severance benefits, in full satisfaction of any benefits Executive is eligible to receive under Executive&#8217;s Employment Agreement dated June 1, 2016 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), subject to the terms and conditions herein and subject to Executive complying with all of Executive&#8217;s legal and contractual obligations to the Company and, with respect to clause 1(c), reasonably cooperating with the Board and management of the Company as part of the Chief Executive Officer transition process&#58;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27.68pt;text-decoration:underline">Cash Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  A lump sum cash amount equal to $2,128,767.12, which payment shall be made on the first payroll date following the effective date of the Release &#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27pt;text-decoration:underline">Continued Health Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Subject to Executive electing continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), for Executive and Executive&#8217;s eligible dependents (if any) within the time period prescribed pursuant to COBRA, the Company will pay the COBRA premiums on a monthly basis for such coverage of Executive and any of Executive&#8217;s eligible dependents covered under the Company&#8217;s group health insurance (that is, medical, dental and vision) plans as of immediately prior to the termination of Executive employment with the Company, until the earlier of (x)&#160;eighteen (18) months following the Termination Date or (y)&#160;the date upon which Executive and </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">such eligible dependents of Executive become covered under another employer&#8217;s group health plans that provide Executive and such eligible dependents with comparable benefits and levels of coverage</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27.68pt;text-decoration:underline">Performance-Based Restricted Stock Unit Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  A Performance Based Restricted Stock Unit Award granted on March 17, 2021 with respect to 18,984 shares has met the performance hurdle with respect to 6,328 shares (such 6,328 shares, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Achieved PRSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), which Achieved PRSUs are now subject to time-based vesting.  On December 31, 2021, if the conditions set forth in this Agreement and the Consulting Agreement are met, such Achieved PRSUs shall become fully vested.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27pt;text-decoration:underline">Deferral Elections</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The Company previously granted Executive certain equity awards (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) covering shares of the Company&#8217;s common stock (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) under the Company&#8217;s 2014&#160;Equity Incentive Plan and the terms and conditions of the applicable award agreements governing such Equity Awards (collectively the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Award Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).  To the extent any Equity Awards are subject to a deferral election by Executive (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Deferral Election</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), the settlement and delivery of the vested Shares subject to the Equity Awards will occur in accordance with such applicable Deferral Election and applicable Award Documents.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Notwithstanding the foregoing, if Executive engages in conduct that constitutes Cause for Executive&#8217;s termination (as defined in Executive&#8217;s Employment Agreement) between the date of this Agreement and the Termination Date, then the Company may terminate Executive&#8217;s employment for Cause, and Executive will not be eligible for, and will not receive, the severance benefits set forth in clauses (a), (b) and (c) of this Section 1.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27pt;text-decoration:underline">Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The Parties agree that for purposes of determining the number of shares of the Company&#8217;s common stock that Executive is entitled to purchase from the Company pursuant to any Equity Awards that are stock options, Executive will be considered to have vested only up to the Termination Date, and all unvested restricted stock unit awards (other than the Achieved PRSUs) will be forfeited as of such date. All of Executive&#8217;s stock options are vested. Executive acknowledges that as of the Termination Date, Executive holds only those outstanding Equity Awards as set forth in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> attached hereto, and Executive will have vested in the portion of such Equity Awards as specified in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> attached hereto.  The Equity Awards, including the exercise of Executive&#8217;s vested options and the underlying Shares, shall continue to be governed by the terms and conditions of the Company&#8217;s Award Documents and any applicable Deferral Election with respect to the Equity Award.  The post-termination exercise period of any of Executive&#8217;s stock options will not begin to run until the final day of the Consulting Term&#59; provided, however, that in no event will any option award be exercisable after the expiration of the award&#8217;s term.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27pt;text-decoration:underline">Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive&#8217;s health insurance benefits shall cease on October 31,&#160;2021, subject to Executive&#8217;s right to continue his&#47;her health insurance under COBRA.  Executive&#8217;s participation in all benefits and incidents of employment, including, but not limited to, participation in the Company&#8217;s 2020 Employee Stock Purchase Plan, and the accrual of bonuses, vacation, and paid time off, shall cease as of the Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27pt;text-decoration:underline">Other Agreements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Concurrently with this Agreement and for the consideration set forth in this Agreement, the Company and Executive shall enter into the Consulting Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  In addition, as of the Termination Date, Executive shall resign from </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Page 2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">all positions with the Company and its subsidiaries, including as a member of the boards of directors of the Company and of its subsidiaries, other than with respect to his duties under the Consulting Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27pt;text-decoration:underline">Payment of Salary and Receipt of All Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive acknowledges and represents that, other than the consideration set forth in this Agreement, the Company has paid or provided all salary, wages, bonuses, accrued vacation&#47;paid time off, premiums, leaves, housing allowances, relocation costs, interest, severance, outplacement costs, fees, reimbursable expenses, commissions, stock, stock options, vesting, and any and all other benefits and compensation due to Executive as of the date hereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27pt;text-decoration:underline">No Pending or Future Lawsuits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive represents that he&#47;she has no lawsuits, claims, or actions pending in his&#47;her name, or on behalf of any other person or entity, against the Company or any of the other Releasees (as defined in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">).  Executive also represents that he&#47;she does not intend to bring any claims on his&#47;her own behalf or on behalf of any other person or entity against the Company or any of the other Releasees.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27pt;text-decoration:underline">Application for Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive understands and agrees that, as a condition of this Agreement, Executive shall not be entitled to any employment with the Company, and Executive hereby waives any right, or alleged right, of employment or re-employment with the Company.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27pt;text-decoration:underline">Trade Secrets and Confidential Information&#47;Company Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive reaffirms and agrees to observe and abide by the terms of the Proprietary Information and Inventions Agreement with the Company entered into on February 7, 2017 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Confidentiality Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), specifically including the provisions therein regarding nondisclosure of the Company&#8217;s trade secrets and confidential and proprietary information, and nonsolicitation of Company employees.   </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27pt;text-decoration:underline">No Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive agrees that he&#47;she will not knowingly encourage, counsel, or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against any of the Releasees, unless under a subpoena or other court order to do so.  Executive agrees both to immediately notify the Company upon receipt of any such subpoena or court order, and to furnish, within three (3) business days of its receipt, a copy of such subpoena or other court order.  If approached by anyone for counsel or assistance in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints against any of the Releasees, Executive shall state no more than that he&#47;she cannot provide counsel or assistance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:3pt;text-decoration:underline">Protected Activity Not Prohibited</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.   Executive understands that nothing in this Agreement shall in any way limit or prohibit Executive from engaging for a lawful purpose in any Protected Activity.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Protected Activity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">&#8221; shall mean filing a charge or complaint, or otherwise communicating, cooperating, or participating with, any state, federal, or other governmental agency, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, and the National Labor Relations Board.  Notwithstanding any restrictions set forth in this Agreement, Executive understands that he&#47;she is not required to obtain authorization from the Company prior to disclosing information to, or communicating with, such agencies, nor is Executive obligated to advise the Company as to any such disclosures or communications.  Notwithstanding, in making any such disclosures or communications, Executive agrees to take all reasonable </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Page 3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">precautions to prevent any unauthorized use or disclosure of any information that may constitute Company confidential information under the Confidentiality Agreement to any parties other than the relevant government agencies.  Executive further understands that &#8220;Protected Activity&#8221; does not include the disclosure of any Company attorney-client privileged communications, and that any such disclosure without the Company&#8217;s written consent shall constitute a material breach of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">Nondisparagement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive agrees to refrain from any disparagement, defamation, libel, or slander of any of the Releasees, and agrees to refrain from (a)&#160;making any public statements regarding the Company other than acknowledging that Executive previously was employed by the Company, served as its Chief Executive Officer, and was a member of its Board of Directors, and (b)&#160;any tortious interference with the contracts and relationships of any of the Releasees.  Executive shall direct any inquiries by potential future employers to the Company&#8217;s human resources department, which shall use its best efforts to provide only the Executive&#8217;s last position and dates of employment.  The members of the Company&#8217;s Board of Directors agree to refrain from any disparagement, defamation, libel, or slander of Executive.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">Breach</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  In addition to the rights provided in the &#8220;Attorneys&#8217; Fees&#8221; section below, Executive acknowledges and agrees that any material breach of this Agreement, unless such breach constitutes a legal action by Executive challenging or seeking a determination in good faith of the validity of the waiver in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> under the ADEA, or of any provision of the Confidentiality Agreement shall entitle the Company immediately to recover and&#47;or cease providing the consideration provided to Executive under this Agreement and to obtain damages, except as provided by law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">No Admission of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive understands and acknowledges that this Agreement constitutes a compromise and settlement of any and all actual or potential disputed claims by Executive.  No action taken by the Company hereto, either previously or in connection with this Agreement, shall be deemed or construed to be (a)&#160;an admission of the truth or falsity of any actual or potential claims or (b)&#160;an acknowledgment or admission by the Company of any fault or liability whatsoever to Executive or to any third party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The Parties shall each bear their own costs, attorneys&#8217; fees, and other fees incurred in connection with the preparation of this Agreement.  Notwithstanding the previous sentence, the Company will reimburse Executive for his reasonable legal fees incurred in the review and negotiation of this Agreement and matters associated with his separation from the Company up to a limit of $15,000.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">ARBITRATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  THE PARTIES AGREE THAT ANY AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS AGREEMENT, THEIR INTERPRETATION, AND ANY OF THE MATTERS HEREIN RELEASED, SHALL BE SUBJECT TO ARBITRATION IN SANTA CLARA COUNTY, BEFORE JUDICIAL ARBITRATION &#38; MEDIATION SERVICES, INC. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">JAMS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES &#38; PROCEDURES (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">JAMS RULES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).  THE ARBITRATOR MAY GRANT INJUNCTIONS AND OTHER RELIEF IN SUCH DISPUTES.  THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH CALIFORNIA LAW, INCLUDING THE CALIFORNIA CODE OF CIVIL PROCEDURE, AND THE ARBITRATOR SHALL APPLY SUBSTANTIVE AND PROCEDURAL CALIFORNIA LAW TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO ANY CONFLICT-OF-LAW PROVISIONS </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Page 4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">OF ANY JURISDICTION.  TO THE EXTENT THAT THE JAMS RULES CONFLICT WITH CALIFORNIA LAW, CALIFORNIA LAW SHALL TAKE PRECEDENCE.  THE DECISION OF THE ARBITRATOR SHALL BE FINAL, CONCLUSIVE, AND BINDING ON THE PARTIES TO THE ARBITRATION.  THE PARTIES AGREE THAT THE PREVAILING PARTY IN ANY ARBITRATION SHALL BE ENTITLED TO INJUNCTIVE RELIEF IN ANY COURT OF COMPETENT JURISDICTION TO ENFORCE THE ARBITRATION AWARD.  THE PARTIES TO THE ARBITRATION SHALL EACH PAY AN EQUAL SHARE OF THE COSTS AND EXPENSES OF SUCH ARBITRATION, AND EACH PARTY SHALL SEPARATELY PAY FOR ITS RESPECTIVE COUNSEL FEES AND EXPENSES&#59; PROVIDED, HOWEVER, THAT THE ARBITRATOR SHALL AWARD ATTORNEYS&#8217; FEES AND COSTS TO THE PREVAILING PARTY, EXCEPT AS PROHIBITED BY LAW.  THE PARTIES HEREBY AGREE TO WAIVE THEIR RIGHT TO HAVE ANY DISPUTE BETWEEN THEM RESOLVED IN A COURT OF LAW BY A JUDGE OR JURY.  NOTWITHSTANDING THE FOREGOING, THIS SECTION WILL NOT PREVENT EITHER PARTY FROM SEEKING INJUNCTIVE RELIEF (OR ANY OTHER PROVISIONAL REMEDY) FROM ANY COURT HAVING JURISDICTION OVER THE PARTIES AND THE SUBJECT MATTER OF THEIR DISPUTE RELATING TO THIS AGREEMENT AND THE AGREEMENTS INCORPORATED HEREIN BY REFERENCE.  SHOULD ANY PART OF THE ARBITRATION AGREEMENT CONTAINED IN THIS PARAGRAPH CONFLICT WITH ANY OTHER ARBITRATION AGREEMENT BETWEEN THE PARTIES, THE PARTIES AGREE THAT THIS ARBITRATION AGREEMENT SHALL GOVERN.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  All payments made pursuant to this Agreement will be subject to any applicable tax withholdings.  The Company makes no representations or warranties with respect to the tax consequences of the payments and any other consideration provided to Executive or made on his&#47;her behalf under the terms of this Agreement.  Executive agrees and understands that he&#47;she is responsible for payment, if any, of local, state, and&#47;or federal taxes on the payments and any other consideration provided hereunder by the Company and any penalties or assessments thereon.  Executive further agrees to indemnify and hold the Company harmless from any claims, demands, deficiencies, penalties, interest, assessments, executions, judgments, or recoveries by any government agency against the Company for any amounts claimed due on account of (a)&#160;Executive&#8217;s failure to pay or delayed payment of, federal or state taxes, or (b) damages sustained by the Company by reason of any such claims, including attorneys&#8217; fees and costs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The payments and benefits under this Agreement are intended to be exempt from or otherwise comply with Section&#160;409A of the Internal Revenue Code of 1986, as amended, and the final Treasury regulations and any guidance promulgated thereunder, and any applicable state law equivalent (together, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), and any ambiguities or ambiguous terms herein will be interpreted to be so exempt or otherwise to so comply.  In no event will any payments pursuant to Section&#160;1.a. be made later than March&#160;15,&#160;2022.  Each payment and benefit payable under this Agreement is intended to constitute a separate payment for purposes of Section&#160;1.409A2(b)(2) of the Treasury Regulations.  In no event will the Company reimburse Executive for any tax imposed or other costs incurred as a result of Section 409A.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The Company represents and warrants that the undersigned has the authority to act on behalf of the Company and to bind the Company and all who may claim through it to the terms and conditions of this Agreement.  Executive represents and warrants that he&#47;she has the capacity to act on his&#47;her own behalf and on behalf of all who might claim through him&#47;her to bind them to the terms and conditions of this Agreement.  Each Party warrants and represents that </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Page 5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">there are no liens or claims of lien or assignments in law or equity or otherwise of or against any of the claims or causes of action released herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">No Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive represents that he&#47;she has had an opportunity to consult with an attorney, and has carefully read and understands the scope and effect of the provisions of this Agreement.  Executive has not relied upon any representations or statements made by the Company that are not specifically set forth in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement shall continue in full force and effect without said provision or portion of provision.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">Attorneys&#8217; Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Except with regard to a legal action challenging or seeking a determination in good faith of the validity of the waiver in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> under the ADEA, in the event that either Party brings an action to enforce or effect its rights under this Agreement, the prevailing Party shall be entitled to recover its costs and expenses, including the costs of mediation, arbitration, litigation, court fees, and reasonable attorneys&#8217; fees incurred in connection with such an action.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">22.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  This Agreement represents the entire agreement and understanding between the Company and Executive concerning the subject matter of this Agreement and Executive&#8217;s employment with and separation from the Company and the events leading thereto and associated therewith, and supersedes and replaces any and all prior agreements and understandings concerning the subject matter of this Agreement and Executive&#8217;s relationship with the Company, with the exception of the Confidentiality Agreement and the Award Documents. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">23.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">No Oral Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  This Agreement may only be amended in a writing signed by Executive and a duly authorized representative of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">24.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  This Agreement shall be governed by the laws of the State of California, without regard for choice-of-law provisions.  Executive consents to personal and exclusive jurisdiction and venue in the State of California.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">25.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  This Agreement may be executed in counterparts and by facsimile, and each counterpart and facsimile shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">26.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21pt;text-decoration:underline">Voluntary Execution of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive understands and agrees that he&#47;she executed this Agreement voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of his&#47;her claims against the Company and any of the other Releasees.  Executive acknowledges that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(a)&#160;&#160;&#160;&#160;he&#47;she has read this Agreement&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;he&#47;she has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of his&#47;her own choice or has elected not to retain legal counsel&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(c)&#160;&#160;&#160;&#160;he&#47;she understands the terms and consequences of this Agreement and of the releases it contains&#59; and</font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Page 6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(d)&#160;&#160;&#160;&#160;he&#47;she is fully aware of the legal and binding effect of this Agreement.</font></div><div style="margin-bottom:24pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below.</font></div><div style="margin-bottom:36pt;margin-top:12pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">SCOTT N. FLANDERS, an individual</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Dated&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">9&#47;22&#47;21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">&#47;s&#47; Scott N. Flanders&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:36pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Scott N. Flanders</font></div><div style="margin-bottom:36pt;margin-top:12pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">EHEALTH, INC.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Dated&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">9&#47;22&#47;21</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">&#47;s&#47; Scott Giesler&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Scott Giesler&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-top:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">SVP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Page 7</font></div></div></div><div id="i5c11a8b6e5b54ef3b24f757153ebe13c_4"></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT A</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Release of Claims to be executed on Termination Date</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">(Defined terms as set forth in the Separation Agreement)</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27pt;text-decoration:underline">Release of Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive agrees that the consideration provided under Executive&#8217;s Separation Agreement represents settlement in full of all outstanding obligations owed to Executive by the Company and its current and former officers, directors, employees, agents, investors, attorneys, shareholders, administrators, affiliates, benefit plans, plan administrators, insurers, trustees, divisions, and subsidiaries, and predecessor and successor corporations and assigns (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Releasees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).  Executive, on his&#47;her own behalf and on behalf of his&#47;her respective heirs, family members, executors, agents, and assigns, hereby and forever releases the Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Executive may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and including the execution date of this Release, including, without limitation&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">a.&#160;&#160;&#160;&#160;any and all claims relating to or arising from Executive&#8217;s employment relationship with the Company and the termination of that relationship&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">b.&#160;&#160;&#160;&#160;any and all claims relating to, or arising from, Executive&#8217;s right to purchase or receive, or actual purchase or receipt of shares of stock of the Company, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">c.&#160;&#160;&#160;&#160;any and all claims for wrongful discharge of employment&#59; termination in violation of public policy&#59; discrimination&#59; harassment&#59; retaliation&#59; breach of contract, both express and implied&#59; breach of covenant of good faith and fair dealing, both express and implied&#59; promissory estoppel&#59; negligent or intentional infliction of emotional distress&#59; fraud&#59; negligent or intentional misrepresentation&#59; negligent or intentional interference with contract or prospective economic advantage&#59; unfair business practices&#59; defamation&#59; libel&#59; slander&#59; negligence&#59; personal injury&#59; assault&#59; battery&#59; invasion of privacy&#59; false imprisonment&#59; conversion&#59; and disability benefits&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">d.&#160;&#160;&#160;&#160;any and all claims for violation of any federal, state, or municipal statute, including, but not limited to, Title&#160;VII of the Civil Rights Act of 1964&#59; the Civil Rights Act of 1991&#59; the Rehabilitation Act of 1973&#59; the Americans with Disabilities Act of 1990&#59; the Equal Pay Act&#59; the Fair Labor Standards Act&#59; the Fair Credit Reporting Act&#59; the Age Discrimination in Employment Act of 1967&#59; the Older Workers Benefit Protection Act&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">the Employee Retirement Income Security Act of 1974&#59; the Worker Adjustment and Retraining Notification Act&#59; the Family and Medical Leave Act&#59; the Sarbanes-Oxley Act of 2002&#59; the California Family Rights Act&#59; the California Labor Code&#59; the California Workers&#8217; Compensation Act&#59; and the California Fair Employment and Housing Act&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">e.&#160;&#160;&#160;&#160;any and all claims for violation of the federal or any state constitution&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">f.&#160;&#160;&#160;&#160;any and all claims arising out of any other laws and regulations relating to employment or employment discrimination&#59;</font></div><div style="height:49.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">Exhibit A to Separation Agreement</font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">g.&#160;&#160;&#160;&#160;any claim for any loss, cost, damage, or expense arising out of any dispute over the nonwithholding or other tax treatment of any of the proceeds received by Executive &#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">h.&#160;&#160;&#160;&#160;any and all claims for attorneys&#8217; fees and costs.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Executive agrees that the release set forth herein shall be and remain in effect in all respects as a complete general release as to the matters released.  This release does not extend to any obligations incurred under the Separation Agreement.  This release does not release any claims for indemnification by the Company pursuant to any agreement, statute or otherwise nor does it release any claims for coverage under any D&#38;O or other similar insurance policy.  This release does not release claims that cannot be released as a matter of law, including, but not limited to, Executive&#8217;s right to file a charge with or participate in a charge by the Equal Employment Opportunity Commission, or any other local, state, or federal administrative body or government agency that is authorized to enforce or administer laws related to employment, against the Company (with the understanding that any such filing or participation does not give Executive the right to recover any monetary damages against the Company&#59; Executive&#8217;s release of claims herein bars Executive from recovering such monetary relief from the Company).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27pt;text-decoration:underline">Acknowledgment of Waiver of Claims under ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive understands and acknowledges that he is waiving and releasing any rights he may have under the Age Discrimination in Employment Act of 1967 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), and that this waiver and release is knowing and voluntary.  Executive understands and agrees that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the effective date of this Release.  Executive understands and acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Executive was already entitled.  Executive further understands and acknowledges that he has been advised by this writing that&#58; (a) he should consult with an attorney </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">prior</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> to executing this Release&#59; (b) he has had twentyone (21) days within which to consider this Release&#59; (c) he has seven (7) days following his execution of this Release to revoke this Release&#59; (d) this Release shall not be effective until after the revocation period has expired&#59; and (e) nothing in this Release prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law.  Executive acknowledges and understands that revocation must be accomplished by a written notification to the General Counsel that is received prior to the effective date.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:27pt;text-decoration:underline">California Civil Code Section 1542</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive acknowledges that he has been advised to consult with legal counsel and is familiar with the provisions of California Civil Code Section&#160;1542, a statute that otherwise prohibits the release of unknown claims, which provides as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:43.2pt;padding-right:43.2pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.</font></div><div style="height:49.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Page 2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Executive, being aware of said code section, agrees to expressly waive any rights he&#47;she may have thereunder, as well as under any other statute or common law principles of similar effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4.&#160;&#160;&#160;&#160;Executive&#8217;s signature below constitutes his&#47;her certification under penalty of perjury that he&#47;she has returned all documents and other items provided to Executive by the Company, developed or obtained by Executive in connection with his&#47;her employment with the Company, or otherwise belonging to the Company, and has not kept any copies thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Understood, Acknowledged &#38; Agreed To&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">&#47;s&#47; Scott Flanders&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Oct 31, 2021&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Scott Flanders&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Date</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:49.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Page 3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">EXHIBIT B</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CONSULTING AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="height:49.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Page 4</font></div></div></div><div id="i5c11a8b6e5b54ef3b24f757153ebe13c_7"></div><hr style="page-break-after:always"><div style="min-height:81pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">EHEALTH, INC.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CONSULTING AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">This Consulting Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Consulting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) is made and entered into as of October 31,&#160;2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), by and between </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">eHealth,&#160;Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Scott N. Flanders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Consultant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) (each herein referred to individually as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">,&#8221; or collectively as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).  Any terms capitalized and not specifically defined herein shall have the meaning ascribed to them under the Separation Agreement and Release by and between the Company and Executive dated September 22,&#160;2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Separation Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, the Company desires to retain Consultant as an independent contractor to perform transition services for a certain period following the Termination Date, and Consultant is willing to perform such services, on the terms described below&#59; and </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">WHEREAS, pursuant to the Separation Agreement, the Parties have agreed to enter into this Consulting Agreement and to set forth the terms of the Parties&#8217; continuing relationship under this Consulting Agreement, as Consultant transitions to an independent contractor of the Company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">NOW, THEREFORE, in consideration of the mutual promises contained herein, the Parties hereby agree as follows&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Services and Compensation</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">In consideration for the payments and benefits provided to Consultant as set forth in the Separation Agreement and as described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> attached hereto, Consultant shall perform the services described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) for the Company (or its designee).</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Confidentiality</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:24.34pt">Definition of Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; means any information (including any and all combinations of individual items of information) that relates to the actual or anticipated business and&#47;or products, research or development of the Company, its affiliates or subsidiaries, or to the Company&#8217;s, its affiliates&#8217; or subsidiaries&#8217; technical data, trade secrets, or know-how, including, but not limited to, research, product plans, or other information regarding the Company&#8217;s, its affiliates&#8217; or subsidiaries&#8217; products or services and markets therefor, customer lists and customers (including, but not limited to, customers of the Company on whom Consultant called or with whom Consultant became acquainted during the term of this Consulting Agreement), software, developments, inventions, discoveries, ideas, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and other business information disclosed by the Company, its affiliates or subsidiaries, either directly or indirectly, in writing, orally or by drawings or inspection of premises, parts, equipment, or other property of Company, its affiliates or subsidiaries.  Notwithstanding the foregoing, Confidential Information shall not include any such information which Consultant can establish (i) was publicly known or made generally available prior to the time of disclosure to Consultant&#59; (ii) becomes publicly known or made generally available after disclosure to Consultant through no wrongful action or inaction of </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:81pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Consultant&#59; or (iii) is in the rightful possession of Consultant, without confidentiality obligations, at the time of disclosure as shown by Consultant&#8217;s then-contemporaneous written records&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> that any combination of individual items of information shall not be deemed to be within any of the foregoing exceptions merely because one or more of the individual items are within such exception, unless the combination as a whole is within such exception.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:25pt">Nonuse and Nondisclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> During and after the term of this Consulting Agreement, Consultant will hold in the strictest confidence, and take all reasonable precautions to prevent any unauthorized use or disclosure of Confidential Information, and Consultant will not (i)&#160;use the Confidential Information for any purpose whatsoever other than as necessary for the performance of the Services on behalf of the Company, or (ii)&#160;disclose the Confidential Information to any third party without the prior written consent of an authorized representative of Company, except that Consultant may disclose Confidential Information to the extent compelled by applicable law&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">provided however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, prior to such disclosure, Consultant shall provide prior written notice to Company and seek a protective order or such similar confidential protection as may be available under applicable law.  Consultant agrees that no ownership of Confidential Information is conveyed to the Consultant.  Without limiting the foregoing, Consultant shall not use or disclose any Company property, intellectual property rights, trade secrets or other proprietary know-how of the Company to invent, author, make, develop, design, or otherwise enable others to invent, author, make, develop, or design identical or substantially similar designs as those developed under this Consulting Agreement for any third party.  Consultant agrees that Consultant&#8217;s obligations under this Section&#160;2.B shall continue after the termination of this Consulting Agreement. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:25pt">Other Client Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Consultant agrees that Consultant will not improperly use, disclose, or induce the Company to use any proprietary information or trade secrets of any former or concurrent employer of Consultant or other person or entity with which Consultant has an obligation to keep in confidence. Consultant also agrees that Consultant will not bring onto the Company&#8217;s premises or transfer onto the Company&#8217;s technology systems any unpublished document, proprietary information, or trade secrets belonging to any third party unless disclosure to, and use by, the Company has been consented to in writing by such third party. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:24.34pt">Third Party Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Consultant recognizes that the Company has received and in the future will receive from third parties their confidential or proprietary information subject to a duty on the Company&#8217;s part to maintain the confidentiality of such information and to use it only for certain limited purposes.  Consultant agrees that at all times during the term of this Consulting Agreement and thereafter, Consultant owes the Company and such third parties a duty to hold all such confidential or proprietary information in the strictest confidence and not to use it or to disclose it to any person, firm, corporation, or other third party except as necessary in carrying out the Services for the Company consistent with the Company&#8217;s agreement with such third party.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Ownership</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:24.34pt">Assignment of Inventions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Consultant agrees that all right, title, and interest in and to any copyrightable material, notes, records, drawings, designs, inventions, improvements, developments, discoveries, ideas and trade secrets conceived, discovered, </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:81pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">authored, invented, developed or reduced to practice by Consultant, solely or in collaboration with others, during the term of this Consulting Agreement and arising out of, or in connection with, performing the Services under this Consulting Agreement and any copyrights, patents, trade secrets, mask work rights or other intellectual property rights relating to the foregoing (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Inventions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), are the sole property of the Company.  Consultant also agrees to promptly make full written disclosure to the Company of any Inventions and to deliver and assign (or cause to be assigned) and hereby irrevocably assigns fully to the Company all right, title and interest in and to the Inventions.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:25pt">Pre-Existing Material</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">s.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Subject to Section&#160;3.A, Consultant will provide the Company with prior written notice if, in the course of performing the Services, Consultant incorporates into any Invention or utilizes in the performance of the Services any invention, discovery, idea, original works of authorship, development, improvements, trade secret, concept, or other proprietary information or intellectual property right owned by Consultant or in which Consultant has an interest, prior to, or separate from, performing the Services under this Consulting Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Prior Invention</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">s</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), and the Company is hereby granted a nonexclusive, royalty-free, perpetual, irrevocable, transferable, worldwide license (with the right to grant and authorize sublicenses) to make, have made, use, import, offer for sale, sell, reproduce, distribute, modify, adapt, prepare derivative works of, display, perform, and otherwise exploit such Prior Inventions, without restriction, including, without limitation, as part of or in connection with such Invention, and to practice any method related thereto.  Consultant will not incorporate any invention, discovery, idea, original works of authorship, development, improvements, trade secret, concept, or other proprietary information or intellectual property right owned by any third party into any Invention without Company&#8217;s prior written permission. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:25pt">Moral Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Any assignment to the Company of Inventions includes all rights of attribution, paternity, integrity, modification, disclosure and withdrawal, and any other rights throughout the world that may be known as or referred to as &#8220;moral rights,&#8221; &#8220;artist&#8217;s rights,&#8221; &#8220;droit moral,&#8221; or the like (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Moral Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).  To the extent that Moral Rights cannot be assigned under applicable law, Consultant hereby waives and agrees not to enforce any and all Moral Rights, including, without limitation, any limitation on subsequent modification, to the extent permitted under applicable law.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:24.34pt">Further Assurances</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Consultant agrees to assist Company, or its designee, at the Company&#8217;s expense, in every proper way to secure the Company&#8217;s rights in Inventions in any and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments that the Company may deem necessary in order to apply for, register, obtain, maintain, defend, and enforce such rights, and in order to deliver, assign and convey to the Company, its successors, assigns and nominees the sole and exclusive right, title, and interest in and to all Inventions and testifying in a suit or other proceeding relating to such Inventions. Consultant further agrees that Consultant&#8217;s obligations under this Section&#160;3.E shall continue after the termination of this Consulting Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%"> </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:25.67pt">Attorney-in-Fact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Consultant agrees that, if the Company is unable because of Consultant&#8217;s unavailability, dissolution, mental or physical incapacity, or for any other reason, to secure Consultant&#8217;s signature with respect to any Inventions, including, without limitation, for the purpose of applying for or pursuing any application for any United States or </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:81pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">foreign patents or mask work or copyright registrations covering the Inventions assigned to the Company in Section&#160;3.A, then Consultant hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as Consultant&#8217;s agent and attorney-in-fact, to act for and on Consultant&#8217;s behalf to execute and file any papers and oaths and to do all other lawfully permitted acts with respect to such Inventions to further the prosecution and issuance of patents, copyright and mask work registrations with the same legal force and effect as if executed by Consultant.  This power of attorney shall be deemed coupled with an interest, and shall be irrevocable.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Conflicting Obligations</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:24.34pt">Consultant represents and warrants that Consultant has no agreements, relationships, or commitments to any other person or entity that conflict with the provisions of this Consulting Agreement, Consultant&#8217;s obligations to the Company under this Consulting Agreement, and&#47;or Consultant&#8217;s ability to perform the Services. Consultant will not enter into any such conflicting agreement during the term of this Consulting Agreement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:25pt">Consultant shall require all Consultant&#8217;s employees, contractors, or other third-parties performing Services under this Consulting Agreement to execute a Confidential Information and Assignment Agreement in the form provided by the Company, and promptly provide a copy of each such executed agreement to the Company. Consultant&#8217;s violation of this Section&#160;4 will be considered a material breach under Section&#160;6.B.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Return of Company Materials </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Upon the termination of this Consulting Agreement, or upon Company&#8217;s earlier request, Consultant will immediately deliver to the Company, and will not keep in Consultant&#8217;s possession, recreate, or deliver to anyone else, any and all Company property, including, but not limited to, Confidential Information, tangible embodiments of the Inventions, all devices and equipment belonging to the Company, all electronically-stored information and passwords to access such property, those records maintained pursuant to Section&#160;3.D and any reproductions of any of the foregoing items that Consultant may have in Consultant&#8217;s possession or control.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Term and Termination</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:24.34pt">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> The term of this Consulting Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Consulting Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) will begin on the Effective Date of this Consulting Agreement and will continue until the earlier of (i)&#160;final completion of the Services, (ii)&#160;termination as provided in Section&#160;6.B or December 31, 2021.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:25pt">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> The Company may terminate this Consulting Agreement upon giving Consultant fourteen (14) days prior written notice of such termination pursuant to Section&#160;11.G of this Consulting Agreement.  The Company may terminate this Consulting Agreement immediately and without prior notice if Consultant refuses to or is unable to perform the Services or is in breach of any material provision of this Consulting Agreement or the Separation Agreement.  Consultant may terminate this Consulting Agreement if Consultant is physically unable to perform the Services or if the Company is in breach of any material provision of this Consulting Agreement or the Separation Agreement.  Upon termination of this Consulting Agreement, Consultant shall have no further obligations to Company.</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:81pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:25pt">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Upon any termination, all rights and duties of the Company and Consultant toward each other shall cease except&#58;  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.02pt">The Company will pay, within thirty (30) days after the effective date of termination, all reimbursable expenses, if any, submitted in accordance with the Company&#8217;s policies and in accordance with the provisions of Section&#160;1 of this Consulting Agreement&#59; and</font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.02pt">Section&#160;2 (Confidentiality), Section&#160;3 (Ownership), Section&#160;4.B (Conflicting Obligations), Section&#160;5 (Return of Company Materials), Section&#160;6 (Term and Termination), Section&#160;7 (Independent Contractor&#59; Benefits), Section&#160;9 (Nonsolicitation), Section&#160;9 (Limitation of Liability), Section&#160;10 (Arbitration and Equitable Relief), and Section&#160;11 (Miscellaneous) will survive termination or expiration of this Consulting Agreement in accordance with their terms.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Independent Contractor&#59; Benefits</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:24.34pt">Independent Contractor.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">It is the express intention of the Company and Consultant that Consultant perform the Services as an independent contractor to the Company. Nothing in this Consulting Agreement shall in any way be construed to constitute Consultant as an agent, employee or representative of the Company. Without limiting the generality of the foregoing, Consultant is not authorized to bind the Company to any liability or obligation or to represent that Consultant has any such authority. Consultant agrees to furnish (or reimburse the Company for) all tools and materials necessary to accomplish this Consulting Agreement and shall incur all expenses associated with performance, except as expressly provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit&#160;1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. Consultant acknowledges and agrees that Consultant is obligated to report as income all compensation received by Consultant pursuant to this Consulting Agreement. Consultant agrees to and acknowledges the obligation to pay all self-employment and other taxes on such income.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:25pt">Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> The Company and Consultant agree that Consultant will receive no Company-sponsored benefits from the Company where benefits include, but are not limited to, paid vacation, sick leave, medical insurance, 401k participation and employee stock purchase plan participation. If Consultant is reclassified by a state or federal agency or court as the Company&#8217;s employee, Consultant will become a reclassified employee and will receive no benefits from the Company, except those mandated by state or federal law, even if by the terms of the Company&#8217;s benefit plans or programs of the Company in effect at the time of such reclassification, Consultant would otherwise be eligible for such benefits.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Nonsolicitation</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">To the fullest extent permitted under applicable law, from the date of this Consulting Agreement until twelve (12) months after the termination of this Consulting Agreement for any reason (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Restricted Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), Consultant will not, without the Company&#8217;s prior written consent, directly or indirectly, solicit any of the Company&#8217;s employees to leave their employment, or attempt to solicit employees of the Company, either for Consultant or for any other person or entity. Consultant agrees that nothing in this Section&#160;8 shall affect Consultant&#8217;s continuing obligations under this Consulting Agreement during and after this twelve (12) month period, including, without limitation, Consultant&#8217;s obligations under Section&#160;2.</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">-5-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:81pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Limitation of Liability</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">IN NO EVENT SHALL COMPANY BE LIABLE TO CONSULTANT OR TO ANY OTHER PARTY FOR ANY INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES, OR DAMAGES FOR LOST PROFITS OR LOSS OF BUSINESS, HOWEVER CAUSED AND UNDER ANY THEORY OF LIABILITY, WHETHER BASED IN CONTRACT, TORT (INCLUDING NEGLIGENCE) OR OTHER THEORY OF LIABILITY, REGARDLESS OF WHETHER COMPANY WAS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. IN NO EVENT SHALL COMPANY&#8217;S LIABILITY ARISING OUT OF OR IN CONNECTION WITH THIS CONSULTING AGREEMENT EXCEED THE AMOUNTS PAID BY COMPANY TO CONSULTANT UNDER THIS CONSULTING AGREEMENT FOR THE SERVICES, DELIVERABLES OR INVENTION GIVING RISE TO SUCH LIABILITY.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21pt">Arbitration and Equitable Relief </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:24.34pt">Arbitration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> IN CONSIDERATION OF CONSULTANT&#8217;S CONSULTING RELATIONSHIP WITH COMPANY, ITS PROMISE TO ARBITRATE ALL DISPUTES RELATED TO CONSULTANT&#8217;S CONSULTING RELATIONSHIP WITH THE COMPANY AND CONSULTANT&#8217;S RECEIPT OF THE COMPENSATION AND OTHER BENEFITS PAID TO CONSULTANT BY COMPANY, AT PRESENT AND IN THE FUTURE, CONSULTANT AGREES THAT ANY AND ALL CONTROVERSIES, CLAIMS, OR DISPUTES WITH ANYONE (INCLUDING COMPANY AND ANY EMPLOYEE, OFFICER, DIRECTOR, SHAREHOLDER OR BENEFIT PLAN OF THE COMPANY IN THEIR CAPACITY AS SUCH OR OTHERWISE), ARISING OUT OF, RELATING TO, OR RESULTING FROM CONSULTANT&#8217;S CONSULTING RELATIONSHIP WITH THE COMPANY OR THE TERMINATION OF CONSULTANT&#8217;S CONSULTING RELATIONSHIP WITH THE COMPANY, INCLUDING ANY BREACH OF THIS CONSULTING AGREEMENT, SHALL BE SUBJECT TO BINDING ARBITRATION UNDER THE FEDERAL ARBITRATION ACT AND PURSUANT TO THE ARBITRATION PROVISIONS SET FORTH IN CALIFORNIA CODE OF CIVIL PROCEDURE SECTIONS&#160;1280 THROUGH 1294.2 (THE &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">CCP ACT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) AND PURSUANT TO CALIFORNIA LAW, AND SHALL BE BROUGHT IN CONSULTANT&#8217;S INDIVIDUAL CAPACITY, AND NOT AS A PLAINTIFF, REPRESENTATIVE OR CLASS MEMBER IN ANY PURPORTED CLASS, COLLECTIVE OR REPRESENTATIVE PROCEEDING.  NOTWITHSTANDING THE FOREGOING, CONSULTANT UNDERSTANDS THAT CONSULTANT MAY BRING A PROCEEDING AS A PRIVATE ATTORNEY GENERAL AS PERMITTED BY LAW.  FOR THE AVOIDANCE OF DOUBT, THE FEDERAL ARBITRATION ACT GOVERNS THIS AGREEMENT AND SHALL CONTINUE TO APPLY WITH FULL FORCE AND EFFECT NOTWITHSTANDING THE APPLICATION OF PROCEDURAL RULES SET FORTH IN THE CCP ACT AND CALIFORNIA LAW. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CONSULTANT AGREES TO ARBITRATE ANY AND ALL COMMON LAW AND&#47;OR STATUTORY CLAIMS UNDER LOCAL, STATE, OR FEDERAL LAW, INCLUDING, BUT NOT LIMITED TO, CLAIMS UNDER TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, THE AMERICANS WITH DISABILITIES ACT OF 1990, THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, THE OLDER WORKERS BENEFIT PROTECTION ACT, THE SARBANES-OXLEY ACT, THE WORKER </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">-6-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:81pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">ADJUSTMENT AND RETRAINING NOTIFICATION ACT, THE CALIFORNIA FAIR EMPLOYMENT AND HOUSING ACT, THE FAMILY AND MEDICAL LEAVE ACT, THE CALIFORNIA FAMILY RIGHTS ACT, THE CALIFORNIA LABOR CODE, CLAIMS RELATING TO EMPLOYMENT OR INDEPENDENT CONTRACTOR STATUS, CLASSIFICATION AND RELATIONSHIP WITH THE COMPANY, AND CLAIMS OF HARASSMENT, DISCRIMINATION,  WRONGFUL TERMINATION, AND BREACH OF CONTRACT, EXCEPT AS PROHIBITED BY LAW. CONSULTANT ALSO AGREES TO ARBITRATE ANY AND ALL DISPUTES ARISING OUT OF OR RELATING TO THE INTERPRETATION OR APPLICATION OF THIS AGREEMENT TO ARBITRATE, BUT NOT TO DISPUTES ABOUT THE ENFORCEABILITY, REVOCABILITY OR VALIDITY OF THIS AGREEMENT TO ARBITRATE OR ANY PORTION HEREOF OR THE CLASS, COLLECTIVE AND REPRESENTATIVE PROCEEDING WAIVER HEREIN.  WITH RESPECT TO ALL SUCH CLAIMS AND DISPUTES THAT CONSULTANT AGREES TO ARBITRATE, CONSULTANT HEREBY EXPRESSLY AGREES TO WAIVE, AND DOES WAIVE, ANY RIGHT TO A TRIAL BY JURY.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">CONSULTANT FURTHER UNDERSTANDS THAT THIS AGREEMENT TO ARBITRATE ALSO APPLIES TO ANY DISPUTES THAT THE COMPANY MAY HAVE WITH CONSULTANT. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:25pt">Procedure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> CONSULTANT AGREES THAT ANY ARBITRATION WILL BE ADMINISTERED BY JUDICIAL ARBITRATION &#38; MEDIATION SERVICES, INC. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">JAMS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES &#38; PROCEDURES (THE &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">JAMS RULES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), WHICH ARE AVAILABLE AT </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">HTTP&#58;&#47;&#47;WWW.JAMSADR.COM&#47;RULES-EMPLOYMENT-ARBITRATION&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> AND FROM HUMAN RESOURCES.  CONSULTANT AGREES THAT THE ARBITRATOR SHALL HAVE THE POWER TO DECIDE ANY MOTIONS BROUGHT BY ANY PARTY TO THE ARBITRATION, INCLUDING MOTIONS FOR SUMMARY JUDGMENT AND&#47;OR ADJUDICATION AND MOTIONS TO DISMISS AND DEMURRERS APPLYING THE STANDARDS SET FORTH UNDER THE CALIFORNIA CODE OF CIVIL PROCEDURE. CONSULTANT AGREES THAT THE ARBITRATOR SHALL ISSUE A WRITTEN DECISION ON THE MERITS. CONSULTANT ALSO AGREES THAT THE ARBITRATOR SHALL HAVE THE POWER TO AWARD ANY REMEDIES AVAILABLE UNDER APPLICABLE LAW, AND THAT THE ARBITRATOR SHALL AWARD ATTORNEYS&#8217; FEES AND COSTS TO THE PREVAILING PARTY WHERE PROVIDED BY APPLICABLE LAW.  CONSULTANT AGREES THAT THE DECREE OR AWARD RENDERED BY THE ARBITRATOR MAY BE ENTERED AS A FINAL AND BINDING JUDGMENT IN ANY COURT HAVING JURISDICTION THEREOF. CONSULTANT AGREES THAT THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH CALIFORNIA LAW, INCLUDING THE CALIFORNIA CODE OF CIVIL PROCEDURE AND THE CALIFORNIA EVIDENCE CODE, AND THAT THE ARBITRATOR SHALL APPLY SUBSTANTIVE AND PROCEDURAL CALIFORNIA LAW TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO RULES OF CONFLICT OF LAW.  TO THE EXTENT THAT THE JAMS RULES CONFLICT WITH CALIFORNIA LAW, CALIFORNIA LAW SHALL TAKE PRECEDENCE.  CONSULTANT FURTHER AGREES THAT ANY ARBITRATION UNDER THIS CONSULTING AGREEMENT SHALL BE CONDUCTED IN SANTA CLARA COUNTY, CALIFORNIA. </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">-7-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:81pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:25pt">Remedy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> EXCEPT AS PROVIDED BY THE CCP ACT AND THIS CONSULTING AGREEMENT, ARBITRATION SHALL BE THE SOLE, EXCLUSIVE, AND FINAL REMEDY FOR ANY DISPUTE BETWEEN CONSULTANT AND THE COMPANY.  ACCORDINGLY, EXCEPT AS PROVIDED FOR BY THE CCP ACT AND THIS CONSULTING AGREEMENT, NEITHER CONSULTANT NOR THE COMPANY WILL BE PERMITTED TO PURSUE COURT ACTION REGARDING CLAIMS THAT ARE SUBJECT TO ARBITRATION. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:24.34pt">Availability of Injunctive Relief</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> IN ACCORDANCE WITH RULE 1281.8 OF THE CALIFORNIA CODE OF CIVIL PROCEDURE, THE PARTIES AGREE THAT ANY PARTY MAY ALSO PETITION THE COURT FOR INJUNCTIVE RELIEF WHERE EITHER PARTY ALLEGES OR CLAIMS A VIOLATION OF ANY AGREEMENT REGARDING INTELLECTUAL PROPERTY, CONFIDENTIAL INFORMATION OR NONINTERFERENCE.  IN THE EVENT EITHER PARTY SEEKS INJUNCTIVE RELIEF, THE PREVAILING PARTY SHALL BE ENTITLED TO RECOVER REASONABLE COSTS AND ATTORNEYS&#8217; FEES.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:25.67pt">Administrative Relief.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> CONSULTANT UNDERSTANDS THAT EXCEPT AS PERMITTED BY LAW THIS CONSULTING AGREEMENT DOES NOT PROHIBIT CONSULTANT FROM PURSUING CERTAIN ADMINISTRATIVE CLAIMS WITH LOCAL, STATE OR FEDERAL ADMINISTRATIVE BODIES OR GOVERNMENT AGENCIES SUCH AS THE DEPARTMENT OF FAIR EMPLOYMENT AND HOUSING, THE EQUAL EMPLOYMENT OPPORTUNITY COMMISSION, THE NATIONAL LABOR RELATIONS BOARD, OR THE WORKERS&#8217; COMPENSATION BOARD.  THIS CONSULTING AGREEMENT DOES, HOWEVER, PRECLUDE CONSULTANT FROM BRINGING ANY ALLEGED WAGE CLAIMS WITH THE DEPARTMENT OF LABOR STANDARDS ENFORCEMENT.  LIKEWISE, THIS CONSULTING AGREEMENT DOES PRECLUDE CONSULTANT FROM PURSUING COURT ACTION REGARDING ANY ADMINISTRATIVE CLAIMS, EXCEPT AS PERMITTED BY LAW.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">F.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:26.33pt">Voluntary Nature of Agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> CONSULTANT ACKNOWLEDGES AND AGREES THAT HE IS EXECUTING THIS CONSULTING AGREEMENT VOLUNTARILY AND WITHOUT ANY DURESS OR UNDUE INFLUENCE BY THE COMPANY OR ANYONE ELSE.  CONSULTANT FURTHER ACKNOWLEDGES AND AGREES THAT HE HAS CAREFULLY READ THIS CONSULTING AGREEMENT AND THAT CONSULTANT HAS ASKED ANY QUESTIONS NEEDED FOR CONSULTANT TO UNDERSTAND THE TERMS, CONSEQUENCES AND BINDING EFFECT OF THIS CONSULTING AGREEMENT AND FULLY UNDERSTAND IT, INCLUDING THAT </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">CONSULTANT IS WAIVING HIS RIGHT TO A JURY TRIAL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  FINALLY, CONSULTANT AGREES THAT HE HAS BEEN PROVIDED AN OPPORTUNITY TO SEEK THE ADVICE OF AN ATTORNEY OF CONSULTANT&#8217;S CHOICE BEFORE SIGNING THIS CONSULTING AGREEMENT.</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">-8-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:81pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21pt">Miscellaneous</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:24.34pt">Governing Law&#59; Consent to Personal Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> This Consulting Agreement shall be governed by the laws of the State of California, without regard to the conflicts of law provisions of any jurisdiction.  To the extent that any lawsuit is permitted under this Consulting Agreement, the Parties hereby expressly consent to the personal and exclusive jurisdiction and venue of the state and federal courts located in California.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:25pt">Assignability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> This Consulting Agreement will be binding upon Consultant&#8217;s heirs, executors, assigns, administrators, and other legal representatives, and will be for the benefit of the Company, its successors, and its assigns.  There are no intended third-party beneficiaries to this Consulting Agreement, except as expressly stated.  Except as may otherwise be provided in this Consulting Agreement, Consultant may not sell, assign or delegate any rights or obligations under this Consulting Agreement. Notwithstanding anything to the contrary herein, Company may assign this Consulting Agreement and its rights and obligations under this Consulting Agreement to any successor to all or substantially all of Company&#8217;s relevant assets, whether by merger, consolidation, reorganization, reincorporation, sale of assets or stock, change of control or otherwise.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:25pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> This Consulting Agreement, together with the Separation Agreement, Equity Documents, and Confidentiality Agreement, constitutes the entire agreement and understanding between the Parties with respect to the subject matter herein and supersedes all prior written and oral agreements, discussions, or representations between the Parties, with the exception of the Separation Agreement, Equity Documents and Confidentiality Agreement.  Consultant represents and warrants that he is not relying on any statement or representation not contained in this Consulting Agreement.  To the extent any terms set forth in any exhibit or schedule conflict with the terms set forth in this Consulting Agreement, the terms of this Consulting Agreement shall control unless otherwise expressly agreed by the Parties in such exhibit or schedule.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:24.34pt">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Headings are used in this Consulting Agreement for reference only and shall not be considered when interpreting this Consulting Agreement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:25.67pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> If a court or other body of competent jurisdiction finds, or the Parties mutually believe, any provision of this Consulting Agreement, or portion thereof, to be invalid or unenforceable, such provision will be enforced to the maximum extent permissible so as to effect the intent of the Parties, and the remainder of this Consulting Agreement will continue in full force and effect. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">F.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:26.33pt">Modification, Waiver.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">No modification of or amendment to this Consulting Agreement, nor any waiver of any rights under this Consulting Agreement, will be effective unless in a writing signed by the Parties.  Waiver by the Company of a breach of any provision of this Consulting Agreement will not operate as a waiver of any other or subsequent breach.</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">-9-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:81pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">G.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:24.34pt">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Any notice or other communication required or permitted by this Consulting Agreement to be given to a Party shall be in writing and shall be deemed given (i)&#160;if delivered personally or by commercial messenger or courier service, (ii)&#160;when sent by confirmed facsimile, or (iii)&#160;if mailed by U.S. registered or certified mail (return receipt requested), to the Party at the Party&#8217;s address written below or at such other address as the Party may have previously specified by like notice.  If by mail, delivery shall be deemed effective three business days after mailing in accordance with this Section&#160;11.G.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.02pt">If to the Company, to&#58;</font></div><div style="text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">2625 Augustine Drive</font></div><div style="text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Santa Clara, CA  95054</font></div><div style="text-align:justify;text-indent:144pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Attention&#58; General Counsel</font></div><div style="text-align:justify;text-indent:144pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.02pt">If to Consultant, to the address for notice on the signature page to this Consulting Agreement or, if no such address is provided, to the last address of Consultant provided by Consultant to the Company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">H.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:24.34pt">Attorneys&#8217; Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> In any court action at law or equity that is brought by one of the Parties to this Consulting Agreement to enforce or interpret the provisions of this Consulting Agreement, the prevailing Party will be entitled to reasonable attorneys&#8217; fees, in addition to any other relief to which that Party may be entitled.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:29.01pt">Signatures.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">This Consulting Agreement may be signed in two counterparts, each of which shall be deemed an original, with the same force and effectiveness as though executed in a single document.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">J.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:28.34pt">Applicability to Past Activities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.   Consultant agrees that if and to the extent that Consultant provided any services or made efforts on behalf of or for the benefit of Company, or related to the current or prospective business of Company in anticipation of Consultant&#8217;s involvement with the Company, that would have been &#8220;Services&#8221; if performed during the term of this Consulting Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Prior Consulting Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) and to the extent that during the Prior Consulting Period&#58; (i)&#160;Consultant received access to any information from or on behalf of Company that would have been &#8220;Confidential Information&#8221; if Consultant received access to such information during the term of this Consulting Agreement&#59; or (ii)&#160;Consultant (a) conceived, created, authored, invented, developed or reduced to practice any item (including any intellectual property rights with respect thereto) on behalf of or for the benefit of Company, or related to the current or prospective business of Company in anticipation of Consultant&#8217;s involvement with Company, that would have been an Invention if conceived, created, authored, invented, developed or reduced to practice during the term of this Consulting Agreement&#59; or (b) incorporated into any such item any pre-existing invention, improvement, development, concept, discovery or other proprietary information that would have been a Prior Invention if incorporated into such item during the term of this Consulting Agreement&#59; then any such information shall be deemed Confidential Information hereunder and any such item shall be deemed an Invention or Prior Invention hereunder, and this Consulting Agreement shall apply to such activities, information or item as if disclosed, conceived, created, authored, invented, developed or reduced to practice during the term of this Consulting Agreement.  </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">-10-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:81pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Consultant further acknowledges that Consultant has been fully compensated for all services provided during any such Prior Consulting Period.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">signature page follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">)</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">-11-</font></div></div></div><div id="i5c11a8b6e5b54ef3b24f757153ebe13c_10"></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">IN WITNESS WHEREOF, the Parties hereto have executed this Consulting Agreement as of the Effective Date set forth above.</font></div><div style="margin-bottom:12pt;margin-top:24pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">CONSULTANT&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;EHEALTH, INC.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">&#47;s&#47; Scott N. Flanders&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Scott Giesler&#160;&#160;&#160;&#160;</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Scott N. Flanders&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Scott Giesler&#160;&#160;&#160;&#160;</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Title&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">SVP&#160;&#160;&#160;&#160;</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Address for Notice&#58;</font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i5c11a8b6e5b54ef3b24f757153ebe13c_13"></div><hr style="page-break-after:always"><div style="min-height:107.56pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">EXHIBIT&#160;1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">SERVICES AND COMPENSATION</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:27pt">Contact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> Consultant&#8217;s principal Company contact&#58;</font></div><div style="padding-left:90pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Fran Soistman</font></div><div style="padding-left:90pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Title&#58;   </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Chief Executive Officer</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:27pt">Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. The Services will include, but will not be limited to, the following&#58;</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:24.34pt">Consultant will provide transitional assistance to the Company with respect to the transition of his duties and responsibilities as Chief Executive Officer of the Company.  Services to be provided shall not exceed eight (8) hours per week.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:25pt">Consultant&#8217;s services will commence immediately following the Termination Date, and terminate as of December&#160;31,&#160;2021 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Scheduled End Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), unless earlier terminated under Section 6.B. of the Consulting Agreement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:27pt">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:24.34pt;text-decoration:underline">Consulting Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The Company will provide Consultant with consulting fee payments equal to $58,333.33 per month during the Consulting Term, paid on a monthly basis, and a final consulting payment equal to $146,232.88 within thirty (30) days following the final day of the Consulting Term. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:25pt;text-decoration:underline">Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive&#8217;s Equity Awards will be governed by the terms and conditions of the Equity Documents (and Deferral Election, as applicable), as well as the terms and conditions of the Separation Agreement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:25pt;text-decoration:underline">Expense Reimbursements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The Company will reimburse Consultant, in accordance with Company policy, for all reasonable expenses incurred by Consultant in performing the Services pursuant to this Consulting Agreement, if Consultant receives written consent from an authorized agent of the Company prior to incurring such expenses and submits receipts for such expenses to the Company in accordance with Company policy.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Exhibit 1 to Consulting Agreement</font></div></div></div><div id="i5c11a8b6e5b54ef3b24f757153ebe13c_16"></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT C</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">EXECUTIVE EQUITY AWARDS</font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.865%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Equity Award Type</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Grant Date</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Number of Shares Subject to Equity Award at Grant</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Number of Underlying Vested Shares as of Termination Date</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Number of Underlying Unvested Shares as of Termination Date</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">PRSU</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">6&#47;14&#47;21</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">13,250 (target)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">13,250</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">PRSU</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3&#47;17&#47;21</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">18,984</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">18,984 (6,328 represent the &#8220;Achieved PRSUs&#8221;)</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">PRSU</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3&#47;17&#47;21</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">18,984 (target)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">18,984</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">RSU</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3&#47;17&#47;21</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">37,968</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">37,968</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">PRSU</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4&#47;21&#47;20</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">24,500</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">PRSU</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4&#47;21&#47;20</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">65,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">RSU</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4&#47;21&#47;20</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">24,500</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">6,125</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">18,375</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">PRSU</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">10&#47;15&#47;19</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">15,834</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">PRSU</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">4&#47;16&#47;19</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">29,166</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">PRSU (Deferred)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">3&#47;30&#47;18</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">167,500</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">167,500 vested&#59;  163,770 to be released subject to terms of the Deferral Election<font style="font-size:7.8pt;position:relative;top:-4.2pt;vertical-align:baseline">1</font></font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">PRSU (Deferred)</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">6&#47;3&#47;16</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">200,000</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">200,000 vested&#59;  195,546 to be released subject to terms of the Deferral Election</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td></tr></table></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> All awards expressed with this formulation have already had a small number of shares released for tax withholding purposes.</font></div><div style="height:62.77pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Exhibit B to Separation Agreement</font></div></div></div><hr style="page-break-after:always"><div style="min-height:85.96pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.865%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">RSU (Deferred)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">6&#47;3&#47;16</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">100,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">100,000 vested&#59;  98,886 to be released subject to terms of the Deferral Election</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">NQ Stock Options</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">6&#47;3&#47;16</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">150,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">150,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">NQ Perf Stock Options</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">6&#47;3&#47;16</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">150,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">150,000</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">RSU (Deferred)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">6&#47;4&#47;15</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">505</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">505 vested&#59;  438 to be released subject to terms of the Deferral Election</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">RSU (Deferred)</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">6&#47;4&#47;15</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">7,370</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">7,370 vested and to be released subject to terms of the Deferral Election</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">0</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:62.77pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">-2-</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.8
<SEQUENCE>4
<FILENAME>exhibit108christinejanofsk.htm
<DESCRIPTION>EX-10.8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia2d547a0744542c99ac61fbd728a3b0f_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">EHEALTH, INC.<br>SEVERANCE AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">&#160;&#160;&#160;&#160;This Severance Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) is by and between </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">eHealth, Inc</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. (together with its subsidiary, eHealthInsurance Services, Inc., the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) and Christine Janofsky (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive and the Company agree that Executive&#8217;s employment with Company constitutes &#8220;at-will&#8221; employment.  Executive and the Company acknowledge that this employment relationship may be terminated at any time, upon written notice to the other party, with or without Cause or Good Reason (as each such term is defined in Section 4 below), at the option either of the Company or Executive.  However, as described in this Agreement, Executive may be entitled to severance benefits depending upon the circumstances of Executive&#8217;s termination of employment.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:22.02pt">Involuntary Termination Other than for Cause or Voluntary Termination for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  If (i) Executive terminates his employment with the Company (or any parent or subsidiary of the Company) for &#8220;Good Reason&#8221; (as defined herein), or (ii) the Company (or any parent or subsidiary of the Company) terminates Executive&#8217;s employment for other than &#8220;Cause&#8221; (as defined herein), and Executive signs and does not revoke a standard release of claims with the Company in a form substantially similar to that attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), then Executive shall receive the following severance benefits from the Company&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:24.69pt">Severance Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive shall receive a single lump-sum cash severance payment (less applicable withholding taxes) in an amount equal to twelve (12) months of Executive&#8217;s then current annual base salary.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:21.36pt">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Subject to Executive timely electing continuation coverage under Title X of the Consolidated Budget Reconciliation Act of 1985 (&#8220;COBRA&#8221;), Executive shall receive one-hundred percent (100%) Company-paid group health, dental and vision coverage (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Company-Paid Coverage</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;). If such coverage included Executive&#8217;s dependents immediately prior to the termination, such dependents shall also be covered at Company expense. Company-Paid Coverage shall continue until the earlier of (i) twelve (12) months following the date of termination, or (ii) the date upon which Executive and his dependents become covered under another employer&#8217;s group health, dental and vision plans that provide Executive and his dependents with comparable benefits and levels of coverage (such earlier date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">COBRA Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).  Notwithstanding the foregoing, if the Company determines, in its sole discretion, that it cannot provide the Company-Paid Coverage without a substantial risk of violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company shall in lieu thereof provide to Executive a taxable monthly payment in an amount equal to the monthly COBRA premium that Executive would be required to pay to continue Executive&#8217;s (and Executive&#8217;s dependents&#8217;, as applicable) group health, dental and vision coverage in effect on the date of Executive&#8217;s employment termination (which amount shall be based on the premium for the first month of COBRA coverage), </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;1.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">which payments shall be made to Executive regardless of whether Executive elects COBRA continuation coverage and shall end on the COBRA Termination Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21.35pt">Involuntary Termination Other than for Cause or Voluntary Termination for Good Reason During the One-Year Period Following a Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  If (i) Executive terminates his employment with the Company (or any parent or subsidiary of the Company) for &#8220;Good Reason&#8221; (as defined herein), or (ii) the Company (or any parent or subsidiary of the Company) terminates Executive&#8217;s employment for other than &#8220;Cause&#8221; (as defined herein) during the one-year period following a Change in Control, and Executive signs and does not revoke the Release, then in addition to the severance benefits provided in Section 2(a) above, Executive shall receive the following severance benefits from the Company&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:24.69pt">Bonus Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive shall receive a single lump-sum cash payment (less applicable withholding taxes) in an amount equal to one hundred percent (100%) of Executive&#8217;s then current target annual bonus.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%;padding-left:21.36pt">Equity Award Vesting.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  One hundred percent (100%) of Executive&#8217;s then outstanding and unvested time-based equity awards (whether stock options, stock appreciation rights, shares of restricted stock, restricted stock units or otherwise) shall become vested and shall otherwise remain subject to the terms and conditions of the applicable equity incentive plan and the award agreements pursuant to which the time-based equity awards were granted. Executive&#8217;s then outstanding and unvested performance-based equity awards, shall vest in accordance with the terms of the applicable equity incentive plan and the award agreements pursuant to which the performance-based equity awards were granted and not pursuant to the terms of this Agreement.  For the avoidance of doubt, all performance-based equity awards, including those where performance goals have been achieved but which remain subject to time-based vesting, shall not be considered time-based awards under the terms of this Agreement and shall be governed by the applicable incentive plan and the award agreements pursuant to which the performance-based equity awards were granted.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:22.7pt">Voluntary Resignation&#59; Termination for Cause&#59; Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  If Executive&#8217;s employment with the Company terminates (i) voluntarily by Executive other than for Good Reason (ii) for Cause by the Company, or (iii) due to Executive&#8217;s death or Disability (as defined hereunder), then Executive shall not be entitled to receive severance or other benefits except for those (if any) as may then be established under the Company&#8217;s then existing severance and benefits plans and practices or pursuant to other written agreements with the Company.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21.35pt">Exclusive Remedy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The provisions of this Section 2 are intended to be and are Executive&#8217;s exclusive rights to severance payments and benefits in the event of termination of service.  The parties hereto agree that nothing herein is intended to result in duplication of severance or any other benefits.</font></div><div style="margin-bottom:12pt;padding-left:4.5pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:18.2pt">Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;2.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:24.69pt">Any amount paid under this Agreement that satisfies the requirements of the &#8220;short-term deferral&#8221; rule set forth in Section 1.409A-l(b)(4) of the regulations issued under Section 409A of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Treasury Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) shall not constitute Deferred Compensation Separation Benefits for purposes of Section 2(e)(ii) below, and consequently shall be paid to Executive promptly following termination as otherwise required by this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21.36pt">Notwithstanding anything to the contrary in this Agreement, if Executive is a &#8220;specified employee&#8221; within the meaning of Section 409A of the Code, and the final regulations and any guidance promulgated thereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) at the time of Executive&#8217;s separation from service (as such term is defined in Section 409A), then the cash severance benefits payable to Executive under this Agreement along with any other severance payments or separation benefits that may be considered deferred compensation under Section 409A (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Deferred Compensation Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) that are otherwise due to Executive on or within the six (6) month period following Executive&#8217;s separation from service shall accrue during such six (6) month period and shall become payable in a lump sum payment on the date six (6) months and one (1) day following the date of Executive&#8217;s separation from service.  All subsequent payments, if any, shall be payable in accordance with the payment schedule applicable to each payment or benefit.  Notwithstanding anything herein to the contrary, if Executive dies following his separation from service but prior to the six (6) month anniversary of his date of separation from service, then any payments delayed in accordance with this Section shall be payable in a lump sum as soon as administratively practicable after the date of Executive&#8217;s death and all other Deferred Compensation Separation Benefits shall be payable in accordance with the payment schedule applicable to each payment or benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:18.03pt">Any amount paid under this Agreement that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-l(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit (as defined below) shall not constitute Deferred Compensation Separation Benefits for purposes of Section 2(e)(ii) above.  For purposes of this Section 2(e), &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Section 409A Limit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; will mean the lesser of two (2) times&#58; (i) Executive&#8217;s annualized compensation based upon the annual rate of pay paid to Executive during the Company&#8217;s taxable year preceding the Company&#8217;s taxable year of Executive&#8217;s termination of employment as determined under Treasury Regulation 1.409A-l(b)(9)(iii)(A)(l)&#59; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which Executive&#8217;s employment is terminated.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:18.69pt">It is the intent of this Agreement to comply with the requirements of Section 409A so that none of the severance payments and benefits to be provided hereunder shall be subject to the additional tax imposed under Section 409A, and any ambiguities herein shall be interpreted to so comply.  The Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition under Section 409A prior to actual payment to Executive.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;3.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.02pt">Notwithstanding any other provisions of this Agreement, Executive&#8217;s receipt of severance payments and benefits under this Agreement is conditioned upon Executive signing and not revoking the Release and subject to the Release becoming effective within sixty (60) days following Executive&#8217;s termination of employment (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Release Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).  No severance will be paid or provided unless the Release becomes effective during the Release Period.  Any severance payments to which Executive is entitled under this Agreement shall be paid by the Company to Executive in cash and in full arrears on the date on which the Release becomes effective or such later date as is required to comply with Section 409A&#59; provided however, that if the Release Period straddles two calendar years, the severance payments to which Executive is entitled under this Agreement shall be paid on the latest of (A) the date on which the Release becomes effective, (B) the first business day of the calendar year following the year in which Executive terminates employment with the Company or (C) such later date as is required to comply with Section 409A. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:18.69pt">With respect to reimbursements or in-kind benefits provided to Executive hereunder (or otherwise) that are not exempt from Section 409A, the following rules shall apply&#58; (A) the amount of expenses eligible for reimbursement, or in-kind benefits provided, during any one of Executive&#8217;s taxable years shall not affect the expenses eligible for reimbursement, or in-kind benefit to be provided in any other taxable year, (B) in the case of any reimbursements of eligible expenses, reimbursement shall be made on or before the last day of Executive&#8217;s taxable year following the taxable year in which the expense was incurred and (C) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Golden Parachute Excise Tax Best Results</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  If any payment or benefit Executive would receive pursuant to this Agreement or otherwise (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) would (i) constitute a &#8220;parachute payment&#8221; within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), then such Payment shall be reduced to the Reduced Amount.  The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Reduced Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; shall be either (x) the largest portion of the Payment that would result in no portion of the Payment being subject to the Excise Tax or (y) the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in Executive&#8217;s receipt, on an after-tax basis, of the greater amount of the Payment notwithstanding that all or some portion of the Payment may be subject to the Excise Tax.  If a reduction in payments or benefits constituting &#8220;parachute payments&#8221; is necessary so that the Payment equals the Reduced Amount, reduction shall occur in the following order&#58; (A) cash payments shall be reduced first and in reverse chronological order such that the cash payment owed on the latest date following the occurrence of the event triggering such excise tax will be the first cash payment to be reduced&#59; (B) accelerated vesting of stock awards shall be cancelled&#47;reduced next and in the reverse order of the date of grant for such stock awards (i.e., the vesting of the most recently granted stock awards will be reduced first)&#59; and (C) employee benefits shall be reduced last and in reverse chronological order such that the benefit owed on the latest date following the occurrence of the event triggering such excise tax will be the first benefit to be reduced.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;4.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The Company shall appoint a nationally recognized accounting firm or consulting firm to make the determinations required hereunder and perform the foregoing calculations.  The Company shall bear all expenses with respect to the determinations by such accounting or consulting firm required to be made hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">The accounting or consulting firm engaged to make the determinations hereunder shall provide its calculations, together with detailed supporting documentation, to the Company and Executive within fifteen (15) calendar days after the date on which right to a Payment is triggered (if requested at that time by the Company or Executive) or such other time as requested by the Company or Executive.  If the accounting or consulting firm determines that no Excise Tax is payable with respect to a Payment, either before or after the application of the Reduced Amount, it shall furnish the Company and Executive with an opinion reasonably acceptable to Executive that no Excise Tax will be imposed with respect to such Payment.  Any good faith determinations of the accounting or consulting firm made hereunder shall be final, binding and conclusive upon the Company and Executive.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Definition of Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The following terms referred to in this Agreement shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:22.02pt">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; shall mean (i) Executive&#8217;s commission of any act of fraud, embezzlement or dishonesty, (ii) Executive&#8217;s conviction of, or plea of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">nolo contendere</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> to, a felony under the laws of the United States or any state thereof, (iii) Executive&#8217;s continued failure to perform lawfully assigned duties for 30 days after receiving written notification from the  Company, (iv) Executive&#8217;s unauthorized use or disclosure of confidential information or trade secrets of the Company, or (v) any other intentional misconduct by Executive that adversely affects the business of the Company in a material manner.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21.35pt">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; means the occurrence of any of the following, in one or a series of related transactions&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:24.69pt">Any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company&#8217;s then outstanding voting securities&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21.36pt">The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:18.03pt">The consummation of the sale, lease or other disposition by the Company of all or substantially all the Company&#8217;s assets.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;5.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:22.7pt">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; means Executive (i) is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, or (ii) is, by reason of any medically determinable physical or mental impairment which can be expected to last for a continuous period of not less than twelve (12) months, receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering Company employees,</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21.35pt">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; means that Executive resigns his employment within 120 days after any of the following is undertaken by the Company (or its acquirer) without Executive&#8217;s express written consent&#58; (i) a reduction in Executive&#8217;s title, (ii) a material reduction of Executive&#8217;s duties, authority or responsibilities&#59; (ii) any material reduction of Executive&#8217;s base salary or potential target bonus (other than a proportionate reduction in Executive&#8217;s base salary or potential bonus that affects all senior management of the Company)&#59; or (iii) a material change in the geographic location at which Executive must perform services&#59; provided that in no instance will the relocation of Executive to a facility or location of thirty-five (35) miles or less from either the Company&#8217;s office located at 2625 Augustine Drive, Santa Clara, California or the Company&#8217;s then current office location in San Francisco, California, or from Executive&#8217;s then current office location (or one of Executive&#8217;s then-current office locations, if applicable) be deemed material for purposes of this Agreement&#59; provided, however, that Good Reason shall not exist unless Executive has provided written notice to the Board of Directors of the purported grounds for the Good Reason within 90 days of its initial existence and the Company has been provided at least 30 days to remedy the condition.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:22.02pt">The Company&#8217;s Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company&#8217;s business and&#47;or assets shall assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession.  For all purposes under this Agreement, the term &#8220;Company&#8221; shall include any successor to the Company&#8217;s business and&#47;or assets which executes and delivers the assumption agreement described in this Section 5(a) or which becomes bound by the terms of this Agreement by operation of law.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21.35pt">Executive&#8217;s Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The terms of this Agreement and all rights of Executive hereunder shall inure to the benefit of, and be enforceable by, Executive&#8217;s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  All notices and other communications required or permitted hereunder shall be in writing, shall be effective when given, and shall in any event be deemed to be given upon receipt or, if earlier, (a) five (5) days after deposit with the U.S. Postal Service or other applicable postal service, if delivered by first class mail, postage prepaid, (b) upon delivery, if delivered by hand, (c) one (1) business day after the business day of deposit with Federal Express or similar overnight courier, freight prepaid, (d) one (1) business day after the business day of facsimile transmission, if delivered by facsimile transmission with copy by first class mail, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;6.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">postage prepaid, (e) upon transmission, if sent by email, and shall be addressed (i) if to Executive, at his or her last known residential address or email address and (ii) if to the Company, at the address of its principal corporate offices (attention&#58; Secretary), or in any such case at such other address as a party may designate by ten (10) days&#8217; advance written notice to the other party pursuant to the provisions above.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Notice of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Any termination by the Company for Cause or by Executive for Good Reason or as a result of a voluntary resignation shall be communicated by a notice of termination to the other party hereto given in accordance with Section 6 of this Agreement.  Such notice shall indicate the specific termination provision in this Agreement relied upon, shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so indicated, and shall specify the termination date (which shall be not more than thirty (30) days after the giving of such notice).  The failure by Executive to include in the notice any fact or circumstance which contributes to a showing of Good Reason shall not waive any right of Executive hereunder or preclude Executive from asserting such fact or circumstance in enforcing his or her rights hereunder.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:22.02pt">No Duty to Mitigate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive shall not be required to mitigate the amount of any payment contemplated by this Agreement, nor shall any such payment be reduced by any earnings that Executive may receive from any other source.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21.35pt">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  No provision of this Agreement shall be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive).  No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:22.7pt">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21.35pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  This Agreement represents the entire agreement between Executive and the Company regarding Executive&#8217;s severance agreement with the Company, and supersede in their entirety all prior representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied), of the parties with respect to the subject matter hereof.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:22.7pt">Choice of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of California (with the exception of its conflict of laws provisions).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:24.03pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision hereof, which shall remain in full force and effect.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;7.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:22.02pt">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  All payments made pursuant to this Agreement will be subject to withholding of applicable income and employment taxes.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21.35pt">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together will constitute one and the same instrument.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;8.</font></div></div></div><div id="ia2d547a0744542c99ac61fbd728a3b0f_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">In Witness Whereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, each of the parties has executed this amended and restated Agreement, in the case of the Company by its duly authorized officer, as of the last date signed below.</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">COMPANY<br><br>eHealth, Inc.</font></div><div style="margin-bottom:12pt;margin-top:36pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">  &#47;s&#47; Scott Flanders&#160;&#160;&#160;&#160;<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">          Scott Flanders<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Title&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline"> Chief Executive Officer&#160;&#160;&#160;&#160;<br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline"> Sep 19, 2021&#160;&#160;&#160;&#160;</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%"><br>EXECUTIVE</font></div><div style="margin-bottom:36pt;margin-top:24pt;padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline"> &#47;s&#47; Christine Janofsky&#160;&#160;&#160;&#160;<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">          Christine Janofsky</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline"> Sep 19, 2021&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;9.</font></div></div></div><div id="ia2d547a0744542c99ac61fbd728a3b0f_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Exhibit A<br><br>eHealth, Inc.<br>Release of Claims</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">This Release of Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) is made by and between eHealth, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), and _______________ (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Whereas</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, Executive has agreed to enter into a release of claims in favor of the Company upon certain events specified in the Severance Agreement by and between Company and Executive (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Severance Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Now Therefore</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, in consideration of the mutual promises made herein, the Parties hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive&#8217;s employment from the Company terminated on ___________________________.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive shall continue to maintain the confidentiality of all confidential and proprietary information of the Company and shall continue to comply with the terms and conditions of the Proprietary Information and Inventions Agreement between Executive and the Company.  Executive shall return all the Company property and confidential and proprietary information in his possession to the Company on the Effective Date of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Payment of Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive acknowledges and represents that the Company has paid all salary, wages, bonuses, accrued vacation, commissions and any and all other benefits due to Executive.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Release of Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Except as set forth in the last paragraph of this Section 4, Executive agrees that the foregoing consideration represents settlement in full of all outstanding obligations owed to Executive by the Company.  Executive, on behalf of himself, and his respective heirs, family members, executors and assigns, hereby fully and forever releases the Company and its past, present and future officers, agents, directors, employees, investors, shareholders, administrators, affiliates, divisions, subsidiaries, parents, predecessor and successor corporations, and assigns, from, and agrees not to sue or otherwise institute or cause to be instituted any legal or administrative proceedings concerning any claim, duty, obligation or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that he may possess arising from any omissions, acts or facts that have occurred up until and including the Effective Date of this Agreement including, without limitation,</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.02pt">any and all claims relating to or arising from Executive&#8217;s employment relationship with the Company and the termination of that relationship&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21.35pt">any and all claims relating to, or arising from, Executive&#8217;s right to purchase, or actual purchase of shares of stock of the Company, including, without limitation, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;1.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.7pt">any and all claims for wrongful discharge of employment&#59; termination in violation of public policy&#59; discrimination&#59; breach of contract, both express and implied&#59; breach of a covenant of good faith and fair dealing, both express and implied&#59; promissory estoppel&#59; negligent or intentional infliction of emotional distress&#59; negligent or intentional misrepresentation&#59; negligent or intentional interference with contract or prospective economic advantage&#59; unfair business practices&#59; defamation&#59; libel&#59; slander&#59; negligence&#59; personal injury&#59; assault&#59; battery&#59; invasion of privacy&#59; false imprisonment&#59; and conversion&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21.35pt">any and all claims for violation of any federal, state or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act of 1990, the Fair Labor Standards Act, Executive Retirement Income Security Act of 1974, The Worker Adjustment and Retraining Notification Act, the California Fair Employment and Housing Act, and Labor Code section 201, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. and section 970, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">et seq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. and all amendments to each such Act as well as the regulations issued thereunder&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.7pt">any and all claims for violation of the federal, or any state, constitution&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:24.03pt">any and all claims arising out of any other laws and regulations relating to employment or employment discrimination&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.02pt">any and all claims for attorneys&#8217; fees and costs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Executive agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released.  This release does not extend to any severance obligations due Executive under the Severance Agreement or to any vested rights to benefits Executive has under any employee benefit plans of the Company.  Nothing in this Agreement waives Executive&#8217;s rights to indemnification or any payments under any fiduciary or directors &#38; officers insurance policy, if any, provided by any act or agreement of the Company, state or federal law or policy of insurance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Acknowledgment of Waiver of Claims under ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive acknowledges that he is waiving and releasing any rights he may have under the Age Discrimination in Employment Act of 1967 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) and that this waiver and release is knowing and voluntary.  Executive and the Company agree that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the Effective Date of this Agreement, Executive acknowledges that the consideration given for this waiver and release Agreement is in addition to anything of value to which Executive was already entitled.  Executive further acknowledges that he has been advised by this writing that (a) he should consult with an attorney prior to executing this Agreement&#59; (b) he has at least twenty-one (21) days within which to consider this Agreement&#59; (c) he has seven (7) days following the execution of this Agreement by the parties to revoke the Agreement&#59; (d) this Agreement shall not be effective until the revocation period has expired&#59; and (e) nothing in this Agreement prevents or precludes Executive from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties or costs for doing so, unless specifically authorized by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;2.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">federal law.  Any revocation should be in writing and delivered to the Vice-President of Human Resources at the Company by close of business on the seventh day from the date that Executive signs this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Civil Code Section 1542</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive represents that he is not aware of any claims against the Company other than the claims that are released by this Agreement.  Executive acknowledges that he has been advised by legal counsel and is familiar with the provisions of California Civil Code 1542, below, which provides as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Executive, being aware of said code section, agrees to expressly waive any rights he may have thereunder, as well as under any statute or common law principles of similar effect.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">No Pending or Future Lawsuits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive represents that he has no lawsuits, claims, or actions pending in his name, or on behalf of any other person or entity, against the Company or any other person or entity referred to herein.  Executive also represents that he does not intend to bring any claims on his own behalf or on behalf of any other person or entity against the Company or any other person or entity referred to herein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">Application for Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive understands and agrees that, as a condition of this Agreement, he shall not be entitled to any employment with the Company, its subsidiaries, or any successor, and he hereby waives any right, or alleged right, of employment or re-employment with the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:27pt">No Cooperation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive agrees that he will not counsel or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against the Company and&#47;or any officer, director, employee, agent, representative, shareholder or attorney of the Company, unless under a subpoena or other court order to do so.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21pt">No Admission of Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  No action taken by the Company, either previously or in connection with this Agreement shall be deemed or construed to be (a) an admission of the truth or falsity of any claims heretofore made or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to Executive or to any third party.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21pt">Costs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The Parties shall each bear their own costs, expert fees, attorneys&#8217; fees and other fees incurred in connection with this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21pt">Authority</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive represents and warrants that he has the capacity to act on his own behalf and on behalf of all who might claim through him to bind them to the terms and conditions of this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;3.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21pt">No Representations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Executive represents that he has had the opportunity to consult with an attorney, and has carefully read and understands the scope and effect of the provisions of this Agreement.  Neither party has relied upon any representations or statements made by the other party hereto which are not specifically set forth in this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21pt">Arbitration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  THE PARTIES AGREE THAT ANY AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS AGREEMENT, THEIR INTERPRETATION, AND ANY OF THE MATTERS HEREIN RELEASED, SHALL BE SUBJECT TO ARBITRATION IN SANTA CLARA COUNTY, BEFORE JUDICIAL ARBITRATION &#38; MEDIATION SERVICES, INC. (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">JAMS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES &#38; PROCEDURES (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">JAMS RULES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).  THE ARBITRATOR MAY GRANT INJUNCTIONS AND OTHER RELIEF IN SUCH DISPUTES.  THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH CALIFORNIA LAW, INCLUDING THE CALIFORNIA CODE OF CIVIL PROCEDURE, AND THE ARBITRATOR SHALL APPLY SUBSTANTIVE AND PROCEDURAL CALIFORNIA LAW TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO ANY CONFLICT-OF-LAW PROVISIONS OF ANY JURISDICTION.  TO THE EXTENT THAT THE JAMS RULES CONFLICT WITH CALIFORNIA LAW, CALIFORNIA LAW SHALL TAKE PRECEDENCE.  THE DECISION OF THE ARBITRATOR SHALL BE FINAL, CONCLUSIVE, AND BINDING ON THE PARTIES TO THE ARBITRATION.  THE PARTIES AGREE THAT THE PREVAILING PARTY IN ANY ARBITRATION SHALL BE ENTITLED TO INJUNCTIVE RELIEF IN ANY COURT OF COMPETENT JURISDICTION TO ENFORCE THE ARBITRATION AWARD.  THE PARTIES TO THE ARBITRATION SHALL EACH PAY AN EQUAL SHARE OF THE COSTS AND EXPENSES OF SUCH ARBITRATION, AND EACH PARTY SHALL SEPARATELY PAY FOR ITS RESPECTIVE COUNSEL FEES AND EXPENSES&#59; PROVIDED, HOWEVER, THAT THE ARBITRATOR SHALL AWARD ATTORNEYS&#8217; FEES AND COSTS TO THE PREVAILING PARTY, EXCEPT AS PROHIBITED BY LAW.  THE PARTIES HEREBY AGREE TO WAIVE THEIR RIGHT TO HAVE ANY DISPUTE BETWEEN THEM RESOLVED IN A COURT OF LAW BY A JUDGE OR JURY.  NOTWITHSTANDING THE FOREGOING, THIS SECTION WILL NOT PREVENT EITHER PARTY FROM SEEKING INJUNCTIVE RELIEF (OR ANY OTHER PROVISIONAL REMEDY) FROM ANY COURT HAVING JURISDICTION OVER THE PARTIES AND THE SUBJECT MATTER OF THEIR DISPUTE RELATING TO THIS AGREEMENT AND THE AGREEMENTS INCORPORATED HEREIN BY REFERENCE.  SHOULD ANY PART OF THE ARBITRATION AGREEMENT CONTAINED IN THIS PARAGRAPH CONFLICT WITH ANY OTHER ARBITRATION AGREEMENT BETWEEN THE PARTIES, THE PARTIES AGREE THAT THIS ARBITRATION AGREEMENT SHALL GOVERN.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">16.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  This Agreement, along with the Severance Agreement, the Proprietary Information and Inventions Agreement, and Executive&#8217;s written equity compensation agreements with the Company, represents the entire agreement and understanding between the Company and Executive concerning Executive&#8217;s separation from the Company.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;4.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">17.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21pt">No Oral Modification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  This Agreement may only be amended in writing signed by Executive and the Chief Executive Officer of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">18.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21pt">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  This Agreement shall be governed by the internal substantive laws, but not the choice of law rules, of the State of California.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">19.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21pt">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  This Agreement is effective eight (8) days after it has been signed by both Parties.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">20.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21pt">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  This Agreement may be executed in counterparts, and each counterpart shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">21.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:21pt">Voluntary Execution of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  This Agreement is executed voluntarily and without any duress or undue influence on the part or behalf of the Parties hereto, with the full intent of releasing all claims.  The Parties acknowledge that&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.02pt">They have read this Agreement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21.35pt">They have had the opportunity of being represented in the preparation, negotiation, and execution of this Agreement by legal counsel of their own choice or that they have voluntarily declined to seek such counsel&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.7pt">They understand the terms and consequences of this Agreement and of the releases it contains&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:21.35pt">They are fully aware of the legal and binding effect of this Agreement.</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;5.</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">In Witness Whereof</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, the Parties have executed this Agreement on the respective dates set forth below.</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">eHealth, Inc.</font></div><div style="margin-bottom:12pt;margin-top:36pt;padding-left:216pt;text-indent:-216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Dated&#58;  &#160;&#160;&#160;&#160;By&#58;&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">&#160;&#160;&#160;&#160;                         <br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">&#91;name, title&#93;</font></div><div style="margin-bottom:12pt;margin-top:36pt;padding-left:216pt;text-indent:-216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Dated&#58;  &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;                        <br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">&#91;name&#93;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;6.</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>5
<FILENAME>exhibit109johnpierantonise.htm
<DESCRIPTION>EX-10.9
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i071e6eb34b954bdc8e3b83809b2dd227_1"></div><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:right;text-indent:36pt"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">eHealthInsurance Services, Inc.<br>2625 Augustine Drive, Second Floor<br>Santa Clara, CA 95054</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">June 5, 2020</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">John Pierantoni</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Dear John&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">I am pleased to offer you a severance agreement with eHealthInsurance Services, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) based on the terms described in this letter agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Letter</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) and the attached </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> (which is incorporated by reference and is made part of this Letter).  Unless otherwise defined in this Letter, capitalized terms will have the meanings that are provided in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">If your employment with the Company is terminated by the Company without Cause and other than due to death or Disability,&#160;then subject to the additional terms and conditions described in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, you will receive continued payment of your base salary as in effect immediately prior to the termination of your employment with the Company, for a period of six (6)&#160;months following the termination of your employment with the Company, payable in accordance with the Company&#8217;s normal payroll practices (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Salary Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).</font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">All payments made under this Letter will be subject to withholding of applicable income, employment and other taxes.  This Letter supersedes any agreement concerning similar subject matter dated prior to the date of this Letter.  This Letter will be governed by the laws of the State of California (with the exception of its conflict of laws provisions).  The invalidity or unenforceability of any provision of this Letter will not affect the validity or enforceability of any other provision of this Letter, which will remain in full force and effect.  This Letter may be modified only by a writing executed by you and a duly authorized officer of the Company (other than you).  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;To accept this Letter, please date and sign this Letter below where indicated.  If you do not accept this Letter by June 7, 2020, this Letter will not become effective.  </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;We thank you for your continued service to the Company. </font></div><div><font><br></font></div><div style="text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Sincerely,</font></div><div style="text-indent:252pt"><font><br></font></div><div style="padding-left:216pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Christina Hoffman</font></div><div style="text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Chief People Officer </font></div><div style="text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">eHealthInsurance Services, Inc.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">8480566_2.docx</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">__________________</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">By signing this Letter, I acknowledge that I have read this Letter carefully and understand its terms and that I enter into this Letter knowingly and voluntarily&#59; and I agree to and accept all the terms set forth in this Letter. </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Agreed and Accepted&#58; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;John Pierantoni</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Dated&#58; 6&#47;5&#47;20&#160;&#160;&#160;&#160;&#47;s&#47; John Pierantoni</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-2-</font></div></div></div><div id="i071e6eb34b954bdc8e3b83809b2dd227_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:right;text-indent:36pt"><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">APPENDIX A</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Any capitalized terms not defined in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> will have the meaning provided in the Letter to which this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> is attached.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:24.34pt">Release of Claims Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%;padding-left:22.02pt;text-decoration:underline">Release Deadline</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The receipt of any severance payments or benefits under the Letter and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) is subject to your signing and not revoking the Company&#8217;s then-standard separation agreement and release of claims (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), which must become effective and irrevocable no later than the sixtieth (60th)&#160;day following the termination of your employment (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Release Deadline Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;).  If the Release does not become effective and irrevocable by the Release Deadline Date, you&#160;will forfeit any right to the Severance Benefits.  In no event will Severance Benefits be paid or provided, or in the case of installments, begin, until the Release actually becomes effective and irrevocable.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%;padding-left:22.02pt;text-decoration:underline">Payment Timing Following Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  If the Release becomes effective and irrevocable by the Release Deadline Date, then in each case subject to Section&#160;B below, the Severance Benefits will be paid, or in the case of installments, will begin, on the date that the Release becomes effective and irrevocable, provided that if the Release Deadline Date occurs in the calendar year following the calendar year in which the termination of your employment occurs, then the Severance Benefits will be paid, or in the case of installments, will begin, on the later of (a)&#160;the date on which the Release becomes effective and irrevocable, or (b)&#160;the first business day of the calendar year immediately following the calendar year in which the termination of your employment occurred (such payment date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Severance Start Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;), but in no event later than March 15th of the calendar year following the calendar year in which the termination of your employment occurs, and any Severance Benefits otherwise payable to you during the period immediately following the termination of your employment with the Company through the Severance Start Date will be paid in a lump sum to you on the Severance Start Date, with any remaining payments to be made as provided in the Letter (or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, as applicable). </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">B.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:25pt">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.02pt">Notwithstanding anything to the contrary in the Letter or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix&#160;A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, no Severance Benefits to be paid or provided to you, if any, when considered together with any other severance payments or separation benefits, are considered deferred compensation under Section 409A of the Code, and the final regulations and any guidance promulgated thereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Section&#160;409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;)&#160;(together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Deferred Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;)&#160;will be paid or otherwise provided until you have a &#8220;separation from service&#8221; within the meaning of Section 409A.  Similarly, no Severance Benefits payable to you, if any, that otherwise would be exempt from Section 409A pursuant to Treasury Regulation Section&#160;1.409A-1(b)(9)&#160;will be payable until you have a &#8220;separation from service&#8221; within the meaning of Section 409A.  Notwithstanding the provisions set forth in Section&#160;A above, provided that the Release becomes effective and irrevocable in accordance with Section&#160;A, in the event that the termination of your employment occurs at a time </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">during the calendar year when the Release could become effective in the calendar year immediately following the calendar year in which the termination of your employment occurs (regardless of which calendar year the Release actually becomes effective and irrevocable), then any Severance Benefits that would be considered Deferred Payments that otherwise are payable between the date of termination of your employment and the Release Deadline Date will be paid, or in the case of installments, will commence, on the Release Deadline Date, and any remaining or other Severance Benefits will be paid in accordance with their payment schedule as provided in the Letter and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.02pt">It is intended that none of the Severance Benefits will constitute Deferred Payments but rather will be exempt from Section&#160;409A as a payment that would fall within the &#8220;short-term deferral period&#8221; as described in subsection (4) below or resulting from an involuntary separation from service as described in subsection (5)&#160;below.  In no event will you have discretion to determine the taxable year of payment of any Deferred Payment.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.02pt"> Notwithstanding anything to the contrary in the Letter or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, if you are a &#8220;specified employee&#8221; within the meaning of Section 409A at the time of your separation from service (other than due to death), then the Deferred Payments, if any, that are payable within the first six (6)&#160;months following your separation from service, will become payable on the first payroll date that occurs on or after the date six (6)&#160;months and one (1)&#160;day following the date of your separation from service.  All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.  Notwithstanding anything herein to the contrary, in the event of your death following your separation from service, but before the six (6)&#160;month anniversary of the separation from service, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of your death and all other Deferred Payments will be payable in accordance with the payment schedule applicable to each payment or benefit.  Each payment and benefit payable under the Letter and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> is intended to constitute a separate payment under Section&#160;1.409A-2(b)(2)&#160;of the Treasury Regulations.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.02pt"> Any amount paid under the Letter or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> that satisfies the requirements of the &#8220;short-term deferral&#8221; rule set forth in Section 1.409A-1(b)(4)&#160;of the Treasury Regulations will not constitute Deferred Payments for purposes of subsection&#160;(1) above.</font></div><div style="margin-top:12pt;padding-right:-9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.02pt"> Any amount paid under the Letter or this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section&#160;1.409A-1(b)(9)(iii)&#160;of the Treasury Regulations that does not exceed the Section 409A Limit (as defined below)&#160;will not constitute Deferred Payments for purposes of subsection&#160;(1) above.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:22.02pt">The foregoing provisions are intended to comply with or be exempt from the requirements of Section 409A so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section&#160;409A, and any ambiguities or ambiguous terms herein will be interpreted to so comply or be exempt.  For purposes of the Letter and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">, to the extent required to be exempt from or comply with Section&#160;409A, references to the &#8220;termination of your employment&#8221; or similar phrases will be references to your &#8220;separation from service&#8221; within the meaning of Section&#160;409A.  The </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Company and you agree to work together in good faith to consider amendments to the Letter and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition before actual payment to you under Section&#160;409A.  In no event will the Company reimburse you for any taxes imposed or other costs incurred as result of Section 409A.   </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">C.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:24.34pt">Limitation on Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  In the event that the Severance Benefits or other payments and benefits payable or provided to you (i)&#160;constitute &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">parachute payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; within the meaning of Section&#160;280G of the Code and (ii)&#160;but for this Section&#160;C, would be subject to the excise tax imposed by Section&#160;4999 of the Code, then your Severance Benefits or other payments or benefits (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">280G Amounts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) will be either&#58; (x) delivered in full, or (y) delivered as to such lesser extent which would result in no portion of such benefits being subject to excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by you on an after-tax basis, of the greatest amount of 280G Amounts, notwithstanding that all or some portion of the 280G&#160;Amounts may be taxable under Section&#160;4999 of the Code.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%;padding-left:22.02pt;text-decoration:underline">Reduction Order</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  In the event that a reduction of 280G Amounts is being made in accordance with this Section&#160;C, the reduction will occur, with respect to the 280G&#160;Amounts considered parachute payments within the meaning of Section&#160;280G of the Code, in the following order&#58; (a) reduction of cash payments in reverse chronological order (that is, the cash payment owed on the latest date following the occurrence of the event triggering the excise tax will be the first cash payment to be reduced)&#59; (b)&#160;cancellation of equity awards that were granted &#8220;contingent on a change in ownership or control&#8221; within the meaning of Code Section 280G in the reverse order of date of grant of the awards (that is, the most recently granted equity awards will be cancelled first)&#59; (c)&#160;reduction of the accelerated vesting of equity awards in the reverse order of date of grant of the awards (that is, the vesting of the most recently granted equity awards will be cancelled first)&#59; and (d)&#160;reduction of employee benefits in reverse chronological order (that is, the benefit owed on the latest date following the occurrence of the event triggering the excise tax will be the first benefit to be reduced).</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">In no event will you have any discretion with respect to the ordering of payments. </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%;padding-left:22.02pt;text-decoration:underline">Calculations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  Unless the Company and you otherwise agree in writing, any determination required under this Section C will be made in writing by a nationally recognized accounting or valuation firm (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Firm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221;) selected by the Company, whose determination will be conclusive and binding upon you and the Company for all purposes.  For purposes of making the calculations required by this Section, the Firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code.  The Company and you will furnish to the Firm such information and documents as the Firm may reasonably request in order to make a determination under this Section. The Company will bear all costs and make all payments for the Firm&#8217;s services relating to any calculations contemplated by this Section.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-5-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:0.12pt;text-indent:0.36pt"><font><br></font></div></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">D.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:24.34pt">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The following terms referred to in the Letter and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> will have the following meanings&#58;</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%;padding-left:22.02pt;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; will mean&#58; (a)&#160;your commission of any act of fraud, embezzlement or dishonesty, (b)&#160;your being convicted of, or your plea of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%">nolo contendere</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> to, a felony under the laws of the United States or any state thereof, (iii) your continued failure to perform lawfully assigned duties for thirty (30) days after receiving written notification from the Company, (iv) your unauthorized use or disclosure of confidential information or trade secrets of the Company, or (v) any other intentional misconduct by you that adversely affects the business of the Company in a material manner.  The foregoing definition does not in any way limit the Company&#8217;s ability to terminate your employment relationship at any time, and the term &#8220;Company&#8221; will be interpreted to include any subsidiary, parent, affiliate or successor thereto, if applicable.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%;padding-left:22.02pt;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">. &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; will mean the Internal Revenue Code of 1986, as amended.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%;padding-left:22.02pt;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; will mean your inability to perform the essential functions of your job due to a permanent and total disability as defined under Section&#160;22(e)(3) of the Code.</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%;padding-left:22.02pt;text-decoration:underline">Section 409A Limit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:115%">Section 409A Limit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8221; will mean two (2)&#160;times the lesser of&#58; (i)&#160;your annualized compensation based upon the annual rate of pay paid to you during your taxable year preceding your taxable year of your termination of employment as determined under, and with such adjustments as are set forth in, Treasury Regulation Section&#160;1.409A1(b)(9)(iii)(A)(1)&#160;and any Internal Revenue Service guidance issued with respect thereto&#59; or (ii)&#160;the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17)&#160;of the Code for the year in which your employment is terminated.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">E.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:25pt">Exclusive Remedy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  The Letter and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> are intended to be and are exclusive and in lieu of and supersede any other rights or remedies to which you may be entitled, whether at law, tort or contract, in equity, or under the Letter and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> (other than the payment of accrued and unpaid wages, as required by law, and any unreimbursed reimbursable expenses).  You will be entitled to no benefits, compensation or other payments or rights upon a termination of your employment other than those expressly set forth in the Letter and this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Appendix A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">-6-</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>a2021q3ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="if77d0149b2bf422e8013277662f17601_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-top:5pt;text-align:right;text-indent:72pt"><font><br></font></div><div style="margin-top:5pt;text-align:right;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Francis Soistman, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of eHealth, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;FRANCIS SOISTMAN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Francis Soistman</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>a2021q3ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i82291fb9172c4b53bb7824afb6de8a51_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Christine Janofsky, certify that&#58;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of eHealth, Inc.&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; CHRISTINE JANOFSKY</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Janofsky</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer <br>(Principal Financial Officer)</font></td></tr></table></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>a2021q3ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie8ab54fad8cc47f7a8e3a5fbea891792_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Chief Executive Officer, Pursuant to</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. Section 1350,</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As Adopted Pursuant to</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 906 of the Sarbanes-Oxley Act of 2002&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of eHealth, Inc. on Form 10-Q (the &#8220;Form 10-Q&#8221;) for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Francis Soistman, Chief Executive Officer of eHealth, Inc., certify, pursuant to 18 U.S.C.&#160;Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58; &#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Form 10-Q, to which this certification is attached as Exhibit&#160;32.1, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and &#160;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of eHealth, Inc.</font></div><div style="margin-top:10pt"><font><br></font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.051%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;FRANCIS SOISTMAN</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Francis Soistman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer<br></font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2021</font></td></tr></table></div><div style="padding-left:9pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to eHealth, Inc. and will be retained by eHealth, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>a2021q3ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i34317014b73545c6a39a2ae01416cddc_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial Officer, Pursuant to</font></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. Section 1350,</font></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As Adopted Pursuant to</font></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 906 of the Sarbanes-Oxley Act of 2002&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of eHealth, Inc. on Form 10-Q (the &#8220;Form 10-Q&#8221;) for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Christine Janofsky, Chief Financial Officer (Principal Financial Officer) of eHealth, Inc., certify, pursuant to 18 U.S.C.&#160;Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Form 10-Q, to which this certification is attached as Exhibit&#160;32.2, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and &#160;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of eHealth, Inc.</font></div><div style="margin-top:10pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.410%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; CHRISTINE JANOFSKY</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christine Janofsky</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer<br>(Principal Financial Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 8, 2021</font></td></tr></table></div><div style="text-indent:9pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to eHealth, Inc. and will be retained by eHealth, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>ehth-20210930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:001ee10b-2bdc-4177-8047-00c9b0c2bbeb,g:3e9ca025-a681-404c-b475-c1976cd6b86b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ehth="http://www.ehealthinsurance.com/20210930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ehealthinsurance.com/20210930">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehth-20210930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehth-20210930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehth-20210930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehth-20210930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.ehealthinsurance.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" roleURI="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofBusinessandSignificantAccountingPolicies" roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Summary of Business and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofBusinessandSignificantAccountingPoliciesPolicies" roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Summary of Business and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2403401 - Disclosure - Summary of Business and Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.ehealthinsurance.com/role/Revenue">
        <link:definition>2104102 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.ehealthinsurance.com/role/RevenueTables">
        <link:definition>2305301 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregationofRevenueDetails" roleURI="http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails">
        <link:definition>2406402 - Disclosure - Revenue - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueCommissionRevenuebySegmentDetails" roleURI="http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails">
        <link:definition>2407403 - Disclosure - Revenue - Commission Revenue by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformation" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation">
        <link:definition>2108103 - Disclosure - Supplemental Financial Statement Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformationTables" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables">
        <link:definition>2309302 - Disclosure - Supplemental Financial Statement Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>2410404 - Disclosure - Supplemental Financial Statement Information- Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformationNarrativeDetails" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails">
        <link:definition>2411405 - Disclosure - Supplemental Financial Statement Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails">
        <link:definition>2412406 - Disclosure - Supplemental Financial Statement Information - Schedule of Allowance for Credit Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails">
        <link:definition>2413407 - Disclosure - Supplemental Financial Statement Information - Schedule of Commissions Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformationScheduleofCreditRiskDetails" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails">
        <link:definition>2414408 - Disclosure - Supplemental Financial Statement Information - Schedule of Credit Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails">
        <link:definition>2415409 - Disclosure - Supplemental Financial Statement Information - Schedule of Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurements">
        <link:definition>2116104 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsTables">
        <link:definition>2317303 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsSummaryofFinancialAssetsDetails" roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails">
        <link:definition>2418410 - Disclosure - Fair Value Measurements - Summary of Financial Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsContractualMaturitiesDetails" roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails">
        <link:definition>2419411 - Disclosure - Fair Value Measurements - Contractual Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsUnrealizedGainsandLossesDetails" roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails">
        <link:definition>2420412 - Disclosure - Fair Value Measurements - Unrealized Gains and Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsUnrealizedGainsandLossesDetails_1" roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1">
        <link:definition>2420412 - Disclosure - Fair Value Measurements - Unrealized Gains and Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2421413 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Equity" roleURI="http://www.ehealthinsurance.com/role/Equity">
        <link:definition>2122105 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTables" roleURI="http://www.ehealthinsurance.com/role/EquityTables">
        <link:definition>2323304 - Disclosure - Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityNarrativeDetails" roleURI="http://www.ehealthinsurance.com/role/EquityNarrativeDetails">
        <link:definition>2424414 - Disclosure - Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityScheduleofStockBasedCompensationExpenseDetails" roleURI="http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails">
        <link:definition>2425415 - Disclosure - Equity - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredStock" roleURI="http://www.ehealthinsurance.com/role/ConvertiblePreferredStock">
        <link:definition>2126106 - Disclosure - Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredStockTables" roleURI="http://www.ehealthinsurance.com/role/ConvertiblePreferredStockTables">
        <link:definition>2327305 - Disclosure - Convertible Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredStockNarrativeDetails" roleURI="http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails">
        <link:definition>2428416 - Disclosure - Convertible Preferred Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertiblePreferredStockSummaryofStockDetails" roleURI="http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails">
        <link:definition>2429417 - Disclosure - Convertible Preferred Stock - Summary of Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAttributabletoCommonStockholders" roleURI="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholders">
        <link:definition>2130107 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAttributabletoCommonStockholdersTables" roleURI="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersTables">
        <link:definition>2331306 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails" roleURI="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails">
        <link:definition>2432418 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails" roleURI="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails">
        <link:definition>2433419 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Anti-Dilutive Shares Excluded from Computation Of Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingencies">
        <link:definition>2134108 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesTables" roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables">
        <link:definition>2335307 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2436420 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformation" roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformation">
        <link:definition>2137109 - Disclosure - Segment and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationTables" roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables">
        <link:definition>2338308 - Disclosure - Segment and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationSegmentOperatingResultsDetails" roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails">
        <link:definition>2439421 - Disclosure - Segment and Geographic Information - Segment Operating Results (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails" roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails">
        <link:definition>2440422 - Disclosure - Segment and Geographic Information - Schedule Of Long-Lived Assets By Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails" roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails">
        <link:definition>2441423 - Disclosure - Segment and Geographic Information - Schedule of Revenue by Major Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.ehealthinsurance.com/role/Leases">
        <link:definition>2142110 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.ehealthinsurance.com/role/LeasesTables">
        <link:definition>2343309 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.ehealthinsurance.com/role/LeasesNarrativeDetails">
        <link:definition>2444424 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalInformationDetails" roleURI="http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails">
        <link:definition>2445425 - Disclosure - Leases - Supplemental Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails" roleURI="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>2446426 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>2446426 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandReorganization" roleURI="http://www.ehealthinsurance.com/role/RestructuringandReorganization">
        <link:definition>2147111 - Disclosure - Restructuring and Reorganization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandReorganizationTables" roleURI="http://www.ehealthinsurance.com/role/RestructuringandReorganizationTables">
        <link:definition>2348310 - Disclosure - Restructuring and Reorganization (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandReorganizationRestructuringandOtherLiabilitiesDetails" roleURI="http://www.ehealthinsurance.com/role/RestructuringandReorganizationRestructuringandOtherLiabilitiesDetails">
        <link:definition>2449427 - Disclosure - Restructuring and Reorganization - Restructuring and Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringandReorganizationNarrativeDetails" roleURI="http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails">
        <link:definition>2450428 - Disclosure - Restructuring and Reorganization - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.ehealthinsurance.com/role/Debt">
        <link:definition>2151112 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDetails" roleURI="http://www.ehealthinsurance.com/role/DebtDetails">
        <link:definition>2452429 - Disclosure - Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.ehealthinsurance.com/role/IncomeTaxes">
        <link:definition>2153113 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesTables">
        <link:definition>2354311 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofIncomeTaxBenefitDetails" roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails">
        <link:definition>2455430 - Disclosure - Income Taxes - Summary of Income Tax Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2456431 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ehth_DescriptionOfBusinessPolicyPolicyTextBlock" abstract="false" name="DescriptionOfBusinessPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember" abstract="true" name="EligibleCommissionsReceivablesPrecedingThreeMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_NonQualifiedHealthPlansMember" abstract="true" name="NonQualifiedHealthPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_OverRecognitionOfLicensingCostsMember" abstract="true" name="OverRecognitionOfLicensingCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_VisionMember" abstract="true" name="VisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" abstract="false" name="DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_AetnaMember" abstract="true" name="AetnaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" abstract="false" name="TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" abstract="false" name="LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_ConvertiblePreferredStockThresholdTradingDays" abstract="false" name="ConvertiblePreferredStockThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_SeasonalityPolicyPolicyTextBlock" abstract="false" name="SeasonalityPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ehth_CreditAgreementAmendmentMember" abstract="true" name="CreditAgreementAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities" abstract="false" name="CashCashEquivalentsAndAvailableForSaleDebtSecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_DisaggregatedOtherAxis" abstract="true" name="DisaggregatedOtherAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ehth_DisaggregatedMedicareAxis" abstract="true" name="DisaggregatedMedicareAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ehth_LineOfCreditFacilityCovenantMinimumLiquidity" abstract="false" name="LineOfCreditFacilityCovenantMinimumLiquidity" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis" abstract="false" name="ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" abstract="false" name="CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" abstract="false" name="CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_ChangeInContractWithCustomerAssetRollForward" abstract="true" name="ChangeInContractWithCustomerAssetRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors" abstract="false" name="ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ehth_DisaggregatedIndividualandFamilyAxis" abstract="true" name="DisaggregatedIndividualandFamilyAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ehth_ConvertiblePreferredStockCovenantLiquidity" abstract="false" name="ConvertiblePreferredStockCovenantLiquidity" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_TechnologyAndContentExpenseMember" abstract="false" name="TechnologyAndContentExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_CustomerCareAndEnrollmentExpense" abstract="false" name="CustomerCareAndEnrollmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember" abstract="true" name="EligibleCommissionsReceivablesSucceedingThreeMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_CommissionMembersApprovedInPriorPeriodsMember" abstract="true" name="CommissionMembersApprovedInPriorPeriodsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_LineOfCreditFacilityBorrowingBasePercentage" abstract="false" name="LineOfCreditFacilityBorrowingBasePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ehth_CommissionMember" abstract="true" name="CommissionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" abstract="false" name="CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_NumberOfHealthInsuranceCarriers" abstract="false" name="NumberOfHealthInsuranceCarriers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ehth_CommissionBonusMember" abstract="true" name="CommissionBonusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_DisaggregatedOtherDomain" abstract="true" name="DisaggregatedOtherDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_CustomerCareAndEnrollmentExpenseMember" abstract="false" name="CustomerCareAndEnrollmentExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_CommissionMembersApprovedDuringCurrentPeriodMember" abstract="true" name="CommissionMembersApprovedDuringCurrentPeriodMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" abstract="false" name="ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ehth_UnitedhealthcareMember" abstract="false" name="UnitedhealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock" abstract="false" name="ScheduleOfStockBasedCompensationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger" abstract="false" name="ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ehth_EchelonHealthSPCLPHIGMember" abstract="true" name="EchelonHealthSPCLPHIGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_SmallBusinessMember" abstract="true" name="SmallBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare" abstract="false" name="ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ehth_IndividualandFamilyMember" abstract="true" name="IndividualandFamilyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_DisaggregatedAncillariesDomain" abstract="true" name="DisaggregatedAncillariesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_IndividualFamilyAndSmallBusinessSegmentsMember" abstract="true" name="IndividualFamilyAndSmallBusinessSegmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_AccruedMarketingExpenses" abstract="false" name="AccruedMarketingExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_PreferredStockDividendRateCashPercentage" abstract="false" name="PreferredStockDividendRateCashPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ehth_PrepaidLicenses" abstract="false" name="PrepaidLicenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_MedicareSegmentMember" abstract="true" name="MedicareSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays" abstract="false" name="ConvertiblePreferredStockThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ehth_IncreaseDecreaseInAccruedMarketingExpenses" abstract="false" name="IncreaseDecreaseInAccruedMarketingExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_LeViasCompliantMember" abstract="true" name="LeViasCompliantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_MedicareAdvantageMember" abstract="true" name="MedicareAdvantageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_MedicareMember" abstract="true" name="MedicareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_IncreaseDecreaseInCommissionsReceivable" abstract="false" name="IncreaseDecreaseInCommissionsReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice" abstract="false" name="ConvertiblePreferredStockRedemptionCallRightWrittenNotice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ehth_DisaggregatedIndividualandFamilyDomain" abstract="true" name="DisaggregatedIndividualandFamilyDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors" abstract="false" name="CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ehth_QualifiedHealthPlansMember" abstract="true" name="QualifiedHealthPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_SegmentOperatingIncomeLoss" abstract="false" name="SegmentOperatingIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" abstract="false" name="ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember" abstract="true" name="EligibleCommissionsReceivablesSucceedingSixMonthsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_UnderRecognitionOfStockBasedCompensationExpenseMember" abstract="true" name="UnderRecognitionOfStockBasedCompensationExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_DisaggregatedMedicareDomain" abstract="true" name="DisaggregatedMedicareDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_BorrowingBasePercentageAxis" abstract="true" name="BorrowingBasePercentageAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ehth_ConvertiblePreferredStockVotesPerShare" abstract="false" name="ConvertiblePreferredStockVotesPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ehth_PreferredStockDividendRatePayableInKindPercentage" abstract="false" name="PreferredStockDividendRatePayableInKindPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ehth_IncrementalCommonSharesAttributableToOptions" abstract="false" name="IncrementalCommonSharesAttributableToOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_HumanaMember" abstract="false" name="HumanaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_MedicareSupplementMember" abstract="true" name="MedicareSupplementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_CenteneMember" abstract="true" name="CenteneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_LineOfCreditFacilityCovenantMaximumLiquidity" abstract="false" name="LineOfCreditFacilityCovenantMaximumLiquidity" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" abstract="false" name="LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" abstract="false" name="IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" abstract="false" name="RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ehth_RestructuringChargesPreTax" abstract="false" name="RestructuringChargesPreTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_AncillariesMember" abstract="true" name="AncillariesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_MedicarePartDMember" abstract="true" name="MedicarePartDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_BorrowingBasePercentageDomain" abstract="true" name="BorrowingBasePercentageDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_CommissionRevenueFromRenewalsMember" abstract="true" name="CommissionRevenueFromRenewalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_PreviousRepurchaseProgramsMember" abstract="true" name="PreviousRepurchaseProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_SaleOfStockConsiderationReceivedOnTransactionGross" abstract="false" name="SaleOfStockConsiderationReceivedOnTransactionGross" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_LineOfCreditFacilityFacilityFeePercentage" abstract="false" name="LineOfCreditFacilityFacilityFeePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ehth_OutOfPeriodAdjustmentsMember" abstract="true" name="OutOfPeriodAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_PreferredStockConvertibleStatedValue" abstract="false" name="PreferredStockConvertibleStatedValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="ehth_PrepaidMaintenanceContractsCurrent" abstract="false" name="PrepaidMaintenanceContractsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_ShorttermMember" abstract="true" name="ShorttermMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_MiscellaneousOtherMember" abstract="true" name="MiscellaneousOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio" abstract="false" name="ConvertiblePreferredStockCovenantAssetCoverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt" abstract="false" name="ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ehth_SponsorshipAndAdvertisingMember" abstract="true" name="SponsorshipAndAdvertisingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_ContractualObligationToBePaidAfterYearFour" abstract="false" name="ContractualObligationToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" abstract="false" name="AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ehth_DentalMember" abstract="true" name="DentalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ehth_DisaggregatedAncillariesAxis" abstract="true" name="DisaggregatedAncillariesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ehth_TechnologyAndContentExpense" abstract="false" name="TechnologyAndContentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>ehth-20210930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:001ee10b-2bdc-4177-8047-00c9b0c2bbeb,g:3e9ca025-a681-404c-b475-c1976cd6b86b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ehth-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e39734c0-3318-45ce-940a-0d1d72bade10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d6d28a98-ecfb-4ba3-aa52-870917e766b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e39734c0-3318-45ce-940a-0d1d72bade10" xlink:to="loc_us-gaap_CommonStockValue_d6d28a98-ecfb-4ba3-aa52-870917e766b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1276289c-e949-4b8c-a9ae-0a961c898ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e39734c0-3318-45ce-940a-0d1d72bade10" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1276289c-e949-4b8c-a9ae-0a961c898ef5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_e068832c-2c51-4cc9-a479-9f77f7fe8a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e39734c0-3318-45ce-940a-0d1d72bade10" xlink:to="loc_us-gaap_TreasuryStockValue_e068832c-2c51-4cc9-a479-9f77f7fe8a68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9f1d900a-fbd6-42bd-baf8-e916a6d2567b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e39734c0-3318-45ce-940a-0d1d72bade10" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9f1d900a-fbd6-42bd-baf8-e916a6d2567b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2205ee72-4367-4efa-ad1a-34f6f536ff85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e39734c0-3318-45ce-940a-0d1d72bade10" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2205ee72-4367-4efa-ad1a-34f6f536ff85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1adfd70d-d719-48c2-a579-c2bd64a4102b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ff552c57-6d9d-402d-9f70-4c8c4f5d7efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1adfd70d-d719-48c2-a579-c2bd64a4102b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ff552c57-6d9d-402d-9f70-4c8c4f5d7efc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8700e6c8-2911-45c4-8420-4bd5c9765c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1adfd70d-d719-48c2-a579-c2bd64a4102b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_8700e6c8-2911-45c4-8420-4bd5c9765c7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_10e96e65-5ef7-4aa5-a07c-e90c5ada7ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1adfd70d-d719-48c2-a579-c2bd64a4102b" xlink:to="loc_us-gaap_LiabilitiesCurrent_10e96e65-5ef7-4aa5-a07c-e90c5ada7ed3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_233baf8a-72b2-47d4-9543-ceffa396a5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1adfd70d-d719-48c2-a579-c2bd64a4102b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_233baf8a-72b2-47d4-9543-ceffa396a5f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_82235231-1fa3-4a9b-8fc2-6a695d8587e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dd75e0d8-cbc4-4f63-8825-2a5ad6d1a0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_82235231-1fa3-4a9b-8fc2-6a695d8587e4" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dd75e0d8-cbc4-4f63-8825-2a5ad6d1a0e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f69e50ff-d823-48d8-adda-87c7c2031879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_82235231-1fa3-4a9b-8fc2-6a695d8587e4" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f69e50ff-d823-48d8-adda-87c7c2031879" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e957a146-4494-4af5-87c6-094e83d66ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_82235231-1fa3-4a9b-8fc2-6a695d8587e4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e957a146-4494-4af5-87c6-094e83d66ce3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_72d0ca96-88b8-444d-887b-d38fb4733757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_82235231-1fa3-4a9b-8fc2-6a695d8587e4" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_72d0ca96-88b8-444d-887b-d38fb4733757" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_b0e1f03b-f12f-4cdf-a2d6-1b737156c8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_82235231-1fa3-4a9b-8fc2-6a695d8587e4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_b0e1f03b-f12f-4cdf-a2d6-1b737156c8a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b10b65f6-8b98-46ab-b2d7-3401baf38ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9f8dac6d-46f4-4bcc-8a56-97c656390f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b10b65f6-8b98-46ab-b2d7-3401baf38ee5" xlink:to="loc_us-gaap_StockholdersEquity_9f8dac6d-46f4-4bcc-8a56-97c656390f3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_40c12a23-1d27-4ef7-a2b8-cecb81fc169d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b10b65f6-8b98-46ab-b2d7-3401baf38ee5" xlink:to="loc_us-gaap_Liabilities_40c12a23-1d27-4ef7-a2b8-cecb81fc169d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_980a2e07-1410-44cb-a45d-1f2484736041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b10b65f6-8b98-46ab-b2d7-3401baf38ee5" xlink:to="loc_us-gaap_CommitmentsAndContingencies_980a2e07-1410-44cb-a45d-1f2484736041" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_13082469-e1dd-4733-bbe0-8dd16b6b5726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b10b65f6-8b98-46ab-b2d7-3401baf38ee5" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_13082469-e1dd-4733-bbe0-8dd16b6b5726" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_241a1217-c198-4f06-a815-5f48349c8ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_3c3f066a-7947-4dcc-8f9c-847a853000b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_241a1217-c198-4f06-a815-5f48349c8ed7" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_3c3f066a-7947-4dcc-8f9c-847a853000b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_2938e4cc-b246-43a1-9533-740e30960e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_241a1217-c198-4f06-a815-5f48349c8ed7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_2938e4cc-b246-43a1-9533-740e30960e6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b93aba9e-7e4d-4dd1-9527-88dd1a5f9b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_241a1217-c198-4f06-a815-5f48349c8ed7" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b93aba9e-7e4d-4dd1-9527-88dd1a5f9b94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f86de55b-106d-47dc-b063-bb65af8e44df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_241a1217-c198-4f06-a815-5f48349c8ed7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f86de55b-106d-47dc-b063-bb65af8e44df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_4de0c291-c9ce-4119-bf08-5c8d07c60ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_241a1217-c198-4f06-a815-5f48349c8ed7" xlink:to="loc_us-gaap_AccountsPayableCurrent_4de0c291-c9ce-4119-bf08-5c8d07c60ccb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AccruedMarketingExpenses_a41e4ec6-f9e9-4c7a-a111-11a9b6e82af0" xlink:href="ehth-20210930.xsd#ehth_AccruedMarketingExpenses"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_241a1217-c198-4f06-a815-5f48349c8ed7" xlink:to="loc_ehth_AccruedMarketingExpenses_a41e4ec6-f9e9-4c7a-a111-11a9b6e82af0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a4c91702-7c1d-4432-aa0b-ae92d3398d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9da6c484-6a1c-4463-a6ef-11327af63693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4c91702-7c1d-4432-aa0b-ae92d3398d4a" xlink:to="loc_us-gaap_AssetsCurrent_9da6c484-6a1c-4463-a6ef-11327af63693" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0ed0c860-9a99-4979-bfc8-a9f44652bf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4c91702-7c1d-4432-aa0b-ae92d3398d4a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0ed0c860-9a99-4979-bfc8-a9f44652bf6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_84159896-6055-4874-a7de-62d725842e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4c91702-7c1d-4432-aa0b-ae92d3398d4a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_84159896-6055-4874-a7de-62d725842e09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7c05916e-0d19-4638-a300-21ad4bb26a10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4c91702-7c1d-4432-aa0b-ae92d3398d4a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7c05916e-0d19-4638-a300-21ad4bb26a10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9438d42a-2ee9-465f-8a36-94dc3e7f503b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4c91702-7c1d-4432-aa0b-ae92d3398d4a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9438d42a-2ee9-465f-8a36-94dc3e7f503b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8127ada5-609b-4437-8de7-b8a04dcfebb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4c91702-7c1d-4432-aa0b-ae92d3398d4a" xlink:to="loc_us-gaap_Goodwill_8127ada5-609b-4437-8de7-b8a04dcfebb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_1836f381-309f-4d34-a23b-1b46b15820ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4c91702-7c1d-4432-aa0b-ae92d3398d4a" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_1836f381-309f-4d34-a23b-1b46b15820ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_debbc63c-4949-4ab0-b23d-1689c961b419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a4c91702-7c1d-4432-aa0b-ae92d3398d4a" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_debbc63c-4949-4ab0-b23d-1689c961b419" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="ehth-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_505e6e3c-49ce-4742-9552-ccf097e21143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_85107718-dd68-4eea-bd14-c002510c8bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_505e6e3c-49ce-4742-9552-ccf097e21143" xlink:to="loc_us-gaap_OperatingIncomeLoss_85107718-dd68-4eea-bd14-c002510c8bf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5a8e5afb-4e60-4610-933c-4325bb22c28c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_505e6e3c-49ce-4742-9552-ccf097e21143" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5a8e5afb-4e60-4610-933c-4325bb22c28c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_bc24ef4d-178b-422b-bc49-8147c5818eca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cca4b3bb-056e-4008-8713-2e418204feb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_bc24ef4d-178b-422b-bc49-8147c5818eca" xlink:to="loc_us-gaap_NetIncomeLoss_cca4b3bb-056e-4008-8713-2e418204feb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4b05a687-b547-4b66-9274-7cb7b096d931" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_bc24ef4d-178b-422b-bc49-8147c5818eca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4b05a687-b547-4b66-9274-7cb7b096d931" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_f5a21261-4682-4374-9bfb-e38b7df71ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_bc24ef4d-178b-422b-bc49-8147c5818eca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_f5a21261-4682-4374-9bfb-e38b7df71ac5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d4d1587f-b9bf-48e1-b041-a3f28c15ecb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ac860622-3366-49b0-8573-734b48903e94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d4d1587f-b9bf-48e1-b041-a3f28c15ecb9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ac860622-3366-49b0-8573-734b48903e94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1aa5f88b-3b08-412c-a4c0-7e31ff77b414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d4d1587f-b9bf-48e1-b041-a3f28c15ecb9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1aa5f88b-3b08-412c-a4c0-7e31ff77b414" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_46ea7b5f-b736-4a02-89f9-4492d66e972f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_65c5e375-bd7c-4f77-a8ad-8fe029631d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_46ea7b5f-b736-4a02-89f9-4492d66e972f" xlink:to="loc_us-gaap_NetIncomeLoss_65c5e375-bd7c-4f77-a8ad-8fe029631d3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDividendsAdjustment_932f6053-4df9-4ff6-887d-cfd1f3f78beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDividendsAdjustment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_46ea7b5f-b736-4a02-89f9-4492d66e972f" xlink:to="loc_us-gaap_TemporaryEquityDividendsAdjustment_932f6053-4df9-4ff6-887d-cfd1f3f78beb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_58606bd5-41ee-44e5-bcac-dd637b277156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_46ea7b5f-b736-4a02-89f9-4492d66e972f" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_58606bd5-41ee-44e5-bcac-dd637b277156" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a1d9d267-2067-46da-8365-2250c4dfbadf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e1b25137-efec-4ba3-8b72-80111d9e7a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a1d9d267-2067-46da-8365-2250c4dfbadf" xlink:to="loc_us-gaap_CostsAndExpenses_e1b25137-efec-4ba3-8b72-80111d9e7a53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3590f955-f863-48a4-828a-61392ec4ba04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a1d9d267-2067-46da-8365-2250c4dfbadf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3590f955-f863-48a4-828a-61392ec4ba04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_76293483-6464-4955-bde2-87eb095cbb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_60878d7e-6659-419e-b2d9-9ebae7bedcae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_76293483-6464-4955-bde2-87eb095cbb4c" xlink:to="loc_us-gaap_CostOfRevenue_60878d7e-6659-419e-b2d9-9ebae7bedcae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_b1bb27fc-6727-4fd4-b158-7311bed1055d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_76293483-6464-4955-bde2-87eb095cbb4c" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_b1bb27fc-6727-4fd4-b158-7311bed1055d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CustomerCareAndEnrollmentExpense_6f3f199b-c1a2-433f-ad6d-4def4e8d0fdb" xlink:href="ehth-20210930.xsd#ehth_CustomerCareAndEnrollmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_76293483-6464-4955-bde2-87eb095cbb4c" xlink:to="loc_ehth_CustomerCareAndEnrollmentExpense_6f3f199b-c1a2-433f-ad6d-4def4e8d0fdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TechnologyAndContentExpense_1872426e-875a-403b-9d07-a9f07c413bd0" xlink:href="ehth-20210930.xsd#ehth_TechnologyAndContentExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_76293483-6464-4955-bde2-87eb095cbb4c" xlink:to="loc_ehth_TechnologyAndContentExpense_1872426e-875a-403b-9d07-a9f07c413bd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_2fb05232-ead1-4f2d-842e-c1c230f73b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_76293483-6464-4955-bde2-87eb095cbb4c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_2fb05232-ead1-4f2d-842e-c1c230f73b3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_df2d76b3-27a2-408c-87f5-26f54a57565e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_76293483-6464-4955-bde2-87eb095cbb4c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_df2d76b3-27a2-408c-87f5-26f54a57565e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_49d0d07c-0889-4a89-ad31-fe3a0817ffa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_76293483-6464-4955-bde2-87eb095cbb4c" xlink:to="loc_us-gaap_RestructuringCharges_49d0d07c-0889-4a89-ad31-fe3a0817ffa7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ehth-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a2930e2-cd75-459e-96bc-1a86fbc0aec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d56f06f5-5ded-424c-8e74-6d9eaa590134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a2930e2-cd75-459e-96bc-1a86fbc0aec2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_d56f06f5-5ded-424c-8e74-6d9eaa590134" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a21694c5-9e81-47b5-92ac-cf80b230e634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a2930e2-cd75-459e-96bc-1a86fbc0aec2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a21694c5-9e81-47b5-92ac-cf80b230e634" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_21be474f-70a1-4f08-ae1c-27f3e9a40267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a2930e2-cd75-459e-96bc-1a86fbc0aec2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_21be474f-70a1-4f08-ae1c-27f3e9a40267" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_594d01ba-520c-4156-8d0c-94b5789ceed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a2930e2-cd75-459e-96bc-1a86fbc0aec2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_594d01ba-520c-4156-8d0c-94b5789ceed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8230e617-24ab-4dd3-bbd1-092784b05795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_110b7875-fcd1-482b-9828-6ad8fb26e8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8230e617-24ab-4dd3-bbd1-092784b05795" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_110b7875-fcd1-482b-9828-6ad8fb26e8f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_8ca38be0-1502-49d3-a8db-088654bbfd03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8230e617-24ab-4dd3-bbd1-092784b05795" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_8ca38be0-1502-49d3-a8db-088654bbfd03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_5c06ad2e-c3ec-408a-8eb4-e7108266acba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8230e617-24ab-4dd3-bbd1-092784b05795" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_5c06ad2e-c3ec-408a-8eb4-e7108266acba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_6044e288-e550-4a09-b984-c54ca5bfe0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8230e617-24ab-4dd3-bbd1-092784b05795" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_6044e288-e550-4a09-b984-c54ca5bfe0e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_b11022ce-2750-44ee-9463-e6ff6dcc98df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8230e617-24ab-4dd3-bbd1-092784b05795" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_b11022ce-2750-44ee-9463-e6ff6dcc98df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_8a1927cb-6852-42db-8da8-d899e51655c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8230e617-24ab-4dd3-bbd1-092784b05795" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_8a1927cb-6852-42db-8da8-d899e51655c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bae1062c-d08a-4866-b999-ece76cdd25c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_us-gaap_NetIncomeLoss_bae1062c-d08a-4866-b999-ece76cdd25c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_dd376392-460b-443d-98bf-8b01df08de19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_dd376392-460b-443d-98bf-8b01df08de19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d2a89d2f-7cea-4ca2-b5c6-bbcfe2cbdae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_us-gaap_Depreciation_d2a89d2f-7cea-4ca2-b5c6-bbcfe2cbdae7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_db6f973d-7230-4a59-ae1b-cdae5abe8c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_db6f973d-7230-4a59-ae1b-cdae5abe8c3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ffa2f62d-2f14-439d-9760-bee03859c056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ffa2f62d-2f14-439d-9760-bee03859c056" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_25263d4e-11c3-4be7-9b6a-8d955c599b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_25263d4e-11c3-4be7-9b6a-8d955c599b77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_301982fe-b542-477e-9611-56f5391b3c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_301982fe-b542-477e-9611-56f5391b3c47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInCommissionsReceivable_35192799-8248-4b94-a091-1d653bb69ab7" xlink:href="ehth-20210930.xsd#ehth_IncreaseDecreaseInCommissionsReceivable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_ehth_IncreaseDecreaseInCommissionsReceivable_35192799-8248-4b94-a091-1d653bb69ab7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_ac8f3460-2808-4a03-983b-94a3b03c507d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_ac8f3460-2808-4a03-983b-94a3b03c507d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_442a58e6-5ae3-48cb-9845-944b6b6ecb73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_442a58e6-5ae3-48cb-9845-944b6b6ecb73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_dc747c3b-fb2b-402a-97b0-5dd111437eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_dc747c3b-fb2b-402a-97b0-5dd111437eb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInAccruedMarketingExpenses_bc7a8de4-7543-48c0-a66d-e8c38e33a97a" xlink:href="ehth-20210930.xsd#ehth_IncreaseDecreaseInAccruedMarketingExpenses"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_ehth_IncreaseDecreaseInAccruedMarketingExpenses_bc7a8de4-7543-48c0-a66d-e8c38e33a97a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_a7692eea-60f4-4d48-9d82-0f5772e217f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_a7692eea-60f4-4d48-9d82-0f5772e217f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_a352e5fb-3944-4240-a809-9149bec24d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_a352e5fb-3944-4240-a809-9149bec24d0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_83679e64-808d-44df-8771-1a5f0543770c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddfd1066-0440-4164-9c7a-9b59f773c502" xlink:to="loc_us-gaap_ShareBasedCompensation_83679e64-808d-44df-8771-1a5f0543770c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6631a953-0570-45a4-90e9-e35a318f26e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_27dcccfb-b01e-472f-a802-83dacd0c9409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6631a953-0570-45a4-90e9-e35a318f26e4" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_27dcccfb-b01e-472f-a802-83dacd0c9409" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0caede1f-234d-4d7a-a2d1-d2b0e1b90bd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6631a953-0570-45a4-90e9-e35a318f26e4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0caede1f-234d-4d7a-a2d1-d2b0e1b90bd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_55a1e8e2-59ee-4df4-9096-083da3d9b169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6631a953-0570-45a4-90e9-e35a318f26e4" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_55a1e8e2-59ee-4df4-9096-083da3d9b169" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_5ed0770d-4b09-466a-ad22-83b36a606847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6631a953-0570-45a4-90e9-e35a318f26e4" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_5ed0770d-4b09-466a-ad22-83b36a606847" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7612109e-7422-4a63-a90a-5f71c7df3745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bed5725b-2c65-42fa-9af4-9fc184e1c520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7612109e-7422-4a63-a90a-5f71c7df3745" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bed5725b-2c65-42fa-9af4-9fc184e1c520" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_2c0fd952-c93b-48ec-ba5f-c01e91e95e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7612109e-7422-4a63-a90a-5f71c7df3745" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_2c0fd952-c93b-48ec-ba5f-c01e91e95e15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f57fa573-56e7-494f-8896-9c0514027ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_069105bc-6b53-49b8-a6a7-54f8f5df4315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f57fa573-56e7-494f-8896-9c0514027ae7" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_069105bc-6b53-49b8-a6a7-54f8f5df4315" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_806141d6-232e-4ebe-8539-a2b053ae7900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f57fa573-56e7-494f-8896-9c0514027ae7" xlink:to="loc_us-gaap_Cash_806141d6-232e-4ebe-8539-a2b053ae7900" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_eba93d22-9d84-4914-ba80-3ce5cec32df7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_760f722d-cc67-478b-ad44-59ddcd9f0988" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_eba93d22-9d84-4914-ba80-3ce5cec32df7" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_760f722d-cc67-478b-ad44-59ddcd9f0988" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PrepaidMaintenanceContractsCurrent_be167b62-674a-483a-8adc-ceca57cc9733" xlink:href="ehth-20210930.xsd#ehth_PrepaidMaintenanceContractsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_eba93d22-9d84-4914-ba80-3ce5cec32df7" xlink:to="loc_ehth_PrepaidMaintenanceContractsCurrent_be167b62-674a-483a-8adc-ceca57cc9733" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_020abb6d-c711-4d94-a128-92d90b49bed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_eba93d22-9d84-4914-ba80-3ce5cec32df7" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_020abb6d-c711-4d94-a128-92d90b49bed4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_2fb01ee1-e494-4c61-80ff-93bed27bb4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_eba93d22-9d84-4914-ba80-3ce5cec32df7" xlink:to="loc_us-gaap_PrepaidInsurance_2fb01ee1-e494-4c61-80ff-93bed27bb4e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PrepaidLicenses_5cd18325-356a-48a7-bcd9-4c6b4a116038" xlink:href="ehth-20210930.xsd#ehth_PrepaidLicenses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_eba93d22-9d84-4914-ba80-3ce5cec32df7" xlink:to="loc_ehth_PrepaidLicenses_5cd18325-356a-48a7-bcd9-4c6b4a116038" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#FairValueMeasurementsSummaryofFinancialAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_89c843a1-10dd-4b6c-8bbd-43dccb020456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_fd5306f7-8180-4558-b168-0320d43b5ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_89c843a1-10dd-4b6c-8bbd-43dccb020456" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_fd5306f7-8180-4558-b168-0320d43b5ee0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_12b0a2e6-70c7-4b22-bc70-324f2e301143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_89c843a1-10dd-4b6c-8bbd-43dccb020456" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_12b0a2e6-70c7-4b22-bc70-324f2e301143" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#FairValueMeasurementsUnrealizedGainsandLossesDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_6d607e2a-6549-4c11-b28c-31c96f290de8" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_3acfd451-d284-433d-ba77-38b53e6a5065" xlink:href="ehth-20210930.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_6d607e2a-6549-4c11-b28c-31c96f290de8" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_3acfd451-d284-433d-ba77-38b53e6a5065" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_039393a3-6851-48d0-bb62-6a208e1b42f8" xlink:href="ehth-20210930.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_6d607e2a-6549-4c11-b28c-31c96f290de8" xlink:to="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_039393a3-6851-48d0-bb62-6a208e1b42f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_70f2d0d1-f3c0-4ab5-b2b2-11d5b1a72a87" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_104f18fd-c9d5-4591-b4c1-b2ac69e86259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_70f2d0d1-f3c0-4ab5-b2b2-11d5b1a72a87" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_104f18fd-c9d5-4591-b4c1-b2ac69e86259" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_36ed5ea7-6c95-43e6-91d7-aef1b6eab975" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_70f2d0d1-f3c0-4ab5-b2b2-11d5b1a72a87" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_36ed5ea7-6c95-43e6-91d7-aef1b6eab975" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0fce2d32-9ca2-492d-b92f-07b896c41ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_17835b5c-c293-4a51-a7ca-d86bbe918091" xlink:href="ehth-20210930.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0fce2d32-9ca2-492d-b92f-07b896c41ba6" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_17835b5c-c293-4a51-a7ca-d86bbe918091" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_a07fea4d-3a12-4db8-89f6-9fa63d18cd53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0fce2d32-9ca2-492d-b92f-07b896c41ba6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_a07fea4d-3a12-4db8-89f6-9fa63d18cd53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_f0566f46-57e8-42fc-ac62-ffc3ab993642" xlink:href="ehth-20210930.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0fce2d32-9ca2-492d-b92f-07b896c41ba6" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_f0566f46-57e8-42fc-ac62-ffc3ab993642" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_a30a5452-a936-4419-8fed-40437cdedf69" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_3515a092-7946-4ce5-9433-481ff70a9112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_a30a5452-a936-4419-8fed-40437cdedf69" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_3515a092-7946-4ce5-9433-481ff70a9112" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_57245152-1fcd-431e-aed8-98a9d4a763ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_a30a5452-a936-4419-8fed-40437cdedf69" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_57245152-1fcd-431e-aed8-98a9d4a763ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dc34dc91-9a72-4f60-88d3-c3cb1d8925b8" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_8732a832-a3b5-4a4f-91ed-6f6dc0a37ee9" xlink:href="ehth-20210930.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dc34dc91-9a72-4f60-88d3-c3cb1d8925b8" xlink:to="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_8732a832-a3b5-4a4f-91ed-6f6dc0a37ee9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_dd60cd0b-a280-4cd4-9fa0-c2362982b8d3" xlink:href="ehth-20210930.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dc34dc91-9a72-4f60-88d3-c3cb1d8925b8" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_dd60cd0b-a280-4cd4-9fa0-c2362982b8d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a504078b-9fbd-472c-9c1f-ed98fcf25c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9e33c3ed-4893-4b7b-9ae6-0b0ed3da3d65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a504078b-9fbd-472c-9c1f-ed98fcf25c29" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9e33c3ed-4893-4b7b-9ae6-0b0ed3da3d65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_f35039e5-102f-4940-9886-d5262a58711c" xlink:href="ehth-20210930.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a504078b-9fbd-472c-9c1f-ed98fcf25c29" xlink:to="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_f35039e5-102f-4940-9886-d5262a58711c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_e1d02a96-dfc2-4584-8646-8bfa2c76f418" xlink:href="ehth-20210930.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a504078b-9fbd-472c-9c1f-ed98fcf25c29" xlink:to="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_e1d02a96-dfc2-4584-8646-8bfa2c76f418" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1" xlink:type="simple" xlink:href="ehth-20210930.xsd#FairValueMeasurementsUnrealizedGainsandLossesDetails_1"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_dccfd5e1-c193-4062-ab50-d954efe4211f" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_94279b51-e1eb-46c1-9bf9-512abb4092bb" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_dccfd5e1-c193-4062-ab50-d954efe4211f" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_94279b51-e1eb-46c1-9bf9-512abb4092bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e3701bc1-71dd-4100-b7bb-dc18397483d0" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_dccfd5e1-c193-4062-ab50-d954efe4211f" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e3701bc1-71dd-4100-b7bb-dc18397483d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_34ca6564-9141-48f5-83c1-b70cf0c5ee53" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_dccfd5e1-c193-4062-ab50-d954efe4211f" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_34ca6564-9141-48f5-83c1-b70cf0c5ee53" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#EquityScheduleofStockBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_3a3c1f21-f01b-4db6-81f7-5646d935c85f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_7d4033a4-02d2-4af2-bb53-73bc55842aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_3a3c1f21-f01b-4db6-81f7-5646d935c85f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_7d4033a4-02d2-4af2-bb53-73bc55842aaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_578e56df-9edd-466a-9665-2a05e38812f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_3a3c1f21-f01b-4db6-81f7-5646d935c85f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_578e56df-9edd-466a-9665-2a05e38812f7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#ConvertiblePreferredStockSummaryofStockDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_845887dd-08d4-4e2c-a94b-7e209639dcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_1996a412-0d8b-42f6-bb72-cf1c03ebe6d6" xlink:href="ehth-20210930.xsd#ehth_SaleOfStockConsiderationReceivedOnTransactionGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_845887dd-08d4-4e2c-a94b-7e209639dcd0" xlink:to="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_1996a412-0d8b-42f6-bb72-cf1c03ebe6d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_70b8ac78-4ca6-400c-9e6a-77afed1f6b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_845887dd-08d4-4e2c-a94b-7e209639dcd0" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_70b8ac78-4ca6-400c-9e6a-77afed1f6b8b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_75e845ed-5468-415f-b6bd-142d49ed303f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncrementalCommonSharesAttributableToOptions_643d4003-d3cb-41a0-bbde-daa6ee504966" xlink:href="ehth-20210930.xsd#ehth_IncrementalCommonSharesAttributableToOptions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_75e845ed-5468-415f-b6bd-142d49ed303f" xlink:to="loc_ehth_IncrementalCommonSharesAttributableToOptions_643d4003-d3cb-41a0-bbde-daa6ee504966" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_09d808d0-9fb3-49b3-8199-ee46e4dd8ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_75e845ed-5468-415f-b6bd-142d49ed303f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_09d808d0-9fb3-49b3-8199-ee46e4dd8ff5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#CommitmentsandContingenciesDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_825648ae-534d-404d-a074-e56d7614a4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear_ba56b909-6949-42c5-81f9-9571c2f0c7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_825648ae-534d-404d-a074-e56d7614a4c3" xlink:to="loc_us-gaap_ContractualObligationDueInFourthYear_ba56b909-6949-42c5-81f9-9571c2f0c7ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear_95a6bdf9-07c3-4a73-90b0-f62a9c00d7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_825648ae-534d-404d-a074-e56d7614a4c3" xlink:to="loc_us-gaap_ContractualObligationDueInThirdYear_95a6bdf9-07c3-4a73-90b0-f62a9c00d7aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear_67a01dbc-6e7a-4150-8e58-713aa50d9337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_825648ae-534d-404d-a074-e56d7614a4c3" xlink:to="loc_us-gaap_ContractualObligationDueInSecondYear_67a01dbc-6e7a-4150-8e58-713aa50d9337" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_05372f8d-d287-425b-859c-06f6a86a1e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_825648ae-534d-404d-a074-e56d7614a4c3" xlink:to="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_05372f8d-d287-425b-859c-06f6a86a1e0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_fea55749-6112-48a5-b283-4125c32f0869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_825648ae-534d-404d-a074-e56d7614a4c3" xlink:to="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_fea55749-6112-48a5-b283-4125c32f0869" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ContractualObligationToBePaidAfterYearFour_b4328714-0716-4285-b893-828f9dac99da" xlink:href="ehth-20210930.xsd#ehth_ContractualObligationToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ContractualObligation_825648ae-534d-404d-a074-e56d7614a4c3" xlink:to="loc_ehth_ContractualObligationToBePaidAfterYearFour_b4328714-0716-4285-b893-828f9dac99da" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SegmentandGeographicInformationSegmentOperatingResultsDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98d436f1-1e77-4519-939c-3494ad415a20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_28f2c0c7-6e88-479b-9f4f-5e678947366c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98d436f1-1e77-4519-939c-3494ad415a20" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_28f2c0c7-6e88-479b-9f4f-5e678947366c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_24da76de-1688-450d-885e-a6951353f820" xlink:href="ehth-20210930.xsd#ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98d436f1-1e77-4519-939c-3494ad415a20" xlink:to="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_24da76de-1688-450d-885e-a6951353f820" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_e69f7b1c-2625-4221-b0f6-3822bc1c9e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98d436f1-1e77-4519-939c-3494ad415a20" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_e69f7b1c-2625-4221-b0f6-3822bc1c9e90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SegmentOperatingIncomeLoss_47b60d59-841d-40d2-ab48-61a78b38f43c" xlink:href="ehth-20210930.xsd#ehth_SegmentOperatingIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98d436f1-1e77-4519-939c-3494ad415a20" xlink:to="loc_ehth_SegmentOperatingIncomeLoss_47b60d59-841d-40d2-ab48-61a78b38f43c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4e1e713c-138a-4d87-b5cd-7db29aaeca34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98d436f1-1e77-4519-939c-3494ad415a20" xlink:to="loc_us-gaap_RestructuringCharges_4e1e713c-138a-4d87-b5cd-7db29aaeca34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6423945f-6a92-412f-810b-8f3d76f48639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_98d436f1-1e77-4519-939c-3494ad415a20" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6423945f-6a92-412f-810b-8f3d76f48639" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_de094bb7-6752-4940-a9c9-5c54bcfcdfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_4cfb443f-591d-4495-805b-f8ddd28c5c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_de094bb7-6752-4940-a9c9-5c54bcfcdfe2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_4cfb443f-591d-4495-805b-f8ddd28c5c50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_60dda6d4-cd58-4f07-980f-805125786d46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_de094bb7-6752-4940-a9c9-5c54bcfcdfe2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_60dda6d4-cd58-4f07-980f-805125786d46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e7340a3f-156f-4787-8ccf-e4d2dc1161a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_de094bb7-6752-4940-a9c9-5c54bcfcdfe2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e7340a3f-156f-4787-8ccf-e4d2dc1161a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fc9fb237-683e-434e-8f3d-296aee5a0beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_de094bb7-6752-4940-a9c9-5c54bcfcdfe2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fc9fb237-683e-434e-8f3d-296aee5a0beb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f3ae098c-7089-46f6-92d9-1f2634088ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_de094bb7-6752-4940-a9c9-5c54bcfcdfe2" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f3ae098c-7089-46f6-92d9-1f2634088ee7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_cf609473-9971-43c1-a315-acf122f0a769" xlink:href="ehth-20210930.xsd#ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_de094bb7-6752-4940-a9c9-5c54bcfcdfe2" xlink:to="loc_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_cf609473-9971-43c1-a315-acf122f0a769" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="ehth-20210930.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fcc9ca45-144f-4480-b149-f49c0c5aa4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4a27e369-7ccb-4948-834d-48d19372dfc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fcc9ca45-144f-4480-b149-f49c0c5aa4ca" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4a27e369-7ccb-4948-834d-48d19372dfc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ba701961-b9c3-430b-8a8f-cc1f3f91bb68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_fcc9ca45-144f-4480-b149-f49c0c5aa4ca" xlink:to="loc_us-gaap_OperatingLeaseLiability_ba701961-b9c3-430b-8a8f-cc1f3f91bb68" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>ehth-20210930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:001ee10b-2bdc-4177-8047-00c9b0c2bbeb,g:3e9ca025-a681-404c-b475-c1976cd6b86b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="ehth-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended" id="i49e7d8f19cdb45e494fc059c6633f64e_CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_a66c3ddd-06fc-4bf6-88d9-7d0992d5824f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_RevenuesAbstract_a66c3ddd-06fc-4bf6-88d9-7d0992d5824f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7e290b6d-d516-4bc3-8f72-07786515be13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_a66c3ddd-06fc-4bf6-88d9-7d0992d5824f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7e290b6d-d516-4bc3-8f72-07786515be13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_7c7453c1-6434-4416-9ee3-94c030d8cc84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_us-gaap_CostOfRevenue_7c7453c1-6434-4416-9ee3-94c030d8cc84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_b2b68ab3-b4c5-49dc-9038-0ff64d982934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_b2b68ab3-b4c5-49dc-9038-0ff64d982934" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CustomerCareAndEnrollmentExpense_f6d9d130-f46a-4223-a7ac-44b0a16fb7e8" xlink:href="ehth-20210930.xsd#ehth_CustomerCareAndEnrollmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_ehth_CustomerCareAndEnrollmentExpense_f6d9d130-f46a-4223-a7ac-44b0a16fb7e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TechnologyAndContentExpense_4c0239b6-7c08-4033-a116-dc5d86ac305b" xlink:href="ehth-20210930.xsd#ehth_TechnologyAndContentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_ehth_TechnologyAndContentExpense_4c0239b6-7c08-4033-a116-dc5d86ac305b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_13269171-cc46-4806-bedb-060550a5c340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_13269171-cc46-4806-bedb-060550a5c340" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ff381d44-e0de-41bd-bc67-04b1b4cc1e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ff381d44-e0de-41bd-bc67-04b1b4cc1e35" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_19acdd07-b8f8-4f1b-93f3-dc81c42e6b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_us-gaap_RestructuringCharges_19acdd07-b8f8-4f1b-93f3-dc81c42e6b3f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ad411b46-3054-48e8-bb96-a7440e0a9039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_us-gaap_CostsAndExpenses_ad411b46-3054-48e8-bb96-a7440e0a9039" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c5baaa73-2054-47b2-949b-39136031eae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_OperatingIncomeLoss_c5baaa73-2054-47b2-949b-39136031eae1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_11661272-52ad-494e-96ac-89323042eb66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_11661272-52ad-494e-96ac-89323042eb66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dea28615-f0a9-4899-8a6b-596844211278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dea28615-f0a9-4899-8a6b-596844211278" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b9f4e088-d52a-49a5-b3ed-e1e40735afa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b9f4e088-d52a-49a5-b3ed-e1e40735afa6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0ae81c42-08ec-42be-ac56-47107ae03adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_NetIncomeLoss_0ae81c42-08ec-42be-ac56-47107ae03adf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDividendsAdjustment_bf88796d-e7ba-4d98-9b5a-38f50cfc8d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDividendsAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_TemporaryEquityDividendsAdjustment_bf88796d-e7ba-4d98-9b5a-38f50cfc8d98" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_db02685e-9381-4198-bba0-a334dcce7ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_db02685e-9381-4198-bba0-a334dcce7ed3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_081fc648-5521-4ecd-a098-84a288bc2c36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_081fc648-5521-4ecd-a098-84a288bc2c36" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_495f54bb-dacd-4f14-97cc-b377022142eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_EarningsPerShareAbstract_495f54bb-dacd-4f14-97cc-b377022142eb" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a2abebe6-3651-46f9-a08a-e1072bde41ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_495f54bb-dacd-4f14-97cc-b377022142eb" xlink:to="loc_us-gaap_EarningsPerShareBasic_a2abebe6-3651-46f9-a08a-e1072bde41ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d9eb8a18-6bfa-4218-a277-c8d9083dbcdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_495f54bb-dacd-4f14-97cc-b377022142eb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d9eb8a18-6bfa-4218-a277-c8d9083dbcdb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1b99bb41-164d-46f0-a67d-ef31dcf905d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1b99bb41-164d-46f0-a67d-ef31dcf905d3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638b3648-7562-45a7-b004-584aa1dc0c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1b99bb41-164d-46f0-a67d-ef31dcf905d3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638b3648-7562-45a7-b004-584aa1dc0c6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79fb8dab-0aaa-4a0a-bade-d3cc116d878d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1b99bb41-164d-46f0-a67d-ef31dcf905d3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79fb8dab-0aaa-4a0a-bade-d3cc116d878d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8f50f3df-90c1-44a2-930a-6d557fb5cb04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8f50f3df-90c1-44a2-930a-6d557fb5cb04" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_018373c9-039b-4bd0-b50c-c87a4c35128d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_5df992dd-e668-498e-a6bb-c2037858099d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8f50f3df-90c1-44a2-930a-6d557fb5cb04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_5df992dd-e668-498e-a6bb-c2037858099d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_eb4029be-f4ec-43cd-bbb9-8d3d93de0983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8f50f3df-90c1-44a2-930a-6d557fb5cb04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_eb4029be-f4ec-43cd-bbb9-8d3d93de0983" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_39719c3a-cc16-4f58-95c7-7dbb0ea3ecfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8f50f3df-90c1-44a2-930a-6d557fb5cb04" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_39719c3a-cc16-4f58-95c7-7dbb0ea3ecfc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_14bf8ba3-eca4-4235-b680-d575d657e1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_StatementTable_14bf8ba3-eca4-4235-b680-d575d657e1a4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e3e40638-ac13-49d7-9810-92012524ac0a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_14bf8ba3-eca4-4235-b680-d575d657e1a4" xlink:to="loc_srt_ProductOrServiceAxis_e3e40638-ac13-49d7-9810-92012524ac0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e3e40638-ac13-49d7-9810-92012524ac0a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e3e40638-ac13-49d7-9810-92012524ac0a" xlink:to="loc_srt_ProductsAndServicesDomain_e3e40638-ac13-49d7-9810-92012524ac0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dc46b630-3d82-4523-8d32-623c266d90aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e3e40638-ac13-49d7-9810-92012524ac0a" xlink:to="loc_srt_ProductsAndServicesDomain_dc46b630-3d82-4523-8d32-623c266d90aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMember_3e252d80-0a08-4654-ace8-18d213b36ce3" xlink:href="ehth-20210930.xsd#ehth_CommissionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dc46b630-3d82-4523-8d32-623c266d90aa" xlink:to="loc_ehth_CommissionMember_3e252d80-0a08-4654-ace8-18d213b36ce3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_dd038ecd-3c79-4ec9-a1fc-f46f371af61f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_dc46b630-3d82-4523-8d32-623c266d90aa" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_dd038ecd-3c79-4ec9-a1fc-f46f371af61f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ehth-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="id25c231aa7394079828e2b3ff06a59f8_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c315de75-2f0a-4e32-a397-aef362856b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c315de75-2f0a-4e32-a397-aef362856b2c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_9fca38a8-885b-4934-ab57-74709ecf21ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_SharesOutstanding_9fca38a8-885b-4934-ab57-74709ecf21ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_98f95043-745a-4177-a216-81399c2c7776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockholdersEquity_98f95043-745a-4177-a216-81399c2c7776" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_922a7ff8-571e-45ac-83ba-ac7fdce561a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_922a7ff8-571e-45ac-83ba-ac7fdce561a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4a7dce5c-885f-4dc7-8297-1f69aa4284b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4a7dce5c-885f-4dc7-8297-1f69aa4284b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_fd21c2b8-0f12-4e35-a031-93878267cf32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_fd21c2b8-0f12-4e35-a031-93878267cf32" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_88cd639d-5a87-49e1-ac2c-079a5585f1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_88cd639d-5a87-49e1-ac2c-079a5585f1fe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock_455e2266-bf81-4fe1-96ff-db49d4994e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock_455e2266-bf81-4fe1-96ff-db49d4994e72" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_dd4382e8-80cb-459a-ad3e-2c3dea033ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_dd4382e8-80cb-459a-ad3e-2c3dea033ab8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d42f66fa-b835-419d-89cb-f2b431672561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d42f66fa-b835-419d-89cb-f2b431672561" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f667a661-fa96-43f6-9d2d-b6e5e4049a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f667a661-fa96-43f6-9d2d-b6e5e4049a3a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_69deed05-b649-419c-8c42-05b651a57649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_69deed05-b649-419c-8c42-05b651a57649" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e5aaf3f7-6a26-4011-90f0-603af1fc2aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_NetIncomeLoss_e5aaf3f7-6a26-4011-90f0-603af1fc2aa7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_67d49167-30dc-4929-afac-b9cda4b11fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_67d49167-30dc-4929-afac-b9cda4b11fb4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_90d0d2e7-97a6-43cd-8f0e-6d7fbfa5de9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_90d0d2e7-97a6-43cd-8f0e-6d7fbfa5de9c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_11c750c7-b0d5-4c6e-9362-6cc47511ad15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_11c750c7-b0d5-4c6e-9362-6cc47511ad15" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_052d0954-1306-4b52-9ae1-4c9c64ed4215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_052d0954-1306-4b52-9ae1-4c9c64ed4215" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b3355b62-9a6d-48c5-b27a-ea181d6f6dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b3355b62-9a6d-48c5-b27a-ea181d6f6dd3" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_48c67f53-9943-4038-ba79-c6c39fd5f733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_15d395ca-c64f-4210-ab33-c9c0bcf0c345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b43cdbf1-023d-4312-974d-8fdd4190e858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c315de75-2f0a-4e32-a397-aef362856b2c" xlink:to="loc_us-gaap_StatementTable_b43cdbf1-023d-4312-974d-8fdd4190e858" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9fbf42ea-3093-4cef-8a6c-7c7f91e4cc86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b43cdbf1-023d-4312-974d-8fdd4190e858" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9fbf42ea-3093-4cef-8a6c-7c7f91e4cc86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9fbf42ea-3093-4cef-8a6c-7c7f91e4cc86_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9fbf42ea-3093-4cef-8a6c-7c7f91e4cc86" xlink:to="loc_us-gaap_EquityComponentDomain_9fbf42ea-3093-4cef-8a6c-7c7f91e4cc86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_91e53883-3788-419e-8e8d-47715854a264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9fbf42ea-3093-4cef-8a6c-7c7f91e4cc86" xlink:to="loc_us-gaap_EquityComponentDomain_91e53883-3788-419e-8e8d-47715854a264" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_73c6c789-a25b-4384-a37c-ee82df1db070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_91e53883-3788-419e-8e8d-47715854a264" xlink:to="loc_us-gaap_CommonStockMember_73c6c789-a25b-4384-a37c-ee82df1db070" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_918c97d0-ef76-4a76-9285-bec1215df154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_91e53883-3788-419e-8e8d-47715854a264" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_918c97d0-ef76-4a76-9285-bec1215df154" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_cd975044-14ba-49ba-a34a-b4760e7a9b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_91e53883-3788-419e-8e8d-47715854a264" xlink:to="loc_us-gaap_TreasuryStockMember_cd975044-14ba-49ba-a34a-b4760e7a9b11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9b516ad8-ef1f-42c1-8cdc-bfc4626f977a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_91e53883-3788-419e-8e8d-47715854a264" xlink:to="loc_us-gaap_RetainedEarningsMember_9b516ad8-ef1f-42c1-8cdc-bfc4626f977a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2df715ca-f04f-4168-9f2b-a29396b416cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_91e53883-3788-419e-8e8d-47715854a264" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2df715ca-f04f-4168-9f2b-a29396b416cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0b0ae844-4fee-4421-b870-311197456e11" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b43cdbf1-023d-4312-974d-8fdd4190e858" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0b0ae844-4fee-4421-b870-311197456e11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0b0ae844-4fee-4421-b870-311197456e11_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0b0ae844-4fee-4421-b870-311197456e11" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0b0ae844-4fee-4421-b870-311197456e11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6fdfd644-188d-403b-885a-78c7009264c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0b0ae844-4fee-4421-b870-311197456e11" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6fdfd644-188d-403b-885a-78c7009264c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7a7b50b0-16a0-44fb-a15c-eac21d6ff931" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6fdfd644-188d-403b-885a-78c7009264c2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7a7b50b0-16a0-44fb-a15c-eac21d6ff931" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i7ef710fcc46f4abbb1a242cbf993a459_SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_NumberOfHealthInsuranceCarriers_439073f5-5a2c-4e49-af35-f160713b4997" xlink:href="ehth-20210930.xsd#ehth_NumberOfHealthInsuranceCarriers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_ehth_NumberOfHealthInsuranceCarriers_439073f5-5a2c-4e49-af35-f160713b4997" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_c0e93d47-a69e-4b35-91ac-1999b0a50adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_c0e93d47-a69e-4b35-91ac-1999b0a50adb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_9a5991eb-aa4d-4f76-95c1-16c9b994e29f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_9a5991eb-aa4d-4f76-95c1-16c9b994e29f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_c8d1f745-6234-48d9-9aa7-57a4163e3141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_us-gaap_CostOfRevenue_c8d1f745-6234-48d9-9aa7-57a4163e3141" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8e6eed63-0213-4200-8a5c-c6eadc683624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_us-gaap_NetIncomeLoss_8e6eed63-0213-4200-8a5c-c6eadc683624" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f36822d1-3457-4d5b-8d83-a8c61ea72e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_us-gaap_EarningsPerShareBasic_f36822d1-3457-4d5b-8d83-a8c61ea72e86" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2b8244ad-d7c1-45d8-8abe-4b3ec38ae902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2b8244ad-d7c1-45d8-8abe-4b3ec38ae902" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c28395d6-9b71-4b2f-a5cd-4de02d52673b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c28395d6-9b71-4b2f-a5cd-4de02d52673b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8a721db5-b0ea-46e1-994a-a89a485ff2d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c28395d6-9b71-4b2f-a5cd-4de02d52673b" xlink:to="loc_srt_ProductOrServiceAxis_8a721db5-b0ea-46e1-994a-a89a485ff2d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8a721db5-b0ea-46e1-994a-a89a485ff2d3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8a721db5-b0ea-46e1-994a-a89a485ff2d3" xlink:to="loc_srt_ProductsAndServicesDomain_8a721db5-b0ea-46e1-994a-a89a485ff2d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_18d57502-d8b1-4de8-bcdc-a2f3b8c2d6e4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8a721db5-b0ea-46e1-994a-a89a485ff2d3" xlink:to="loc_srt_ProductsAndServicesDomain_18d57502-d8b1-4de8-bcdc-a2f3b8c2d6e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_482728fc-27a7-46c5-8268-28d1fba0201b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_18d57502-d8b1-4de8-bcdc-a2f3b8c2d6e4" xlink:to="loc_us-gaap_LicenseMember_482728fc-27a7-46c5-8268-28d1fba0201b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_d1dcf316-1fa3-4a41-bd48-d98caf446beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c28395d6-9b71-4b2f-a5cd-4de02d52673b" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_d1dcf316-1fa3-4a41-bd48-d98caf446beb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_d1dcf316-1fa3-4a41-bd48-d98caf446beb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_d1dcf316-1fa3-4a41-bd48-d98caf446beb" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_d1dcf316-1fa3-4a41-bd48-d98caf446beb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_6697c8e7-0061-4a24-ade6-9ffd454533e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_d1dcf316-1fa3-4a41-bd48-d98caf446beb" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_6697c8e7-0061-4a24-ade6-9ffd454533e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember_dbd4286e-98af-4d0c-8664-24d6cd720315" xlink:href="ehth-20210930.xsd#ehth_UnderRecognitionOfStockBasedCompensationExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_6697c8e7-0061-4a24-ade6-9ffd454533e9" xlink:to="loc_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember_dbd4286e-98af-4d0c-8664-24d6cd720315" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OverRecognitionOfLicensingCostsMember_3ea27d41-511c-44fa-bb4c-94f03a1afccc" xlink:href="ehth-20210930.xsd#ehth_OverRecognitionOfLicensingCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_6697c8e7-0061-4a24-ade6-9ffd454533e9" xlink:to="loc_ehth_OverRecognitionOfLicensingCostsMember_3ea27d41-511c-44fa-bb4c-94f03a1afccc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OutOfPeriodAdjustmentsMember_4c0d4586-a163-4845-98d5-33bce3b483a4" xlink:href="ehth-20210930.xsd#ehth_OutOfPeriodAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_6697c8e7-0061-4a24-ade6-9ffd454533e9" xlink:to="loc_ehth_OutOfPeriodAdjustmentsMember_4c0d4586-a163-4845-98d5-33bce3b483a4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#RevenueDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="extended" id="i27d50d14b99645c1837740fafedd2692_RevenueDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f547b7ec-dd60-4e1c-85fa-fb92cbc6a3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f5774950-8428-4e0e-9b2a-1f1f69f7b146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f547b7ec-dd60-4e1c-85fa-fb92cbc6a3d6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f5774950-8428-4e0e-9b2a-1f1f69f7b146" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f547b7ec-dd60-4e1c-85fa-fb92cbc6a3d6" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_00dce4b6-9062-42ab-82d8-6f340903934b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:to="loc_srt_ProductOrServiceAxis_00dce4b6-9062-42ab-82d8-6f340903934b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_00dce4b6-9062-42ab-82d8-6f340903934b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_00dce4b6-9062-42ab-82d8-6f340903934b" xlink:to="loc_srt_ProductsAndServicesDomain_00dce4b6-9062-42ab-82d8-6f340903934b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_00dce4b6-9062-42ab-82d8-6f340903934b" xlink:to="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareMember_c61c98c0-8a7e-483a-8ba8-792472e6a3b1" xlink:href="ehth-20210930.xsd#ehth_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:to="loc_ehth_MedicareMember_c61c98c0-8a7e-483a-8ba8-792472e6a3b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualandFamilyMember_34cecf72-7215-4de7-86b5-1222b320cce9" xlink:href="ehth-20210930.xsd#ehth_IndividualandFamilyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:to="loc_ehth_IndividualandFamilyMember_34cecf72-7215-4de7-86b5-1222b320cce9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AncillariesMember_7034a643-6f58-478d-a096-c2f4b021f696" xlink:href="ehth-20210930.xsd#ehth_AncillariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:to="loc_ehth_AncillariesMember_7034a643-6f58-478d-a096-c2f4b021f696" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SmallBusinessMember_c71b85cf-84a2-4751-9f0c-f7c115e852fc" xlink:href="ehth-20210930.xsd#ehth_SmallBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:to="loc_ehth_SmallBusinessMember_c71b85cf-84a2-4751-9f0c-f7c115e852fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionBonusMember_cf9563ec-5de0-46d8-9528-85000e4e47e8" xlink:href="ehth-20210930.xsd#ehth_CommissionBonusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:to="loc_ehth_CommissionBonusMember_cf9563ec-5de0-46d8-9528-85000e4e47e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMember_f4b9e2e8-c823-4f85-bb6b-25209b4e1e93" xlink:href="ehth-20210930.xsd#ehth_CommissionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:to="loc_ehth_CommissionMember_f4b9e2e8-c823-4f85-bb6b-25209b4e1e93" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_8f725f72-8819-4574-bd96-5f8e243dd7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_8f725f72-8819-4574-bd96-5f8e243dd7a2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedMedicareAxis_8c3f7010-93cd-4576-998d-5b7416c117cd" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedMedicareAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:to="loc_ehth_DisaggregatedMedicareAxis_8c3f7010-93cd-4576-998d-5b7416c117cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedMedicareDomain_8c3f7010-93cd-4576-998d-5b7416c117cd_default" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedMedicareDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ehth_DisaggregatedMedicareAxis_8c3f7010-93cd-4576-998d-5b7416c117cd" xlink:to="loc_ehth_DisaggregatedMedicareDomain_8c3f7010-93cd-4576-998d-5b7416c117cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedMedicareDomain_568e3065-5b37-48a0-87b7-f3a3846be1aa" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedMedicareDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ehth_DisaggregatedMedicareAxis_8c3f7010-93cd-4576-998d-5b7416c117cd" xlink:to="loc_ehth_DisaggregatedMedicareDomain_568e3065-5b37-48a0-87b7-f3a3846be1aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareAdvantageMember_a0b2f22e-1d86-43f0-9400-f6455fd83c8d" xlink:href="ehth-20210930.xsd#ehth_MedicareAdvantageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedMedicareDomain_568e3065-5b37-48a0-87b7-f3a3846be1aa" xlink:to="loc_ehth_MedicareAdvantageMember_a0b2f22e-1d86-43f0-9400-f6455fd83c8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSupplementMember_5f7a5da3-5f5c-44c9-82ae-83d65a1e5bae" xlink:href="ehth-20210930.xsd#ehth_MedicareSupplementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedMedicareDomain_568e3065-5b37-48a0-87b7-f3a3846be1aa" xlink:to="loc_ehth_MedicareSupplementMember_5f7a5da3-5f5c-44c9-82ae-83d65a1e5bae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicarePartDMember_3f1e5b14-909b-4607-9f09-8319dac0b787" xlink:href="ehth-20210930.xsd#ehth_MedicarePartDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedMedicareDomain_568e3065-5b37-48a0-87b7-f3a3846be1aa" xlink:to="loc_ehth_MedicarePartDMember_3f1e5b14-909b-4607-9f09-8319dac0b787" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedIndividualandFamilyAxis_96b26d5f-40cf-41be-a330-70b996ef0683" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedIndividualandFamilyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:to="loc_ehth_DisaggregatedIndividualandFamilyAxis_96b26d5f-40cf-41be-a330-70b996ef0683" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedIndividualandFamilyDomain_96b26d5f-40cf-41be-a330-70b996ef0683_default" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedIndividualandFamilyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyAxis_96b26d5f-40cf-41be-a330-70b996ef0683" xlink:to="loc_ehth_DisaggregatedIndividualandFamilyDomain_96b26d5f-40cf-41be-a330-70b996ef0683_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedIndividualandFamilyDomain_856c75d7-4a5f-4cc8-9ab8-5df3d4bed537" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedIndividualandFamilyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyAxis_96b26d5f-40cf-41be-a330-70b996ef0683" xlink:to="loc_ehth_DisaggregatedIndividualandFamilyDomain_856c75d7-4a5f-4cc8-9ab8-5df3d4bed537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_NonQualifiedHealthPlansMember_ffd049ad-dbbc-49af-ad96-3189f6d5151d" xlink:href="ehth-20210930.xsd#ehth_NonQualifiedHealthPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyDomain_856c75d7-4a5f-4cc8-9ab8-5df3d4bed537" xlink:to="loc_ehth_NonQualifiedHealthPlansMember_ffd049ad-dbbc-49af-ad96-3189f6d5151d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_QualifiedHealthPlansMember_d65c5968-c723-4223-9e6a-355f0001fc9f" xlink:href="ehth-20210930.xsd#ehth_QualifiedHealthPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyDomain_856c75d7-4a5f-4cc8-9ab8-5df3d4bed537" xlink:to="loc_ehth_QualifiedHealthPlansMember_d65c5968-c723-4223-9e6a-355f0001fc9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedAncillariesAxis_eaddbacc-e194-41df-b924-cd73c6c58f1a" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedAncillariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:to="loc_ehth_DisaggregatedAncillariesAxis_eaddbacc-e194-41df-b924-cd73c6c58f1a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedAncillariesDomain_eaddbacc-e194-41df-b924-cd73c6c58f1a_default" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedAncillariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ehth_DisaggregatedAncillariesAxis_eaddbacc-e194-41df-b924-cd73c6c58f1a" xlink:to="loc_ehth_DisaggregatedAncillariesDomain_eaddbacc-e194-41df-b924-cd73c6c58f1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedAncillariesDomain_9df7de53-79d5-4792-866c-9305d080c03a" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedAncillariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ehth_DisaggregatedAncillariesAxis_eaddbacc-e194-41df-b924-cd73c6c58f1a" xlink:to="loc_ehth_DisaggregatedAncillariesDomain_9df7de53-79d5-4792-866c-9305d080c03a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ShorttermMember_3b2be219-d021-468c-801c-fb8e871f185a" xlink:href="ehth-20210930.xsd#ehth_ShorttermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_9df7de53-79d5-4792-866c-9305d080c03a" xlink:to="loc_ehth_ShorttermMember_3b2be219-d021-468c-801c-fb8e871f185a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DentalMember_b1fceb89-c2cc-4732-9e1e-55ad1fa48a48" xlink:href="ehth-20210930.xsd#ehth_DentalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_9df7de53-79d5-4792-866c-9305d080c03a" xlink:to="loc_ehth_DentalMember_b1fceb89-c2cc-4732-9e1e-55ad1fa48a48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_VisionMember_802bebf2-fdfb-4623-9d21-1248d66ce288" xlink:href="ehth-20210930.xsd#ehth_VisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_9df7de53-79d5-4792-866c-9305d080c03a" xlink:to="loc_ehth_VisionMember_802bebf2-fdfb-4623-9d21-1248d66ce288" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OtherMember_18b60545-0480-42cc-9eb8-3653086ea851" xlink:href="ehth-20210930.xsd#ehth_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_9df7de53-79d5-4792-866c-9305d080c03a" xlink:to="loc_ehth_OtherMember_18b60545-0480-42cc-9eb8-3653086ea851" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedOtherAxis_f2fc1181-d5db-42da-8b00-3658fcd92d3c" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedOtherAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:to="loc_ehth_DisaggregatedOtherAxis_f2fc1181-d5db-42da-8b00-3658fcd92d3c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedOtherDomain_f2fc1181-d5db-42da-8b00-3658fcd92d3c_default" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedOtherDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ehth_DisaggregatedOtherAxis_f2fc1181-d5db-42da-8b00-3658fcd92d3c" xlink:to="loc_ehth_DisaggregatedOtherDomain_f2fc1181-d5db-42da-8b00-3658fcd92d3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedOtherDomain_959d212e-acda-44c1-ba32-a4692fb37557" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedOtherDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ehth_DisaggregatedOtherAxis_f2fc1181-d5db-42da-8b00-3658fcd92d3c" xlink:to="loc_ehth_DisaggregatedOtherDomain_959d212e-acda-44c1-ba32-a4692fb37557" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SponsorshipAndAdvertisingMember_70abed03-fbc4-42b9-9f86-9d7026f65033" xlink:href="ehth-20210930.xsd#ehth_SponsorshipAndAdvertisingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedOtherDomain_959d212e-acda-44c1-ba32-a4692fb37557" xlink:to="loc_ehth_SponsorshipAndAdvertisingMember_70abed03-fbc4-42b9-9f86-9d7026f65033" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MiscellaneousOtherMember_0f564ba4-8308-41c4-92d9-19dc58e69197" xlink:href="ehth-20210930.xsd#ehth_MiscellaneousOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_DisaggregatedOtherDomain_959d212e-acda-44c1-ba32-a4692fb37557" xlink:to="loc_ehth_MiscellaneousOtherMember_0f564ba4-8308-41c4-92d9-19dc58e69197" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#RevenueCommissionRevenuebySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails" xlink:type="extended" id="ie3d5368a2a8a4434a78395840eb0f534_RevenueCommissionRevenuebySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e35e9b0a-4b5f-4797-8446-a4d043fa054e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f63212bb-ed67-47e5-be4a-02f3fa6becac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e35e9b0a-4b5f-4797-8446-a4d043fa054e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f63212bb-ed67-47e5-be4a-02f3fa6becac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d9025c1a-faa4-45e2-a94e-bd19cdec0efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e35e9b0a-4b5f-4797-8446-a4d043fa054e" xlink:to="loc_us-gaap_EarningsPerShareBasic_d9025c1a-faa4-45e2-a94e-bd19cdec0efc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_216edf3d-e6cc-403b-bd6c-33e950e91e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e35e9b0a-4b5f-4797-8446-a4d043fa054e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_216edf3d-e6cc-403b-bd6c-33e950e91e9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_01776087-855c-47e2-a56c-0d62d3aacc5e" xlink:href="ehth-20210930.xsd#ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e35e9b0a-4b5f-4797-8446-a4d043fa054e" xlink:to="loc_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_01776087-855c-47e2-a56c-0d62d3aacc5e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_5630d6f2-371a-432e-8f3b-9d2d183e9ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e35e9b0a-4b5f-4797-8446-a4d043fa054e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_5630d6f2-371a-432e-8f3b-9d2d183e9ffc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2ad3d1be-a395-4088-bcc2-37aa9dbee791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5630d6f2-371a-432e-8f3b-9d2d183e9ffc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2ad3d1be-a395-4088-bcc2-37aa9dbee791" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2ad3d1be-a395-4088-bcc2-37aa9dbee791_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2ad3d1be-a395-4088-bcc2-37aa9dbee791" xlink:to="loc_us-gaap_SegmentDomain_2ad3d1be-a395-4088-bcc2-37aa9dbee791_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d390f2f5-707c-4843-9f51-30b4f2a5330e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2ad3d1be-a395-4088-bcc2-37aa9dbee791" xlink:to="loc_us-gaap_SegmentDomain_d390f2f5-707c-4843-9f51-30b4f2a5330e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSegmentMember_89c3b426-e72b-4c2f-84a2-8e2f02824ee2" xlink:href="ehth-20210930.xsd#ehth_MedicareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d390f2f5-707c-4843-9f51-30b4f2a5330e" xlink:to="loc_ehth_MedicareSegmentMember_89c3b426-e72b-4c2f-84a2-8e2f02824ee2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_76e3d4c4-ba7c-4144-8f56-dbd68feed853" xlink:href="ehth-20210930.xsd#ehth_IndividualFamilyAndSmallBusinessSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d390f2f5-707c-4843-9f51-30b4f2a5330e" xlink:to="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_76e3d4c4-ba7c-4144-8f56-dbd68feed853" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_40a9edb0-b57a-4fe0-a75e-bab8fe800a49" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5630d6f2-371a-432e-8f3b-9d2d183e9ffc" xlink:to="loc_srt_ProductOrServiceAxis_40a9edb0-b57a-4fe0-a75e-bab8fe800a49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_40a9edb0-b57a-4fe0-a75e-bab8fe800a49_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_40a9edb0-b57a-4fe0-a75e-bab8fe800a49" xlink:to="loc_srt_ProductsAndServicesDomain_40a9edb0-b57a-4fe0-a75e-bab8fe800a49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_37cf7f9d-6c2c-4fe1-b412-42188d515d95" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_40a9edb0-b57a-4fe0-a75e-bab8fe800a49" xlink:to="loc_srt_ProductsAndServicesDomain_37cf7f9d-6c2c-4fe1-b412-42188d515d95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMember_c9b1b06a-39fc-459c-9545-79711f17d711" xlink:href="ehth-20210930.xsd#ehth_CommissionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_37cf7f9d-6c2c-4fe1-b412-42188d515d95" xlink:to="loc_ehth_CommissionMember_c9b1b06a-39fc-459c-9545-79711f17d711" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_7b130f81-c3af-49ec-b4ed-144edcdbdad4" xlink:href="ehth-20210930.xsd#ehth_CommissionMembersApprovedDuringCurrentPeriodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_CommissionMember_c9b1b06a-39fc-459c-9545-79711f17d711" xlink:to="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_7b130f81-c3af-49ec-b4ed-144edcdbdad4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionRevenueFromRenewalsMember_955bebb6-6ddd-402a-8eab-065bf51ff6f9" xlink:href="ehth-20210930.xsd#ehth_CommissionRevenueFromRenewalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_CommissionMember_c9b1b06a-39fc-459c-9545-79711f17d711" xlink:to="loc_ehth_CommissionRevenueFromRenewalsMember_955bebb6-6ddd-402a-8eab-065bf51ff6f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_131bcdae-4c8a-4a1d-a6d9-353ef1767caa" xlink:href="ehth-20210930.xsd#ehth_CommissionMembersApprovedInPriorPeriodsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_CommissionMember_c9b1b06a-39fc-459c-9545-79711f17d711" xlink:to="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_131bcdae-4c8a-4a1d-a6d9-353ef1767caa" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SupplementalFinancialStatementInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails" xlink:type="extended" id="ic082c6ed9dd64db196a34818bd768459_SupplementalFinancialStatementInformationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_6c39f4f8-91c1-443b-9dbb-29169d4dd86f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_6caeec11-147f-462a-b7ea-4b6bf2a08038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_6c39f4f8-91c1-443b-9dbb-29169d4dd86f" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_6caeec11-147f-462a-b7ea-4b6bf2a08038" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff_9e310d17-fd23-4ae2-acc3-8c85e24680ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_6c39f4f8-91c1-443b-9dbb-29169d4dd86f" xlink:to="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff_9e310d17-fd23-4ae2-acc3-8c85e24680ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Deposits_588cc9ec-975a-4fb9-95fa-6f6cecaa65d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Deposits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_6c39f4f8-91c1-443b-9dbb-29169d4dd86f" xlink:to="loc_us-gaap_Deposits_588cc9ec-975a-4fb9-95fa-6f6cecaa65d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_1f20e309-cb86-4e4a-9ca1-65f381d688dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_6c39f4f8-91c1-443b-9dbb-29169d4dd86f" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_1f20e309-cb86-4e4a-9ca1-65f381d688dd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_07f60b55-5bd9-4d5e-91d6-b128cc690ca6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_1f20e309-cb86-4e4a-9ca1-65f381d688dd" xlink:to="loc_srt_StatementGeographicalAxis_07f60b55-5bd9-4d5e-91d6-b128cc690ca6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_07f60b55-5bd9-4d5e-91d6-b128cc690ca6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_07f60b55-5bd9-4d5e-91d6-b128cc690ca6" xlink:to="loc_srt_SegmentGeographicalDomain_07f60b55-5bd9-4d5e-91d6-b128cc690ca6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_606fcab5-ba2d-46e6-9746-83e7db7060ec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_07f60b55-5bd9-4d5e-91d6-b128cc690ca6" xlink:to="loc_srt_SegmentGeographicalDomain_606fcab5-ba2d-46e6-9746-83e7db7060ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_a7498c34-55e7-4eb2-915c-8d53ee529f5a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_606fcab5-ba2d-46e6-9746-83e7db7060ec" xlink:to="loc_country_CN_a7498c34-55e7-4eb2-915c-8d53ee529f5a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails" xlink:type="extended" id="i6a4b737bc8044459b9c1bc584125e977_SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_dd0eab9a-954c-4e43-8bc0-710ca62a640b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ChangeInContractWithCustomerAssetRollForward_2cf83e11-0502-4f4a-8927-27e57cefa454" xlink:href="ehth-20210930.xsd#ehth_ChangeInContractWithCustomerAssetRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_dd0eab9a-954c-4e43-8bc0-710ca62a640b" xlink:to="loc_ehth_ChangeInContractWithCustomerAssetRollForward_2cf83e11-0502-4f4a-8927-27e57cefa454" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_c2fc3eae-0aba-4f76-b786-60805d176bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_2cf83e11-0502-4f4a-8927-27e57cefa454" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_c2fc3eae-0aba-4f76-b786-60805d176bba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1413ddc2-df38-40ee-8579-477f81a13cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_2cf83e11-0502-4f4a-8927-27e57cefa454" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1413ddc2-df38-40ee-8579-477f81a13cf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCommissionsReceived_43634c92-0c73-48a5-8a5d-dd298ee062be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCommissionsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_2cf83e11-0502-4f4a-8927-27e57cefa454" xlink:to="loc_us-gaap_ProceedsFromCommissionsReceived_43634c92-0c73-48a5-8a5d-dd298ee062be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease_90badb51-e30f-4df7-9f1b-931cb03f7e62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_2cf83e11-0502-4f4a-8927-27e57cefa454" xlink:to="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease_90badb51-e30f-4df7-9f1b-931cb03f7e62" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_b8b9f8d9-eaef-4a73-843c-45c634cd6b56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_6b644292-e555-443b-a3f5-e25452b987d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_dd0eab9a-954c-4e43-8bc0-710ca62a640b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_6b644292-e555-443b-a3f5-e25452b987d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9da235ee-e911-40a4-a1f0-10565550dfbe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6b644292-e555-443b-a3f5-e25452b987d9" xlink:to="loc_srt_ProductOrServiceAxis_9da235ee-e911-40a4-a1f0-10565550dfbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9da235ee-e911-40a4-a1f0-10565550dfbe_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9da235ee-e911-40a4-a1f0-10565550dfbe" xlink:to="loc_srt_ProductsAndServicesDomain_9da235ee-e911-40a4-a1f0-10565550dfbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_37a85265-4ba9-4950-bfa9-8fe0aa2183ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9da235ee-e911-40a4-a1f0-10565550dfbe" xlink:to="loc_srt_ProductsAndServicesDomain_37a85265-4ba9-4950-bfa9-8fe0aa2183ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_4d3ab74a-0086-4926-a09d-fca48ed20780" xlink:href="ehth-20210930.xsd#ehth_CommissionMembersApprovedDuringCurrentPeriodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_37a85265-4ba9-4950-bfa9-8fe0aa2183ab" xlink:to="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_4d3ab74a-0086-4926-a09d-fca48ed20780" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionRevenueFromRenewalsMember_ac85baae-2fef-443a-acdd-4d441ac097d8" xlink:href="ehth-20210930.xsd#ehth_CommissionRevenueFromRenewalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_37a85265-4ba9-4950-bfa9-8fe0aa2183ab" xlink:to="loc_ehth_CommissionRevenueFromRenewalsMember_ac85baae-2fef-443a-acdd-4d441ac097d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_e642447e-f08b-4a20-b138-0c4d115409b4" xlink:href="ehth-20210930.xsd#ehth_CommissionMembersApprovedInPriorPeriodsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_37a85265-4ba9-4950-bfa9-8fe0aa2183ab" xlink:to="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_e642447e-f08b-4a20-b138-0c4d115409b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_623d17c1-1cdb-4037-a324-dea243c7a508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6b644292-e555-443b-a3f5-e25452b987d9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_623d17c1-1cdb-4037-a324-dea243c7a508" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_623d17c1-1cdb-4037-a324-dea243c7a508_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_623d17c1-1cdb-4037-a324-dea243c7a508" xlink:to="loc_us-gaap_SegmentDomain_623d17c1-1cdb-4037-a324-dea243c7a508_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3c72fc97-9cfd-4867-9e22-5ad24d84bc58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_623d17c1-1cdb-4037-a324-dea243c7a508" xlink:to="loc_us-gaap_SegmentDomain_3c72fc97-9cfd-4867-9e22-5ad24d84bc58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSegmentMember_67dcb4d9-6ca3-4ba0-8043-54cbfe7a3d57" xlink:href="ehth-20210930.xsd#ehth_MedicareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3c72fc97-9cfd-4867-9e22-5ad24d84bc58" xlink:to="loc_ehth_MedicareSegmentMember_67dcb4d9-6ca3-4ba0-8043-54cbfe7a3d57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_242db675-049f-4d8f-892a-5e6559af4fa4" xlink:href="ehth-20210930.xsd#ehth_IndividualFamilyAndSmallBusinessSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3c72fc97-9cfd-4867-9e22-5ad24d84bc58" xlink:to="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_242db675-049f-4d8f-892a-5e6559af4fa4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails" xlink:type="extended" id="idc2a826be3cc4f69b8bf513eedc238b6_SupplementalFinancialStatementInformationScheduleofCreditRiskDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_05156a44-f835-4e42-836d-d13afde61b99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1f975047-594e-4e68-8a17-c33d42353af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_05156a44-f835-4e42-836d-d13afde61b99" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1f975047-594e-4e68-8a17-c33d42353af5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_26e38de0-078e-4576-92bc-2e8b96a26be3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_05156a44-f835-4e42-836d-d13afde61b99" xlink:to="loc_us-gaap_ConcentrationRiskTable_26e38de0-078e-4576-92bc-2e8b96a26be3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_639f815d-ce9d-465d-9978-e6ad0dcc0bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_26e38de0-078e-4576-92bc-2e8b96a26be3" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_639f815d-ce9d-465d-9978-e6ad0dcc0bda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_639f815d-ce9d-465d-9978-e6ad0dcc0bda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_639f815d-ce9d-465d-9978-e6ad0dcc0bda" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_639f815d-ce9d-465d-9978-e6ad0dcc0bda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_05517828-3389-4e61-80b0-c05045333786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_639f815d-ce9d-465d-9978-e6ad0dcc0bda" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_05517828-3389-4e61-80b0-c05045333786" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_64cf3410-ad9c-4948-93d3-394db03fa5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_05517828-3389-4e61-80b0-c05045333786" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_64cf3410-ad9c-4948-93d3-394db03fa5f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ff25ea62-4666-4de1-8468-4eaeace246f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_26e38de0-078e-4576-92bc-2e8b96a26be3" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ff25ea62-4666-4de1-8468-4eaeace246f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ff25ea62-4666-4de1-8468-4eaeace246f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ff25ea62-4666-4de1-8468-4eaeace246f1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ff25ea62-4666-4de1-8468-4eaeace246f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_31a8cacc-53f5-46b1-b406-8897a3b5772d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ff25ea62-4666-4de1-8468-4eaeace246f1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_31a8cacc-53f5-46b1-b406-8897a3b5772d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_c6753196-236d-4d56-8ca9-8bab1ccfcd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_31a8cacc-53f5-46b1-b406-8897a3b5772d" xlink:to="loc_us-gaap_AccountsReceivableMember_c6753196-236d-4d56-8ca9-8bab1ccfcd5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_d41e9fbb-5563-48ab-b6a3-65592ccb3584" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_26e38de0-078e-4576-92bc-2e8b96a26be3" xlink:to="loc_srt_MajorCustomersAxis_d41e9fbb-5563-48ab-b6a3-65592ccb3584" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d41e9fbb-5563-48ab-b6a3-65592ccb3584_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_d41e9fbb-5563-48ab-b6a3-65592ccb3584" xlink:to="loc_srt_NameOfMajorCustomerDomain_d41e9fbb-5563-48ab-b6a3-65592ccb3584_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_98f505f2-40b4-4730-b304-935ec3c1bd4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_d41e9fbb-5563-48ab-b6a3-65592ccb3584" xlink:to="loc_srt_NameOfMajorCustomerDomain_98f505f2-40b4-4730-b304-935ec3c1bd4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_HumanaMember_a3f7e87e-8a39-4994-ba3f-12752f124a94" xlink:href="ehth-20210930.xsd#ehth_HumanaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_98f505f2-40b4-4730-b304-935ec3c1bd4d" xlink:to="loc_ehth_HumanaMember_a3f7e87e-8a39-4994-ba3f-12752f124a94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnitedhealthcareMember_0c0a604c-46b1-47cb-b687-47aa9bc56ce0" xlink:href="ehth-20210930.xsd#ehth_UnitedhealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_98f505f2-40b4-4730-b304-935ec3c1bd4d" xlink:to="loc_ehth_UnitedhealthcareMember_0c0a604c-46b1-47cb-b687-47aa9bc56ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AetnaMember_b6f9554e-1e8c-4b4d-9995-a52025b22acc" xlink:href="ehth-20210930.xsd#ehth_AetnaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_98f505f2-40b4-4730-b304-935ec3c1bd4d" xlink:to="loc_ehth_AetnaMember_b6f9554e-1e8c-4b4d-9995-a52025b22acc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CenteneMember_131a15da-85f3-4e24-88e2-16326ca439c4" xlink:href="ehth-20210930.xsd#ehth_CenteneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_98f505f2-40b4-4730-b304-935ec3c1bd4d" xlink:to="loc_ehth_CenteneMember_131a15da-85f3-4e24-88e2-16326ca439c4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#FairValueMeasurementsSummaryofFinancialAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails" xlink:type="extended" id="iab5d5d2464014740adee6ffcc4ecaec9_FairValueMeasurementsSummaryofFinancialAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_52c9724e-5a8c-488c-8dbf-22f7898c43b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_ff9dde77-bceb-4e8b-b805-ac08a1a3ad08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_52c9724e-5a8c-488c-8dbf-22f7898c43b1" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_ff9dde77-bceb-4e8b-b805-ac08a1a3ad08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_8f00fa34-3f37-4004-9128-73a267e4313f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_ff9dde77-bceb-4e8b-b805-ac08a1a3ad08" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_8f00fa34-3f37-4004-9128-73a267e4313f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1e76f2d2-cf98-4ff3-baca-9c328c468ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_ff9dde77-bceb-4e8b-b805-ac08a1a3ad08" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1e76f2d2-cf98-4ff3-baca-9c328c468ba1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_749415f6-9ad1-4f7d-b4ce-4ec03e1a055c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_ff9dde77-bceb-4e8b-b805-ac08a1a3ad08" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_749415f6-9ad1-4f7d-b4ce-4ec03e1a055c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_52c9724e-5a8c-488c-8dbf-22f7898c43b1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_41d61875-ddcf-42eb-915b-48ba456e4c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_41d61875-ddcf-42eb-915b-48ba456e4c8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_41d61875-ddcf-42eb-915b-48ba456e4c8a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_41d61875-ddcf-42eb-915b-48ba456e4c8a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_41d61875-ddcf-42eb-915b-48ba456e4c8a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a72a332c-4b6d-4383-946d-b2b90a6df803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_41d61875-ddcf-42eb-915b-48ba456e4c8a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a72a332c-4b6d-4383-946d-b2b90a6df803" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_2b194840-1bac-4626-9fe6-53db702de4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a72a332c-4b6d-4383-946d-b2b90a6df803" xlink:to="loc_us-gaap_MoneyMarketFundsMember_2b194840-1bac-4626-9fe6-53db702de4a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_bed2a4a2-e102-42d6-8860-419234c3f7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a72a332c-4b6d-4383-946d-b2b90a6df803" xlink:to="loc_us-gaap_CommercialPaperMember_bed2a4a2-e102-42d6-8860-419234c3f7b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_902563fa-f87f-482c-b89e-9821486132aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_902563fa-f87f-482c-b89e-9821486132aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_902563fa-f87f-482c-b89e-9821486132aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_902563fa-f87f-482c-b89e-9821486132aa" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_902563fa-f87f-482c-b89e-9821486132aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb98c383-eb45-43b9-9bfe-8fbb629266ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_902563fa-f87f-482c-b89e-9821486132aa" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb98c383-eb45-43b9-9bfe-8fbb629266ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_63f88cb7-6f47-45bc-b80c-642765044c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb98c383-eb45-43b9-9bfe-8fbb629266ea" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_63f88cb7-6f47-45bc-b80c-642765044c7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_ec8a8d57-37e6-4947-a01e-d9dab015e189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb98c383-eb45-43b9-9bfe-8fbb629266ea" xlink:to="loc_us-gaap_CommercialPaperMember_ec8a8d57-37e6-4947-a01e-d9dab015e189" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_76bdbb47-7f72-4ae0-bb31-a58694723393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb98c383-eb45-43b9-9bfe-8fbb629266ea" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_76bdbb47-7f72-4ae0-bb31-a58694723393" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_4af5f6b6-b786-4fc6-93aa-8b85f8474648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_4af5f6b6-b786-4fc6-93aa-8b85f8474648" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4af5f6b6-b786-4fc6-93aa-8b85f8474648_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_4af5f6b6-b786-4fc6-93aa-8b85f8474648" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4af5f6b6-b786-4fc6-93aa-8b85f8474648_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_08a9f7ff-1849-4271-8301-86d7997865ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_4af5f6b6-b786-4fc6-93aa-8b85f8474648" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_08a9f7ff-1849-4271-8301-86d7997865ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_89f4fada-3ea7-48fa-8a5f-c4a350e30315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_08a9f7ff-1849-4271-8301-86d7997865ee" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_89f4fada-3ea7-48fa-8a5f-c4a350e30315" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_aa6b74eb-9638-4fa4-88b2-dd040ccb95e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_89f4fada-3ea7-48fa-8a5f-c4a350e30315" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_aa6b74eb-9638-4fa4-88b2-dd040ccb95e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_cbdce5fa-d118-4fee-9c82-57a754b42249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_89f4fada-3ea7-48fa-8a5f-c4a350e30315" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_cbdce5fa-d118-4fee-9c82-57a754b42249" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_310fdc07-98d5-4302-a5a8-bd928a57505a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_310fdc07-98d5-4302-a5a8-bd928a57505a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_310fdc07-98d5-4302-a5a8-bd928a57505a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_310fdc07-98d5-4302-a5a8-bd928a57505a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_310fdc07-98d5-4302-a5a8-bd928a57505a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b09feb94-addf-452b-a56e-a06ee16be0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_310fdc07-98d5-4302-a5a8-bd928a57505a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b09feb94-addf-452b-a56e-a06ee16be0ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f6400171-15b0-4e05-8901-df3e25893b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b09feb94-addf-452b-a56e-a06ee16be0ca" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f6400171-15b0-4e05-8901-df3e25893b65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0a5349f4-ebcc-4cca-b2cd-057a8d4eed72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b09feb94-addf-452b-a56e-a06ee16be0ca" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0a5349f4-ebcc-4cca-b2cd-057a8d4eed72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7318b560-b0f2-4be9-be73-0e19739c8d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b09feb94-addf-452b-a56e-a06ee16be0ca" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7318b560-b0f2-4be9-be73-0e19739c8d19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_23af3604-765b-4efb-a83a-448cb1bc17d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_23af3604-765b-4efb-a83a-448cb1bc17d7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_23af3604-765b-4efb-a83a-448cb1bc17d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_23af3604-765b-4efb-a83a-448cb1bc17d7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_23af3604-765b-4efb-a83a-448cb1bc17d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f887a556-3315-465a-9036-ea1d48c88736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_23af3604-765b-4efb-a83a-448cb1bc17d7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f887a556-3315-465a-9036-ea1d48c88736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_416dc361-0947-4eb1-9a66-502eb0cec3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f887a556-3315-465a-9036-ea1d48c88736" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_416dc361-0947-4eb1-9a66-502eb0cec3b1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#FairValueMeasurementsUnrealizedGainsandLossesDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails" xlink:type="extended" id="i2567a266865043c2831af8d336f84f67_FairValueMeasurementsUnrealizedGainsandLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_83dd390b-eddf-457e-bbe1-591eb646b31b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:to="loc_us-gaap_CashAndCashEquivalentsAbstract_83dd390b-eddf-457e-bbe1-591eb646b31b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4a5b93f8-ddc3-4346-867c-b9d0464cb9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_83dd390b-eddf-457e-bbe1-591eb646b31b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4a5b93f8-ddc3-4346-867c-b9d0464cb9cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_198830a7-9866-45dc-be8f-328334cbc3fe" xlink:href="ehth-20210930.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_83dd390b-eddf-457e-bbe1-591eb646b31b" xlink:to="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_198830a7-9866-45dc-be8f-328334cbc3fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_35b27faa-30d7-4993-b591-3759adf798c3" xlink:href="ehth-20210930.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_83dd390b-eddf-457e-bbe1-591eb646b31b" xlink:to="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_35b27faa-30d7-4993-b591-3759adf798c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_95768210-b544-4151-a6be-4a03fda07c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_83dd390b-eddf-457e-bbe1-591eb646b31b" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_95768210-b544-4151-a6be-4a03fda07c66" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_89e549a7-e6d0-4ced-933a-6361130be6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_89e549a7-e6d0-4ced-933a-6361130be6f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_65cb0e05-f9e5-40c7-88cd-c1b8528edc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_89e549a7-e6d0-4ced-933a-6361130be6f0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_65cb0e05-f9e5-40c7-88cd-c1b8528edc74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_5550b2f7-bb37-4050-bae1-bb8a57efb1cc" xlink:href="ehth-20210930.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_89e549a7-e6d0-4ced-933a-6361130be6f0" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_5550b2f7-bb37-4050-bae1-bb8a57efb1cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_c8e29d5c-32b0-4cd7-bf4e-1e0872e8cadf" xlink:href="ehth-20210930.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_89e549a7-e6d0-4ced-933a-6361130be6f0" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_c8e29d5c-32b0-4cd7-bf4e-1e0872e8cadf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_734c11cd-39cb-4ad3-90a8-67ff96c434fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_89e549a7-e6d0-4ced-933a-6361130be6f0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_734c11cd-39cb-4ad3-90a8-67ff96c434fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_1ed31f61-8a29-449d-a1a2-58608e57a20c" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_1ed31f61-8a29-449d-a1a2-58608e57a20c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c517b19d-1b17-4363-a181-7b0a710d9b74" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c517b19d-1b17-4363-a181-7b0a710d9b74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ed8d3274-0211-4df3-9df9-c497640996c1" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ed8d3274-0211-4df3-9df9-c497640996c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_8a39fac4-0452-40be-a170-e059aedfd4ca" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_8a39fac4-0452-40be-a170-e059aedfd4ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e243350a-e61a-4ddf-b2f6-140e09c55dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e243350a-e61a-4ddf-b2f6-140e09c55dad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_35969cf4-e9b8-40f6-a15e-7241003420e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e243350a-e61a-4ddf-b2f6-140e09c55dad" xlink:to="loc_us-gaap_FinancialInstrumentAxis_35969cf4-e9b8-40f6-a15e-7241003420e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_35969cf4-e9b8-40f6-a15e-7241003420e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_35969cf4-e9b8-40f6-a15e-7241003420e5" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_35969cf4-e9b8-40f6-a15e-7241003420e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7832a46d-ea80-4d49-8e7f-75c37351d240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_35969cf4-e9b8-40f6-a15e-7241003420e5" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7832a46d-ea80-4d49-8e7f-75c37351d240" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_06c0bc2c-38b7-45df-8d9c-76d503933863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7832a46d-ea80-4d49-8e7f-75c37351d240" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_06c0bc2c-38b7-45df-8d9c-76d503933863" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_daa030d8-a078-4cbb-bf78-c89e8f820ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7832a46d-ea80-4d49-8e7f-75c37351d240" xlink:to="loc_us-gaap_CommercialPaperMember_daa030d8-a078-4cbb-bf78-c89e8f820ef1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_e8919f59-1159-4cfb-9300-6d7b74ffa716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7832a46d-ea80-4d49-8e7f-75c37351d240" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_e8919f59-1159-4cfb-9300-6d7b74ffa716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_f6f88cbf-5540-435b-a1d2-ab039879a5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e243350a-e61a-4ddf-b2f6-140e09c55dad" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_f6f88cbf-5540-435b-a1d2-ab039879a5ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_f6f88cbf-5540-435b-a1d2-ab039879a5ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_f6f88cbf-5540-435b-a1d2-ab039879a5ed" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_f6f88cbf-5540-435b-a1d2-ab039879a5ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e6a17a38-1ba7-46f8-987d-53ec8289b121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_f6f88cbf-5540-435b-a1d2-ab039879a5ed" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e6a17a38-1ba7-46f8-987d-53ec8289b121" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_7c02a3a3-eabb-4247-a2c8-c5ecec674cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e6a17a38-1ba7-46f8-987d-53ec8289b121" xlink:to="loc_us-gaap_MoneyMarketFundsMember_7c02a3a3-eabb-4247-a2c8-c5ecec674cd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_df5823b7-5c1a-48bf-a48d-30cf2c9d71dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e6a17a38-1ba7-46f8-987d-53ec8289b121" xlink:to="loc_us-gaap_CommercialPaperMember_df5823b7-5c1a-48bf-a48d-30cf2c9d71dc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#EquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/EquityNarrativeDetails" xlink:type="extended" id="i59e7f0d15eb047e3af44a50913606208_EquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e4709fe4-3f21-44bd-a560-6d9db46dac95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_a05574c2-34a8-464e-a1a1-f75e1c8e06d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e4709fe4-3f21-44bd-a560-6d9db46dac95" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_a05574c2-34a8-464e-a1a1-f75e1c8e06d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_522396c3-c12f-4914-9bcd-ad2afc6143d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e4709fe4-3f21-44bd-a560-6d9db46dac95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_522396c3-c12f-4914-9bcd-ad2afc6143d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_a9ce77ad-4447-42ce-a750-45c26027d7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e4709fe4-3f21-44bd-a560-6d9db46dac95" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_a9ce77ad-4447-42ce-a750-45c26027d7bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes_d96ca262-d734-4720-98fd-e48551cdaaaf" xlink:href="ehth-20210930.xsd#ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e4709fe4-3f21-44bd-a560-6d9db46dac95" xlink:to="loc_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes_d96ca262-d734-4720-98fd-e48551cdaaaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_ec92f48d-7e21-4caf-830c-f853396062b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e4709fe4-3f21-44bd-a560-6d9db46dac95" xlink:to="loc_us-gaap_TreasuryStockShares_ec92f48d-7e21-4caf-830c-f853396062b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_e38cf595-f709-4668-890e-5b962c796193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e4709fe4-3f21-44bd-a560-6d9db46dac95" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_e38cf595-f709-4668-890e-5b962c796193" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_cf79cd17-7053-4876-9b95-111070fbf240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_e38cf595-f709-4668-890e-5b962c796193" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_cf79cd17-7053-4876-9b95-111070fbf240" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_cf79cd17-7053-4876-9b95-111070fbf240_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cf79cd17-7053-4876-9b95-111070fbf240" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_cf79cd17-7053-4876-9b95-111070fbf240_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_416b3381-1a6c-49eb-a915-2edb63549780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cf79cd17-7053-4876-9b95-111070fbf240" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_416b3381-1a6c-49eb-a915-2edb63549780" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreviousRepurchaseProgramsMember_b9167799-1d91-4784-8b2c-1a4bb6fb801d" xlink:href="ehth-20210930.xsd#ehth_PreviousRepurchaseProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_416b3381-1a6c-49eb-a915-2edb63549780" xlink:to="loc_ehth_PreviousRepurchaseProgramsMember_b9167799-1d91-4784-8b2c-1a4bb6fb801d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9fd052b7-2b57-43af-9faa-86c05a2bd51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_e38cf595-f709-4668-890e-5b962c796193" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9fd052b7-2b57-43af-9faa-86c05a2bd51a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9fd052b7-2b57-43af-9faa-86c05a2bd51a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9fd052b7-2b57-43af-9faa-86c05a2bd51a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9fd052b7-2b57-43af-9faa-86c05a2bd51a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_878e9531-7838-43e3-899f-875ff84e289e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9fd052b7-2b57-43af-9faa-86c05a2bd51a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_878e9531-7838-43e3-899f-875ff84e289e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b851b914-b8c4-4a95-aede-a50714e602e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_878e9531-7838-43e3-899f-875ff84e289e" xlink:to="loc_us-gaap_SubsequentEventMember_b851b914-b8c4-4a95-aede-a50714e602e3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#EquityScheduleofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended" id="ib12085b69d6044c3b031951e0332d6e1_EquityScheduleofStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4085dfb8-4812-4370-826e-7c5f98fd0e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2506bbea-95a6-4c71-8df8-640379cf87cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4085dfb8-4812-4370-826e-7c5f98fd0e29" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2506bbea-95a6-4c71-8df8-640379cf87cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_c951be9e-7316-4154-8752-79fa0b812992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4085dfb8-4812-4370-826e-7c5f98fd0e29" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_c951be9e-7316-4154-8752-79fa0b812992" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_11790174-0528-449e-b705-30b98173c0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4085dfb8-4812-4370-826e-7c5f98fd0e29" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_11790174-0528-449e-b705-30b98173c0b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a84f386e-9dc0-4fd9-8a55-169291350e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4085dfb8-4812-4370-826e-7c5f98fd0e29" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a84f386e-9dc0-4fd9-8a55-169291350e90" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2228ca62-b09b-45cc-9586-db94dc4bbc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a84f386e-9dc0-4fd9-8a55-169291350e90" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2228ca62-b09b-45cc-9586-db94dc4bbc4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2228ca62-b09b-45cc-9586-db94dc4bbc4a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2228ca62-b09b-45cc-9586-db94dc4bbc4a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2228ca62-b09b-45cc-9586-db94dc4bbc4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7b464f0c-374a-4ead-b216-ff92d710a323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2228ca62-b09b-45cc-9586-db94dc4bbc4a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7b464f0c-374a-4ead-b216-ff92d710a323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_73504d4c-d88d-4ef3-9590-055b7bad0b75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b464f0c-374a-4ead-b216-ff92d710a323" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_73504d4c-d88d-4ef3-9590-055b7bad0b75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CustomerCareAndEnrollmentExpenseMember_8671ddba-e000-478d-b95d-200b3e45f4c1" xlink:href="ehth-20210930.xsd#ehth_CustomerCareAndEnrollmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b464f0c-374a-4ead-b216-ff92d710a323" xlink:to="loc_ehth_CustomerCareAndEnrollmentExpenseMember_8671ddba-e000-478d-b95d-200b3e45f4c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TechnologyAndContentExpenseMember_a4ecca24-ac56-46e7-8dcb-fa74722fa98b" xlink:href="ehth-20210930.xsd#ehth_TechnologyAndContentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b464f0c-374a-4ead-b216-ff92d710a323" xlink:to="loc_ehth_TechnologyAndContentExpenseMember_a4ecca24-ac56-46e7-8dcb-fa74722fa98b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c715458a-65e1-430f-9a99-e01dcd0f799b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b464f0c-374a-4ead-b216-ff92d710a323" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c715458a-65e1-430f-9a99-e01dcd0f799b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_52dc43d7-0174-482a-8d6e-659a607a96b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a84f386e-9dc0-4fd9-8a55-169291350e90" xlink:to="loc_us-gaap_AwardTypeAxis_52dc43d7-0174-482a-8d6e-659a607a96b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_52dc43d7-0174-482a-8d6e-659a607a96b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_52dc43d7-0174-482a-8d6e-659a607a96b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_52dc43d7-0174-482a-8d6e-659a607a96b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ab79297-b97b-4dae-b17f-598686ccce93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_52dc43d7-0174-482a-8d6e-659a607a96b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ab79297-b97b-4dae-b17f-598686ccce93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4dc34344-6983-4297-a11e-ca2be7a60861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ab79297-b97b-4dae-b17f-598686ccce93" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4dc34344-6983-4297-a11e-ca2be7a60861" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ac5fe7be-9a36-48df-bbf8-0ad5c3996dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ab79297-b97b-4dae-b17f-598686ccce93" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ac5fe7be-9a36-48df-bbf8-0ad5c3996dd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_b45164f7-6462-4538-b629-2ef54ce3a09e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ab79297-b97b-4dae-b17f-598686ccce93" xlink:to="loc_us-gaap_EmployeeStockMember_b45164f7-6462-4538-b629-2ef54ce3a09e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_464fdf09-8d18-49a9-90c9-77dac1a9b212" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a84f386e-9dc0-4fd9-8a55-169291350e90" xlink:to="loc_srt_TitleOfIndividualAxis_464fdf09-8d18-49a9-90c9-77dac1a9b212" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_464fdf09-8d18-49a9-90c9-77dac1a9b212_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_464fdf09-8d18-49a9-90c9-77dac1a9b212" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_464fdf09-8d18-49a9-90c9-77dac1a9b212_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_28212bf2-2aab-41cd-9646-bd00793266fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_464fdf09-8d18-49a9-90c9-77dac1a9b212" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_28212bf2-2aab-41cd-9646-bd00793266fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_20c2d65c-2a27-4e8d-bc0a-6a88e2b3ef64" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_28212bf2-2aab-41cd-9646-bd00793266fe" xlink:to="loc_srt_ChiefExecutiveOfficerMember_20c2d65c-2a27-4e8d-bc0a-6a88e2b3ef64" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#ConvertiblePreferredStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails" xlink:type="extended" id="i4544d3a7eaf14631bd890b0e563f2cbb_ConvertiblePreferredStockNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_dfc1d5cf-745e-4faf-b727-73d94983899e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_dfc1d5cf-745e-4faf-b727-73d94983899e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_63ccdcd8-5403-4fad-a4d9-3e45aafbc2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_63ccdcd8-5403-4fad-a4d9-3e45aafbc2a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_4fc5caf2-0bbc-4435-a24d-f705aad19d21" xlink:href="ehth-20210930.xsd#ehth_SaleOfStockConsiderationReceivedOnTransactionGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_4fc5caf2-0bbc-4435-a24d-f705aad19d21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_859830c0-b63c-43a7-adf3-b6fcd446faf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_859830c0-b63c-43a7-adf3-b6fcd446faf3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_22468f94-a41a-43cd-97eb-7473aaef1652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_22468f94-a41a-43cd-97eb-7473aaef1652" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_e4ea4771-3c3d-4569-9e52-b1621283005f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_e4ea4771-3c3d-4569-9e52-b1621283005f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreferredStockConvertibleStatedValue_82843770-84fb-4d3c-bbc5-63e2931904f4" xlink:href="ehth-20210930.xsd#ehth_PreferredStockConvertibleStatedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_PreferredStockConvertibleStatedValue_82843770-84fb-4d3c-bbc5-63e2931904f4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreferredStockDividendRatePayableInKindPercentage_278b9e8f-a659-4eb9-984d-3ec2b96549aa" xlink:href="ehth-20210930.xsd#ehth_PreferredStockDividendRatePayableInKindPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_PreferredStockDividendRatePayableInKindPercentage_278b9e8f-a659-4eb9-984d-3ec2b96549aa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreferredStockDividendRateCashPercentage_71df6fe5-cd5a-43b5-942a-d4d75b7e02af" xlink:href="ehth-20210930.xsd#ehth_PreferredStockDividendRateCashPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_PreferredStockDividendRateCashPercentage_71df6fe5-cd5a-43b5-942a-d4d75b7e02af" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionPrice_94e27c63-edd4-44cc-ade0-449e29660668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockConvertibleConversionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionPrice_94e27c63-edd4-44cc-ade0-449e29660668" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare_a4ca309b-eb63-49cd-bcdb-b483c183e3fd" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare_a4ca309b-eb63-49cd-bcdb-b483c183e3fd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice_a67d51ce-c032-43e3-89a9-0a75d02da3fd" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice_a67d51ce-c032-43e3-89a9-0a75d02da3fd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors_e595e579-19bc-4159-9ee5-d96e3e998331" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors_e595e579-19bc-4159-9ee5-d96e3e998331" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors_1e2d191c-9fa0-4413-abc1-2263bc3b7516" xlink:href="ehth-20210930.xsd#ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors_1e2d191c-9fa0-4413-abc1-2263bc3b7516" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockVotesPerShare_4f32aff9-5bd1-4d85-b6b3-676f48de1f1d" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockVotesPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockVotesPerShare_4f32aff9-5bd1-4d85-b6b3-676f48de1f1d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger_9ba297b7-4d48-4dff-9b6a-463f2bef6674" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger_9ba297b7-4d48-4dff-9b6a-463f2bef6674" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays_4c8ad8e3-da33-4f42-b441-e3aef66135e2" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays_4c8ad8e3-da33-4f42-b441-e3aef66135e2" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockThresholdTradingDays_ea612c03-c262-4979-8c34-b5b4b070f4fb" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockThresholdTradingDays_ea612c03-c262-4979-8c34-b5b4b070f4fb" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt_8b2c9e6e-39c7-4620-94fe-bb21c923693d" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt_8b2c9e6e-39c7-4620-94fe-bb21c923693d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio_7d13b6a3-40f7-4a75-a07b-1a95a7c2ccb2" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio_7d13b6a3-40f7-4a75-a07b-1a95a7c2ccb2" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockCovenantLiquidity_0dc01125-43d1-471d-a34c-37c047611e89" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockCovenantLiquidity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockCovenantLiquidity_0dc01125-43d1-471d-a34c-37c047611e89" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_eb6c0512-4d8f-46d7-8714-adea9fe82172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_eb6c0512-4d8f-46d7-8714-adea9fe82172" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis_4335001b-ac1a-457e-93ec-6eaa3d268375" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis_4335001b-ac1a-457e-93ec-6eaa3d268375" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_bcd4b8b1-3cfa-432d-b06d-56bc85ae1585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_bcd4b8b1-3cfa-432d-b06d-56bc85ae1585" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_bdef3dd7-42dd-44b8-a73c-95cc23abbf17" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_bcd4b8b1-3cfa-432d-b06d-56bc85ae1585" xlink:to="loc_srt_StatementScenarioAxis_bdef3dd7-42dd-44b8-a73c-95cc23abbf17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_bdef3dd7-42dd-44b8-a73c-95cc23abbf17_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_bdef3dd7-42dd-44b8-a73c-95cc23abbf17" xlink:to="loc_srt_ScenarioUnspecifiedDomain_bdef3dd7-42dd-44b8-a73c-95cc23abbf17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_db5a8d51-4cf8-44c2-83c8-a6c11548197f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_bdef3dd7-42dd-44b8-a73c-95cc23abbf17" xlink:to="loc_srt_ScenarioUnspecifiedDomain_db5a8d51-4cf8-44c2-83c8-a6c11548197f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_424afffe-d788-4626-bff5-f401bd76f18d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_db5a8d51-4cf8-44c2-83c8-a6c11548197f" xlink:to="loc_srt_ScenarioForecastMember_424afffe-d788-4626-bff5-f401bd76f18d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_55097f25-e466-4fd5-b119-4ed875182b74" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_bcd4b8b1-3cfa-432d-b06d-56bc85ae1585" xlink:to="loc_srt_RangeAxis_55097f25-e466-4fd5-b119-4ed875182b74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55097f25-e466-4fd5-b119-4ed875182b74_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_55097f25-e466-4fd5-b119-4ed875182b74" xlink:to="loc_srt_RangeMember_55097f25-e466-4fd5-b119-4ed875182b74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e76953f9-4160-4c95-852d-0357a7ad6c0e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_55097f25-e466-4fd5-b119-4ed875182b74" xlink:to="loc_srt_RangeMember_e76953f9-4160-4c95-852d-0357a7ad6c0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fb48f072-6771-43e3-aa94-b117021c3e92" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e76953f9-4160-4c95-852d-0357a7ad6c0e" xlink:to="loc_srt_MinimumMember_fb48f072-6771-43e3-aa94-b117021c3e92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9d7192ef-bc06-47ca-848e-aadb07704854" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e76953f9-4160-4c95-852d-0357a7ad6c0e" xlink:to="loc_srt_MaximumMember_9d7192ef-bc06-47ca-848e-aadb07704854" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c2b903a7-7969-4d4e-b843-79a6537fcf4a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_bcd4b8b1-3cfa-432d-b06d-56bc85ae1585" xlink:to="loc_srt_CounterpartyNameAxis_c2b903a7-7969-4d4e-b843-79a6537fcf4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c2b903a7-7969-4d4e-b843-79a6537fcf4a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_c2b903a7-7969-4d4e-b843-79a6537fcf4a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c2b903a7-7969-4d4e-b843-79a6537fcf4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5dc1f88-76cf-4fa4-8d60-7c4528a6d2f3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_c2b903a7-7969-4d4e-b843-79a6537fcf4a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5dc1f88-76cf-4fa4-8d60-7c4528a6d2f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EchelonHealthSPCLPHIGMember_206e416e-53b0-414b-ad70-1a58f893445d" xlink:href="ehth-20210930.xsd#ehth_EchelonHealthSPCLPHIGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5dc1f88-76cf-4fa4-8d60-7c4528a6d2f3" xlink:to="loc_ehth_EchelonHealthSPCLPHIGMember_206e416e-53b0-414b-ad70-1a58f893445d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails" xlink:type="extended" id="i19c3ce9f9fad4c7282b5637a41542ce5_NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_20ac5ae4-4d7d-4d29-afbf-001d4eeb729b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_298fb561-c20d-40b4-80a0-4d7c8183f364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_20ac5ae4-4d7d-4d29-afbf-001d4eeb729b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_298fb561-c20d-40b4-80a0-4d7c8183f364" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f120b45f-292e-4be3-8b57-791c1b1b3cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_20ac5ae4-4d7d-4d29-afbf-001d4eeb729b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f120b45f-292e-4be3-8b57-791c1b1b3cf7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e27d51eb-2639-4f69-a953-8e1fbfc548af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f120b45f-292e-4be3-8b57-791c1b1b3cf7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e27d51eb-2639-4f69-a953-8e1fbfc548af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e27d51eb-2639-4f69-a953-8e1fbfc548af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e27d51eb-2639-4f69-a953-8e1fbfc548af" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e27d51eb-2639-4f69-a953-8e1fbfc548af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c684a98-b334-4a91-808d-68f0d517f051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e27d51eb-2639-4f69-a953-8e1fbfc548af" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c684a98-b334-4a91-808d-68f0d517f051" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_72578368-008c-49b3-8935-7eadee38c7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c684a98-b334-4a91-808d-68f0d517f051" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_72578368-008c-49b3-8935-7eadee38c7e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5f633747-94b4-4184-9303-18123a270cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c684a98-b334-4a91-808d-68f0d517f051" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5f633747-94b4-4184-9303-18123a270cee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fd370de1-dc28-43df-8cbe-6daffcfd2e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c684a98-b334-4a91-808d-68f0d517f051" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fd370de1-dc28-43df-8cbe-6daffcfd2e88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_8e35c23d-54dd-415c-bc03-9833c6af1ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c684a98-b334-4a91-808d-68f0d517f051" xlink:to="loc_us-gaap_EmployeeStockMember_8e35c23d-54dd-415c-bc03-9833c6af1ad8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="ie64eb4399db54141880d84d4333e530d_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_13a2705e-c928-4c4f-aed1-f7a5373a952c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_13a2705e-c928-4c4f-aed1-f7a5373a952c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_f7f301ac-a87b-4ce3-886f-b0dacfd41949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_f7f301ac-a87b-4ce3-886f-b0dacfd41949" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear_e73c5294-365c-4b03-b894-253c56ec6870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_ContractualObligationDueInSecondYear_e73c5294-365c-4b03-b894-253c56ec6870" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear_20c46d00-963f-4f3b-8b35-685868429873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_ContractualObligationDueInThirdYear_20c46d00-963f-4f3b-8b35-685868429873" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear_2968e72e-4453-47f1-b67a-65426c0cbd38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_ContractualObligationDueInFourthYear_2968e72e-4453-47f1-b67a-65426c0cbd38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ContractualObligationToBePaidAfterYearFour_9883e268-eab9-41e7-ac56-4af9ce42005e" xlink:href="ehth-20210930.xsd#ehth_ContractualObligationToBePaidAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_ehth_ContractualObligationToBePaidAfterYearFour_9883e268-eab9-41e7-ac56-4af9ce42005e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_05dfef69-18f4-4f0a-89d6-0d6269fa6834" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_ContractualObligation_05dfef69-18f4-4f0a-89d6-0d6269fa6834" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_c31a154e-f734-4937-88a1-635bd2ee2fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_c31a154e-f734-4937-88a1-635bd2ee2fd6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_26ecbec2-b70c-4278-8c22-43c39bb26a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_26ecbec2-b70c-4278-8c22-43c39bb26a3c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_2fafad94-0a72-4f08-ba72-db6f91521c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_LossContingenciesTable_2fafad94-0a72-4f08-ba72-db6f91521c21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8cd12bf3-d8c0-45b6-9e66-1072f65030b4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2fafad94-0a72-4f08-ba72-db6f91521c21" xlink:to="loc_srt_LitigationCaseAxis_8cd12bf3-d8c0-45b6-9e66-1072f65030b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8cd12bf3-d8c0-45b6-9e66-1072f65030b4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_8cd12bf3-d8c0-45b6-9e66-1072f65030b4" xlink:to="loc_srt_LitigationCaseTypeDomain_8cd12bf3-d8c0-45b6-9e66-1072f65030b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_797187a6-60a6-4e47-b13d-54deb9d2aa3c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_8cd12bf3-d8c0-45b6-9e66-1072f65030b4" xlink:to="loc_srt_LitigationCaseTypeDomain_797187a6-60a6-4e47-b13d-54deb9d2aa3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LeViasCompliantMember_30db4c59-98c6-477f-a5b5-98ed8e48b412" xlink:href="ehth-20210930.xsd#ehth_LeViasCompliantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_797187a6-60a6-4e47-b13d-54deb9d2aa3c" xlink:to="loc_ehth_LeViasCompliantMember_30db4c59-98c6-477f-a5b5-98ed8e48b412" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SegmentandGeographicInformationSegmentOperatingResultsDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails" xlink:type="extended" id="i2a55e8f47f8841298a2589f61bcb15b9_SegmentandGeographicInformationSegmentOperatingResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_28862977-c275-4496-bfc6-7ac89825aca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_NumberOfOperatingSegments_28862977-c275-4496-bfc6-7ac89825aca8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3983c375-a8b9-4c9c-85df-14129a5f7ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3983c375-a8b9-4c9c-85df-14129a5f7ff1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SegmentOperatingIncomeLoss_1d0c4517-ea64-455e-a857-f48153e4d999" xlink:href="ehth-20210930.xsd#ehth_SegmentOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_ehth_SegmentOperatingIncomeLoss_1d0c4517-ea64-455e-a857-f48153e4d999" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_05e6b784-836d-43c1-8f55-bb47fd7248a4" xlink:href="ehth-20210930.xsd#ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_05e6b784-836d-43c1-8f55-bb47fd7248a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_644dd838-dce0-496b-9f1e-7021af3de756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_644dd838-dce0-496b-9f1e-7021af3de756" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6723eab8-a9dc-42e2-bab0-a654eb48c70f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6723eab8-a9dc-42e2-bab0-a654eb48c70f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_768a1e85-8706-4e5a-b7dc-19aae248ffea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_RestructuringCharges_768a1e85-8706-4e5a-b7dc-19aae248ffea" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a6c9eb85-374a-4274-ae3b-eb3acd771d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a6c9eb85-374a-4274-ae3b-eb3acd771d10" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2e1ca617-7acf-40e0-b80d-a582c136a809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2e1ca617-7acf-40e0-b80d-a582c136a809" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_52fc8387-e3a5-42d6-8bbe-3668ba981d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_52fc8387-e3a5-42d6-8bbe-3668ba981d7c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_656ec613-6ba3-498a-8afd-3c2c2e3ec06b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_656ec613-6ba3-498a-8afd-3c2c2e3ec06b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c9767159-4077-4830-b6e7-7952e2f2872f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_656ec613-6ba3-498a-8afd-3c2c2e3ec06b" xlink:to="loc_srt_ConsolidationItemsAxis_c9767159-4077-4830-b6e7-7952e2f2872f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c9767159-4077-4830-b6e7-7952e2f2872f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_c9767159-4077-4830-b6e7-7952e2f2872f" xlink:to="loc_srt_ConsolidationItemsDomain_c9767159-4077-4830-b6e7-7952e2f2872f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_fcd3088d-568e-4bb6-ad84-dcd0211870b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_c9767159-4077-4830-b6e7-7952e2f2872f" xlink:to="loc_srt_ConsolidationItemsDomain_fcd3088d-568e-4bb6-ad84-dcd0211870b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_26f843b8-dc1d-44d2-9c4e-d6cf097afcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_fcd3088d-568e-4bb6-ad84-dcd0211870b6" xlink:to="loc_us-gaap_OperatingSegmentsMember_26f843b8-dc1d-44d2-9c4e-d6cf097afcbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_a466506c-47fd-477f-8597-cdd26eab5fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_fcd3088d-568e-4bb6-ad84-dcd0211870b6" xlink:to="loc_us-gaap_CorporateNonSegmentMember_a466506c-47fd-477f-8597-cdd26eab5fd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0cf30d93-051d-44e2-900b-7d1cefad8c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_656ec613-6ba3-498a-8afd-3c2c2e3ec06b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0cf30d93-051d-44e2-900b-7d1cefad8c21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0cf30d93-051d-44e2-900b-7d1cefad8c21_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0cf30d93-051d-44e2-900b-7d1cefad8c21" xlink:to="loc_us-gaap_SegmentDomain_0cf30d93-051d-44e2-900b-7d1cefad8c21_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_faeef90b-6c0a-44cf-9c32-5fab802041ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0cf30d93-051d-44e2-900b-7d1cefad8c21" xlink:to="loc_us-gaap_SegmentDomain_faeef90b-6c0a-44cf-9c32-5fab802041ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSegmentMember_52b8e6fb-93d0-44b9-adaa-25334efa1e95" xlink:href="ehth-20210930.xsd#ehth_MedicareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_faeef90b-6c0a-44cf-9c32-5fab802041ac" xlink:to="loc_ehth_MedicareSegmentMember_52b8e6fb-93d0-44b9-adaa-25334efa1e95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_50fe975b-3f30-4992-8eba-1873f116ea6a" xlink:href="ehth-20210930.xsd#ehth_IndividualFamilyAndSmallBusinessSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_faeef90b-6c0a-44cf-9c32-5fab802041ac" xlink:to="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_50fe975b-3f30-4992-8eba-1873f116ea6a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails" xlink:type="extended" id="i7b33241003994030b886960112e7b3e2_SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ff71d5ca-c670-4cdd-bd29-5d413aec6501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_2dce00b6-08e3-4187-ad32-49a094042543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ff71d5ca-c670-4cdd-bd29-5d413aec6501" xlink:to="loc_us-gaap_NoncurrentAssets_2dce00b6-08e3-4187-ad32-49a094042543" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf6e5f50-6384-4501-a7f0-7ea8ea106083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ff71d5ca-c670-4cdd-bd29-5d413aec6501" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf6e5f50-6384-4501-a7f0-7ea8ea106083" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_833b81ad-aa7b-47c5-8485-962baccc59f9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf6e5f50-6384-4501-a7f0-7ea8ea106083" xlink:to="loc_srt_StatementGeographicalAxis_833b81ad-aa7b-47c5-8485-962baccc59f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_833b81ad-aa7b-47c5-8485-962baccc59f9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_833b81ad-aa7b-47c5-8485-962baccc59f9" xlink:to="loc_srt_SegmentGeographicalDomain_833b81ad-aa7b-47c5-8485-962baccc59f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1f17f6aa-ee79-469c-8739-ef58da93f7d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_833b81ad-aa7b-47c5-8485-962baccc59f9" xlink:to="loc_srt_SegmentGeographicalDomain_1f17f6aa-ee79-469c-8739-ef58da93f7d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6d2865d2-b9b1-4db7-ae69-67ff488389f8" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1f17f6aa-ee79-469c-8739-ef58da93f7d9" xlink:to="loc_country_US_6d2865d2-b9b1-4db7-ae69-67ff488389f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_c8e5ad45-3bd6-4399-af86-5b6ccb2c22a9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1f17f6aa-ee79-469c-8739-ef58da93f7d9" xlink:to="loc_country_CN_c8e5ad45-3bd6-4399-af86-5b6ccb2c22a9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails" xlink:type="extended" id="id72a0f3a5aca438c96f23c2d6bb97200_SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_a3c5116f-917e-4c3e-b88f-9e0fade9e985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_09bc60d8-615c-4ab3-8fd8-44c0bdf94296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_a3c5116f-917e-4c3e-b88f-9e0fade9e985" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_09bc60d8-615c-4ab3-8fd8-44c0bdf94296" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a4ac1b8f-d380-470d-b438-1e9e7b650ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_a3c5116f-917e-4c3e-b88f-9e0fade9e985" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a4ac1b8f-d380-470d-b438-1e9e7b650ed6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_a811b5f2-6aff-43ae-86d5-5cb4c70bad00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a4ac1b8f-d380-470d-b438-1e9e7b650ed6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_a811b5f2-6aff-43ae-86d5-5cb4c70bad00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a811b5f2-6aff-43ae-86d5-5cb4c70bad00_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_a811b5f2-6aff-43ae-86d5-5cb4c70bad00" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a811b5f2-6aff-43ae-86d5-5cb4c70bad00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_74bdf103-3412-4b46-b8f0-d2c91aeb4238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_a811b5f2-6aff-43ae-86d5-5cb4c70bad00" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_74bdf103-3412-4b46-b8f0-d2c91aeb4238" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_d04e6607-c9ff-4114-9c81-49f17d4ea810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_74bdf103-3412-4b46-b8f0-d2c91aeb4238" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_d04e6607-c9ff-4114-9c81-49f17d4ea810" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_762ce1a8-4973-4b88-b574-985366411a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a4ac1b8f-d380-470d-b438-1e9e7b650ed6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_762ce1a8-4973-4b88-b574-985366411a3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_762ce1a8-4973-4b88-b574-985366411a3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_762ce1a8-4973-4b88-b574-985366411a3a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_762ce1a8-4973-4b88-b574-985366411a3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_10864253-7a24-4e43-b1ea-333c644a8566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_762ce1a8-4973-4b88-b574-985366411a3a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_10864253-7a24-4e43-b1ea-333c644a8566" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_b7732832-d827-4048-9052-0a757f9d3149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_10864253-7a24-4e43-b1ea-333c644a8566" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_b7732832-d827-4048-9052-0a757f9d3149" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_8a170ed6-7a7e-47a6-95ed-bcbf6eff515c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a4ac1b8f-d380-470d-b438-1e9e7b650ed6" xlink:to="loc_srt_MajorCustomersAxis_8a170ed6-7a7e-47a6-95ed-bcbf6eff515c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8a170ed6-7a7e-47a6-95ed-bcbf6eff515c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_8a170ed6-7a7e-47a6-95ed-bcbf6eff515c" xlink:to="loc_srt_NameOfMajorCustomerDomain_8a170ed6-7a7e-47a6-95ed-bcbf6eff515c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_765bf12a-01bc-46d9-a4ea-5f92bad5f21f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_8a170ed6-7a7e-47a6-95ed-bcbf6eff515c" xlink:to="loc_srt_NameOfMajorCustomerDomain_765bf12a-01bc-46d9-a4ea-5f92bad5f21f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnitedhealthcareMember_856b104b-5a0d-4ce1-978e-8155e806fa36" xlink:href="ehth-20210930.xsd#ehth_UnitedhealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_765bf12a-01bc-46d9-a4ea-5f92bad5f21f" xlink:to="loc_ehth_UnitedhealthcareMember_856b104b-5a0d-4ce1-978e-8155e806fa36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AetnaMember_d71447e1-e0ae-4fa6-b4c5-8b74518714db" xlink:href="ehth-20210930.xsd#ehth_AetnaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_765bf12a-01bc-46d9-a4ea-5f92bad5f21f" xlink:to="loc_ehth_AetnaMember_d71447e1-e0ae-4fa6-b4c5-8b74518714db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_HumanaMember_7f6ebef0-3da9-4ab4-bced-ec97fc8684c1" xlink:href="ehth-20210930.xsd#ehth_HumanaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_765bf12a-01bc-46d9-a4ea-5f92bad5f21f" xlink:to="loc_ehth_HumanaMember_7f6ebef0-3da9-4ab4-bced-ec97fc8684c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CenteneMember_12a72edc-c1f4-4116-8f79-628ae710df4d" xlink:href="ehth-20210930.xsd#ehth_CenteneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_765bf12a-01bc-46d9-a4ea-5f92bad5f21f" xlink:to="loc_ehth_CenteneMember_12a72edc-c1f4-4116-8f79-628ae710df4d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/LeasesNarrativeDetails" xlink:type="extended" id="ie8bca2f5de944bc09cace0f0ef0397e9_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_a3ab500b-4d55-4d97-af70-da7ffa740774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_421d903f-9693-46fa-aa11-ecf7552ab997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a3ab500b-4d55-4d97-af70-da7ffa740774" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_421d903f-9693-46fa-aa11-ecf7552ab997" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_37917a38-3471-4ed4-8448-96fb827d9e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a3ab500b-4d55-4d97-af70-da7ffa740774" xlink:to="loc_us-gaap_OperatingLeaseCost_37917a38-3471-4ed4-8448-96fb827d9e1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_49d35496-91e5-489d-9935-6327b4691634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a3ab500b-4d55-4d97-af70-da7ffa740774" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_49d35496-91e5-489d-9935-6327b4691634" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_511ddcab-a45e-4152-af49-2ab677be7d7d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_49d35496-91e5-489d-9935-6327b4691634" xlink:to="loc_srt_RangeAxis_511ddcab-a45e-4152-af49-2ab677be7d7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_511ddcab-a45e-4152-af49-2ab677be7d7d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_511ddcab-a45e-4152-af49-2ab677be7d7d" xlink:to="loc_srt_RangeMember_511ddcab-a45e-4152-af49-2ab677be7d7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_39b82684-64c7-438a-b8ba-f7208b788c76" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_511ddcab-a45e-4152-af49-2ab677be7d7d" xlink:to="loc_srt_RangeMember_39b82684-64c7-438a-b8ba-f7208b788c76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_33fa6a2c-8726-4c96-96fa-d296bf5b7ab6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_39b82684-64c7-438a-b8ba-f7208b788c76" xlink:to="loc_srt_MinimumMember_33fa6a2c-8726-4c96-96fa-d296bf5b7ab6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c56179d9-e7c0-4a12-b996-a5b8542bc4be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_39b82684-64c7-438a-b8ba-f7208b788c76" xlink:to="loc_srt_MaximumMember_c56179d9-e7c0-4a12-b996-a5b8542bc4be" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#RestructuringandReorganizationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails" xlink:type="extended" id="ic8496a86d8244fec91a659e57734feb7_RestructuringandReorganizationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_6d77c92b-233e-45b1-bd78-81a7fbda53b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_6d77c92b-233e-45b1-bd78-81a7fbda53b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce_cabc0ae1-7f9f-48e0-bae3-5e711aaff341" xlink:href="ehth-20210930.xsd#ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:to="loc_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce_cabc0ae1-7f9f-48e0-bae3-5e711aaff341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_RestructuringChargesPreTax_a192d030-e773-4588-af50-c989806cee80" xlink:href="ehth-20210930.xsd#ehth_RestructuringChargesPreTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:to="loc_ehth_RestructuringChargesPreTax_a192d030-e773-4588-af50-c989806cee80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_767641c6-2ced-4207-b9c2-8f8da99db4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:to="loc_us-gaap_RestructuringReserve_767641c6-2ced-4207-b9c2-8f8da99db4b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_a5c7a07c-8071-4c76-9ae6-5579f9f8223b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_a5c7a07c-8071-4c76-9ae6-5579f9f8223b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_24ae960b-cf55-440a-9a05-0ff054568196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_24ae960b-cf55-440a-9a05-0ff054568196" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_485783fe-fe7a-495b-9bbf-34a9df6205eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_485783fe-fe7a-495b-9bbf-34a9df6205eb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_db3fa008-1dd7-4d06-a26c-dd9adbd254b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_485783fe-fe7a-495b-9bbf-34a9df6205eb" xlink:to="loc_srt_StatementScenarioAxis_db3fa008-1dd7-4d06-a26c-dd9adbd254b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_db3fa008-1dd7-4d06-a26c-dd9adbd254b9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_db3fa008-1dd7-4d06-a26c-dd9adbd254b9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_db3fa008-1dd7-4d06-a26c-dd9adbd254b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0185a173-989c-422f-9219-b7b68d2047da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_db3fa008-1dd7-4d06-a26c-dd9adbd254b9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0185a173-989c-422f-9219-b7b68d2047da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_e011b500-2f7f-45e1-a8c0-c83801e8748b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_0185a173-989c-422f-9219-b7b68d2047da" xlink:to="loc_srt_ScenarioForecastMember_e011b500-2f7f-45e1-a8c0-c83801e8748b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_ed8949e6-1415-4c4f-9cbf-c41c86815e18" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_485783fe-fe7a-495b-9bbf-34a9df6205eb" xlink:to="loc_srt_TitleOfIndividualAxis_ed8949e6-1415-4c4f-9cbf-c41c86815e18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ed8949e6-1415-4c4f-9cbf-c41c86815e18_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_ed8949e6-1415-4c4f-9cbf-c41c86815e18" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ed8949e6-1415-4c4f-9cbf-c41c86815e18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1bcdf47b-f0d2-4c0f-bd49-6b28a0461879" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_ed8949e6-1415-4c4f-9cbf-c41c86815e18" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1bcdf47b-f0d2-4c0f-bd49-6b28a0461879" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_d9d3a592-a3c3-4ab0-9495-1511065a2c16" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1bcdf47b-f0d2-4c0f-bd49-6b28a0461879" xlink:to="loc_srt_ChiefExecutiveOfficerMember_d9d3a592-a3c3-4ab0-9495-1511065a2c16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9dd7f37a-f71d-41ab-8cc6-a0615ec5cab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_485783fe-fe7a-495b-9bbf-34a9df6205eb" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9dd7f37a-f71d-41ab-8cc6-a0615ec5cab2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9dd7f37a-f71d-41ab-8cc6-a0615ec5cab2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9dd7f37a-f71d-41ab-8cc6-a0615ec5cab2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9dd7f37a-f71d-41ab-8cc6-a0615ec5cab2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_95415522-48b5-4031-9fe7-e528dbcc4269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9dd7f37a-f71d-41ab-8cc6-a0615ec5cab2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_95415522-48b5-4031-9fe7-e528dbcc4269" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1e9ea92a-4a06-4d51-88ae-b666438c9776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_95415522-48b5-4031-9fe7-e528dbcc4269" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1e9ea92a-4a06-4d51-88ae-b666438c9776" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/DebtDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#DebtDetails"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/DebtDetails" xlink:type="extended" id="i240dbe96b9c1448a8988044fa9a73b1c_DebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_0582da55-30f3-4d03-9aba-3e0fbaf5222d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_0582da55-30f3-4d03-9aba-3e0fbaf5222d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityBorrowingBasePercentage_306c3ed5-e8a9-450e-b20f-2c8d7c32766e" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityBorrowingBasePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_ehth_LineOfCreditFacilityBorrowingBasePercentage_306c3ed5-e8a9-450e-b20f-2c8d7c32766e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_486a3cf3-f968-46b1-b3a7-8d6249c13b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_486a3cf3-f968-46b1-b3a7-8d6249c13b42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityFacilityFeePercentage_bf9c5475-de07-4c1e-b806-500e25233374" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityFacilityFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_ehth_LineOfCreditFacilityFacilityFeePercentage_bf9c5475-de07-4c1e-b806-500e25233374" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d9e82804-8872-4fcf-92fe-9f3c712e58b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d9e82804-8872-4fcf-92fe-9f3c712e58b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents_f570007f-0635-4973-aad6-75b420539f11" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents_f570007f-0635-4973-aad6-75b420539f11" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents_92d3fa2a-78f7-4a2c-9e08-5061a82c169d" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents_92d3fa2a-78f7-4a2c-9e08-5061a82c169d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMinimumLiquidity_7db2ef1d-744a-40cb-94cb-f3f9a4120423" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityCovenantMinimumLiquidity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMinimumLiquidity_7db2ef1d-744a-40cb-94cb-f3f9a4120423" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMaximumLiquidity_ca48a9e8-f8f3-40ca-9113-39381ce20048" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityCovenantMaximumLiquidity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMaximumLiquidity_ca48a9e8-f8f3-40ca-9113-39381ce20048" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_c3a82e18-86f1-48bc-b7f2-2284f806bcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_c3a82e18-86f1-48bc-b7f2-2284f806bcaa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_806480d0-5e34-46a1-9281-209e2353413b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_us-gaap_LineOfCredit_806480d0-5e34-46a1-9281-209e2353413b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ef6bb0f3-21c2-4231-b98c-80cc1fc714ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_us-gaap_DebtInstrumentTable_ef6bb0f3-21c2-4231-b98c-80cc1fc714ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_BorrowingBasePercentageAxis_5d26a57c-b0f9-4565-896a-40e1550b07fa" xlink:href="ehth-20210930.xsd#ehth_BorrowingBasePercentageAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ef6bb0f3-21c2-4231-b98c-80cc1fc714ca" xlink:to="loc_ehth_BorrowingBasePercentageAxis_5d26a57c-b0f9-4565-896a-40e1550b07fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_BorrowingBasePercentageDomain_5d26a57c-b0f9-4565-896a-40e1550b07fa_default" xlink:href="ehth-20210930.xsd#ehth_BorrowingBasePercentageDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ehth_BorrowingBasePercentageAxis_5d26a57c-b0f9-4565-896a-40e1550b07fa" xlink:to="loc_ehth_BorrowingBasePercentageDomain_5d26a57c-b0f9-4565-896a-40e1550b07fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_BorrowingBasePercentageDomain_7ea550cf-4569-4c64-96df-15c38bf9cad9" xlink:href="ehth-20210930.xsd#ehth_BorrowingBasePercentageDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ehth_BorrowingBasePercentageAxis_5d26a57c-b0f9-4565-896a-40e1550b07fa" xlink:to="loc_ehth_BorrowingBasePercentageDomain_7ea550cf-4569-4c64-96df-15c38bf9cad9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember_a88282be-4968-4a24-851b-100bf3e76932" xlink:href="ehth-20210930.xsd#ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_BorrowingBasePercentageDomain_7ea550cf-4569-4c64-96df-15c38bf9cad9" xlink:to="loc_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember_a88282be-4968-4a24-851b-100bf3e76932" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember_652656c5-7514-4099-8418-af50ec9281ef" xlink:href="ehth-20210930.xsd#ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_BorrowingBasePercentageDomain_7ea550cf-4569-4c64-96df-15c38bf9cad9" xlink:to="loc_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember_652656c5-7514-4099-8418-af50ec9281ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember_9c1c8a01-f883-4773-b02b-83179cb66f17" xlink:href="ehth-20210930.xsd#ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ehth_BorrowingBasePercentageDomain_7ea550cf-4569-4c64-96df-15c38bf9cad9" xlink:to="loc_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember_9c1c8a01-f883-4773-b02b-83179cb66f17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_60eb1319-7888-4ae3-b7de-428d3b303874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ef6bb0f3-21c2-4231-b98c-80cc1fc714ca" xlink:to="loc_us-gaap_CreditFacilityAxis_60eb1319-7888-4ae3-b7de-428d3b303874" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_60eb1319-7888-4ae3-b7de-428d3b303874_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_60eb1319-7888-4ae3-b7de-428d3b303874" xlink:to="loc_us-gaap_CreditFacilityDomain_60eb1319-7888-4ae3-b7de-428d3b303874_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c1f1a8cb-0fa0-4a6c-8938-b5ad3e67fffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_60eb1319-7888-4ae3-b7de-428d3b303874" xlink:to="loc_us-gaap_CreditFacilityDomain_c1f1a8cb-0fa0-4a6c-8938-b5ad3e67fffc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b7a58c8d-b00d-4180-8b85-7444e47e684b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c1f1a8cb-0fa0-4a6c-8938-b5ad3e67fffc" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b7a58c8d-b00d-4180-8b85-7444e47e684b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_bb9dfafb-5e4b-4946-89ed-3e631d26bc69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c1f1a8cb-0fa0-4a6c-8938-b5ad3e67fffc" xlink:to="loc_us-gaap_LetterOfCreditMember_bb9dfafb-5e4b-4946-89ed-3e631d26bc69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bda3c089-5162-42dd-841c-01c0fed132a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ef6bb0f3-21c2-4231-b98c-80cc1fc714ca" xlink:to="loc_us-gaap_DebtInstrumentAxis_bda3c089-5162-42dd-841c-01c0fed132a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bda3c089-5162-42dd-841c-01c0fed132a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_bda3c089-5162-42dd-841c-01c0fed132a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bda3c089-5162-42dd-841c-01c0fed132a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_37a35c20-7fb8-4ec5-8a83-63df0ed6428e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_bda3c089-5162-42dd-841c-01c0fed132a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_37a35c20-7fb8-4ec5-8a83-63df0ed6428e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CreditAgreementAmendmentMember_c8b8804d-d7f6-47c2-a599-577c60d29cc8" xlink:href="ehth-20210930.xsd#ehth_CreditAgreementAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_37a35c20-7fb8-4ec5-8a83-63df0ed6428e" xlink:to="loc_ehth_CreditAgreementAmendmentMember_c8b8804d-d7f6-47c2-a599-577c60d29cc8" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>ehth-20210930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:001ee10b-2bdc-4177-8047-00c9b0c2bbeb,g:3e9ca025-a681-404c-b475-c1976cd6b86b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_49cff2da-ddb2-4fd5-8061-a96e10446cf8_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_ff421aa1-2df5-48ef-b929-e6668b8a6276_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_28571b6a-dd49-4173-9a6d-336792f217ea_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c235704d-8970-4df9-9ab0-7a71aa7554ae_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_25838fdd-d0a7-4377-b3ef-9fa137752a86_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_711f57f5-2857-467e-ad34-9ed303870c83_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_4729d7e7-02ae-4486-87d4-2bdabc17c9ac_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_f21c0553-631d-41df-9f94-08fdcc35f6af_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_e661821c-1584-4ed9-8433-3584a4d5720d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_17fca123-3fe8-4e5e-9957-ad6e72bcbb26_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_56ebc7a7-02d8-47cc-9195-6ca420b8b2c4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3e5d166f-00a1-4e45-b355-a19d2ba20d21_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_3c203978-6525-4b13-b068-4b0745050cd6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d52e7fec-8705-4a0e-a992-6fc1b31c63bb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_ab4e181f-7abb-44a5-99c3-d7a4a15bb887_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_539e0ad1-8992-457d-a7a9-0b9c072f6cd5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_3be0d23c-56cf-421b-ac44-338d87603ec0_terseLabel_en-US" xlink:label="lab_ehth_CommissionMembersApprovedDuringCurrentPeriodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Revenue from Members Approved During the Period</link:label>
    <link:label id="lab_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_label_en-US" xlink:label="lab_ehth_CommissionMembersApprovedDuringCurrentPeriodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission, Members Approved During Current Period [Member]</link:label>
    <link:label id="lab_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_documentation_en-US" xlink:label="lab_ehth_CommissionMembersApprovedDuringCurrentPeriodMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission, Members Approved During Current Period [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember" xlink:href="ehth-20210930.xsd#ehth_CommissionMembersApprovedDuringCurrentPeriodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember" xlink:to="lab_ehth_CommissionMembersApprovedDuringCurrentPeriodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligationDueInSecondYear_0ba7d5b5-99cc-4cdd-a01f-3ed33e46ebd1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInSecondYear_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInSecondYear" xlink:to="lab_us-gaap_ContractualObligationDueInSecondYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_dbe3ff6b-220a-4ac9-9d65-2b8c8b464e5f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in allowance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:to="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_07442965-a02e-4dec-b20a-7553191beab7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_8c467f05-e697-4f0c-84fe-7f721dfdb693_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contract Assets - Commissions Receivable</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_747154d5-b81f-4c94-83d1-1500e9c5c52c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related contingent payments</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_655ecb85-c235-4c90-9623-5e64560002a2_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_cf47a5f7-7ccb-4f58-ac65-f144274a25fe_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term of operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_1409e2ed-1595-46c3-b7c4-1ee8743ec31f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Contingencies and Guarantees [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:to="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_3f2e535a-1220-4462-a5ed-2bba484ef9d5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_a8d91e10-29e3-4c8e-8c09-bd02f7d32386_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2021</link:label>
    <link:label id="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:to="lab_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f665be7-555d-4f34-87be-f826e9f03305_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_216659b4-29c2-4c0e-8223-25fe59b5dfb1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7f2e9ea6-ff20-4089-9dad-604a7e241139_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d977b1b3-9db6-45d3-8dba-0284345c3fca_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt_cf5183d3-68f4-49e4-a162-f484c05d8fcc_terseLabel_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum ownership percentage needed for consent to incur debt in excess of $175 million</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt_label_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Minimum Ownership Percentage Needed For Consent To Incur Debt</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt_documentation_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Minimum Ownership Percentage Needed For Consent To Incur Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt" xlink:to="lab_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_fb889b56-ade8-413e-8e0d-fbbb1e8e6913_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Unrealized Gains and Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_f4805e30-8afb-4126-abb1-d162bc14e11e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_733b9f40-8ce1-4ea4-886a-b6002bf0b6b2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_9f9ede91-b69d-46fe-a205-aad0e418f298_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_c26214a7-5200-4d24-aa75-4862a674b504_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_8443ad8c-5bfd-467d-a74c-b094d2c7d0e3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_fd037861-e2a0-4fcb-9459-95c4c3ab8899_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_cba9797d-8b88-4c5b-a9d8-e015580cfaaf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate used to recognize operating lease right-of-use-assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_68014abb-8fe0-459d-96b1-5680383e121b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_14383316-5e55-429d-b315-96990f5024f5_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which the Company is licensed to market and sell health insurance</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_1cd168bd-5b8a-420a-86d2-25b28815c229_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_a63b1ef5-899e-443d-a624-3adb172e8a2e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from redemption and maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock_0d8a6ff7-91de-4a88-b535-0cbc72fd0767_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid-in-kind dividend and accretion related to convertible preferred stock</link:label>
    <link:label id="lab_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock_label_en-US" xlink:label="lab_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in Carrying Amount of Redeemable Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock" xlink:to="lab_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d6c59df6-db0f-46b6-9ad6-bfd0474e079b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_598f5d16-bed6-4d0f-aadf-ff635590f732_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_32c7f12d-49fc-4dfc-8415-38efde580176_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_c7e0eab8-5b46-4c04-b0aa-73f2b3fc75d3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_MedicareSupplementMember_245f527c-ffa3-448d-b518-cb6bf3399844_terseLabel_en-US" xlink:label="lab_ehth_MedicareSupplementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Supplement</link:label>
    <link:label id="lab_ehth_MedicareSupplementMember_label_en-US" xlink:label="lab_ehth_MedicareSupplementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Supplement [Member]</link:label>
    <link:label id="lab_ehth_MedicareSupplementMember_documentation_en-US" xlink:label="lab_ehth_MedicareSupplementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Supplement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSupplementMember" xlink:href="ehth-20210930.xsd#ehth_MedicareSupplementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_MedicareSupplementMember" xlink:to="lab_ehth_MedicareSupplementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_d2a7828c-ea03-4926-a17a-36728181068e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Contractual Maturities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_UnitedhealthcareMember_4ec7421a-9535-4018-aed5-e30caf06d57d_terseLabel_en-US" xlink:label="lab_ehth_UnitedhealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnitedHealthcare</link:label>
    <link:label id="lab_ehth_UnitedhealthcareMember_label_en-US" xlink:label="lab_ehth_UnitedhealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unitedhealthcare [Member]</link:label>
    <link:label id="lab_ehth_UnitedhealthcareMember_documentation_en-US" xlink:label="lab_ehth_UnitedhealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UnitedHealthcare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnitedhealthcareMember" xlink:href="ehth-20210930.xsd#ehth_UnitedhealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_UnitedhealthcareMember" xlink:to="lab_ehth_UnitedhealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_2468c603-a260-44fb-961a-ef10edfa1ba6_terseLabel_en-US" xlink:label="lab_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="ehth-20210930.xsd#ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_2e5f9c21-c6a6-42df-b268-0d169f760305_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Major customer revenue, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_cd7f5942-eed7-42c3-ab7a-55d176c70cc9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_8270af3a-fbdd-4010-843f-578ebf6997be_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_e57bf534-1738-47bc-93cc-1d587c021d2f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis_35cc257a-4934-4b50-9d5f-4d7242364192_terseLabel_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued paid-in-kind dividends, common stock equivalent, as-converted (in shares)</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis_label_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Accrued Paid-In-Kind Dividends, Common Stock Equivalent, As-Converted Basis</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis_documentation_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Accrued Paid-In-Kind Dividends, Common Stock Equivalent, As-Converted Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis" xlink:to="lab_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Deposits_f5fbfc86-3315-44ea-963e-6067e53d7668_terseLabel_en-US" xlink:label="lab_us-gaap_Deposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits</link:label>
    <link:label id="lab_us-gaap_Deposits_label_en-US" xlink:label="lab_us-gaap_Deposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Deposits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Deposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Deposits" xlink:to="lab_us-gaap_Deposits" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_cc22f391-a3c1-4047-8b9a-cf1f941ef376_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketingAndAdvertisingExpense_9a3a78ac-88cd-4302-9e55-3f5778c3f3e5_terseLabel_en-US" xlink:label="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing and advertising</link:label>
    <link:label id="lab_us-gaap_MarketingAndAdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing and Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketingAndAdvertisingExpense" xlink:to="lab_us-gaap_MarketingAndAdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityDividendsAdjustment_b9bde585-084e-4a27-8de0-3ad8a41f16a5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityDividendsAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid-in-kind dividends for preferred stock</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityDividendsAdjustment_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityDividendsAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Dividends, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDividendsAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDividendsAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityDividendsAdjustment" xlink:to="lab_us-gaap_TemporaryEquityDividendsAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_82eb5e06-91ff-4593-af16-70c9a5038bb1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember_bd59f7d7-38c6-4e68-b985-c6dda4474bd2_terseLabel_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Succeeding Three Months</link:label>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember_label_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Succeeding Three Months [Member]</link:label>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember_documentation_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Succeeding Three Months [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember" xlink:href="ehth-20210930.xsd#ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember" xlink:to="lab_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_75a1d1d0-36c3-4b1e-be27-23f210583d65_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_fac058cc-aec4-4b26-b67f-b29d3e971314_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:to="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedIndividualandFamilyDomain_95a88c92-84cb-4edb-97ee-3257d494c253_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedIndividualandFamilyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Individual and Family [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedIndividualandFamilyDomain_label_en-US" xlink:label="lab_ehth_DisaggregatedIndividualandFamilyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Individual and Family [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedIndividualandFamilyDomain_documentation_en-US" xlink:label="lab_ehth_DisaggregatedIndividualandFamilyDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Individual and Family [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedIndividualandFamilyDomain" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedIndividualandFamilyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyDomain" xlink:to="lab_ehth_DisaggregatedIndividualandFamilyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock_841a6f83-5141-45c4-ab5f-622eabcae876_terseLabel_en-US" xlink:label="lab_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Stock-Based Compensation Expense By Award Type</link:label>
    <link:label id="lab_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock_label_en-US" xlink:label="lab_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Stock-Based Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock_documentation_en-US" xlink:label="lab_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Stock-Based Compensation Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock" xlink:href="ehth-20210930.xsd#ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock" xlink:to="lab_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_BorrowingBasePercentageAxis_95e12915-3d1a-478d-8bf5-8bac33ec5bbe_terseLabel_en-US" xlink:label="lab_ehth_BorrowingBasePercentageAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing Base Percentage [Axis]</link:label>
    <link:label id="lab_ehth_BorrowingBasePercentageAxis_label_en-US" xlink:label="lab_ehth_BorrowingBasePercentageAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing Base Percentage [Axis]</link:label>
    <link:label id="lab_ehth_BorrowingBasePercentageAxis_documentation_en-US" xlink:label="lab_ehth_BorrowingBasePercentageAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing Base Percentage [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_BorrowingBasePercentageAxis" xlink:href="ehth-20210930.xsd#ehth_BorrowingBasePercentageAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_BorrowingBasePercentageAxis" xlink:to="lab_ehth_BorrowingBasePercentageAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_NonQualifiedHealthPlansMember_61490d94-f03e-4716-bf18-c1eb29bfe39b_terseLabel_en-US" xlink:label="lab_ehth_NonQualifiedHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Qualified Health Plans</link:label>
    <link:label id="lab_ehth_NonQualifiedHealthPlansMember_label_en-US" xlink:label="lab_ehth_NonQualifiedHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Qualified Health Plans [Member]</link:label>
    <link:label id="lab_ehth_NonQualifiedHealthPlansMember_documentation_en-US" xlink:label="lab_ehth_NonQualifiedHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Qualified Health Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_NonQualifiedHealthPlansMember" xlink:href="ehth-20210930.xsd#ehth_NonQualifiedHealthPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_NonQualifiedHealthPlansMember" xlink:to="lab_ehth_NonQualifiedHealthPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_97df25be-9c33-439a-b9a1-f0b38fc7f2ff_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of shares to satisfy employee tax withholding obligations (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_56511e0d-db72-4ef1-a8a6-6c7a2a747524_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_79121712-8cf4-44d1-a979-64ccfe364338_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount capitalized in internal-use software</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Amount Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be5798d2-5d0f-4fda-b4cd-edddbced2092_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_b07a6ec1-0c10-41b3-8277-05913a2cd499_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments in connection with leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_ef3fd629-4fc6-4b05-bec9-4d7e5e46e4ff_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_11134f4b-bdd8-4fe7-b694-91417a273883_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_fdfdb415-7344-4240-8635-770775cd6f7e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_1c296c1a-f6d4-4afb-870e-3fbeaa6067ba_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to common stockholders per share - basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_596bd0d5-137e-43a0-b21c-969db8ab518e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2683ea0e-10a9-4417-bf16-054d8a98e2ad_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_e81714d1-888e-4ab8-8bdd-96ead4a90d8d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_2ad29f26-ef1c-48e0-8757-cc75d019ec2c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of preferred stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_2b4dc11b-53ac-4329-a782-39075410a486_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedMedicareDomain_91b804e0-d338-4485-9426-8abf6c199d33_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedMedicareDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Medicare [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedMedicareDomain_label_en-US" xlink:label="lab_ehth_DisaggregatedMedicareDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Medicare [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedMedicareDomain_documentation_en-US" xlink:label="lab_ehth_DisaggregatedMedicareDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Medicare [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedMedicareDomain" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedMedicareDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedMedicareDomain" xlink:to="lab_ehth_DisaggregatedMedicareDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_0a92f97e-9074-46b9-b107-6cf010bd6280_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_a8fe4f9e-4ec1-4b0c-a0a6-de2b9a3ba444_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue by Segment</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_78233986-cfca-4a0f-9713-a54730f2bd1c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CommissionMember_9deaccc2-c6ed-46b7-a8cc-da314ff7df68_terseLabel_en-US" xlink:label="lab_ehth_CommissionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission</link:label>
    <link:label id="lab_ehth_CommissionMember_label_en-US" xlink:label="lab_ehth_CommissionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission [Member]</link:label>
    <link:label id="lab_ehth_CommissionMember_documentation_en-US" xlink:label="lab_ehth_CommissionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMember" xlink:href="ehth-20210930.xsd#ehth_CommissionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CommissionMember" xlink:to="lab_ehth_CommissionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_4a66e773-bb16-47b3-a0e1-2afcacdc76e1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_8034c26b-7bb8-4faa-941a-9869bf5d8753_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_9d599241-e90f-450f-94fb-853fcda0b59a_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_2bec510b-1841-4402-990e-7e99d5a8a609_verboseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative effect from the adoption of ASU 2016-13</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_de81f1b5-89a7-4485-954c-a0deabeaf0df_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_323ef8cb-55e5-486e-bccf-01938a0ebbda_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of shares to satisfy employee tax withholding obligations</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_100dc30b-60c1-4c6b-a01c-4153bc00a78d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outflows related to operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_53ce08a8-a469-4c7d-aa4a-96d65e7d283c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_4c36502e-3a74-4425-b72f-42295a0ccd24_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_5d927ff5-e2d7-4d39-a3ac-7ba3d6c6e86c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Positions eliminated</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligationDueInFourthYear_e648342a-de62-46af-a1f3-c9e8012fef60_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInFourthYear_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInFourthYear" xlink:to="lab_us-gaap_ContractualObligationDueInFourthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ConvertiblePreferredStockVotesPerShare_f93b20ef-b95f-4fb2-8bce-c85f5be8459f_terseLabel_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes per share</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockVotesPerShare_label_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Votes Per Share</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockVotesPerShare_documentation_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Votes Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockVotesPerShare" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockVotesPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ConvertiblePreferredStockVotesPerShare" xlink:to="lab_ehth_ConvertiblePreferredStockVotesPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_db06a7f0-dd93-4095-807a-96dc679645a7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend rate</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePercentage_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendRatePercentage" xlink:to="lab_us-gaap_PreferredStockDividendRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CreditAgreementAmendmentMember_232631d3-0d00-4da3-b8a2-9d2cfd9ea034_terseLabel_en-US" xlink:label="lab_ehth_CreditAgreementAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement Amendment</link:label>
    <link:label id="lab_ehth_CreditAgreementAmendmentMember_label_en-US" xlink:label="lab_ehth_CreditAgreementAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement Amendment [Member]</link:label>
    <link:label id="lab_ehth_CreditAgreementAmendmentMember_documentation_en-US" xlink:label="lab_ehth_CreditAgreementAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CreditAgreementAmendmentMember" xlink:href="ehth-20210930.xsd#ehth_CreditAgreementAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CreditAgreementAmendmentMember" xlink:to="lab_ehth_CreditAgreementAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_8e35f3c6-7b53-4187-b2e2-b1c2c7f85a33_terseLabel_en-US" xlink:label="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain</link:label>
    <link:label id="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:label id="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="ehth-20210930.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors_87fa0085-9cb2-435e-821a-47608169131c_terseLabel_en-US" xlink:label="lab_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum common stock ownership percentage needed to nominate individual to board of directors</link:label>
    <link:label id="lab_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors_label_en-US" xlink:label="lab_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Minimum Ownership Percentage Needed To Nominate Individual To Board Of Directors</link:label>
    <link:label id="lab_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors_documentation_en-US" xlink:label="lab_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Minimum Ownership Percentage Needed To Nominate Individual To Board Of Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors" xlink:href="ehth-20210930.xsd#ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors" xlink:to="lab_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6208ae26-4d95-468d-b955-0ea1038594d1_totalLabel_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain</link:label>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-For-Sale Debt Securities, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-For-Sale Debt Securities, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_0bad281d-2c9a-4fd0-ac01-36c90d4966ac_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_5a7ba1a4-6440-44eb-b547-7ddb2ebc0dc0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7ced8081-d967-4e53-b106-b2314078af17_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_9142851a-b418-4242-9827-9d5b3022187a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_a6ba12e8-4e07-443e-bf8a-5941d6f6b7dc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_RestructuringChargesPreTax_2a9de4ba-a068-4fb1-b2cf-35defdcdd143_terseLabel_en-US" xlink:label="lab_ehth_RestructuringChargesPreTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax restructuring charges</link:label>
    <link:label id="lab_ehth_RestructuringChargesPreTax_label_en-US" xlink:label="lab_ehth_RestructuringChargesPreTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Pre-Tax</link:label>
    <link:label id="lab_ehth_RestructuringChargesPreTax_documentation_en-US" xlink:label="lab_ehth_RestructuringChargesPreTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges, Pre-Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_RestructuringChargesPreTax" xlink:href="ehth-20210930.xsd#ehth_RestructuringChargesPreTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_RestructuringChargesPreTax" xlink:to="lab_ehth_RestructuringChargesPreTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_7d177a7e-78d5-4592-8e9e-4b7592d7d1ab_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockSharesConverted1_f3cd3113-d7d1-40f6-ab3d-467285e5f226_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares converted (in shares)</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockSharesConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Shares Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:to="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_0b65e6de-a5c8-4bcc-bd24-cfd54f7df778_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, convertible preferred stock, and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_PreferredStockDividendRateCashPercentage_430c66bc-1a22-4a98-a3ab-6bca76d03dfa_terseLabel_en-US" xlink:label="lab_ehth_PreferredStockDividendRateCashPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend rate, cash</link:label>
    <link:label id="lab_ehth_PreferredStockDividendRateCashPercentage_label_en-US" xlink:label="lab_ehth_PreferredStockDividendRateCashPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Cash, Percentage</link:label>
    <link:label id="lab_ehth_PreferredStockDividendRateCashPercentage_documentation_en-US" xlink:label="lab_ehth_PreferredStockDividendRateCashPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Cash, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreferredStockDividendRateCashPercentage" xlink:href="ehth-20210930.xsd#ehth_PreferredStockDividendRateCashPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_PreferredStockDividendRateCashPercentage" xlink:to="lab_ehth_PreferredStockDividendRateCashPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_4ebb668f-fdbb-416f-99e8-23e2f03dc486_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_591ef78f-9b84-43e9-9d35-f589e1cfdae5_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_df2624f4-5f19-4c8c-a676-d71df3c260d7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_7c6b5b36-d048-4250-9699-91657b4dce52_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_d7792286-bcca-4cd8-b0e6-df1c63900fab_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency bonds</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_5e2f9734-6a42-49ab-83b8-92174073b9ba_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_7c1a5472-8e1c-408d-84f7-84387a4c242a_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_5f9473c9-8b78-47ee-9f5e-9104233c1882_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8d0c4109-35fa-4137-9440-91ec6c4e3545_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, convertible preferred stock, and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_192ebf8a-72d6-4e05-a97c-8f3c443d47ba_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_f23f9fcd-3034-4a07-a921-a4743a7db8f6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_e16d7e70-0311-43e5-a794-4f521dbfbf63_negatedTotalLabel_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Loss</link:label>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-For-Sale Debt Securities, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-For-Sale Debt Securities, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_74ea6cb8-b9ff-4409-afab-a60628df478a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Prepaid Expenses And Other Current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_d8ca866b-741c-492a-ae82-fe05204e8ef9_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share Attributable to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_6d211120-2353-4988-9d1b-c8c0aed06c5b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_e2bfcb97-0225-4316-a4bf-042cd106521f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of shares to satisfy employee tax withholding obligations</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cash Used to Settle Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2c7ef65c-e265-4f15-b1f8-eb987d536b3e_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2161881b-b5fc-48e1-bf52-818d75063529_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with equity incentive plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_7c618dcc-fa84-464d-bf24-0c762647f372_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_7b77e007-fed2-49f5-9bc6-2def813b8a67_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_d48e0659-5ad7-450d-8fc7-2ce2b208e9c0_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9b69d9c1-2b16-4f01-8398-b145941c4287_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9eaabf4f-66da-4419-9fa9-69b408413501_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_341d8215-85b5-4dbd-bd24-5e58bad4a8f9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ShorttermMember_77ca4be4-4620-46fa-ac4d-6d364cb51505_terseLabel_en-US" xlink:label="lab_ehth_ShorttermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term</link:label>
    <link:label id="lab_ehth_ShorttermMember_label_en-US" xlink:label="lab_ehth_ShorttermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term [Member]</link:label>
    <link:label id="lab_ehth_ShorttermMember_documentation_en-US" xlink:label="lab_ehth_ShorttermMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ShorttermMember" xlink:href="ehth-20210930.xsd#ehth_ShorttermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ShorttermMember" xlink:to="lab_ehth_ShorttermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_cad21afd-936d-4cfe-bedc-1f8699ca7810_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period Of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_654220ff-13f7-458d-b401-5695d3d8e8b3_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_33b0bf79-3ae8-4c70-a43d-4d9d1a5ddee7_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_0eada965-dd82-4a21-8cf8-fafc59d7d76b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_ecf8848e-7d33-4f6f-b98f-7a7bf7ddf360_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_48a4a53e-dfd7-4ea0-9c88-dba71115f012_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income, 2022</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_dd53f2d1-dcae-4620-bc21-455c0859be67_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of earnout liability</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_1f0bcb7a-5a3a-4666-a751-fa681eabab7e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToDevelopSoftware_bc035d8d-d082-4fc7-b5ea-d77b8afb5e62_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized internal-use software and website development costs</link:label>
    <link:label id="lab_us-gaap_PaymentsToDevelopSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Develop Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToDevelopSoftware" xlink:to="lab_us-gaap_PaymentsToDevelopSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_100cd451-4347-4b69-b539-949a0b35b4ae_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued in equity offering</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_e0be38fc-c137-499c-9a3a-0757da378f33_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_4f85aa37-7204-4361-b4be-0877d49138c7_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_b488834c-40be-4b6a-aeb8-d762985373c2_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1b03a45b-64ae-4d36-9bcd-b16cd09637f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Components Of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_31fdb04b-bec3-4996-a9db-d041ec83751a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_cf9bafba-5076-4746-bf30-81af2376abe2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligation_02446a0f-11b3-4d8c-aa3f-9e1d5c7551ed_totalLabel_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ContractualObligation_label_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligation" xlink:to="lab_us-gaap_ContractualObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_302f9eaf-0078-496a-885b-5ff58ccf2474_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_8cb8d5f9-3332-49a1-bf49-e81d2bef9d44_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_IncreaseDecreaseInAccruedMarketingExpenses_0937bb3c-fe69-4138-a0d3-8633b93fa8fe_terseLabel_en-US" xlink:label="lab_ehth_IncreaseDecreaseInAccruedMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued marketing expenses</link:label>
    <link:label id="lab_ehth_IncreaseDecreaseInAccruedMarketingExpenses_label_en-US" xlink:label="lab_ehth_IncreaseDecreaseInAccruedMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Accrued Marketing Expenses</link:label>
    <link:label id="lab_ehth_IncreaseDecreaseInAccruedMarketingExpenses_documentation_en-US" xlink:label="lab_ehth_IncreaseDecreaseInAccruedMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in accrued marketing expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInAccruedMarketingExpenses" xlink:href="ehth-20210930.xsd#ehth_IncreaseDecreaseInAccruedMarketingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_IncreaseDecreaseInAccruedMarketingExpenses" xlink:to="lab_ehth_IncreaseDecreaseInAccruedMarketingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b9584453-9970-4391-90f4-a8a200b58222_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued in equity offering (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_BorrowingBasePercentageDomain_776f8a1f-ef5e-436d-98d6-16814899cf97_terseLabel_en-US" xlink:label="lab_ehth_BorrowingBasePercentageDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing Base Percentage [Domain]</link:label>
    <link:label id="lab_ehth_BorrowingBasePercentageDomain_label_en-US" xlink:label="lab_ehth_BorrowingBasePercentageDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing Base Percentage [Domain]</link:label>
    <link:label id="lab_ehth_BorrowingBasePercentageDomain_documentation_en-US" xlink:label="lab_ehth_BorrowingBasePercentageDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Borrowing Base Percentage [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_BorrowingBasePercentageDomain" xlink:href="ehth-20210930.xsd#ehth_BorrowingBasePercentageDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_BorrowingBasePercentageDomain" xlink:to="lab_ehth_BorrowingBasePercentageDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff_e812626e-6b2f-49a3-9c1e-fdbf4940564d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-off</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff" xlink:to="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_8a929802-7ed1-4321-8dd5-c66e43086066_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_b1df29d1-961f-4f39-8341-5907b8e36a75_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_56084b6c-917b-4554-85b8-19caab13e8d8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_c6c785e8-ae98-4e56-a349-268e2ceb4655_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_104f8380-800d-454a-8ca9-636318c68e85_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_bbe1e3b2-6848-4b9c-978e-d8bdbf92fa94_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_b9e51881-253a-44c3-b555-a442563124c3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember_045f69d6-c4a5-4e74-8229-bafd3f40ccb9_terseLabel_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Succeeding Six Months</link:label>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember_label_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Succeeding Six Months [Member]</link:label>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember_documentation_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Succeeding Six Months [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember" xlink:href="ehth-20210930.xsd#ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember" xlink:to="lab_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_3f94cec5-73d1-4cb2-af04-393e9aa4ca69_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a0f6efbe-f35d-4015-94d3-f51157bfaa5c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_d167934b-7924-4ffa-bba6-06bd865c3081_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9c347ca9-c7ee-4a9e-9e0c-0242f71d9db0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_NumberOfHealthInsuranceCarriers_0e13c396-f183-46bd-b03d-9ea867ee2a92_terseLabel_en-US" xlink:label="lab_ehth_NumberOfHealthInsuranceCarriers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of health insurance carriers (more than)</link:label>
    <link:label id="lab_ehth_NumberOfHealthInsuranceCarriers_label_en-US" xlink:label="lab_ehth_NumberOfHealthInsuranceCarriers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Health Insurance Carriers</link:label>
    <link:label id="lab_ehth_NumberOfHealthInsuranceCarriers_documentation_en-US" xlink:label="lab_ehth_NumberOfHealthInsuranceCarriers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Health Insurance Carriers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_NumberOfHealthInsuranceCarriers" xlink:href="ehth-20210930.xsd#ehth_NumberOfHealthInsuranceCarriers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_NumberOfHealthInsuranceCarriers" xlink:to="lab_ehth_NumberOfHealthInsuranceCarriers" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_IncrementalCommonSharesAttributableToOptions_8e177b47-ff0c-4c08-b261-55426aa89f94_terseLabel_en-US" xlink:label="lab_ehth_IncrementalCommonSharesAttributableToOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of common stock (in shares)</link:label>
    <link:label id="lab_ehth_IncrementalCommonSharesAttributableToOptions_label_en-US" xlink:label="lab_ehth_IncrementalCommonSharesAttributableToOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable To Options</link:label>
    <link:label id="lab_ehth_IncrementalCommonSharesAttributableToOptions_documentation_en-US" xlink:label="lab_ehth_IncrementalCommonSharesAttributableToOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable To Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncrementalCommonSharesAttributableToOptions" xlink:href="ehth-20210930.xsd#ehth_IncrementalCommonSharesAttributableToOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_IncrementalCommonSharesAttributableToOptions" xlink:to="lab_ehth_IncrementalCommonSharesAttributableToOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_32489049-7eda-4665-8f31-eea98db422b0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e92c1a7c-cad6-4e29-bb30-94243af13145_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_a8f3fe41-a65b-455a-ab47-a4171ce93532_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_bec7b28c-a752-464e-b410-58f0a772dfeb_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_b24809a6-b54c-4eae-81de-f80fa8ed56b3_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_1d7956f6-40e1-4bf0-a505-73eb5637bc6e_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b59de9ea-b51f-4a78-89d6-6d135ad9f7ce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_ce328370-9e50-4667-966c-906d3528f1b5_totalLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_c6d21440-c425-48f0-8bf3-6f51838c2692_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b8e1dc7d-2407-4386-80d7-812f9bb0a38d_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_829be6af-89bd-478e-bbcc-e145e02f0515_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_d1013e55-5cb7-4ef9-855c-1894e9001e35_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_ed467286-536b-4a2d-9fd0-f8e3542243eb_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_327cb2f6-80d9-415f-bf38-204209844f1c_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_70c4580c-6842-4198-ba4e-07c13f7bf425_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of Closing Date</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3912a46e-e421-404a-b48f-0107a73f2587_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of September 30, 2021</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ContractualObligationToBePaidAfterYearFour_8fc5a85c-617d-4099-aa3f-4a4fd1ab89ea_terseLabel_en-US" xlink:label="lab_ehth_ContractualObligationToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_ehth_ContractualObligationToBePaidAfterYearFour_label_en-US" xlink:label="lab_ehth_ContractualObligationToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, After Year Four</link:label>
    <link:label id="lab_ehth_ContractualObligationToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_ehth_ContractualObligationToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ContractualObligationToBePaidAfterYearFour" xlink:href="ehth-20210930.xsd#ehth_ContractualObligationToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ContractualObligationToBePaidAfterYearFour" xlink:to="lab_ehth_ContractualObligationToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio_0b4f8105-9755-4ad7-b5db-de52dd4e6c9e_terseLabel_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset coverage ratio</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio_label_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Covenant, Asset Coverage Ratio</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio_documentation_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Covenant, Asset Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio" xlink:to="lab_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1a54de01-324a-4b47-b9aa-3a441bb0dc4a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DescriptionOfBusinessPolicyPolicyTextBlock_c538b34e-d649-4c47-b105-d7df688f98a0_terseLabel_en-US" xlink:label="lab_ehth_DescriptionOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business</link:label>
    <link:label id="lab_ehth_DescriptionOfBusinessPolicyPolicyTextBlock_label_en-US" xlink:label="lab_ehth_DescriptionOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Business, Policy [Policy Text Block]</link:label>
    <link:label id="lab_ehth_DescriptionOfBusinessPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_ehth_DescriptionOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description Of Business, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DescriptionOfBusinessPolicyPolicyTextBlock" xlink:href="ehth-20210930.xsd#ehth_DescriptionOfBusinessPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DescriptionOfBusinessPolicyPolicyTextBlock" xlink:to="lab_ehth_DescriptionOfBusinessPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LeViasCompliantMember_4b323527-cba3-4f98-8aae-9ebbe9c5f50c_terseLabel_en-US" xlink:label="lab_ehth_LeViasCompliantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Le'Vias Compliant</link:label>
    <link:label id="lab_ehth_LeViasCompliantMember_label_en-US" xlink:label="lab_ehth_LeViasCompliantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Le'Vias Compliant [Member]</link:label>
    <link:label id="lab_ehth_LeViasCompliantMember_documentation_en-US" xlink:label="lab_ehth_LeViasCompliantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Le'Vias Compliant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LeViasCompliantMember" xlink:href="ehth-20210930.xsd#ehth_LeViasCompliantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LeViasCompliantMember" xlink:to="lab_ehth_LeViasCompliantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_aa36cf1e-8324-400f-ba3c-90f49d001cb1_negatedLabel_en-US" xlink:label="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Loss</link:label>
    <link:label id="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:label id="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="ehth-20210930.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_038ecaeb-84e5-4b63-ad69-be3a2a3cc741_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_23c0499e-d50b-4f44-b16e-7ee5b5f01c6b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_f1d73f9b-4188-4e2e-9785-f12817a67349_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_f95a609e-8144-4def-9252-84bbd6060ffd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_106e9f34-1958-4b58-8a10-da73a1b3e293_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_399693ee-5bd8-410a-8cfc-e39250a32306_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_de02a82c-d156-4951-b591-1df8a8f15de6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_SponsorshipAndAdvertisingMember_db5d9eba-4f9e-446d-8512-f733c5351591_terseLabel_en-US" xlink:label="lab_ehth_SponsorshipAndAdvertisingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sponsorship and Advertising Revenue</link:label>
    <link:label id="lab_ehth_SponsorshipAndAdvertisingMember_label_en-US" xlink:label="lab_ehth_SponsorshipAndAdvertisingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sponsorship And Advertising [Member]</link:label>
    <link:label id="lab_ehth_SponsorshipAndAdvertisingMember_documentation_en-US" xlink:label="lab_ehth_SponsorshipAndAdvertisingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sponsorship And Advertising</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SponsorshipAndAdvertisingMember" xlink:href="ehth-20210930.xsd#ehth_SponsorshipAndAdvertisingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_SponsorshipAndAdvertisingMember" xlink:to="lab_ehth_SponsorshipAndAdvertisingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_93150432-f862-4fbc-b885-519f371af97c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_3c5309f2-f987-49af-b5e8-b2864f87189c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_28b5da3b-cc00-403a-8437-0fea400c0ae2_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice_aec1c168-2d7e-47a9-880f-4b9b4b970351_terseLabel_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption call right, number of days for written notice</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice_label_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Redemption Call Right, Written Notice</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice_documentation_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Redemption Call Right, Written Notice</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice" xlink:to="lab_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_be2e9121-1bf3-4f64-9e5e-bb8161e89914_totalLabel_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_label_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-For-Sale Debt Securities, Amortized Cost</link:label>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_documentation_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-For-Sale Debt Securities, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:to="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_663f48be-3415-4254-b395-1619dcc7484d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_2535cbec-bb93-4a8a-838a-af6da2413158_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities &#8211; current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_d13fe44c-f525-4453-8d5c-7e2b167e3008_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_0be109dc-ff86-48db-9a1e-f8637474d218_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in preferred stock redemption value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_36389a2b-a64d-4524-bedb-18e8c132c8c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_9160c145-54be-460c-b8ee-d3737f08ba6d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_19c7bfec-9aa4-458d-a74b-c39b7b6db5e4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Reorganization</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_d2d87004-08fc-487c-8910-d01e0bbfcb97_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_43a6f684-7d45-4bcb-a56d-76b949968aae_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_10ddd332-64de-4af8-94ed-6ced028eff9f_totalLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_cb19f13c-2c6d-4e77-87a8-d640088682c0_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_QualifiedHealthPlansMember_05018238-79a1-4517-81c1-0c6e294e29ad_terseLabel_en-US" xlink:label="lab_ehth_QualifiedHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Health Plans</link:label>
    <link:label id="lab_ehth_QualifiedHealthPlansMember_label_en-US" xlink:label="lab_ehth_QualifiedHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Health Plans [Member]</link:label>
    <link:label id="lab_ehth_QualifiedHealthPlansMember_documentation_en-US" xlink:label="lab_ehth_QualifiedHealthPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Qualified Health Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_QualifiedHealthPlansMember" xlink:href="ehth-20210930.xsd#ehth_QualifiedHealthPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_QualifiedHealthPlansMember" xlink:to="lab_ehth_QualifiedHealthPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease_08d3bdd9-3b17-45b4-8e59-f31c6ce37924_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in credit loss allowance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" xlink:to="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_6919413f-7b00-45f5-a19f-affbb8baa9a7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_9c60c102-0f8b-4d57-b849-59eefada89df_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_MedicareMember_37e23a3b-0c9a-4f7c-bc42-c3854879a1e8_terseLabel_en-US" xlink:label="lab_ehth_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_ehth_MedicareMember_label_en-US" xlink:label="lab_ehth_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:label id="lab_ehth_MedicareMember_documentation_en-US" xlink:label="lab_ehth_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareMember" xlink:href="ehth-20210930.xsd#ehth_MedicareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_MedicareMember" xlink:to="lab_ehth_MedicareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_f0e41e22-507d-4e81-ae34-cbf3db62cc56_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_388daaad-2430-45ac-983d-561dc4f6f212_negatedTerseLabel_en-US" xlink:label="lab_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_label_en-US" xlink:label="lab_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated Share-based Compensation Expense, Net Of Restructuring Reversal Expense</link:label>
    <link:label id="lab_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_documentation_en-US" xlink:label="lab_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocated Share-based Compensation Expense, Net Of Restructuring Reversal Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" xlink:href="ehth-20210930.xsd#ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" xlink:to="lab_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c95be88f-1e31-489c-95d5-15337c7fc513_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CustomerCareAndEnrollmentExpenseMember_fb507d7f-6faf-40e6-a452-f2f3218852e3_terseLabel_en-US" xlink:label="lab_ehth_CustomerCareAndEnrollmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer care and enrollment</link:label>
    <link:label id="lab_ehth_CustomerCareAndEnrollmentExpenseMember_label_en-US" xlink:label="lab_ehth_CustomerCareAndEnrollmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Care And Enrollment Expense [Member]</link:label>
    <link:label id="lab_ehth_CustomerCareAndEnrollmentExpenseMember_documentation_en-US" xlink:label="lab_ehth_CustomerCareAndEnrollmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Care And Enrollment Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CustomerCareAndEnrollmentExpenseMember" xlink:href="ehth-20210930.xsd#ehth_CustomerCareAndEnrollmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CustomerCareAndEnrollmentExpenseMember" xlink:to="lab_ehth_CustomerCareAndEnrollmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidInsurance_4bde4fda-eda0-4ee2-b77c-239b28b7254a_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid insurance</link:label>
    <link:label id="lab_us-gaap_PrepaidInsurance_label_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b1e67aec-bb12-4953-92ed-d78c5b21049f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment and other assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_05f2b529-131e-4a69-b3da-b867863c69ea_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_180dfe08-e0f7-4fee-b35d-38fa33276273_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents_2a67a051-1cf5-4e97-b82a-7d7fca605d80_terseLabel_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant, minimum cash and cash equivalents</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents_label_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Minimum Cash And Cash Equivalents</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents_documentation_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Minimum Cash And Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" xlink:to="lab_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_f63e33de-7b48-41b1-86fc-0e7f8f6adb55_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_f7ac3b68-782d-4a15-87f2-58d8471d8c20_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_81172df7-52d1-4988-9836-cd3bbc18e639_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_299b604d-e5c8-45eb-bfdf-40d48822e981_totalLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_62d692a7-9bfb-4983-b79a-a3fafe45ab6b_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Lease Maturities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_52a6a152-580e-4030-b58b-4c88bd82069e_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_58a341f8-950d-4161-885b-ae7bad277b6d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Revenue By Major Customers</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_d7e969e5-5f87-4cf9-996a-53f32b5dcdbb_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_07016e60-f990-436b-a443-6bb139b41df8_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_34b76e5e-cf7f-4fc3-bafb-a44c18baec84_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_75bbd413-21ac-43fc-a2f8-acb04ad2592e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce_c78cc5f9-079a-48fe-8352-67313f75941d_terseLabel_en-US" xlink:label="lab_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of total workforce</link:label>
    <link:label id="lab_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce_label_en-US" xlink:label="lab_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Cost, Number Of Positions Eliminated, Percentage Of Total Workforce</link:label>
    <link:label id="lab_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce_documentation_en-US" xlink:label="lab_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Cost, Number Of Positions Eliminated, Percentage Of Total Workforce</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" xlink:href="ehth-20210930.xsd#ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" xlink:to="lab_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_MedicareAdvantageMember_6cb455d1-8600-4890-885e-1814fc6cd38e_terseLabel_en-US" xlink:label="lab_ehth_MedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Advantage</link:label>
    <link:label id="lab_ehth_MedicareAdvantageMember_label_en-US" xlink:label="lab_ehth_MedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Advantage [Member]</link:label>
    <link:label id="lab_ehth_MedicareAdvantageMember_documentation_en-US" xlink:label="lab_ehth_MedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Advantage [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareAdvantageMember" xlink:href="ehth-20210930.xsd#ehth_MedicareAdvantageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_MedicareAdvantageMember" xlink:to="lab_ehth_MedicareAdvantageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ff8fb8f2-ae49-48dc-a273-63ab0c16be53_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMaximumLiquidity_6acb1495-7f34-40df-8107-c49ded7f6509_terseLabel_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMaximumLiquidity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum liquidity</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMaximumLiquidity_label_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMaximumLiquidity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Maximum Liquidity</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMaximumLiquidity_documentation_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMaximumLiquidity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Maximum Liquidity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMaximumLiquidity" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityCovenantMaximumLiquidity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LineOfCreditFacilityCovenantMaximumLiquidity" xlink:to="lab_ehth_LineOfCreditFacilityCovenantMaximumLiquidity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_74074bbe-5575-44f8-92c6-211f54349059_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_36413c80-78a6-4fd1-90ad-b26de5e80b7c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LineOfCreditFacilityBorrowingBasePercentage_0709da1c-5802-4189-a6ff-fa41e1d31a79_terseLabel_en-US" xlink:label="lab_ehth_LineOfCreditFacilityBorrowingBasePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing base percentage</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityBorrowingBasePercentage_label_en-US" xlink:label="lab_ehth_LineOfCreditFacilityBorrowingBasePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Borrowing Base, Percentage</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityBorrowingBasePercentage_documentation_en-US" xlink:label="lab_ehth_LineOfCreditFacilityBorrowingBasePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Borrowing Base, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityBorrowingBasePercentage" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityBorrowingBasePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LineOfCreditFacilityBorrowingBasePercentage" xlink:to="lab_ehth_LineOfCreditFacilityBorrowingBasePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_375d4af8-0e80-47fe-8225-92a979d57448_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_b6daf7ec-0434-4769-996f-aecf08bc2022_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities &#8211; non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_f8cf5104-edca-4609-98c6-eb8d723ad08f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_4582bfab-5976-4f92-942d-3c1b9b8200ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_15cd224d-c599-4ded-9666-3adf9ede5ffa_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ConvertiblePreferredStockCovenantLiquidity_4e6848ae-6a0d-436a-a086-2df10a20fbdb_terseLabel_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockCovenantLiquidity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum liquidity amount</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockCovenantLiquidity_label_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockCovenantLiquidity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Covenant, Liquidity</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockCovenantLiquidity_documentation_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockCovenantLiquidity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Covenant, Liquidity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockCovenantLiquidity" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockCovenantLiquidity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ConvertiblePreferredStockCovenantLiquidity" xlink:to="lab_ehth_ConvertiblePreferredStockCovenantLiquidity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_d7b22c50-d38e-4bdc-bdc9-9cad364006ed_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_6e3fc539-f6a7-4d3f-b71f-6b5fbcb224a9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_8973e9ed-8cb2-4cd0-a810-5bfcbe36d004_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_3e9b53e6-3633-4765-a73f-4af680ef8b02_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_d19609e2-646c-4e7b-9c54-955502e75ddc_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_a46f0754-4f2e-432b-a030-80e6647237f9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_f4d16ebe-da28-4599-9436-82b4100de3f7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:to="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_a371e705-3c2c-477b-a41f-3a4aad80e797_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_ec915baa-8c35-420e-9d71-dbcf5638177d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for employee stock purchase program (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_d0b189b7-34ae-40b3-bd8d-595db1b1b6d0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_cbd7970c-f005-41cd-9cea-9d82be13a6db_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_d42c748b-ffc8-44cd-9d89-1a4c5c14b3bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_bd6f96d8-bff9-4b1e-8bbc-eb3c77b491cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_4d8c62c9-b50b-4413-ae80-ad5a1c640c54_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_a19ec32f-6505-46f8-8b96-f8e752485589_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_531dc29d-927f-44cf-b01e-2a207ed3b5be_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember_44d59f02-48c9-40a8-a137-111e05b62416_terseLabel_en-US" xlink:label="lab_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Under-Recognition Of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember_label_en-US" xlink:label="lab_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Under-Recognition Of Stock-Based Compensation Expense [Member]</link:label>
    <link:label id="lab_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember_documentation_en-US" xlink:label="lab_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Under-Recognition Of Stock-Based Compensation Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember" xlink:href="ehth-20210930.xsd#ehth_UnderRecognitionOfStockBasedCompensationExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember" xlink:to="lab_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockConvertibleConversionPrice_377060ad-c0a7-4122-82b6-06688eb68dd4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleConversionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion rate (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockConvertibleConversionPrice_label_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleConversionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionPrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockConvertibleConversionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockConvertibleConversionPrice" xlink:to="lab_us-gaap_PreferredStockConvertibleConversionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_0bf9a1f0-c11b-4bff-823e-251c1218d685_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from exercise of common stock options and employee stock purchases</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_156f5c79-7902-4b1c-9a6e-bfff9ccd8d71_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_48efee42-b60c-4ce2-ad09-b03356870df2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_5dd55311-c272-4394-97c7-71bcc40a70cf_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_AncillariesMember_4e7dbc76-c6b7-4e51-bd62-faaf2378c5ca_terseLabel_en-US" xlink:label="lab_ehth_AncillariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ancillary</link:label>
    <link:label id="lab_ehth_AncillariesMember_label_en-US" xlink:label="lab_ehth_AncillariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ancillaries [Member]</link:label>
    <link:label id="lab_ehth_AncillariesMember_documentation_en-US" xlink:label="lab_ehth_AncillariesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ancillaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AncillariesMember" xlink:href="ehth-20210930.xsd#ehth_AncillariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_AncillariesMember" xlink:to="lab_ehth_AncillariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_466d28e2-a961-48e9-89fc-80b95e055d4a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_471b19c1-4c1d-4908-a6af-bb644ff78007_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_328cc0e8-e2cc-4294-9fca-4cfca71c0e60_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_89ce436f-ca67-4c61-95f1-a7618059c6fd_negatedTerseLabel_en-US" xlink:label="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Loss</link:label>
    <link:label id="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label id="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="ehth-20210930.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_61b550c0-7645-4b97-a5c0-c0af758fef3c_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_40abceb9-b6f1-417e-8217-a256aa49104f_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing and advertising</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c9e5085d-3301-49e9-8a18-ee80ce6a2ccd_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_c11ece91-74a8-42fa-836b-d35229c0f7b8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_78e1cb6d-0495-4e99-a84f-bca751e8617a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_4f95db1a-a07d-4e31-86a5-a306c9710598_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent_ea007bb2-b78a-4fec-8457-3341267e9887_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets &#8211; commissions receivable &#8211; non-current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward_686873c8-64ec-4f2d-b705-01c2de0577c6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward" xlink:to="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_75610f4f-498e-4e92-b3ca-9741a125c9d3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes_6b9abd77-80b8-4e61-8a10-650bf80dc49f_terseLabel_en-US" xlink:label="lab_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares that were previously surrendered by employees to satisfy tax withholdings (in shares)</link:label>
    <link:label id="lab_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes_label_en-US" xlink:label="lab_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares Outstanding, Shares Acquired, Previously Cancelled Vested Shares Withheld For Tax Purposes</link:label>
    <link:label id="lab_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes_documentation_en-US" xlink:label="lab_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares Outstanding, Shares Acquired, Previously Cancelled Vested Shares Withheld For Tax Purposes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" xlink:href="ehth-20210930.xsd#ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" xlink:to="lab_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c277f69d-a97d-4e49-9692-67c60834d199_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7d3d326a-72fc-46bb-84c5-fd493aef7660_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_204563ff-8587-451c-9de3-606e79f41932_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Impact</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_8dbf695d-8641-4a47-a3c4-b78439f1bca1_terseLabel_en-US" xlink:label="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain</link:label>
    <link:label id="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_label_en-US" xlink:label="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Gains, before Tax</link:label>
    <link:label id="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_documentation_en-US" xlink:label="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Gains, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" xlink:href="ehth-20210930.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" xlink:to="lab_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_6dac1d9a-d286-4f02-b52f-a2783d0b143c_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_777a10f2-5b38-4601-a705-58b6e668acd2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_ed7c9668-d779-4f4c-8b09-5f4e2e2d28af_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_fc7ff45d-a39f-49a7-a44c-9c833be07753_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_9cf00fbb-a35f-4a64-b153-e20985211f73_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_06b53bfd-9294-4d57-9e9a-8cb0da593486_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_1b2213ed-60fa-41a1-9d83-ff956dde92b7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_23a59510-8366-4d2a-ad13-46c22f4159a7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_92690739-9a9d-4075-8ddc-5a4b6f02d473_terseLabel_en-US" xlink:label="lab_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in revenue</link:label>
    <link:label id="lab_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_documentation_en-US" xlink:label="lab_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="ehth-20210930.xsd#ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_AccruedMarketingExpenses_33f96eba-9a29-4cce-a421-dfb181241af1_terseLabel_en-US" xlink:label="lab_ehth_AccruedMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued marketing expenses</link:label>
    <link:label id="lab_ehth_AccruedMarketingExpenses_label_en-US" xlink:label="lab_ehth_AccruedMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Marketing Expenses.</link:label>
    <link:label id="lab_ehth_AccruedMarketingExpenses_documentation_en-US" xlink:label="lab_ehth_AccruedMarketingExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total carrying values as of the balance sheet date of liabilities incurred through that date and payable for obligations related to marketing and advertising services received from vendors. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AccruedMarketingExpenses" xlink:href="ehth-20210930.xsd#ehth_AccruedMarketingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_AccruedMarketingExpenses" xlink:to="lab_ehth_AccruedMarketingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_42af639c-ba38-4c4a-9d0a-77614ddad1ef_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2e480065-3782-43c1-85c2-73766bd15f55_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_PrepaidLicenses_8b0b3138-59a5-46c8-944b-4b7ce6e5e2d7_terseLabel_en-US" xlink:label="lab_ehth_PrepaidLicenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid licenses</link:label>
    <link:label id="lab_ehth_PrepaidLicenses_label_en-US" xlink:label="lab_ehth_PrepaidLicenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Licenses</link:label>
    <link:label id="lab_ehth_PrepaidLicenses_documentation_en-US" xlink:label="lab_ehth_PrepaidLicenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Licenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PrepaidLicenses" xlink:href="ehth-20210930.xsd#ehth_PrepaidLicenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_PrepaidLicenses" xlink:to="lab_ehth_PrepaidLicenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_35b6889a-803b-452e-8197-56aaa69ae7d5_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income, remainder of 2021</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_VisionMember_330c236b-98ec-4b8d-9b95-b387663a86c8_terseLabel_en-US" xlink:label="lab_ehth_VisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vision</link:label>
    <link:label id="lab_ehth_VisionMember_label_en-US" xlink:label="lab_ehth_VisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vision [Member]</link:label>
    <link:label id="lab_ehth_VisionMember_documentation_en-US" xlink:label="lab_ehth_VisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vision [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_VisionMember" xlink:href="ehth-20210930.xsd#ehth_VisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_VisionMember" xlink:to="lab_ehth_VisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1df36b59-fbb1-4455-9f57-30fdc15a4ab7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_aa15f77c-abe8-4e7c-8c53-710527aa6e6f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_e0c2421b-bd0c-4143-a26a-a1ec533dfd8e_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_7831f4ec-e4dc-4783-830d-03fb4f31c819_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_583a4fb9-d0c9-4a12-83d3-939244146880_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement of earnout liability (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_9971cc14-217c-4bf7-a034-800604c6b5f7_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_71061ce4-251d-411f-ad21-9973ab266b99_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_SeasonalityPolicyPolicyTextBlock_2a5184bd-efe1-4684-a780-8ed8bbb03b53_terseLabel_en-US" xlink:label="lab_ehth_SeasonalityPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seasonality</link:label>
    <link:label id="lab_ehth_SeasonalityPolicyPolicyTextBlock_label_en-US" xlink:label="lab_ehth_SeasonalityPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seasonality Policy [Policy Text Block]</link:label>
    <link:label id="lab_ehth_SeasonalityPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_ehth_SeasonalityPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Seasonality Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SeasonalityPolicyPolicyTextBlock" xlink:href="ehth-20210930.xsd#ehth_SeasonalityPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_SeasonalityPolicyPolicyTextBlock" xlink:to="lab_ehth_SeasonalityPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_c1216177-1c50-43d7-bf9c-d04e725d2f6f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_967cd4f1-1c02-43e7-973d-06f9f505410b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligationDueInNextTwelveMonths_9598f1c1-21b9-4bab-b018-ae8c7c53262f_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:to="lab_us-gaap_ContractualObligationDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_1434f0e8-4573-4b8d-a27b-5e9516e58e32_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4a912dd6-77ea-49a0-9cf8-01d714f752ff_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_08d6ae3e-fe2e-435b-afb9-42c6515502a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before benefit from income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_f419b8d5-4b55-4c82-9876-87cd66524464_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_3480bd9f-3989-4122-80c4-af53095ff946_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_b6e76715-7604-4116-ae48-2b6da808567e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_TechnologyAndContentExpense_b8e3e513-fef3-48d4-8aa9-fa1290287b1b_terseLabel_en-US" xlink:label="lab_ehth_TechnologyAndContentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology and content</link:label>
    <link:label id="lab_ehth_TechnologyAndContentExpense_label_en-US" xlink:label="lab_ehth_TechnologyAndContentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology And Content Expense</link:label>
    <link:label id="lab_ehth_TechnologyAndContentExpense_documentation_en-US" xlink:label="lab_ehth_TechnologyAndContentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total expense recognized in the period for technology and content. Technology and content expenses consist primarily of compensation and benefits costs for personnel associated with developing and enhancing our website technology as well as maintaining our website.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TechnologyAndContentExpense" xlink:href="ehth-20210930.xsd#ehth_TechnologyAndContentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_TechnologyAndContentExpense" xlink:to="lab_ehth_TechnologyAndContentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_46dc63f3-ca00-4678-afc9-79e7a336f0de_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_f18daa92-740f-4a13-b990-468becde8908_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_d0c1ebc8-d11d-46d0-bef7-49bdcd6b7126_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies, Estimates and Judgments</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ae669494-4f31-4907-82fd-783680bd9b61_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e34c1b97-986f-42ad-9868-0a65d46f974e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_90a85f06-1b5d-4d69-8c70-cac79af1989f_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_OverRecognitionOfLicensingCostsMember_46271245-9b0a-4dcc-9ced-4dabcb4da31a_terseLabel_en-US" xlink:label="lab_ehth_OverRecognitionOfLicensingCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Recognition Of Licensing Costs</link:label>
    <link:label id="lab_ehth_OverRecognitionOfLicensingCostsMember_label_en-US" xlink:label="lab_ehth_OverRecognitionOfLicensingCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Recognition Of Licensing Costs [Member]</link:label>
    <link:label id="lab_ehth_OverRecognitionOfLicensingCostsMember_documentation_en-US" xlink:label="lab_ehth_OverRecognitionOfLicensingCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Recognition Of Licensing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OverRecognitionOfLicensingCostsMember" xlink:href="ehth-20210930.xsd#ehth_OverRecognitionOfLicensingCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_OverRecognitionOfLicensingCostsMember" xlink:to="lab_ehth_OverRecognitionOfLicensingCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bd0667ae-797f-435a-a2f4-5070a2658760_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_ce9a63eb-3212-4ef9-99c4-98b17872668d_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ChangeInContractWithCustomerAssetRollForward_2f75e2fc-c34a-43aa-a664-06389027fb6f_terseLabel_en-US" xlink:label="lab_ehth_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_ehth_ChangeInContractWithCustomerAssetRollForward_label_en-US" xlink:label="lab_ehth_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Asset [Roll Forward]</link:label>
    <link:label id="lab_ehth_ChangeInContractWithCustomerAssetRollForward_documentation_en-US" xlink:label="lab_ehth_ChangeInContractWithCustomerAssetRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ChangeInContractWithCustomerAssetRollForward" xlink:href="ehth-20210930.xsd#ehth_ChangeInContractWithCustomerAssetRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward" xlink:to="lab_ehth_ChangeInContractWithCustomerAssetRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedAncillariesDomain_13e6391e-1c54-49f6-846d-96190000406a_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedAncillariesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Ancillaries [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedAncillariesDomain_label_en-US" xlink:label="lab_ehth_DisaggregatedAncillariesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Ancillaries [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedAncillariesDomain_documentation_en-US" xlink:label="lab_ehth_DisaggregatedAncillariesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Ancillaries [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedAncillariesDomain" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedAncillariesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedAncillariesDomain" xlink:to="lab_ehth_DisaggregatedAncillariesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_IncreaseDecreaseInCommissionsReceivable_2c2d67fa-3603-4aa2-b5a9-cb550601b18b_terseLabel_en-US" xlink:label="lab_ehth_IncreaseDecreaseInCommissionsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets &#8211; commissions receivable</link:label>
    <link:label id="lab_ehth_IncreaseDecreaseInCommissionsReceivable_label_en-US" xlink:label="lab_ehth_IncreaseDecreaseInCommissionsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Commissions Receivable</link:label>
    <link:label id="lab_ehth_IncreaseDecreaseInCommissionsReceivable_documentation_en-US" xlink:label="lab_ehth_IncreaseDecreaseInCommissionsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Commissions Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInCommissionsReceivable" xlink:href="ehth-20210930.xsd#ehth_IncreaseDecreaseInCommissionsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_IncreaseDecreaseInCommissionsReceivable" xlink:to="lab_ehth_IncreaseDecreaseInCommissionsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_1dd21439-f433-46f9-8bc5-c795c35aa495_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_d8922033-2d0c-49b6-a3f1-95a65af4461f_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_f2ab9a93-3e57-4d45-b0c8-8c5261438fc8_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_5f09132c-d8e4-4979-928b-ce63aec8bf7e_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e70cb2c9-ef0c-4371-92d5-fa81eb70a3d5_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_261dedd5-e144-4510-8912-804968a9040b_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_81ddcd75-a31d-4fbc-b862-40c977b61d7b_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_a5c7de2b-104b-45ad-ba5c-4f4d316c4c79_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Statement Information</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_7eada50d-c614-4e85-8233-7cb7aafbe984_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income, 2023</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors_f1710e09-a37b-4c1a-963a-b2ecc1e61e9e_terseLabel_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of nominations to board of directors</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors_label_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Number Of Nominations To Board Of Directors</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors_documentation_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Number Of Nominations To Board Of Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors" xlink:to="lab_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare_8c6685bf-92b9-4d41-a64e-79c33d2b1b38_terseLabel_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption put right, percentage of accrued value</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare_label_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Redemption Put Right, Percentage Of Accrued Value Per Share</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare_documentation_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Redemption Value, Percentage Of Accrued Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare" xlink:to="lab_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_af3512b4-dc1c-43e1-a5b5-fddeb9295028_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_0b85c90a-9d99-480f-97dd-88103a7b20f0_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_f08345c7-fdea-4b2c-bc67-3db1b9418faa_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Business and Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_9bb48e95-1198-450e-b13d-70ee0a22ca82_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period Of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_e73b123c-87e0-437e-953a-401da63346d4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_f88538dc-1279-4bf8-a567-922b399e7105_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCommissionsReceived_5d25a01b-b291-4bca-9750-e42660885155_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCommissionsReceived" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash receipts</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCommissionsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCommissionsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Commissions Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCommissionsReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCommissionsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCommissionsReceived" xlink:to="lab_us-gaap_ProceedsFromCommissionsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligationDueInThirdYear_cd1b871a-9bb4-4c80-bd31-8f5976528abc_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_ContractualObligationDueInThirdYear_label_en-US" xlink:label="lab_us-gaap_ContractualObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligationDueInThirdYear" xlink:to="lab_us-gaap_ContractualObligationDueInThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4f9a3f7f-037f-479e-85e7-a3a9604465dc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_16a15177-42f3-4a2a-a0c9-7c577cd43cd1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_16500ef4-6b5c-4ab6-9cb7-35484e34e732_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1a2864f4-d499-4dcf-8419-05249cd04953_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_cdf5ac2a-00df-45bf-a1ae-f905b56842fd_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bond</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_f7148808-8fea-4670-aff0-d2e3c8fe260d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Others</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_40c6a5b3-91db-41cd-8a23-406e3bb7ad05_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:to="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_7a9c7e18-e6ee-41be-8b41-fd36a41afd6c_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_OutOfPeriodAdjustmentsMember_da1fde24-a022-47cc-a802-7bb3d7c2796a_terseLabel_en-US" xlink:label="lab_ehth_OutOfPeriodAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Out-Of-Period Adjustments</link:label>
    <link:label id="lab_ehth_OutOfPeriodAdjustmentsMember_label_en-US" xlink:label="lab_ehth_OutOfPeriodAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Out-Of-Period Adjustments [Member]</link:label>
    <link:label id="lab_ehth_OutOfPeriodAdjustmentsMember_documentation_en-US" xlink:label="lab_ehth_OutOfPeriodAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Out-Of-Period Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OutOfPeriodAdjustmentsMember" xlink:href="ehth-20210930.xsd#ehth_OutOfPeriodAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_OutOfPeriodAdjustmentsMember" xlink:to="lab_ehth_OutOfPeriodAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e043c054-9468-428e-a84b-ad1db67cdcae_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3cf43763-b1a7-4117-a5b2-abe9b5eb00c9_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in per share calculation - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_2c9bb22f-ad32-4740-9d0f-5786a6b5494c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_ee32dc2d-b758-4686-a1fb-a64ca7e58e29_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to common stockholders per share - diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_93872c76-5169-4ded-baa6-8c2db82ca1e7_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ConvertiblePreferredStockThresholdTradingDays_1e094a3b-d9e1-47a5-a84a-0a21f434fa0a_terseLabel_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockThresholdTradingDays_label_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Threshold Trading Days</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockThresholdTradingDays_documentation_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockThresholdTradingDays" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ConvertiblePreferredStockThresholdTradingDays" xlink:to="lab_ehth_ConvertiblePreferredStockThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_2e8e1f6e-24d6-499b-8f14-e544c749edf3_terseLabel_en-US" xlink:label="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Contractual Obligations</link:label>
    <link:label id="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_label_en-US" xlink:label="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:to="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_2a419114-a852-4722-8707-eda493b14f03_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_39a03f1f-c326-4410-b027-01b07b8f1708_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_864049d2-cb3e-4a23-b563-dc9348450c0a_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_ebaccce8-d79c-4f12-8c6b-283252687266_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_fb5b62e8-b7ba-41e7-8b61-f8db1641671f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_ad65e2db-ce48-4f29-8074-935164e3301a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_f1c442c8-94cf-47e7-8f14-293885d43dc6_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_45646fe3-9eb2-4085-adf7-5622f8fe6f89_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average number of shares used in per share amounts:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_c7141692-d7eb-4b54-a54b-20f60fcbeec0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes &#8211; non-current</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CenteneMember_c950955a-85ac-40a5-92b1-4673c8c09315_terseLabel_en-US" xlink:label="lab_ehth_CenteneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centene</link:label>
    <link:label id="lab_ehth_CenteneMember_label_en-US" xlink:label="lab_ehth_CenteneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centene [Member]</link:label>
    <link:label id="lab_ehth_CenteneMember_documentation_en-US" xlink:label="lab_ehth_CenteneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Centene</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CenteneMember" xlink:href="ehth-20210930.xsd#ehth_CenteneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CenteneMember" xlink:to="lab_ehth_CenteneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents_a8cf4451-edbd-493a-afa3-b4a3202e5967_terseLabel_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant, maximum cash and cash equivalents</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents_label_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Maximum Cash And Cash Equivalents</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents_documentation_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Maximum Cash And Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" xlink:to="lab_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_OtherMember_0fad7d64-ba76-48b1-912b-e19e75e2606f_terseLabel_en-US" xlink:label="lab_ehth_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ehth_OtherMember_label_en-US" xlink:label="lab_ehth_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_ehth_OtherMember_documentation_en-US" xlink:label="lab_ehth_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OtherMember" xlink:href="ehth-20210930.xsd#ehth_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_OtherMember" xlink:to="lab_ehth_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CommissionMembersApprovedInPriorPeriodsMember_07812d18-b4d0-47f8-a4bf-06f9f4f8bb5e_terseLabel_en-US" xlink:label="lab_ehth_CommissionMembersApprovedInPriorPeriodsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Commission Revenue from Members Approved in Prior Periods</link:label>
    <link:label id="lab_ehth_CommissionMembersApprovedInPriorPeriodsMember_label_en-US" xlink:label="lab_ehth_CommissionMembersApprovedInPriorPeriodsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission, Members Approved In Prior Periods [Member]</link:label>
    <link:label id="lab_ehth_CommissionMembersApprovedInPriorPeriodsMember_documentation_en-US" xlink:label="lab_ehth_CommissionMembersApprovedInPriorPeriodsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission, Members Approved In Prior Periods [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember" xlink:href="ehth-20210930.xsd#ehth_CommissionMembersApprovedInPriorPeriodsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember" xlink:to="lab_ehth_CommissionMembersApprovedInPriorPeriodsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_HumanaMember_7f81654d-d898-48a5-9845-4a7a1786f19e_terseLabel_en-US" xlink:label="lab_ehth_HumanaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Humana</link:label>
    <link:label id="lab_ehth_HumanaMember_label_en-US" xlink:label="lab_ehth_HumanaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Humana [Member]</link:label>
    <link:label id="lab_ehth_HumanaMember_documentation_en-US" xlink:label="lab_ehth_HumanaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Humana [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_HumanaMember" xlink:href="ehth-20210930.xsd#ehth_HumanaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_HumanaMember" xlink:to="lab_ehth_HumanaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_2c0044f0-b59a-4eac-8d70-1a855a27032b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_2ba616a5-03d9-46cb-ac8b-1cd94451cd4c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and reorganization charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_63019dab-b6f4-468a-86f0-1b5a9040faf0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and reorganization charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_087246d1-b30d-43b3-acbb-d1886ed594a8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_10757e21-eb83-4bf6-98a6-f82d5586694d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_6f447ce5-290a-43c4-9425-5b47d3e53008_negatedNetLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock_c581b4a7-cfea-4d54-babd-2cea0e5d7372_terseLabel_en-US" xlink:label="lab_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Stock-Based Compensation Expense By Operating Function</link:label>
    <link:label id="lab_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock_label_en-US" xlink:label="lab_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Stock-Based Compensation Expense By Operating Function [Table Text Block]</link:label>
    <link:label id="lab_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock_documentation_en-US" xlink:label="lab_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Stock-Based Compensation Expense By Operating Function [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" xlink:href="ehth-20210930.xsd#ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" xlink:to="lab_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_3d62a57c-fdbd-48d3-a1be-8145e3b4264f_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_5dadea2c-7129-4932-a127-100021019fbe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Assets Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_b0b9a83e-736a-452e-8fda-51fbee4cd448_totalLabel_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_label_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-For-Sale Debt Securities</link:label>
    <link:label id="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_documentation_en-US" xlink:label="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents And Available-For-Sale Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:to="lab_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8670846e-042f-4a5a-92e0-f06ad234866d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_78eca19d-0330-4628-b405-24744975d96a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Restructuring and Other Related Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_31cd472f-6786-479e-a226-c0f5951cdaa4_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_fa7d6172-643d-40eb-ad94-08d15432afd7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_9ccf4873-371c-4c44-a629-096e0acaa6a3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9a725b2b-56e9-45ff-b460-54208ffeee02_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d3d16830-98a5-4860-b406-ecc00dee068b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_685f0631-4686-4e73-9bbf-e70998fe5b74_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_298525e1-9ed7-4c7a-ac9d-5027bdbfa685_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_23e8a31c-7cd0-484f-86b0-645e00c371eb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CommissionBonusMember_bfff2d29-e56c-43df-8099-7e0291baee9e_terseLabel_en-US" xlink:label="lab_ehth_CommissionBonusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Bonus and Other</link:label>
    <link:label id="lab_ehth_CommissionBonusMember_label_en-US" xlink:label="lab_ehth_CommissionBonusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Bonus [Member]</link:label>
    <link:label id="lab_ehth_CommissionBonusMember_documentation_en-US" xlink:label="lab_ehth_CommissionBonusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Bonus [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionBonusMember" xlink:href="ehth-20210930.xsd#ehth_CommissionBonusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CommissionBonusMember" xlink:to="lab_ehth_CommissionBonusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_ec835b00-a140-4be2-b866-91957a1d89a5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_685fb27b-82a6-4117-9794-1910341c7caf_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_6d87bc1a-c1db-4c28-bbe0-7fddc1f03db3_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_MiscellaneousOtherMember_4b2cfbbd-1a8e-465d-8e5d-267117d4f2ec_terseLabel_en-US" xlink:label="lab_ehth_MiscellaneousOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ehth_MiscellaneousOtherMember_label_en-US" xlink:label="lab_ehth_MiscellaneousOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miscellaneous Other [Member]</link:label>
    <link:label id="lab_ehth_MiscellaneousOtherMember_documentation_en-US" xlink:label="lab_ehth_MiscellaneousOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miscellaneous Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MiscellaneousOtherMember" xlink:href="ehth-20210930.xsd#ehth_MiscellaneousOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_MiscellaneousOtherMember" xlink:to="lab_ehth_MiscellaneousOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_PreferredStockDividendRatePayableInKindPercentage_a9b8a778-d981-4f8b-8079-b004d9d6c80c_terseLabel_en-US" xlink:label="lab_ehth_PreferredStockDividendRatePayableInKindPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend rate, payable-in-kind</link:label>
    <link:label id="lab_ehth_PreferredStockDividendRatePayableInKindPercentage_label_en-US" xlink:label="lab_ehth_PreferredStockDividendRatePayableInKindPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Payable-In-Kind, Percentage</link:label>
    <link:label id="lab_ehth_PreferredStockDividendRatePayableInKindPercentage_documentation_en-US" xlink:label="lab_ehth_PreferredStockDividendRatePayableInKindPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Dividend Rate, Payable-In-Kind, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreferredStockDividendRatePayableInKindPercentage" xlink:href="ehth-20210930.xsd#ehth_PreferredStockDividendRatePayableInKindPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_PreferredStockDividendRatePayableInKindPercentage" xlink:to="lab_ehth_PreferredStockDividendRatePayableInKindPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_bbe3d01c-10e6-491b-96b8-5502e97353aa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_11781b06-8b72-4d6e-837f-11dbbf7ec9c1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_dd6d494e-6d87-4b2f-8baf-644f713aea15_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in 1 year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_SegmentOperatingIncomeLoss_7ea7a4ff-ead7-43ae-a9e1-3e354212fe67_terseLabel_en-US" xlink:label="lab_ehth_SegmentOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment profit (loss)</link:label>
    <link:label id="lab_ehth_SegmentOperatingIncomeLoss_label_en-US" xlink:label="lab_ehth_SegmentOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Operating Income (Loss)</link:label>
    <link:label id="lab_ehth_SegmentOperatingIncomeLoss_documentation_en-US" xlink:label="lab_ehth_SegmentOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SegmentOperatingIncomeLoss" xlink:href="ehth-20210930.xsd#ehth_SegmentOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_SegmentOperatingIncomeLoss" xlink:to="lab_ehth_SegmentOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_c14406b1-3600-432a-bd99-917cbe741a9f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_f59e4794-539d-489b-9894-1f460e2a76c2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_c6e7e400-fa07-4815-9290-6b658e0b0aa0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_a9b8cbb4-24ec-4633-bf0e-113412f30274_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_PreviousRepurchaseProgramsMember_1fd74a4a-6e50-41bb-a67c-01805391262b_terseLabel_en-US" xlink:label="lab_ehth_PreviousRepurchaseProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previous share repurchase programs</link:label>
    <link:label id="lab_ehth_PreviousRepurchaseProgramsMember_label_en-US" xlink:label="lab_ehth_PreviousRepurchaseProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previous Repurchase Programs [Member]</link:label>
    <link:label id="lab_ehth_PreviousRepurchaseProgramsMember_documentation_en-US" xlink:label="lab_ehth_PreviousRepurchaseProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previous Repurchase Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreviousRepurchaseProgramsMember" xlink:href="ehth-20210930.xsd#ehth_PreviousRepurchaseProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_PreviousRepurchaseProgramsMember" xlink:to="lab_ehth_PreviousRepurchaseProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_cd0aacfd-6bf9-4daa-bc1f-a7217bbd511c_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares repurchased under share repurchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_65475645-629f-43d9-b8c6-fac9d2ee4289_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_16921411-0878-4b29-b831-5cdeff7fbb57_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to common stockholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LineOfCreditFacilityFacilityFeePercentage_aebd60b2-b4c2-4c59-bf78-42704ca66204_terseLabel_en-US" xlink:label="lab_ehth_LineOfCreditFacilityFacilityFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility fee percentage</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityFacilityFeePercentage_label_en-US" xlink:label="lab_ehth_LineOfCreditFacilityFacilityFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Facility Fee Percentage</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityFacilityFeePercentage_documentation_en-US" xlink:label="lab_ehth_LineOfCreditFacilityFacilityFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Facility Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityFacilityFeePercentage" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityFacilityFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LineOfCreditFacilityFacilityFeePercentage" xlink:to="lab_ehth_LineOfCreditFacilityFacilityFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_075518bb-1de9-4527-944b-c4d6d0486955_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_TechnologyAndContentExpenseMember_ea5d4d0a-5622-417e-b7e4-185feb806baf_terseLabel_en-US" xlink:label="lab_ehth_TechnologyAndContentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology and content</link:label>
    <link:label id="lab_ehth_TechnologyAndContentExpenseMember_label_en-US" xlink:label="lab_ehth_TechnologyAndContentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology And Content Expense [Member]</link:label>
    <link:label id="lab_ehth_TechnologyAndContentExpenseMember_documentation_en-US" xlink:label="lab_ehth_TechnologyAndContentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology And Content Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TechnologyAndContentExpenseMember" xlink:href="ehth-20210930.xsd#ehth_TechnologyAndContentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_TechnologyAndContentExpenseMember" xlink:to="lab_ehth_TechnologyAndContentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_37d005aa-6a4c-4d53-8b1a-2fd533149058_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_0eb9eac1-7c67-44a8-9b25-f01753c337bc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedOtherAxis_f8a464c0-e9e9-4bf1-b27b-0ba3de507dae_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedOtherAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Other [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedOtherAxis_label_en-US" xlink:label="lab_ehth_DisaggregatedOtherAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Other [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedOtherAxis_documentation_en-US" xlink:label="lab_ehth_DisaggregatedOtherAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedOtherAxis" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedOtherAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedOtherAxis" xlink:to="lab_ehth_DisaggregatedOtherAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_424b8c2a-f833-460f-a1e0-53e73e0058ae_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_996e3502-bde3-4de6-9f08-11731e1c06ec_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of securities in net loss positions</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_fd1bdcfd-9cd3-4a17-9cc1-7fa409f60299_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_e62a08b5-c05c-4245-86b1-8682c89b14d7_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit to stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d3eb5447-c5b2-4a12-b786-396d1886d64c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_d38ca435-eb81-4b24-91eb-5b6cf2e9c02e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_fe2b3e2f-220b-4e8c-a0a6-3dd3ed18718a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_c971bcb8-73da-4d30-9e4e-b03a4687ab12_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_SmallBusinessMember_0df23aa5-e4ac-490a-93cd-1af9acfb93bc_terseLabel_en-US" xlink:label="lab_ehth_SmallBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Small Business</link:label>
    <link:label id="lab_ehth_SmallBusinessMember_label_en-US" xlink:label="lab_ehth_SmallBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Small Business [Member]</link:label>
    <link:label id="lab_ehth_SmallBusinessMember_documentation_en-US" xlink:label="lab_ehth_SmallBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Small Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SmallBusinessMember" xlink:href="ehth-20210930.xsd#ehth_SmallBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_SmallBusinessMember" xlink:to="lab_ehth_SmallBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_PreferredStockConvertibleStatedValue_2bb2c6cf-ca2a-4d81-bd42-919fe81cba03_terseLabel_en-US" xlink:label="lab_ehth_PreferredStockConvertibleStatedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated value (in dollars per share)</link:label>
    <link:label id="lab_ehth_PreferredStockConvertibleStatedValue_label_en-US" xlink:label="lab_ehth_PreferredStockConvertibleStatedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Convertible, Stated Value</link:label>
    <link:label id="lab_ehth_PreferredStockConvertibleStatedValue_documentation_en-US" xlink:label="lab_ehth_PreferredStockConvertibleStatedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Convertible, Stated Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreferredStockConvertibleStatedValue" xlink:href="ehth-20210930.xsd#ehth_PreferredStockConvertibleStatedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_PreferredStockConvertibleStatedValue" xlink:to="lab_ehth_PreferredStockConvertibleStatedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2c2066f9-bf59-4bb8-b04e-33d91297ea6c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cf399660-86aa-4e7b-896d-57f94eb668d9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1174967a-592e-4551-a230-f66398f67492_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_f50648a7-617b-42b4-a9cf-87107d9c7fa6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract assets &#8211; commissions receivable &#8211; current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_4436a9ab-71c4-4a82-a449-f41354c1aa2e_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_bc1f993d-2c95-4c25-ad74-299873d5a422_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_EchelonHealthSPCLPHIGMember_3ef6f67f-c2c1-408a-a5be-38a77a5f831d_terseLabel_en-US" xlink:label="lab_ehth_EchelonHealthSPCLPHIGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">H.I.G</link:label>
    <link:label id="lab_ehth_EchelonHealthSPCLPHIGMember_label_en-US" xlink:label="lab_ehth_EchelonHealthSPCLPHIGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Echelon Health SPC, LP (H.I.G) [Member]</link:label>
    <link:label id="lab_ehth_EchelonHealthSPCLPHIGMember_documentation_en-US" xlink:label="lab_ehth_EchelonHealthSPCLPHIGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Echelon Health SPC, LP (H.I.G)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EchelonHealthSPCLPHIGMember" xlink:href="ehth-20210930.xsd#ehth_EchelonHealthSPCLPHIGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_EchelonHealthSPCLPHIGMember" xlink:to="lab_ehth_EchelonHealthSPCLPHIGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_610424e4-e230-462c-bfa0-402426bfb77e_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Credit Risk</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bcd98ddd-78b8-4fe8-845f-46ea5c386989_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_e5e7e056-3286-4832-8489-d0d8370ecd5a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_93bf501e-ca0f-484e-a1ae-1a8cdcaa2370_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_294a2c2e-c0f8-42ce-a3aa-00ef4a9ef03a_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4eb1f23e-1440-4e37-9f02-0ffd2db3e51e_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_fb518c71-a5f9-4993-bf20-49202db9f711_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of internally developed software</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_a9e41845-302d-4775-88e1-243e64e1ffad_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_22221c2c-7393-4a8a-9f39-4305570ffaff_terseLabel_en-US" xlink:label="lab_ehth_IndividualFamilyAndSmallBusinessSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual, Family and Small Business</link:label>
    <link:label id="lab_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_label_en-US" xlink:label="lab_ehth_IndividualFamilyAndSmallBusinessSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual, Family, And Small Business Segments [Member]</link:label>
    <link:label id="lab_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_documentation_en-US" xlink:label="lab_ehth_IndividualFamilyAndSmallBusinessSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual, Family, And Small Business Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember" xlink:href="ehth-20210930.xsd#ehth_IndividualFamilyAndSmallBusinessSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember" xlink:to="lab_ehth_IndividualFamilyAndSmallBusinessSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_bf8e2e6f-d4cd-418e-b13f-03f9bafbd7b7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d1ce0ffe-818c-43aa-a443-6dbd8383e416_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e513ed89-c7c7-47b0-ba61-d30f79dc25ee_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with equity incentive plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_191938fe-6a85-4f44-9789-4a80dac19fe8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c48c8024-6940-4355-af47-940775986992_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in diluted share calculation (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_a62e34ae-9431-4afc-89c5-3c7d9a722869_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cdaff0e5-8ae1-43b6-8c6b-3411eb2bab33_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_eda728f5-e2f4-417a-8417-16b817ad4132_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_d0da83f9-d05d-4631-a83d-f609a4642595_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_31da71c7-f144-4df8-9515-0991a10e12ea_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CommissionRevenueFromRenewalsMember_6069080f-933a-4d78-9a3b-b90f7d6b3eef_terseLabel_en-US" xlink:label="lab_ehth_CommissionRevenueFromRenewalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Revenue from Renewals of Small Business Members During the Period</link:label>
    <link:label id="lab_ehth_CommissionRevenueFromRenewalsMember_label_en-US" xlink:label="lab_ehth_CommissionRevenueFromRenewalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Revenue From Renewals [Member]</link:label>
    <link:label id="lab_ehth_CommissionRevenueFromRenewalsMember_documentation_en-US" xlink:label="lab_ehth_CommissionRevenueFromRenewalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commission Revenue From Renewals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionRevenueFromRenewalsMember" xlink:href="ehth-20210930.xsd#ehth_CommissionRevenueFromRenewalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CommissionRevenueFromRenewalsMember" xlink:to="lab_ehth_CommissionRevenueFromRenewalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_9d697159-2418-4aad-8075-2682ac67801f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedIndividualandFamilyAxis_eaaba532-c82e-401c-9c6d-e84a959e3f00_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedIndividualandFamilyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Individual and Family [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedIndividualandFamilyAxis_label_en-US" xlink:label="lab_ehth_DisaggregatedIndividualandFamilyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Individual and Family [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedIndividualandFamilyAxis_documentation_en-US" xlink:label="lab_ehth_DisaggregatedIndividualandFamilyAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Individual and Family [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedIndividualandFamilyAxis" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedIndividualandFamilyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyAxis" xlink:to="lab_ehth_DisaggregatedIndividualandFamilyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_88284cea-445c-45fb-95b1-0a562b8f8967_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_96b7af88-a6ab-4e4d-939d-18c40a726a2e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedMedicareAxis_af8c9e77-e558-4a19-a835-090eafb30c66_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedMedicareAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Medicare [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedMedicareAxis_label_en-US" xlink:label="lab_ehth_DisaggregatedMedicareAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Medicare [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedMedicareAxis_documentation_en-US" xlink:label="lab_ehth_DisaggregatedMedicareAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disagregated Medicare [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedMedicareAxis" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedMedicareAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedMedicareAxis" xlink:to="lab_ehth_DisaggregatedMedicareAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_cafd46bb-9511-4fa1-b6ef-b44cd3dd5051_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_5853fe86-bc2f-4be5-abb1-a911b45cdb12_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_cf50230b-d229-4bfb-bc73-220951322366_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_11258fb4-cf12-4464-8091-6b5a2c64d1be_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays_6e84e056-47a7-439a-8eb8-9858d403b90e_terseLabel_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold consecutive trading days</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays_label_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Threshold Consecutive Trading Days</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays_documentation_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays" xlink:to="lab_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_13ab2a4d-57b3-451b-a433-62439281cb1d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock for employee stock purchase program</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_764e84a6-3d65-45d9-b121-eb6a0d320d83_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized holding gain (loss) for available for sales debt securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_da5bd1c0-3f75-436f-a24b-8001e84eda0f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_dd3581c4-b2a1-4fc1-b6a5-8b1df08e288f_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_dbdb6985-d2dc-4039-ad84-e69b67b0fa18_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_80d4d8e1-a136-4dcf-ab56-fa202117d2b3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_9411778a-d95c-4922-b8a1-0ba10051eb18_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLineItems" xlink:to="lab_us-gaap_TemporaryEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember_f73257c4-8b97-4963-9dbf-db1427a717bf_terseLabel_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Preceding Three Months</link:label>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember_label_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Preceding Three Months [Member]</link:label>
    <link:label id="lab_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember_documentation_en-US" xlink:label="lab_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eligible Commissions Receivables, Preceding Three Months [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember" xlink:href="ehth-20210930.xsd#ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember" xlink:to="lab_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f81b902c-5898-44ac-b9cf-ff9e6543a273_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_8e90f079-736f-48a2-a7ea-fb4ac6ad8334_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in preferred stock redemption value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_9c466c34-75c9-4ae5-bedf-91def3e16b51_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_04f55e34-2d73-43c9-872e-c85a11640fc9_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedAncillariesAxis_05c03906-1455-481e-af99-9dd2af2a116e_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedAncillariesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Ancillaries [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedAncillariesAxis_label_en-US" xlink:label="lab_ehth_DisaggregatedAncillariesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Ancillaries [Axis]</link:label>
    <link:label id="lab_ehth_DisaggregatedAncillariesAxis_documentation_en-US" xlink:label="lab_ehth_DisaggregatedAncillariesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Ancillaries [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedAncillariesAxis" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedAncillariesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedAncillariesAxis" xlink:to="lab_ehth_DisaggregatedAncillariesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_28d00bf2-4624-402c-ac24-dea411379dba_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_CustomerCareAndEnrollmentExpense_f8243306-670c-4e80-8176-7e1a4d1ee49f_terseLabel_en-US" xlink:label="lab_ehth_CustomerCareAndEnrollmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer care and enrollment</link:label>
    <link:label id="lab_ehth_CustomerCareAndEnrollmentExpense_label_en-US" xlink:label="lab_ehth_CustomerCareAndEnrollmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Care And Enrollment Expense</link:label>
    <link:label id="lab_ehth_CustomerCareAndEnrollmentExpense_documentation_en-US" xlink:label="lab_ehth_CustomerCareAndEnrollmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total expense recognized in the period related to providing customer care and enrollment services. These services include pre-sales assistance to applicants who call our customer care center and enrollment services to applicants during the underwriting process.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CustomerCareAndEnrollmentExpense" xlink:href="ehth-20210930.xsd#ehth_CustomerCareAndEnrollmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_CustomerCareAndEnrollmentExpense" xlink:to="lab_ehth_CustomerCareAndEnrollmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5e8edf94-fdcc-4aeb-be42-731d35f9befa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_MedicarePartDMember_6ca715e6-33f7-4efa-aef4-afa3b2a5a624_terseLabel_en-US" xlink:label="lab_ehth_MedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D</link:label>
    <link:label id="lab_ehth_MedicarePartDMember_label_en-US" xlink:label="lab_ehth_MedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D [Member]</link:label>
    <link:label id="lab_ehth_MedicarePartDMember_documentation_en-US" xlink:label="lab_ehth_MedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicarePartDMember" xlink:href="ehth-20210930.xsd#ehth_MedicarePartDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_MedicarePartDMember" xlink:to="lab_ehth_MedicarePartDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DisaggregatedOtherDomain_cc1a324d-6bb0-452e-9d6d-fa27f0ebee55_terseLabel_en-US" xlink:label="lab_ehth_DisaggregatedOtherDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Other [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedOtherDomain_label_en-US" xlink:label="lab_ehth_DisaggregatedOtherDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Other [Domain]</link:label>
    <link:label id="lab_ehth_DisaggregatedOtherDomain_documentation_en-US" xlink:label="lab_ehth_DisaggregatedOtherDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregated Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedOtherDomain" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedOtherDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DisaggregatedOtherDomain" xlink:to="lab_ehth_DisaggregatedOtherDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_daa3a4b5-7e90-4093-b2b5-0c3b50522903_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_6d638266-e1b2-4c50-b00d-eba97aeeee24_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_086d7d9d-b17c-4fe5-b6ca-c734e9828b65_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_220465df-b496-4e40-9e3e-d94a3e270557_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_AetnaMember_c2c23f72-0b44-4f5c-8bec-11be54246a81_terseLabel_en-US" xlink:label="lab_ehth_AetnaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna</link:label>
    <link:label id="lab_ehth_AetnaMember_label_en-US" xlink:label="lab_ehth_AetnaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna [Member]</link:label>
    <link:label id="lab_ehth_AetnaMember_documentation_en-US" xlink:label="lab_ehth_AetnaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AetnaMember" xlink:href="ehth-20210930.xsd#ehth_AetnaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_AetnaMember" xlink:to="lab_ehth_AetnaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock_ffefbe73-1509-47f9-a658-2d6a7e7bde02_terseLabel_en-US" xlink:label="lab_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Long Lived Assets By Geographical Areas</link:label>
    <link:label id="lab_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Long Lived Assets By Geographical Areas [Table Text Block]</link:label>
    <link:label id="lab_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock_documentation_en-US" xlink:label="lab_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Long Lived Assets By Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="ehth-20210930.xsd#ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_af98ea4c-c88b-40c8-8c72-b6064a051e15_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_DentalMember_394fb414-aac4-441c-a424-850cd75e1fb5_terseLabel_en-US" xlink:label="lab_ehth_DentalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dental</link:label>
    <link:label id="lab_ehth_DentalMember_label_en-US" xlink:label="lab_ehth_DentalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dental [Member]</link:label>
    <link:label id="lab_ehth_DentalMember_documentation_en-US" xlink:label="lab_ehth_DentalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dental [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DentalMember" xlink:href="ehth-20210930.xsd#ehth_DentalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_DentalMember" xlink:to="lab_ehth_DentalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_MedicareSegmentMember_054bf2c2-e984-462f-a0ce-6105d24cb78a_terseLabel_en-US" xlink:label="lab_ehth_MedicareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_ehth_MedicareSegmentMember_label_en-US" xlink:label="lab_ehth_MedicareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Segment [Member]</link:label>
    <link:label id="lab_ehth_MedicareSegmentMember_documentation_en-US" xlink:label="lab_ehth_MedicareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSegmentMember" xlink:href="ehth-20210930.xsd#ehth_MedicareSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_MedicareSegmentMember" xlink:to="lab_ehth_MedicareSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_PrepaidMaintenanceContractsCurrent_81c94339-2940-43e9-9303-72200df0d6b8_terseLabel_en-US" xlink:label="lab_ehth_PrepaidMaintenanceContractsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid maintenance contracts</link:label>
    <link:label id="lab_ehth_PrepaidMaintenanceContractsCurrent_label_en-US" xlink:label="lab_ehth_PrepaidMaintenanceContractsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Maintenance Contracts Current</link:label>
    <link:label id="lab_ehth_PrepaidMaintenanceContractsCurrent_documentation_en-US" xlink:label="lab_ehth_PrepaidMaintenanceContractsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Maintenance Contracts (Current)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PrepaidMaintenanceContractsCurrent" xlink:href="ehth-20210930.xsd#ehth_PrepaidMaintenanceContractsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_PrepaidMaintenanceContractsCurrent" xlink:to="lab_ehth_PrepaidMaintenanceContractsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_e93c14ca-323f-47b3-abec-fda75568b46d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New claims filed</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_68edc4d3-5c21-4c2f-a1d3-c63388eef05f_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockTextBlock_afe00b3d-c2a4-4c4f-967a-beda378c90cc_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockTextBlock_label_en-US" xlink:label="lab_us-gaap_PreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockTextBlock" xlink:to="lab_us-gaap_PreferredStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock_e0cbbfcc-2794-4ca7-9f9d-d09577493796_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Change in Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_b4f4109f-534d-42d5-91ef-8f5d4c05456b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_b662fe55-aa73-49b4-902d-4fdf41105192_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_d3549695-6713-4e2e-965e-dd82ef26d9e0_terseLabel_en-US" xlink:label="lab_ehth_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds</link:label>
    <link:label id="lab_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_label_en-US" xlink:label="lab_ehth_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Consideration Received On Transaction, Gross</link:label>
    <link:label id="lab_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_documentation_en-US" xlink:label="lab_ehth_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Consideration Received On Transaction, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:href="ehth-20210930.xsd#ehth_SaleOfStockConsiderationReceivedOnTransactionGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:to="lab_ehth_SaleOfStockConsiderationReceivedOnTransactionGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_7126342d-2f52-448c-af3e-1a9273a0db52_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger_107d99b7-f114-4535-b57b-a72217a00298_terseLabel_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold percentage of conversion price</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Threshold Percentage Of Stock Price Trigger</link:label>
    <link:label id="lab_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger_documentation_en-US" xlink:label="lab_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Threshold Percentage Of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger" xlink:to="lab_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseMember_38d05f45-084d-49aa-82fb-ae88e5f1fda9_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License</link:label>
    <link:label id="lab_us-gaap_LicenseMember_label_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseMember" xlink:to="lab_us-gaap_LicenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_4be7119d-2679-4801-8d6a-d832a2e37dab_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a0b049c8-0ea5-4889-a69e-5c6b035f0aa6_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_1228e70b-8f41-40b5-9344-965380c5c4cf_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_83976e99-38da-4e64-ba08-ee1ad2babf05_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in 1 year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_cf985ff6-d32c-4a17-94b6-63d7050c1625_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_b953bb74-5fdc-4649-9d3c-a38dccbd8a1d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_IndividualandFamilyMember_d60f7bfa-0a88-44d5-9126-f666c80e2132_terseLabel_en-US" xlink:label="lab_ehth_IndividualandFamilyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual and Family</link:label>
    <link:label id="lab_ehth_IndividualandFamilyMember_label_en-US" xlink:label="lab_ehth_IndividualandFamilyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual and Family [Member]</link:label>
    <link:label id="lab_ehth_IndividualandFamilyMember_documentation_en-US" xlink:label="lab_ehth_IndividualandFamilyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual and Family [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualandFamilyMember" xlink:href="ehth-20210930.xsd#ehth_IndividualandFamilyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_IndividualandFamilyMember" xlink:to="lab_ehth_IndividualandFamilyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_c062c7fe-e77d-4652-b6c1-54ca036b2d08_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_05d4ebfe-5927-49d4-8c44-d6ad90a425ec_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_da6a3751-80dc-4a59-bbd3-3fcdc5a40098_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMinimumLiquidity_e8d1b647-5e81-4046-a04a-0546c11b738a_terseLabel_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMinimumLiquidity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum liquidity</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMinimumLiquidity_label_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMinimumLiquidity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Minimum Liquidity</link:label>
    <link:label id="lab_ehth_LineOfCreditFacilityCovenantMinimumLiquidity_documentation_en-US" xlink:label="lab_ehth_LineOfCreditFacilityCovenantMinimumLiquidity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Covenant, Minimum Liquidity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMinimumLiquidity" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityCovenantMinimumLiquidity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ehth_LineOfCreditFacilityCovenantMinimumLiquidity" xlink:to="lab_ehth_LineOfCreditFacilityCovenantMinimumLiquidity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionOfDividends_9b04e243-bb4c-4be9-92dc-f25f836fd4e7_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionOfDividends" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued paid-in-kind dividends</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionOfDividends_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionOfDividends" xlink:to="lab_us-gaap_TemporaryEquityAccretionOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>ehth-20210930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:001ee10b-2bdc-4177-8047-00c9b0c2bbeb,g:3e9ca025-a681-404c-b475-c1976cd6b86b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="simple" xlink:href="ehth-20210930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_041deec0-3be8-4dc9-8a1e-34869b62da95" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_DocumentType_041deec0-3be8-4dc9-8a1e-34869b62da95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_f2ba56e8-e0cd-4dc6-bfee-c7ee43c9bed2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_DocumentQuarterlyReport_f2ba56e8-e0cd-4dc6-bfee-c7ee43c9bed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_afc1cd45-a9cb-4bd0-863a-67c728bf90a5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_DocumentPeriodEndDate_afc1cd45-a9cb-4bd0-863a-67c728bf90a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_dd49999d-0787-44c2-8478-462e04a850fa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_DocumentTransitionReport_dd49999d-0787-44c2-8478-462e04a850fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5d6b89f4-6280-4e90-9b87-fb5f4de57edb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityFileNumber_5d6b89f4-6280-4e90-9b87-fb5f4de57edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_0394ddd3-c0cc-4cbb-bfcf-6950c11b2f6e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityRegistrantName_0394ddd3-c0cc-4cbb-bfcf-6950c11b2f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_39ec5051-ad10-4031-bdbb-b2c6bbcedcce" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityIncorporationStateCountryCode_39ec5051-ad10-4031-bdbb-b2c6bbcedcce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_51ae7402-720a-41ab-9904-6955946f1af6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityTaxIdentificationNumber_51ae7402-720a-41ab-9904-6955946f1af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_6cee6560-78f8-4cb9-8612-4958673254b1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityAddressAddressLine1_6cee6560-78f8-4cb9-8612-4958673254b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_fa17c019-1747-4ab1-afe0-a17d02c8c2f4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityAddressCityOrTown_fa17c019-1747-4ab1-afe0-a17d02c8c2f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_6f2db024-b5c0-4baf-9796-907d79cc8d71" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityAddressStateOrProvince_6f2db024-b5c0-4baf-9796-907d79cc8d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b61248f7-548d-47d7-9f8c-424154edcac4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityAddressPostalZipCode_b61248f7-548d-47d7-9f8c-424154edcac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0db8c6ce-91c5-4dcc-9fac-78e47e885744" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_CityAreaCode_0db8c6ce-91c5-4dcc-9fac-78e47e885744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b2bea7f0-541f-44ed-a9bf-77d70b89c8b3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_LocalPhoneNumber_b2bea7f0-541f-44ed-a9bf-77d70b89c8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7520cce1-0f5c-4f22-93f4-3f058c82d874" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_Security12bTitle_7520cce1-0f5c-4f22-93f4-3f058c82d874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_4f1c6fbc-fc74-42cf-900c-8c244f25d2cb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_TradingSymbol_4f1c6fbc-fc74-42cf-900c-8c244f25d2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_afcd88d3-c14c-4a40-8d87-8bb8df278203" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_SecurityExchangeName_afcd88d3-c14c-4a40-8d87-8bb8df278203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_a00de15a-403f-4fae-92c0-d575ac7b63dc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityCurrentReportingStatus_a00de15a-403f-4fae-92c0-d575ac7b63dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_be31171b-32b9-4bb6-ab74-a342b20e2a32" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityInteractiveDataCurrent_be31171b-32b9-4bb6-ab74-a342b20e2a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_8d58c966-b183-4b2c-85d8-1d056c9725f4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityFilerCategory_8d58c966-b183-4b2c-85d8-1d056c9725f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_c76869e7-d3f0-4095-ac61-b02a7ea8f5bb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntitySmallBusiness_c76869e7-d3f0-4095-ac61-b02a7ea8f5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e5218a87-b5a7-4e65-848e-4daa7ad74c49" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityEmergingGrowthCompany_e5218a87-b5a7-4e65-848e-4daa7ad74c49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_e9598207-fa69-442a-b4d4-c826822a7061" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityShellCompany_e9598207-fa69-442a-b4d4-c826822a7061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_286b743e-0110-4201-ba3f-7a49c80922b2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_286b743e-0110-4201-ba3f-7a49c80922b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9c8e1e72-d22e-4151-982c-ec889cb0cc77" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_AmendmentFlag_9c8e1e72-d22e-4151-982c-ec889cb0cc77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_5f2c0a8e-b0af-4393-a781-5bf7336d7f22" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_DocumentFiscalYearFocus_5f2c0a8e-b0af-4393-a781-5bf7336d7f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_6614abca-cebc-4c0a-b709-0e979b9dc275" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_DocumentFiscalPeriodFocus_6614abca-cebc-4c0a-b709-0e979b9dc275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_10fcfcbc-a5d0-4dfc-b56f-3abc9560066d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_EntityCentralIndexKey_10fcfcbc-a5d0-4dfc-b56f-3abc9560066d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_08f7bf12-c7c1-47ee-a8f7-8cccedeb476d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d3b1c05a-c3ff-467b-9086-dacfce48e4d9" xlink:to="loc_dei_CurrentFiscalYearEndDate_08f7bf12-c7c1-47ee-a8f7-8cccedeb476d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ehth-20210930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_14586ee7-99e9-4697-b0cf-e6dd1bb407df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_a6dbcc8b-0b66-4f64-9c00-f0468a368703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_14586ee7-99e9-4697-b0cf-e6dd1bb407df" xlink:to="loc_us-gaap_AssetsAbstract_a6dbcc8b-0b66-4f64-9c00-f0468a368703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_a081e967-5cf7-4f32-8ef4-0384619e4537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a6dbcc8b-0b66-4f64-9c00-f0468a368703" xlink:to="loc_us-gaap_AssetsCurrentAbstract_a081e967-5cf7-4f32-8ef4-0384619e4537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8f0853ab-6dcf-48cd-9d0d-54722e0d4d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a081e967-5cf7-4f32-8ef4-0384619e4537" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8f0853ab-6dcf-48cd-9d0d-54722e0d4d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_6a8d8786-8d71-477c-9406-56e5e8402511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a081e967-5cf7-4f32-8ef4-0384619e4537" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_6a8d8786-8d71-477c-9406-56e5e8402511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_895aab2c-6484-420a-a0f8-59fbb5e3a15e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a081e967-5cf7-4f32-8ef4-0384619e4537" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_895aab2c-6484-420a-a0f8-59fbb5e3a15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_ddcb463c-f021-4484-8aa5-2ae6823e95d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a081e967-5cf7-4f32-8ef4-0384619e4537" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_ddcb463c-f021-4484-8aa5-2ae6823e95d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_71d88e41-28fb-4a4f-9c53-13dc7fc375ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a081e967-5cf7-4f32-8ef4-0384619e4537" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_71d88e41-28fb-4a4f-9c53-13dc7fc375ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_49c44bf4-9e71-4a8f-9df1-e47898da4ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a081e967-5cf7-4f32-8ef4-0384619e4537" xlink:to="loc_us-gaap_AssetsCurrent_49c44bf4-9e71-4a8f-9df1-e47898da4ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_984e0669-a0e8-474b-ae7e-4e0cea07fa32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a6dbcc8b-0b66-4f64-9c00-f0468a368703" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetNoncurrent_984e0669-a0e8-474b-ae7e-4e0cea07fa32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_36e53c6e-56d6-471d-ade5-1b7557baaa0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a6dbcc8b-0b66-4f64-9c00-f0468a368703" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_36e53c6e-56d6-471d-ade5-1b7557baaa0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a159181b-423e-480d-97bb-c91418b76815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a6dbcc8b-0b66-4f64-9c00-f0468a368703" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a159181b-423e-480d-97bb-c91418b76815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_d0647a2f-930d-49aa-84a5-128f8719cb60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a6dbcc8b-0b66-4f64-9c00-f0468a368703" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_d0647a2f-930d-49aa-84a5-128f8719cb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_68de54e3-75dd-4c4d-b635-b6012b9a48f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a6dbcc8b-0b66-4f64-9c00-f0468a368703" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_68de54e3-75dd-4c4d-b635-b6012b9a48f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ede83af8-9788-4261-8888-fe63f5dce90e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a6dbcc8b-0b66-4f64-9c00-f0468a368703" xlink:to="loc_us-gaap_Goodwill_ede83af8-9788-4261-8888-fe63f5dce90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c2803d46-49f1-41a1-a083-9ff8c82e7ff5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a6dbcc8b-0b66-4f64-9c00-f0468a368703" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c2803d46-49f1-41a1-a083-9ff8c82e7ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_57f3f3d9-af8b-4c8a-a8e5-818edf7ff6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a6dbcc8b-0b66-4f64-9c00-f0468a368703" xlink:to="loc_us-gaap_Assets_57f3f3d9-af8b-4c8a-a8e5-818edf7ff6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_961a8390-77e8-49ec-ae63-3bd4f2289993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_14586ee7-99e9-4697-b0cf-e6dd1bb407df" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_961a8390-77e8-49ec-ae63-3bd4f2289993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_7b3cda5e-472d-4262-8b64-91366d4604ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_961a8390-77e8-49ec-ae63-3bd4f2289993" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_7b3cda5e-472d-4262-8b64-91366d4604ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e2cf9cd1-da0c-4ef3-9255-b5835141fcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7b3cda5e-472d-4262-8b64-91366d4604ff" xlink:to="loc_us-gaap_AccountsPayableCurrent_e2cf9cd1-da0c-4ef3-9255-b5835141fcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_76f26e5b-5015-4fe0-86ef-6f58b49860e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7b3cda5e-472d-4262-8b64-91366d4604ff" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_76f26e5b-5015-4fe0-86ef-6f58b49860e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AccruedMarketingExpenses_b8ba2b9f-fea1-4deb-85ed-ce33650951d9" xlink:href="ehth-20210930.xsd#ehth_AccruedMarketingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7b3cda5e-472d-4262-8b64-91366d4604ff" xlink:to="loc_ehth_AccruedMarketingExpenses_b8ba2b9f-fea1-4deb-85ed-ce33650951d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_3a3e7b29-ab30-4048-a1a7-1157ae2a8bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7b3cda5e-472d-4262-8b64-91366d4604ff" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_3a3e7b29-ab30-4048-a1a7-1157ae2a8bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0bd1fa6b-bfaa-4056-bde8-899da0c30d35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7b3cda5e-472d-4262-8b64-91366d4604ff" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0bd1fa6b-bfaa-4056-bde8-899da0c30d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_423413e3-146e-4997-8719-a00ee376023e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7b3cda5e-472d-4262-8b64-91366d4604ff" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_423413e3-146e-4997-8719-a00ee376023e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cda55ef8-36fa-41e7-a640-b506d95129d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_7b3cda5e-472d-4262-8b64-91366d4604ff" xlink:to="loc_us-gaap_LiabilitiesCurrent_cda55ef8-36fa-41e7-a640-b506d95129d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d8b69727-7e1a-41d8-ab87-c057e193e110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_961a8390-77e8-49ec-ae63-3bd4f2289993" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d8b69727-7e1a-41d8-ab87-c057e193e110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_26e57786-23b9-445b-9c56-0a1f4bd0ede1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_961a8390-77e8-49ec-ae63-3bd4f2289993" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_26e57786-23b9-445b-9c56-0a1f4bd0ede1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_400f5bf4-5222-453c-b9d4-a3e885d1e0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_961a8390-77e8-49ec-ae63-3bd4f2289993" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_400f5bf4-5222-453c-b9d4-a3e885d1e0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c9acdeb8-d6f9-4a77-bd10-9f81a2458158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_961a8390-77e8-49ec-ae63-3bd4f2289993" xlink:to="loc_us-gaap_Liabilities_c9acdeb8-d6f9-4a77-bd10-9f81a2458158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b6294dc2-893f-4887-a1a8-91309ec8b540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_961a8390-77e8-49ec-ae63-3bd4f2289993" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b6294dc2-893f-4887-a1a8-91309ec8b540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_bc2f5f28-0d61-45da-87cf-5e191767372f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_961a8390-77e8-49ec-ae63-3bd4f2289993" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_bc2f5f28-0d61-45da-87cf-5e191767372f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_0a5b09c5-06f1-40e7-8ac3-95e7f0129d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_961a8390-77e8-49ec-ae63-3bd4f2289993" xlink:to="loc_us-gaap_StockholdersEquityAbstract_0a5b09c5-06f1-40e7-8ac3-95e7f0129d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d5158fcf-6571-4f41-82b5-ca8594243679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0a5b09c5-06f1-40e7-8ac3-95e7f0129d50" xlink:to="loc_us-gaap_CommonStockValue_d5158fcf-6571-4f41-82b5-ca8594243679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b84e2917-453f-47ef-85be-27ed8ff687dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0a5b09c5-06f1-40e7-8ac3-95e7f0129d50" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b84e2917-453f-47ef-85be-27ed8ff687dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_abc93d78-b160-4072-8191-e3d4a955504b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0a5b09c5-06f1-40e7-8ac3-95e7f0129d50" xlink:to="loc_us-gaap_TreasuryStockValue_abc93d78-b160-4072-8191-e3d4a955504b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_157a885f-61bc-4cab-abf1-39df7917cdb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0a5b09c5-06f1-40e7-8ac3-95e7f0129d50" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_157a885f-61bc-4cab-abf1-39df7917cdb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_63beec75-ccb2-4366-9991-481b8624b564" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0a5b09c5-06f1-40e7-8ac3-95e7f0129d50" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_63beec75-ccb2-4366-9991-481b8624b564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4a62f23c-a3c6-4f77-a87a-1d4e19ce8d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0a5b09c5-06f1-40e7-8ac3-95e7f0129d50" xlink:to="loc_us-gaap_StockholdersEquity_4a62f23c-a3c6-4f77-a87a-1d4e19ce8d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_81788490-0627-4b74-b2b7-f2f746c02516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_961a8390-77e8-49ec-ae63-3bd4f2289993" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_81788490-0627-4b74-b2b7-f2f746c02516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="ehth-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_65254b1a-aebb-4f69-96f0-05b55f33ce93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_14bf8ba3-eca4-4235-b680-d575d657e1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65254b1a-aebb-4f69-96f0-05b55f33ce93" xlink:to="loc_us-gaap_StatementTable_14bf8ba3-eca4-4235-b680-d575d657e1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e3e40638-ac13-49d7-9810-92012524ac0a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_14bf8ba3-eca4-4235-b680-d575d657e1a4" xlink:to="loc_srt_ProductOrServiceAxis_e3e40638-ac13-49d7-9810-92012524ac0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dc46b630-3d82-4523-8d32-623c266d90aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e3e40638-ac13-49d7-9810-92012524ac0a" xlink:to="loc_srt_ProductsAndServicesDomain_dc46b630-3d82-4523-8d32-623c266d90aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMember_3e252d80-0a08-4654-ace8-18d213b36ce3" xlink:href="ehth-20210930.xsd#ehth_CommissionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dc46b630-3d82-4523-8d32-623c266d90aa" xlink:to="loc_ehth_CommissionMember_3e252d80-0a08-4654-ace8-18d213b36ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_dd038ecd-3c79-4ec9-a1fc-f46f371af61f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_dc46b630-3d82-4523-8d32-623c266d90aa" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_dd038ecd-3c79-4ec9-a1fc-f46f371af61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_14bf8ba3-eca4-4235-b680-d575d657e1a4" xlink:to="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_a66c3ddd-06fc-4bf6-88d9-7d0992d5824f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_RevenuesAbstract_a66c3ddd-06fc-4bf6-88d9-7d0992d5824f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7e290b6d-d516-4bc3-8f72-07786515be13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_a66c3ddd-06fc-4bf6-88d9-7d0992d5824f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7e290b6d-d516-4bc3-8f72-07786515be13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_7c7453c1-6434-4416-9ee3-94c030d8cc84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_us-gaap_CostOfRevenue_7c7453c1-6434-4416-9ee3-94c030d8cc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingAndAdvertisingExpense_b2b68ab3-b4c5-49dc-9038-0ff64d982934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_us-gaap_MarketingAndAdvertisingExpense_b2b68ab3-b4c5-49dc-9038-0ff64d982934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CustomerCareAndEnrollmentExpense_f6d9d130-f46a-4223-a7ac-44b0a16fb7e8" xlink:href="ehth-20210930.xsd#ehth_CustomerCareAndEnrollmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_ehth_CustomerCareAndEnrollmentExpense_f6d9d130-f46a-4223-a7ac-44b0a16fb7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TechnologyAndContentExpense_4c0239b6-7c08-4033-a116-dc5d86ac305b" xlink:href="ehth-20210930.xsd#ehth_TechnologyAndContentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_ehth_TechnologyAndContentExpense_4c0239b6-7c08-4033-a116-dc5d86ac305b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_13269171-cc46-4806-bedb-060550a5c340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_13269171-cc46-4806-bedb-060550a5c340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ff381d44-e0de-41bd-bc67-04b1b4cc1e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ff381d44-e0de-41bd-bc67-04b1b4cc1e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_19acdd07-b8f8-4f1b-93f3-dc81c42e6b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_us-gaap_RestructuringCharges_19acdd07-b8f8-4f1b-93f3-dc81c42e6b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ad411b46-3054-48e8-bb96-a7440e0a9039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_8ec16c2e-977c-4555-ab89-06c0b25e3961" xlink:to="loc_us-gaap_CostsAndExpenses_ad411b46-3054-48e8-bb96-a7440e0a9039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c5baaa73-2054-47b2-949b-39136031eae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_OperatingIncomeLoss_c5baaa73-2054-47b2-949b-39136031eae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_11661272-52ad-494e-96ac-89323042eb66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_11661272-52ad-494e-96ac-89323042eb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dea28615-f0a9-4899-8a6b-596844211278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_dea28615-f0a9-4899-8a6b-596844211278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b9f4e088-d52a-49a5-b3ed-e1e40735afa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b9f4e088-d52a-49a5-b3ed-e1e40735afa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0ae81c42-08ec-42be-ac56-47107ae03adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_NetIncomeLoss_0ae81c42-08ec-42be-ac56-47107ae03adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDividendsAdjustment_bf88796d-e7ba-4d98-9b5a-38f50cfc8d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDividendsAdjustment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_TemporaryEquityDividendsAdjustment_bf88796d-e7ba-4d98-9b5a-38f50cfc8d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_db02685e-9381-4198-bba0-a334dcce7ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_db02685e-9381-4198-bba0-a334dcce7ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_081fc648-5521-4ecd-a098-84a288bc2c36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_081fc648-5521-4ecd-a098-84a288bc2c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_495f54bb-dacd-4f14-97cc-b377022142eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_EarningsPerShareAbstract_495f54bb-dacd-4f14-97cc-b377022142eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a2abebe6-3651-46f9-a08a-e1072bde41ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_495f54bb-dacd-4f14-97cc-b377022142eb" xlink:to="loc_us-gaap_EarningsPerShareBasic_a2abebe6-3651-46f9-a08a-e1072bde41ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d9eb8a18-6bfa-4218-a277-c8d9083dbcdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_495f54bb-dacd-4f14-97cc-b377022142eb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d9eb8a18-6bfa-4218-a277-c8d9083dbcdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1b99bb41-164d-46f0-a67d-ef31dcf905d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1b99bb41-164d-46f0-a67d-ef31dcf905d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638b3648-7562-45a7-b004-584aa1dc0c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1b99bb41-164d-46f0-a67d-ef31dcf905d3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_638b3648-7562-45a7-b004-584aa1dc0c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79fb8dab-0aaa-4a0a-bade-d3cc116d878d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1b99bb41-164d-46f0-a67d-ef31dcf905d3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_79fb8dab-0aaa-4a0a-bade-d3cc116d878d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8f50f3df-90c1-44a2-930a-6d557fb5cb04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b165ca86-a05d-426c-8cbd-5490018cf863" xlink:to="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8f50f3df-90c1-44a2-930a-6d557fb5cb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_018373c9-039b-4bd0-b50c-c87a4c35128d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8f50f3df-90c1-44a2-930a-6d557fb5cb04" xlink:to="loc_us-gaap_NetIncomeLoss_018373c9-039b-4bd0-b50c-c87a4c35128d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_5df992dd-e668-498e-a6bb-c2037858099d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8f50f3df-90c1-44a2-930a-6d557fb5cb04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_5df992dd-e668-498e-a6bb-c2037858099d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_eb4029be-f4ec-43cd-bbb9-8d3d93de0983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8f50f3df-90c1-44a2-930a-6d557fb5cb04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_eb4029be-f4ec-43cd-bbb9-8d3d93de0983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_39719c3a-cc16-4f58-95c7-7dbb0ea3ecfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8f50f3df-90c1-44a2-930a-6d557fb5cb04" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_39719c3a-cc16-4f58-95c7-7dbb0ea3ecfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ehth-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3a0d3b3b-5330-41f2-a17a-d8a17a1b61ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b43cdbf1-023d-4312-974d-8fdd4190e858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3a0d3b3b-5330-41f2-a17a-d8a17a1b61ec" xlink:to="loc_us-gaap_StatementTable_b43cdbf1-023d-4312-974d-8fdd4190e858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9fbf42ea-3093-4cef-8a6c-7c7f91e4cc86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b43cdbf1-023d-4312-974d-8fdd4190e858" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9fbf42ea-3093-4cef-8a6c-7c7f91e4cc86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_91e53883-3788-419e-8e8d-47715854a264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9fbf42ea-3093-4cef-8a6c-7c7f91e4cc86" xlink:to="loc_us-gaap_EquityComponentDomain_91e53883-3788-419e-8e8d-47715854a264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_73c6c789-a25b-4384-a37c-ee82df1db070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_91e53883-3788-419e-8e8d-47715854a264" xlink:to="loc_us-gaap_CommonStockMember_73c6c789-a25b-4384-a37c-ee82df1db070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_918c97d0-ef76-4a76-9285-bec1215df154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_91e53883-3788-419e-8e8d-47715854a264" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_918c97d0-ef76-4a76-9285-bec1215df154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_cd975044-14ba-49ba-a34a-b4760e7a9b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_91e53883-3788-419e-8e8d-47715854a264" xlink:to="loc_us-gaap_TreasuryStockMember_cd975044-14ba-49ba-a34a-b4760e7a9b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9b516ad8-ef1f-42c1-8cdc-bfc4626f977a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_91e53883-3788-419e-8e8d-47715854a264" xlink:to="loc_us-gaap_RetainedEarningsMember_9b516ad8-ef1f-42c1-8cdc-bfc4626f977a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2df715ca-f04f-4168-9f2b-a29396b416cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_91e53883-3788-419e-8e8d-47715854a264" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2df715ca-f04f-4168-9f2b-a29396b416cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0b0ae844-4fee-4421-b870-311197456e11" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b43cdbf1-023d-4312-974d-8fdd4190e858" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0b0ae844-4fee-4421-b870-311197456e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6fdfd644-188d-403b-885a-78c7009264c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_0b0ae844-4fee-4421-b870-311197456e11" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6fdfd644-188d-403b-885a-78c7009264c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7a7b50b0-16a0-44fb-a15c-eac21d6ff931" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6fdfd644-188d-403b-885a-78c7009264c2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7a7b50b0-16a0-44fb-a15c-eac21d6ff931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c315de75-2f0a-4e32-a397-aef362856b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b43cdbf1-023d-4312-974d-8fdd4190e858" xlink:to="loc_us-gaap_StatementLineItems_c315de75-2f0a-4e32-a397-aef362856b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c315de75-2f0a-4e32-a397-aef362856b2c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_9fca38a8-885b-4934-ab57-74709ecf21ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_SharesOutstanding_9fca38a8-885b-4934-ab57-74709ecf21ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_98f95043-745a-4177-a216-81399c2c7776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockholdersEquity_98f95043-745a-4177-a216-81399c2c7776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_922a7ff8-571e-45ac-83ba-ac7fdce561a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_922a7ff8-571e-45ac-83ba-ac7fdce561a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4a7dce5c-885f-4dc7-8297-1f69aa4284b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_4a7dce5c-885f-4dc7-8297-1f69aa4284b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_fd21c2b8-0f12-4e35-a031-93878267cf32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_fd21c2b8-0f12-4e35-a031-93878267cf32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_88cd639d-5a87-49e1-ac2c-079a5585f1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_88cd639d-5a87-49e1-ac2c-079a5585f1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock_455e2266-bf81-4fe1-96ff-db49d4994e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock_455e2266-bf81-4fe1-96ff-db49d4994e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_dd4382e8-80cb-459a-ad3e-2c3dea033ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_dd4382e8-80cb-459a-ad3e-2c3dea033ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d42f66fa-b835-419d-89cb-f2b431672561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_d42f66fa-b835-419d-89cb-f2b431672561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f667a661-fa96-43f6-9d2d-b6e5e4049a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f667a661-fa96-43f6-9d2d-b6e5e4049a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_69deed05-b649-419c-8c42-05b651a57649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_69deed05-b649-419c-8c42-05b651a57649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e5aaf3f7-6a26-4011-90f0-603af1fc2aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_NetIncomeLoss_e5aaf3f7-6a26-4011-90f0-603af1fc2aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_67d49167-30dc-4929-afac-b9cda4b11fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_67d49167-30dc-4929-afac-b9cda4b11fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_90d0d2e7-97a6-43cd-8f0e-6d7fbfa5de9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_90d0d2e7-97a6-43cd-8f0e-6d7fbfa5de9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_11c750c7-b0d5-4c6e-9362-6cc47511ad15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_11c750c7-b0d5-4c6e-9362-6cc47511ad15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_052d0954-1306-4b52-9ae1-4c9c64ed4215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_052d0954-1306-4b52-9ae1-4c9c64ed4215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b3355b62-9a6d-48c5-b27a-ea181d6f6dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_b3355b62-9a6d-48c5-b27a-ea181d6f6dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_48c67f53-9943-4038-ba79-c6c39fd5f733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_SharesOutstanding_48c67f53-9943-4038-ba79-c6c39fd5f733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_15d395ca-c64f-4210-ab33-c9c0bcf0c345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c38734f8-9690-49d4-a7e4-068e0f557a5a" xlink:to="loc_us-gaap_StockholdersEquity_15d395ca-c64f-4210-ab33-c9c0bcf0c345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ehth-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_b0319f61-3af7-4ad3-89c7-f6a7c18278ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a00d95c-95f8-40a0-9857-61ace350cdab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b0319f61-3af7-4ad3-89c7-f6a7c18278ce" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a00d95c-95f8-40a0-9857-61ace350cdab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_77a7abe9-8c93-45ac-9ede-04c26cad5749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a00d95c-95f8-40a0-9857-61ace350cdab" xlink:to="loc_us-gaap_NetIncomeLoss_77a7abe9-8c93-45ac-9ede-04c26cad5749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cde8b711-5437-49d2-a30e-a8c08a9105d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a00d95c-95f8-40a0-9857-61ace350cdab" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cde8b711-5437-49d2-a30e-a8c08a9105d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f1872dce-03ba-424f-ba89-de668ec9fb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cde8b711-5437-49d2-a30e-a8c08a9105d2" xlink:to="loc_us-gaap_Depreciation_f1872dce-03ba-424f-ba89-de668ec9fb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_0183c84a-78ad-4508-99e0-1b742ef0652e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cde8b711-5437-49d2-a30e-a8c08a9105d2" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_0183c84a-78ad-4508-99e0-1b742ef0652e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2f656790-9370-4936-a77b-12bc8fc2ad1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cde8b711-5437-49d2-a30e-a8c08a9105d2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2f656790-9370-4936-a77b-12bc8fc2ad1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5658bd2a-94eb-4e18-8f35-c81c11cc11bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cde8b711-5437-49d2-a30e-a8c08a9105d2" xlink:to="loc_us-gaap_ShareBasedCompensation_5658bd2a-94eb-4e18-8f35-c81c11cc11bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a00ebf18-d928-4e6b-af9e-8b00c4854491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cde8b711-5437-49d2-a30e-a8c08a9105d2" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_a00ebf18-d928-4e6b-af9e-8b00c4854491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_31917b21-b40b-473e-bdb1-b07146d3a0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cde8b711-5437-49d2-a30e-a8c08a9105d2" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_31917b21-b40b-473e-bdb1-b07146d3a0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62ed1f87-2599-4024-b32e-675d95710f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cde8b711-5437-49d2-a30e-a8c08a9105d2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62ed1f87-2599-4024-b32e-675d95710f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2c8ea3c6-ff90-47fe-9f0d-ff0cb89fb75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62ed1f87-2599-4024-b32e-675d95710f7f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2c8ea3c6-ff90-47fe-9f0d-ff0cb89fb75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInCommissionsReceivable_ce02af8d-7cc6-49bb-a4c5-c928b384b718" xlink:href="ehth-20210930.xsd#ehth_IncreaseDecreaseInCommissionsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62ed1f87-2599-4024-b32e-675d95710f7f" xlink:to="loc_ehth_IncreaseDecreaseInCommissionsReceivable_ce02af8d-7cc6-49bb-a4c5-c928b384b718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_e3db7c1f-aeb2-4995-a692-64da2b7e2314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62ed1f87-2599-4024-b32e-675d95710f7f" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_e3db7c1f-aeb2-4995-a692-64da2b7e2314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5317ade9-50de-4151-a01e-5b3436f0f0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62ed1f87-2599-4024-b32e-675d95710f7f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_5317ade9-50de-4151-a01e-5b3436f0f0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_47edca22-8595-4dc4-a5ad-6879a1443fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62ed1f87-2599-4024-b32e-675d95710f7f" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_47edca22-8595-4dc4-a5ad-6879a1443fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInAccruedMarketingExpenses_6d161913-9343-4abe-ac29-97d9765c6712" xlink:href="ehth-20210930.xsd#ehth_IncreaseDecreaseInAccruedMarketingExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62ed1f87-2599-4024-b32e-675d95710f7f" xlink:to="loc_ehth_IncreaseDecreaseInAccruedMarketingExpenses_6d161913-9343-4abe-ac29-97d9765c6712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_fa4cd3fe-03c8-43ae-96f2-cd3b8ee370ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62ed1f87-2599-4024-b32e-675d95710f7f" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_fa4cd3fe-03c8-43ae-96f2-cd3b8ee370ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_797d5b0f-a444-4556-8288-da749bbf09d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62ed1f87-2599-4024-b32e-675d95710f7f" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_797d5b0f-a444-4556-8288-da749bbf09d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42c2a7c4-5035-4946-8d39-b65d090e1575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a00d95c-95f8-40a0-9857-61ace350cdab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42c2a7c4-5035-4946-8d39-b65d090e1575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4542c6fe-f467-4bee-9ef7-33373f74fdfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b0319f61-3af7-4ad3-89c7-f6a7c18278ce" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4542c6fe-f467-4bee-9ef7-33373f74fdfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_7d89cb24-20dc-4ea4-8b6f-7a236978e1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4542c6fe-f467-4bee-9ef7-33373f74fdfc" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_7d89cb24-20dc-4ea4-8b6f-7a236978e1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c0139c52-b11f-4177-a9ea-6de2719c1169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4542c6fe-f467-4bee-9ef7-33373f74fdfc" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c0139c52-b11f-4177-a9ea-6de2719c1169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_25896c2c-463e-45cd-a304-3bc30c7c242a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4542c6fe-f467-4bee-9ef7-33373f74fdfc" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_25896c2c-463e-45cd-a304-3bc30c7c242a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_361ee513-fb77-4911-95c6-4ebf1d7592fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4542c6fe-f467-4bee-9ef7-33373f74fdfc" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_361ee513-fb77-4911-95c6-4ebf1d7592fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b8f3d8cc-2c26-426f-ba82-1f0aa6696d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4542c6fe-f467-4bee-9ef7-33373f74fdfc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b8f3d8cc-2c26-426f-ba82-1f0aa6696d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59e93a28-da43-42d0-935e-3a80501644e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b0319f61-3af7-4ad3-89c7-f6a7c18278ce" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59e93a28-da43-42d0-935e-3a80501644e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_0fb92405-3d53-4bb9-9b70-23571b5be6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59e93a28-da43-42d0-935e-3a80501644e7" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_0fb92405-3d53-4bb9-9b70-23571b5be6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e365e01c-0759-4d34-94b4-199ccde4a374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59e93a28-da43-42d0-935e-3a80501644e7" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e365e01c-0759-4d34-94b4-199ccde4a374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_5f15ae42-5638-45a5-adeb-3e75e0f7f630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59e93a28-da43-42d0-935e-3a80501644e7" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_5f15ae42-5638-45a5-adeb-3e75e0f7f630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_adff65ae-49c6-45df-ab23-eda624d1a9af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59e93a28-da43-42d0-935e-3a80501644e7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards_adff65ae-49c6-45df-ab23-eda624d1a9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_12a74ace-5567-4f86-99ef-e2f77522ec70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59e93a28-da43-42d0-935e-3a80501644e7" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_12a74ace-5567-4f86-99ef-e2f77522ec70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_f9723d48-861e-4e17-bed2-fa97db1d4a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59e93a28-da43-42d0-935e-3a80501644e7" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_f9723d48-861e-4e17-bed2-fa97db1d4a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e7fe187b-3dfd-47b4-a5de-0230c70f7686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_59e93a28-da43-42d0-935e-3a80501644e7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e7fe187b-3dfd-47b4-a5de-0230c70f7686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_40340778-7277-4b9e-a696-5f8981f87bfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b0319f61-3af7-4ad3-89c7-f6a7c18278ce" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_40340778-7277-4b9e-a696-5f8981f87bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_db3c6d68-4c72-4468-99dc-18fcc4729289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b0319f61-3af7-4ad3-89c7-f6a7c18278ce" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_db3c6d68-4c72-4468-99dc-18fcc4729289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3409beae-713e-4c67-85fe-c5fc62408ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b0319f61-3af7-4ad3-89c7-f6a7c18278ce" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3409beae-713e-4c67-85fe-c5fc62408ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_80a35201-a034-4944-9c48-f7366a8d8fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b0319f61-3af7-4ad3-89c7-f6a7c18278ce" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_80a35201-a034-4944-9c48-f7366a8d8fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies" xlink:type="simple" xlink:href="ehth-20210930.xsd#SummaryofBusinessandSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bd0f3c41-7cb3-45b1-a213-a1369ff101e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_dc83ded5-3aba-4a91-b368-f4eb35803ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bd0f3c41-7cb3-45b1-a213-a1369ff101e5" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_dc83ded5-3aba-4a91-b368-f4eb35803ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="ehth-20210930.xsd#SummaryofBusinessandSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_aee619c2-923c-42cd-9600-f1eff6b3cf1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DescriptionOfBusinessPolicyPolicyTextBlock_949e813f-033d-42ed-88d6-c6334fe353eb" xlink:href="ehth-20210930.xsd#ehth_DescriptionOfBusinessPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aee619c2-923c-42cd-9600-f1eff6b3cf1c" xlink:to="loc_ehth_DescriptionOfBusinessPolicyPolicyTextBlock_949e813f-033d-42ed-88d6-c6334fe353eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3b9ccb77-71b5-4888-b546-46e033346533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aee619c2-923c-42cd-9600-f1eff6b3cf1c" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3b9ccb77-71b5-4888-b546-46e033346533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_892af79c-961f-42fa-97bc-c131ddd46706" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aee619c2-923c-42cd-9600-f1eff6b3cf1c" xlink:to="loc_us-gaap_UseOfEstimates_892af79c-961f-42fa-97bc-c131ddd46706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SeasonalityPolicyPolicyTextBlock_78171e32-7bd3-4ae2-aa0e-3231b360fffc" xlink:href="ehth-20210930.xsd#ehth_SeasonalityPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aee619c2-923c-42cd-9600-f1eff6b3cf1c" xlink:to="loc_ehth_SeasonalityPolicyPolicyTextBlock_78171e32-7bd3-4ae2-aa0e-3231b360fffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d25a8830-37bb-485e-a4df-95b718ae2ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aee619c2-923c-42cd-9600-f1eff6b3cf1c" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d25a8830-37bb-485e-a4df-95b718ae2ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fa67cf7c-26bc-46d2-8a4b-b3f0992d05ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c28395d6-9b71-4b2f-a5cd-4de02d52673b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fa67cf7c-26bc-46d2-8a4b-b3f0992d05ac" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c28395d6-9b71-4b2f-a5cd-4de02d52673b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8a721db5-b0ea-46e1-994a-a89a485ff2d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c28395d6-9b71-4b2f-a5cd-4de02d52673b" xlink:to="loc_srt_ProductOrServiceAxis_8a721db5-b0ea-46e1-994a-a89a485ff2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_18d57502-d8b1-4de8-bcdc-a2f3b8c2d6e4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8a721db5-b0ea-46e1-994a-a89a485ff2d3" xlink:to="loc_srt_ProductsAndServicesDomain_18d57502-d8b1-4de8-bcdc-a2f3b8c2d6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_482728fc-27a7-46c5-8268-28d1fba0201b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_18d57502-d8b1-4de8-bcdc-a2f3b8c2d6e4" xlink:to="loc_us-gaap_LicenseMember_482728fc-27a7-46c5-8268-28d1fba0201b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_d1dcf316-1fa3-4a41-bd48-d98caf446beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c28395d6-9b71-4b2f-a5cd-4de02d52673b" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_d1dcf316-1fa3-4a41-bd48-d98caf446beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_6697c8e7-0061-4a24-ade6-9ffd454533e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_d1dcf316-1fa3-4a41-bd48-d98caf446beb" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_6697c8e7-0061-4a24-ade6-9ffd454533e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember_dbd4286e-98af-4d0c-8664-24d6cd720315" xlink:href="ehth-20210930.xsd#ehth_UnderRecognitionOfStockBasedCompensationExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_6697c8e7-0061-4a24-ade6-9ffd454533e9" xlink:to="loc_ehth_UnderRecognitionOfStockBasedCompensationExpenseMember_dbd4286e-98af-4d0c-8664-24d6cd720315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OverRecognitionOfLicensingCostsMember_3ea27d41-511c-44fa-bb4c-94f03a1afccc" xlink:href="ehth-20210930.xsd#ehth_OverRecognitionOfLicensingCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_6697c8e7-0061-4a24-ade6-9ffd454533e9" xlink:to="loc_ehth_OverRecognitionOfLicensingCostsMember_3ea27d41-511c-44fa-bb4c-94f03a1afccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OutOfPeriodAdjustmentsMember_4c0d4586-a163-4845-98d5-33bce3b483a4" xlink:href="ehth-20210930.xsd#ehth_OutOfPeriodAdjustmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_6697c8e7-0061-4a24-ade6-9ffd454533e9" xlink:to="loc_ehth_OutOfPeriodAdjustmentsMember_4c0d4586-a163-4845-98d5-33bce3b483a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c28395d6-9b71-4b2f-a5cd-4de02d52673b" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_NumberOfHealthInsuranceCarriers_439073f5-5a2c-4e49-af35-f160713b4997" xlink:href="ehth-20210930.xsd#ehth_NumberOfHealthInsuranceCarriers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_ehth_NumberOfHealthInsuranceCarriers_439073f5-5a2c-4e49-af35-f160713b4997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_c0e93d47-a69e-4b35-91ac-1999b0a50adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_c0e93d47-a69e-4b35-91ac-1999b0a50adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_9a5991eb-aa4d-4f76-95c1-16c9b994e29f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_9a5991eb-aa4d-4f76-95c1-16c9b994e29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_c8d1f745-6234-48d9-9aa7-57a4163e3141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_us-gaap_CostOfRevenue_c8d1f745-6234-48d9-9aa7-57a4163e3141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8e6eed63-0213-4200-8a5c-c6eadc683624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_us-gaap_NetIncomeLoss_8e6eed63-0213-4200-8a5c-c6eadc683624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f36822d1-3457-4d5b-8d83-a8c61ea72e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_us-gaap_EarningsPerShareBasic_f36822d1-3457-4d5b-8d83-a8c61ea72e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2b8244ad-d7c1-45d8-8abe-4b3ec38ae902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_5e97e750-c0ac-48bf-8ae9-0d6ab8e044e8" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2b8244ad-d7c1-45d8-8abe-4b3ec38ae902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Revenue" xlink:type="simple" xlink:href="ehth-20210930.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a022472d-982f-4a59-9fc4-6d1e0fd422e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_473ff90e-e4a7-47e1-8eed-2ec0f5f60bc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a022472d-982f-4a59-9fc4-6d1e0fd422e9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_473ff90e-e4a7-47e1-8eed-2ec0f5f60bc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RevenueTables" xlink:type="simple" xlink:href="ehth-20210930.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_702f3bed-c87d-4c99-969c-b834a0952633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_3a6e6f75-d806-448b-a788-a9030b7d162a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_702f3bed-c87d-4c99-969c-b834a0952633" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_3a6e6f75-d806-448b-a788-a9030b7d162a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#RevenueDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f7795e6c-541d-4295-a0d4-01738790c8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f7795e6c-541d-4295-a0d4-01738790c8ab" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_00dce4b6-9062-42ab-82d8-6f340903934b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:to="loc_srt_ProductOrServiceAxis_00dce4b6-9062-42ab-82d8-6f340903934b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_00dce4b6-9062-42ab-82d8-6f340903934b" xlink:to="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareMember_c61c98c0-8a7e-483a-8ba8-792472e6a3b1" xlink:href="ehth-20210930.xsd#ehth_MedicareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:to="loc_ehth_MedicareMember_c61c98c0-8a7e-483a-8ba8-792472e6a3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualandFamilyMember_34cecf72-7215-4de7-86b5-1222b320cce9" xlink:href="ehth-20210930.xsd#ehth_IndividualandFamilyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:to="loc_ehth_IndividualandFamilyMember_34cecf72-7215-4de7-86b5-1222b320cce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AncillariesMember_7034a643-6f58-478d-a096-c2f4b021f696" xlink:href="ehth-20210930.xsd#ehth_AncillariesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:to="loc_ehth_AncillariesMember_7034a643-6f58-478d-a096-c2f4b021f696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SmallBusinessMember_c71b85cf-84a2-4751-9f0c-f7c115e852fc" xlink:href="ehth-20210930.xsd#ehth_SmallBusinessMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:to="loc_ehth_SmallBusinessMember_c71b85cf-84a2-4751-9f0c-f7c115e852fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionBonusMember_cf9563ec-5de0-46d8-9528-85000e4e47e8" xlink:href="ehth-20210930.xsd#ehth_CommissionBonusMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:to="loc_ehth_CommissionBonusMember_cf9563ec-5de0-46d8-9528-85000e4e47e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMember_f4b9e2e8-c823-4f85-bb6b-25209b4e1e93" xlink:href="ehth-20210930.xsd#ehth_CommissionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:to="loc_ehth_CommissionMember_f4b9e2e8-c823-4f85-bb6b-25209b4e1e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_8f725f72-8819-4574-bd96-5f8e243dd7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_66b4c0f8-0428-4337-a61f-d6a536c8591d" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_8f725f72-8819-4574-bd96-5f8e243dd7a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedMedicareAxis_8c3f7010-93cd-4576-998d-5b7416c117cd" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedMedicareAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:to="loc_ehth_DisaggregatedMedicareAxis_8c3f7010-93cd-4576-998d-5b7416c117cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedMedicareDomain_568e3065-5b37-48a0-87b7-f3a3846be1aa" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedMedicareDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedMedicareAxis_8c3f7010-93cd-4576-998d-5b7416c117cd" xlink:to="loc_ehth_DisaggregatedMedicareDomain_568e3065-5b37-48a0-87b7-f3a3846be1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareAdvantageMember_a0b2f22e-1d86-43f0-9400-f6455fd83c8d" xlink:href="ehth-20210930.xsd#ehth_MedicareAdvantageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedMedicareDomain_568e3065-5b37-48a0-87b7-f3a3846be1aa" xlink:to="loc_ehth_MedicareAdvantageMember_a0b2f22e-1d86-43f0-9400-f6455fd83c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSupplementMember_5f7a5da3-5f5c-44c9-82ae-83d65a1e5bae" xlink:href="ehth-20210930.xsd#ehth_MedicareSupplementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedMedicareDomain_568e3065-5b37-48a0-87b7-f3a3846be1aa" xlink:to="loc_ehth_MedicareSupplementMember_5f7a5da3-5f5c-44c9-82ae-83d65a1e5bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicarePartDMember_3f1e5b14-909b-4607-9f09-8319dac0b787" xlink:href="ehth-20210930.xsd#ehth_MedicarePartDMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedMedicareDomain_568e3065-5b37-48a0-87b7-f3a3846be1aa" xlink:to="loc_ehth_MedicarePartDMember_3f1e5b14-909b-4607-9f09-8319dac0b787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedIndividualandFamilyAxis_96b26d5f-40cf-41be-a330-70b996ef0683" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedIndividualandFamilyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:to="loc_ehth_DisaggregatedIndividualandFamilyAxis_96b26d5f-40cf-41be-a330-70b996ef0683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedIndividualandFamilyDomain_856c75d7-4a5f-4cc8-9ab8-5df3d4bed537" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedIndividualandFamilyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyAxis_96b26d5f-40cf-41be-a330-70b996ef0683" xlink:to="loc_ehth_DisaggregatedIndividualandFamilyDomain_856c75d7-4a5f-4cc8-9ab8-5df3d4bed537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_NonQualifiedHealthPlansMember_ffd049ad-dbbc-49af-ad96-3189f6d5151d" xlink:href="ehth-20210930.xsd#ehth_NonQualifiedHealthPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyDomain_856c75d7-4a5f-4cc8-9ab8-5df3d4bed537" xlink:to="loc_ehth_NonQualifiedHealthPlansMember_ffd049ad-dbbc-49af-ad96-3189f6d5151d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_QualifiedHealthPlansMember_d65c5968-c723-4223-9e6a-355f0001fc9f" xlink:href="ehth-20210930.xsd#ehth_QualifiedHealthPlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedIndividualandFamilyDomain_856c75d7-4a5f-4cc8-9ab8-5df3d4bed537" xlink:to="loc_ehth_QualifiedHealthPlansMember_d65c5968-c723-4223-9e6a-355f0001fc9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedAncillariesAxis_eaddbacc-e194-41df-b924-cd73c6c58f1a" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedAncillariesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:to="loc_ehth_DisaggregatedAncillariesAxis_eaddbacc-e194-41df-b924-cd73c6c58f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedAncillariesDomain_9df7de53-79d5-4792-866c-9305d080c03a" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedAncillariesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedAncillariesAxis_eaddbacc-e194-41df-b924-cd73c6c58f1a" xlink:to="loc_ehth_DisaggregatedAncillariesDomain_9df7de53-79d5-4792-866c-9305d080c03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ShorttermMember_3b2be219-d021-468c-801c-fb8e871f185a" xlink:href="ehth-20210930.xsd#ehth_ShorttermMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_9df7de53-79d5-4792-866c-9305d080c03a" xlink:to="loc_ehth_ShorttermMember_3b2be219-d021-468c-801c-fb8e871f185a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DentalMember_b1fceb89-c2cc-4732-9e1e-55ad1fa48a48" xlink:href="ehth-20210930.xsd#ehth_DentalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_9df7de53-79d5-4792-866c-9305d080c03a" xlink:to="loc_ehth_DentalMember_b1fceb89-c2cc-4732-9e1e-55ad1fa48a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_VisionMember_802bebf2-fdfb-4623-9d21-1248d66ce288" xlink:href="ehth-20210930.xsd#ehth_VisionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_9df7de53-79d5-4792-866c-9305d080c03a" xlink:to="loc_ehth_VisionMember_802bebf2-fdfb-4623-9d21-1248d66ce288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_OtherMember_18b60545-0480-42cc-9eb8-3653086ea851" xlink:href="ehth-20210930.xsd#ehth_OtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedAncillariesDomain_9df7de53-79d5-4792-866c-9305d080c03a" xlink:to="loc_ehth_OtherMember_18b60545-0480-42cc-9eb8-3653086ea851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedOtherAxis_f2fc1181-d5db-42da-8b00-3658fcd92d3c" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedOtherAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:to="loc_ehth_DisaggregatedOtherAxis_f2fc1181-d5db-42da-8b00-3658fcd92d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DisaggregatedOtherDomain_959d212e-acda-44c1-ba32-a4692fb37557" xlink:href="ehth-20210930.xsd#ehth_DisaggregatedOtherDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedOtherAxis_f2fc1181-d5db-42da-8b00-3658fcd92d3c" xlink:to="loc_ehth_DisaggregatedOtherDomain_959d212e-acda-44c1-ba32-a4692fb37557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SponsorshipAndAdvertisingMember_70abed03-fbc4-42b9-9f86-9d7026f65033" xlink:href="ehth-20210930.xsd#ehth_SponsorshipAndAdvertisingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedOtherDomain_959d212e-acda-44c1-ba32-a4692fb37557" xlink:to="loc_ehth_SponsorshipAndAdvertisingMember_70abed03-fbc4-42b9-9f86-9d7026f65033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MiscellaneousOtherMember_0f564ba4-8308-41c4-92d9-19dc58e69197" xlink:href="ehth-20210930.xsd#ehth_MiscellaneousOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_DisaggregatedOtherDomain_959d212e-acda-44c1-ba32-a4692fb37557" xlink:to="loc_ehth_MiscellaneousOtherMember_0f564ba4-8308-41c4-92d9-19dc58e69197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f547b7ec-dd60-4e1c-85fa-fb92cbc6a3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bbbbe5ea-3e0f-4c39-b3e1-e63f859c7d47" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_f547b7ec-dd60-4e1c-85fa-fb92cbc6a3d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f5774950-8428-4e0e-9b2a-1f1f69f7b146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f547b7ec-dd60-4e1c-85fa-fb92cbc6a3d6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f5774950-8428-4e0e-9b2a-1f1f69f7b146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#RevenueCommissionRevenuebySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2a1db36b-1a1c-408a-81f6-b4424c26f8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_5630d6f2-371a-432e-8f3b-9d2d183e9ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2a1db36b-1a1c-408a-81f6-b4424c26f8bf" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_5630d6f2-371a-432e-8f3b-9d2d183e9ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2ad3d1be-a395-4088-bcc2-37aa9dbee791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5630d6f2-371a-432e-8f3b-9d2d183e9ffc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2ad3d1be-a395-4088-bcc2-37aa9dbee791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d390f2f5-707c-4843-9f51-30b4f2a5330e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2ad3d1be-a395-4088-bcc2-37aa9dbee791" xlink:to="loc_us-gaap_SegmentDomain_d390f2f5-707c-4843-9f51-30b4f2a5330e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSegmentMember_89c3b426-e72b-4c2f-84a2-8e2f02824ee2" xlink:href="ehth-20210930.xsd#ehth_MedicareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d390f2f5-707c-4843-9f51-30b4f2a5330e" xlink:to="loc_ehth_MedicareSegmentMember_89c3b426-e72b-4c2f-84a2-8e2f02824ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_76e3d4c4-ba7c-4144-8f56-dbd68feed853" xlink:href="ehth-20210930.xsd#ehth_IndividualFamilyAndSmallBusinessSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d390f2f5-707c-4843-9f51-30b4f2a5330e" xlink:to="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_76e3d4c4-ba7c-4144-8f56-dbd68feed853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_40a9edb0-b57a-4fe0-a75e-bab8fe800a49" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5630d6f2-371a-432e-8f3b-9d2d183e9ffc" xlink:to="loc_srt_ProductOrServiceAxis_40a9edb0-b57a-4fe0-a75e-bab8fe800a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_37cf7f9d-6c2c-4fe1-b412-42188d515d95" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_40a9edb0-b57a-4fe0-a75e-bab8fe800a49" xlink:to="loc_srt_ProductsAndServicesDomain_37cf7f9d-6c2c-4fe1-b412-42188d515d95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMember_c9b1b06a-39fc-459c-9545-79711f17d711" xlink:href="ehth-20210930.xsd#ehth_CommissionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_37cf7f9d-6c2c-4fe1-b412-42188d515d95" xlink:to="loc_ehth_CommissionMember_c9b1b06a-39fc-459c-9545-79711f17d711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_7b130f81-c3af-49ec-b4ed-144edcdbdad4" xlink:href="ehth-20210930.xsd#ehth_CommissionMembersApprovedDuringCurrentPeriodMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_CommissionMember_c9b1b06a-39fc-459c-9545-79711f17d711" xlink:to="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_7b130f81-c3af-49ec-b4ed-144edcdbdad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionRevenueFromRenewalsMember_955bebb6-6ddd-402a-8eab-065bf51ff6f9" xlink:href="ehth-20210930.xsd#ehth_CommissionRevenueFromRenewalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_CommissionMember_c9b1b06a-39fc-459c-9545-79711f17d711" xlink:to="loc_ehth_CommissionRevenueFromRenewalsMember_955bebb6-6ddd-402a-8eab-065bf51ff6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_131bcdae-4c8a-4a1d-a6d9-353ef1767caa" xlink:href="ehth-20210930.xsd#ehth_CommissionMembersApprovedInPriorPeriodsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_CommissionMember_c9b1b06a-39fc-459c-9545-79711f17d711" xlink:to="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_131bcdae-4c8a-4a1d-a6d9-353ef1767caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e35e9b0a-4b5f-4797-8446-a4d043fa054e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_5630d6f2-371a-432e-8f3b-9d2d183e9ffc" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_e35e9b0a-4b5f-4797-8446-a4d043fa054e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f63212bb-ed67-47e5-be4a-02f3fa6becac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e35e9b0a-4b5f-4797-8446-a4d043fa054e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f63212bb-ed67-47e5-be4a-02f3fa6becac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d9025c1a-faa4-45e2-a94e-bd19cdec0efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e35e9b0a-4b5f-4797-8446-a4d043fa054e" xlink:to="loc_us-gaap_EarningsPerShareBasic_d9025c1a-faa4-45e2-a94e-bd19cdec0efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_216edf3d-e6cc-403b-bd6c-33e950e91e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e35e9b0a-4b5f-4797-8446-a4d043fa054e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_216edf3d-e6cc-403b-bd6c-33e950e91e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_01776087-855c-47e2-a56c-0d62d3aacc5e" xlink:href="ehth-20210930.xsd#ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e35e9b0a-4b5f-4797-8446-a4d043fa054e" xlink:to="loc_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax_01776087-855c-47e2-a56c-0d62d3aacc5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation" xlink:type="simple" xlink:href="ehth-20210930.xsd#SupplementalFinancialStatementInformation"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6e8ffde9-d556-431c-a31a-bded57de7d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_443a037c-4fa8-427a-9bc3-133ee6e598d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6e8ffde9-d556-431c-a31a-bded57de7d48" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_443a037c-4fa8-427a-9bc3-133ee6e598d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables" xlink:type="simple" xlink:href="ehth-20210930.xsd#SupplementalFinancialStatementInformationTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_372617b2-96ff-48c4-9cc1-27541fffb53d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_6b8890e1-3163-4616-b8c8-05a5f67caa35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_372617b2-96ff-48c4-9cc1-27541fffb53d" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_6b8890e1-3163-4616-b8c8-05a5f67caa35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_92a6c688-48b8-450b-a758-8a631b355ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_372617b2-96ff-48c4-9cc1-27541fffb53d" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_92a6c688-48b8-450b-a758-8a631b355ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock_790fcde8-f73b-4149-8a1f-71a8012fb5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_372617b2-96ff-48c4-9cc1-27541fffb53d" xlink:to="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock_790fcde8-f73b-4149-8a1f-71a8012fb5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_94dfcbee-a003-40dd-a486-959a09eea332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_372617b2-96ff-48c4-9cc1-27541fffb53d" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_94dfcbee-a003-40dd-a486-959a09eea332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_def13395-2bbc-4c6c-b896-10eb5df01904" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_372617b2-96ff-48c4-9cc1-27541fffb53d" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_def13395-2bbc-4c6c-b896-10eb5df01904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_c2fc0470-f092-4d44-8519-0d6ba6c77c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_372617b2-96ff-48c4-9cc1-27541fffb53d" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_c2fc0470-f092-4d44-8519-0d6ba6c77c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0c07b5b7-7cd0-4b74-b38a-8f1d2a62abca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_be52a33b-eafe-429f-a360-2921cef3ced8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0c07b5b7-7cd0-4b74-b38a-8f1d2a62abca" xlink:to="loc_us-gaap_Cash_be52a33b-eafe-429f-a360-2921cef3ced8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_7564c1bd-ce26-4b36-8d4f-5daa465da9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0c07b5b7-7cd0-4b74-b38a-8f1d2a62abca" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_7564c1bd-ce26-4b36-8d4f-5daa465da9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_101eb7fe-fa08-4cad-b4ed-4f6f2b6300cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0c07b5b7-7cd0-4b74-b38a-8f1d2a62abca" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_101eb7fe-fa08-4cad-b4ed-4f6f2b6300cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_c72e078c-192b-4549-99c5-f1cce6e7a73e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0c07b5b7-7cd0-4b74-b38a-8f1d2a62abca" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_c72e078c-192b-4549-99c5-f1cce6e7a73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_96265fb9-e518-442a-bf14-fb7322098d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0c07b5b7-7cd0-4b74-b38a-8f1d2a62abca" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_96265fb9-e518-442a-bf14-fb7322098d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SupplementalFinancialStatementInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b35e0453-bf7f-45c1-b156-406e3a94b9a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_1f20e309-cb86-4e4a-9ca1-65f381d688dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b35e0453-bf7f-45c1-b156-406e3a94b9a3" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_1f20e309-cb86-4e4a-9ca1-65f381d688dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_07f60b55-5bd9-4d5e-91d6-b128cc690ca6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_1f20e309-cb86-4e4a-9ca1-65f381d688dd" xlink:to="loc_srt_StatementGeographicalAxis_07f60b55-5bd9-4d5e-91d6-b128cc690ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_606fcab5-ba2d-46e6-9746-83e7db7060ec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_07f60b55-5bd9-4d5e-91d6-b128cc690ca6" xlink:to="loc_srt_SegmentGeographicalDomain_606fcab5-ba2d-46e6-9746-83e7db7060ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_a7498c34-55e7-4eb2-915c-8d53ee529f5a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_606fcab5-ba2d-46e6-9746-83e7db7060ec" xlink:to="loc_country_CN_a7498c34-55e7-4eb2-915c-8d53ee529f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_6c39f4f8-91c1-443b-9dbb-29169d4dd86f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_1f20e309-cb86-4e4a-9ca1-65f381d688dd" xlink:to="loc_us-gaap_CashAndCashEquivalentsLineItems_6c39f4f8-91c1-443b-9dbb-29169d4dd86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_6caeec11-147f-462a-b7ea-4b6bf2a08038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_6c39f4f8-91c1-443b-9dbb-29169d4dd86f" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_6caeec11-147f-462a-b7ea-4b6bf2a08038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff_9e310d17-fd23-4ae2-acc3-8c85e24680ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_6c39f4f8-91c1-443b-9dbb-29169d4dd86f" xlink:to="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff_9e310d17-fd23-4ae2-acc3-8c85e24680ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Deposits_588cc9ec-975a-4fb9-95fa-6f6cecaa65d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Deposits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_6c39f4f8-91c1-443b-9dbb-29169d4dd86f" xlink:to="loc_us-gaap_Deposits_588cc9ec-975a-4fb9-95fa-6f6cecaa65d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_be086dca-6d56-45b9-9bbc-6f8a83be640b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward_1c0e804d-c311-47a7-836a-4354a7f940cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_be086dca-6d56-45b9-9bbc-6f8a83be640b" xlink:to="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward_1c0e804d-c311-47a7-836a-4354a7f940cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_4651d86f-a551-416f-ba25-5d5234ba5926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward_1c0e804d-c311-47a7-836a-4354a7f940cd" xlink:to="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_4651d86f-a551-416f-ba25-5d5234ba5926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_63c56eaa-c62e-48aa-b25c-517a45bb8862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward_1c0e804d-c311-47a7-836a-4354a7f940cd" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_63c56eaa-c62e-48aa-b25c-517a45bb8862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_41a75b79-0ef5-49cf-b28c-86745721c808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward_1c0e804d-c311-47a7-836a-4354a7f940cd" xlink:to="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_41a75b79-0ef5-49cf-b28c-86745721c808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_2b6c40fb-e195-44f6-b0fe-7b0b40a862ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_6b644292-e555-443b-a3f5-e25452b987d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_2b6c40fb-e195-44f6-b0fe-7b0b40a862ce" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_6b644292-e555-443b-a3f5-e25452b987d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9da235ee-e911-40a4-a1f0-10565550dfbe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6b644292-e555-443b-a3f5-e25452b987d9" xlink:to="loc_srt_ProductOrServiceAxis_9da235ee-e911-40a4-a1f0-10565550dfbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_37a85265-4ba9-4950-bfa9-8fe0aa2183ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9da235ee-e911-40a4-a1f0-10565550dfbe" xlink:to="loc_srt_ProductsAndServicesDomain_37a85265-4ba9-4950-bfa9-8fe0aa2183ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_4d3ab74a-0086-4926-a09d-fca48ed20780" xlink:href="ehth-20210930.xsd#ehth_CommissionMembersApprovedDuringCurrentPeriodMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_37a85265-4ba9-4950-bfa9-8fe0aa2183ab" xlink:to="loc_ehth_CommissionMembersApprovedDuringCurrentPeriodMember_4d3ab74a-0086-4926-a09d-fca48ed20780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionRevenueFromRenewalsMember_ac85baae-2fef-443a-acdd-4d441ac097d8" xlink:href="ehth-20210930.xsd#ehth_CommissionRevenueFromRenewalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_37a85265-4ba9-4950-bfa9-8fe0aa2183ab" xlink:to="loc_ehth_CommissionRevenueFromRenewalsMember_ac85baae-2fef-443a-acdd-4d441ac097d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_e642447e-f08b-4a20-b138-0c4d115409b4" xlink:href="ehth-20210930.xsd#ehth_CommissionMembersApprovedInPriorPeriodsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_37a85265-4ba9-4950-bfa9-8fe0aa2183ab" xlink:to="loc_ehth_CommissionMembersApprovedInPriorPeriodsMember_e642447e-f08b-4a20-b138-0c4d115409b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_623d17c1-1cdb-4037-a324-dea243c7a508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6b644292-e555-443b-a3f5-e25452b987d9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_623d17c1-1cdb-4037-a324-dea243c7a508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3c72fc97-9cfd-4867-9e22-5ad24d84bc58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_623d17c1-1cdb-4037-a324-dea243c7a508" xlink:to="loc_us-gaap_SegmentDomain_3c72fc97-9cfd-4867-9e22-5ad24d84bc58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSegmentMember_67dcb4d9-6ca3-4ba0-8043-54cbfe7a3d57" xlink:href="ehth-20210930.xsd#ehth_MedicareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3c72fc97-9cfd-4867-9e22-5ad24d84bc58" xlink:to="loc_ehth_MedicareSegmentMember_67dcb4d9-6ca3-4ba0-8043-54cbfe7a3d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_242db675-049f-4d8f-892a-5e6559af4fa4" xlink:href="ehth-20210930.xsd#ehth_IndividualFamilyAndSmallBusinessSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3c72fc97-9cfd-4867-9e22-5ad24d84bc58" xlink:to="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_242db675-049f-4d8f-892a-5e6559af4fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_dd0eab9a-954c-4e43-8bc0-710ca62a640b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6b644292-e555-443b-a3f5-e25452b987d9" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_dd0eab9a-954c-4e43-8bc0-710ca62a640b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ChangeInContractWithCustomerAssetRollForward_2cf83e11-0502-4f4a-8927-27e57cefa454" xlink:href="ehth-20210930.xsd#ehth_ChangeInContractWithCustomerAssetRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_dd0eab9a-954c-4e43-8bc0-710ca62a640b" xlink:to="loc_ehth_ChangeInContractWithCustomerAssetRollForward_2cf83e11-0502-4f4a-8927-27e57cefa454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_c2fc3eae-0aba-4f76-b786-60805d176bba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_2cf83e11-0502-4f4a-8927-27e57cefa454" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_c2fc3eae-0aba-4f76-b786-60805d176bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1413ddc2-df38-40ee-8579-477f81a13cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_2cf83e11-0502-4f4a-8927-27e57cefa454" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1413ddc2-df38-40ee-8579-477f81a13cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCommissionsReceived_43634c92-0c73-48a5-8a5d-dd298ee062be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCommissionsReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_2cf83e11-0502-4f4a-8927-27e57cefa454" xlink:to="loc_us-gaap_ProceedsFromCommissionsReceived_43634c92-0c73-48a5-8a5d-dd298ee062be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease_90badb51-e30f-4df7-9f1b-931cb03f7e62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_2cf83e11-0502-4f4a-8927-27e57cefa454" xlink:to="loc_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease_90badb51-e30f-4df7-9f1b-931cb03f7e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_b8b9f8d9-eaef-4a73-843c-45c634cd6b56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_ChangeInContractWithCustomerAssetRollForward_2cf83e11-0502-4f4a-8927-27e57cefa454" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_b8b9f8d9-eaef-4a73-843c-45c634cd6b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_33048d2a-0dab-46a1-bbf2-3f716e22d3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_26e38de0-078e-4576-92bc-2e8b96a26be3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_33048d2a-0dab-46a1-bbf2-3f716e22d3b8" xlink:to="loc_us-gaap_ConcentrationRiskTable_26e38de0-078e-4576-92bc-2e8b96a26be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_639f815d-ce9d-465d-9978-e6ad0dcc0bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_26e38de0-078e-4576-92bc-2e8b96a26be3" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_639f815d-ce9d-465d-9978-e6ad0dcc0bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_05517828-3389-4e61-80b0-c05045333786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_639f815d-ce9d-465d-9978-e6ad0dcc0bda" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_05517828-3389-4e61-80b0-c05045333786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_64cf3410-ad9c-4948-93d3-394db03fa5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_05517828-3389-4e61-80b0-c05045333786" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_64cf3410-ad9c-4948-93d3-394db03fa5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ff25ea62-4666-4de1-8468-4eaeace246f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_26e38de0-078e-4576-92bc-2e8b96a26be3" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ff25ea62-4666-4de1-8468-4eaeace246f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_31a8cacc-53f5-46b1-b406-8897a3b5772d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ff25ea62-4666-4de1-8468-4eaeace246f1" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_31a8cacc-53f5-46b1-b406-8897a3b5772d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_c6753196-236d-4d56-8ca9-8bab1ccfcd5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_31a8cacc-53f5-46b1-b406-8897a3b5772d" xlink:to="loc_us-gaap_AccountsReceivableMember_c6753196-236d-4d56-8ca9-8bab1ccfcd5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_d41e9fbb-5563-48ab-b6a3-65592ccb3584" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_26e38de0-078e-4576-92bc-2e8b96a26be3" xlink:to="loc_srt_MajorCustomersAxis_d41e9fbb-5563-48ab-b6a3-65592ccb3584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_98f505f2-40b4-4730-b304-935ec3c1bd4d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_d41e9fbb-5563-48ab-b6a3-65592ccb3584" xlink:to="loc_srt_NameOfMajorCustomerDomain_98f505f2-40b4-4730-b304-935ec3c1bd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_HumanaMember_a3f7e87e-8a39-4994-ba3f-12752f124a94" xlink:href="ehth-20210930.xsd#ehth_HumanaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_98f505f2-40b4-4730-b304-935ec3c1bd4d" xlink:to="loc_ehth_HumanaMember_a3f7e87e-8a39-4994-ba3f-12752f124a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnitedhealthcareMember_0c0a604c-46b1-47cb-b687-47aa9bc56ce0" xlink:href="ehth-20210930.xsd#ehth_UnitedhealthcareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_98f505f2-40b4-4730-b304-935ec3c1bd4d" xlink:to="loc_ehth_UnitedhealthcareMember_0c0a604c-46b1-47cb-b687-47aa9bc56ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AetnaMember_b6f9554e-1e8c-4b4d-9995-a52025b22acc" xlink:href="ehth-20210930.xsd#ehth_AetnaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_98f505f2-40b4-4730-b304-935ec3c1bd4d" xlink:to="loc_ehth_AetnaMember_b6f9554e-1e8c-4b4d-9995-a52025b22acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CenteneMember_131a15da-85f3-4e24-88e2-16326ca439c4" xlink:href="ehth-20210930.xsd#ehth_CenteneMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_98f505f2-40b4-4730-b304-935ec3c1bd4d" xlink:to="loc_ehth_CenteneMember_131a15da-85f3-4e24-88e2-16326ca439c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_05156a44-f835-4e42-836d-d13afde61b99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_26e38de0-078e-4576-92bc-2e8b96a26be3" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_05156a44-f835-4e42-836d-d13afde61b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1f975047-594e-4e68-8a17-c33d42353af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_05156a44-f835-4e42-836d-d13afde61b99" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1f975047-594e-4e68-8a17-c33d42353af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6f47f640-13f7-4448-855c-f79313eab243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PrepaidMaintenanceContractsCurrent_08a72d76-8fda-4909-b472-3e2c3458769a" xlink:href="ehth-20210930.xsd#ehth_PrepaidMaintenanceContractsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6f47f640-13f7-4448-855c-f79313eab243" xlink:to="loc_ehth_PrepaidMaintenanceContractsCurrent_08a72d76-8fda-4909-b472-3e2c3458769a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PrepaidLicenses_495fafce-c719-4205-93ec-7b48649b4466" xlink:href="ehth-20210930.xsd#ehth_PrepaidLicenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6f47f640-13f7-4448-855c-f79313eab243" xlink:to="loc_ehth_PrepaidLicenses_495fafce-c719-4205-93ec-7b48649b4466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_d3f4b0a9-2517-4491-af4b-8a49d958c006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6f47f640-13f7-4448-855c-f79313eab243" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_d3f4b0a9-2517-4491-af4b-8a49d958c006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_3cee1ffe-0bd2-4141-8271-e75af9b01244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6f47f640-13f7-4448-855c-f79313eab243" xlink:to="loc_us-gaap_PrepaidInsurance_3cee1ffe-0bd2-4141-8271-e75af9b01244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_f95b3a35-886e-4dab-adf1-8346c56c5cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6f47f640-13f7-4448-855c-f79313eab243" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_f95b3a35-886e-4dab-adf1-8346c56c5cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6f970ca7-06b6-4a7f-862a-ca4713cba2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6f47f640-13f7-4448-855c-f79313eab243" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6f970ca7-06b6-4a7f-862a-ca4713cba2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="ehth-20210930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8d00d16d-5c7d-4129-9be5-10bc9feb97c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_52fc67ff-59bd-4dcc-ae3d-9087e71774b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8d00d16d-5c7d-4129-9be5-10bc9feb97c2" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_52fc67ff-59bd-4dcc-ae3d-9087e71774b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="ehth-20210930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b43e0cd6-a7e6-4e5f-b9a5-274b2c3998f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_8a7ea9a8-27e1-4400-bcb5-506e6a29e627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b43e0cd6-a7e6-4e5f-b9a5-274b2c3998f2" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_8a7ea9a8-27e1-4400-bcb5-506e6a29e627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_9f7eb0b3-11c8-4708-9205-d67c5679975f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b43e0cd6-a7e6-4e5f-b9a5-274b2c3998f2" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_9f7eb0b3-11c8-4708-9205-d67c5679975f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_0496f6d9-6fde-45f0-b68d-7c2d6b34b383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b43e0cd6-a7e6-4e5f-b9a5-274b2c3998f2" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_0496f6d9-6fde-45f0-b68d-7c2d6b34b383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_6d7e5934-ae9f-4176-a51a-a7ac149593fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b43e0cd6-a7e6-4e5f-b9a5-274b2c3998f2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_6d7e5934-ae9f-4176-a51a-a7ac149593fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#FairValueMeasurementsSummaryofFinancialAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0b203ed4-6f5a-4c10-9866-5d8447addbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0b203ed4-6f5a-4c10-9866-5d8447addbc0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_41d61875-ddcf-42eb-915b-48ba456e4c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_41d61875-ddcf-42eb-915b-48ba456e4c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a72a332c-4b6d-4383-946d-b2b90a6df803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_41d61875-ddcf-42eb-915b-48ba456e4c8a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a72a332c-4b6d-4383-946d-b2b90a6df803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_2b194840-1bac-4626-9fe6-53db702de4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a72a332c-4b6d-4383-946d-b2b90a6df803" xlink:to="loc_us-gaap_MoneyMarketFundsMember_2b194840-1bac-4626-9fe6-53db702de4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_bed2a4a2-e102-42d6-8860-419234c3f7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_a72a332c-4b6d-4383-946d-b2b90a6df803" xlink:to="loc_us-gaap_CommercialPaperMember_bed2a4a2-e102-42d6-8860-419234c3f7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_902563fa-f87f-482c-b89e-9821486132aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_902563fa-f87f-482c-b89e-9821486132aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb98c383-eb45-43b9-9bfe-8fbb629266ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_902563fa-f87f-482c-b89e-9821486132aa" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb98c383-eb45-43b9-9bfe-8fbb629266ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_63f88cb7-6f47-45bc-b80c-642765044c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb98c383-eb45-43b9-9bfe-8fbb629266ea" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_63f88cb7-6f47-45bc-b80c-642765044c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_ec8a8d57-37e6-4947-a01e-d9dab015e189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb98c383-eb45-43b9-9bfe-8fbb629266ea" xlink:to="loc_us-gaap_CommercialPaperMember_ec8a8d57-37e6-4947-a01e-d9dab015e189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_76bdbb47-7f72-4ae0-bb31-a58694723393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cb98c383-eb45-43b9-9bfe-8fbb629266ea" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_76bdbb47-7f72-4ae0-bb31-a58694723393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_4af5f6b6-b786-4fc6-93aa-8b85f8474648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_4af5f6b6-b786-4fc6-93aa-8b85f8474648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_08a9f7ff-1849-4271-8301-86d7997865ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_4af5f6b6-b786-4fc6-93aa-8b85f8474648" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_08a9f7ff-1849-4271-8301-86d7997865ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_89f4fada-3ea7-48fa-8a5f-c4a350e30315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_08a9f7ff-1849-4271-8301-86d7997865ee" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_89f4fada-3ea7-48fa-8a5f-c4a350e30315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_aa6b74eb-9638-4fa4-88b2-dd040ccb95e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_89f4fada-3ea7-48fa-8a5f-c4a350e30315" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_aa6b74eb-9638-4fa4-88b2-dd040ccb95e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_cbdce5fa-d118-4fee-9c82-57a754b42249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_89f4fada-3ea7-48fa-8a5f-c4a350e30315" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_cbdce5fa-d118-4fee-9c82-57a754b42249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_310fdc07-98d5-4302-a5a8-bd928a57505a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_310fdc07-98d5-4302-a5a8-bd928a57505a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b09feb94-addf-452b-a56e-a06ee16be0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_310fdc07-98d5-4302-a5a8-bd928a57505a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b09feb94-addf-452b-a56e-a06ee16be0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f6400171-15b0-4e05-8901-df3e25893b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b09feb94-addf-452b-a56e-a06ee16be0ca" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f6400171-15b0-4e05-8901-df3e25893b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_0a5349f4-ebcc-4cca-b2cd-057a8d4eed72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b09feb94-addf-452b-a56e-a06ee16be0ca" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_0a5349f4-ebcc-4cca-b2cd-057a8d4eed72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7318b560-b0f2-4be9-be73-0e19739c8d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b09feb94-addf-452b-a56e-a06ee16be0ca" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7318b560-b0f2-4be9-be73-0e19739c8d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_23af3604-765b-4efb-a83a-448cb1bc17d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_23af3604-765b-4efb-a83a-448cb1bc17d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f887a556-3315-465a-9036-ea1d48c88736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_23af3604-765b-4efb-a83a-448cb1bc17d7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f887a556-3315-465a-9036-ea1d48c88736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_416dc361-0947-4eb1-9a66-502eb0cec3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f887a556-3315-465a-9036-ea1d48c88736" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_416dc361-0947-4eb1-9a66-502eb0cec3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_52c9724e-5a8c-488c-8dbf-22f7898c43b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f4b492e-e5c6-4dde-a28a-2f3365c8e37b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_52c9724e-5a8c-488c-8dbf-22f7898c43b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_ff9dde77-bceb-4e8b-b805-ac08a1a3ad08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_52c9724e-5a8c-488c-8dbf-22f7898c43b1" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_ff9dde77-bceb-4e8b-b805-ac08a1a3ad08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_8f00fa34-3f37-4004-9128-73a267e4313f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_ff9dde77-bceb-4e8b-b805-ac08a1a3ad08" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_8f00fa34-3f37-4004-9128-73a267e4313f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1e76f2d2-cf98-4ff3-baca-9c328c468ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_ff9dde77-bceb-4e8b-b805-ac08a1a3ad08" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_1e76f2d2-cf98-4ff3-baca-9c328c468ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_749415f6-9ad1-4f7d-b4ce-4ec03e1a055c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_ff9dde77-bceb-4e8b-b805-ac08a1a3ad08" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_749415f6-9ad1-4f7d-b4ce-4ec03e1a055c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#FairValueMeasurementsContractualMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5de434ef-1b1b-4f03-aaa2-908d89b36494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b40f1227-479e-4834-9998-b88a3a686203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5de434ef-1b1b-4f03-aaa2-908d89b36494" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b40f1227-479e-4834-9998-b88a3a686203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_3f31a9aa-eaf7-4e38-a7c9-652cf5886e51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_b40f1227-479e-4834-9998-b88a3a686203" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_3f31a9aa-eaf7-4e38-a7c9-652cf5886e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_fdc55e21-93d2-4649-ac14-80f652920961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5de434ef-1b1b-4f03-aaa2-908d89b36494" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_fdc55e21-93d2-4649-ac14-80f652920961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d0f467a3-7a67-4a32-a3ec-ee3c585c7392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_fdc55e21-93d2-4649-ac14-80f652920961" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_d0f467a3-7a67-4a32-a3ec-ee3c585c7392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#FairValueMeasurementsUnrealizedGainsandLossesDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_81dec502-2586-41de-a6d2-cc198dfdcaff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e243350a-e61a-4ddf-b2f6-140e09c55dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_81dec502-2586-41de-a6d2-cc198dfdcaff" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e243350a-e61a-4ddf-b2f6-140e09c55dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_35969cf4-e9b8-40f6-a15e-7241003420e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e243350a-e61a-4ddf-b2f6-140e09c55dad" xlink:to="loc_us-gaap_FinancialInstrumentAxis_35969cf4-e9b8-40f6-a15e-7241003420e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7832a46d-ea80-4d49-8e7f-75c37351d240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_35969cf4-e9b8-40f6-a15e-7241003420e5" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7832a46d-ea80-4d49-8e7f-75c37351d240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_06c0bc2c-38b7-45df-8d9c-76d503933863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7832a46d-ea80-4d49-8e7f-75c37351d240" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_06c0bc2c-38b7-45df-8d9c-76d503933863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_daa030d8-a078-4cbb-bf78-c89e8f820ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7832a46d-ea80-4d49-8e7f-75c37351d240" xlink:to="loc_us-gaap_CommercialPaperMember_daa030d8-a078-4cbb-bf78-c89e8f820ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_e8919f59-1159-4cfb-9300-6d7b74ffa716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7832a46d-ea80-4d49-8e7f-75c37351d240" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_e8919f59-1159-4cfb-9300-6d7b74ffa716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_f6f88cbf-5540-435b-a1d2-ab039879a5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e243350a-e61a-4ddf-b2f6-140e09c55dad" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_f6f88cbf-5540-435b-a1d2-ab039879a5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e6a17a38-1ba7-46f8-987d-53ec8289b121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_f6f88cbf-5540-435b-a1d2-ab039879a5ed" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e6a17a38-1ba7-46f8-987d-53ec8289b121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_7c02a3a3-eabb-4247-a2c8-c5ecec674cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e6a17a38-1ba7-46f8-987d-53ec8289b121" xlink:to="loc_us-gaap_MoneyMarketFundsMember_7c02a3a3-eabb-4247-a2c8-c5ecec674cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_df5823b7-5c1a-48bf-a48d-30cf2c9d71dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_e6a17a38-1ba7-46f8-987d-53ec8289b121" xlink:to="loc_us-gaap_CommercialPaperMember_df5823b7-5c1a-48bf-a48d-30cf2c9d71dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_e243350a-e61a-4ddf-b2f6-140e09c55dad" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_83dd390b-eddf-457e-bbe1-591eb646b31b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:to="loc_us-gaap_CashAndCashEquivalentsAbstract_83dd390b-eddf-457e-bbe1-591eb646b31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4a5b93f8-ddc3-4346-867c-b9d0464cb9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_83dd390b-eddf-457e-bbe1-591eb646b31b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4a5b93f8-ddc3-4346-867c-b9d0464cb9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_198830a7-9866-45dc-be8f-328334cbc3fe" xlink:href="ehth-20210930.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_83dd390b-eddf-457e-bbe1-591eb646b31b" xlink:to="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax_198830a7-9866-45dc-be8f-328334cbc3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_35b27faa-30d7-4993-b591-3759adf798c3" xlink:href="ehth-20210930.xsd#ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_83dd390b-eddf-457e-bbe1-591eb646b31b" xlink:to="loc_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_35b27faa-30d7-4993-b591-3759adf798c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_95768210-b544-4151-a6be-4a03fda07c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_83dd390b-eddf-457e-bbe1-591eb646b31b" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_95768210-b544-4151-a6be-4a03fda07c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_89e549a7-e6d0-4ced-933a-6361130be6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_89e549a7-e6d0-4ced-933a-6361130be6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_65cb0e05-f9e5-40c7-88cd-c1b8528edc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_89e549a7-e6d0-4ced-933a-6361130be6f0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_65cb0e05-f9e5-40c7-88cd-c1b8528edc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_5550b2f7-bb37-4050-bae1-bb8a57efb1cc" xlink:href="ehth-20210930.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_89e549a7-e6d0-4ced-933a-6361130be6f0" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax_5550b2f7-bb37-4050-bae1-bb8a57efb1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_c8e29d5c-32b0-4cd7-bf4e-1e0872e8cadf" xlink:href="ehth-20210930.xsd#ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_89e549a7-e6d0-4ced-933a-6361130be6f0" xlink:to="loc_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax_c8e29d5c-32b0-4cd7-bf4e-1e0872e8cadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_734c11cd-39cb-4ad3-90a8-67ff96c434fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_89e549a7-e6d0-4ced-933a-6361130be6f0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_734c11cd-39cb-4ad3-90a8-67ff96c434fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_1ed31f61-8a29-449d-a1a2-58608e57a20c" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost_1ed31f61-8a29-449d-a1a2-58608e57a20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c517b19d-1b17-4363-a181-7b0a710d9b74" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c517b19d-1b17-4363-a181-7b0a710d9b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ed8d3274-0211-4df3-9df9-c497640996c1" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ed8d3274-0211-4df3-9df9-c497640996c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_8a39fac4-0452-40be-a170-e059aedfd4ca" xlink:href="ehth-20210930.xsd#ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_77d09d39-857e-44ba-a80a-60758bdea050" xlink:to="loc_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities_8a39fac4-0452-40be-a170-e059aedfd4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1" xlink:type="simple" xlink:href="ehth-20210930.xsd#FairValueMeasurementsUnrealizedGainsandLossesDetails_1"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d950be34-83f1-4061-952e-9952528dfdf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_bd3749ac-367e-42fb-8e88-1ff732caa2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d950be34-83f1-4061-952e-9952528dfdf6" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_bd3749ac-367e-42fb-8e88-1ff732caa2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Equity" xlink:type="simple" xlink:href="ehth-20210930.xsd#Equity"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/Equity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_953b59d3-ce0c-401c-a651-3ed3ac3c6099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_d7d7d512-c127-47ec-a1d1-7ea0850da6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_953b59d3-ce0c-401c-a651-3ed3ac3c6099" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_d7d7d512-c127-47ec-a1d1-7ea0850da6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityTables" xlink:type="simple" xlink:href="ehth-20210930.xsd#EquityTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/EquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_33488cd7-89ed-4da3-b4e7-1b6bfc8141ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock_ebd7662c-e095-42f7-aaa5-1e29b6063112" xlink:href="ehth-20210930.xsd#ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_33488cd7-89ed-4da3-b4e7-1b6bfc8141ff" xlink:to="loc_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock_ebd7662c-e095-42f7-aaa5-1e29b6063112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock_1ec2ab05-18b9-41b0-8cae-656d324c788e" xlink:href="ehth-20210930.xsd#ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_33488cd7-89ed-4da3-b4e7-1b6bfc8141ff" xlink:to="loc_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock_1ec2ab05-18b9-41b0-8cae-656d324c788e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#EquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/EquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_6254bda4-186a-4370-a4d4-db519ddcd934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_e38cf595-f709-4668-890e-5b962c796193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_6254bda4-186a-4370-a4d4-db519ddcd934" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_e38cf595-f709-4668-890e-5b962c796193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_cf79cd17-7053-4876-9b95-111070fbf240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_e38cf595-f709-4668-890e-5b962c796193" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_cf79cd17-7053-4876-9b95-111070fbf240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_416b3381-1a6c-49eb-a915-2edb63549780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_cf79cd17-7053-4876-9b95-111070fbf240" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_416b3381-1a6c-49eb-a915-2edb63549780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreviousRepurchaseProgramsMember_b9167799-1d91-4784-8b2c-1a4bb6fb801d" xlink:href="ehth-20210930.xsd#ehth_PreviousRepurchaseProgramsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_416b3381-1a6c-49eb-a915-2edb63549780" xlink:to="loc_ehth_PreviousRepurchaseProgramsMember_b9167799-1d91-4784-8b2c-1a4bb6fb801d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9fd052b7-2b57-43af-9faa-86c05a2bd51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_e38cf595-f709-4668-890e-5b962c796193" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9fd052b7-2b57-43af-9faa-86c05a2bd51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_878e9531-7838-43e3-899f-875ff84e289e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9fd052b7-2b57-43af-9faa-86c05a2bd51a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_878e9531-7838-43e3-899f-875ff84e289e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_b851b914-b8c4-4a95-aede-a50714e602e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_878e9531-7838-43e3-899f-875ff84e289e" xlink:to="loc_us-gaap_SubsequentEventMember_b851b914-b8c4-4a95-aede-a50714e602e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e4709fe4-3f21-44bd-a560-6d9db46dac95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_e38cf595-f709-4668-890e-5b962c796193" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e4709fe4-3f21-44bd-a560-6d9db46dac95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_a05574c2-34a8-464e-a1a1-f75e1c8e06d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e4709fe4-3f21-44bd-a560-6d9db46dac95" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_a05574c2-34a8-464e-a1a1-f75e1c8e06d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_522396c3-c12f-4914-9bcd-ad2afc6143d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e4709fe4-3f21-44bd-a560-6d9db46dac95" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_522396c3-c12f-4914-9bcd-ad2afc6143d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_a9ce77ad-4447-42ce-a750-45c26027d7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e4709fe4-3f21-44bd-a560-6d9db46dac95" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_a9ce77ad-4447-42ce-a750-45c26027d7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes_d96ca262-d734-4720-98fd-e48551cdaaaf" xlink:href="ehth-20210930.xsd#ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e4709fe4-3f21-44bd-a560-6d9db46dac95" xlink:to="loc_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes_d96ca262-d734-4720-98fd-e48551cdaaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_ec92f48d-7e21-4caf-830c-f853396062b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_e4709fe4-3f21-44bd-a560-6d9db46dac95" xlink:to="loc_us-gaap_TreasuryStockShares_ec92f48d-7e21-4caf-830c-f853396062b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#EquityScheduleofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_4b4b92cf-ec17-4d5d-8994-d4e1e8b8b41f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a84f386e-9dc0-4fd9-8a55-169291350e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_4b4b92cf-ec17-4d5d-8994-d4e1e8b8b41f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a84f386e-9dc0-4fd9-8a55-169291350e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_2228ca62-b09b-45cc-9586-db94dc4bbc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a84f386e-9dc0-4fd9-8a55-169291350e90" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_2228ca62-b09b-45cc-9586-db94dc4bbc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7b464f0c-374a-4ead-b216-ff92d710a323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_2228ca62-b09b-45cc-9586-db94dc4bbc4a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7b464f0c-374a-4ead-b216-ff92d710a323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_73504d4c-d88d-4ef3-9590-055b7bad0b75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b464f0c-374a-4ead-b216-ff92d710a323" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_73504d4c-d88d-4ef3-9590-055b7bad0b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CustomerCareAndEnrollmentExpenseMember_8671ddba-e000-478d-b95d-200b3e45f4c1" xlink:href="ehth-20210930.xsd#ehth_CustomerCareAndEnrollmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b464f0c-374a-4ead-b216-ff92d710a323" xlink:to="loc_ehth_CustomerCareAndEnrollmentExpenseMember_8671ddba-e000-478d-b95d-200b3e45f4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_TechnologyAndContentExpenseMember_a4ecca24-ac56-46e7-8dcb-fa74722fa98b" xlink:href="ehth-20210930.xsd#ehth_TechnologyAndContentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b464f0c-374a-4ead-b216-ff92d710a323" xlink:to="loc_ehth_TechnologyAndContentExpenseMember_a4ecca24-ac56-46e7-8dcb-fa74722fa98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c715458a-65e1-430f-9a99-e01dcd0f799b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7b464f0c-374a-4ead-b216-ff92d710a323" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c715458a-65e1-430f-9a99-e01dcd0f799b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_52dc43d7-0174-482a-8d6e-659a607a96b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a84f386e-9dc0-4fd9-8a55-169291350e90" xlink:to="loc_us-gaap_AwardTypeAxis_52dc43d7-0174-482a-8d6e-659a607a96b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ab79297-b97b-4dae-b17f-598686ccce93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_52dc43d7-0174-482a-8d6e-659a607a96b4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ab79297-b97b-4dae-b17f-598686ccce93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4dc34344-6983-4297-a11e-ca2be7a60861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ab79297-b97b-4dae-b17f-598686ccce93" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4dc34344-6983-4297-a11e-ca2be7a60861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ac5fe7be-9a36-48df-bbf8-0ad5c3996dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ab79297-b97b-4dae-b17f-598686ccce93" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ac5fe7be-9a36-48df-bbf8-0ad5c3996dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_b45164f7-6462-4538-b629-2ef54ce3a09e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7ab79297-b97b-4dae-b17f-598686ccce93" xlink:to="loc_us-gaap_EmployeeStockMember_b45164f7-6462-4538-b629-2ef54ce3a09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_464fdf09-8d18-49a9-90c9-77dac1a9b212" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a84f386e-9dc0-4fd9-8a55-169291350e90" xlink:to="loc_srt_TitleOfIndividualAxis_464fdf09-8d18-49a9-90c9-77dac1a9b212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_28212bf2-2aab-41cd-9646-bd00793266fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_464fdf09-8d18-49a9-90c9-77dac1a9b212" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_28212bf2-2aab-41cd-9646-bd00793266fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_20c2d65c-2a27-4e8d-bc0a-6a88e2b3ef64" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_28212bf2-2aab-41cd-9646-bd00793266fe" xlink:to="loc_srt_ChiefExecutiveOfficerMember_20c2d65c-2a27-4e8d-bc0a-6a88e2b3ef64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4085dfb8-4812-4370-826e-7c5f98fd0e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a84f386e-9dc0-4fd9-8a55-169291350e90" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4085dfb8-4812-4370-826e-7c5f98fd0e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2506bbea-95a6-4c71-8df8-640379cf87cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4085dfb8-4812-4370-826e-7c5f98fd0e29" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2506bbea-95a6-4c71-8df8-640379cf87cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_c951be9e-7316-4154-8752-79fa0b812992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4085dfb8-4812-4370-826e-7c5f98fd0e29" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_c951be9e-7316-4154-8752-79fa0b812992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_11790174-0528-449e-b705-30b98173c0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4085dfb8-4812-4370-826e-7c5f98fd0e29" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_11790174-0528-449e-b705-30b98173c0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/ConvertiblePreferredStock" xlink:type="simple" xlink:href="ehth-20210930.xsd#ConvertiblePreferredStock"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/ConvertiblePreferredStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_de8224f8-7a09-4ccc-8dcf-5a18d81a688e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockTextBlock_9288dd7f-cdaf-45a7-8229-97cbc24e2788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_de8224f8-7a09-4ccc-8dcf-5a18d81a688e" xlink:to="loc_us-gaap_PreferredStockTextBlock_9288dd7f-cdaf-45a7-8229-97cbc24e2788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/ConvertiblePreferredStockTables" xlink:type="simple" xlink:href="ehth-20210930.xsd#ConvertiblePreferredStockTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/ConvertiblePreferredStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_634a80a7-1777-4f3e-a238-8bbbb53e41a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_5be81c84-f3f4-4817-be5a-80487ff9a557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_634a80a7-1777-4f3e-a238-8bbbb53e41a0" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_5be81c84-f3f4-4817-be5a-80487ff9a557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#ConvertiblePreferredStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_8b0cf8ea-5440-4164-b288-7eb020475e94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_bcd4b8b1-3cfa-432d-b06d-56bc85ae1585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_8b0cf8ea-5440-4164-b288-7eb020475e94" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_bcd4b8b1-3cfa-432d-b06d-56bc85ae1585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_bdef3dd7-42dd-44b8-a73c-95cc23abbf17" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_bcd4b8b1-3cfa-432d-b06d-56bc85ae1585" xlink:to="loc_srt_StatementScenarioAxis_bdef3dd7-42dd-44b8-a73c-95cc23abbf17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_db5a8d51-4cf8-44c2-83c8-a6c11548197f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_bdef3dd7-42dd-44b8-a73c-95cc23abbf17" xlink:to="loc_srt_ScenarioUnspecifiedDomain_db5a8d51-4cf8-44c2-83c8-a6c11548197f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_424afffe-d788-4626-bff5-f401bd76f18d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_db5a8d51-4cf8-44c2-83c8-a6c11548197f" xlink:to="loc_srt_ScenarioForecastMember_424afffe-d788-4626-bff5-f401bd76f18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_55097f25-e466-4fd5-b119-4ed875182b74" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_bcd4b8b1-3cfa-432d-b06d-56bc85ae1585" xlink:to="loc_srt_RangeAxis_55097f25-e466-4fd5-b119-4ed875182b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e76953f9-4160-4c95-852d-0357a7ad6c0e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_55097f25-e466-4fd5-b119-4ed875182b74" xlink:to="loc_srt_RangeMember_e76953f9-4160-4c95-852d-0357a7ad6c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fb48f072-6771-43e3-aa94-b117021c3e92" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e76953f9-4160-4c95-852d-0357a7ad6c0e" xlink:to="loc_srt_MinimumMember_fb48f072-6771-43e3-aa94-b117021c3e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9d7192ef-bc06-47ca-848e-aadb07704854" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e76953f9-4160-4c95-852d-0357a7ad6c0e" xlink:to="loc_srt_MaximumMember_9d7192ef-bc06-47ca-848e-aadb07704854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c2b903a7-7969-4d4e-b843-79a6537fcf4a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_bcd4b8b1-3cfa-432d-b06d-56bc85ae1585" xlink:to="loc_srt_CounterpartyNameAxis_c2b903a7-7969-4d4e-b843-79a6537fcf4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5dc1f88-76cf-4fa4-8d60-7c4528a6d2f3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_c2b903a7-7969-4d4e-b843-79a6537fcf4a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5dc1f88-76cf-4fa4-8d60-7c4528a6d2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EchelonHealthSPCLPHIGMember_206e416e-53b0-414b-ad70-1a58f893445d" xlink:href="ehth-20210930.xsd#ehth_EchelonHealthSPCLPHIGMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5dc1f88-76cf-4fa4-8d60-7c4528a6d2f3" xlink:to="loc_ehth_EchelonHealthSPCLPHIGMember_206e416e-53b0-414b-ad70-1a58f893445d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_bcd4b8b1-3cfa-432d-b06d-56bc85ae1585" xlink:to="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_dfc1d5cf-745e-4faf-b727-73d94983899e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_dfc1d5cf-745e-4faf-b727-73d94983899e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_63ccdcd8-5403-4fad-a4d9-3e45aafbc2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_63ccdcd8-5403-4fad-a4d9-3e45aafbc2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_4fc5caf2-0bbc-4435-a24d-f705aad19d21" xlink:href="ehth-20210930.xsd#ehth_SaleOfStockConsiderationReceivedOnTransactionGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_4fc5caf2-0bbc-4435-a24d-f705aad19d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_859830c0-b63c-43a7-adf3-b6fcd446faf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_859830c0-b63c-43a7-adf3-b6fcd446faf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_22468f94-a41a-43cd-97eb-7473aaef1652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_22468f94-a41a-43cd-97eb-7473aaef1652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_e4ea4771-3c3d-4569-9e52-b1621283005f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_e4ea4771-3c3d-4569-9e52-b1621283005f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreferredStockConvertibleStatedValue_82843770-84fb-4d3c-bbc5-63e2931904f4" xlink:href="ehth-20210930.xsd#ehth_PreferredStockConvertibleStatedValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_PreferredStockConvertibleStatedValue_82843770-84fb-4d3c-bbc5-63e2931904f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreferredStockDividendRatePayableInKindPercentage_278b9e8f-a659-4eb9-984d-3ec2b96549aa" xlink:href="ehth-20210930.xsd#ehth_PreferredStockDividendRatePayableInKindPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_PreferredStockDividendRatePayableInKindPercentage_278b9e8f-a659-4eb9-984d-3ec2b96549aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_PreferredStockDividendRateCashPercentage_71df6fe5-cd5a-43b5-942a-d4d75b7e02af" xlink:href="ehth-20210930.xsd#ehth_PreferredStockDividendRateCashPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_PreferredStockDividendRateCashPercentage_71df6fe5-cd5a-43b5-942a-d4d75b7e02af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionPrice_94e27c63-edd4-44cc-ade0-449e29660668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockConvertibleConversionPrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionPrice_94e27c63-edd4-44cc-ade0-449e29660668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare_a4ca309b-eb63-49cd-bcdb-b483c183e3fd" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare_a4ca309b-eb63-49cd-bcdb-b483c183e3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice_a67d51ce-c032-43e3-89a9-0a75d02da3fd" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice_a67d51ce-c032-43e3-89a9-0a75d02da3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors_e595e579-19bc-4159-9ee5-d96e3e998331" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors_e595e579-19bc-4159-9ee5-d96e3e998331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors_1e2d191c-9fa0-4413-abc1-2263bc3b7516" xlink:href="ehth-20210930.xsd#ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors_1e2d191c-9fa0-4413-abc1-2263bc3b7516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockVotesPerShare_4f32aff9-5bd1-4d85-b6b3-676f48de1f1d" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockVotesPerShare"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockVotesPerShare_4f32aff9-5bd1-4d85-b6b3-676f48de1f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger_9ba297b7-4d48-4dff-9b6a-463f2bef6674" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger_9ba297b7-4d48-4dff-9b6a-463f2bef6674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays_4c8ad8e3-da33-4f42-b441-e3aef66135e2" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays_4c8ad8e3-da33-4f42-b441-e3aef66135e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockThresholdTradingDays_ea612c03-c262-4979-8c34-b5b4b070f4fb" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockThresholdTradingDays"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockThresholdTradingDays_ea612c03-c262-4979-8c34-b5b4b070f4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt_8b2c9e6e-39c7-4620-94fe-bb21c923693d" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt_8b2c9e6e-39c7-4620-94fe-bb21c923693d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio_7d13b6a3-40f7-4a75-a07b-1a95a7c2ccb2" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio_7d13b6a3-40f7-4a75-a07b-1a95a7c2ccb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockCovenantLiquidity_0dc01125-43d1-471d-a34c-37c047611e89" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockCovenantLiquidity"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockCovenantLiquidity_0dc01125-43d1-471d-a34c-37c047611e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_eb6c0512-4d8f-46d7-8714-adea9fe82172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_eb6c0512-4d8f-46d7-8714-adea9fe82172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis_4335001b-ac1a-457e-93ec-6eaa3d268375" xlink:href="ehth-20210930.xsd#ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_865ba460-071c-45bb-8f48-84406c40488d" xlink:to="loc_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis_4335001b-ac1a-457e-93ec-6eaa3d268375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#ConvertiblePreferredStockSummaryofStockDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_4727148f-6cb6-40d9-aeb6-656957a0de4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_dd13ebe9-957a-4818-9f97-fd5db3790107" xlink:href="ehth-20210930.xsd#ehth_SaleOfStockConsiderationReceivedOnTransactionGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_4727148f-6cb6-40d9-aeb6-656957a0de4d" xlink:to="loc_ehth_SaleOfStockConsiderationReceivedOnTransactionGross_dd13ebe9-957a-4818-9f97-fd5db3790107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_b7cb5a53-4d10-47f7-8e45-effb78606661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_4727148f-6cb6-40d9-aeb6-656957a0de4d" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_b7cb5a53-4d10-47f7-8e45-effb78606661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_271f5516-35f7-49a2-afff-fd9899627ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_4727148f-6cb6-40d9-aeb6-656957a0de4d" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_271f5516-35f7-49a2-afff-fd9899627ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_494d357c-e120-459f-92fd-df7627ca9aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_4727148f-6cb6-40d9-aeb6-656957a0de4d" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_494d357c-e120-459f-92fd-df7627ca9aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_14fa6053-0c04-4830-bb88-20c3052ed82d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_494d357c-e120-459f-92fd-df7627ca9aac" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_14fa6053-0c04-4830-bb88-20c3052ed82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionOfDividends_f8167e5c-2f7b-4f12-969c-7632e1b45b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionOfDividends"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_494d357c-e120-459f-92fd-df7627ca9aac" xlink:to="loc_us-gaap_TemporaryEquityAccretionOfDividends_f8167e5c-2f7b-4f12-969c-7632e1b45b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_c90a2792-fd0e-4c4e-b10c-70d14d79116d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_494d357c-e120-459f-92fd-df7627ca9aac" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_c90a2792-fd0e-4c4e-b10c-70d14d79116d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_7d7687ec-6337-4f86-8179-a155b32af92f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_494d357c-e120-459f-92fd-df7627ca9aac" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_7d7687ec-6337-4f86-8179-a155b32af92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholders" xlink:type="simple" xlink:href="ehth-20210930.xsd#NetLossPerShareAttributabletoCommonStockholders"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholders" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4bd51fd3-dc95-48b2-a7a7-8cdc5d5ee785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_5e9ed479-c271-42fb-9cee-f237a54c765d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4bd51fd3-dc95-48b2-a7a7-8cdc5d5ee785" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_5e9ed479-c271-42fb-9cee-f237a54c765d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersTables" xlink:type="simple" xlink:href="ehth-20210930.xsd#NetLossPerShareAttributabletoCommonStockholdersTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b6aacdd1-d891-4ce0-a99f-46f75c357809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_84e5a181-20d8-4872-b6e3-3a8355657654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b6aacdd1-d891-4ce0-a99f-46f75c357809" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_84e5a181-20d8-4872-b6e3-3a8355657654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_f0f80f2f-3a20-4998-911b-3e803590ced5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b6aacdd1-d891-4ce0-a99f-46f75c357809" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_f0f80f2f-3a20-4998-911b-3e803590ced5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6dff1569-a918-437f-a57b-043a7f534a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_ddd06ddc-1d32-4d5b-ac24-b3926a4a4c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6dff1569-a918-437f-a57b-043a7f534a0c" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_ddd06ddc-1d32-4d5b-ac24-b3926a4a4c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_42cdfcff-13b5-4a23-9fa3-ce1d8f5244d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_ddd06ddc-1d32-4d5b-ac24-b3926a4a4c1d" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_42cdfcff-13b5-4a23-9fa3-ce1d8f5244d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_f8688901-950f-4c49-a5c9-35a5159d18e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6dff1569-a918-437f-a57b-043a7f534a0c" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_f8688901-950f-4c49-a5c9-35a5159d18e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ff27c80c-1bfe-4a79-a2ad-3a26cbea5e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_f8688901-950f-4c49-a5c9-35a5159d18e2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ff27c80c-1bfe-4a79-a2ad-3a26cbea5e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IncrementalCommonSharesAttributableToOptions_981dfb26-a183-4039-b11a-6a2ea73d0123" xlink:href="ehth-20210930.xsd#ehth_IncrementalCommonSharesAttributableToOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_f8688901-950f-4c49-a5c9-35a5159d18e2" xlink:to="loc_ehth_IncrementalCommonSharesAttributableToOptions_981dfb26-a183-4039-b11a-6a2ea73d0123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_611c0be5-1afd-4295-8b5c-008a5b4a4548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_f8688901-950f-4c49-a5c9-35a5159d18e2" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_611c0be5-1afd-4295-8b5c-008a5b4a4548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_06d7311a-6f2e-4890-8f57-28319f306805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6dff1569-a918-437f-a57b-043a7f534a0c" xlink:to="loc_us-gaap_EarningsPerShareBasic_06d7311a-6f2e-4890-8f57-28319f306805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d501fbec-030f-48bb-bbee-af78072076d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6dff1569-a918-437f-a57b-043a7f534a0c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d501fbec-030f-48bb-bbee-af78072076d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_aafde278-7507-4107-9a6a-0013d7bdb2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f120b45f-292e-4be3-8b57-791c1b1b3cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_aafde278-7507-4107-9a6a-0013d7bdb2ff" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f120b45f-292e-4be3-8b57-791c1b1b3cf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e27d51eb-2639-4f69-a953-8e1fbfc548af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f120b45f-292e-4be3-8b57-791c1b1b3cf7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e27d51eb-2639-4f69-a953-8e1fbfc548af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c684a98-b334-4a91-808d-68f0d517f051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e27d51eb-2639-4f69-a953-8e1fbfc548af" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c684a98-b334-4a91-808d-68f0d517f051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_72578368-008c-49b3-8935-7eadee38c7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c684a98-b334-4a91-808d-68f0d517f051" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_72578368-008c-49b3-8935-7eadee38c7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5f633747-94b4-4184-9303-18123a270cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c684a98-b334-4a91-808d-68f0d517f051" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5f633747-94b4-4184-9303-18123a270cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fd370de1-dc28-43df-8cbe-6daffcfd2e88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c684a98-b334-4a91-808d-68f0d517f051" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fd370de1-dc28-43df-8cbe-6daffcfd2e88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_8e35c23d-54dd-415c-bc03-9833c6af1ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c684a98-b334-4a91-808d-68f0d517f051" xlink:to="loc_us-gaap_EmployeeStockMember_8e35c23d-54dd-415c-bc03-9833c6af1ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_20ac5ae4-4d7d-4d29-afbf-001d4eeb729b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f120b45f-292e-4be3-8b57-791c1b1b3cf7" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_20ac5ae4-4d7d-4d29-afbf-001d4eeb729b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_298fb561-c20d-40b4-80a0-4d7c8183f364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_20ac5ae4-4d7d-4d29-afbf-001d4eeb729b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_298fb561-c20d-40b4-80a0-4d7c8183f364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="ehth-20210930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9d501b66-6fe9-4214-b2b1-9f783d45754e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_3e3be4f9-0e71-4a3c-8073-4e262dd470e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9d501b66-6fe9-4214-b2b1-9f783d45754e" xlink:to="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_3e3be4f9-0e71-4a3c-8073-4e262dd470e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables" xlink:type="simple" xlink:href="ehth-20210930.xsd#CommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_70bf228c-abaa-40d6-8bbc-66e6242e407f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_575ac796-7324-4781-a76f-3469e4f25e04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_70bf228c-abaa-40d6-8bbc-66e6242e407f" xlink:to="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_575ac796-7324-4781-a76f-3469e4f25e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0917f521-30cf-40ee-96f2-7c2ce256ea2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_2fafad94-0a72-4f08-ba72-db6f91521c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0917f521-30cf-40ee-96f2-7c2ce256ea2a" xlink:to="loc_us-gaap_LossContingenciesTable_2fafad94-0a72-4f08-ba72-db6f91521c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8cd12bf3-d8c0-45b6-9e66-1072f65030b4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2fafad94-0a72-4f08-ba72-db6f91521c21" xlink:to="loc_srt_LitigationCaseAxis_8cd12bf3-d8c0-45b6-9e66-1072f65030b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_797187a6-60a6-4e47-b13d-54deb9d2aa3c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_8cd12bf3-d8c0-45b6-9e66-1072f65030b4" xlink:to="loc_srt_LitigationCaseTypeDomain_797187a6-60a6-4e47-b13d-54deb9d2aa3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LeViasCompliantMember_30db4c59-98c6-477f-a5b5-98ed8e48b412" xlink:href="ehth-20210930.xsd#ehth_LeViasCompliantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_797187a6-60a6-4e47-b13d-54deb9d2aa3c" xlink:to="loc_ehth_LeViasCompliantMember_30db4c59-98c6-477f-a5b5-98ed8e48b412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2fafad94-0a72-4f08-ba72-db6f91521c21" xlink:to="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_13a2705e-c928-4c4f-aed1-f7a5373a952c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear_13a2705e-c928-4c4f-aed1-f7a5373a952c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_f7f301ac-a87b-4ce3-886f-b0dacfd41949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_ContractualObligationDueInNextTwelveMonths_f7f301ac-a87b-4ce3-886f-b0dacfd41949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInSecondYear_e73c5294-365c-4b03-b894-253c56ec6870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInSecondYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_ContractualObligationDueInSecondYear_e73c5294-365c-4b03-b894-253c56ec6870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInThirdYear_20c46d00-963f-4f3b-8b35-685868429873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInThirdYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_ContractualObligationDueInThirdYear_20c46d00-963f-4f3b-8b35-685868429873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligationDueInFourthYear_2968e72e-4453-47f1-b67a-65426c0cbd38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligationDueInFourthYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_ContractualObligationDueInFourthYear_2968e72e-4453-47f1-b67a-65426c0cbd38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ContractualObligationToBePaidAfterYearFour_9883e268-eab9-41e7-ac56-4af9ce42005e" xlink:href="ehth-20210930.xsd#ehth_ContractualObligationToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_ehth_ContractualObligationToBePaidAfterYearFour_9883e268-eab9-41e7-ac56-4af9ce42005e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_05dfef69-18f4-4f0a-89d6-0d6269fa6834" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_ContractualObligation_05dfef69-18f4-4f0a-89d6-0d6269fa6834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_c31a154e-f734-4937-88a1-635bd2ee2fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_c31a154e-f734-4937-88a1-635bd2ee2fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_26ecbec2-b70c-4278-8c22-43c39bb26a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_928e13db-aca1-49c8-be0f-1b86f451fc53" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_26ecbec2-b70c-4278-8c22-43c39bb26a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformation" xlink:type="simple" xlink:href="ehth-20210930.xsd#SegmentandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ddd9ad84-3921-44fb-9198-13e5dc828aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_e839872f-3357-48e4-9561-a5af9af01e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ddd9ad84-3921-44fb-9198-13e5dc828aa0" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_e839872f-3357-48e4-9561-a5af9af01e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables" xlink:type="simple" xlink:href="ehth-20210930.xsd#SegmentandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_123f0580-340b-4bfb-bef5-0b4b486be240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_50f245d7-3e2c-40cd-aa04-0a72213d0409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_123f0580-340b-4bfb-bef5-0b4b486be240" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_50f245d7-3e2c-40cd-aa04-0a72213d0409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock_e331008b-4a75-4276-bd8c-7ab17a438ca9" xlink:href="ehth-20210930.xsd#ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_123f0580-340b-4bfb-bef5-0b4b486be240" xlink:to="loc_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock_e331008b-4a75-4276-bd8c-7ab17a438ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_ce9c3de5-0d28-4012-9314-dba5d16da3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_123f0580-340b-4bfb-bef5-0b4b486be240" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_ce9c3de5-0d28-4012-9314-dba5d16da3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SegmentandGeographicInformationSegmentOperatingResultsDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_da599ba9-c85c-4c0e-afbb-9478e1091385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_656ec613-6ba3-498a-8afd-3c2c2e3ec06b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_da599ba9-c85c-4c0e-afbb-9478e1091385" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_656ec613-6ba3-498a-8afd-3c2c2e3ec06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c9767159-4077-4830-b6e7-7952e2f2872f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_656ec613-6ba3-498a-8afd-3c2c2e3ec06b" xlink:to="loc_srt_ConsolidationItemsAxis_c9767159-4077-4830-b6e7-7952e2f2872f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_fcd3088d-568e-4bb6-ad84-dcd0211870b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_c9767159-4077-4830-b6e7-7952e2f2872f" xlink:to="loc_srt_ConsolidationItemsDomain_fcd3088d-568e-4bb6-ad84-dcd0211870b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_26f843b8-dc1d-44d2-9c4e-d6cf097afcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_fcd3088d-568e-4bb6-ad84-dcd0211870b6" xlink:to="loc_us-gaap_OperatingSegmentsMember_26f843b8-dc1d-44d2-9c4e-d6cf097afcbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_a466506c-47fd-477f-8597-cdd26eab5fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_fcd3088d-568e-4bb6-ad84-dcd0211870b6" xlink:to="loc_us-gaap_CorporateNonSegmentMember_a466506c-47fd-477f-8597-cdd26eab5fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0cf30d93-051d-44e2-900b-7d1cefad8c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_656ec613-6ba3-498a-8afd-3c2c2e3ec06b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0cf30d93-051d-44e2-900b-7d1cefad8c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_faeef90b-6c0a-44cf-9c32-5fab802041ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0cf30d93-051d-44e2-900b-7d1cefad8c21" xlink:to="loc_us-gaap_SegmentDomain_faeef90b-6c0a-44cf-9c32-5fab802041ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_MedicareSegmentMember_52b8e6fb-93d0-44b9-adaa-25334efa1e95" xlink:href="ehth-20210930.xsd#ehth_MedicareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_faeef90b-6c0a-44cf-9c32-5fab802041ac" xlink:to="loc_ehth_MedicareSegmentMember_52b8e6fb-93d0-44b9-adaa-25334efa1e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_50fe975b-3f30-4992-8eba-1873f116ea6a" xlink:href="ehth-20210930.xsd#ehth_IndividualFamilyAndSmallBusinessSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_faeef90b-6c0a-44cf-9c32-5fab802041ac" xlink:to="loc_ehth_IndividualFamilyAndSmallBusinessSegmentsMember_50fe975b-3f30-4992-8eba-1873f116ea6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_656ec613-6ba3-498a-8afd-3c2c2e3ec06b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_28862977-c275-4496-bfc6-7ac89825aca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_NumberOfOperatingSegments_28862977-c275-4496-bfc6-7ac89825aca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3983c375-a8b9-4c9c-85df-14129a5f7ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3983c375-a8b9-4c9c-85df-14129a5f7ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_SegmentOperatingIncomeLoss_1d0c4517-ea64-455e-a857-f48153e4d999" xlink:href="ehth-20210930.xsd#ehth_SegmentOperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_ehth_SegmentOperatingIncomeLoss_1d0c4517-ea64-455e-a857-f48153e4d999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_05e6b784-836d-43c1-8f55-bb47fd7248a4" xlink:href="ehth-20210930.xsd#ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense_05e6b784-836d-43c1-8f55-bb47fd7248a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_644dd838-dce0-496b-9f1e-7021af3de756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_644dd838-dce0-496b-9f1e-7021af3de756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_6723eab8-a9dc-42e2-bab0-a654eb48c70f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_6723eab8-a9dc-42e2-bab0-a654eb48c70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_768a1e85-8706-4e5a-b7dc-19aae248ffea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_RestructuringCharges_768a1e85-8706-4e5a-b7dc-19aae248ffea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a6c9eb85-374a-4274-ae3b-eb3acd771d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a6c9eb85-374a-4274-ae3b-eb3acd771d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2e1ca617-7acf-40e0-b80d-a582c136a809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2e1ca617-7acf-40e0-b80d-a582c136a809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_52fc8387-e3a5-42d6-8bbe-3668ba981d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b0e5a675-ddb8-4fff-8ff6-0f44f1905bf8" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_52fc8387-e3a5-42d6-8bbe-3668ba981d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0e9a414b-1e87-426a-87b4-1cc03f2727e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf6e5f50-6384-4501-a7f0-7ea8ea106083" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0e9a414b-1e87-426a-87b4-1cc03f2727e2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf6e5f50-6384-4501-a7f0-7ea8ea106083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_833b81ad-aa7b-47c5-8485-962baccc59f9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf6e5f50-6384-4501-a7f0-7ea8ea106083" xlink:to="loc_srt_StatementGeographicalAxis_833b81ad-aa7b-47c5-8485-962baccc59f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1f17f6aa-ee79-469c-8739-ef58da93f7d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_833b81ad-aa7b-47c5-8485-962baccc59f9" xlink:to="loc_srt_SegmentGeographicalDomain_1f17f6aa-ee79-469c-8739-ef58da93f7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_6d2865d2-b9b1-4db7-ae69-67ff488389f8" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1f17f6aa-ee79-469c-8739-ef58da93f7d9" xlink:to="loc_country_US_6d2865d2-b9b1-4db7-ae69-67ff488389f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_c8e5ad45-3bd6-4399-af86-5b6ccb2c22a9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1f17f6aa-ee79-469c-8739-ef58da93f7d9" xlink:to="loc_country_CN_c8e5ad45-3bd6-4399-af86-5b6ccb2c22a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ff71d5ca-c670-4cdd-bd29-5d413aec6501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf6e5f50-6384-4501-a7f0-7ea8ea106083" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_ff71d5ca-c670-4cdd-bd29-5d413aec6501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_2dce00b6-08e3-4187-ad32-49a094042543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ff71d5ca-c670-4cdd-bd29-5d413aec6501" xlink:to="loc_us-gaap_NoncurrentAssets_2dce00b6-08e3-4187-ad32-49a094042543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_70614098-a9e0-417a-aba6-d8d2cad91cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a4ac1b8f-d380-470d-b438-1e9e7b650ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_70614098-a9e0-417a-aba6-d8d2cad91cb0" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a4ac1b8f-d380-470d-b438-1e9e7b650ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_a811b5f2-6aff-43ae-86d5-5cb4c70bad00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a4ac1b8f-d380-470d-b438-1e9e7b650ed6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_a811b5f2-6aff-43ae-86d5-5cb4c70bad00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_74bdf103-3412-4b46-b8f0-d2c91aeb4238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_a811b5f2-6aff-43ae-86d5-5cb4c70bad00" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_74bdf103-3412-4b46-b8f0-d2c91aeb4238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_d04e6607-c9ff-4114-9c81-49f17d4ea810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_74bdf103-3412-4b46-b8f0-d2c91aeb4238" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_d04e6607-c9ff-4114-9c81-49f17d4ea810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_762ce1a8-4973-4b88-b574-985366411a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a4ac1b8f-d380-470d-b438-1e9e7b650ed6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_762ce1a8-4973-4b88-b574-985366411a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_10864253-7a24-4e43-b1ea-333c644a8566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_762ce1a8-4973-4b88-b574-985366411a3a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_10864253-7a24-4e43-b1ea-333c644a8566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_b7732832-d827-4048-9052-0a757f9d3149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_10864253-7a24-4e43-b1ea-333c644a8566" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_b7732832-d827-4048-9052-0a757f9d3149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_8a170ed6-7a7e-47a6-95ed-bcbf6eff515c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a4ac1b8f-d380-470d-b438-1e9e7b650ed6" xlink:to="loc_srt_MajorCustomersAxis_8a170ed6-7a7e-47a6-95ed-bcbf6eff515c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_765bf12a-01bc-46d9-a4ea-5f92bad5f21f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_8a170ed6-7a7e-47a6-95ed-bcbf6eff515c" xlink:to="loc_srt_NameOfMajorCustomerDomain_765bf12a-01bc-46d9-a4ea-5f92bad5f21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_UnitedhealthcareMember_856b104b-5a0d-4ce1-978e-8155e806fa36" xlink:href="ehth-20210930.xsd#ehth_UnitedhealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_765bf12a-01bc-46d9-a4ea-5f92bad5f21f" xlink:to="loc_ehth_UnitedhealthcareMember_856b104b-5a0d-4ce1-978e-8155e806fa36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_AetnaMember_d71447e1-e0ae-4fa6-b4c5-8b74518714db" xlink:href="ehth-20210930.xsd#ehth_AetnaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_765bf12a-01bc-46d9-a4ea-5f92bad5f21f" xlink:to="loc_ehth_AetnaMember_d71447e1-e0ae-4fa6-b4c5-8b74518714db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_HumanaMember_7f6ebef0-3da9-4ab4-bced-ec97fc8684c1" xlink:href="ehth-20210930.xsd#ehth_HumanaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_765bf12a-01bc-46d9-a4ea-5f92bad5f21f" xlink:to="loc_ehth_HumanaMember_7f6ebef0-3da9-4ab4-bced-ec97fc8684c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CenteneMember_12a72edc-c1f4-4116-8f79-628ae710df4d" xlink:href="ehth-20210930.xsd#ehth_CenteneMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_765bf12a-01bc-46d9-a4ea-5f92bad5f21f" xlink:to="loc_ehth_CenteneMember_12a72edc-c1f4-4116-8f79-628ae710df4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_a3c5116f-917e-4c3e-b88f-9e0fade9e985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_a4ac1b8f-d380-470d-b438-1e9e7b650ed6" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_a3c5116f-917e-4c3e-b88f-9e0fade9e985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_09bc60d8-615c-4ab3-8fd8-44c0bdf94296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_a3c5116f-917e-4c3e-b88f-9e0fade9e985" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_09bc60d8-615c-4ab3-8fd8-44c0bdf94296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Leases" xlink:type="simple" xlink:href="ehth-20210930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_61bff431-5431-489b-a069-33556aa26a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_99e36711-1afb-4853-873c-cb39430c6a15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_61bff431-5431-489b-a069-33556aa26a6d" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_99e36711-1afb-4853-873c-cb39430c6a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesTables" xlink:type="simple" xlink:href="ehth-20210930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f7583036-d762-402a-9a88-d2373518b92c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_44d62818-930d-4c3a-b57d-c8890e2f15ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f7583036-d762-402a-9a88-d2373518b92c" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_44d62818-930d-4c3a-b57d-c8890e2f15ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6fd9ed46-2dda-4f2c-8c4b-ab6442ccab68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f7583036-d762-402a-9a88-d2373518b92c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_6fd9ed46-2dda-4f2c-8c4b-ab6442ccab68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6f54bebd-74db-488d-bf6d-ec40eaf8c6be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_49d35496-91e5-489d-9935-6327b4691634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6f54bebd-74db-488d-bf6d-ec40eaf8c6be" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_49d35496-91e5-489d-9935-6327b4691634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_511ddcab-a45e-4152-af49-2ab677be7d7d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_49d35496-91e5-489d-9935-6327b4691634" xlink:to="loc_srt_RangeAxis_511ddcab-a45e-4152-af49-2ab677be7d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_39b82684-64c7-438a-b8ba-f7208b788c76" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_511ddcab-a45e-4152-af49-2ab677be7d7d" xlink:to="loc_srt_RangeMember_39b82684-64c7-438a-b8ba-f7208b788c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_33fa6a2c-8726-4c96-96fa-d296bf5b7ab6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_39b82684-64c7-438a-b8ba-f7208b788c76" xlink:to="loc_srt_MinimumMember_33fa6a2c-8726-4c96-96fa-d296bf5b7ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c56179d9-e7c0-4a12-b996-a5b8542bc4be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_39b82684-64c7-438a-b8ba-f7208b788c76" xlink:to="loc_srt_MaximumMember_c56179d9-e7c0-4a12-b996-a5b8542bc4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_a3ab500b-4d55-4d97-af70-da7ffa740774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_49d35496-91e5-489d-9935-6327b4691634" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_a3ab500b-4d55-4d97-af70-da7ffa740774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_421d903f-9693-46fa-aa11-ecf7552ab997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a3ab500b-4d55-4d97-af70-da7ffa740774" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_421d903f-9693-46fa-aa11-ecf7552ab997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_37917a38-3471-4ed4-8448-96fb827d9e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_a3ab500b-4d55-4d97-af70-da7ffa740774" xlink:to="loc_us-gaap_OperatingLeaseCost_37917a38-3471-4ed4-8448-96fb827d9e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#LeasesSupplementalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6f2993d6-d448-46b3-be05-fe55fb7dd02e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5bc0bc79-db58-4126-ae83-a0679f159777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6f2993d6-d448-46b3-be05-fe55fb7dd02e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5bc0bc79-db58-4126-ae83-a0679f159777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c35e1651-5584-43fe-9d22-1ec5e5eb6567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6f2993d6-d448-46b3-be05-fe55fb7dd02e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c35e1651-5584-43fe-9d22-1ec5e5eb6567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_ba6208ae-5870-40dd-9d31-13b000521501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6f2993d6-d448-46b3-be05-fe55fb7dd02e" xlink:to="loc_us-gaap_OperatingLeaseExpense_ba6208ae-5870-40dd-9d31-13b000521501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_25663055-0596-4caf-bd64-075b98ab6c18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6f2993d6-d448-46b3-be05-fe55fb7dd02e" xlink:to="loc_us-gaap_OperatingLeasePayments_25663055-0596-4caf-bd64-075b98ab6c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_00c3dda3-a8ff-4560-9a33-68a72f94d6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4e4e5ac7-71a0-4fb1-b512-c11a45b0875b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00c3dda3-a8ff-4560-9a33-68a72f94d6f0" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4e4e5ac7-71a0-4fb1-b512-c11a45b0875b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_f9415357-f63e-4486-9212-7980cb7f68fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4e4e5ac7-71a0-4fb1-b512-c11a45b0875b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_f9415357-f63e-4486-9212-7980cb7f68fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2f28bc3b-13f0-41d1-833e-b6d480071da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4e4e5ac7-71a0-4fb1-b512-c11a45b0875b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2f28bc3b-13f0-41d1-833e-b6d480071da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_488b9bd4-3298-4c72-82d3-c773bbd670de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4e4e5ac7-71a0-4fb1-b512-c11a45b0875b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_488b9bd4-3298-4c72-82d3-c773bbd670de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7d739ac9-2f0c-486f-b844-89fb9b5fadc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4e4e5ac7-71a0-4fb1-b512-c11a45b0875b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7d739ac9-2f0c-486f-b844-89fb9b5fadc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1ecc0f62-0ceb-4b2b-a388-ed288617d846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4e4e5ac7-71a0-4fb1-b512-c11a45b0875b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1ecc0f62-0ceb-4b2b-a388-ed288617d846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_65c138e9-14ce-4641-8328-953987fed8ba" xlink:href="ehth-20210930.xsd#ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4e4e5ac7-71a0-4fb1-b512-c11a45b0875b" xlink:to="loc_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_65c138e9-14ce-4641-8328-953987fed8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7b856d43-1f64-4c3d-b1f6-edeb0d868003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4e4e5ac7-71a0-4fb1-b512-c11a45b0875b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7b856d43-1f64-4c3d-b1f6-edeb0d868003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0892b541-e441-4f89-8e00-6e5e8af58584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4e4e5ac7-71a0-4fb1-b512-c11a45b0875b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0892b541-e441-4f89-8e00-6e5e8af58584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5f075ec4-d69b-4d0e-baa4-bccb051723e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4e4e5ac7-71a0-4fb1-b512-c11a45b0875b" xlink:to="loc_us-gaap_OperatingLeaseLiability_5f075ec4-d69b-4d0e-baa4-bccb051723e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_f10305ec-f4d1-4ac6-839d-12b6c9e730cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00c3dda3-a8ff-4560-9a33-68a72f94d6f0" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_f10305ec-f4d1-4ac6-839d-12b6c9e730cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_fe72e00e-4d8c-4002-921a-f5a6a6f93d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00c3dda3-a8ff-4560-9a33-68a72f94d6f0" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_fe72e00e-4d8c-4002-921a-f5a6a6f93d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_41acea2d-d685-4868-807a-d3eb82bc8e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_00c3dda3-a8ff-4560-9a33-68a72f94d6f0" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_41acea2d-d685-4868-807a-d3eb82bc8e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="ehth-20210930.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RestructuringandReorganization" xlink:type="simple" xlink:href="ehth-20210930.xsd#RestructuringandReorganization"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/RestructuringandReorganization" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d3a47126-f47c-4fdc-8449-25bf2df3b77c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_fba24692-d85e-4b04-b59a-772e6046b213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_d3a47126-f47c-4fdc-8449-25bf2df3b77c" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_fba24692-d85e-4b04-b59a-772e6046b213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RestructuringandReorganizationTables" xlink:type="simple" xlink:href="ehth-20210930.xsd#RestructuringandReorganizationTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/RestructuringandReorganizationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4c3a96b1-14ae-4641-88d8-6ef2a3deb601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_11067d02-a9c1-4fe5-9a58-e64505f06fad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4c3a96b1-14ae-4641-88d8-6ef2a3deb601" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_11067d02-a9c1-4fe5-9a58-e64505f06fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RestructuringandReorganizationRestructuringandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#RestructuringandReorganizationRestructuringandOtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/RestructuringandReorganizationRestructuringandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e880083c-1394-454e-ab2b-3cfc8e7621c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_61e2af74-6626-481c-8434-90014c2669ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e880083c-1394-454e-ab2b-3cfc8e7621c5" xlink:to="loc_us-gaap_RestructuringReserveRollForward_61e2af74-6626-481c-8434-90014c2669ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_87de43ff-c3a2-443c-96f9-e9f419912808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_61e2af74-6626-481c-8434-90014c2669ce" xlink:to="loc_us-gaap_RestructuringReserve_87de43ff-c3a2-443c-96f9-e9f419912808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c447fe0a-fe17-4d1e-8b4b-6d58422f9134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_61e2af74-6626-481c-8434-90014c2669ce" xlink:to="loc_us-gaap_RestructuringCharges_c447fe0a-fe17-4d1e-8b4b-6d58422f9134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_f64cafed-1bb8-428b-b009-222d75329f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_61e2af74-6626-481c-8434-90014c2669ce" xlink:to="loc_us-gaap_PaymentsForRestructuring_f64cafed-1bb8-428b-b009-222d75329f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_b334bb70-7661-4b35-a3e2-d07769b6b324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_61e2af74-6626-481c-8434-90014c2669ce" xlink:to="loc_us-gaap_RestructuringReserve_b334bb70-7661-4b35-a3e2-d07769b6b324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#RestructuringandReorganizationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e6e3b65d-2462-42b0-9ece-fb408026e9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_485783fe-fe7a-495b-9bbf-34a9df6205eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_e6e3b65d-2462-42b0-9ece-fb408026e9fb" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_485783fe-fe7a-495b-9bbf-34a9df6205eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_db3fa008-1dd7-4d06-a26c-dd9adbd254b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_485783fe-fe7a-495b-9bbf-34a9df6205eb" xlink:to="loc_srt_StatementScenarioAxis_db3fa008-1dd7-4d06-a26c-dd9adbd254b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0185a173-989c-422f-9219-b7b68d2047da" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_db3fa008-1dd7-4d06-a26c-dd9adbd254b9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0185a173-989c-422f-9219-b7b68d2047da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_e011b500-2f7f-45e1-a8c0-c83801e8748b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_0185a173-989c-422f-9219-b7b68d2047da" xlink:to="loc_srt_ScenarioForecastMember_e011b500-2f7f-45e1-a8c0-c83801e8748b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_ed8949e6-1415-4c4f-9cbf-c41c86815e18" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_485783fe-fe7a-495b-9bbf-34a9df6205eb" xlink:to="loc_srt_TitleOfIndividualAxis_ed8949e6-1415-4c4f-9cbf-c41c86815e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1bcdf47b-f0d2-4c0f-bd49-6b28a0461879" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_ed8949e6-1415-4c4f-9cbf-c41c86815e18" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1bcdf47b-f0d2-4c0f-bd49-6b28a0461879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_d9d3a592-a3c3-4ab0-9495-1511065a2c16" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1bcdf47b-f0d2-4c0f-bd49-6b28a0461879" xlink:to="loc_srt_ChiefExecutiveOfficerMember_d9d3a592-a3c3-4ab0-9495-1511065a2c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9dd7f37a-f71d-41ab-8cc6-a0615ec5cab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_485783fe-fe7a-495b-9bbf-34a9df6205eb" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9dd7f37a-f71d-41ab-8cc6-a0615ec5cab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_95415522-48b5-4031-9fe7-e528dbcc4269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9dd7f37a-f71d-41ab-8cc6-a0615ec5cab2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_95415522-48b5-4031-9fe7-e528dbcc4269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1e9ea92a-4a06-4d51-88ae-b666438c9776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_95415522-48b5-4031-9fe7-e528dbcc4269" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1e9ea92a-4a06-4d51-88ae-b666438c9776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_485783fe-fe7a-495b-9bbf-34a9df6205eb" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_6d77c92b-233e-45b1-bd78-81a7fbda53b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_6d77c92b-233e-45b1-bd78-81a7fbda53b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce_cabc0ae1-7f9f-48e0-bae3-5e711aaff341" xlink:href="ehth-20210930.xsd#ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:to="loc_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce_cabc0ae1-7f9f-48e0-bae3-5e711aaff341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_RestructuringChargesPreTax_a192d030-e773-4588-af50-c989806cee80" xlink:href="ehth-20210930.xsd#ehth_RestructuringChargesPreTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:to="loc_ehth_RestructuringChargesPreTax_a192d030-e773-4588-af50-c989806cee80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_767641c6-2ced-4207-b9c2-8f8da99db4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:to="loc_us-gaap_RestructuringReserve_767641c6-2ced-4207-b9c2-8f8da99db4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_a5c7a07c-8071-4c76-9ae6-5579f9f8223b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1_a5c7a07c-8071-4c76-9ae6-5579f9f8223b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_24ae960b-cf55-440a-9a05-0ff054568196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9370f97f-79a1-4a32-a6c6-0afff74dc2bb" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_24ae960b-cf55-440a-9a05-0ff054568196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/Debt" xlink:type="simple" xlink:href="ehth-20210930.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8e4d2100-3a35-47ad-b5de-3ff7df3da182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_8c144b1a-e0f6-4b36-ae3d-1399fbb0fe57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8e4d2100-3a35-47ad-b5de-3ff7df3da182" xlink:to="loc_us-gaap_LongTermDebtTextBlock_8c144b1a-e0f6-4b36-ae3d-1399fbb0fe57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/DebtDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#DebtDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1c7964a5-cfa2-4d97-9420-db14efa648f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ef6bb0f3-21c2-4231-b98c-80cc1fc714ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1c7964a5-cfa2-4d97-9420-db14efa648f7" xlink:to="loc_us-gaap_DebtInstrumentTable_ef6bb0f3-21c2-4231-b98c-80cc1fc714ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_BorrowingBasePercentageAxis_5d26a57c-b0f9-4565-896a-40e1550b07fa" xlink:href="ehth-20210930.xsd#ehth_BorrowingBasePercentageAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ef6bb0f3-21c2-4231-b98c-80cc1fc714ca" xlink:to="loc_ehth_BorrowingBasePercentageAxis_5d26a57c-b0f9-4565-896a-40e1550b07fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_BorrowingBasePercentageDomain_7ea550cf-4569-4c64-96df-15c38bf9cad9" xlink:href="ehth-20210930.xsd#ehth_BorrowingBasePercentageDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_BorrowingBasePercentageAxis_5d26a57c-b0f9-4565-896a-40e1550b07fa" xlink:to="loc_ehth_BorrowingBasePercentageDomain_7ea550cf-4569-4c64-96df-15c38bf9cad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember_a88282be-4968-4a24-851b-100bf3e76932" xlink:href="ehth-20210930.xsd#ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_BorrowingBasePercentageDomain_7ea550cf-4569-4c64-96df-15c38bf9cad9" xlink:to="loc_ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember_a88282be-4968-4a24-851b-100bf3e76932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember_652656c5-7514-4099-8418-af50ec9281ef" xlink:href="ehth-20210930.xsd#ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_BorrowingBasePercentageDomain_7ea550cf-4569-4c64-96df-15c38bf9cad9" xlink:to="loc_ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember_652656c5-7514-4099-8418-af50ec9281ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember_9c1c8a01-f883-4773-b02b-83179cb66f17" xlink:href="ehth-20210930.xsd#ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ehth_BorrowingBasePercentageDomain_7ea550cf-4569-4c64-96df-15c38bf9cad9" xlink:to="loc_ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember_9c1c8a01-f883-4773-b02b-83179cb66f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_60eb1319-7888-4ae3-b7de-428d3b303874" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ef6bb0f3-21c2-4231-b98c-80cc1fc714ca" xlink:to="loc_us-gaap_CreditFacilityAxis_60eb1319-7888-4ae3-b7de-428d3b303874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c1f1a8cb-0fa0-4a6c-8938-b5ad3e67fffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_60eb1319-7888-4ae3-b7de-428d3b303874" xlink:to="loc_us-gaap_CreditFacilityDomain_c1f1a8cb-0fa0-4a6c-8938-b5ad3e67fffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b7a58c8d-b00d-4180-8b85-7444e47e684b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c1f1a8cb-0fa0-4a6c-8938-b5ad3e67fffc" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b7a58c8d-b00d-4180-8b85-7444e47e684b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_bb9dfafb-5e4b-4946-89ed-3e631d26bc69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c1f1a8cb-0fa0-4a6c-8938-b5ad3e67fffc" xlink:to="loc_us-gaap_LetterOfCreditMember_bb9dfafb-5e4b-4946-89ed-3e631d26bc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bda3c089-5162-42dd-841c-01c0fed132a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ef6bb0f3-21c2-4231-b98c-80cc1fc714ca" xlink:to="loc_us-gaap_DebtInstrumentAxis_bda3c089-5162-42dd-841c-01c0fed132a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_37a35c20-7fb8-4ec5-8a83-63df0ed6428e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_bda3c089-5162-42dd-841c-01c0fed132a7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_37a35c20-7fb8-4ec5-8a83-63df0ed6428e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_CreditAgreementAmendmentMember_c8b8804d-d7f6-47c2-a599-577c60d29cc8" xlink:href="ehth-20210930.xsd#ehth_CreditAgreementAmendmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_37a35c20-7fb8-4ec5-8a83-63df0ed6428e" xlink:to="loc_ehth_CreditAgreementAmendmentMember_c8b8804d-d7f6-47c2-a599-577c60d29cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ef6bb0f3-21c2-4231-b98c-80cc1fc714ca" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_0582da55-30f3-4d03-9aba-3e0fbaf5222d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_0582da55-30f3-4d03-9aba-3e0fbaf5222d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityBorrowingBasePercentage_306c3ed5-e8a9-450e-b20f-2c8d7c32766e" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityBorrowingBasePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_ehth_LineOfCreditFacilityBorrowingBasePercentage_306c3ed5-e8a9-450e-b20f-2c8d7c32766e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_486a3cf3-f968-46b1-b3a7-8d6249c13b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_486a3cf3-f968-46b1-b3a7-8d6249c13b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityFacilityFeePercentage_bf9c5475-de07-4c1e-b806-500e25233374" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityFacilityFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_ehth_LineOfCreditFacilityFacilityFeePercentage_bf9c5475-de07-4c1e-b806-500e25233374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d9e82804-8872-4fcf-92fe-9f3c712e58b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d9e82804-8872-4fcf-92fe-9f3c712e58b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents_f570007f-0635-4973-aad6-75b420539f11" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents_f570007f-0635-4973-aad6-75b420539f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents_92d3fa2a-78f7-4a2c-9e08-5061a82c169d" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents_92d3fa2a-78f7-4a2c-9e08-5061a82c169d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMinimumLiquidity_7db2ef1d-744a-40cb-94cb-f3f9a4120423" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityCovenantMinimumLiquidity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMinimumLiquidity_7db2ef1d-744a-40cb-94cb-f3f9a4120423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ehth_LineOfCreditFacilityCovenantMaximumLiquidity_ca48a9e8-f8f3-40ca-9113-39381ce20048" xlink:href="ehth-20210930.xsd#ehth_LineOfCreditFacilityCovenantMaximumLiquidity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_ehth_LineOfCreditFacilityCovenantMaximumLiquidity_ca48a9e8-f8f3-40ca-9113-39381ce20048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_c3a82e18-86f1-48bc-b7f2-2284f806bcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_c3a82e18-86f1-48bc-b7f2-2284f806bcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_806480d0-5e34-46a1-9281-209e2353413b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3490819f-d675-493a-b2bb-c3e8ab421839" xlink:to="loc_us-gaap_LineOfCredit_806480d0-5e34-46a1-9281-209e2353413b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxes" xlink:type="simple" xlink:href="ehth-20210930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_61882e58-51d0-45c5-a2de-e9ba7f321275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f47bec0e-0f19-4842-85e8-4bf7477a40ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_61882e58-51d0-45c5-a2de-e9ba7f321275" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f47bec0e-0f19-4842-85e8-4bf7477a40ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="ehth-20210930.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c6083074-85f9-4508-b095-902faaa00c08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ef40950d-cb11-4732-b8bb-815b6ad44ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c6083074-85f9-4508-b095-902faaa00c08" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ef40950d-cb11-4732-b8bb-815b6ad44ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#IncomeTaxesSummaryofIncomeTaxBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d3867eef-0bc1-45cc-8cd6-c23a2249046a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2d4a5bf1-efdb-4916-9355-da56b8766aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3867eef-0bc1-45cc-8cd6-c23a2249046a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2d4a5bf1-efdb-4916-9355-da56b8766aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_03aec3a4-809d-4a5d-8350-89436b19194a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3867eef-0bc1-45cc-8cd6-c23a2249046a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_03aec3a4-809d-4a5d-8350-89436b19194a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7a305fc8-a8ec-49e4-b450-d82868cd3322" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3867eef-0bc1-45cc-8cd6-c23a2249046a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7a305fc8-a8ec-49e4-b450-d82868cd3322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="ehth-20210930.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_141a533f-7dfe-4720-bb5a-a021ada25223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b948c33d-43fb-4996-82d8-f661c5e26367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_141a533f-7dfe-4720-bb5a-a021ada25223" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b948c33d-43fb-4996-82d8-f661c5e26367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a63aea30-e3c4-42fa-9214-71e321170426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_141a533f-7dfe-4720-bb5a-a021ada25223" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a63aea30-e3c4-42fa-9214-71e321170426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>ehth-20210930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:ehth="http://www.ehealthinsurance.com/20210930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ehth-20210930.xsd" xlink:type="simple"/>
    <context id="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icf7a643bd0844ee692d39d0f7d9dd31b_I20211101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2021-11-01</instant>
        </period>
    </context>
    <context id="i942081d424f34699add16e658f851ed1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i759d5300c26749239484a4f23e10ce0a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0273079a37b24f93bde9cf3de6f118a8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3b864a8e10634cc386d2e4b1b66f73c9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifb2628c9d51a46139995f5f56f04eb1b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5334a64f425448d4aa5dd0966023fad5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icc76aa4ecb8a42b3bb83ea9ae9209b0f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4f614f83f3b14aceb5dddc72972dc625_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1c18bac640fb4358b74a9021f64f8f09_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i079a9bbf2d8444019d86c147c114b59f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1e357e366d8f4c42ad7a50b0355c2477_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i26c4eb4348de4a19a5f72c79a61f308d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0f613da7232e4dffaa5665383fbfb47b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2f721d7c0f874c25b09289e676fdcbac_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i61a6496ebf1f45f38f971210c3817264_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic4897b9072b44635b238daed55d2a37a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i370978c8564c4fcdadb9f1ea0c93f92a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i877f626f60a8448690bb833acb808b17_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iebbf9ee7e6494e258504f10868840783_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iecb1fedd8d124030a82eedac5b7a9e86_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5a48fdb953934f5bb836534b0414bbb6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i22fd73312a7c407e9083c80dffa106ff_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic86196f7d0f9445781c8ca4767d942db_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i531b3484676346ac94040d2dc4065a31_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ibabacd5b0f804aabada2cd5365f24498_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i33e718004b6a4f5aa57db218524b5773_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifefede64050246d08daebbf50765bb4f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6d5eb3c604944f028aede8e47b8499b7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia86272a5d3aa4258b2f07ea45b88ff59_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i391fe734bef14823a887a006994653ec_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i8bd8ce3993854b8e97b6b76978a4d09c_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ie7fbdf6185ab4c1da95b8b7ef4dd0e03_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i98ccd6154a98467786e1d4ef694bc1b1_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2dde38ab27e34c2389470563ce4f40dd_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie7ebb4122db248399d55925e46f33a97_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i150bf8ca70274905a045d294be04c55f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i40d62c8d4357468a811e6df8b3eb306f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6c86001988504201bc82e067924ed6cf_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i9def4cfc83f54b30addf32c96889fca4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i90037718d9204b0384103fade0d6cc45_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i8de5a03a387f4e069c2641fc24a40166_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i66989f5e965f4615937f019de6f617c4_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i3afb9956061e4743b8afadadf5214bfe_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i5ccdcb106e384ddeb87a904ee03a58ec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i556e4d2503564d02a306ef205e40b6e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie21f15744a034c72bc7d41e0bf1b76f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2012813b7e7f4d55b5f995c8c974f514_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9da432b99fc042a88112d75776ee1823_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1ae5a20475f543a7a5f9fde45d7bc4b1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iadf2c5122ad64d28a8d34ec6b3182521_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2df0c24aa97b454985d49591cb833558_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i280b8878146141b5a2280971a470a37e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib088409742214844b1196f2379e1f6ab_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia776a591bb4d4eabab7db24eecef27c1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i94afe3fa9f0f4d32bdfb8049be90c448_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3eb5bda82ad94139a7613a0c425e11c0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibda03bb57f0b4466a93ac7974d90a217_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5df02cc0922640229ea054a72d8338e3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i023ad41593504141a87219e927134521_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3aca269a6c854fa48018d8b33d96f58f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib87b2fd6b0e94d1194ca2219f67dbe72_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i952e9678a9584f75a5d6851f6e9eeb1b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9d26bc89cf9d42679d5552c59c55cdbf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifd8aecbec0954165b87a5ec97df1d4e2_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i83756e9e70664bbb9d9ce121c6030638_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7ee387271fcb47c8ae521d21b67a6519_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="id84eb822e5c644a4a6c213ee899e2d4e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i53205ea49e0b458292f697b7a5c56a93_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">ehth:UnderRecognitionOfStockBasedCompensationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i373a791d3cae4ac8ac03bd94922adf11_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">ehth:OverRecognitionOfLicensingCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7f1209faee954d01bec8ebffed7361b4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">ehth:OutOfPeriodAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0659c47707f64baa904993c672f45c27_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">ehth:OutOfPeriodAdjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia8d44d8be1ff4d9ba8d66ea2c112a2de_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib8e13b0d1c22425ca8ca7bebe6811adf_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1cd73075ac5746c1ac3c693924ea8745_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i79a3575bc66645c4873d69cd381d6522_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibb69f48720624bd2ba3990d45781b58b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareSupplementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i90eeed6c273749e88dabae5495cf6c9d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareSupplementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4e3aa4585c2a420aac2dbbcd2a763c5e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareSupplementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if58e722068de4216be2a26dc1df27ada_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicareSupplementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifab10f50711a46a8b9bdcbee99dfed11_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicarePartDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7a03b84610f148308bee0aedeeeeded4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicarePartDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if432dd7d445c47b68e3465e50a0cce99_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicarePartDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iae4bbc252a254aca8e08652db1ae75f4_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedMedicareAxis">ehth:MedicarePartDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5bf2b0808d5d4b95ad14fb56678b89df_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i64b14a1e7cf747b5bdd0af47f7efa4bf_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i288de29276794a4b98de7093838e980b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2b2f0942dcca4e079dc5dd9bcd2a7f2b_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i07e75d14864c4f86befd75db7d14b2be_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:NonQualifiedHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i36c47733c755462195bb2209eb595273_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:NonQualifiedHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i3fa14ebfc4094081974d71ef4e246a62_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:NonQualifiedHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i48aa029a268b4ec2b76e22c7b495a170_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:NonQualifiedHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i851cd6431ca8482eb6cf6148f01f3118_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:QualifiedHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibc8fa77be2f04de88bb71b5c8d8a8e8c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:QualifiedHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if1430539e8454dec87d06cc7d906f6c3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:QualifiedHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7cfe3cb32fd14c69820a09d8cf0a7ec5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedIndividualandFamilyAxis">ehth:QualifiedHealthPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i865072ee20694d9a916202d1277bb59a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia8d71827a12044b98aca58d93cc8b447_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i12b7def10b7c4144a3529c00d81371ea_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic140144201d545bb89a26e563ea54efc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:IndividualandFamilyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibccfac65e89e46b0a4779b6a9f5a1595_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:ShorttermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifb2e1ef01a8a49be95e5633382fff52e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:ShorttermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifb08ebace2994766abfc06f5a7ca01e0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:ShorttermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib04f6ab9257d4c3c82133b0ebf9ec119_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:ShorttermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9b84638a44674aae820620c1ad281b03_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:DentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3f329a84a77c4b40a18c88baac1fa79e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:DentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib265edd981cb4329b96667e22174e69a_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:DentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9226a70837c94f539c18e81cea08edff_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:DentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if35afead23854a98ba1ae85afef88254_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if334ca37e8184c3bb05e9970b42f9537_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia15e62c7d2ac4d8783c355c63461fb13_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia9ba1db851374ea0bdc62b19987a5f2d_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5794689700d84cc19cd5b25cb7e1a896_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i75a8cb208fd74edb96d789382c6d519f_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9f0cf3d15ecd4e02aba71ef693d79134_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic4e89f067c984a58aee8388d3f4e26f6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedAncillariesAxis">ehth:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie938c6c5a4b344bb9a1e717ea937a556_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0717ef9e88ca45c68fd977740d8d5fbb_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if45ec5bca96d4cffba4e82a71f5a9909_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic33a9cc99b61453181708c8ac5a2aa97_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:AncillariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i77dc76304d9f4dc794d414ab98cc2411_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:SmallBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibdb8cd80cf0c4da9853fa98df8f7fd37_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:SmallBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i411334780a0440f9b3aa7d1cd64fd42e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:SmallBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id66e7ebb7d4e493789cd440c77019454_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:SmallBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4787e3cd9c774e0486d6813affce59e3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionBonusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0e50511dfd494fd4b8f5a928e5ead478_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionBonusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ieed01c48dc4640938d300839252fb560_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionBonusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8cfcd2d5b5b040a09df39b1ff8138e51_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionBonusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1c3369cffbd74e249a3e3bcbd0df3054_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:SponsorshipAndAdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ice58cf46aa33484b9c94c1f20980a068_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:SponsorshipAndAdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6c4ce1d15f494a5996713fb811a2066e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:SponsorshipAndAdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7c7bf84cecf545a7a3974f7c1cfe3799_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:SponsorshipAndAdvertisingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0336634f72994ba8b44ad3381f004b4e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:MiscellaneousOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifc891b5b3b9c469f8a49e2e7a57facb8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:MiscellaneousOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2b1f428af2a34ebd8d75cfdee0ffd03b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:MiscellaneousOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6053607ddf734936ad39bb851ebfddc8_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:DisaggregatedOtherAxis">ehth:MiscellaneousOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i60f7bd4ed2c54782bc3f2260952e6258_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i71df5a32a01545eca393c3d91f915fec_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i351266363f7a4e1b8813c1836650f960_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i20e9c547df0148a987469593fc0dd987_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="icde2beb0631d4a4287783b69cf7d4e1d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idb0006a549d140b98d5bf1d2830e36e6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i4a16931904664e00b694766bb038e051_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i828454e449d849978e8c318cd2776b04_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i911f48697817404ab0c1d37ff5c70eb3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie30b009d33834b2784f9f5fde66749b8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7ddb689a8fbc45558ae1921f6350e8fd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5fb878914bf0422e994e7b471e4529cb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7afaf2016ac0443f80caca194735e56e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if0d09f83aa5a4ea2a65c601a78f12257_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i48026c37588241f584802f09d54f9ecf_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia2733db6c0ea4360b6296e5e62c73ccb_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6b76269dbb014c83960a5587af0692a7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3b68547b7b4546788f2a85f5b220c5e4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if7da352e8a9c40eb9cbd7fb732779cfe_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i89f5b05319a44a1cad8dcf843dfca2f6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1947f932e9cd407bb62d56755087564a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib2908788ec3a452c97c238d92d2d6035_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iacc349161dd6466bbcd492c1b35bd633_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2c979359de9d4404ab9ede567f6f6ece_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5ef44b438b8345fb9a5e4685fa068d53_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib56fc804e10645e19884d6bf939a1e47_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if141fe6636bb4186bf1303c83e6e12ae_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2f9533cbf4c24f3584970b6fd8bf789e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1758dd3c120e4914bdef33946facb083_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic84a9e32128947c58eaef205f493a0c8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i88f0ca026fd6441dacb2cb5e02eaa395_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8aa4da10fcd0440f893af9317b139b55_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedDuringCurrentPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="idf89006ab2ec48268296871b08a85218_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idc92029c098b4a3f9121ab760ccd9f11_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifc72c1bed1c841499706dc72a9f006a6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ife96baa989854bd5b161f91c7ee2b238_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7c18eadfc0c5443f8b7c31b736463ad6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5f03cec81030405695e2198510c5675c_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i5e56edcaffd445c099ce1763d8e2bac1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3ee271f47aa44a19bcbb4c37143a41fc_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionMembersApprovedInPriorPeriodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib6e1b062da104b6c93845164602f2f2c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i359b7b468f5540df8ade4326d6c36a90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib46a8ba9e5024efe8bf5aba81c5b9600_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3e3e7808533446fa841efe0261464aab_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1845a379344d4ba7b78716155f0ecf21_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7485ea45ef6d477b95fa116525c62450_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i799a45e99b484907806a69b59e333c89_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7b25b5471f2842f191c5c90038a9fce3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib803d8adedf24fbdbcb6cc7f5c5f99e9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifd6a2b2a5d6143c983bec97ffe0e0bd6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ehth:CommissionRevenueFromRenewalsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8f376e41d3214a4a8692048243ef8566_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i55279fea227b4f7992ca05764db25cfe_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic38fa4c27d674faaa2153103268bc6f2_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i07543f61382c4935bdeec18bab41cc0e_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i523d407abcc34388915c073912053b35_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id2046c7d044743ceaad71b60d4431854_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i352b2ea156634799b87eb09859219c43_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i29e568455e4e48e0a5ef2ebf86b689a0_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7fc6666241c84c42af5630376e4ae6d3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6a7cfd923d224bb6b7fe901abc5d9385_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i850ab8c5df8746729fb79a1ced686481_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i86f303cf73634348bebc5dab18fff7f4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibaab6d0a0d8545a186157b9fcb246894_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i47719e7e84e544339538a6b07e7b4dff_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib53890909b2842a6922819e1edeaa771_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifa1c7c5fa3884882909610f165c0d007_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5610009dd37b4384bc33a616a6aab127_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i50134f65952c447c8536c4c509d440b0_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4e7212367a01499c93d6d4b809f9ed9c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iad309707646240918be65ddd93e7dcf8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic5d5ade3741d4a9185c2b653a4af9ecb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib6f15061ad6e471cbda9021bf8810571_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie38b6c1b1c9c45fdba0d48aa1ce710c2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id2deb8ce979e4e7ebc3e73924fdf8984_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie4abea0af5374b2ea1c4c1f3394ae378_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i20249488a86d4517ad2ce8519062fb47_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib1196177b8cd4b4889d59fe382f0884a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if6f25d09031048a4ad52c1658b5f4ec4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i336d38756e4c40b1ba67a778fec1c8b7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i24ead09862b2413a86a888c37af9278b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4d257f4867664e9e9883a4c86aab2afc_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id70b3e6e37f5474eac6b0c1c37de4585_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i85a1662f85774554ac4dd94f6a4bd607_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i4d97d81f0af64632a38c7998284dd90c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i6bb1b3fedcf14b3d9257f06b935d3e4a_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i70979db466f8423f9755a5fb92cb03ae_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib7fa9733a3384f39b6dcfeb1f1ee2a6f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia7fcfcdb20334394afbf1256cc0e0662_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifcd9ed25d2764e9db6588f766c6ceb7c_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i491b5e834621498ca113938980a0be07_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id423dd6355054bb288a4cc0434f373bf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ic58f49a9465c47028f47e4656f464863_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i129ac8211d8e4c0ba7a255b8dab26a32_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i8bcd9764a5744c69a32ac980ad18308e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if4e09372bd664c3ab1b9f51f41199eb8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd42b9bb33c044dbb1de60bee9c42876_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec3221d11bf648bfb054e3fc5ae908f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icd4b24a0a2e341d199c0c81e18f6fe7a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i717e94aee1cb438cabdc9a27ae11551f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ef7c7b9f546496b9cfa4c224aed630e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i506a76e2d8ca425cbdb5ae11dd6cd259_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i746a758123914e1d937d531d3b4f1360_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5847226e38d1465db0569a5ceb228ff4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i002e42fc0f9446dea52b4be056b82628_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4f22b60783114271b6d18262ae59b3e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i723227d94b364d578aed1bb6c4c7d173_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icbd22cf0dccc41498bd9e877ebc39f93_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i980493d2590e4651b3a1f828bf64d0e6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iae0c078eeb4f4e9eb08d1321632981e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id40bd3241bac4466a336bb6f5771fbef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6dd7aca5034144ce9adb12f61bcad4b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f3ecf18721d481caad5f826b596a46f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2dba4eac468c476b9642c00c8d545983_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1b68294e77e84233b3a350690a075beb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i007949f0ecbd4d28a3fc49a2fbb4899d_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia88748e076ec49309ce124b0255894ee_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i81970b5cc22849c79344d636832e6166_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i62c9f97d16144d79b7c6fc675d93c63f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie5b86e4a17824c849cfbd6758868c90c_I20210922">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2021-09-22</instant>
        </period>
    </context>
    <context id="i772c44978dc24667b2c627577234e585_D20211001-20211108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-11-08</endDate>
        </period>
    </context>
    <context id="i35c1fdbec1c54ee8a4e0d47f73f57d02_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">ehth:PreviousRepurchaseProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1c6e47a0194e4a0d80cb752cc22efef5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i13884cc2d99e4cdca2c6d705a5357058_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iff865bc5ba294fe1a8f363fa0a398bae_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if870e8c7cb0242ba8a5c2b4b20121f1f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i27e01cc9738244978808f5a333f4fb54_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i460c059f80ca40628e4e5afaff80cc5e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i58966c27927746fab2aa950798c6ed8e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1cead6ea1a294d599363076673911adf_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ife779febc9214b9d9f667dc5dce85356_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iecda63b246a6400e9b5384de30aae603_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie4fedf3dee684a9698a7fa96f6d62fd4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ideb486a863af4417a98de87d059c62b5_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia5734b0b91d441278f565d646dc3d8b0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8edbc452bd9741e797e8dbd8b3399e72_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ice545f8f5bdb4b2fbe3864ed0eea00e2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i90df302f532b402fa538eed1092beab9_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7a5df46f99ab4327bcb5856e5d342696_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:CustomerCareAndEnrollmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic776873fdaff4484b896e658fb1dacfc_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:CustomerCareAndEnrollmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i6f1064a52d154cec94e9b6c3036d94f7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:CustomerCareAndEnrollmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib5086b187a3b4d09a240002bc9755ba1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:CustomerCareAndEnrollmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ibad2aa3a8cc44b218b307dfd6f4d7625_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:TechnologyAndContentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2bd41afc910548ce9002b75544cdf8b6_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:TechnologyAndContentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i61ff6162f5f44a859043de58c54befec_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:TechnologyAndContentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i98ea343e414e4f2daab5caa63d2dd869_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ehth:TechnologyAndContentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i154a3a36dc224680b714cc68444215d8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icb4e953743a04c219eeb943727baf738_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9890280d5b954508a226b55c81aeaf25_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4c5deda3fcee4a46bf2d57a2cb6c387e_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i538a335bee9d4605ac36f25f4181afa7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i05a980eb0e6b4490bb82b24144c3b3c8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i26a73d8f5e7749d9aa6a2add8248dab7_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i2066383d954548c7a2a439ea4837e924_D20230630-20230630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="i10b063ee9a3341c08e50e129ebfdff8a_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="i411da4d1faed43bea99e5a09b88c09cb_I20270430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2027-04-30</instant>
        </period>
    </context>
    <context id="id4e0a9ea40624a0c8ff143de3025b216_I20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ehth:EchelonHealthSPCLPHIGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="i745ac50b018842c299fbdeda74cca4fd_D20240430-20240430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="icb998d550c844cf9af4331570da45fc4_I20210217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ehth:EchelonHealthSPCLPHIGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-17</instant>
        </period>
    </context>
    <context id="i0e6cbb434882488fb8c40546664dd72a_I20210217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <instant>2021-02-17</instant>
        </period>
    </context>
    <context id="i43de0639e96543369be5664fcb0fb527_I20230817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-17</instant>
        </period>
    </context>
    <context id="i6156a60f5d5a4f659313e014d9aa6e94_I20210217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-17</instant>
        </period>
    </context>
    <context id="iee6fe712df744b2590f8f3fc4983ca39_I20210217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-17</instant>
        </period>
    </context>
    <context id="i4a83bcf547574a6b95583d2323256a2f_D20210430-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2021-04-30</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if073c25e8f81417c919277ea8f455b19_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5d6d24f666c04e62a06ca4c5cf46e773_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia5e0e7005d3f4062a071addcafc27c06_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9e30025f0e894023bc09a663cf9f1b11_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia579f87161bd4c4bbfb8854b3b172133_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icbfdeb0605ef4c5f870e8f2f7cd707a4_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i229764ec8611404cb78a18d3f3ea7742_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iebe8f8a1f6c74de99d0800095353e8d6_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib307fc5e33fc48b29073be7772a66cf6_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1be182ab19bb49e5ad85243990d16da7_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic43e48e719fb4602912e4b0b7aa5e097_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iecb19833c8e8461f9982c3ef70588776_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i340227a27cb64be1b3a57692746b5bbe_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6b044301e060489699b1d5da2e923272_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic70c39ada9ec49e5a840c9102e12c415_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9fba14fb6ba94783a410123eed9f78a3_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="if22877f27abe4b9e9bcea617938a333a_D20200408-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2020-04-08</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i4d162a37afc94df8a25268308d382345_D20200707-20201013">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2020-07-07</startDate>
            <endDate>2020-10-13</endDate>
        </period>
    </context>
    <context id="i21698a317c0745a9b39abd2f8c067af4_D20190701-20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">ehth:LeViasCompliantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-01</endDate>
        </period>
    </context>
    <context id="i78acf1a81a984826bfe2cedc7f25d60d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i599f7c7be93c4814890c266b5ec47df8_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0ef09b5449f84c8ead10851320de6c76_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7a6293eb4d8349d9a31d1b1a2fd3ed11_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:MedicareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic5da3c7f6d5d4610954eeac8d16c4dbe_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8a41b5baa43d4ed18e1b54843fc57273_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i467949b0884e43b0a011bdf4fadde010_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i039e32b3c64041e49cb0878ecaabafd1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ehth:IndividualFamilyAndSmallBusinessSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i91c81e16d0784d4d958fe95d1f894a24_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaef638b0fa1046eb9911d6d4747f5df0_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i8ad8d3eeb32049fe90a788e0eda6b25d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i23411f69f39b432f81bcc3da7c590e76_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia8a334e29b924ce49cd96becafc4d8fb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i74d37c58f9574acc85052b984bfa332e_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="iaae702e195164e63ba0beb670c74dde5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i22910efbde7440648884b8f7e2613f28_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i9d576e424126448ab8ccca7322a38757_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i90ca3570cf7d49f6a8e32f5b5cb816e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id9c3527283ec406d936905c741fd644e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i807a2c2c69384b17a0895525b7e3edd3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icaaefcb4864c42c9977406372dae345d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia99590146c5a4c1da65f6789c51d6d45_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0361883d6d844e64919f623c50758d9f_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:UnitedhealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ifed085705a1141f7b66607c7f088c4f7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iedb3906c92b9439bb9f00fb896ef8c19_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2c33a4818d8a4dd1b84a8c1a8ef5eda5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4eb35f5535224b48aab5f6959f231bec_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:AetnaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ic37891f447e942e58713991d7596b9e8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic6e791641d474976aa090740b18829e9_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7f2574a154db4f12910857916c1fb936_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2b3c828fd9844044b536167585b76ad7_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:HumanaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7aee3ac4c576453099eae47761de55e3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4c33c1733414490c92126731233e4e66_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ie78c1d1beb9648dfa9a878f03a582e82_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2ccf79aa1d6a4dc9a005e080c3858ac1_D20200101-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ehth:CenteneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i1fd910c49a244d5c84e732a5b01119c4_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3f4d4b8270d044b59fee38b2066bc5db_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2ce9e77371e64f6a8892196a9e45088f_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="ic22af0ed9d5a46f7a09827528922c14b_D20210201-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib8e43307bfae4745be61c3650614ae16_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b88d930749840dda7fc079ab96c882a_I20180917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-17</instant>
        </period>
    </context>
    <context id="i157113a553d840878f52e68b6c57d78d_I20180917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-17</instant>
        </period>
    </context>
    <context id="ifa14883525614cf79dab683249f898ec_I20191220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-20</instant>
        </period>
    </context>
    <context id="i8887c4dc48dd49678b387048f0530ba7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:BorrowingBasePercentageAxis">ehth:EligibleCommissionsReceivablesPrecedingThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8ec55043cfb045c2aa1b9f8dd9a631ce_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:BorrowingBasePercentageAxis">ehth:EligibleCommissionsReceivablesSucceedingThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieca95dd280a443e393ddf3ccbcca1f92_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ehth:BorrowingBasePercentageAxis">ehth:EligibleCommissionsReceivablesSucceedingSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i724149df6b244d9cb6760b3d59438694_D20180917-20180917">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-17</startDate>
            <endDate>2018-09-17</endDate>
        </period>
    </context>
    <context id="iea337c22bd714443919d49600be45338_D20191220-20191220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-20</startDate>
            <endDate>2019-12-20</endDate>
        </period>
    </context>
    <context id="ica1b5f7280934d02b7e7917401872662_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ehth:CreditAgreementAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id8ba51940194417ebfd20f82ded0000b_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ehth:CreditAgreementAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i35b23d73e2ba484d8591b732fcc5f47c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ehth:CreditAgreementAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="insurance_carrier">
        <measure>ehth:insurance_carrier</measure>
    </unit>
    <unit id="state">
        <measure>ehth:state</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="security">
        <measure>ehth:security</measure>
    </unit>
    <unit id="day">
        <measure>ehth:day</measure>
    </unit>
    <unit id="claim">
        <measure>ehth:claim</measure>
    </unit>
    <unit id="plaintiff">
        <measure>ehth:plaintiff</measure>
    </unit>
    <unit id="segment">
        <measure>ehth:segment</measure>
    </unit>
    <unit id="employee">
        <measure>ehth:employee</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80L2ZyYWc6MTk2YjBiNjJlYzIyNGZhYzliMWFjM2NhZTJkMGVjYjcvdGFibGU6NTY0MTkzMjA5NTUxNDg0MmFhNjE2ZGY2ZTIxYzY0YzMvdGFibGVyYW5nZTo1NjQxOTMyMDk1NTE0ODQyYWE2MTZkZjZlMjFjNjRjM18zLTEtMS0xLTA_805ed3b1-3a7c-47f8-bbb1-db94377043a2">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80L2ZyYWc6MTk2YjBiNjJlYzIyNGZhYzliMWFjM2NhZTJkMGVjYjcvdGFibGU6NTY0MTkzMjA5NTUxNDg0MmFhNjE2ZGY2ZTIxYzY0YzMvdGFibGVyYW5nZTo1NjQxOTMyMDk1NTE0ODQyYWE2MTZkZjZlMjFjNjRjM181LTEtMS0xLTA_7e488d10-41bb-4b13-9f2d-e89f91e865ee">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80L2ZyYWc6MTk2YjBiNjJlYzIyNGZhYzliMWFjM2NhZTJkMGVjYjcvdGFibGU6NTY0MTkzMjA5NTUxNDg0MmFhNjE2ZGY2ZTIxYzY0YzMvdGFibGVyYW5nZTo1NjQxOTMyMDk1NTE0ODQyYWE2MTZkZjZlMjFjNjRjM182LTEtMS0xLTA_3ce42fb0-87b9-44d5-bf55-bd69365396c1">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80L2ZyYWc6MTk2YjBiNjJlYzIyNGZhYzliMWFjM2NhZTJkMGVjYjcvdGFibGU6NTY0MTkzMjA5NTUxNDg0MmFhNjE2ZGY2ZTIxYzY0YzMvdGFibGVyYW5nZTo1NjQxOTMyMDk1NTE0ODQyYWE2MTZkZjZlMjFjNjRjM185LTEtMS0xLTA_bdfa1ce4-3ba1-4a9a-87e4-0a52c0f7872c">0001333493</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80L2ZyYWc6MTk2YjBiNjJlYzIyNGZhYzliMWFjM2NhZTJkMGVjYjcvdGFibGU6NTY0MTkzMjA5NTUxNDg0MmFhNjE2ZGY2ZTIxYzY0YzMvdGFibGVyYW5nZTo1NjQxOTMyMDk1NTE0ODQyYWE2MTZkZjZlMjFjNjRjM18xMC0xLTEtMS0w_07e47616-1d08-4562-ae9a-d2b2fde2ecd6">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i3aca269a6c854fa48018d8b33d96f58f_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNC0wLTEtMS0w_60f9a9ee-3a38-457d-b1c8-5c6bce90da25">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <dei:DocumentType
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMzA3_29b01eb4-299a-4b34-8d5c-0d93e4777e6c">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMzA0_fa564492-40b5-42d1-9a02-47aa05aa16bd">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMTE_d7554414-7154-4ec8-ac53-27d772c738d5">2021-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMzAy_1f11b6fb-c383-4938-833c-39452020cf28">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMjk4_ef2ed3ad-a802-4afd-b080-0f9e8ee21384">001-33071</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMzAz_5ef1ee40-eeed-42cd-bb6b-6a94fd5f6e60">EHEALTH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6Njc0OWE2ZTQyNjgzNGNmZjlmYjc3MDYxMDRjMTAxMDAvdGFibGVyYW5nZTo2NzQ5YTZlNDI2ODM0Y2ZmOWZiNzcwNjEwNGMxMDEwMF8wLTAtMS0xLTA_71864b57-7dea-4f51-a09c-3b7576962262">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6Njc0OWE2ZTQyNjgzNGNmZjlmYjc3MDYxMDRjMTAxMDAvdGFibGVyYW5nZTo2NzQ5YTZlNDI2ODM0Y2ZmOWZiNzcwNjEwNGMxMDEwMF8wLTItMS0xLTA_784d443e-e42a-4099-9e08-72b1c1930c4f">56-2357876</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMjk5_2ff7a770-2237-48a5-8ae4-d140b8a63c99">2625 AUGUSTINE DRIVE, SECOND FLOOR</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMzA2_02b476e3-4d9f-459b-9ac9-d4410de61d22">SANTA CLARA</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMjk0_72cd8b9c-4250-4ad5-ab30-bb4c57095a52">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMjk1_673c95fe-628e-4a8b-8526-29a4aa7b6b27">95054</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMjk2_38a10899-62f2-4221-88fd-5ad46ced3560">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF82NTM_357c900c-1f54-4902-9ba6-a7bdbea091c2">584-2700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6ZmExZWU0NTBmZTA2NDhlMjg1ZDkzZDNmNDAxNzI5MDQvdGFibGVyYW5nZTpmYTFlZTQ1MGZlMDY0OGUyODVkOTNkM2Y0MDE3MjkwNF8xLTAtMS0xLTA_5b1b176f-7e12-4ca5-8b76-70525e2bd837">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6ZmExZWU0NTBmZTA2NDhlMjg1ZDkzZDNmNDAxNzI5MDQvdGFibGVyYW5nZTpmYTFlZTQ1MGZlMDY0OGUyODVkOTNkM2Y0MDE3MjkwNF8xLTEtMS0xLTA_73fb98cf-6d1c-4c6b-9449-10e1586dad9c">EHTH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6ZmExZWU0NTBmZTA2NDhlMjg1ZDkzZDNmNDAxNzI5MDQvdGFibGVyYW5nZTpmYTFlZTQ1MGZlMDY0OGUyODVkOTNkM2Y0MDE3MjkwNF8xLTItMS0xLTA_630c6594-3acd-422f-9f19-296ae86f6638">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMjk3_b8dfe5e9-615b-41a0-b058-daa13ed8e5e2">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMzAw_885cc04b-aada-4efe-b9b5-c9452fac549c">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6MjA2MWJiNzFkMDFkNGUyMDg2YWI3MjgxNDVmMWYzODAvdGFibGVyYW5nZToyMDYxYmI3MWQwMWQ0ZTIwODZhYjcyODE0NWYxZjM4MF8wLTAtMS0xLTA_44aa684f-cfda-4a79-bf66-6a8698835820">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6MjA2MWJiNzFkMDFkNGUyMDg2YWI3MjgxNDVmMWYzODAvdGFibGVyYW5nZToyMDYxYmI3MWQwMWQ0ZTIwODZhYjcyODE0NWYxZjM4MF8xLTQtMS0xLTA_fec0075e-40c8-4150-9abb-41baf9872382">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGFibGU6MjA2MWJiNzFkMDFkNGUyMDg2YWI3MjgxNDVmMWYzODAvdGFibGVyYW5nZToyMDYxYmI3MWQwMWQ0ZTIwODZhYjcyODE0NWYxZjM4MF8yLTQtMS0xLTA_9b9c6dc1-4574-48ed-ad98-2b05c823cc96">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMzAx_03f4ec84-4c9b-454b-9810-ae0fbabbfb45">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="icf7a643bd0844ee692d39d0f7d9dd31b_I20211101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xL2ZyYWc6MjcyZDE5OGRkMmQzNDkzYmI0ZmI1YWE3ZTAzMmU2N2QvdGV4dHJlZ2lvbjoyNzJkMTk4ZGQyZDM0OTNiYjRmYjVhYTdlMDMyZTY3ZF8yMjgy_6592956b-c272-45b3-96be-d023f6b1142c"
      unitRef="shares">26388112</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMy0xLTEtMS0w_3109826f-773c-417c-acc6-33c3f80a8443"
      unitRef="usd">157530000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMy0zLTEtMS0w_ac4a11bb-e4d7-486f-851d-d6c471a89fee"
      unitRef="usd">43759000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNC0xLTEtMS0w_12cb0125-c0bd-4aa4-8343-c0a621b37d51"
      unitRef="usd">70212000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNC0zLTEtMS0w_973cd248-37a9-408f-998f-7395871cea8e"
      unitRef="usd">49620000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNS0xLTEtMS0w_afb70e4b-5c57-4083-9169-edec942225ca"
      unitRef="usd">1305000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNS0zLTEtMS0w_c7f0cd2d-e5b7-4572-8091-5f90beb9e305"
      unitRef="usd">1799000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNi0xLTEtMS0w_c3ccab4a-412c-4f89-843d-db75b009d1ae"
      unitRef="usd">194197000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNi0zLTEtMS0w_b0c470d1-5569-4b38-ba4c-549e9f2c8ba1"
      unitRef="usd">219153000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNy0xLTEtMS0w_9a012dde-dc74-46a5-824a-74f35ad437c5"
      unitRef="usd">36653000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNy0zLTEtMS0w_06f2a0e0-4c0f-4c3a-bd07-1da910ffb435"
      unitRef="usd">16661000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOC0xLTEtMS0w_c6c695cb-07cb-479d-bd54-579786acd07a"
      unitRef="usd">459897000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOC0zLTEtMS0w_a4ef4595-7fda-42b2-a40a-60640a12be13"
      unitRef="usd">330992000</us-gaap:AssetsCurrent>
    <us-gaap:ContractWithCustomerAssetNetNoncurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOS0xLTEtMS0w_d3392f06-25ed-4e55-b582-1f7ae6e0ca72"
      unitRef="usd">563171000</us-gaap:ContractWithCustomerAssetNetNoncurrent>
    <us-gaap:ContractWithCustomerAssetNetNoncurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOS0zLTEtMS0w_f9e8d5fc-5f1a-4394-a3ba-3b83620cc224"
      unitRef="usd">573252000</us-gaap:ContractWithCustomerAssetNetNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTAtMS0xLTEtMA_6f97af61-8882-4695-98b6-7f02d0765d05"
      unitRef="usd">13795000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTAtMy0xLTEtMA_07cb5ec8-79d1-418e-8f4d-63364b505854"
      unitRef="usd">14609000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTItMS0xLTEtMA_92035fae-d71a-411e-8d30-a3a8cb9ca30f"
      unitRef="usd">38693000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTItMy0xLTEtMA_adf0cfc9-05b4-4267-8b84-5052befdd4dd"
      unitRef="usd">42558000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTMtMS0xLTEtMA_a3d23428-fd9a-4dce-93c8-9e526b66ea5e"
      unitRef="usd">3354000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTMtMy0xLTEtMA_771b9f87-82e8-4711-9fb8-a744d7d9c306"
      unitRef="usd">3354000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTQtMS0xLTEtMA_3e65f51f-84d8-4f66-a33c-a0aa391eeb8f"
      unitRef="usd">8153000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTQtMy0xLTEtMA_fb23a37a-2ca0-4833-b6c8-b309f76b307c"
      unitRef="usd">8569000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTUtMS0xLTEtMA_aa0e0069-8b04-4983-9014-26103445f3d7"
      unitRef="usd">40233000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTUtMy0xLTEtMA_3964d77d-fea3-4afe-8421-55c3cc3cde1b"
      unitRef="usd">40233000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTYtMS0xLTEtMA_619656c4-f743-4aba-9e05-42f5e58f5864"
      unitRef="usd">32307000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTYtMy0xLTEtMA_badf2027-c006-488e-a6d5-6961ba416881"
      unitRef="usd">26455000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTctMS0xLTEtMA_d2df6bc6-66eb-4185-b9c8-20a08a2c5f69"
      unitRef="usd">1159603000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTctMy0xLTEtMA_d4569728-416a-47a6-9953-462068b66f5c"
      unitRef="usd">1040022000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjAtMS0xLTEtMA_5a98efc5-1437-4bc7-b7a6-a160fb68c45d"
      unitRef="usd">10084000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjAtMy0xLTEtMA_d97efac3-28eb-4ea2-9676-9133521a2c9b"
      unitRef="usd">36921000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjEtMS0xLTEtMA_a4ebc50e-fb26-4ae7-a79c-fa2a1574755c"
      unitRef="usd">20424000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjEtMy0xLTEtMA_93ce37c2-5e41-4572-ae76-22f89096d113"
      unitRef="usd">20542000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <ehth:AccruedMarketingExpenses
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjItMS0xLTEtMA_5e81b6e6-7ab5-4e95-8dd4-0fa0365d69f8"
      unitRef="usd">11263000</ehth:AccruedMarketingExpenses>
    <ehth:AccruedMarketingExpenses
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjItMy0xLTEtMA_8a61d91c-006a-4d3f-aafe-517efebf3aec"
      unitRef="usd">17788000</ehth:AccruedMarketingExpenses>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjQtMS0xLTEtMA_fa0b57da-c1eb-4a6e-a34f-acf227c62f25"
      unitRef="usd">5570000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjQtMy0xLTEtMA_294efc7c-77df-4766-84ab-0e37f25faaaf"
      unitRef="usd">5192000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjUtMS0xLTEtMA_225c40cc-9686-4279-bcd2-557d50733961"
      unitRef="usd">10547000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjUtMy0xLTEtMA_8c1e456e-b4ff-4909-b9c0-d5ef37d91249"
      unitRef="usd">308000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjYtMS0xLTEtMA_0dfc378c-846b-4248-80fa-6ecd0006ad6f"
      unitRef="usd">4546000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjYtMy0xLTEtMA_d9730304-e7ad-477a-a47f-77fb5f54d0a2"
      unitRef="usd">3657000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjctMS0xLTEtMA_f2a6f78b-b922-47e3-a8e3-81afed6da6dc"
      unitRef="usd">62434000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjctMy0xLTEtMA_fc64627f-a1a3-4c25-9756-78e60e35dfff"
      unitRef="usd">84408000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjgtMS0xLTEtMA_e5c9150e-a8c2-4b53-82c8-abd2d36116cb"
      unitRef="usd">52185000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjgtMy0xLTEtMA_c0b94042-c45c-4332-b7ce-89ffa7e675c5"
      unitRef="usd">72317000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjktMS0xLTEtMA_ce2a3e68-cfbb-41c5-b245-fa8327ea2d49"
      unitRef="usd">37138000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjktMy0xLTEtMA_8dd10fb0-60d3-4cd0-8e67-50c5e4edd50e"
      unitRef="usd">41369000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzAtMS0xLTEtMA_37ce7a80-88a1-4768-8064-6644e361e4e4"
      unitRef="usd">4747000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzAtMy0xLTEtMA_895d489e-e29f-400b-a15e-e0bc1ac39f76"
      unitRef="usd">4370000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzEtMS0xLTEtMA_21901118-736e-46e2-97f3-59a93173e8b4"
      unitRef="usd">156504000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzEtMy0xLTEtMA_f2c82846-1978-4782-ab46-14ced2a76dcd"
      unitRef="usd">202464000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzItMS0xLTEtMA_27de52b2-d690-4e3c-8794-6ee46e0b04be"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzItMy0xLTEtMA_da23f0db-05c5-4d01-a973-6d1630dbc55b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzMtMS0xLTEtMA_93d60651-88d3-43c0-8ccc-ba722c009b70"
      unitRef="usd">225438000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzMtMy0xLTEtMA_b7c1e801-3c04-4559-b6f4-b080c391953e"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockValue
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzUtMS0xLTEtMA_67f4ff3a-faee-43a3-8ad8-6e1a21bc39ea"
      unitRef="usd">38000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzUtMy0xLTEtMA_c1ed0323-1ba4-463e-8f80-6a886a540a12"
      unitRef="usd">38000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzYtMS0xLTEtMA_aa65a59b-82ae-424b-b8ab-368ad9a6c421"
      unitRef="usd">744784000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzYtMy0xLTEtMA_effeaa50-9e6e-4471-87b2-c397dfb10fde"
      unitRef="usd">721013000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockValue
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzctMS0xLTEtMA_2acbfa4e-50cb-4391-af59-6040c0cc07c9"
      unitRef="usd">199998000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzctMy0xLTEtMA_e5e15142-ba25-4497-9ae7-ec708f2f9259"
      unitRef="usd">199998000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzgtMS0xLTEtMA_bb44507d-572a-498d-a121-938031966d00"
      unitRef="usd">232519000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzgtMy0xLTEtMA_e0767b25-f544-4f1a-ba74-87b6dadf7af4"
      unitRef="usd">316155000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzktMS0xLTEtMA_5efb177b-e65e-4d0e-b9c1-8fe4cf5d33e4"
      unitRef="usd">318000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzktMy0xLTEtMA_23659aac-e96b-4ca6-9b5a-3e0277e23a69"
      unitRef="usd">350000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDAtMS0xLTEtMA_3adfcfc7-13b4-4669-9407-67c67238defc"
      unitRef="usd">777661000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDAtMy0xLTEtMA_a7d99179-ef04-42e8-812f-d02c653646e7"
      unitRef="usd">837558000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDEtMS0xLTEtMA_baf273b0-d469-449d-b433-55e8e967a1da"
      unitRef="usd">1159603000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDEtMy0xLTEtMA_518524af-b08d-469d-a46b-ad21ff86b3e8"
      unitRef="usd">1040022000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0273079a37b24f93bde9cf3de6f118a8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMy0xLTEtMS0w_09a6b808-0534-43b5-ab8c-f8f98444b327"
      unitRef="usd">59191000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b864a8e10634cc386d2e4b1b66f73c9_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMy0zLTEtMS0w_173b81ec-2060-4dd8-b239-bc36a8c08056"
      unitRef="usd">73544000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb2628c9d51a46139995f5f56f04eb1b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMy01LTEtMS0w_d0707883-6241-4d16-8411-98f15101f52c"
      unitRef="usd">276066000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5334a64f425448d4aa5dd0966023fad5_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMy03LTEtMS0w_3e361a9b-2139-47d0-9d68-28b07048e0ee"
      unitRef="usd">253986000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc76aa4ecb8a42b3bb83ea9ae9209b0f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNC0xLTEtMS0w_3d929bb9-a91e-4942-8530-0ab79f341237"
      unitRef="usd">4723000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f614f83f3b14aceb5dddc72972dc625_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNC0zLTEtMS0w_8f038a66-38ea-4a74-827b-6ce2f569de7e"
      unitRef="usd">20740000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c18bac640fb4358b74a9021f64f8f09_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNC01LTEtMS0w_e16d5e99-aa74-40fb-81a1-773acc0a212e"
      unitRef="usd">18619000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i079a9bbf2d8444019d86c147c114b59f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNC03LTEtMS0w_aab9f496-0fd6-4b01-93c1-5a4987f95a2d"
      unitRef="usd">35472000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNS0xLTEtMS0w_2c95bea2-929d-4d21-b203-05205ec2e9a9"
      unitRef="usd">63914000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNS0zLTEtMS0w_88404364-a2f2-4e89-82cf-cca2a20eb08a"
      unitRef="usd">94284000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNS01LTEtMS0w_2bf53919-0625-4918-af77-e8bf66a8cbe9"
      unitRef="usd">294685000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNS03LTEtMS0w_3b684586-57ea-4642-8e39-5a3148db2210"
      unitRef="usd">289458000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNy0xLTEtMS0w_da12d8d9-e232-4bf0-8761-7836f0e4e7c6"
      unitRef="usd">-25000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNy0zLTEtMS0w_39e07cd7-3ee5-4f44-bac7-460d33621268"
      unitRef="usd">482000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNy01LTEtMS0w_7fc000b3-cbf3-48fe-a7c7-59ac30f2e6dd"
      unitRef="usd">1217000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfNy03LTEtMS0w_5cec756f-f21a-417b-9a28-678a5ff87b34"
      unitRef="usd">2160000</us-gaap:CostOfRevenue>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOC0xLTEtMS0w_22edba6b-9b7a-4d91-bbe3-f4bb3820a916"
      unitRef="usd">43317000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOC0zLTEtMS0w_7ac08d89-1139-47c4-b775-58d2ac9e458c"
      unitRef="usd">33405000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOC01LTEtMS0w_c79fef99-b6f3-4263-943d-1ef3e094b059"
      unitRef="usd">138772000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOC03LTEtMS0w_2df02ff2-6717-4b61-9595-2ea8ce44eef4"
      unitRef="usd">104042000</us-gaap:MarketingAndAdvertisingExpense>
    <ehth:CustomerCareAndEnrollmentExpense
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOS0xLTEtMS0w_35b83c25-bbc2-4be4-861a-6f64d30ee57f"
      unitRef="usd">48956000</ehth:CustomerCareAndEnrollmentExpense>
    <ehth:CustomerCareAndEnrollmentExpense
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOS0zLTEtMS0w_50b64929-d202-4509-994d-31f4cd459c71"
      unitRef="usd">43342000</ehth:CustomerCareAndEnrollmentExpense>
    <ehth:CustomerCareAndEnrollmentExpense
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOS01LTEtMS0w_c2781a69-c8f2-4699-91eb-b26837dc9e71"
      unitRef="usd">121480000</ehth:CustomerCareAndEnrollmentExpense>
    <ehth:CustomerCareAndEnrollmentExpense
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfOS03LTEtMS0w_e8f7df14-4e18-426e-bd7f-e1c088147764"
      unitRef="usd">101025000</ehth:CustomerCareAndEnrollmentExpense>
    <ehth:TechnologyAndContentExpense
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTAtMS0xLTEtMA_92661424-d8c7-4aa4-9490-191ce2a0c2db"
      unitRef="usd">20369000</ehth:TechnologyAndContentExpense>
    <ehth:TechnologyAndContentExpense
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTAtMy0xLTEtMA_f1655439-9430-4fe6-bc20-ee623e9aab5d"
      unitRef="usd">17673000</ehth:TechnologyAndContentExpense>
    <ehth:TechnologyAndContentExpense
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTAtNS0xLTEtMA_1dbbfcfb-328d-44af-9528-3636421b6fce"
      unitRef="usd">63996000</ehth:TechnologyAndContentExpense>
    <ehth:TechnologyAndContentExpense
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTAtNy0xLTEtMA_a0ae7666-612c-483a-937f-0c5289dad7f6"
      unitRef="usd">46786000</ehth:TechnologyAndContentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTEtMS0xLTEtMA_cab6a7bb-96f5-4251-8f0b-da7ce732691d"
      unitRef="usd">16640000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTEtMy0xLTEtMA_5539d169-c8d7-4348-8932-708fd2887d91"
      unitRef="usd">19942000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTEtNS0xLTEtMA_0bb1c6c3-e691-4d85-99aa-23e41e122b82"
      unitRef="usd">57812000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTEtNy0xLTEtMA_5a414351-6fee-4292-9665-e7cf17fd1c1e"
      unitRef="usd">60308000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTItMS0xLTEtMA_715f15c6-0a9c-4f75-bb98-c1ccad7b2e84"
      unitRef="usd">121000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTItMy0xLTEtMA_91e75712-1599-4b2f-adde-016a62c1033f"
      unitRef="usd">287000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTItNS0xLTEtMA_77653940-5e17-41b3-b87d-0bd758a71bb8"
      unitRef="usd">416000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTItNy0xLTEtMA_250b1325-346d-42b3-82d2-f79c8cc73f24"
      unitRef="usd">1207000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RestructuringCharges
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTQtMS0xLTEtMA_e16ce87e-6afc-43e0-9d75-49fc863f1df5"
      unitRef="usd">573000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTQtMy0xLTEtMA_705a5505-f2f7-48ea-9b00-ca401662234c"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTQtNS0xLTEtMA_b8815212-c584-4f12-8798-7bba12dc9a26"
      unitRef="usd">3004000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTQtNy0xLTEtMA_f6757721-4a96-4822-ba17-f97a0e63b39e"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:CostsAndExpenses
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTYtMS0xLTEtMA_5eb5ffdb-41b8-43c8-9629-18afd75c7a10"
      unitRef="usd">129951000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTYtMy0xLTEtMA_38a73804-aaa4-40dd-84bb-2f81c475998e"
      unitRef="usd">115131000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTYtNS0xLTEtMA_f130bde8-9718-4f89-8701-00df98f2bde0"
      unitRef="usd">386697000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTYtNy0xLTEtMA_1c40b59e-7473-49b9-bff4-e0da32cacb51"
      unitRef="usd">315528000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTctMS0xLTEtMA_b3d5517e-ccb3-4c25-8c12-683dd2feeb65"
      unitRef="usd">-66037000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTctMy0xLTEtMA_a5e2cdfa-94e8-4358-b683-9e0382e45bfd"
      unitRef="usd">-20847000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTctNS0xLTEtMA_f250d806-605b-40f8-baf7-c3207661013f"
      unitRef="usd">-92012000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTctNy0xLTEtMA_5fb8fec5-06e4-451d-b353-16b03f582d7b"
      unitRef="usd">-26070000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTgtMS0xLTEtMA_5c9ec167-8b8b-4e7e-8b74-332cdeb55665"
      unitRef="usd">189000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTgtMy0xLTEtMA_6235bd63-8661-4471-aefc-6f46d833bf13"
      unitRef="usd">-101000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTgtNS0xLTEtMA_0c831089-d314-4df6-8a12-b0293f93bb21"
      unitRef="usd">511000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTgtNy0xLTEtMA_10a7caaa-62d7-446b-8810-341fb37ac10d"
      unitRef="usd">724000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTktMS0xLTEtMA_b03dde15-b925-481f-93e9-ec81cdeb0bd9"
      unitRef="usd">-65848000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTktMy0xLTEtMA_a4b70b88-3677-4046-94c3-b2afef607529"
      unitRef="usd">-20948000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTktNS0xLTEtMA_ca8ef228-0713-4b42-8725-2c1848a82e2c"
      unitRef="usd">-91501000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMTktNy0xLTEtMA_96827cb4-c1de-40c6-b76f-a9325d30a529"
      unitRef="usd">-25346000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjAtMS0xLTEtMA_67561739-f919-44d2-8204-f71c3524f98e"
      unitRef="usd">-12834000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjAtMy0xLTEtMA_cbfb2cce-08e4-4da6-aa56-733b2eace4f5"
      unitRef="usd">-6443000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjAtNS0xLTEtMA_f793fe67-d2c5-46b1-990b-b49f170e3681"
      unitRef="usd">-19278000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjAtNy0xLTEtMA_3e85c0ed-3773-452a-8677-075751ad36a9"
      unitRef="usd">-10923000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjEtMS0xLTEtMA_fefcf39e-ecf6-42f9-bd5e-b9b896b6eb2a"
      unitRef="usd">-53014000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjEtMy0xLTEtMA_0c55ceda-8458-4b10-8c0b-36b0bc3cedb3"
      unitRef="usd">-14505000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjEtNS0xLTEtMA_6d976586-e8f5-4c2e-8e9f-25e938fff4d8"
      unitRef="usd">-72223000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjEtNy0xLTEtMA_e48c06c5-3022-4035-9937-40860a9fc1a5"
      unitRef="usd">-14423000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquityDividendsAdjustment
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjMtMS0xLTEtMA_9d0a0e5a-6590-4fd0-9d6d-88b692d0cb3a"
      unitRef="usd">4561000</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:TemporaryEquityDividendsAdjustment
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjMtMy0xLTEtMA_4234da59-7e19-4423-bc88-2393286cdb8f"
      unitRef="usd">0</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:TemporaryEquityDividendsAdjustment
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjMtNS0xLTEtMA_a3f4c5d8-0f65-4275-bde5-76a9f8d7645f"
      unitRef="usd">7643000</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:TemporaryEquityDividendsAdjustment
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjMtNy0xLTEtMA_3f317fda-9f45-404d-b907-e796a8cb4f01"
      unitRef="usd">0</us-gaap:TemporaryEquityDividendsAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjQtMS0xLTEtMA_13627e4d-98e8-421e-9f46-2901359a96dc"
      unitRef="usd">2373000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjQtMy0xLTEtMA_59e7bf88-98a7-48cd-a556-42459a9f71ea"
      unitRef="usd">0</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjQtNS0xLTEtMA_6ef6b9a8-58e1-410d-baf5-508b70b3906d"
      unitRef="usd">3770000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjQtNy0xLTEtMA_fd10eaed-5db3-44a5-985f-e51696f08eb1"
      unitRef="usd">0</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjYtMS0xLTEtMA_0fb08296-acda-43ba-9f0a-24e55c827cb0"
      unitRef="usd">-59948000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjYtMy0xLTEtMA_a9a3366a-8fef-4f9c-a894-6507d60ec014"
      unitRef="usd">-14505000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjYtNS0xLTEtMA_87f52b20-d730-449f-97bb-c860bfcc899f"
      unitRef="usd">-83636000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjYtNy0xLTEtMA_6f645f09-f53c-4639-b38a-af7ea956c6ae"
      unitRef="usd">-14423000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjktMS0xLTEtMA_651e1436-f62f-4241-9302-ca76de3e77e2"
      unitRef="usdPerShare">-2.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjktMy0xLTEtMA_15053ff6-5d62-4223-bb81-87c2a1319264"
      unitRef="usdPerShare">-0.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjktNS0xLTEtMA_e78c9129-e444-41d5-a15f-8e57b30e1523"
      unitRef="usdPerShare">-3.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMjktNy0xLTEtMA_b64b6945-fb83-4694-8b84-c77d502e98b5"
      unitRef="usdPerShare">-0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzAtMS0xLTEtMA_07a2c3a0-0635-4eb4-a5b2-70cfa04f3142"
      unitRef="usdPerShare">-2.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzAtMy0xLTEtMA_fa08ca0c-95a8-4d0d-a29d-36e740529d9d"
      unitRef="usdPerShare">-0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzAtNS0xLTEtMA_ad35b797-fffa-4141-abe4-58fc00eef9ad"
      unitRef="usdPerShare">-3.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzAtNy0xLTEtMA_cec049fe-0d71-402e-95de-e50fd04ef223"
      unitRef="usdPerShare">-0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItMS0xLTEtMA_4185176e-9475-48ed-a43c-2680052cab85"
      unitRef="shares">26786000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItMS0xLTEtMA_4c2ec322-9466-4ac3-94f2-cde4951f3f3c"
      unitRef="shares">26786000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItMy0xLTEtMA_bcd6144a-62c1-47a2-951a-3ad4dd5e2c54"
      unitRef="shares">26487000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItMy0xLTEtMA_fbea499e-36f1-4c03-a1c1-3e846734b2d1"
      unitRef="shares">26487000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItNS0xLTEtMA_3d7f67e6-6fd3-4cb1-9750-e64941e26489"
      unitRef="shares">26688000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItNS0xLTEtMA_e36bd231-6e84-46f7-a91c-0f0937cc0aee"
      unitRef="shares">26688000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItNy0xLTEtMA_68b68290-411e-489f-9fb5-ebb9492ab146"
      unitRef="shares">25838000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzItNy0xLTEtMA_f61202bc-d07e-4c76-bb9e-6eb76deb7a02"
      unitRef="shares">25838000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzUtMS0xLTEtMA_7e366031-452c-49af-8c55-4e4d2909e97f"
      unitRef="usd">-53014000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzUtMy0xLTEtMA_b3c3395a-0201-436a-be21-9107c401abb3"
      unitRef="usd">-14505000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzUtNS0xLTEtMA_dbe4c1f4-7d42-4bbd-9c0d-10959efc3c49"
      unitRef="usd">-72223000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzUtNy0xLTEtMA_dc60aac0-8aab-44af-bf25-76d26d87f7a2"
      unitRef="usd">-14423000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzYtMS0xLTEtMA_1fc150f5-87e8-4066-8999-13b609f7d327"
      unitRef="usd">3000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzYtMy0xLTEtMA_539c4009-d20c-4e1b-b87e-fe600b926a4c"
      unitRef="usd">-97000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzYtNS0xLTEtMA_6a323464-93ba-4897-88f7-bbf141ff7fd1"
      unitRef="usd">-48000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzYtNy0xLTEtMA_87491eff-a484-4607-816d-bc005b955625"
      unitRef="usd">71000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzctMS0xLTEtMA_a519fc64-5b3c-4eef-b50b-9f9410cdf21f"
      unitRef="usd">-26000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzctMy0xLTEtMA_b5fa596d-fe35-4661-b6e4-400b6bdde9fe"
      unitRef="usd">104000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzctNS0xLTEtMA_c6e7fa75-e035-418a-b2b2-69ea6002aa79"
      unitRef="usd">16000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzctNy0xLTEtMA_878dbd1e-fc90-4b2d-bd13-9dc17dea10ed"
      unitRef="usd">73000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzgtMS0xLTEtMA_46cbd76c-9454-4206-8617-55e37df25fdc"
      unitRef="usd">-53037000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzgtMy0xLTEtMA_c946ac4f-b875-47fa-aa0c-58d6d11e5227"
      unitRef="usd">-14498000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzgtNS0xLTEtMA_4302e1fd-84cc-4687-bdd3-4473d6416b58"
      unitRef="usd">-72255000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xOS9mcmFnOjdhNzJkZjg3OWM0NzRjZjdiMjM0MjFmNjRiMWJhYzcwL3RhYmxlOjE2ZjkwOGRmYmRkNjQyZDM5MGY3MmZiOTA3MGVkYTZmL3RhYmxlcmFuZ2U6MTZmOTA4ZGZiZGQ2NDJkMzkwZjcyZmI5MDcwZWRhNmZfMzgtNy0xLTEtMA_5fa8cf31-02e1-4183-bf26-71dba41d06f7"
      unitRef="usd">-14279000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="i1e357e366d8f4c42ad7a50b0355c2477_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy0xLTEtMS0w_867b7dd8-5ec7-424b-a7dc-7cb83000d9be"
      unitRef="shares">38094000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i1e357e366d8f4c42ad7a50b0355c2477_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy0zLTEtMS0w_35f00569-ed28-42a9-88ea-fb89d340778d"
      unitRef="usd">38000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i26c4eb4348de4a19a5f72c79a61f308d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy01LTEtMS0w_0e3d6d61-3cff-4e46-88fd-981e7d887f89"
      unitRef="usd">738906000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i0f613da7232e4dffaa5665383fbfb47b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy03LTEtMS0w_7256aa9a-5452-4cc8-b4b5-27f59a08d70f"
      unitRef="shares">11925000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i0f613da7232e4dffaa5665383fbfb47b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy05LTEtMS0w_3b01419c-f149-4240-ae61-3dbae52d34b1"
      unitRef="usd">-199998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2f721d7c0f874c25b09289e676fdcbac_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy0xMS0xLTEtMA_421e57fd-9eff-41b8-93a9-81a9606dd919"
      unitRef="usd">292467000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i61a6496ebf1f45f38f971210c3817264_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy0xMy0xLTEtMA_2e344695-a9a6-4073-a985-cc583fde6669"
      unitRef="usd">341000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic4897b9072b44635b238daed55d2a37a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMy0xNS0xLTEtMA_1e981603-13ef-4a64-b98e-67c028722ab2"
      unitRef="usd">831754000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i370978c8564c4fcdadb9f1ea0c93f92a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNC0xLTEtMS0w_852aa0f8-5d85-492b-86ff-2bdc1f5a1861"
      unitRef="shares">231000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i877f626f60a8448690bb833acb808b17_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNC01LTEtMS0w_2453fbdd-9d96-44fe-a0f7-522a097ae2db"
      unitRef="usd">1933000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNC0xNS0xLTEtMA_f611645e-d21a-4e8c-9306-4f9ef33b1add"
      unitRef="usd">1933000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i877f626f60a8448690bb833acb808b17_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNS01LTEtMS0w_9cf733cb-54e7-4807-88b4-3a48716cd914"
      unitRef="usd">2061000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="iebbf9ee7e6494e258504f10868840783_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNS03LTEtMS0w_dd53c07c-b84e-46d3-8ba3-7a5b562ca0c1"
      unitRef="shares">51000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNS0xNS0xLTEtMA_290c266f-41c6-46b2-ae03-704f5007f6e5"
      unitRef="usd">2061000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock
      contextRef="iecb1fedd8d124030a82eedac5b7a9e86_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNi0xMS0xLTEtMA_c76d26cc-57e0-4015-b4c0-32403b85c579"
      unitRef="usd">6934000</us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock>
    <us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfNi0xNS0xLTEtMA_e66075ce-2427-4ed9-817e-e52ff7b0acb9"
      unitRef="usd">6934000</us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i877f626f60a8448690bb833acb808b17_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfOC01LTEtMS0w_5246cef3-ff17-48ad-93d2-80eebca10100"
      unitRef="usd">6006000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfOC0xNS0xLTEtMA_74293d5b-633e-4919-adb0-e074592e14fb"
      unitRef="usd">6006000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5a48fdb953934f5bb836534b0414bbb6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfOS0xMy0xLTEtMA_0af7871c-4658-4180-8c59-689b0c75728f"
      unitRef="usd">-23000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfOS0xNS0xLTEtMA_92ed64ee-4d94-4955-ae47-3804a6164769"
      unitRef="usd">-23000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="iecb1fedd8d124030a82eedac5b7a9e86_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTAtMTEtMS0xLTA_3c82c022-02cf-4334-a418-dc0ae525add6"
      unitRef="usd">-53014000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTAtMTUtMS0xLTA_b7e38522-1afc-4bb1-94d2-dc20a0436969"
      unitRef="usd">-53014000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i22fd73312a7c407e9083c80dffa106ff_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtMS0xLTEtMA_7b8e8835-c157-4c4a-8b2f-80ff031ad2b9"
      unitRef="shares">38325000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i22fd73312a7c407e9083c80dffa106ff_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtMy0xLTEtMA_121051fd-85aa-489c-8214-4b7becdcc6ec"
      unitRef="usd">38000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic86196f7d0f9445781c8ca4767d942db_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtNS0xLTEtMA_dea35dd8-7a28-427a-9ab9-631d7353673f"
      unitRef="usd">744784000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i531b3484676346ac94040d2dc4065a31_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtNy0xLTEtMA_3d9a168a-ef84-467d-84e4-90d5689d695e"
      unitRef="shares">11976000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i531b3484676346ac94040d2dc4065a31_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtOS0xLTEtMA_d900bc42-7e95-45b3-b39c-aad0fe33d137"
      unitRef="usd">-199998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibabacd5b0f804aabada2cd5365f24498_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtMTEtMS0xLTA_9ed6a9c1-4f5c-466a-ae7d-86e62ca2e998"
      unitRef="usd">232519000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i33e718004b6a4f5aa57db218524b5773_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtMTMtMS0xLTA_1538459a-0f97-4392-80fd-c6c4f9cb864d"
      unitRef="usd">318000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjkzMmUyYWYxOTdkZDRhZWRiMjEwNjJiZTIwM2IwNGY3L3RhYmxlcmFuZ2U6OTMyZTJhZjE5N2RkNGFlZGIyMTA2MmJlMjAzYjA0ZjdfMTEtMTUtMS0xLTA_c2213e41-95a0-4783-9d65-cea575030ba0"
      unitRef="usd">777661000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ifefede64050246d08daebbf50765bb4f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy0xLTEtMS0w_d20d0ca6-5334-4043-9730-e8fec131e5d3"
      unitRef="shares">37373000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ifefede64050246d08daebbf50765bb4f_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy0zLTEtMS0w_b8096761-d045-4bc1-9f9f-f9392edcbf70"
      unitRef="usd">37000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6d5eb3c604944f028aede8e47b8499b7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy01LTEtMS0w_9a0f7dbf-eaa3-4109-b512-a344f9ec2dc0"
      unitRef="usd">720976000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ia86272a5d3aa4258b2f07ea45b88ff59_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy03LTEtMS0w_e1ea8ce4-c895-42b6-b828-77ba35c6fdd8"
      unitRef="shares">11698000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia86272a5d3aa4258b2f07ea45b88ff59_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy05LTEtMS0w_8b4ff494-e030-46ad-9fd6-aa4919f7c9ba"
      unitRef="usd">-199998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i391fe734bef14823a887a006994653ec_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy0xMS0xLTEtMA_e0c1c01f-b267-49e3-85d2-1be616f4f255"
      unitRef="usd">270787000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8bd8ce3993854b8e97b6b76978a4d09c_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy0xMy0xLTEtMA_180bbff3-7b17-4cf0-b903-fb1073d22019"
      unitRef="usd">253000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie7fbdf6185ab4c1da95b8b7ef4dd0e03_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMy0xNS0xLTEtMA_b96ea82f-f118-4d6a-893e-6b0ffbc85d6d"
      unitRef="usd">792055000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i98ccd6154a98467786e1d4ef694bc1b1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfNS0xLTEtMS0w_96b28bba-5efa-470d-8143-225e42755b5e"
      unitRef="shares">275000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i98ccd6154a98467786e1d4ef694bc1b1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfNS0zLTEtMS0w_e60d706c-9856-4dec-9f7d-0eae7696dd6c"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2dde38ab27e34c2389470563ce4f40dd_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfNS01LTEtMS0w_bd2c1ace-aa72-449d-8265-3ef0503df868"
      unitRef="usd">262000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfNS0xNS0xLTEtMA_ec8175bb-39d5-4c24-8395-e514ecc6a54c"
      unitRef="usd">263000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2dde38ab27e34c2389470563ce4f40dd_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfNi01LTEtMS0w_6cc4b426-680a-4115-b85f-3f83d4c7a019"
      unitRef="usd">9014000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ie7ebb4122db248399d55925e46f33a97_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfNi03LTEtMS0w_e562a2ba-fd1a-4cbb-b522-da4a3a84b042"
      unitRef="shares">112000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfNi0xNS0xLTEtMA_4cd07b27-60d5-4ae2-b030-6086293c8861"
      unitRef="usd">9014000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2dde38ab27e34c2389470563ce4f40dd_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfOS01LTEtMS0w_e56a7a58-6601-4bb0-a7c9-7558fdde2182"
      unitRef="usd">6880000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfOS0xNS0xLTEtMA_85116cad-46ac-407e-ad8f-9d4c8396a20e"
      unitRef="usd">6880000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i150bf8ca70274905a045d294be04c55f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTAtMTMtMS0xLTA_d9003b4c-22a3-467d-9a7e-41fe981eb926"
      unitRef="usd">7000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTAtMTUtMS0xLTA_ef72d8f9-6dbb-46b2-b918-8326aeaca74a"
      unitRef="usd">7000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i40d62c8d4357468a811e6df8b3eb306f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTEtMTEtMS0xLTA_21637352-1f1b-4431-a1d9-7726e3a12085"
      unitRef="usd">-14505000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTEtMTUtMS0xLTA_a3d92c80-66b0-4446-acbd-f3980ece0d9f"
      unitRef="usd">-14505000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i6c86001988504201bc82e067924ed6cf_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItMS0xLTEtMA_008c3426-7b46-4a81-bdf1-484e929d7d11"
      unitRef="shares">37648000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i6c86001988504201bc82e067924ed6cf_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItMy0xLTEtMA_0ea8d81b-7aef-4d3b-8abd-184934c19006"
      unitRef="usd">38000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9def4cfc83f54b30addf32c96889fca4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItNS0xLTEtMA_d3f9d0eb-4b08-40b8-bca9-78d46f4d3691"
      unitRef="usd">719104000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i90037718d9204b0384103fade0d6cc45_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItNy0xLTEtMA_32efafa9-3422-431d-9ad9-89e045f91277"
      unitRef="shares">11810000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i90037718d9204b0384103fade0d6cc45_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItOS0xLTEtMA_0881f458-ee11-47af-8de9-d1ce3a29bef1"
      unitRef="usd">-199998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8de5a03a387f4e069c2641fc24a40166_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItMTEtMS0xLTA_9eac98a8-a2f0-4a8b-8877-a3c9cce3acf5"
      unitRef="usd">256282000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i66989f5e965f4615937f019de6f617c4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItMTMtMS0xLTA_14acb93f-c72e-461a-ad24-3927e39c1d68"
      unitRef="usd">260000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3afb9956061e4743b8afadadf5214bfe_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yMi9mcmFnOjRiYzJkMDA5NzU2OTRjN2E5Y2QwOTIyMzA4ZDQ3YTAwL3RhYmxlOjAwMGFiMjJlNGNiZTRkNDViYTIzNjZiNzRjNjk2ZmRiL3RhYmxlcmFuZ2U6MDAwYWIyMmU0Y2JlNGQ0NWJhMjM2NmI3NGM2OTZmZGJfMTItMTUtMS0xLTA_1cd99fe0-3461-4331-bb5b-5893a7966bab"
      unitRef="usd">775686000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i5ccdcb106e384ddeb87a904ee03a58ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy0xLTEtMS0w_558f9251-33c9-4980-988d-ff4505784ac6"
      unitRef="shares">37755000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i5ccdcb106e384ddeb87a904ee03a58ec_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy0zLTEtMS0w_210c6858-450e-435e-854e-c66df533e94f"
      unitRef="usd">38000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i556e4d2503564d02a306ef205e40b6e7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy01LTEtMS0w_45f39890-6988-4abe-a3d3-eac63232f65c"
      unitRef="usd">721013000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ie21f15744a034c72bc7d41e0bf1b76f6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy03LTEtMS0w_91970227-b5fa-4238-9681-b5de3b480d2f"
      unitRef="shares">11831000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ie21f15744a034c72bc7d41e0bf1b76f6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy05LTEtMS0w_53443c32-8cc6-412c-93ff-4320d76047b7"
      unitRef="usd">-199998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2012813b7e7f4d55b5f995c8c974f514_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy0xMS0xLTEtMA_913ac367-4242-490c-abf5-7619a238107a"
      unitRef="usd">316155000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9da432b99fc042a88112d75776ee1823_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy0xMy0xLTEtMA_46efca2b-459c-40b6-945f-9f54d1038717"
      unitRef="usd">350000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMy0xNS0xLTEtMA_610a4dd5-910d-4e86-9939-b224eae7ec96"
      unitRef="usd">837558000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i1ae5a20475f543a7a5f9fde45d7bc4b1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNC0xLTEtMS0w_3c52b3eb-8ea9-40c3-b559-35eecacac89c"
      unitRef="shares">532000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iadf2c5122ad64d28a8d34ec6b3182521_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNC01LTEtMS0w_a7611e03-c89f-426d-99ef-586f86947cc7"
      unitRef="usd">2735000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNC0xNS0xLTEtMA_e5701fbf-19b3-4be9-b2d4-a733c44c25cd"
      unitRef="usd">2735000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iadf2c5122ad64d28a8d34ec6b3182521_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNS01LTEtMS0w_b9501279-2926-4d99-9d5e-fbde15699cd3"
      unitRef="usd">7968000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i2df0c24aa97b454985d49591cb833558_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNS03LTEtMS0w_f4f2acba-5779-490d-8a5d-9ea3dfbc2fb2"
      unitRef="shares">145000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNS0xNS0xLTEtMA_6ea41d1a-a4c8-4252-a467-4b6d3a05ba2b"
      unitRef="usd">7968000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock
      contextRef="i280b8878146141b5a2280971a470a37e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNi0xMS0xLTEtMA_938e20fe-87f0-42b1-a616-d9fc0a43c548"
      unitRef="usd">11413000</us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock>
    <us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNi0xNS0xLTEtMA_3f5c5887-1aaf-4740-b095-24c1cdafc49d"
      unitRef="usd">11413000</us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i1ae5a20475f543a7a5f9fde45d7bc4b1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNy0xLTEtMS0w_a4f24de9-c46e-4c85-90b7-b0279d38cdd6"
      unitRef="shares">38000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iadf2c5122ad64d28a8d34ec6b3182521_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNy01LTEtMS0w_12f75d12-b691-4ae2-8168-378edca6c3f4"
      unitRef="usd">2248000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfNy0xNS0xLTEtMA_cdcfcc27-4988-4a6d-9429-c25323fc0d49"
      unitRef="usd">2248000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iadf2c5122ad64d28a8d34ec6b3182521_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfOC01LTEtMS0w_2efbd46b-8db7-4929-b581-f63d67890888"
      unitRef="usd">26756000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfOC0xNS0xLTEtMA_dd8c3793-c6c7-403f-9600-e7c4f4dc2e9c"
      unitRef="usd">26756000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib088409742214844b1196f2379e1f6ab_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfOS0xMy0xLTEtMA_6e56cc44-297e-40af-bd26-72840d37a8f3"
      unitRef="usd">-32000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfOS0xNS0xLTEtMA_880ff9f5-8048-4dbe-80dd-aae5cc08b87b"
      unitRef="usd">-32000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i280b8878146141b5a2280971a470a37e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTAtMTEtMS0xLTA_69fbcc3d-ca0b-475d-96a4-55812ab95be9"
      unitRef="usd">-72223000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTAtMTUtMS0xLTA_dffb040e-c977-4318-aba7-9c64245c4ce7"
      unitRef="usd">-72223000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i22fd73312a7c407e9083c80dffa106ff_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtMS0xLTEtMA_cbaa68cc-9242-4fef-a98b-cfd2a42ff4ae"
      unitRef="shares">38325000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i22fd73312a7c407e9083c80dffa106ff_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtMy0xLTEtMA_b874a4e4-79b6-4305-a7c7-167a79fa459e"
      unitRef="usd">38000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic86196f7d0f9445781c8ca4767d942db_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtNS0xLTEtMA_9211b4bf-da03-4502-be21-9c19a0d1ea75"
      unitRef="usd">744784000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i531b3484676346ac94040d2dc4065a31_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtNy0xLTEtMA_7619b431-50c5-45c7-be51-4f841911e5d9"
      unitRef="shares">11976000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i531b3484676346ac94040d2dc4065a31_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtOS0xLTEtMA_0e1757a1-1d27-42b8-84d5-7edd8c4a0501"
      unitRef="usd">-199998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibabacd5b0f804aabada2cd5365f24498_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtMTEtMS0xLTA_19ba269b-19eb-4023-a56c-a78d59ba8495"
      unitRef="usd">232519000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i33e718004b6a4f5aa57db218524b5773_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtMTMtMS0xLTA_a6b5132e-a41e-4830-b88e-1cf5b1abc060"
      unitRef="usd">318000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc0NTFhYjY0YzIwNDQxNDZiNWYxNDdjNmFlOWU3NDZhL3RhYmxlcmFuZ2U6NzQ1MWFiNjRjMjA0NDE0NmI1ZjE0N2M2YWU5ZTc0NmFfMTEtMTUtMS0xLTA_82ceae9a-5be4-4392-a0c9-f5add16ffc81"
      unitRef="usd">777661000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ia776a591bb4d4eabab7db24eecef27c1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy0xLTEtMS0w_082e83e0-5178-4bb6-a9e2-fef5a7be2b3d"
      unitRef="shares">34752000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia776a591bb4d4eabab7db24eecef27c1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy0zLTEtMS0w_d30254df-b0ef-4525-a452-02d7b6f03c1e"
      unitRef="usd">35000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i94afe3fa9f0f4d32bdfb8049be90c448_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy01LTEtMS0w_7631307b-4c19-46e5-af69-014803756e9b"
      unitRef="usd">455159000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i3eb5bda82ad94139a7613a0c425e11c0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy03LTEtMS0w_06630ed8-3615-4f9e-b893-fbee01a3d208"
      unitRef="shares">11616000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i3eb5bda82ad94139a7613a0c425e11c0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy05LTEtMS0w_4f79b1d3-5f5a-4cd7-baa7-a1723679745c"
      unitRef="usd">-199998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibda03bb57f0b4466a93ac7974d90a217_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy0xMS0xLTEtMA_883e1d0f-dfd1-4bf3-8271-0292e6e384c6"
      unitRef="usd">271852000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5df02cc0922640229ea054a72d8338e3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy0xMy0xLTEtMA_7f114412-d523-4346-b625-cdc9cafb7d3d"
      unitRef="usd">116000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i023ad41593504141a87219e927134521_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMy0xNS0xLTEtMA_11be6491-cba4-42ca-9c61-4f90239e954b"
      unitRef="usd">527164000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib87b2fd6b0e94d1194ca2219f67dbe72_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNC0xMS0xLTEtMA_cec07249-88fc-4ac3-8479-51a229687570"
      unitRef="usd">-1147000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i952e9678a9584f75a5d6851f6e9eeb1b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNC0xNS0xLTEtMA_a7e9d216-0289-4211-ae06-c22ab63fb67d"
      unitRef="usd">-1147000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9d26bc89cf9d42679d5552c59c55cdbf_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNS0xLTEtMS0w_f8c4ed9d-c867-49f9-8955-ec5b5afacb02"
      unitRef="shares">531000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9d26bc89cf9d42679d5552c59c55cdbf_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNS0zLTEtMS0w_ee8c5916-160c-409d-ba1f-77aaef8037ed"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifd8aecbec0954165b87a5ec97df1d4e2_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNS01LTEtMS0w_185b1b1e-b5b8-4b3a-ab51-88ea2f2e9a2d"
      unitRef="usd">1576000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNS0xNS0xLTEtMA_4575ace6-02ea-431c-addc-cd51f5d24fee"
      unitRef="usd">1577000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ifd8aecbec0954165b87a5ec97df1d4e2_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNi01LTEtMS0w_eb936155-6c12-4462-be57-8406e68c9940"
      unitRef="usd">17174000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i83756e9e70664bbb9d9ce121c6030638_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNi03LTEtMS0w_9c32f7e3-3a23-455a-a184-5f081a401b73"
      unitRef="shares">194000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNi0xNS0xLTEtMA_7e9092ad-0d1a-465e-8891-9015aba0f3a8"
      unitRef="usd">17174000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i9d26bc89cf9d42679d5552c59c55cdbf_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNy0xLTEtMS0w_0a731dad-ab1b-45fd-be50-ca8b4ab26101"
      unitRef="shares">2070000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i9d26bc89cf9d42679d5552c59c55cdbf_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNy0zLTEtMS0w_ed3b424e-f550-4de7-96fd-8882ff6308fa"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ifd8aecbec0954165b87a5ec97df1d4e2_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNy01LTEtMS0w_6a13ced2-6932-4802-a5a5-b58ca81e078d"
      unitRef="usd">228022000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfNy0xNS0xLTEtMA_5fac66fe-b398-4927-9828-f6a79ee5b700"
      unitRef="usd">228024000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i9d26bc89cf9d42679d5552c59c55cdbf_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfOC0xLTEtMS0w_d5dff5d9-5d85-4398-a0f1-dbe7f163006b"
      unitRef="shares">295000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ifd8aecbec0954165b87a5ec97df1d4e2_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfOC01LTEtMS0w_fd86b890-45e0-401d-b97f-0ee8dd65db39"
      unitRef="usd">28521000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfOC0xNS0xLTEtMA_30bc9a7e-6080-4055-9f6d-0cf366e7f473"
      unitRef="usd">28521000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifd8aecbec0954165b87a5ec97df1d4e2_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfOS01LTEtMS0w_382b3414-cf58-4aef-af2f-8de6004326c6"
      unitRef="usd">23000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfOS0xNS0xLTEtMA_fa374163-2c09-495f-84d2-97cd86eb18cd"
      unitRef="usd">23000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7ee387271fcb47c8ae521d21b67a6519_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTAtMTMtMS0xLTA_9e6e0697-416a-4fd8-be0f-1a6cfa67d0fd"
      unitRef="usd">144000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTAtMTUtMS0xLTA_dcd4937c-49c9-4919-95b6-b64e81657e20"
      unitRef="usd">144000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="id84eb822e5c644a4a6c213ee899e2d4e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTEtMTEtMS0xLTA_db2a72b4-7002-45ef-8fa3-1cad03107d2e"
      unitRef="usd">-14423000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTEtMTUtMS0xLTA_578bff87-a6a3-47e8-aa34-0cc466f1cded"
      unitRef="usd">-14423000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i6c86001988504201bc82e067924ed6cf_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItMS0xLTEtMA_71a14dde-03a8-45b3-9b62-7f547c4cc93a"
      unitRef="shares">37648000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i6c86001988504201bc82e067924ed6cf_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItMy0xLTEtMA_c9365de0-2900-49e2-9b0d-8b1205b4ea85"
      unitRef="usd">38000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9def4cfc83f54b30addf32c96889fca4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItNS0xLTEtMA_4400a07d-3403-4569-aa90-ee6ba239a107"
      unitRef="usd">719104000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i90037718d9204b0384103fade0d6cc45_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItNy0xLTEtMA_4bd99289-2a4b-4727-9e10-3a0a5a697361"
      unitRef="shares">11810000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i90037718d9204b0384103fade0d6cc45_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItOS0xLTEtMA_b0ebb642-7637-4072-b44c-e55937e49747"
      unitRef="usd">-199998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8de5a03a387f4e069c2641fc24a40166_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItMTEtMS0xLTA_d274af5a-5613-48f3-aa8c-b0d344948e62"
      unitRef="usd">256282000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i66989f5e965f4615937f019de6f617c4_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItMTMtMS0xLTA_1c876bd1-aad9-42b7-b964-5afc7ce3ce46"
      unitRef="usd">260000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3afb9956061e4743b8afadadf5214bfe_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yNS9mcmFnOjFhYmZmNWVjZTE3ZDQzMzNhMzc2NzlhM2Y0NzYxM2RlL3RhYmxlOjc4NTEwN2I5MWRmOTRjOTBiMTIyMmNjODVkOWM5OTBmL3RhYmxlcmFuZ2U6Nzg1MTA3YjkxZGY5NGM5MGIxMjIyY2M4NWQ5Yzk5MGZfMTItMTUtMS0xLTA_a76d344a-7e1f-4a1b-acc4-e72a2798c3f6"
      unitRef="usd">775686000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMy0xLTEtMS0w_c42e1ca1-31f5-4bcd-acfe-6dc90ac3f80b"
      unitRef="usd">-72223000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMy0zLTEtMS0w_102b4b84-d4ea-4f7f-8e58-d0ab3907b1a8"
      unitRef="usd">-14423000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNS0xLTEtMS0w_dd71a0f3-9b8c-4043-ad4e-7a7bc22c96d1"
      unitRef="usd">3700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNS0zLTEtMS0w_6a5ed80f-3eb4-4651-ba2a-f02860c77df9"
      unitRef="usd">2604000</us-gaap:Depreciation>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNi0xLTEtMS0w_20377929-95bd-47ea-8338-d631bad56c83"
      unitRef="usd">9140000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNi0zLTEtMS0w_2e552495-b232-4aa9-9eb0-0493bb6da456"
      unitRef="usd">5307000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNy0xLTEtMS0w_2767afb0-52c2-42c3-b693-e926816767ba"
      unitRef="usd">416000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNy0zLTEtMS0w_62d5bb44-0b4c-48f4-9884-879b5954a3e8"
      unitRef="usd">1207000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ShareBasedCompensation
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfOC0xLTEtMS0w_f2d9a6d2-f9d3-4d5b-8370-848c0dec0a09"
      unitRef="usd">24881000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfOC0zLTEtMS0w_0da54035-6525-4f1d-ae5e-a267a9ed5ac9"
      unitRef="usd">21722000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfOS0xLTEtMS0w_23543c3d-bc9e-46c1-8122-1f90c2f5e83f"
      unitRef="usd">-20134000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfOS0zLTEtMS0w_a14fc96f-c68f-4f0f-8833-97e211caf404"
      unitRef="usd">-10982000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTItMS0xLTEtMA_ae61e99c-9516-431b-b1f9-867f9fa5390a"
      unitRef="usd">-908000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTItMy0xLTEtMA_7dd2bf65-f015-4ae1-a78f-dab344dd6c91"
      unitRef="usd">-421000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTQtMS0xLTEtMA_9ec6ec29-f636-4e15-897a-0c427e8344ac"
      unitRef="usd">-493000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTQtMy0xLTEtMA_06d7aa1f-29c7-4f32-a6ef-5cbd644a76ae"
      unitRef="usd">1522000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <ehth:IncreaseDecreaseInCommissionsReceivable
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTUtMS0xLTEtMA_c3af405d-7d2f-4392-8ac3-8e46340e5da9"
      unitRef="usd">35244000</ehth:IncreaseDecreaseInCommissionsReceivable>
    <ehth:IncreaseDecreaseInCommissionsReceivable
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTUtMy0xLTEtMA_e5f6a4ca-ec62-4f48-866b-cf36723a9498"
      unitRef="usd">-16772000</ehth:IncreaseDecreaseInCommissionsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTYtMS0xLTEtMA_c66e9d01-e088-4d45-88c6-75d87f6323f5"
      unitRef="usd">20790000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTYtMy0xLTEtMA_8cc85d80-711b-4625-8ae0-4c2c05eada08"
      unitRef="usd">9398000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTctMS0xLTEtMA_138315ae-38e4-46a0-9918-02710792394b"
      unitRef="usd">-26913000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTctMy0xLTEtMA_7474cb1f-b3e8-4ead-a08c-7778f6e07cec"
      unitRef="usd">-3196000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTgtMS0xLTEtMA_72b667b2-6e67-45b5-b514-2d35c60a124e"
      unitRef="usd">-118000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTgtMy0xLTEtMA_303643d6-2e52-40d6-8df0-bfcf92f9272f"
      unitRef="usd">-7438000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <ehth:IncreaseDecreaseInAccruedMarketingExpenses
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTktMS0xLTEtMA_d757be99-2f30-4f74-830e-8a4b87e68466"
      unitRef="usd">-6525000</ehth:IncreaseDecreaseInAccruedMarketingExpenses>
    <ehth:IncreaseDecreaseInAccruedMarketingExpenses
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMTktMy0xLTEtMA_560ab3d3-8690-428b-b927-41f7c22b42c2"
      unitRef="usd">-5449000</ehth:IncreaseDecreaseInAccruedMarketingExpenses>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjAtMS0xLTEtMA_39d89aef-6694-470c-9a3f-3ec2eae477af"
      unitRef="usd">10240000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjAtMy0xLTEtMA_b8ce12f7-6e01-458c-8456-5f55d5407dae"
      unitRef="usd">23901000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjEtMS0xLTEtMA_2a6d6ade-f0b2-4b31-944e-ea9525851b9d"
      unitRef="usd">1360000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjEtMy0xLTEtMA_cd64dc47-5bd5-444f-aced-a9ca3f61cb1e"
      unitRef="usd">3059000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjItMS0xLTEtMA_9fa5ca08-7023-4555-9450-5e113f5b32bd"
      unitRef="usd">-60321000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjItMy0xLTEtMA_5a3c2257-39c9-4d2d-b4c5-10bd7c4b346c"
      unitRef="usd">-10959000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjQtMS0xLTEtMA_f2d589fd-35aa-48b5-b9b9-96579a7ac504"
      unitRef="usd">12589000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjQtMy0xLTEtMA_b610fb2d-be63-4a6b-bc70-fbfd9f9df8b7"
      unitRef="usd">12082000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjUtMS0xLTEtMA_dc5eb367-0226-4dcd-a007-a5cfef125b57"
      unitRef="usd">3554000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjUtMy0xLTEtMA_ca0c6f88-b0e1-4015-8fb2-edd34cac0c61"
      unitRef="usd">6454000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjYtMS0xLTEtMA_26b13fde-dd19-4d63-a7df-f332da29b3ce"
      unitRef="usd">88967000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjYtMy0xLTEtMA_388cf309-db17-44a9-9536-9367b7b942d2"
      unitRef="usd">180505000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjctMS0xLTEtMA_fc00a161-fcb3-4ec4-91c0-0b75e3fc343c"
      unitRef="usd">68288000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMjctMy0xLTEtMA_95d05db4-10ec-41b0-a8c4-6f91defc92cb"
      unitRef="usd">70750000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzAtMS0xLTEtMA_f3ca7ee2-1565-447c-b80b-34e509272f92"
      unitRef="usd">-36822000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzAtMy0xLTEtMA_e3f43051-a4e3-44ca-9a83-10d2db878542"
      unitRef="usd">-128291000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzItMS0xLTEtMA_c0cf61b7-2919-4359-8edc-715a1a52dd7b"
      unitRef="usd">214025000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzItMy0xLTEtMA_27ff6ffa-1710-45cd-98e7-09ee105b0a12"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzMtMS0xLTEtMA_334dee4f-83a3-452c-a7d1-2f3cc4ebd573"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzMtMy0xLTEtMA_30be7d91-47b6-47a4-b8e6-d70730d53a0f"
      unitRef="usd">228024000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzQtMS0xLTEtMA_8250774e-c8af-4a05-bacd-56c858264a8e"
      unitRef="usd">4983000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzQtMy0xLTEtMA_9069d909-fc9a-4508-93f3-59a7393d6570"
      unitRef="usd">1577000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzUtMS0xLTEtMA_84d4ce77-69ab-47a1-b1de-78a43bd62db2"
      unitRef="usd">-7968000</us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards>
    <us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzUtMy0xLTEtMA_61493c57-9b44-4ea2-9691-e99634d00287"
      unitRef="usd">-17174000</us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzktMS0xLTEtMA_f39e7a2f-a318-4726-a571-e3c1b53036e4"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfMzktMy0xLTEtMA_b5d1077e-e3a2-40d0-87c5-d26c8848299f"
      unitRef="usd">8751000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDAtMS0xLTEtMA_0bb451b9-91b6-4c0d-82a4-7ad0ecf4494e"
      unitRef="usd">126000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDAtMy0xLTEtMA_4727ce92-4413-4ef4-9ad8-00c434d3843e"
      unitRef="usd">121000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDEtMS0xLTEtMA_f37f5961-6184-4513-a9bb-fe72542e3d11"
      unitRef="usd">210914000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDEtMy0xLTEtMA_7e59c48f-6fb8-4148-a91e-9a7ad9c03cea"
      unitRef="usd">203555000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDItMS0xLTEtMA_497d5b29-2a5b-405b-9eef-33e8cac9d007"
      unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDItMy0xLTEtMA_4047117b-9bac-47ba-bce9-908a92329139"
      unitRef="usd">62000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDMtMS0xLTEtMA_ea26f4b4-742f-43ac-b327-ed40b5453c07"
      unitRef="usd">113771000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDMtMy0xLTEtMA_38404e58-4dd8-4125-a772-550911d046b5"
      unitRef="usd">64367000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDQtMS0xLTEtMA_5ff4354b-0eb9-4361-9ac5-6fecddcf46fa"
      unitRef="usd">47113000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i023ad41593504141a87219e927134521_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDQtMy0xLTEtMA_6160fcf2-79ac-4712-808c-266aafeaa606"
      unitRef="usd">26820000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDUtMS0xLTEtMA_7bdd48c8-d7d3-481f-8299-23638aa88ebd"
      unitRef="usd">160884000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3afb9956061e4743b8afadadf5214bfe_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8yOC9mcmFnOmQ3YWQ5NzBhZGIyMTRlMWE4NjhmNjZhNjhjMTkyZGZiL3RhYmxlOmIyODg0NDQ1NjVlMzRlYTg5NmZkMDRjNzMwZWFmYTQ0L3RhYmxlcmFuZ2U6YjI4ODQ0NDU2NWUzNGVhODk2ZmQwNGM3MzBlYWZhNDRfNDUtMy0xLTEtMA_136a0ee7-859d-4f18-ba2e-c6b5bf7c6899"
      unitRef="usd">91187000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfODk2Mw_bec94f25-5fea-446e-8895-a02dd4e70c53">Summary of Business and Significant Accounting Policies&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;eHealth, Inc. (the &#x201c;Company,&#x201d; &#x201c;eHealth,&#x201d; &#x201c;we&#x201d; or &#x201c;us&#x201d;) is a leading health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Our mission is to connect every person with the highest quality, most affordable health insurance and Medicare plans for their life circumstances. Our platform integrates proprietary and third-party developed educational content regarding health insurance plans with decision support tools to aid consumers in what has traditionally been a confusing and opaque health insurance purchasing process, and to help them obtain the health insurance products that meet their individual health and economic needs. Our omnichannel consumer engagement platform enables consumers to use our services online, through interactive chat, or by telephone with a licensed insurance agent. We have created a marketplace that offers consumers a broad choice of insurance products that includes thousands of Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business and other ancillary health insurance products from over 200 health insurance carriers across all fifty states and the District of Columbia.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Basis of Presentation &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The accompanying condensed consolidated balance sheet as of September 30, 2021, the condensed consolidated statements of comprehensive loss and stockholders&#x2019; equity for the three and nine months ended September 30, 2021 and 2020, and the condensed consolidated statements of cash flows for the nine months ended September 30, 2021 and 2020 are unaudited. The condensed consolidated balance sheet data as of December 31, 2020 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission on February 26, 2021 and amended on April 29, 2021. The accompanying financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and reflect all normal recurring adjustments that are necessary to present fairly the results for the interim periods presented. The condensed consolidated financial statements include the accounts of eHealth, Inc. and its direct and indirect wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with those rules and regulations. Certain prior period amounts have been reclassified to conform with our current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020 and include all adjustments necessary for the fair presentation of our financial position as of September 30, 2021 and December 31, 2020, and our results of operations for the periods presented. The results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for any subsequent period or for the year ending December 31, 2021 and therefore should not be relied upon as an indicator of future results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the issuance of our consolidated financial statements for the year ended December 31, 2020, we identified certain errors, including a $3.0&#160;million under-recognition of stock-based compensation expense and a $1.5&#160;million over-recognition of licensing costs for the year ended December 31, 2020. We adjusted for these items in the first quarter of 2021 and the adjustments reduced our net loss by approximately $1.5&#160;million, or $0.06 per basic and diluted share in our Condensed Consolidated Statement of Comprehensive Loss for the three months ended March 31, 2021. These items also reduced our net loss by approximately $1.5&#160;million, or $0.06 per basic and diluted share, on our Condensed Consolidated Statement of Comprehensive Loss for the nine months ended September 30, 2021. We evaluated the effects of these out-of-period adjustments, both qualitatively and quantitatively, and concluded that the errors and the correction thereof were immaterial both individually and in the aggregate to the current reporting period and the periods in which they originated, including quarterly reporting.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies, Estimates and Judgments &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates, including those related to, but not limited to, the useful lives of intangible assets, fair value of investments, recoverability of intangible assets, the commissions we expect to collect for each approved member cohort, valuation allowance for deferred income taxes, provision (benefit) for income taxes and the assumptions used in determining stock-based compensation. We base our estimates of the carrying value of certain assets and liabilities on historical experience and on various other assumptions that we believe to be reasonable. Actual results may differ from these estimates. There have been no material changes to our significant accounting policies discussed in our Annual Report on Form 10-K for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Seasonality &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Open enrollment periods drive the seasonality of our business. A greater number of our Medicare-related health insurance plans are sold in our fourth quarter during the Medicare annual enrollment period when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, our Medicare plan-related commission revenue is highest in our fourth quarter. Our Medicare plan-related commission revenue is also elevated in the first quarter compared to the second and third quarters as a result of the reintroduction of the Medicare Advantage open enrollment period in the first quarter of 2019. Any changes to or adoption of open enrollment or special enrollment periods may change the seasonality of our business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The majority of our individual and family health insurance plans is sold in the fourth quarter during the annual open enrollment period as defined under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act. In the states where the Federally Facilitated marketplace operates as the state health insurance exchange, individuals and families generally are not able to purchase individual and family health insurance outside of the annual enrollment period, unless they qualify for a special enrollment period as a result of certain qualifying events, such as losing employer-sponsored health insurance or moving to another state. Extended open enrollment or special enrollment periods may change the seasonality of our individual and family health insurance business.  For example, the COVID-related special enrollment period which ended on August 15, 2021 has caused increased commission revenue from the sale of individual and family health insurance plans outside of the open enrollment period. In addition, we may experience changes in seasonality due to the extension of the 2022 open enrollment period to January 15, 2022 for most states.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Income Taxes (Topic 740) &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2019, the Financial Accounting Standard Board (&#x201c;FASB&#x201d;) issued ASU No. 2019-12, Income Tax, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, which aims to simplify the accounting for income taxes. We adopted this guidance in the first quarter of 2021, and it did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; In October 2020, the FASB issued ASU No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;. ASU 2020-10 is intended to facilitate codification updates for technical corrections, such as conforming amendments, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements. It contains amendments that improve the consistency of the codification by including all disclosure guidance in the appropriate disclosure section and other updates that vary in nature. We adopted this guidance in the first quarter of 2021 with no material impact on our condensed consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Debt with Conversion and Other Options (Topic 470) and Contracts in Entity's Own Equity (Topic 815)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; &#x2013; In June 2020, the FASB issued ASU No. 2020-06 to simplify the accounting for convertible instruments and improve the usefulness and relevance of information regarding convertible instruments. This ASU reduces the number of accounting models for converting debt instruments and convertible preferred stock. ASU No. 2020-06 is effective for us in 2022, with early adoption permitted. We early adopted this guidance in the first quarter of 2021, and it did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <ehth:DescriptionOfBusinessPolicyPolicyTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfODk3MA_584f6af1-cd07-4820-a7b8-791f27eece2f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;eHealth, Inc. (the &#x201c;Company,&#x201d; &#x201c;eHealth,&#x201d; &#x201c;we&#x201d; or &#x201c;us&#x201d;) is a leading health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Our mission is to connect every person with the highest quality, most affordable health insurance and Medicare plans for their life circumstances. Our platform integrates proprietary and third-party developed educational content regarding health insurance plans with decision support tools to aid consumers in what has traditionally been a confusing and opaque health insurance purchasing process, and to help them obtain the health insurance products that meet their individual health and economic needs. Our omnichannel consumer engagement platform enables consumers to use our services online, through interactive chat, or by telephone with a licensed insurance agent. We have created a marketplace that offers consumers a broad choice of insurance products that includes thousands of Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business and other ancillary health insurance products from over 200 health insurance carriers across all fifty states and the District of Columbia.&lt;/span&gt;</ehth:DescriptionOfBusinessPolicyPolicyTextBlock>
    <ehth:NumberOfHealthInsuranceCarriers
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfMTIyMg_8860382b-d9f0-455f-ae40-2d2ce6212812"
      unitRef="insurance_carrier">200</ehth:NumberOfHealthInsuranceCarriers>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfMTI2Mg_efc97489-1d8c-4682-be80-3b2e3ab7bd0a"
      unitRef="state">50</us-gaap:NumberOfStatesInWhichEntityOperates>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfODk2MA_34eb88fd-723b-4e04-a843-c7c611523f37">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Basis of Presentation &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The accompanying condensed consolidated balance sheet as of September 30, 2021, the condensed consolidated statements of comprehensive loss and stockholders&#x2019; equity for the three and nine months ended September 30, 2021 and 2020, and the condensed consolidated statements of cash flows for the nine months ended September 30, 2021 and 2020 are unaudited. The condensed consolidated balance sheet data as of December 31, 2020 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission on February 26, 2021 and amended on April 29, 2021. The accompanying financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and reflect all normal recurring adjustments that are necessary to present fairly the results for the interim periods presented. The condensed consolidated financial statements include the accounts of eHealth, Inc. and its direct and indirect wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with those rules and regulations. Certain prior period amounts have been reclassified to conform with our current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020 and include all adjustments necessary for the fair presentation of our financial position as of September 30, 2021 and December 31, 2020, and our results of operations for the periods presented. The results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for any subsequent period or for the year ending December 31, 2021 and therefore should not be relied upon as an indicator of future results.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the issuance of our consolidated financial statements for the year ended December 31, 2020, we identified certain errors, including a $3.0&#160;million under-recognition of stock-based compensation expense and a $1.5&#160;million over-recognition of licensing costs for the year ended December 31, 2020. We adjusted for these items in the first quarter of 2021 and the adjustments reduced our net loss by approximately $1.5&#160;million, or $0.06 per basic and diluted share in our Condensed Consolidated Statement of Comprehensive Loss for the three months ended March 31, 2021. These items also reduced our net loss by approximately $1.5&#160;million, or $0.06 per basic and diluted share, on our Condensed Consolidated Statement of Comprehensive Loss for the nine months ended September 30, 2021. We evaluated the effects of these out-of-period adjustments, both qualitatively and quantitatively, and concluded that the errors and the correction thereof were immaterial both individually and in the aggregate to the current reporting period and the periods in which they originated, including quarterly reporting.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i53205ea49e0b458292f697b7a5c56a93_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfMzcwMg_d0b16cda-bca3-4813-84ec-e0ac6914d880"
      unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:CostOfRevenue
      contextRef="i373a791d3cae4ac8ac03bd94922adf11_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfMzc2NQ_a81f6694-3ce3-4632-af1c-a96f8839fdba"
      unitRef="usd">1500000</us-gaap:CostOfRevenue>
    <us-gaap:NetIncomeLoss
      contextRef="i7f1209faee954d01bec8ebffed7361b4_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfMzk1Nw_789f17f8-eff4-45d7-b7a0-54f5cb54c0e1"
      unitRef="usd">-1500000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7f1209faee954d01bec8ebffed7361b4_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfMzk2NA_07d3d055-d22d-408c-bdbc-e232fe987246"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7f1209faee954d01bec8ebffed7361b4_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfMzk2NA_cdfcc80d-ce29-4363-96e8-321111f0b478"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="i0659c47707f64baa904993c672f45c27_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfNDE2NA_8d81e599-363c-4aa0-994b-6a1f2d2df6ab"
      unitRef="usd">-1500000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0659c47707f64baa904993c672f45c27_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfNDE3MQ_9cbbc716-14eb-4d99-8fe7-0c406d6ca590"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0659c47707f64baa904993c672f45c27_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfNDE3MQ_c75718f0-eb7e-43a2-b2b1-ba77baf2a664"
      unitRef="usdPerShare">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:UseOfEstimates
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfODk3MQ_bd369a30-0d62-4f9c-8d91-0bffe239e56f">Significant Accounting Policies, Estimates and Judgments &#x2013; The preparation of condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates, including those related to, but not limited to, the useful lives of intangible assets, fair value of investments, recoverability of intangible assets, the commissions we expect to collect for each approved member cohort, valuation allowance for deferred income taxes, provision (benefit) for income taxes and the assumptions used in determining stock-based compensation. We base our estimates of the carrying value of certain assets and liabilities on historical experience and on various other assumptions that we believe to be reasonable. Actual results may differ from these estimates.</us-gaap:UseOfEstimates>
    <ehth:SeasonalityPolicyPolicyTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfODk3Mg_ec63f06f-f489-42d5-af67-ecfdf270b4c1">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Seasonality &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Open enrollment periods drive the seasonality of our business. A greater number of our Medicare-related health insurance plans are sold in our fourth quarter during the Medicare annual enrollment period when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, our Medicare plan-related commission revenue is highest in our fourth quarter. Our Medicare plan-related commission revenue is also elevated in the first quarter compared to the second and third quarters as a result of the reintroduction of the Medicare Advantage open enrollment period in the first quarter of 2019. Any changes to or adoption of open enrollment or special enrollment periods may change the seasonality of our business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The majority of our individual and family health insurance plans is sold in the fourth quarter during the annual open enrollment period as defined under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act. In the states where the Federally Facilitated marketplace operates as the state health insurance exchange, individuals and families generally are not able to purchase individual and family health insurance outside of the annual enrollment period, unless they qualify for a special enrollment period as a result of certain qualifying events, such as losing employer-sponsored health insurance or moving to another state. Extended open enrollment or special enrollment periods may change the seasonality of our individual and family health insurance business.  For example, the COVID-related special enrollment period which ended on August 15, 2021 has caused increased commission revenue from the sale of individual and family health insurance plans outside of the open enrollment period. In addition, we may experience changes in seasonality due to the extension of the 2022 open enrollment period to January 15, 2022 for most states.&lt;/span&gt;&lt;/div&gt;</ehth:SeasonalityPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNC9mcmFnOmVmZTE1YzYxMTYwMTRmMGFhYmI0YzU2NjBmNjM5ODU3L3RleHRyZWdpb246ZWZlMTVjNjExNjAxNGYwYWFiYjRjNTY2MGY2Mzk4NTdfODk2Ng_68fde2a5-faa0-4425-805d-da66efd53046">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Income Taxes (Topic 740) &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2019, the Financial Accounting Standard Board (&#x201c;FASB&#x201d;) issued ASU No. 2019-12, Income Tax, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, which aims to simplify the accounting for income taxes. We adopted this guidance in the first quarter of 2021, and it did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; In October 2020, the FASB issued ASU No. 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;. ASU 2020-10 is intended to facilitate codification updates for technical corrections, such as conforming amendments, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements. It contains amendments that improve the consistency of the codification by including all disclosure guidance in the appropriate disclosure section and other updates that vary in nature. We adopted this guidance in the first quarter of 2021 with no material impact on our condensed consolidated financial statements and disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Debt with Conversion and Other Options (Topic 470) and Contracts in Entity's Own Equity (Topic 815)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt; &#x2013; In June 2020, the FASB issued ASU No. 2020-06 to simplify the accounting for convertible instruments and improve the usefulness and relevance of information regarding convertible instruments. This ASU reduces the number of accounting models for converting debt instruments and convertible preferred stock. ASU No. 2020-06 is effective for us in 2022, with early adoption permitted. We early adopted this guidance in the first quarter of 2021, and it did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjQ5Mw_22090a29-915a-435c-8179-915e8f5b9ac3">Revenue&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below depicts the disaggregation of revenue by product and is consistent with how we evaluate our financial performance (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Supplement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Part D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Individual and Family &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-Qualified Health Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Qualified Health Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Individual and Family&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ancillary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dental&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Ancillary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Small Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Commission Bonus and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sponsorship and Advertising Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Other Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;We define our Individual and Family plan offerings as major medical individual and family health insurance plans, which does not include Medicare-related, small business or ancillary plans. Individual and family health insurance plans include both qualified and non-qualified plans. Qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are offered through the government-run health insurance exchange in the relevant jurisdiction. Non-qualified health plans are Individual and Family plans that meet the requirements of the Affordable Care Act and are not offered through the exchange in the relevant jurisdiction. Individuals that purchase non-qualified health plans cannot receive a subsidy in connection with the purchase of those plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Commission revenue by segment is presented in the table below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Members Approved During the Period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Commission Revenue from Members Approved in Prior Periods&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Medicare Segment Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Individual, Family and Small Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Members Approved During the Period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Renewals of Small Business Members During the Period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Commission Revenue from Members Approved in Prior Periods &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total IFP/SMB Segment Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Commission Revenue from Members Approved During the Period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Renewals of Small Business Members During the Period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Net Commission Revenue from Members Approved in Prior Periods &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;These amounts include commission bonus revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;These amounts reflect our revised estimates of cash collections for certain members approved prior to the relevant reporting period that are recognized as adjustments to revenue within the relevant reporting period. The net adjustment revenue includes both increases in revenue for certain prior period cohorts as well as reductions in revenue for certain prior period cohorts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, beginning in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;The impacts of total net commission revenue from members approved in prior periods were $0.37 and $0.62 per basic and diluted share for the three months ended September 30, 2021 and 2020, respectively. The impacts of total net commission revenue from members approved in prior periods were $0.65 and $1.14 per basic and diluted share, for the nine months ended September 30, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;The total reductions to revenue from members approved in prior periods were $3.2 million and $3.7 million for the three months ended September 30, 2021 and 2020, respectively, and $22.6 million and $5.3 million for the nine months ended September 30, 2021 and 2020, respectively. These reductions to revenue primarily related to the Medicare segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjQ5NA_e73c9a89-215b-4778-b1e3-c3b06188a778">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below depicts the disaggregation of revenue by product and is consistent with how we evaluate our financial performance (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Supplement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare Part D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Individual and Family &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-Qualified Health Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Qualified Health Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Individual and Family&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ancillary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dental&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Ancillary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Small Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Commission Bonus and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sponsorship and Advertising Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Other Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:11.65pt"&gt;We define our Individual and Family plan offerings as major medical individual and family health insurance plans, which does not include Medicare-related, small business or ancillary plans. Individual and family health insurance plans include both qualified and non-qualified plans. Qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are offered through the government-run health insurance exchange in the relevant jurisdiction. Non-qualified health plans are Individual and Family plans that meet the requirements of the Affordable Care Act and are not offered through the exchange in the relevant jurisdiction. Individuals that purchase non-qualified health plans cannot receive a subsidy in connection with the purchase of those plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Commission revenue by segment is presented in the table below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.262%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Members Approved During the Period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Commission Revenue from Members Approved in Prior Periods&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Medicare Segment Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Individual, Family and Small Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Members Approved During the Period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Renewals of Small Business Members During the Period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Commission Revenue from Members Approved in Prior Periods &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total IFP/SMB Segment Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Commission Revenue from Members Approved During the Period&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission Revenue from Renewals of Small Business Members During the Period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Net Commission Revenue from Members Approved in Prior Periods &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Commission Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;These amounts include commission bonus revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;These amounts reflect our revised estimates of cash collections for certain members approved prior to the relevant reporting period that are recognized as adjustments to revenue within the relevant reporting period. The net adjustment revenue includes both increases in revenue for certain prior period cohorts as well as reductions in revenue for certain prior period cohorts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, beginning in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;The impacts of total net commission revenue from members approved in prior periods were $0.37 and $0.62 per basic and diluted share for the three months ended September 30, 2021 and 2020, respectively. The impacts of total net commission revenue from members approved in prior periods were $0.65 and $1.14 per basic and diluted share, for the nine months ended September 30, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;The total reductions to revenue from members approved in prior periods were $3.2 million and $3.7 million for the three months ended September 30, 2021 and 2020, respectively, and $22.6 million and $5.3 million for the nine months ended September 30, 2021 and 2020, respectively. These reductions to revenue primarily related to the Medicare segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8d44d8be1ff4d9ba8d66ea2c112a2de_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMy0xLTEtMS0w_69978ede-baf6-4172-a4f6-cfa472250082"
      unitRef="usd">36557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8e13b0d1c22425ca8ca7bebe6811adf_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMy0zLTEtMS0w_5713fdfd-6f14-4f21-8bb7-fc07f0233581"
      unitRef="usd">41901000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1cd73075ac5746c1ac3c693924ea8745_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMy01LTEtMS0w_0a9b2bde-8b62-4785-9b8f-b87da358c462"
      unitRef="usd">209224000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79a3575bc66645c4873d69cd381d6522_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMy03LTEtMS0w_a8d2c716-03c6-48f4-8789-0b439a78420d"
      unitRef="usd">168834000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb69f48720624bd2ba3990d45781b58b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNC0xLTEtMS0w_0016e0c9-474a-4f21-8c18-9db79ddbf2ec"
      unitRef="usd">3214000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90eeed6c273749e88dabae5495cf6c9d_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNC0zLTEtMS0w_acaa8c57-4194-413a-8122-53ef4e677eef"
      unitRef="usd">7321000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e3aa4585c2a420aac2dbbcd2a763c5e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNC01LTEtMS0w_d6df5dc7-bbf2-41a2-a270-044969616a7a"
      unitRef="usd">15357000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if58e722068de4216be2a26dc1df27ada_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNC03LTEtMS0w_b1b3f04a-de88-4083-ad88-054567b06521"
      unitRef="usd">32384000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifab10f50711a46a8b9bdcbee99dfed11_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNS0xLTEtMS0w_5747b3f8-b92a-448a-9093-f4d5ad3553b2"
      unitRef="usd">1338000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a03b84610f148308bee0aedeeeeded4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNS0zLTEtMS0w_dc6f34cf-0d62-44d8-baf0-bcf4c87204e0"
      unitRef="usd">329000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if432dd7d445c47b68e3465e50a0cce99_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNS01LTEtMS0w_7f65b91f-8443-4e7d-a451-3c57d7458c46"
      unitRef="usd">-2953000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae4bbc252a254aca8e08652db1ae75f4_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNS03LTEtMS0w_b8cf0b7d-03b9-41b1-8dd7-fdc2cd31328c"
      unitRef="usd">7148000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bf2b0808d5d4b95ad14fb56678b89df_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNi0xLTEtMS0w_cfc3524c-d512-46d7-9296-8cafd3d7ab2f"
      unitRef="usd">41109000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64b14a1e7cf747b5bdd0af47f7efa4bf_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNi0zLTEtMS0w_fac2a22b-2e6d-4f12-8988-4ee1887113d3"
      unitRef="usd">49551000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i288de29276794a4b98de7093838e980b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNi01LTEtMS0w_73a465bd-eb6f-47eb-9f29-5cd2d24d7d51"
      unitRef="usd">221628000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b2f0942dcca4e079dc5dd9bcd2a7f2b_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfNi03LTEtMS0w_7b2e1df5-c5cd-4c2e-aef9-c64d9630faef"
      unitRef="usd">208366000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07e75d14864c4f86befd75db7d14b2be_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOC0xLTEtMS0w_3a4d1c04-4e03-4cf6-90a1-d4486e3e649e"
      unitRef="usd">5909000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36c47733c755462195bb2209eb595273_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOC0zLTEtMS0w_7edee2b7-cc76-44fd-8786-34cd34d18083"
      unitRef="usd">9915000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fa14ebfc4094081974d71ef4e246a62_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOC01LTEtMS0w_4177eeff-8bbc-424c-997d-733fa9594ddb"
      unitRef="usd">20352000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48aa029a268b4ec2b76e22c7b495a170_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOC03LTEtMS0w_599bfe07-5a45-4831-8fe9-ec99558a158a"
      unitRef="usd">12585000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i851cd6431ca8482eb6cf6148f01f3118_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOS0xLTEtMS0w_a5c7b901-ffd6-446e-abf1-79d8ee1c30aa"
      unitRef="usd">2266000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc8fa77be2f04de88bb71b5c8d8a8e8c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOS0zLTEtMS0w_665c2c11-2fb3-443a-8d81-fb83906f6e9a"
      unitRef="usd">1466000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1430539e8454dec87d06cc7d906f6c3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOS01LTEtMS0w_e06ea226-fdcd-4b3a-91d5-7d25ce0ab30e"
      unitRef="usd">7204000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7cfe3cb32fd14c69820a09d8cf0a7ec5_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfOS03LTEtMS0w_4005cf0a-c797-483b-91d0-2561eace2fec"
      unitRef="usd">3559000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i865072ee20694d9a916202d1277bb59a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTAtMS0xLTEtMA_7f16393d-b70d-43d3-9b49-c92e930dbb3b"
      unitRef="usd">8175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8d71827a12044b98aca58d93cc8b447_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTAtMy0xLTEtMA_22944c37-ab10-4578-8d8d-a255fae74a1a"
      unitRef="usd">11381000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12b7def10b7c4144a3529c00d81371ea_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTAtNS0xLTEtMA_8ae6f534-e4f2-458e-822c-99e28ef29827"
      unitRef="usd">27556000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic140144201d545bb89a26e563ea54efc_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTAtNy0xLTEtMA_4fcc5d26-3ec1-4b24-9ab3-2fb05f79c4ec"
      unitRef="usd">16144000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibccfac65e89e46b0a4779b6a9f5a1595_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTItMS0xLTEtMA_d7ee8e11-a523-44f8-b727-37a13b0f31dc"
      unitRef="usd">1370000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb2e1ef01a8a49be95e5633382fff52e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTItMy0xLTEtMA_4a865147-1bfe-47bc-96e1-a9ac128e79bb"
      unitRef="usd">2438000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb08ebace2994766abfc06f5a7ca01e0_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTItNS0xLTEtMA_c3c8a889-21c7-4cf5-8d3a-c376a1a428f6"
      unitRef="usd">4639000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib04f6ab9257d4c3c82133b0ebf9ec119_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTItNy0xLTEtMA_4898958f-f16b-469d-8fff-5fd53c5970ce"
      unitRef="usd">6724000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b84638a44674aae820620c1ad281b03_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTMtMS0xLTEtMA_0954bd5b-6f31-4e62-8252-4646937e4c1b"
      unitRef="usd">3938000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f329a84a77c4b40a18c88baac1fa79e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTMtMy0xLTEtMA_41f50381-ee9c-4ea9-b620-262e4da72614"
      unitRef="usd">4452000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib265edd981cb4329b96667e22174e69a_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTMtNS0xLTEtMA_7dd0e204-d3d5-4e20-9f2a-fbad32f71bc5"
      unitRef="usd">9326000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9226a70837c94f539c18e81cea08edff_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTMtNy0xLTEtMA_4a7bb788-9a69-4664-bdd1-35006d0f56ce"
      unitRef="usd">5791000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if35afead23854a98ba1ae85afef88254_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTQtMS0xLTEtMA_aaeb666d-a816-4600-8a1b-39c79df0a32a"
      unitRef="usd">642000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if334ca37e8184c3bb05e9970b42f9537_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTQtMy0xLTEtMA_19db8b63-4dff-46b7-8623-4089b5f6d896"
      unitRef="usd">1798000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia15e62c7d2ac4d8783c355c63461fb13_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTQtNS0xLTEtMA_05ec7b6a-6442-4101-934b-576ada008d87"
      unitRef="usd">1781000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9ba1db851374ea0bdc62b19987a5f2d_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTQtNy0xLTEtMA_90a64d91-1863-4116-9b30-7edc1e531f57"
      unitRef="usd">2228000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5794689700d84cc19cd5b25cb7e1a896_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTUtMS0xLTEtMA_e33e1509-efa6-4bb7-b304-6757451e4d25"
      unitRef="usd">845000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75a8cb208fd74edb96d789382c6d519f_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTUtMy0xLTEtMA_08789488-0c8b-45f5-8f6c-ab5024ed7279"
      unitRef="usd">847000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f0cf3d15ecd4e02aba71ef693d79134_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTUtNS0xLTEtMA_da160765-92d6-447c-94b9-8de4e37030f7"
      unitRef="usd">1901000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4e89f067c984a58aee8388d3f4e26f6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTUtNy0xLTEtMA_db05a3d0-7946-42dc-9923-313756ed198f"
      unitRef="usd">2693000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie938c6c5a4b344bb9a1e717ea937a556_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTYtMS0xLTEtMA_e6bf78dc-3325-491f-968e-3ff1376d5bdf"
      unitRef="usd">6795000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0717ef9e88ca45c68fd977740d8d5fbb_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTYtMy0xLTEtMA_10fa469e-1267-4861-90e1-544ea14a66f0"
      unitRef="usd">9535000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if45ec5bca96d4cffba4e82a71f5a9909_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTYtNS0xLTEtMA_6647c462-1a2b-4eb0-bef9-87005b10d455"
      unitRef="usd">17647000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic33a9cc99b61453181708c8ac5a2aa97_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTYtNy0xLTEtMA_a85ce5d7-89ad-4e02-ab15-2253dafb14ae"
      unitRef="usd">17436000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77dc76304d9f4dc794d414ab98cc2411_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTctMS0xLTEtMA_a9ce4292-59a2-4b50-afcc-f3e2264da58a"
      unitRef="usd">2190000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibdb8cd80cf0c4da9853fa98df8f7fd37_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTctMy0xLTEtMA_b66ffa33-7c89-4701-b153-b1636c99be30"
      unitRef="usd">1723000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i411334780a0440f9b3aa7d1cd64fd42e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTctNS0xLTEtMA_276b42d3-dc94-435b-88b3-e948a2352cc7"
      unitRef="usd">7703000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id66e7ebb7d4e493789cd440c77019454_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTctNy0xLTEtMA_4de3b522-3646-4529-866c-279597886d6c"
      unitRef="usd">6975000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4787e3cd9c774e0486d6813affce59e3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTgtMS0xLTEtMA_1243ee7e-a9a4-4985-907f-0efeda9c5731"
      unitRef="usd">922000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e50511dfd494fd4b8f5a928e5ead478_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTgtMy0xLTEtMA_05495262-52cb-477b-b311-2d103b561921"
      unitRef="usd">1354000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieed01c48dc4640938d300839252fb560_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTgtNS0xLTEtMA_1d97bac6-aa91-4a3f-aca4-b9aec409dc1c"
      unitRef="usd">1532000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8cfcd2d5b5b040a09df39b1ff8138e51_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTgtNy0xLTEtMA_3cfc30c2-09da-4275-a672-c18248d7a38a"
      unitRef="usd">5065000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0273079a37b24f93bde9cf3de6f118a8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTktMS0xLTEtMA_59bdf115-e7df-472a-95e9-7eebf25a9fd4"
      unitRef="usd">59191000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b864a8e10634cc386d2e4b1b66f73c9_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTktMy0xLTEtMA_2cfd6b67-4d8c-4f53-83ea-df307bc10d2f"
      unitRef="usd">73544000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb2628c9d51a46139995f5f56f04eb1b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTktNS0xLTEtMA_8842e3b7-85ee-421b-9392-f271a0d0ed4a"
      unitRef="usd">276066000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5334a64f425448d4aa5dd0966023fad5_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMTktNy0xLTEtMA_b2d8aa9e-ec41-4856-9fa7-f714dc972d1d"
      unitRef="usd">253986000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c3369cffbd74e249a3e3bcbd0df3054_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjEtMS0xLTEtMA_970c96ce-7db7-4619-bada-2b3c0eb82d15"
      unitRef="usd">4165000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice58cf46aa33484b9c94c1f20980a068_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjEtMy0xLTEtMA_d5af26e3-bf81-4e08-ad2c-b872f6ad700a"
      unitRef="usd">18855000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c4ce1d15f494a5996713fb811a2066e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjEtNS0xLTEtMA_5f43e0f8-eb4f-49dc-9d91-92faa8469572"
      unitRef="usd">16002000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c7bf84cecf545a7a3974f7c1cfe3799_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjEtNy0xLTEtMA_be4c9f10-e227-4cde-a41e-42649c9f51a2"
      unitRef="usd">32114000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0336634f72994ba8b44ad3381f004b4e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjItMS0xLTEtMA_8a6dd826-b85e-430f-b93a-bd610730e532"
      unitRef="usd">558000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc891b5b3b9c469f8a49e2e7a57facb8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjItMy0xLTEtMA_f3580f80-938d-490f-8bec-9edc0f716fe3"
      unitRef="usd">1885000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b1f428af2a34ebd8d75cfdee0ffd03b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjItNS0xLTEtMA_828921e2-7bdd-4424-a68e-9db3dd189a8d"
      unitRef="usd">2617000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6053607ddf734936ad39bb851ebfddc8_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjItNy0xLTEtMA_0a4140c7-273d-436c-83a6-a011cf2a829f"
      unitRef="usd">3358000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc76aa4ecb8a42b3bb83ea9ae9209b0f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjMtMS0xLTEtMA_6a41de8f-d005-49be-ac39-00f002d37822"
      unitRef="usd">4723000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f614f83f3b14aceb5dddc72972dc625_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjMtMy0xLTEtMA_04176bb2-d6e4-4c91-8e69-52e16ab1605b"
      unitRef="usd">20740000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c18bac640fb4358b74a9021f64f8f09_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjMtNS0xLTEtMA_90a77647-8057-4f16-9d39-b35e3728224f"
      unitRef="usd">18619000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i079a9bbf2d8444019d86c147c114b59f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjMtNy0xLTEtMA_91495d8d-f349-45f6-8cdc-21f57c6eb4af"
      unitRef="usd">35472000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjQtMS0xLTEtMA_d9a5e167-b138-4170-96e7-cb71f1868818"
      unitRef="usd">63914000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjQtMy0xLTEtMA_509d62a3-4813-49f1-b4db-bf9a9bd35d46"
      unitRef="usd">94284000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjQtNS0xLTEtMA_6c650add-9406-4176-99db-734aca82a17a"
      unitRef="usd">294685000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOjQ0Yzc0OTk5NGUzZDQ2YWM4OTc3YmE3Yzk0MGQ4ZTcxL3RhYmxlcmFuZ2U6NDRjNzQ5OTk0ZTNkNDZhYzg5NzdiYTdjOTQwZDhlNzFfMjQtNy0xLTEtMA_25745ef6-ea6a-48c0-a71f-5c8a56ee4702"
      unitRef="usd">289458000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i60f7bd4ed2c54782bc3f2260952e6258_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMy0xLTEtMS0w_569725b2-3a18-4df2-82da-5b92a5661a8c"
      unitRef="usd">42698000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71df5a32a01545eca393c3d91f915fec_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMy0zLTEtMS0w_e34bf98f-ec7b-49e9-bbba-5d01b281a6bb"
      unitRef="usd">52040000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i351266363f7a4e1b8813c1836650f960_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMy01LTEtMS0w_949180ea-ac84-4310-9ac2-53f5174c9742"
      unitRef="usd">235974000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20e9c547df0148a987469593fc0dd987_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMy03LTEtMS0w_bdb3bd67-4836-4e9e-9a86-df2158104d7f"
      unitRef="usd">205330000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icde2beb0631d4a4287783b69cf7d4e1d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNC0xLTEtMS0w_21234fd1-0a6c-4ba9-bdb5-5b39312d68ec"
      unitRef="usd">-171000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb0006a549d140b98d5bf1d2830e36e6_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNC0zLTEtMS0w_31c0c53e-6142-443d-8eb8-c3dd5305b654"
      unitRef="usd">-698000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a16931904664e00b694766bb038e051_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNC01LTEtMS0w_e522922a-b736-4aef-8e7b-eb13aefebc00"
      unitRef="usd">-11700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i828454e449d849978e8c318cd2776b04_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNC03LTEtMS0w_eded4b9a-8df5-4da8-8ff6-8127564e3664"
      unitRef="usd">8966000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i911f48697817404ab0c1d37ff5c70eb3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNS0xLTEtMS0w_56d786cf-e865-4a4a-bbf0-72617b1f1307"
      unitRef="usd">42527000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie30b009d33834b2784f9f5fde66749b8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNS0zLTEtMS0w_f2e39a0e-a69d-4e25-b496-1b842e048bd8"
      unitRef="usd">51342000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ddb689a8fbc45558ae1921f6350e8fd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNS01LTEtMS0w_695e8c5c-6e64-411c-a8ba-8cb0e91e4678"
      unitRef="usd">224274000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5fb878914bf0422e994e7b471e4529cb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNS03LTEtMS0w_b94d3677-4a43-4d82-bb87-abb4c88b0375"
      unitRef="usd">214296000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7afaf2016ac0443f80caca194735e56e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNy0xLTEtMS0w_0d9efa07-c4de-488d-b230-b2874fa12e5d"
      unitRef="usd">4892000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0d09f83aa5a4ea2a65c601a78f12257_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNy0zLTEtMS0w_af5a1f27-1e12-4082-a02a-7ba9cc7d7756"
      unitRef="usd">4012000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48026c37588241f584802f09d54f9ecf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNy01LTEtMS0w_163ab5d3-4193-4435-babf-92f3e5afeaa7"
      unitRef="usd">16495000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2733db6c0ea4360b6296e5e62c73ccb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfNy03LTEtMS0w_9fb8e468-431b-4ccb-a098-15ffe49f53b9"
      unitRef="usd">14170000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b76269dbb014c83960a5587af0692a7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOC0xLTEtMS0w_94c5572f-8a31-4a12-82a3-5338f542f9fa"
      unitRef="usd">1744000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b68547b7b4546788f2a85f5b220c5e4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOC0zLTEtMS0w_9f202601-833f-46eb-a430-2d45c3c5740c"
      unitRef="usd">1122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7da352e8a9c40eb9cbd7fb732779cfe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOC01LTEtMS0w_cf7db437-258e-440b-8f2e-3892e3c93e70"
      unitRef="usd">6154000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89f5b05319a44a1cad8dcf843dfca2f6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOC03LTEtMS0w_3f1acb9b-4782-460d-b0c6-882697094a6d"
      unitRef="usd">5005000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1947f932e9cd407bb62d56755087564a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOS0xLTEtMS0w_ee2067c5-41e3-4db3-ba49-df48f6d17dc6"
      unitRef="usd">10028000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib2908788ec3a452c97c238d92d2d6035_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOS0zLTEtMS0w_4fdd1937-cae0-42e5-a66c-f157f64945f4"
      unitRef="usd">17068000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacc349161dd6466bbcd492c1b35bd633_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOS01LTEtMS0w_212f59ad-36b4-426f-9676-cc233591ec26"
      unitRef="usd">29143000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c979359de9d4404ab9ede567f6f6ece_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfOS03LTEtMS0w_6254724a-9547-46c7-929d-d69c1b89f700"
      unitRef="usd">20515000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ef44b438b8345fb9a5e4685fa068d53_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTAtMS0xLTEtMA_74d80582-ba67-42a6-9330-156bbb059837"
      unitRef="usd">16664000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib56fc804e10645e19884d6bf939a1e47_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTAtMy0xLTEtMA_36390b71-b0d7-4a2d-b7fe-7b63b7a3c2a9"
      unitRef="usd">22202000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if141fe6636bb4186bf1303c83e6e12ae_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTAtNS0xLTEtMA_3c2da1e5-fa1c-46d9-8864-598c65bd4a95"
      unitRef="usd">51792000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f9533cbf4c24f3584970b6fd8bf789e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTAtNy0xLTEtMA_054132ea-4f94-4265-a304-1eeae5222465"
      unitRef="usd">39690000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1758dd3c120e4914bdef33946facb083_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTItMS0xLTEtMA_a2eba4a0-fa27-41c4-90dc-6b59bcd8a556"
      unitRef="usd">47590000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic84a9e32128947c58eaef205f493a0c8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTItMy0xLTEtMA_1400eb4b-c7b4-4909-bd5b-dca862c289e3"
      unitRef="usd">56052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88f0ca026fd6441dacb2cb5e02eaa395_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTItNS0xLTEtMA_b9d24017-f357-4993-8864-1e833ee375f1"
      unitRef="usd">252469000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8aa4da10fcd0440f893af9317b139b55_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTItNy0xLTEtMA_33209c0a-b167-4ad8-a11b-34ad8ee119fe"
      unitRef="usd">219500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf89006ab2ec48268296871b08a85218_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTMtMS0xLTEtMA_f5c2c32b-51cf-406b-9965-5ed1e0bb75fb"
      unitRef="usd">1744000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc92029c098b4a3f9121ab760ccd9f11_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTMtMy0xLTEtMA_67ffd8da-df05-4d93-b214-38fe871ca352"
      unitRef="usd">1122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc72c1bed1c841499706dc72a9f006a6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTMtNS0xLTEtMA_06fe4779-60ae-410e-8968-11f0a4ad5c05"
      unitRef="usd">6154000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife96baa989854bd5b161f91c7ee2b238_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTMtNy0xLTEtMA_ec74f418-b485-44a1-a67a-e0d652f4032a"
      unitRef="usd">5005000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c18eadfc0c5443f8b7c31b736463ad6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTQtMS0xLTEtMA_02f5ca1b-486f-48e3-8bcc-367eeeb7c443"
      unitRef="usd">9857000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f03cec81030405695e2198510c5675c_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTQtMy0xLTEtMA_682006cd-96c6-4256-bdfd-6ffe874eb24a"
      unitRef="usd">16370000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e56edcaffd445c099ce1763d8e2bac1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTQtNS0xLTEtMA_31cc04d0-6c5a-4d00-83f2-a87f7ff48326"
      unitRef="usd">17443000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ee271f47aa44a19bcbb4c37143a41fc_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTQtNy0xLTEtMA_b64ebe5d-da1e-413d-bfd6-dd09e33ab74d"
      unitRef="usd">29481000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0273079a37b24f93bde9cf3de6f118a8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTUtMS0xLTEtMA_6ee577c4-30eb-43a0-bb4f-3112de5e6b44"
      unitRef="usd">59191000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b864a8e10634cc386d2e4b1b66f73c9_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTUtMy0xLTEtMA_582fc1e2-a258-4360-a750-805cd97dea8a"
      unitRef="usd">73544000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb2628c9d51a46139995f5f56f04eb1b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTUtNS0xLTEtMA_d2dfda49-99f8-4703-b496-eb4871ed370a"
      unitRef="usd">276066000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5334a64f425448d4aa5dd0966023fad5_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RhYmxlOmNmNzdmOWVjYmRlYzQyNzlhZTExMTg2NTYxYTliNzIyL3RhYmxlcmFuZ2U6Y2Y3N2Y5ZWNiZGVjNDI3OWFlMTExODY1NjFhOWI3MjJfMTUtNy0xLTEtMA_e77d6d6a-8495-41f5-a043-16475ec47035"
      unitRef="usd">253986000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7c18eadfc0c5443f8b7c31b736463ad6_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjAzMw_09b40c27-d694-4f75-a23e-4b8b259826f1"
      unitRef="usdPerShare">0.37</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7c18eadfc0c5443f8b7c31b736463ad6_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjAzMw_7662be22-10e3-42c5-b21f-13cca31b8fda"
      unitRef="usdPerShare">0.37</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5f03cec81030405695e2198510c5675c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjA0MA_85a00039-ed08-4579-9259-e72209403c99"
      unitRef="usdPerShare">0.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5f03cec81030405695e2198510c5675c_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjA0MA_bc3ec806-802c-46b8-871c-f335f2d2b26c"
      unitRef="usdPerShare">0.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5e56edcaffd445c099ce1763d8e2bac1_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjE4NA_48cd7dc8-f9eb-4eef-a0ae-e23d7f67dc73"
      unitRef="usdPerShare">0.65</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5e56edcaffd445c099ce1763d8e2bac1_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjE4NA_48dba395-783e-4457-b118-23eec42ccda0"
      unitRef="usdPerShare">0.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3ee271f47aa44a19bcbb4c37143a41fc_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjE5MQ_8373f003-784d-4e3f-9bcc-a24cbfa71c13"
      unitRef="usdPerShare">1.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3ee271f47aa44a19bcbb4c37143a41fc_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjE5MQ_d3e2edbc-aebb-4f16-adef-af6a1609f7e2"
      unitRef="usdPerShare">1.14</us-gaap:EarningsPerShareDiluted>
    <ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c18eadfc0c5443f8b7c31b736463ad6_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjM0NQ_8ddda1a0-cf43-4552-9f74-8c04d5290ac7"
      unitRef="usd">-3200000</ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax>
    <ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f03cec81030405695e2198510c5675c_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjM1Mg_d1a4d4d8-e47f-4c54-b401-2731dd9d3c96"
      unitRef="usd">-3700000</ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax>
    <ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e56edcaffd445c099ce1763d8e2bac1_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjM4NA_9dc4e668-c996-45f4-8192-ee3aa1344e42"
      unitRef="usd">-22600000</ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax>
    <ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ee271f47aa44a19bcbb4c37143a41fc_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8zNy9mcmFnOmI2ZGFhY2UyOWZkOTQyZWNiYTNmYmYyN2Y3OTUwZDhiL3RleHRyZWdpb246YjZkYWFjZTI5ZmQ5NDJlY2JhM2ZiZjI3Zjc5NTBkOGJfMjM5MQ_5edce167-86e3-4628-9140-eb0d457890bb"
      unitRef="usd">-5300000</ehth:IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNDIyOA_b5b53aec-8fae-4bd6-bca9-be22d8df6c5d">Supplemental Financial Statement Information&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Restricted Cash &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider all investments with an original maturity of 90 days or less from the date of purchase to be cash equivalents. Cash and cash equivalents are stated at fair value. We also invest in marketable securities that are measured and recorded at fair value. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further discussion about our marketable securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cash, cash equivalent and restricted cash balances are summarized as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.078%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2021 and December 31, 2020, we had $3.4 million of restricted cash which was classified as a non-current asset on our Condensed Consolidated Balance Sheets. This amount collateralizes letters of credit related to certain lease commitments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Assets and Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not require collateral or other security for our contract assets and accounts receivable. We believe the potential for collection issues with any of our customers was minimal as of September 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We estimate an allowance for credit losses using relevant available information from internal and external sources, related to past events, current conditions, and reasonable and supportable forecasts. Specifically, for the purpose of measuring the probability of default parameters, we utilize Capital IQ&#x2019;s, Standard &amp;amp; Poor&#x2019;s and Moody&#x2019;s analytics. Our estimates of loss given default are determined by using our historical collections data as well as historical information obtained through our research and review of other insurance related companies. Our estimated exposure at default is determined by applying these internal and external data sources to our commission receivable balances. As such, we apply an immediate reversion method and revert to historical loss information when computing our credit loss exposure. Credit loss expenses are assessed quarterly and included in general and administrative expense on our Condensed Consolidated Statement of Comprehensive Loss. There were no write-offs during any of the three or nine month periods ended September 30, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We considered the impact of recent events and global economic conditions when evaluating the appropriate adjustments to our allowance for credit losses as of September 30, 2021. We also considered the current and expected future economic and market conditions surrounding the COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the allowance for credit losses for the nine months ended September 30, 2021 is summarized as follows (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contract assets &#x2013; commission receivable activities, net of credit loss allowances&#160;are summarized as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Medicare Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;IFP/SMB Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from members approved during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from renewals of small business members during the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net commission revenue from members approved in prior periods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash receipts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276,825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in credit loss allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Medicare Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;IFP/SMB Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from members approved during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from renewals of small business members during the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net commission revenue from members approved in prior periods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash receipts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in credit loss allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial instruments that are exposed to concentrations of credit risk principally consist of cash, cash equivalents, marketable securities, contract assets &#x2013; commissions receivable, and accounts receivable. We invest our cash and cash equivalents with major banks and financial institutions and such investments are in excess of federally insured limits. We also have deposits with major banks in China that are denominated in both U.S. dollars and Chinese Yuan Renminbi and are not insured by the U.S. federal government. The deposits in China were $3.8&#160;million as of September 30, 2021. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for more information regarding our marketable securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not require collateral or other security for either our contract assets or accounts receivable. Carriers that represented 10% or more of our total contract assets and accounts receivable balance are summarized as of the dates presented below:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Humana&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;UnitedHealthCare &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aetna&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centene &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Percentages include the carriers' subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the contract assets and accounts receivable of WellCare are included in the percentage calculation for September 30, 2021 and December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prepaid Expenses and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Current&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our prepaid expenses and other current assets are summarized as of the periods presented as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.276%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid maintenance contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNDIyMQ_16383e09-994b-4276-80af-f6c6c207dbbc">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cash, cash equivalent and restricted cash balances are summarized as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.078%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNDIzMQ_65c0ebc8-a0a7-4c43-bb4c-1ffd0f05ae83">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cash, cash equivalent and restricted cash balances are summarized as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.078%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:Cash
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfMS0xLTEtMS0w_a7e7eb2d-c45c-48e5-b931-ed6e505db631"
      unitRef="usd">37765000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfMS0zLTEtMS0w_dd2b4eb5-dc3c-4a94-8aae-ee2e4a791d5e"
      unitRef="usd">39552000</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfMi0xLTEtMS0w_ad6bd7b3-e022-44cd-9556-6be30f676940"
      unitRef="usd">119765000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfMi0zLTEtMS0w_edea9e42-a40f-4abf-a564-972830b466bd"
      unitRef="usd">4207000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfMy0xLTEtMS0w_14ea1ac5-a4f4-4892-9e03-779b0db39987"
      unitRef="usd">157530000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfMy0zLTEtMS0w_4238fb76-5c3c-442d-a9a4-c7e91f43ed96"
      unitRef="usd">43759000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfNC0xLTEtMS0w_319d145c-5a55-426a-b897-7ebb954f413d"
      unitRef="usd">3354000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfNC0zLTEtMS0w_13389649-98b5-4419-836b-ae680e5beb84"
      unitRef="usd">3354000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfNS0xLTEtMS0w_6950c83c-144e-4194-b3b9-09e3a449c1c0"
      unitRef="usd">160884000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOmQ0MWVjZWJlMjgwMDRhYjE4NjZmM2ZlNWNlZDY2YzY0L3RhYmxlcmFuZ2U6ZDQxZWNlYmUyODAwNGFiMTg2NmYzZmU1Y2VkNjZjNjRfNS0zLTEtMS0w_3a2db234-80b9-456d-98df-caf85719d9c8"
      unitRef="usd">47113000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNTEz_060864d4-787b-40da-bd8f-8214f356961a"
      unitRef="usd">3400000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNTEz_4d15d5a7-a857-4c63-8960-2a916834cf56"
      unitRef="usd">3400000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossWriteoff
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfMTk0Nw_0a4c49e0-8045-48ee-867e-2b4f29b96054"
      unitRef="usd">0</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossWriteoff>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossWriteoff
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfMTk0Nw_d4c41c18-77db-44a2-92ea-8be8fce92b45"
      unitRef="usd">0</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossWriteoff>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossWriteoff
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfMTk0Nw_df72cb80-98b0-4913-b4ea-d918638a0cd7"
      unitRef="usd">0</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossWriteoff>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossWriteoff
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfMTk0Nw_eff0ca74-3700-4846-ac9c-faa76618374d"
      unitRef="usd">0</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossWriteoff>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNDIzMw_9314a8f0-dab7-4a60-a7fd-e8451293288b">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the allowance for credit losses for the nine months ended September 30, 2021 is summarized as follows (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.485%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock>
    <us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjJhM2FlNzVlOTc5OTQ2YzE5ZGZiZjg3NjA5OTM1NjI3L3RhYmxlcmFuZ2U6MmEzYWU3NWU5Nzk5NDZjMTlkZmJmODc2MDk5MzU2MjdfMS0xLTEtMS0w_793ee4c9-708e-430b-9087-194a11127bc5"
      unitRef="usd">2026000</us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjJhM2FlNzVlOTc5OTQ2YzE5ZGZiZjg3NjA5OTM1NjI3L3RhYmxlcmFuZ2U6MmEzYWU3NWU5Nzk5NDZjMTlkZmJmODc2MDk5MzU2MjdfMi0xLTEtMS0w_a61f0cd2-2c12-40ff-a2f4-6e8c73eb33ef"
      unitRef="usd">207000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjJhM2FlNzVlOTc5OTQ2YzE5ZGZiZjg3NjA5OTM1NjI3L3RhYmxlcmFuZ2U6MmEzYWU3NWU5Nzk5NDZjMTlkZmJmODc2MDk5MzU2MjdfMy0xLTEtMS0w_95ac9106-61fd-4301-872e-62cf2b50a631"
      unitRef="usd">1819000</us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNDI0MA_cc95bab0-0e13-445d-834b-a181dd289858">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our contract assets &#x2013; commission receivable activities, net of credit loss allowances&#160;are summarized as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Medicare Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;IFP/SMB Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;792,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from members approved during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from renewals of small business members during the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net commission revenue from members approved in prior periods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash receipts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276,825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in credit loss allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Medicare Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;IFP/SMB Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from members approved during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commission revenue from renewals of small business members during the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net commission revenue from members approved in prior periods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash receipts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201,256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net change in credit loss allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,536)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;(1)Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item.</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ib6e1b062da104b6c93845164602f2f2c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfMi0xLTEtMS0w_f82dd35b-ffe2-4846-a3fa-b037844c841f"
      unitRef="usd">739637000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i359b7b468f5540df8ade4326d6c36a90_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfMi0zLTEtMS0w_d68ab950-6721-486a-8891-796ce9c98b81"
      unitRef="usd">52768000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfMi01LTEtMS0w_64de4c31-d31e-429d-995c-d370a8e2b079"
      unitRef="usd">792405000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i351266363f7a4e1b8813c1836650f960_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfMy0xLTEtMS0w_b376bc4c-9b28-4fbb-902b-455223dc2c6d"
      unitRef="usd">235974000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48026c37588241f584802f09d54f9ecf_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfMy0zLTEtMS0w_7c64db7e-022f-4515-8786-b8866bd097b5"
      unitRef="usd">16495000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88f0ca026fd6441dacb2cb5e02eaa395_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfMy01LTEtMS0w_1110cb61-f045-493d-b8f2-b585d4f7c7db"
      unitRef="usd">252469000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib46a8ba9e5024efe8bf5aba81c5b9600_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNC0xLTEtMS0w_91abe160-d9d0-46d5-bddf-171b774255a5"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7da352e8a9c40eb9cbd7fb732779cfe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNC0zLTEtMS0w_9c18847d-e017-4623-aabb-e01547ed7c28"
      unitRef="usd">6154000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc72c1bed1c841499706dc72a9f006a6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNC01LTEtMS0w_73f46167-8f0b-4360-a6a9-b2558c4817d0"
      unitRef="usd">6154000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a16931904664e00b694766bb038e051_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNS0xLTEtMS0w_3a59c245-4efa-4e55-ac38-23816e6f03f9"
      unitRef="usd">-11700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacc349161dd6466bbcd492c1b35bd633_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNS0zLTEtMS0w_a047b3fe-f18c-49bd-b66a-bb43fea8bcea"
      unitRef="usd">29143000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e56edcaffd445c099ce1763d8e2bac1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNS01LTEtMS0w_fd5ed4c1-2f4a-436e-b7c2-5b3c084f8696"
      unitRef="usd">17443000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ProceedsFromCommissionsReceived
      contextRef="i3e3e7808533446fa841efe0261464aab_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNi0xLTEtMS0w_3ba589b9-6915-42d4-af50-02cd79d555f6"
      unitRef="usd">276825000</us-gaap:ProceedsFromCommissionsReceived>
    <us-gaap:ProceedsFromCommissionsReceived
      contextRef="i1845a379344d4ba7b78716155f0ecf21_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNi0zLTEtMS0w_87a5a1f3-5ad8-48b2-80fe-aee33951409d"
      unitRef="usd">34485000</us-gaap:ProceedsFromCommissionsReceived>
    <us-gaap:ProceedsFromCommissionsReceived
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNi01LTEtMS0w_ef5bd9bd-95fa-4715-8738-bd389849de7b"
      unitRef="usd">311310000</us-gaap:ProceedsFromCommissionsReceived>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="i3e3e7808533446fa841efe0261464aab_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNy0xLTEtMS0w_bd0abe1c-57f2-42e9-811c-aa8abd10e2e3"
      unitRef="usd">188000</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="i1845a379344d4ba7b78716155f0ecf21_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNy0zLTEtMS0w_fcd0c535-b501-4506-b85f-b7d33591b2ea"
      unitRef="usd">19000</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfNy01LTEtMS0w_75ca1a31-a7b1-40ee-a3d0-d746bfaf1d9e"
      unitRef="usd">207000</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i7485ea45ef6d477b95fa116525c62450_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfOC0xLTEtMS0w_c602e175-41af-47fc-9daf-3512496be5ce"
      unitRef="usd">687274000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i799a45e99b484907806a69b59e333c89_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfOC0zLTEtMS0w_83fe779f-fbae-4a81-91c4-b29c014394c9"
      unitRef="usd">70094000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjMxM2U5YTY0MzRlOTRkOGI4YjFmZDAyMjE1NjRiNmRiL3RhYmxlcmFuZ2U6MzEzZTlhNjQzNGU5NGQ4YjhiMWZkMDIyMTU2NGI2ZGJfOC01LTEtMS0w_c9caa734-9c12-47ad-8e4e-edffebb858b6"
      unitRef="usd">757368000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i7b25b5471f2842f191c5c90038a9fce3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfMi0xLTEtMS0w_141346c9-10ea-443b-bc5a-99778a4930a2"
      unitRef="usd">550922000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ib803d8adedf24fbdbcb6cc7f5c5f99e9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfMi0zLTEtMS0w_e4b2e620-aa61-49d1-acbd-b50dcd1a62a7"
      unitRef="usd">38300000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i023ad41593504141a87219e927134521_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfMi01LTEtMS0w_e78a21a7-c07d-4ecf-ae23-048310a5afc4"
      unitRef="usd">589222000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20e9c547df0148a987469593fc0dd987_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfMy0xLTEtMS0w_d0fa458a-bf44-4238-a6c0-87cda76a9dcd"
      unitRef="usd">205330000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2733db6c0ea4360b6296e5e62c73ccb_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfMy0zLTEtMS0w_28947ab6-7dba-4c94-8537-e51a719fd304"
      unitRef="usd">14170000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8aa4da10fcd0440f893af9317b139b55_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfMy01LTEtMS0w_14720dc1-1ffc-40fe-84fa-5b893bf1484a"
      unitRef="usd">219500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd6a2b2a5d6143c983bec97ffe0e0bd6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNC0xLTEtMS0w_e520bb59-a313-4a2e-8850-449c12ad59b8"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89f5b05319a44a1cad8dcf843dfca2f6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNC0zLTEtMS0w_1ce0e92d-a28a-4aff-bb66-301c1a1f7b54"
      unitRef="usd">5005000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife96baa989854bd5b161f91c7ee2b238_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNC01LTEtMS0w_bcbe0871-1871-4073-9603-59ee75ba1b4a"
      unitRef="usd">5005000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i828454e449d849978e8c318cd2776b04_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNS0xLTEtMS0w_a4194635-7728-4038-9c4c-123f959b211f"
      unitRef="usd">8966000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c979359de9d4404ab9ede567f6f6ece_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNS0zLTEtMS0w_3a99e481-cc11-4ebb-85ee-29d7a9556cca"
      unitRef="usd">20515000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ee271f47aa44a19bcbb4c37143a41fc_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNS01LTEtMS0w_97b51512-b2e7-4d84-8e01-3000d3e07295"
      unitRef="usd">29481000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ProceedsFromCommissionsReceived
      contextRef="i8f376e41d3214a4a8692048243ef8566_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNi0xLTEtMS0w_ff7f6e2a-fef9-41ca-939d-cdf9da4527e0"
      unitRef="usd">201256000</us-gaap:ProceedsFromCommissionsReceived>
    <us-gaap:ProceedsFromCommissionsReceived
      contextRef="i55279fea227b4f7992ca05764db25cfe_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNi0zLTEtMS0w_705ad6a3-68f8-43ce-a980-7962543cd059"
      unitRef="usd">35957000</us-gaap:ProceedsFromCommissionsReceived>
    <us-gaap:ProceedsFromCommissionsReceived
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNi01LTEtMS0w_b1fb39a4-57fc-41bc-a510-145c4188826a"
      unitRef="usd">237213000</us-gaap:ProceedsFromCommissionsReceived>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="i8f376e41d3214a4a8692048243ef8566_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNy0xLTEtMS0w_7e27cad8-f46a-45ed-9be3-00b6ea3678c4"
      unitRef="usd">-1536000</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="i55279fea227b4f7992ca05764db25cfe_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNy0zLTEtMS0w_95f9f4c2-8474-48a2-afc3-4d2d03f371c4"
      unitRef="usd">-114000</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfNy01LTEtMS0w_0f3485a2-b412-42d5-ab5e-d38210fe45ca"
      unitRef="usd">-1650000</us-gaap:ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="ic38fa4c27d674faaa2153103268bc6f2_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfOC0xLTEtMS0w_0c545d41-e79d-4c33-9e2f-a165b61f844b"
      unitRef="usd">562426000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i07543f61382c4935bdeec18bab41cc0e_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfOC0zLTEtMS0w_dfdf0af8-1e7b-400c-ab1c-40bb750e8d8b"
      unitRef="usd">41919000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i3afb9956061e4743b8afadadf5214bfe_I20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjI3NzVjMTQxZDU5YjQ5ZjNhZjM4NWFmY2JkYjAwMjI4L3RhYmxlcmFuZ2U6Mjc3NWMxNDFkNTliNDlmM2FmMzg1YWZjYmRiMDAyMjhfOC01LTEtMS0w_66f582cc-2a47-410a-8f22-251b27b47f31"
      unitRef="usd">604345000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:Deposits
      contextRef="i523d407abcc34388915c073912053b35_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfMzQ3Nw_af58861b-c51e-4e2e-becc-f0a3cb4e478f"
      unitRef="usd">3800000</us-gaap:Deposits>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNDIzNA_366fae82-ba0a-4bd0-a565-284ae9e5220c">Carriers that represented 10% or more of our total contract assets and accounts receivable balance are summarized as of the dates presented below:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Humana&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;UnitedHealthCare &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aetna&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centene &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Percentages include the carriers' subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the contract assets and accounts receivable of WellCare are included in the percentage calculation for September 30, 2021 and December 31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id2046c7d044743ceaad71b60d4431854_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfMS0xLTEtMS0w_138e395f-10b7-418d-bef2-e2b27ca0c10e"
      unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i352b2ea156634799b87eb09859219c43_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfMS0zLTEtMS0w_553ac249-7b76-410d-b5e9-94cee2e7ea4f"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i29e568455e4e48e0a5ef2ebf86b689a0_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfMi0xLTEtMS0w_674c8937-39c2-48b8-8647-e60930d9822d"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7fc6666241c84c42af5630376e4ae6d3_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfMi0zLTEtMS0w_92aea5e0-ba73-45af-91e6-b2c72031cd40"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6a7cfd923d224bb6b7fe901abc5d9385_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfMy0xLTEtMS0w_bb5a4321-3fa2-4f21-948f-40cd28f0ecb1"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i850ab8c5df8746729fb79a1ced686481_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfMy0zLTEtMS0w_964e142e-c38b-4211-b0d3-a26a4b50a053"
      unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i86f303cf73634348bebc5dab18fff7f4_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfNC0xLTEtMS0w_25814a18-e161-40ec-b1fe-b3b09bbb8c09"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ibaab6d0a0d8545a186157b9fcb246894_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjRmYzI3OGY1YTRjMjQ2MWRhOTgxZjIxZjYwM2QyNzI4L3RhYmxlcmFuZ2U6NGZjMjc4ZjVhNGMyNDYxZGE5ODFmMjFmNjAzZDI3MjhfNC0zLTEtMS0w_1a7d2579-4381-40d0-9683-97244dac35e3"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RleHRyZWdpb246ZTQyNDYzMzQxYzRlNGE4Mzg4NDIzNjMwMjcyMGExZGJfNDI0MQ_f980755e-3b58-4aa7-a484-f46c7c56eb23">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our prepaid expenses and other current assets are summarized as of the periods presented as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.276%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid maintenance contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Others&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <ehth:PrepaidMaintenanceContractsCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfMS0xLTEtMS0w_0a78b057-3287-4e67-a2b4-cbf3a29baa3f"
      unitRef="usd">8448000</ehth:PrepaidMaintenanceContractsCurrent>
    <ehth:PrepaidMaintenanceContractsCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfMS0zLTEtMS0w_8bb3a347-8792-491e-b976-b37976b4d0e3"
      unitRef="usd">7715000</ehth:PrepaidMaintenanceContractsCurrent>
    <ehth:PrepaidLicenses
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfMi0xLTEtMS0w_816f199c-b876-4813-aee7-4d962ca9a8e6"
      unitRef="usd">3302000</ehth:PrepaidLicenses>
    <ehth:PrepaidLicenses
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfMi0zLTEtMS0w_26d616dd-ccfa-4707-97d5-84573aabda9a"
      unitRef="usd">0</ehth:PrepaidLicenses>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfMy0xLTEtMS0w_59ae1d75-b193-4010-b6e7-550fc6c02102"
      unitRef="usd">23828000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfMy0zLTEtMS0w_7991bcd8-7a78-4fd8-876a-fd008cf386c1"
      unitRef="usd">6628000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidInsurance
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfNC0xLTEtMS0w_56a0004c-a19d-4ebc-b9c6-1b481412378d"
      unitRef="usd">672000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfNC0zLTEtMS0w_12e39c1c-d329-41a1-877a-faaf9d7566b2"
      unitRef="usd">1672000</us-gaap:PrepaidInsurance>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfNi0xLTEtMS0w_51b18a37-725f-499a-b8d4-cfba7961db53"
      unitRef="usd">403000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:OtherAssetsMiscellaneousCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfNi0zLTEtMS0w_b6c964c3-2212-46a8-a6d8-1e36c72ce3de"
      unitRef="usd">646000</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfNy0xLTEtMS0w_97a7fb5f-8ad3-41d9-9126-6c6983145421"
      unitRef="usd">36653000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80My9mcmFnOmU0MjQ2MzM0MWM0ZTRhODM4ODQyMzYzMDI3MjBhMWRiL3RhYmxlOjY3ZmIzYjNjNWEwMzQxMjY5Y2RkNTMxMTYzMjNjNDc3L3RhYmxlcmFuZ2U6NjdmYjNiM2M1YTAzNDEyNjljZGQ1MzExNjMyM2M0NzdfNy0zLTEtMS0w_889e4157-509a-4d40-91a2-654171c81c73"
      unitRef="usd">16661000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RleHRyZWdpb246YzJhNTRiYWY4YjkxNDJhNTg1MDliZjc2NmZmNWEyYTZfMjQ2NQ_2db5619b-40aa-4a42-8200-e2f77ecf1897">Fair Value Measurements&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We define fair value as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques we use to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. We classify the inputs used to measure fair value into the following hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:90.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unobservable inputs for the asset or liability.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial assets measured at fair value on a recurring basis are summarized below by their classification within the fair value hierarchy as of the dates presented below (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bond&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2021, our cash equivalents consisted of money market funds and commercial paper with original maturity of 90 days or less were classified as Level 1 and 2, respectively. We endeavor to utilize the best available information in measuring fair value. We used observable prices in active markets in determining the classification of our money market funds as Level 1. Our Level 2 assets consisted of available for sale marketable securities, which included commercial paper, agency bonds, and a corporate bond with maturities of less than one year. We classify our marketable debt securities within Level 2 in the fair value hierarchy, because we use quoted market prices to the extent available or alternative pricing sources and models utilizing market observable inputs to determine fair value. Our portfolio primarily consisted of financial instruments with a credit rating of AA or equivalent by S&amp;amp;P Rating and Moody's Investor Services. There were no transfers between the hierarchy levels during either the nine months ended September 30, 2021 or the year ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our cash equivalents and available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in 1 year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized gains and losses on available-for-sale debt securities that are not credit related are included in accumulated other comprehensive income and summarized as follows as of September 30, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bond&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;As of September 30, 2021, we had forty-one securities in net loss positions and their unrealized losses were immaterial individually and in aggregate. We did not record any credit losses regarding our available-for-sales debt securities during the nine months ended September 30, 2021. We do not intend to sell these securities and it is more likely than not that we will not be required to sell these securities before the recovery of their amortized cost basis.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RleHRyZWdpb246YzJhNTRiYWY4YjkxNDJhNTg1MDliZjc2NmZmNWEyYTZfMjQ3Mw_317891ca-63bc-4802-8800-cdc3aaef1fb0">We classify the inputs used to measure fair value into the following hierarchy:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:90.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unobservable inputs for the asset or liability.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RleHRyZWdpb246YzJhNTRiYWY4YjkxNDJhNTg1MDliZjc2NmZmNWEyYTZfMjQ2Nw_f882c011-8891-44ca-884d-3be3f19669b7">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial assets measured at fair value on a recurring basis are summarized below by their classification within the fair value hierarchy as of the dates presented below (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bond&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.137%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;As of September 30, 2021, o</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i47719e7e84e544339538a6b07e7b4dff_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNC0xLTEtMS0w_8c3cc523-c80a-4494-a1f0-bf1679738634"
      unitRef="usd">19371000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i47719e7e84e544339538a6b07e7b4dff_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNC0xLTEtMS0w_e3c83499-acf1-4230-bc1a-a88380225bf9"
      unitRef="usd">19371000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib53890909b2842a6922819e1edeaa771_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNC0zLTEtMS0w_139853a5-ddf5-471d-8f77-6c492256de9b"
      unitRef="usd">19371000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ifa1c7c5fa3884882909610f165c0d007_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNC01LTEtMS0w_26643c56-3c90-43a1-a272-aafed4d44844"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5610009dd37b4384bc33a616a6aab127_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNC03LTEtMS0w_4119d34c-e6b5-4291-91d3-70d758464c3e"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i50134f65952c447c8536c4c509d440b0_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNC05LTEtMS0w_2da19d0b-90f8-4611-ae1e-589c248aca20"
      unitRef="usd">19371000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i4e7212367a01499c93d6d4b809f9ed9c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNS0xLTEtMS0w_91c27bde-2731-4b2e-8d0c-6de16b83352b"
      unitRef="usd">100394000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iad309707646240918be65ddd93e7dcf8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNS0zLTEtMS0w_1b6ab3cf-8fc0-40df-9315-34ce87a505f4"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic5d5ade3741d4a9185c2b653a4af9ecb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNS01LTEtMS0w_d0e34237-6729-4114-acb5-87039fda36a6"
      unitRef="usd">100394000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib6f15061ad6e471cbda9021bf8810571_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNS03LTEtMS0w_907dfb85-a865-4478-921f-07b3361d768d"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie38b6c1b1c9c45fdba0d48aa1ce710c2_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfNS05LTEtMS0w_a0277e36-efff-4245-ad6d-bd5555466819"
      unitRef="usd">100394000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="id2deb8ce979e4e7ebc3e73924fdf8984_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOC0xLTEtMS0w_5fc9ceb6-45d6-4785-adec-56bdad18fa19"
      unitRef="usd">1276000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ie4abea0af5374b2ea1c4c1f3394ae378_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOC0zLTEtMS0w_9136d07d-2569-4a53-b6d2-cbfb2b449500"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i20249488a86d4517ad2ce8519062fb47_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOC01LTEtMS0w_2545d599-8f0f-4553-8a47-b331081b30be"
      unitRef="usd">1276000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ib1196177b8cd4b4889d59fe382f0884a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOC03LTEtMS0w_55b7dce2-78c2-40c4-a722-aa8d4d5f43e0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="if6f25d09031048a4ad52c1658b5f4ec4_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOC05LTEtMS0w_a6106d31-97e1-4111-9a4e-e80c45ba67ad"
      unitRef="usd">1276000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i336d38756e4c40b1ba67a778fec1c8b7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOS0xLTEtMS0w_60f3064a-c9c5-4cce-90bd-1c382336e3ec"
      unitRef="usd">66414000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i24ead09862b2413a86a888c37af9278b_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOS0zLTEtMS0w_43bf04be-7f81-45cf-b6be-1da2eafdf25f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i4d257f4867664e9e9883a4c86aab2afc_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOS01LTEtMS0w_40714407-f7d9-476d-a6a2-d09f1b305096"
      unitRef="usd">66414000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="id70b3e6e37f5474eac6b0c1c37de4585_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOS03LTEtMS0w_112c8713-bf9a-4578-a825-12f03d7b53d6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i85a1662f85774554ac4dd94f6a4bd607_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfOS05LTEtMS0w_9fd25e9e-c66a-48c8-a417-86a21da4fbee"
      unitRef="usd">66414000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i4d97d81f0af64632a38c7998284dd90c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTEtMS0xLTEtMA_fd092baa-9a35-42c4-b3a3-28c63829d65e"
      unitRef="usd">2522000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i6bb1b3fedcf14b3d9257f06b935d3e4a_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTEtMy0xLTEtMA_5e06c2d8-e6af-4181-9f08-14b75dc128bb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i70979db466f8423f9755a5fb92cb03ae_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTEtNS0xLTEtMA_f179278d-4bef-402f-ad2f-3a2c088fe188"
      unitRef="usd">2522000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ib7fa9733a3384f39b6dcfeb1f1ee2a6f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTEtNy0xLTEtMA_95ad2f0d-5434-4d24-94b6-b7e8cc2423c7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ia7fcfcdb20334394afbf1256cc0e0662_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTEtOS0xLTEtMA_fb5a6ea2-0c89-4f56-8f42-83337d767451"
      unitRef="usd">2522000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifcd9ed25d2764e9db6588f766c6ceb7c_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTQtMS0xLTEtMA_a2c9f289-4949-4eb5-9a69-d68d992e6845"
      unitRef="usd">189977000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i491b5e834621498ca113938980a0be07_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTQtMy0xLTEtMA_1c945384-b4fc-4593-9114-8aa3de8c77ac"
      unitRef="usd">19371000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id423dd6355054bb288a4cc0434f373bf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTQtNS0xLTEtMA_8f0854b2-1870-4e8f-910e-91ff3ddc42be"
      unitRef="usd">170606000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic58f49a9465c47028f47e4656f464863_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTQtNy0xLTEtMA_ade39669-66b3-4b71-8fb3-99e23daac2af"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i129ac8211d8e4c0ba7a255b8dab26a32_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjIxYTc0ZGU1MjE1ZjQ2NDBhNTQ0MWUzNzMyM2E1ZmE0L3RhYmxlcmFuZ2U6MjFhNzRkZTUyMTVmNDY0MGE1NDQxZTM3MzIzYTVmYTRfMTQtOS0xLTEtMA_1101848a-c224-4cc4-aaf9-b80b8c0aaef8"
      unitRef="usd">189977000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i8bcd9764a5744c69a32ac980ad18308e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNC0xLTEtMS0w_e06d6202-b81c-4b96-a5d7-bae343786fce"
      unitRef="usd">4207000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if4e09372bd664c3ab1b9f51f41199eb8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNC0zLTEtMS0w_3603e990-6d4b-4725-87f8-92840a10bb10"
      unitRef="usd">4207000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ibd42b9bb33c044dbb1de60bee9c42876_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNC01LTEtMS0w_ceaf35f4-fddd-4f0c-9e6f-a180b6932f2b"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iec3221d11bf648bfb054e3fc5ae908f2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNC03LTEtMS0w_707bb74a-8708-4ead-a98b-37710bf83648"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="icd4b24a0a2e341d199c0c81e18f6fe7a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNC05LTEtMS0w_7161224f-42e7-4a4a-8e4f-05a05f76a4dd"
      unitRef="usd">4207000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i717e94aee1cb438cabdc9a27ae11551f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNi0xLTEtMS0w_d73fda8f-82a6-4675-bfe5-ea0fc7b5a1fe"
      unitRef="usd">35423000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i9ef7c7b9f546496b9cfa4c224aed630e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNi0zLTEtMS0w_0212dfce-7690-43ca-b8a8-da5b36f7b77e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i506a76e2d8ca425cbdb5ae11dd6cd259_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNi01LTEtMS0w_d5dae0a1-c18b-4a40-81a3-caddda5042fd"
      unitRef="usd">35423000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i746a758123914e1d937d531d3b4f1360_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNi03LTEtMS0w_a3ac61dd-ced8-45bc-9384-2e298ee9fcba"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i5847226e38d1465db0569a5ceb228ff4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNi05LTEtMS0w_0a87ff3f-05d5-4967-b95a-3847649edda0"
      unitRef="usd">35423000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i002e42fc0f9446dea52b4be056b82628_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNy0xLTEtMS0w_35087fef-281d-4705-beb0-76bf0882eba2"
      unitRef="usd">14197000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i4f22b60783114271b6d18262ae59b3e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNy0zLTEtMS0w_d1e9cb8d-8551-4238-b968-cdfdc2a8f44b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i723227d94b364d578aed1bb6c4c7d173_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNy01LTEtMS0w_06c31b95-826b-4a63-9594-ee14c2b73165"
      unitRef="usd">14197000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="icbd22cf0dccc41498bd9e877ebc39f93_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNy03LTEtMS0w_d003e7e1-18ea-41e2-93b0-ff0326cbd744"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i980493d2590e4651b3a1f828bf64d0e6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfNy05LTEtMS0w_d829ac3f-088c-41d6-b687-63ac3ec38fa0"
      unitRef="usd">14197000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iae0c078eeb4f4e9eb08d1321632981e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfOC0xLTEtMS0w_e02209d6-c147-4f69-a895-0e3fc6a6379f"
      unitRef="usd">53827000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id40bd3241bac4466a336bb6f5771fbef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfOC0zLTEtMS0w_57b4c4c9-a0fb-4b09-8580-01bd8777d6cf"
      unitRef="usd">4207000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6dd7aca5034144ce9adb12f61bcad4b2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfOC01LTEtMS0w_faad7800-2110-4f79-b454-b46f64b7fef7"
      unitRef="usd">49620000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7f3ecf18721d481caad5f826b596a46f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfOC03LTEtMS0w_1cb04f62-22f9-4bb3-be96-1c11702a4bb8"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2dba4eac468c476b9642c00c8d545983_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjg4ZTAxNzY4ZmRhZTQwNjhhZTk5OWJhMjMwYjRkZjZmL3RhYmxlcmFuZ2U6ODhlMDE3NjhmZGFlNDA2OGFlOTk5YmEyMzBiNGRmNmZfOC05LTEtMS0w_3d5c76e2-8cc2-448c-bf95-f5893e271526"
      unitRef="usd">53827000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RleHRyZWdpb246YzJhNTRiYWY4YjkxNDJhNTg1MDliZjc2NmZmNWEyYTZfMjQ3Mg_7ae960f4-0c38-4ea1-ad73-e590293313e7">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our cash equivalents and available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in 1 year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjJlZTRmYzBlYzljNzQxZTRiMThlYTUxN2E1OGM3ZGRlL3RhYmxlcmFuZ2U6MmVlNGZjMGVjOWM3NDFlNGIxOGVhNTE3YTU4YzdkZGVfMi0xLTEtMS0w_4f3960b1-fe84-4e4d-9daf-366ac4376be0"
      unitRef="usd">189980000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjJlZTRmYzBlYzljNzQxZTRiMThlYTUxN2E1OGM3ZGRlL3RhYmxlcmFuZ2U6MmVlNGZjMGVjOWM3NDFlNGIxOGVhNTE3YTU4YzdkZGVfMi0zLTEtMS0w_b21e82f2-0d6f-4321-b51a-74a1b3c91357"
      unitRef="usd">189977000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RleHRyZWdpb246YzJhNTRiYWY4YjkxNDJhNTg1MDliZjc2NmZmNWEyYTZfMjQ2NA_16bdfc95-d159-4473-bd11-e5d35dd33b4e">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized gains and losses on available-for-sale debt securities that are not credit related are included in accumulated other comprehensive income and summarized as follows as of September 30, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Short-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bond&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1b68294e77e84233b3a350690a075beb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMi0xLTEtMS0w_b18087aa-c2c9-4f86-ab50-d7640b870e22"
      unitRef="usd">19371000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax
      contextRef="i1b68294e77e84233b3a350690a075beb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMi0zLTEtMS0w_25be5938-46a4-446b-af60-96083d2252c2"
      unitRef="usd">0</ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax>
    <ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1b68294e77e84233b3a350690a075beb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMi01LTEtMS0w_28a49f21-556f-4798-9d61-eb3db1dc3791"
      unitRef="usd">0</ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i1b68294e77e84233b3a350690a075beb_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMi03LTEtMS0w_aa1ab839-c595-496f-be66-c1f2d9e2b8f5"
      unitRef="usd">19371000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i007949f0ecbd4d28a3fc49a2fbb4899d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMy0xLTEtMS0w_91596cc5-b0bb-4d66-a4b8-b8e05524ca56"
      unitRef="usd">100398000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax
      contextRef="i007949f0ecbd4d28a3fc49a2fbb4899d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMy0zLTEtMS0w_5f7225b6-6670-43b1-95c1-a6f912f1f038"
      unitRef="usd">0</ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax>
    <ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i007949f0ecbd4d28a3fc49a2fbb4899d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMy01LTEtMS0w_ece2cee4-c88d-41e3-8296-7ff1773a1348"
      unitRef="usd">4000</ehth:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i007949f0ecbd4d28a3fc49a2fbb4899d_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMy03LTEtMS0w_5f13473d-6759-42fd-94fd-84072f10f390"
      unitRef="usd">100394000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="ia88748e076ec49309ce124b0255894ee_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNi0xLTEtMS0w_df01d1a4-807b-48ba-a7e4-7c27f69ff1c9"
      unitRef="usd">1276000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia88748e076ec49309ce124b0255894ee_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNi0zLTEtMS0w_f7691255-481b-4764-8d44-484098846355"
      unitRef="usd">0</ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax>
    <ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia88748e076ec49309ce124b0255894ee_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNi01LTEtMS0w_da816915-5f43-415b-97b3-465324485c6e"
      unitRef="usd">0</ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ia88748e076ec49309ce124b0255894ee_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNi03LTEtMS0w_d193f0d5-1a5a-41be-bda6-5de2afddc67e"
      unitRef="usd">1276000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="i81970b5cc22849c79344d636832e6166_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNy0xLTEtMS0w_0a794fcc-3238-46b1-a0bb-4d5d056d4e23"
      unitRef="usd">66413000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i81970b5cc22849c79344d636832e6166_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNy0zLTEtMS0w_69cd2caf-3743-4a15-bcce-c6138db453da"
      unitRef="usd">4000</ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax>
    <ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i81970b5cc22849c79344d636832e6166_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNy01LTEtMS0w_f377fb9b-d21c-4ef4-a5bb-2f24f9d89ede"
      unitRef="usd">3000</ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i81970b5cc22849c79344d636832e6166_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfNy03LTEtMS0w_16d49b23-e59e-4932-b2a6-2c9b8b08c5cb"
      unitRef="usd">66414000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent
      contextRef="i62c9f97d16144d79b7c6fc675d93c63f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfOC0xLTEtMS0w_3b88de48-4cde-4900-8811-351a0d9d1a2f"
      unitRef="usd">2522000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent>
    <ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i62c9f97d16144d79b7c6fc675d93c63f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfOC0zLTEtMS0w_a38635c5-a35a-4b26-83d1-02dc51406fb2"
      unitRef="usd">0</ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax>
    <ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i62c9f97d16144d79b7c6fc675d93c63f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfOC01LTEtMS0w_9e1bcacd-7e9d-480a-b092-32340eb0cd2e"
      unitRef="usd">0</ehth:DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i62c9f97d16144d79b7c6fc675d93c63f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfOC03LTEtMS0w_9975e96a-0729-4766-a2bd-563313b2aae0"
      unitRef="usd">2522000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <ehth:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMTEtMS0xLTEtMA_c1ee966d-6abd-4572-9761-9486ce6c6474"
      unitRef="usd">189980000</ehth:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost>
    <ehth:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMTEtMy0xLTEtMA_cdcd3dc2-b561-42dd-83d9-c0e493742644"
      unitRef="usd">4000</ehth:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <ehth:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMTEtNS0xLTEtMA_0558f0c2-7314-491f-88c0-b57aee4ada59"
      unitRef="usd">7000</ehth:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <ehth:CashCashEquivalentsAndAvailableForSaleDebtSecurities
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RhYmxlOjAzMGQ4NjRkNDM1MjRlZDc5OWM1ODYwNWYzOTFiNjAwL3RhYmxlcmFuZ2U6MDMwZDg2NGQ0MzUyNGVkNzk5YzU4NjA1ZjM5MWI2MDBfMTEtNy0xLTEtMA_df8b00c9-0f1f-4d34-b476-ea5bafa66be0"
      unitRef="usd">189977000</ehth:CashCashEquivalentsAndAvailableForSaleDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80Ni9mcmFnOmMyYTU0YmFmOGI5MTQyYTU4NTA5YmY3NjZmZjVhMmE2L3RleHRyZWdpb246YzJhNTRiYWY4YjkxNDJhNTg1MDliZjc2NmZmNWEyYTZfMjA4Mg_f02bbf4e-884b-4a76-80cb-457bb902f031"
      unitRef="security">41</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMTAzMQ_909debda-5a9a-4e81-a51c-d1934f9137a6">Equity&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2021 Inducement Plan &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 22, 2021, the Company adopted an inducement plan (the &#x201c;2021 Inducement Plan&#x201d;), pursuant to which the Company reserved 410,000 shares of its common stock (subject to customary adjustments in the event of a change in capital structure of the Company) to be used exclusively for grants of awards to individuals who were not previously employees or directors of the Company, other than following a bona fide period of non-employment, as an inducement material to the individual's entry into employment with the Company within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules (&#x201c;Nasdaq Rules&#x201d;). The Inducement Plan was approved by the Company's board of directors (the &#x201c;Board&#x201d;) without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Rules, and the terms and conditions of the Inducement Plan and awards to be granted thereunder are substantially similar to the Company's stockholder-approved Amended and Restated 2014 Equity Incentive Plan.  As of September 30, 2021, no shares were issued under the 2021 Inducement Plan. Subsequently, 390,584 shares were issued under the 2021 Inducement Plan in October 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Repurchase Programs &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no stock repurchase activity during the three and nine months ended September 30, 2021. In addition to 10.7 million shares repurchased under our previous repurchase programs, we have in treasury 1.3 million shares as of September 30, 2021 that were previously surrendered by employees to satisfy tax withholding due in connection with the vesting of certain restricted stock units. As of September 30, 2021 and December 31, 2020, we had a total of 12.0 million shares and 11.8 million shares, respectively, held in treasury. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For accounting purposes, common stock repurchased under our stock repurchase programs is recorded based upon the settlement date of the applicable trade. Such repurchased shares are held in treasury and are presented using the cost method.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Expense &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our stock-based compensation expense is summarized as follows by award types (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;Amounts include market-based and performance-based restricted stock units.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock-based compensation expense by operating function for the periods presented below&#160;(in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing and advertising&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer care and enrollment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology and content&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount capitalized in internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;Stock-based compensation expense for both three and nine months ended September 30, 2021 was impacted by a $4.1&#160;million credit related to forfeited equity awards due to our chief executive officer's separation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ie5b86e4a17824c849cfbd6758868c90c_I20210922"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMjc0ODc3OTA3MzIzNA_6aff4547-8851-490f-8f8f-ea17539c9513"
      unitRef="shares">410000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMjc0ODc3OTA3MzQ4Ng_2bb787c9-72d7-436e-b5e9-05c60cb824bf"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i772c44978dc24667b2c627577234e585_D20211001-20211108"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMjc0ODc3OTA3NDU1MQ_ec7c8aa9-b264-4200-83ca-e1a1c5e8793e"
      unitRef="shares">390584</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfNDk_177a2203-bdb7-4090-b036-f1461836cf21"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfNDk_7d5afe05-1061-422b-85fe-0191407ff0a4"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i35c1fdbec1c54ee8a4e0d47f73f57d02_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfOTc_a550bd49-bd56-4f46-a0c5-93a41f250da1"
      unitRef="shares">10700000</us-gaap:TreasuryStockSharesAcquired>
    <ehth:TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMTc5_7d1903d3-7ca3-4778-a321-39ad4731b708"
      unitRef="shares">1300000</ehth:TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes>
    <us-gaap:TreasuryStockShares
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMzc2_89d71a65-9c06-4d34-a94d-390cef948683"
      unitRef="shares">12000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMzkw_05483b54-f3de-49ff-b18b-9b537712ee28"
      unitRef="shares">11800000</us-gaap:TreasuryStockShares>
    <ehth:ScheduleOfStockBasedCompensationExpenseTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMTAyOQ_48893d6f-ad86-4995-b858-315a789e7025">Our stock-based compensation expense is summarized as follows by award types (in thousands):&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units*&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;Amounts include market-based and performance-based restricted stock units.&lt;/span&gt;&lt;/div&gt;</ehth:ScheduleOfStockBasedCompensationExpenseTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1c6e47a0194e4a0d80cb752cc22efef5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMi0xLTEtMS0w_17438b96-bc6d-486f-8301-30adf7403c43"
      unitRef="usd">4666000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i13884cc2d99e4cdca2c6d705a5357058_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMi0zLTEtMS0w_4b88a39f-4ce7-41ed-b499-d409fbd04325"
      unitRef="usd">6078000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iff865bc5ba294fe1a8f363fa0a398bae_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMi01LTEtMS0w_96f7b525-cee2-4d82-93a8-a6e741511488"
      unitRef="usd">23031000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if870e8c7cb0242ba8a5c2b4b20121f1f_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMi03LTEtMS0w_8d3a1ae1-2d6e-4a2f-9904-bced1ac5868a"
      unitRef="usd">20855000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i27e01cc9738244978808f5a333f4fb54_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMy0xLTEtMS0w_ef6e8912-e7ef-4489-bc43-1243a3d1788b"
      unitRef="usd">82000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i460c059f80ca40628e4e5afaff80cc5e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMy0zLTEtMS0w_2870a32f-5393-40c6-b054-ba42eb5f3dda"
      unitRef="usd">254000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i58966c27927746fab2aa950798c6ed8e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMy01LTEtMS0w_b4a8af3c-1286-4b87-88d7-2e1a3d9f730f"
      unitRef="usd">402000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1cead6ea1a294d599363076673911adf_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfMy03LTEtMS0w_40b4e7cf-70a3-4f16-9025-a1ff0b175699"
      unitRef="usd">867000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ife779febc9214b9d9f667dc5dce85356_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNC0xLTEtMS0w_581256bd-d9cf-41c0-ac9d-053919176b10"
      unitRef="usd">486000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iecda63b246a6400e9b5384de30aae603_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNC0zLTEtMS0w_4eb5b7ce-4b71-449a-ac0e-090f545968f1"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie4fedf3dee684a9698a7fa96f6d62fd4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNC01LTEtMS0w_6f684abb-3543-45f4-b0bb-b695520c9646"
      unitRef="usd">1448000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ideb486a863af4417a98de87d059c62b5_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNC03LTEtMS0w_9a029512-a7d5-47f6-b39a-c04afb2d83dc"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNS0xLTEtMS0w_0146ff14-0dad-4373-8fbc-775e67e20c9f"
      unitRef="usd">5234000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNS0zLTEtMS0w_a2b55fc4-2750-4e86-99a7-92d10b27b760"
      unitRef="usd">6332000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNS01LTEtMS0w_3bad2193-39a7-46ba-9a07-48f49077f4d1"
      unitRef="usd">24881000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjIxODUxMTAxZjEwMjRmMDViZmQ4YWZjZDc5MDljMmVmL3RhYmxlcmFuZ2U6MjE4NTExMDFmMTAyNGYwNWJmZDhhZmNkNzkwOWMyZWZfNS03LTEtMS0w_023d1cf6-51d1-4067-8faa-8645ec23298a"
      unitRef="usd">21722000</us-gaap:AllocatedShareBasedCompensationExpense>
    <ehth:ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMTAyMQ_499ecddc-4336-4963-979e-280604554a65">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock-based compensation expense by operating function for the periods presented below&#160;(in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing and advertising&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer care and enrollment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology and content&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount capitalized in internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*&#160;&#160;&#160;&#160;Stock-based compensation expense for both three and nine months ended September 30, 2021 was impacted by a $4.1&#160;million credit related to forfeited equity awards due to our chief executive officer's separation.&lt;/span&gt;&lt;/div&gt;</ehth:ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia5734b0b91d441278f565d646dc3d8b0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMi0xLTEtMS0w_28cb2f6a-9cc1-4c01-97c7-c0b9fe4ca972"
      unitRef="usd">2297000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8edbc452bd9741e797e8dbd8b3399e72_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMi0zLTEtMS0w_a584bd75-54ce-42ef-8832-444ccb7103a8"
      unitRef="usd">1869000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ice545f8f5bdb4b2fbe3864ed0eea00e2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMi01LTEtMS0w_48ed3516-6b28-4378-b74d-03306e162854"
      unitRef="usd">6922000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i90df302f532b402fa538eed1092beab9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMi03LTEtMS0w_e143af2d-8316-49cd-94ff-e8a2422f3a94"
      unitRef="usd">5138000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7a5df46f99ab4327bcb5856e5d342696_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMy0xLTEtMS0w_b0bdef97-256a-410c-a4c7-5cb92f9bbef2"
      unitRef="usd">740000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic776873fdaff4484b896e658fb1dacfc_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMy0zLTEtMS0w_6c68752d-1d62-4e87-9b6b-ffcb4285ce8c"
      unitRef="usd">527000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6f1064a52d154cec94e9b6c3036d94f7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMy01LTEtMS0w_f20d0586-84e6-404f-9c9b-b71791a9831e"
      unitRef="usd">1901000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib5086b187a3b4d09a240002bc9755ba1_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfMy03LTEtMS0w_4ce5dc15-8331-41ac-8d99-e0d31cfc9793"
      unitRef="usd">1762000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibad2aa3a8cc44b218b307dfd6f4d7625_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNC0xLTEtMS0w_cb9606ca-79e4-449d-b93f-4a32c1026a2a"
      unitRef="usd">2380000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2bd41afc910548ce9002b75544cdf8b6_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNC0zLTEtMS0w_83134c62-ac1e-49cc-8f04-bdf4afcd9517"
      unitRef="usd">1430000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i61ff6162f5f44a859043de58c54befec_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNC01LTEtMS0w_bbaafff1-9aff-4a09-b630-3dd77679a23f"
      unitRef="usd">7483000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i98ea343e414e4f2daab5caa63d2dd869_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNC03LTEtMS0w_2d21ba05-dc95-4082-8556-563d016c1d2a"
      unitRef="usd">2965000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i154a3a36dc224680b714cc68444215d8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNS0xLTEtMS0w_522fd74d-a64e-448b-a3f8-d472c905128b"
      unitRef="usd">-183000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icb4e953743a04c219eeb943727baf738_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNS0zLTEtMS0w_c9b2cf6e-1010-443a-b661-fc81cecee19b"
      unitRef="usd">2506000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9890280d5b954508a226b55c81aeaf25_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNS01LTEtMS0w_cce9718d-f683-4960-a39c-80c6d2864f4f"
      unitRef="usd">8575000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4c5deda3fcee4a46bf2d57a2cb6c387e_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNS03LTEtMS0w_d58e2fbd-eb29-40e4-8d02-49ef23b2388d"
      unitRef="usd">11857000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNy0xLTEtMS0w_51fc82b6-bd6a-4895-ad7c-284618fdc903"
      unitRef="usd">5234000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNy0zLTEtMS0w_95ae30d8-e733-40de-a553-66ef7f471018"
      unitRef="usd">6332000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNy01LTEtMS0w_90b0c5d9-fa76-492d-9c7e-f7f7b3c24b6d"
      unitRef="usd">24881000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfNy03LTEtMS0w_3b41b7e4-0aa8-4103-86b8-97002304854f"
      unitRef="usd">21722000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOC0xLTEtMS0w_08e5b362-c4fe-4646-8000-4d1f5709330a"
      unitRef="usd">772000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOC0zLTEtMS0w_f24e365f-3b67-45c9-8fe6-a547f7eaeda6"
      unitRef="usd">548000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOC01LTEtMS0w_99de9a82-bbd7-4039-af0e-7a4bc10712f7"
      unitRef="usd">1875000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOC03LTEtMS0w_0cfcbe80-9483-47ac-a3c8-51375ca65f76"
      unitRef="usd">1278000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOS0xLTEtMS0w_19748f36-c814-4675-a704-06218203649c"
      unitRef="usd">6006000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOS0zLTEtMS0w_9632c59d-8447-44e1-9c29-3cbd16dd6ef7"
      unitRef="usd">6880000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOS01LTEtMS0w_28253f2e-297e-4465-b8c2-64baa8d22edd"
      unitRef="usd">26756000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RhYmxlOjc3ZjQ5OTM2MGRiNjQ5ODg5N2Y5OWE4OGYwZDkxNmQ2L3RhYmxlcmFuZ2U6NzdmNDk5MzYwZGI2NDk4ODk3Zjk5YTg4ZjBkOTE2ZDZfOS03LTEtMS0w_30efbe4e-3575-40f6-a824-181b5935c364"
      unitRef="usd">23000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i538a335bee9d4605ac36f25f4181afa7_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMTA5OTUxMTYzMjI5Nw_7726ef97-c3e8-483d-b723-efcd82f92d10"
      unitRef="usd">-4100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i05a980eb0e6b4490bb82b24144c3b3c8_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl80OS9mcmFnOjg3NzYxODcwMDYzZDQ5MGY4M2VkYjc3YmNkYjZjYmI4L3RleHRyZWdpb246ODc3NjE4NzAwNjNkNDkwZjgzZWRiNzdiY2RiNmNiYjhfMTA5OTUxMTYzMjI5Nw_bc3308b7-e9d9-41e2-8bbf-ce40158b1a2c"
      unitRef="usd">-4100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:PreferredStockTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfOTUyOA_dcdc669b-ec11-4bea-b4ef-cc121517e7a2">Convertible Preferred Stock&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 30, 2021 (the &#x201c;Closing Date&#x201d;), we issued and sold to Echelon Health SPV, LP (&#x201c;H.I.G.&#x201d;), an investment vehicle of H.I.G. Capital, in a private placement, 2,250,000 shares of our newly designated Series A convertible preferred stock (the &#x201c;Series A preferred stock&#x201d;), par value $0.001 per share, at an aggregate purchase price of $225.0&#160;million. We received $214.0&#160;million in net proceeds from the private placement with H.I.G., net of sales commissions and certain transaction fees totaling $11.0 million. The Series A preferred stock ranks senior to all other equity securities of the Company with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; Dividends initially accrue on the Series A preferred stock daily at 8% per annum on the stated value of $100 per share (&#x201c;Stated Value&#x201d;) and compound semiannually, payable in kind (&#x201c;PIK&#x201d;) until the second anniversary of the Closing Date on June 30 and December 31 of each year (each, a &#x201c;Dividend Payment Date&#x201d;), beginning on June 30, 2021, and thereafter 6% PIK and 2% payable in cash in arrears on June 30 and December 31 of each year, beginning on June 30, 2023. PIK dividends are cumulative and are added to the Accrued Value (as defined below). &#x201c;Accrued Value&#x201d; means, as of any date, with respect to any share of Series A preferred stock, the sum of the Stated Value per share plus, on each Dividend Payment Date, on a cumulative basis, all accrued PIK dividends on such share that have not previously compounded and been added to the Accrued Value. The Series A preferred stock participates, on an as-converted basis in all dividends paid to the holders of our common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Conversion Rights &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013; The Series A preferred stock is convertible at any time into common stock at a conversion rate equal to (i) the Accrued Value plus accrued PIK dividends that have not yet been added to the Accrued Value, (ii) divided by the conversion price as of the applicable conversion date (the &#x201c;Conversion Price&#x201d;). As of the date of this report, the Conversion Price is equal to $79.5861 per share. This Conversion Price is subject to further adjustment and the number of shares of common stock issuable upon conversion of the Series A preferred stock is subject to certain limitations, each as set forth in the Certificate of Designations of Series A preferred stock, as filed with the Secretary of State of the State of Delaware on April 30, 2021 (the &#x201c;Certificate of Designations&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redemption Put Right &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; At any time on or after the sixth anniversary of the Closing Date, holders of the Series A preferred stock will have the right to cause the Company to redeem all or any portion of the Series A preferred stock in cash at an amount equal to the greater of (i) 135% of the Accrued Value per share as of the redemption date, plus accrued PIK dividends that have not yet been added to the Accrued Value and (ii) the amount per share that would be payable on an as-converted basis on such Series A preferred stock at the then-current Accrued Value, plus accrued PIK dividends that have not yet been added to the Accrued Value, and in either case of (i) or (ii) plus any unpaid cash dividends that would have otherwise been settled in cash in connection with such conversion (the greater of (i) and (ii), the &#x201c;Redemption Price&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Redemption Call Right &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; At any time on or after the sixth anniversary of the Closing Date, the Company will have the right (but not the obligation) to redeem out of legally available funds and for cash consideration all (but not less than all) of the Series A preferred stock upon at least 30 days prior written notice at an amount equal to the Redemption Price.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Board Nomination Rights &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013; H.I.G. is entitled to nominate one individual for election to the the Board so long as it continues to own at least 30% of the common stock issuable or issued upon conversion of the Series A preferred stock originally issued to it in the private placement. H.I.G. also has the right to nominate an additional individual to the Board if the Company fails to maintain certain levels of commissions receivable and liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Voting Rights &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013; The Series A preferred stock will vote together with the common stock as a single class on all matters submitted to a vote of the holders of the common stock (subject to certain voting limitations set forth in, and the terms and conditions of, the Certificate of Designations). Each holder of Series A preferred stock shall be entitled to the number of votes, rounded down to the nearest whole number, equal to the product of (i) the aggregate Accrued Value of the issued and outstanding shares of Series A preferred stock divided by the Minimum Price (as defined below), multiplied by (ii) a fraction, the numerator of which is the number of shares of Series A preferred stock held by such holder and the denominator of which is the aggregate number of issued and outstanding shares of Series A preferred stock. &#x201c;Minimum Price&#x201d; means the lower of: (i) the Nasdaq Official Closing Price per share of common stock on the Closing Date; or (ii) the average Nasdaq Official Closing Price per share of common stock for the five trading days immediately prior to the Closing Date. Holders of Series A preferred stock will have one vote per share on any matter on which the holders of the Series A preferred stock are entitled to vote separately as a class (subject to certain voting limitations set forth in, and the terms and conditions of, the Certificate of Designations).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Mandatory Conversion of the Series A Preferred Stock  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013; At any time on or after the third anniversary of the Closing Date, if the volume-weighted average price per share of our common stock is greater than 167.5% of the then-current Conversion Price for 20 consecutive trading days in a 30-day trading day period, the Company will have the right to convert all, but not less than all, of the Series A preferred stock into common stock at a conversion rate with respect to each share of Series A preferred stock of (i) the Accrued Value plus accrued PIK dividends that have not yet been added to the Accrued Value, (ii) divided by the then applicable Conversion Price.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Covenants and Liquidity Requirements &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013; As long as H.I.G. continues to own at least 30% of the Series A preferred stock originally issued to it in the private placement, the consent of H.I.G. will be required for the Company to incur certain indebtedness and to take certain other corporate actions as set forth in the Company's investment agreement with H.I.G. entered into on February 17, 2021 (the &#x201c;Investment Agreement&#x201d;).  In addition, the Company is required to maintain an asset coverage ratio (as defined in the Investment Agreement) of at least 2x, which increases to 2.5x thirty months after the date of the Investment Agreement.  Additionally, the Investment Agreement requires the Company to maintain a minimum liquidity amount (as defined in the Investment Agreement) for certain periods that ranges from $65&#160;million to $125&#160;million. If the Company fails to maintain the minimum asset coverage ratio or minimum liquidity amount as of a certain date or for a certain time period required by the Investment Agreement and H.I.G continues to own at least 30% of the Series A preferred stock originally issued to it in the private placement, H.I.G will have the right to nominate an additional director to the Board, and the consent of H.I.G. will be required to approve the Company's annual budget, hire or terminate certain key executives, and incur &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;certain indebtedness as outlined in the Investment Agreement. H.I.G. will no longer have these additional board nomination and consent rights if the Company is able to satisfy the minimum liquidity amount requirements in the Investment Agreement for any subsequent 12 consecutive months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Series A preferred stock is considered temporary equity in our condensed consolidated financial statements. We have determined there are no material embedded features that require recognition as a derivative asset or liability. We recognized the Series A preferred stock at its stated amount less issuance costs of $11.0 million, or $214.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2021, the estimated Series A preferred stock redemption value equals 135% of the Accrued Value per share as of the redemption date, plus any accrued and unpaid dividends, which is significantly in excess of the fair value of the common stock into which the Series A preferred stock is convertible as of September 30, 2021. We have elected to apply the accretion method to adjust the carrying value of the Series A preferred stock to its redemption value at the earliest date of redemption, April 30, 2027. Amounts recognized to accrete the Series A preferred stock to its estimated redemption value are treated as a deemed dividend and are recorded as a reduction to retained earnings. The estimated redemption value will vary in subsequent periods due to the redemption put right described above and we have elected to recognize such changes prospectively.  No shares of Series A preferred stock have been converted and the Series A preferred stock was convertible into 2.9&#160;million shares of common stock as of September 30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the proceeds and changes to our Series A preferred stock (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross proceeds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net proceeds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of Closing Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued paid-in-kind dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in preferred stock redemption value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PreferredStockTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMTY0_86e95a49-4fdf-4051-95d0-b1f4e4af4248"
      unitRef="shares">2250000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i26a73d8f5e7749d9aa6a2add8248dab7_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMjc5_6c9b2735-1eb7-4d8e-a870-30dd3403e926"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <ehth:SaleOfStockConsiderationReceivedOnTransactionGross
      contextRef="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMzI3_d930209a-6102-453a-9ee4-f33562874f4a"
      unitRef="usd">225000000</ehth:SaleOfStockConsiderationReceivedOnTransactionGross>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i26a73d8f5e7749d9aa6a2add8248dab7_I20210430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMzQz_ba64ff5c-4e3b-4dbf-b0d6-af34bb0608e0"
      unitRef="usd">214000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNDY1_7fae3db9-e63c-4392-91f8-27896adfa5c6"
      unitRef="usd">11000000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfODEz_9d0db2d5-5fbc-417d-a2f2-47029f401cf5"
      unitRef="number">0.08</us-gaap:PreferredStockDividendRatePercentage>
    <ehth:PreferredStockConvertibleStatedValue
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfODQ5_57b6d49e-d9aa-478f-9dd7-97eb0c003ee4"
      unitRef="usdPerShare">100</ehth:PreferredStockConvertibleStatedValue>
    <ehth:PreferredStockDividendRatePayableInKindPercentage
      contextRef="i2066383d954548c7a2a439ea4837e924_D20230630-20230630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMTA5Nw_1861b1e0-703b-45c3-ad38-4c4e9d973d66"
      unitRef="number">0.06</ehth:PreferredStockDividendRatePayableInKindPercentage>
    <ehth:PreferredStockDividendRateCashPercentage
      contextRef="i2066383d954548c7a2a439ea4837e924_D20230630-20230630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMTEwOA_fd2078ae-f195-4384-8fca-cfc49f316e95"
      unitRef="number">0.02</ehth:PreferredStockDividendRateCashPercentage>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="i10b063ee9a3341c08e50e129ebfdff8a_I20210531"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMjIwNw_97aa2126-8b44-4a7f-9b44-28e5b5bc0505"
      unitRef="usdPerShare">79.5861</us-gaap:PreferredStockConvertibleConversionPrice>
    <ehth:ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare
      contextRef="i411da4d1faed43bea99e5a09b88c09cb_I20270430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMjg5MA_5d271ed0-e760-4b9a-b299-1b2db52de9b7"
      unitRef="number">1.35</ehth:ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare>
    <ehth:ConvertiblePreferredStockRedemptionCallRightWrittenNotice
      contextRef="i411da4d1faed43bea99e5a09b88c09cb_I20270430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMzc0NQ_5fad303d-4874-4102-bea6-1382a74d004c"
      unitRef="day">30</ehth:ConvertiblePreferredStockRedemptionCallRightWrittenNotice>
    <ehth:ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors
      contextRef="id4e0a9ea40624a0c8ff143de3025b216_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMzg3Ng_6dc9cc9a-d37e-41f5-959a-f4ef850b4070"
      unitRef="state">1</ehth:ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors>
    <ehth:CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors
      contextRef="id4e0a9ea40624a0c8ff143de3025b216_I20210430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfMzk5Mw_d4392431-8172-4c1d-bf25-8790b409847c"
      unitRef="number">0.30</ehth:CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors>
    <ehth:ConvertiblePreferredStockVotesPerShare
      contextRef="i26a73d8f5e7749d9aa6a2add8248dab7_I20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNTUzMQ_d38cd55b-3a26-4778-baeb-5089cfe9c801"
      unitRef="state">1</ehth:ConvertiblePreferredStockVotesPerShare>
    <ehth:ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger
      contextRef="i745ac50b018842c299fbdeda74cca4fd_D20240430-20240430"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNTk4Ng_2ae0b084-6369-4348-af63-405c0d3bc987"
      unitRef="number">1.675</ehth:ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger>
    <ehth:ConvertiblePreferredStockThresholdConsecutiveTradingDays
      contextRef="i745ac50b018842c299fbdeda74cca4fd_D20240430-20240430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNjAzMA_e7f5c184-4277-479f-8963-024b4d36aba4"
      unitRef="day">20</ehth:ConvertiblePreferredStockThresholdConsecutiveTradingDays>
    <ehth:ConvertiblePreferredStockThresholdTradingDays
      contextRef="i745ac50b018842c299fbdeda74cca4fd_D20240430-20240430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNjA2Mw_656cf688-d6bb-4a5f-a3e0-351d9403099e"
      unitRef="day">30</ehth:ConvertiblePreferredStockThresholdTradingDays>
    <ehth:ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt
      contextRef="icb998d550c844cf9af4331570da45fc4_I20210217"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNjUyOA_54841ddd-9bdb-470f-9ff3-d77f0b9d5ff3"
      unitRef="number">0.30</ehth:ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt>
    <ehth:ConvertiblePreferredStockCovenantAssetCoverageRatio
      contextRef="i0e6cbb434882488fb8c40546664dd72a_I20210217"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNjk5Ng_6152b23d-ba80-4c35-a52e-ba7c8a60155c"
      unitRef="number">2</ehth:ConvertiblePreferredStockCovenantAssetCoverageRatio>
    <ehth:ConvertiblePreferredStockCovenantAssetCoverageRatio
      contextRef="i43de0639e96543369be5664fcb0fb527_I20230817"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNzAyMA_0899e486-623a-458b-b780-aa8019d91641"
      unitRef="number">2.5</ehth:ConvertiblePreferredStockCovenantAssetCoverageRatio>
    <ehth:ConvertiblePreferredStockCovenantLiquidity
      contextRef="i6156a60f5d5a4f659313e014d9aa6e94_I20210217"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNzI2MA_c0eec618-7fb6-4113-af3e-323c39972321"
      unitRef="usd">65000000</ehth:ConvertiblePreferredStockCovenantLiquidity>
    <ehth:ConvertiblePreferredStockCovenantLiquidity
      contextRef="iee6fe712df744b2590f8f3fc4983ca39_I20210217"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNzI2Ng_a8d729f6-8c3d-4461-89b2-94c42996c954"
      unitRef="usd">125000000</ehth:ConvertiblePreferredStockCovenantLiquidity>
    <ehth:ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt
      contextRef="icb998d550c844cf9af4331570da45fc4_I20210217"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfNzQ4Nw_508bb041-8144-4b09-bb46-1d26af1b9348"
      unitRef="number">0.30</ehth:ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfODM5MA_7fae3db9-e63c-4392-91f8-27896adfa5c6"
      unitRef="usd">11000000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i26a73d8f5e7749d9aa6a2add8248dab7_I20210430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfODM5Nw_ba64ff5c-4e3b-4dbf-b0d6-af34bb0608e0"
      unitRef="usd">214000000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <ehth:ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfODQ4Ng_8fba2664-7908-460d-8383-4bad6277e087"
      unitRef="number">1.35</ehth:ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfOTI3MA_71867a1e-45b9-4f4f-bfc2-70daa8f7ea0c"
      unitRef="shares">0</us-gaap:ConversionOfStockSharesConverted1>
    <ehth:ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfOTM4Mw_914e95ca-bbf4-4fe9-acac-8eaf0f736ce8"
      unitRef="shares">2900000</ehth:ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RleHRyZWdpb246MTJmMTVmNmU5YjgxNDU3ZWFiN2VlOTcyMzRmOWM4ZjZfOTUzMA_f408ba6e-9ca4-46c1-a9b6-ef522c415a6a">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the proceeds and changes to our Series A preferred stock (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross proceeds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net proceeds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of Closing Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued paid-in-kind dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in preferred stock redemption value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <ehth:SaleOfStockConsiderationReceivedOnTransactionGross
      contextRef="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RhYmxlOjM1M2FkNDlmMjU2OTRhZWQ4OTllNjdmMTI2NDk4YTA0L3RhYmxlcmFuZ2U6MzUzYWQ0OWYyNTY5NGFlZDg5OWU2N2YxMjY0OThhMDRfMC0yLTEtMS0w_fd03dff4-bea8-481c-81bd-af0587b93d75"
      unitRef="usd">225000000</ehth:SaleOfStockConsiderationReceivedOnTransactionGross>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RhYmxlOjM1M2FkNDlmMjU2OTRhZWQ4OTllNjdmMTI2NDk4YTA0L3RhYmxlcmFuZ2U6MzUzYWQ0OWYyNTY5NGFlZDg5OWU2N2YxMjY0OThhMDRfMS0yLTEtMS0w_81152123-039e-4b11-8851-78e0ec9b1fa3"
      unitRef="usd">10975000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i62bd92b031dc46ee938800c64916afe9_D20210430-20210430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RhYmxlOjM1M2FkNDlmMjU2OTRhZWQ4OTllNjdmMTI2NDk4YTA0L3RhYmxlcmFuZ2U6MzUzYWQ0OWYyNTY5NGFlZDg5OWU2N2YxMjY0OThhMDRfMi0yLTEtMS0w_2fd2b0df-6fbc-4c78-9f16-65414a297ec9"
      unitRef="usd">214025000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i26a73d8f5e7749d9aa6a2add8248dab7_I20210430"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RhYmxlOjM1M2FkNDlmMjU2OTRhZWQ4OTllNjdmMTI2NDk4YTA0L3RhYmxlcmFuZ2U6MzUzYWQ0OWYyNTY5NGFlZDg5OWU2N2YxMjY0OThhMDRfNC0yLTEtMS0w_b03de381-8cf6-4240-8f81-f5069daf57aa"
      unitRef="usd">214025000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityAccretionOfDividends
      contextRef="i4a83bcf547574a6b95583d2323256a2f_D20210430-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RhYmxlOjM1M2FkNDlmMjU2OTRhZWQ4OTllNjdmMTI2NDk4YTA0L3RhYmxlcmFuZ2U6MzUzYWQ0OWYyNTY5NGFlZDg5OWU2N2YxMjY0OThhMDRfNS0yLTEtMS0w_c820e7a3-3008-4b53-a358-7710501720f0"
      unitRef="usd">7643000</us-gaap:TemporaryEquityAccretionOfDividends>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i4a83bcf547574a6b95583d2323256a2f_D20210430-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RhYmxlOjM1M2FkNDlmMjU2OTRhZWQ4OTllNjdmMTI2NDk4YTA0L3RhYmxlcmFuZ2U6MzUzYWQ0OWYyNTY5NGFlZDg5OWU2N2YxMjY0OThhMDRfNi0yLTEtMS0w_9e1dfc74-1767-490e-8691-3dce8ebf49eb"
      unitRef="usd">3770000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81Mi9mcmFnOjEyZjE1ZjZlOWI4MTQ1N2VhYjdlZTk3MjM0ZjljOGY2L3RhYmxlOjM1M2FkNDlmMjU2OTRhZWQ4OTllNjdmMTI2NDk4YTA0L3RhYmxlcmFuZ2U6MzUzYWQ0OWYyNTY5NGFlZDg5OWU2N2YxMjY0OThhMDRfNy0yLTEtMS0w_8562b03f-ab5a-49d8-ab8a-1f7e509d494a"
      unitRef="usd">225438000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RleHRyZWdpb246N2NmNWZiZjViNDEwNDlmOWI2OGIzOWViMDdjNzMxYTFfMjA2Ng_cb4c6061-6ae1-45fc-9b50-ef921064a4eb">Net Loss Per Share Attributable to Common Stockholders&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Series A preferred stock is considered a participating security which requires the use of two-class method for the computation of basic and diluted per share amounts. Under the two-class method, earnings available to common stockholders for the period are allocated between common stockholders and participating securities according to dividends accumulated and participation rights in undistributed earnings. Net loss attributable to common stockholders is not allocated to the convertible preferred stock as the holder of the Series A preferred stock does not have a contractual obligation to share in losses. Basic net loss attributable to common stockholders per share is computed by dividing net loss available to common stockholders by the weighted-average number of shares of common stock outstanding for the period. Diluted net loss attributable to common stockholders per share is computed by dividing the net loss available to common stockholders for the period by the weighted average number of common and common equivalent shares outstanding during the period. Diluted net loss attributable to common stockholders per share reflects all potential dilutive common stock equivalent shares, including conversion of preferred stock, stock options, restricted stock units and shares to be issued under our employee stock purchase program (&#x201c;ESPP&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net loss attributable to common stockholders per share (in thousands, except per share amounts):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in per share calculation &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in diluted share calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders per share &#x2013; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each of the three and nine months ended September 30, 2021 and 2020, we had securities outstanding that could potentially dilute per share amounts, but the shares from the assumed conversion or exercise of these securities were excluded in the computation of diluted net loss per share as their effect would have been anti-dilutive. The number of outstanding anti-dilutive shares that were excluded from the computation of diluted net income (loss) per share consisted of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,201&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RleHRyZWdpb246N2NmNWZiZjViNDEwNDlmOWI2OGIzOWViMDdjNzMxYTFfMjA2Mw_e790ad04-93e6-4489-a0c2-c1b02390493e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net loss attributable to common stockholders per share (in thousands, except per share amounts):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83,636)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in per share calculation &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used in diluted share calculation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders per share &#x2013; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfMy0xLTEtMS0w_35c1f391-5294-4ce0-a3f3-d21a71efa85e"
      unitRef="usd">-59948000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfMy0zLTEtMS0w_ca618b2d-e2ab-4b7d-afff-f591875ba4ab"
      unitRef="usd">-14505000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfMy01LTEtMS0w_0bfdadcd-8819-431c-a037-dd3c64d12254"
      unitRef="usd">-83636000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfMy03LTEtMS0w_d3809256-d886-45a8-8b6a-30bc34727b62"
      unitRef="usd">-14423000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNS0xLTEtMS0w_9d3b9790-7281-4f7e-9835-7b838abd922c"
      unitRef="shares">26786000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNS0zLTEtMS0w_8f7f5dd1-ff24-4657-bae1-1809d5bc38a5"
      unitRef="shares">26487000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNS01LTEtMS0w_6de6b208-fb84-45cb-9f17-c9815405429a"
      unitRef="shares">26688000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNS03LTEtMS0w_b9c4cf2a-0249-416f-9f7b-28b649e4ae82"
      unitRef="shares">25838000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <ehth:IncrementalCommonSharesAttributableToOptions
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNi0xLTEtMS0w_77d9fadd-16a4-412a-b21e-400b0942904b"
      unitRef="shares">0</ehth:IncrementalCommonSharesAttributableToOptions>
    <ehth:IncrementalCommonSharesAttributableToOptions
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNi0zLTEtMS0w_d3f1f7db-805f-43bd-bb1a-6defea499eed"
      unitRef="shares">0</ehth:IncrementalCommonSharesAttributableToOptions>
    <ehth:IncrementalCommonSharesAttributableToOptions
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNi01LTEtMS0w_90f536f8-41fb-491b-8517-18e2a2a4328b"
      unitRef="shares">0</ehth:IncrementalCommonSharesAttributableToOptions>
    <ehth:IncrementalCommonSharesAttributableToOptions
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNi03LTEtMS0w_54ebf7cf-0f3c-4ad4-8ec1-bc9f1aaef914"
      unitRef="shares">0</ehth:IncrementalCommonSharesAttributableToOptions>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNy0xLTEtMS0w_3be13faa-5ff2-4f1b-95b4-7fd0b5a0ee2b"
      unitRef="shares">26786000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNy0zLTEtMS0w_280abca7-4137-415c-b6c3-ee7acd850011"
      unitRef="shares">26487000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNy01LTEtMS0w_824ad166-d17e-469f-a11b-b4059162ea9d"
      unitRef="shares">26688000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfNy03LTEtMS0w_21c54e28-1caf-4d9d-8a3e-48dd162b0426"
      unitRef="shares">25838000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS0xLTEtMS0w_302f5217-72d9-462d-a64d-b015a1c6f5e7"
      unitRef="usdPerShare">-2.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS0xLTEtMS0w_f3cd95ac-4d50-4d7c-95d5-100cb3a9e7ce"
      unitRef="usdPerShare">-2.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS0zLTEtMS0w_8b4e6b4b-03b2-43d6-ba17-cb8f89acd427"
      unitRef="usdPerShare">-0.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS0zLTEtMS0w_e5a756f5-0a36-4b16-b987-bcce92c07f35"
      unitRef="usdPerShare">-0.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS01LTEtMS0w_5cc71833-db27-4f5d-8fe2-14a69932e254"
      unitRef="usdPerShare">-3.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS01LTEtMS0w_c185eb37-2994-44b6-8ace-35e2c3271d37"
      unitRef="usdPerShare">-3.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS03LTEtMS0w_e80c6ed1-0472-42db-9167-cb9a1c74d810"
      unitRef="usdPerShare">-0.56</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOjc2MjdkMzQ5N2NmOTQ5NjRiYjhkOGNmYTYwNjM2NjAzL3RhYmxlcmFuZ2U6NzYyN2QzNDk3Y2Y5NDk2NGJiOGQ4Y2ZhNjA2MzY2MDNfOS03LTEtMS0w_fa71f2bf-dfc5-4855-a2b9-b31f03bb22c4"
      unitRef="usdPerShare">-0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RleHRyZWdpb246N2NmNWZiZjViNDEwNDlmOWI2OGIzOWViMDdjNzMxYTFfMjA2NQ_db0c174e-d17c-4ffe-add6-971eeaf3992e">The number of outstanding anti-dilutive shares that were excluded from the computation of diluted net income (loss) per share consisted of the following (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;748&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,201&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if073c25e8f81417c919277ea8f455b19_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMi0xLTEtMS0w_4009b581-802f-4459-9cba-654ad32c682c"
      unitRef="shares">2866000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5d6d24f666c04e62a06ca4c5cf46e773_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMi0zLTEtMS0w_da6b6f93-5aa5-40f1-b5dd-7b2d6a63dd0d"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia5e0e7005d3f4062a071addcafc27c06_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMi01LTEtMS0w_67aff4e1-c810-45d7-9e5e-1a20da1857a4"
      unitRef="shares">1595000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9e30025f0e894023bc09a663cf9f1b11_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMi03LTEtMS0w_38702861-9d20-449a-adca-d7b98b01324d"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia579f87161bd4c4bbfb8854b3b172133_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMy0xLTEtMS0w_e631a274-2acf-4e20-9145-63bdf5545021"
      unitRef="shares">1134000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icbfdeb0605ef4c5f870e8f2f7cd707a4_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMy0zLTEtMS0w_aee83f7a-ec02-40be-939c-de81aa257087"
      unitRef="shares">599000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i229764ec8611404cb78a18d3f3ea7742_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMy01LTEtMS0w_5c511f74-c872-47b7-9e2d-e4ebd05af9d7"
      unitRef="shares">1055000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iebe8f8a1f6c74de99d0800095353e8d6_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfMy03LTEtMS0w_927e9bd6-94fe-4527-ba8f-072193fff188"
      unitRef="shares">748000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib307fc5e33fc48b29073be7772a66cf6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNC0xLTEtMS0w_5aa8d338-4bc5-4b5b-b554-5c4498b985d5"
      unitRef="shares">278000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1be182ab19bb49e5ad85243990d16da7_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNC0zLTEtMS0w_9941e55a-130f-4442-8b80-8d8da5ab9647"
      unitRef="shares">414000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic43e48e719fb4602912e4b0b7aa5e097_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNC01LTEtMS0w_d807bc4b-86cf-476c-b04e-c6a80d042681"
      unitRef="shares">330000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iecb19833c8e8461f9982c3ef70588776_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNC03LTEtMS0w_d13b13c0-57e5-4c2b-a24a-6d34ca4e1bb2"
      unitRef="shares">453000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i340227a27cb64be1b3a57692746b5bbe_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNS0xLTEtMS0w_fc855527-fe0f-460f-9694-747f6344cb63"
      unitRef="shares">7000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6b044301e060489699b1d5da2e923272_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNS0zLTEtMS0w_cab29a76-6ddf-4981-92fb-1362a18061a9"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic70c39ada9ec49e5a840c9102e12c415_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNS01LTEtMS0w_2e536f4f-8efe-47d3-91df-41254a0106d6"
      unitRef="shares">12000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9fba14fb6ba94783a410123eed9f78a3_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNS03LTEtMS0w_9ead96aa-d610-40a7-90ee-436d7a52e75b"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNi0xLTEtMS0w_406a251f-1267-4f27-b75e-e5fed5283869"
      unitRef="shares">4285000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNi0zLTEtMS0w_d97ac120-a712-4354-804c-13911e8744dc"
      unitRef="shares">1013000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNi01LTEtMS0w_533d14dd-b36f-4946-bdcb-13464e9ca0ab"
      unitRef="shares">2992000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81NS9mcmFnOjdjZjVmYmY1YjQxMDQ5ZjliNjhiMzllYjA3YzczMWExL3RhYmxlOmRlNDY2YTllMTEwNzQyMDNiNGY2Mzc5MDA2OWQzMDliL3RhYmxlcmFuZ2U6ZGU0NjZhOWUxMTA3NDIwM2I0ZjYzNzkwMDY5ZDMwOWJfNi03LTEtMS0w_b16da1dc-4f37-4cf3-a348-4d9dc0669d7e"
      unitRef="shares">1201000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RleHRyZWdpb246YzVhNzQxMGFmZjczNGE5YmJmMTYxMTUyNmMxZmRhNjlfNjE1Ng_ff331933-f79d-4d8d-8357-45fb33912d87">Commitments and Contingencies&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Service and Licensing Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into service and licensing agreements with third party vendors to provide various services, including network access, equipment maintenance, and software licensing. As the benefits of these agreements are experienced uniformly over the applicable contractual periods, we record the related service and licensing expenses on a straight-line basis, although actual cash payment obligations under certain of these agreements fluctuate over the terms of the agreements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our future minimum payments under non-cancellable contractual service and licensing obligations as of September 30, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;For the Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for commitments related to our operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;From time to time, we receive inquiries from governmental bodies and also may be subject to various legal proceedings and claims arising in the ordinary course of business. We assess contingencies to determine the degree of probability and range of possible loss for potential accrual in our condensed consolidated financial statements. An estimated loss contingency is accrued in the condensed consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. There was no material litigation-related accrual during the three and nine months ended September 30, 2021. Legal proceedings or other contingencies could result in material costs, even if we ultimately prevail.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Securities Class Action &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013; On April 8, 2020 and April 30, 2020, two purported class action lawsuits were filed against us, our then-chief executive officer, Scott N. Flanders, our then-chief financial officer, Derek N. Yung, and our then-chief operating officer, David K. Francis (collectively, the &#x201c;Defendants&#x201d;), in the United States District Court for the Northern District of California. The cases are captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Patel v. eHealth, Inc., et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;., Case No. 5:20-cv-02395 (N.D. Cal.) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Bertrand v. eHealth, Inc. et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, Case No. 4:20-cv-02967 (N.D. Cal.). The complaints allege, among other things, that we and Messrs. Flanders, Yung and Francis made materially false and misleading statements and/or failed to disclose material information regarding our accounting and modeling assumptions, rate of member churn and our profitability during the alleged class period of March 19, 2018 to April 7, 2020. The complaints allege that we and Messrs. Flanders, Yung and Francis violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The complaints seek compensatory and (in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Patel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; lawsuit) punitive damages, attorneys&#x2019; fees and costs, and such other relief as the court deems proper. On June 24, 2020, the court consolidated the above-referenced matters under the caption&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt; In re eHealth Securities Litig.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, Master File No. 4:20-cv-02395-JST (N.D. Cal.). The court also appointed a lead plaintiff and lead counsel for the consolidated matter. The lead plaintiff filed an amended complaint on August 25, 2020, which the Defendants moved to dismiss on October 23, 2020. The Defendants&#x2019; motion, which the plaintiff opposed, was granted in part and denied in part on August 12, 2021.  The court dismissed the plaintiff's claims to the extent premised upon alleged misrepresentations or omissions relating to churn, but denied the Defendants motion with respect to alleged misstatements regarding purported operating costs.  On October 1, 2021, the Company filed an answer denying in part and admitting in part the remaining allegations, and denying any wrongdoing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Derivative Actions &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 7, 2020 and October 13, 2020, two derivative lawsuits were filed against our then-chief executive officer, Mr. Flanders, our then-chief financial officer, Mr. Yung, our then-chief operating officer, Mr. Francis, and the members of our Board  at the time of filing of the complaints (collectively, the &#x201c;Individual Defendants&#x201d;), in the United States District Court for the Northern District of California and the Superior Court of California, County of Santa Clara. The cases are captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Chernet v. Flanders et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;., Case No. 3:20-cv-04477-SK (N.D. Cal.), and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Lincolnshire Police Pension Fund v. Flanders et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;, Case No. 20CV371555 (Cal. Super. Ct.), and also name the Company as a nominal defendant. A third derivative lawsuit was filed against the same defendants on October 5, 2021 in the United States District Court for the Northern District of California, captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Badwal v. Flanders et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;., Case No. 4:21-cv-07795 (N.D. Cal.). The complaints allege, among &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;other things, that beginning on March 19, 2018, the Individual Defendants made or caused the Company to make materially false and misleading statements and/or failed to disclose material information regarding our accounting and modeling assumptions, rate of member churn, profitability, and internal controls. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Chernet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Lincolnshire&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; complaints purport to assert claims for breach of fiduciary duty, unjust enrichment and waste of corporate assets. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Chernet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; lawsuit also alleges that the Individual Defendants violated Sections 14(a), 10(b), and 20(a) of the Securities Exchange Act of 1934, and asserts claims for abuse of control and gross mismanagement. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Badwal&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; complaint purports to assert a claim for breach of fiduciary duty, an insider trading claim, and violations of Section 14(a), 10(b) and 20D of the Securities Exchange Act of 1934.  The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Chernet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Lincolnshire&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; complaints seek damages, restitution, attorneys&#x2019; fees and costs, and certain measures with respect to our corporate governance and internal procedures, and (in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Lincolnshire&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; lawsuit) equitable and/or injunctive relief. The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Badwal&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; complaint seeks damages, declaratory relief, corporate governance measures, equitable and injunctive relief, restitution and disgorgement, and attorneys' fees and costs.  On August 10, 2020, the parties filed a Stipulation and Proposed Order in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Chernet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; matter to stay the action until and through the resolution of the Defendants' anticipated motion to dismiss the consolidated securities class action, and filed a similar stipulation in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Lincolnshire&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; matter on December 11, 2020.  The &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Chernet&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; stipulation was granted by the court on August 12, 2020 and the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Lincolnshire&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; stipulation on December 11, 2020. The agreed-upon stays terminated with the filing of an answer in the securities class action and the parties are engaged in discussions regarding further proceedings. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;The Gonzalez and Le&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Vias Complaints&lt;/span&gt; &#x2013; On April 6, 2018, a former employee, Lupita Gonzalez, filed a complaint against us in the Superior Court of the State of California for the County of Sacramento (the &#x201c;Gonzalez Complaint&#x201d;). On July 1, 2019, two other current or former employees, Michael Le&#x2019;Vias and Ramona Meadows, filed a related complaint against us and eHealth Ins. Serv. Co., in the Superior Court of the State of California for the County of Santa Clara (the &#x201c;Le&#x2019;Vias Complaint&#x201d;). Both complaints asserted claims under the California Private Attorney General Act on behalf of all current and former hourly-paid or non-exempt employees who work or have worked for us in California, based on alleged failures to comply with California wage and hour laws. The parties have entered into a court-approved settlement agreement that resolves both matters related to the Gonzalez and Le'Vias Complaints, and both the Gonzalez and Le'Vias Complaints have been dismissed with prejudice.</us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock>
    <srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RleHRyZWdpb246YzVhNzQxMGFmZjczNGE5YmJmMTYxMTUyNmMxZmRhNjlfNjE1Nw_e8f56709-b8c7-4b31-b9fc-7e82d08da05a">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our future minimum payments under non-cancellable contractual service and licensing obligations as of September 30, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;For the Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock>
    <us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RhYmxlOjIyMGYzOWEwZDYwMzQwNjQ5YjBjZDQ2Y2QyNzYxNDk1L3RhYmxlcmFuZ2U6MjIwZjM5YTBkNjAzNDA2NDliMGNkNDZjZDI3NjE0OTVfMS0xLTEtMS0w_71be8867-13fb-4675-b210-0f9c60e984f0"
      unitRef="usd">2845000</us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear>
    <us-gaap:ContractualObligationDueInNextTwelveMonths
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RhYmxlOjIyMGYzOWEwZDYwMzQwNjQ5YjBjZDQ2Y2QyNzYxNDk1L3RhYmxlcmFuZ2U6MjIwZjM5YTBkNjAzNDA2NDliMGNkNDZjZDI3NjE0OTVfMi0xLTEtMS0w_1aff71c6-73ff-4c06-92e1-ffa7a1285817"
      unitRef="usd">10407000</us-gaap:ContractualObligationDueInNextTwelveMonths>
    <us-gaap:ContractualObligationDueInSecondYear
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RhYmxlOjIyMGYzOWEwZDYwMzQwNjQ5YjBjZDQ2Y2QyNzYxNDk1L3RhYmxlcmFuZ2U6MjIwZjM5YTBkNjAzNDA2NDliMGNkNDZjZDI3NjE0OTVfMy0xLTEtMS0w_bc0097a2-a217-4a9c-9905-3cb4a000028e"
      unitRef="usd">8067000</us-gaap:ContractualObligationDueInSecondYear>
    <us-gaap:ContractualObligationDueInThirdYear
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RhYmxlOjIyMGYzOWEwZDYwMzQwNjQ5YjBjZDQ2Y2QyNzYxNDk1L3RhYmxlcmFuZ2U6MjIwZjM5YTBkNjAzNDA2NDliMGNkNDZjZDI3NjE0OTVfNC0xLTEtMS0w_b66bdb71-e7fa-41cf-a8e7-c2703dec72c5"
      unitRef="usd">2256000</us-gaap:ContractualObligationDueInThirdYear>
    <us-gaap:ContractualObligationDueInFourthYear
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RhYmxlOjIyMGYzOWEwZDYwMzQwNjQ5YjBjZDQ2Y2QyNzYxNDk1L3RhYmxlcmFuZ2U6MjIwZjM5YTBkNjAzNDA2NDliMGNkNDZjZDI3NjE0OTVfNS0xLTEtMS0w_f038c1b4-2e1e-47e8-8ca0-3a276c754db0"
      unitRef="usd">0</us-gaap:ContractualObligationDueInFourthYear>
    <ehth:ContractualObligationToBePaidAfterYearFour
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RhYmxlOjIyMGYzOWEwZDYwMzQwNjQ5YjBjZDQ2Y2QyNzYxNDk1L3RhYmxlcmFuZ2U6MjIwZjM5YTBkNjAzNDA2NDliMGNkNDZjZDI3NjE0OTVfNi0xLTEtMS0w_4945701e-1635-4ea2-9859-693f5847f3aa"
      unitRef="usd">0</ehth:ContractualObligationToBePaidAfterYearFour>
    <us-gaap:ContractualObligation
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RhYmxlOjIyMGYzOWEwZDYwMzQwNjQ5YjBjZDQ2Y2QyNzYxNDk1L3RhYmxlcmFuZ2U6MjIwZjM5YTBkNjAzNDA2NDliMGNkNDZjZDI3NjE0OTVfNy0xLTEtMS0w_0409bd70-67e0-4dc1-94b9-9f108afdf861"
      unitRef="usd">23575000</us-gaap:ContractualObligation>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="if22877f27abe4b9e9bcea617938a333a_D20200408-20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RleHRyZWdpb246YzVhNzQxMGFmZjczNGE5YmJmMTYxMTUyNmMxZmRhNjlfMTUzNQ_b67ae687-737a-40ff-957a-c2e4e8bcbe1a"
      unitRef="claim">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i4d162a37afc94df8a25268308d382345_D20200707-20201013"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RleHRyZWdpb246YzVhNzQxMGFmZjczNGE5YmJmMTYxMTUyNmMxZmRhNjlfMzEzMw_fc582cdd-3f2c-4ad9-b903-291c3d00a3d4"
      unitRef="claim">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i21698a317c0745a9b39abd2f8c067af4_D20190701-20190701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl81OC9mcmFnOmM1YTc0MTBhZmY3MzRhOWJiZjE2MTE1MjZjMWZkYTY5L3RleHRyZWdpb246YzVhNzQxMGFmZjczNGE5YmJmMTYxMTUyNmMxZmRhNjlfNTE0MQ_318974f3-3b7e-4809-9eca-828d4bfc74fc"
      unitRef="plaintiff">2</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMjI4MA_4297cf9a-b0f4-415d-8ad0-280746449eae">Segment and Geographic Information&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We report segment information based on how our chief executive officer, who is our chief operating decision maker ("CODM"), regularly reviews our operating results, allocates resources and makes decisions regarding our business operations. The performance measures of our segments include total revenue and profit. Our business structure is comprised of&#160;two&#160;operating segments: Medicare and Individual, Family and Small Business. Please refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Business and Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Notes to Consolidated Financial Statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in Part II, Item 8 of the Annual Report on Form 10-K for the year ended December 31, 2020 for our accounting policies relating to operating segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of our operating segments are summarized for the periods presented below (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual, Family and Small Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment profit (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare segment profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,882)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual, Family and Small Business segment profit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total segment profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,881)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,722)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,899)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and reorganization charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss before benefit from income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,848)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;During the first quarter of 2021, we revised the calculation of segment profit by excluding amortization of capitalized software development costs to enhance comparability of our financial metrics with peer companies. The amortization of capitalized software development costs were $3.4 million and $2.1 million for the three months ended September 30, 2021 and 2020, respectively, and $9.1 million and $5.3 million for the nine months ended September 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Depreciation and amortization has been adjusted to include amortization of software development costs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no inter-segment revenue transactions for the periods presented. With the exception of contract assets &#x2013; commissions receivable, which is presented by segment in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Supplemental Financial Statement Information&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, our CODM does not separately evaluate assets by segment, and therefore, assets by segment are not presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Geographic Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our long-lived assets primarily consist of property and equipment and internally-developed software. Our long-lived assets are attributed to the geographic location in which they are located. Long-lived assets by geographical area are summarized as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:58.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all revenue for the three and nine months ended September 30, 2021 and 2020&#160;was generated from customers located in the United States. Carriers representing 10% or more of our total revenue are summarized as follows:&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;UnitedHealthCare &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aetna &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Humana&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centene &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;__________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Percentages include the carriers' subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the revenue of WellCare is included in the percentage calculation for the three and nine months ended September 30, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMzg4_54c4d7ea-1858-4f83-b45c-8701d91107d3"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMjI3NQ_df7f4e20-aad7-44eb-9ab1-8d7ec4fe9784">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of our operating segments are summarized for the periods presented below (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual, Family and Small Business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment profit (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare segment profit (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,882)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual, Family and Small Business segment profit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total segment profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,383)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,581)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,206)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,234)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,881)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,722)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,899)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and reorganization charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss before benefit from income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,848)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt;_____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;During the first quarter of 2021, we revised the calculation of segment profit by excluding amortization of capitalized software development costs to enhance comparability of our financial metrics with peer companies. The amortization of capitalized software development costs were $3.4 million and $2.1 million for the three months ended September 30, 2021 and 2020, respectively, and $9.1 million and $5.3 million for the nine months ended September 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;(2)Depreciation and amortization has been adjusted to include amortization of software development costs.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78acf1a81a984826bfe2cedc7f25d60d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMy0xLTEtMS0w_e11330df-9f00-493c-80fb-7dc31a5ffab2"
      unitRef="usd">46381000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i599f7c7be93c4814890c266b5ec47df8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMy0zLTEtMS0w_61d5a716-7cdd-4672-af1b-4fcc0347d790"
      unitRef="usd">70361000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ef09b5449f84c8ead10851320de6c76_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMy01LTEtMS0w_b97e0a8c-4e71-4942-a17d-ac9b3bf449ea"
      unitRef="usd">240633000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a6293eb4d8349d9a31d1b1a2fd3ed11_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMy03LTEtMS0w_003021bb-bb12-4698-b2ee-db8077123d29"
      unitRef="usd">246891000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5da3c7f6d5d4610954eeac8d16c4dbe_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNC0xLTEtMS0w_62b78901-0768-470d-ab5a-78726df36a06"
      unitRef="usd">17533000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a41b5baa43d4ed18e1b54843fc57273_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNC0zLTEtMS0w_bbf8d34e-db5a-40f6-9ce3-8f4dea67592b"
      unitRef="usd">23923000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i467949b0884e43b0a011bdf4fadde010_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNC01LTEtMS0w_81dd316c-293c-4e55-83a5-4820f9532efa"
      unitRef="usd">54052000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i039e32b3c64041e49cb0878ecaabafd1_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNC03LTEtMS0w_1a07dd71-54fc-436b-ae7b-03b91a58d8e8"
      unitRef="usd">42567000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91c81e16d0784d4d958fe95d1f894a24_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNS0xLTEtMS0w_9887d40d-245d-45c2-b662-c40a8106ed38"
      unitRef="usd">63914000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaef638b0fa1046eb9911d6d4747f5df0_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNS0zLTEtMS0w_c5d3b279-180e-4858-8698-48ecfe99800f"
      unitRef="usd">94284000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ad8d3eeb32049fe90a788e0eda6b25d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNS01LTEtMS0w_b1eceefe-bf8e-4086-99d4-7f4774d420ca"
      unitRef="usd">294685000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23411f69f39b432f81bcc3da7c590e76_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfNS03LTEtMS0w_41f61397-385c-4ab5-a45d-ce88d3320854"
      unitRef="usd">289458000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i78acf1a81a984826bfe2cedc7f25d60d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOC0xLTEtMS0w_56a5f2d8-bb9c-4ef9-add6-202dec7c87cc"
      unitRef="usd">-52882000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i599f7c7be93c4814890c266b5ec47df8_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOC0zLTEtMS0w_449f90aa-453e-4582-bc87-fd1d8a0d36bf"
      unitRef="usd">-14139000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i0ef09b5449f84c8ead10851320de6c76_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOC01LTEtMS0w_0e9310cf-6613-4e7d-8f03-6ef9b8b9b333"
      unitRef="usd">-46141000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i7a6293eb4d8349d9a31d1b1a2fd3ed11_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOC03LTEtMS0w_29eb7a22-7a50-4b84-9ccb-cdeec83792be"
      unitRef="usd">23993000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="ic5da3c7f6d5d4610954eeac8d16c4dbe_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOS0xLTEtMS0w_bfb402fb-9510-4dda-b302-26c7ff9fd59b"
      unitRef="usd">12499000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i8a41b5baa43d4ed18e1b54843fc57273_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOS0zLTEtMS0w_c03fc242-aec6-4c3b-bf74-b3d2e85fb377"
      unitRef="usd">18487000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i467949b0884e43b0a011bdf4fadde010_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOS01LTEtMS0w_12252427-4bcd-4875-b46f-bde0a1af66d6"
      unitRef="usd">38476000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i039e32b3c64041e49cb0878ecaabafd1_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfOS03LTEtMS0w_9ad658b6-b107-49db-826e-b82e9608e33b"
      unitRef="usd">24153000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i91c81e16d0784d4d958fe95d1f894a24_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTAtMS0xLTEtMA_33a04c53-55b3-458e-be0c-676d42ff404e"
      unitRef="usd">-40383000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="iaef638b0fa1046eb9911d6d4747f5df0_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTAtMy0xLTEtMA_414c8709-7032-496a-b401-c5c89d1600cb"
      unitRef="usd">4348000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i8ad8d3eeb32049fe90a788e0eda6b25d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTAtNS0xLTEtMA_5628a9b4-13a5-474d-9f57-dff449252769"
      unitRef="usd">-7665000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i23411f69f39b432f81bcc3da7c590e76_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTAtNy0xLTEtMA_e795aa5b-7b19-4d9c-a3ce-91e3d7605e33"
      unitRef="usd">48146000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="ia8a334e29b924ce49cd96becafc4d8fb_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTEtMS0xLTEtMA_ce3abb36-46d9-4a5a-aaf0-54a43a1b5c24"
      unitRef="usd">-14827000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i74d37c58f9574acc85052b984bfa332e_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTEtMy0xLTEtMA_9f3fdc59-38e8-469f-8bda-d12ef151ce29"
      unitRef="usd">-15581000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="iaae702e195164e63ba0beb670c74dde5_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTEtNS0xLTEtMA_fdf161fa-facc-4093-8e28-cc7fcdf3acb4"
      unitRef="usd">-43206000</ehth:SegmentOperatingIncomeLoss>
    <ehth:SegmentOperatingIncomeLoss
      contextRef="i22910efbde7440648884b8f7e2613f28_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTEtNy0xLTEtMA_b5749eca-aee0-4748-b55b-cbacf89a77ff"
      unitRef="usd">-43376000</ehth:SegmentOperatingIncomeLoss>
    <ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTItMS0xLTEtMA_952ceb23-6da1-480c-8b87-da246fa4f355"
      unitRef="usd">5234000</ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense>
    <ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTItMy0xLTEtMA_db8e7ba9-dd8d-4119-b5e4-5d28200fd434"
      unitRef="usd">6332000</ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense>
    <ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTItNS0xLTEtMA_2c5a29b1-3824-4a21-b996-e35af829751c"
      unitRef="usd">24881000</ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense>
    <ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTItNy0xLTEtMA_1a6cfd62-9fe5-4c9a-80dc-224173708253"
      unitRef="usd">21722000</ehth:AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTQtMS0xLTEtMA_2b2cd089-84ba-4dd7-b88c-5d178aa4a1d6"
      unitRef="usd">4899000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTQtMy0xLTEtMA_eb4d1529-a57f-494f-a4a0-917ee31f0587"
      unitRef="usd">2995000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTQtNS0xLTEtMA_32bb5412-4014-40b3-9771-3f0b195cd73b"
      unitRef="usd">12840000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTQtNy0xLTEtMA_e14de518-02c1-4906-8bf4-0ecc8f884d7b"
      unitRef="usd">7911000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTUtMS0xLTEtMA_2e556781-f98b-430d-8fa3-23e104f31c00"
      unitRef="usd">121000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTUtMy0xLTEtMA_858f0b8a-9aeb-4a87-9773-c2644bd679f0"
      unitRef="usd">287000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTUtNS0xLTEtMA_09960910-2880-405f-a1e7-c92c0069b798"
      unitRef="usd">416000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTUtNy0xLTEtMA_fa04b52a-4b6b-4ac3-86b5-d0dbd6171743"
      unitRef="usd">1207000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RestructuringCharges
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTctMS0xLTEtMA_fa065998-cee5-4bfc-bf7c-f99f7e839938"
      unitRef="usd">573000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTctMy0xLTEtMA_73f81cff-de9b-46e5-ba3c-8dcc91f0907b"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTctNS0xLTEtMA_a2b8ed7f-83d2-4cd0-9167-6e3ab7e26c0f"
      unitRef="usd">3004000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTctNy0xLTEtMA_18d666b1-3bc7-4143-bd2d-00aeb40a00fb"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTgtMS0xLTEtMA_9dc7c228-3cee-49f2-8ef1-695cfd6aa549"
      unitRef="usd">189000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTgtMy0xLTEtMA_c147e370-5132-4479-a114-f08d77ac6705"
      unitRef="usd">-101000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTgtNS0xLTEtMA_847ec8fa-dc3e-4d26-9c17-f4f0ffd1090e"
      unitRef="usd">511000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTgtNy0xLTEtMA_62685d50-8a89-45ea-998d-cfbd1de458d4"
      unitRef="usd">724000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTktMS0xLTEtMA_77dec6b2-1b60-4db2-8c03-02cf84badbd5"
      unitRef="usd">-65848000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTktMy0xLTEtMA_cec1d475-0c95-4e39-8acc-7b3441d8ba47"
      unitRef="usd">-20948000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTktNS0xLTEtMA_37bc2a53-5b7b-4ea1-8400-d7c64886ba4d"
      unitRef="usd">-91501000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjBiZGUzZjEzYWRhNzQwNzJhNzgwMGE0YzU0ZjI0ODAyL3RhYmxlcmFuZ2U6MGJkZTNmMTNhZGE3NDA3MmE3ODAwYTRjNTRmMjQ4MDJfMTktNy0xLTEtMA_d2a58c0c-4175-496e-a83d-eeb7b5d7df54"
      unitRef="usd">-25346000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMTA3NA_07973a90-b01d-4203-9eb1-2d2e68c1d7a8"
      unitRef="usd">3400000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMTA4MQ_991d3d48-fabc-468e-be67-0b88a584f6d2"
      unitRef="usd">2100000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMTEyMQ_2ea6ffeb-74bd-4e73-99fb-fc20c33fbd92"
      unitRef="usd">9100000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMTEyOA_e9d70401-33c6-4780-91bf-f3251420772b"
      unitRef="usd">5300000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <ehth:ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMjI4Ng_240f480e-8ebf-40d5-a4d8-3b0fafb08621">Long-lived assets by geographical area are summarized as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;China&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</ehth:ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:NoncurrentAssets
      contextRef="i9d576e424126448ab8ccca7322a38757_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjM3OGNmMTg0YjNmODRhODhiNGNhNGFlN2QzZmE3NmE3L3RhYmxlcmFuZ2U6Mzc4Y2YxODRiM2Y4NGE4OGI0Y2E0YWU3ZDNmYTc2YTdfMS0xLTEtMS0w_dbbaba14-5078-4201-a685-bfeae81becf0"
      unitRef="usd">45465000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i90ca3570cf7d49f6a8e32f5b5cb816e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjM3OGNmMTg0YjNmODRhODhiNGNhNGFlN2QzZmE3NmE3L3RhYmxlcmFuZ2U6Mzc4Y2YxODRiM2Y4NGE4OGI0Y2E0YWU3ZDNmYTc2YTdfMS0zLTEtMS0w_5fc5c066-fcd3-45e2-b8a7-7240af7e8022"
      unitRef="usd">40500000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i523d407abcc34388915c073912053b35_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjM3OGNmMTg0YjNmODRhODhiNGNhNGFlN2QzZmE3NmE3L3RhYmxlcmFuZ2U6Mzc4Y2YxODRiM2Y4NGE4OGI0Y2E0YWU3ZDNmYTc2YTdfMi0xLTEtMS0w_cb6e06d2-11a9-447f-b73d-4ab36a6fdefd"
      unitRef="usd">637000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="id9c3527283ec406d936905c741fd644e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjM3OGNmMTg0YjNmODRhODhiNGNhNGFlN2QzZmE3NmE3L3RhYmxlcmFuZ2U6Mzc4Y2YxODRiM2Y4NGE4OGI0Y2E0YWU3ZDNmYTc2YTdfMi0zLTEtMS0w_fa3f7ede-73b6-4b98-adcb-7c6823a5cee8"
      unitRef="usd">565000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjM3OGNmMTg0YjNmODRhODhiNGNhNGFlN2QzZmE3NmE3L3RhYmxlcmFuZ2U6Mzc4Y2YxODRiM2Y4NGE4OGI0Y2E0YWU3ZDNmYTc2YTdfMy0xLTEtMS0w_b22911ff-ce67-4afe-9bb4-45aedaf98467"
      unitRef="usd">46102000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjM3OGNmMTg0YjNmODRhODhiNGNhNGFlN2QzZmE3NmE3L3RhYmxlcmFuZ2U6Mzc4Y2YxODRiM2Y4NGE4OGI0Y2E0YWU3ZDNmYTc2YTdfMy0zLTEtMS0w_fc4bfb62-c507-4d91-bb1a-a37e7081752b"
      unitRef="usd">41065000</us-gaap:NoncurrentAssets>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RleHRyZWdpb246YzI0OWEwMjUxMDEwNDgwY2I1ZjYwNzMwMTNmMzE5OGFfMjI3OA_9646ce5b-5e6e-441e-9505-c66a86bbbf35">Carriers representing 10% or more of our total revenue are summarized as follows:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;UnitedHealthCare &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aetna &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Humana&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Centene &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;__________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Percentages include the carriers' subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the revenue of WellCare is included in the percentage calculation for the three and nine months ended September 30, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i807a2c2c69384b17a0895525b7e3edd3_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi0xLTEtMS0zMjkyNQ_b3259d58-5139-4533-b03d-3f4afcdbdcbe"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icaaefcb4864c42c9977406372dae345d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi0zLTEtMS0zMjkyNQ_eb757e02-1cfa-4adb-a70e-55d8c6b2dfb6"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia99590146c5a4c1da65f6789c51d6d45_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi01LTEtMS0zMjkyNQ_da7e0920-bafb-4f77-ace8-c51107903cc2"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0361883d6d844e64919f623c50758d9f_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi03LTEtMS0zMjkyNQ_792fa8be-b43e-4ffb-8d44-b1855f0c6af1"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifed085705a1141f7b66607c7f088c4f7_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi0xLTEtMS0w_9e73071a-db2e-43b5-9824-a2bb6b297365"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iedb3906c92b9439bb9f00fb896ef8c19_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi0zLTEtMS0w_c29ada72-c867-4d91-8f04-a71005b40b30"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2c33a4818d8a4dd1b84a8c1a8ef5eda5_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi01LTEtMS0w_942da05e-0aae-416d-aee3-9fd68798715b"
      unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4eb35f5535224b48aab5f6959f231bec_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfMi03LTEtMS0w_e169bac4-c9c7-4932-86c5-e45ae9a5ca56"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic37891f447e942e58713991d7596b9e8_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNC0xLTEtMS0w_f674956c-2fd4-4190-891b-83594052b94b"
      unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic6e791641d474976aa090740b18829e9_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNC0zLTEtMS0w_8ce5893d-4447-4061-a3d4-e3d5fc4e4dd3"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7f2574a154db4f12910857916c1fb936_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNC01LTEtMS0w_44e2631f-2a5c-4b93-a6af-ae3cbba99c20"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2b3c828fd9844044b536167585b76ad7_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNC03LTEtMS0w_b0d1d0c2-e881-4e48-b89c-f49480f405fb"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7aee3ac4c576453099eae47761de55e3_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNS0xLTEtMS0w_3faa129a-ffd6-42ea-8e8e-39e617d4afc9"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4c33c1733414490c92126731233e4e66_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNS0zLTEtMS0w_2d60be9a-fce5-46b1-9d72-07ebff160f6f"
      unitRef="number">0.08</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie78c1d1beb9648dfa9a878f03a582e82_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNS01LTEtMS0w_96ea85da-2662-4a4d-8826-b9cd786b8457"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2ccf79aa1d6a4dc9a005e080c3858ac1_D20200101-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82MS9mcmFnOmMyNDlhMDI1MTAxMDQ4MGNiNWY2MDczMDEzZjMxOThhL3RhYmxlOjRlMTJhNDUwNmNkMTRlYjk5MDA4OTUxZWUyMTRkMjE3L3RhYmxlcmFuZ2U6NGUxMmE0NTA2Y2QxNGViOTkwMDg5NTFlZTIxNGQyMTdfNS03LTEtMS0w_ee49983d-ed76-481e-99c0-8b0daf41996f"
      unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfMTEwMQ_0bd93761-2c0a-4234-a91e-fe04c9f16e51">Leases&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our leases have remaining lease terms of 2 to 8 years. Certain of these leases have free or escalating rent payment provisions. We recognize lease expense on a straight-line basis over the terms of the leases, although actual cash payment obligations under certain of these agreements fluctuate over the terms of the agreements. Most leases include options to renew, and the exercise of these options is at our discretion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total operating lease expenses were $1.9 million and $2.1 million for the three months ended September 30, 2021 and 2020, and $5.7 million and $6.4 million for the nine months ended September 30, 2021 and 2020, respectively and sublease income was immaterial for both periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases are as follows (dollars in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term of operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate used to recognize operating lease right-of-use-assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash outflows related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2021, maturities of operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Noncancellable sublease income for the remainder of 2021 and years ending December 31, 2022 and 2023 of $0.3 million, $0.4 million, and $0.4 million, respectively, is not included in the table above.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="i1fd910c49a244d5c84e732a5b01119c4_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfNTU_4948ce53-25dc-44d0-8463-c374a13a3088">P2Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="i3f4d4b8270d044b59fee38b2066bc5db_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfNjE_7f94cb83-ec95-496e-9820-372dcbfd54fd">P8Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:OperatingLeaseCost
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfNDcw_24c457b3-f96f-4c13-87dd-6d7759ba1432"
      unitRef="usd">1900000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfNDc3_edd3cd8a-d8f9-40ce-9bec-42e6f1bb27ba"
      unitRef="usd">2100000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfNDkx_1b3553cd-e857-4940-aec7-9cc9b2924415"
      unitRef="usd">5700000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfNDk4_de7d5448-bea0-4d26-b7fc-4a2b866c4ab1"
      unitRef="usd">6400000</us-gaap:OperatingLeaseCost>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfMTEwNQ_d054e1fe-e216-463c-af64-8e0224e29564">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental information related to leases are as follows (dollars in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term of operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate used to recognize operating lease right-of-use-assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash outflows related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfMS0xLTEtMS0w_e634a838-edaf-45ab-8d22-a22653c62ef2">P6Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfMS0zLTEtMS0w_5a49c346-dfd5-4959-89a1-8a931a653e13">P7Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfMi0xLTEtMS0w_cc4e1c5f-5a90-4ec6-9eca-c72d21e8102c"
      unitRef="number">0.054</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfMi0zLTEtMS0w_475e91b4-a8ef-4864-9edb-fd29b5c99c85"
      unitRef="number">0.054</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseExpense
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfNS0xLTEtMS0w_2ba35eb8-ad90-4561-94f2-faf88d295b28"
      unitRef="usd">5738000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfNS0zLTEtMS0w_b6dac049-5585-4e30-829a-608c46de1d84"
      unitRef="usd">6411000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeasePayments
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfNi0xLTEtMS0w_37e8d443-dd9f-4ba2-811c-03babc3bb521"
      unitRef="usd">5722000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOmEyMzNiZDZkMDI0MTQwYzhiMTFjOTllMWNkMWFiMjQxL3RhYmxlcmFuZ2U6YTIzM2JkNmQwMjQxNDBjOGIxMWM5OWUxY2QxYWIyNDFfNi0zLTEtMS0w_30ebc1d7-0e55-4f4a-b5da-38f86cd34940"
      unitRef="usd">5173000</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfMTEwOA_ccb36018-edb0-46a8-9553-a0dc77445f55">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September 30, 2021, maturities of operating lease liabilities are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;____________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt"&gt;Noncancellable sublease income for the remainder of 2021 and years ending December 31, 2022 and 2023 of $0.3 million, $0.4 million, and $0.4 million, respectively, is not included in the table above.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfMS0xLTEtMS0w_719fd2b7-e102-4cd5-becc-7a3d584076a5"
      unitRef="usd">1926000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfMi0xLTEtMS0w_1f8dca16-bc79-4cdd-a3b9-d0b3e022ba81"
      unitRef="usd">7701000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfMy0xLTEtMS0w_f7b884e3-a1a4-4a69-a855-9c173e537876"
      unitRef="usd">8033000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfNC0xLTEtMS0w_b9ab929d-4cdc-4586-bc57-5c3c21fb5eaa"
      unitRef="usd">7832000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfNS0xLTEtMS0w_3f3c0fb6-5bb3-4485-a2a7-6b71c61dfb54"
      unitRef="usd">8009000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <ehth:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfNi0xLTEtMS0w_29336ce6-e4ee-4fa7-ab14-7f271d7efe44"
      unitRef="usd">19407000</ehth:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfNy0xLTEtMS0w_8aad0b5f-3fbc-47b2-94fc-ef381a0f206c"
      unitRef="usd">52908000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfOC0xLTEtMS0w_45f7bfe9-8b0f-4ab6-ac7e-bf6106e3da47"
      unitRef="usd">10200000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RhYmxlOjMzMDEyOWVmYzU1MjQxZjc4ZTU4NGM0ZjE3ZTIxZjZiL3RhYmxlcmFuZ2U6MzMwMTI5ZWZjNTUyNDFmNzhlNTg0YzRmMTdlMjFmNmJfOS0xLTEtMS0w_4336206c-d3df-45b5-80a3-87bb77e735a9"
      unitRef="usd">42708000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfMTAzNA_5e5fd28f-4a00-45df-83db-a2dfef6f3a94"
      unitRef="usd">300000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfMTAzOA_6d2da63a-5533-4f8f-9305-66189011f177"
      unitRef="usd">400000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82NC9mcmFnOjk0NTNkNWM4ZGU4YzRkMDY5OTRjMTMwZjRlMzNkOTNiL3RleHRyZWdpb246OTQ1M2Q1YzhkZThjNGQwNjk5NGMxMzBmNGUzM2Q5M2JfMTA0Ng_e39e83a7-7f6f-44ef-bb59-b035186f2923"
      unitRef="usd">400000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfNjI3_107c8d28-c877-4109-9aa5-331df915a7cd">Restructuring and Reorganization&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our restructuring and reorganization costs and liabilities consist primarily of severance, transition and other related costs. The following table summarizes the cash-based restructuring and reorganization related liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and reorganization charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, we eliminated approximately 89 full-time positions, primarily in the United States, representing approximately 5% of our workforce, primarily within our customer care and enrollment group, and to a lesser extent, in our marketing and advertising, technology and content, and general and administrative groups. Total pre-tax restructuring charges  were $2.4&#160;million for the nine months ended September 30, 2021, which primarily related to employee termination benefits. Substantially all of the restructuring charges resulted in cash expenditures. The restructuring activities were completed by March&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, we announced the transition of our chief executive officer. Mr. Scott Flanders resigned as a member of our Board and chief executive officer, effective October 31, 2021. We recognized $0.5&#160;million in severance costs related to his separation in September 2021 and we expect to recognize an additional $1.9&#160;million in the fourth quarter of 2021. Stock-based compensation expense for both three and nine months ended September 30, 2021 was impacted by a $4.1&#160;million credit related to forfeited equity awards due to Mr. Flanders' separation, which was included in general and administrative expenses on our Condensed Consolidated Statement of Comprehensive Loss.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfMjc0ODc3OTA3NTMxMw_8402f2d3-e1ab-4e61-b5c0-b44c26122119">The following table summarizes the cash-based restructuring and reorganization related liabilities (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring and reorganization charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i759d5300c26749239484a4f23e10ce0a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RhYmxlOjM3N2IyZTRhY2I0NzQ3Njk5MjVlYzJjZTRiMjk0NDQwL3RhYmxlcmFuZ2U6Mzc3YjJlNGFjYjQ3NDc2OTkyNWVjMmNlNGIyOTQ0NDBfMS0xLTEtMS0yOTc5NQ_024b440d-0ca7-41ab-bf89-822eb575bd39"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RhYmxlOjM3N2IyZTRhY2I0NzQ3Njk5MjVlYzJjZTRiMjk0NDQwL3RhYmxlcmFuZ2U6Mzc3YjJlNGFjYjQ3NDc2OTkyNWVjMmNlNGIyOTQ0NDBfMi0xLTEtMS0yOTc5NQ_bf481f5f-38d7-41e2-b8c6-3537c51c903c"
      unitRef="usd">3004000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RhYmxlOjM3N2IyZTRhY2I0NzQ3Njk5MjVlYzJjZTRiMjk0NDQwL3RhYmxlcmFuZ2U6Mzc3YjJlNGFjYjQ3NDc2OTkyNWVjMmNlNGIyOTQ0NDBfMy0xLTEtMS0yOTc5NQ_a206b536-76d9-4afc-9dc6-cecce96404c6"
      unitRef="usd">2466000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RhYmxlOjM3N2IyZTRhY2I0NzQ3Njk5MjVlYzJjZTRiMjk0NDQwL3RhYmxlcmFuZ2U6Mzc3YjJlNGFjYjQ3NDc2OTkyNWVjMmNlNGIyOTQ0NDBfNC0xLTEtMS0yOTc5NQ_3c581d09-a7d8-4913-9ba6-395d99a73bf0"
      unitRef="usd">538000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="i2ce9e77371e64f6a8892196a9e45088f_D20210201-20210228"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfNjE_e44a279f-5296-4231-b365-8461a977afa9"
      unitRef="employee">89</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <ehth:RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce
      contextRef="i2ce9e77371e64f6a8892196a9e45088f_D20210201-20210228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfMTQ0_e564f005-0271-481a-85b5-f9e2f824568e"
      unitRef="number">0.05</ehth:RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce>
    <ehth:RestructuringChargesPreTax
      contextRef="ic22af0ed9d5a46f7a09827528922c14b_D20210201-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfNTQ5NzU1ODEzOTUzOA_89153e0f-1d21-4194-aab8-9f15a74c451e"
      unitRef="usd">2400000</ehth:RestructuringChargesPreTax>
    <us-gaap:RestructuringReserve
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfMTA5OTUxMTYzMDM0Mg_0bb31582-f709-4f11-8f32-dd98c66b0f4e"
      unitRef="usd">500000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1
      contextRef="ib8e43307bfae4745be61c3650614ae16_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfMTA5OTUxMTYzMzI3NQ_d38ec248-dc10-4244-80ce-a367551f41e0"
      unitRef="usd">1900000</us-gaap:RestructuringAndRelatedCostExpectedCostRemaining1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i538a335bee9d4605ac36f25f4181afa7_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfMTA5OTUxMTYzMzc2MA_7726ef97-c3e8-483d-b723-efcd82f92d10"
      unitRef="usd">-4100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i05a980eb0e6b4490bb82b24144c3b3c8_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl82Ny9mcmFnOjMxNzliOTlkYzQ0YTRhYWNiM2VlODFjMzZmYzlmZjVlL3RleHRyZWdpb246MzE3OWI5OWRjNDRhNGFhY2IzZWU4MWMzNmZjOWZmNWVfMTA5OTUxMTYzMzc2MA_bc3308b7-e9d9-41e2-8bbf-ce40158b1a2c"
      unitRef="usd">-4100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMzkxMw_74aeaa12-042c-4eac-88d2-340e905eff5f">Debt&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 17, 2018, we entered into a Credit Agreement with Royal Bank of Canada (&#x201c;RBC&#x201d;), as administrative agent and collateral agent (the &#x201c;Credit Agreement&#x201d;). The Credit Agreement provides for a $40.0 million secured asset-backed revolving credit facility with a $5.0 million letter of credit sub-facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 20, 2019, we amended our revolving credit facility agreement with RBC (the &#x201c;Amendment&#x201d;) and increased the borrowing amount from $40.0 million to $75.0&#160;million. The maturity date has been extended to December 20, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The borrowing base under the Credit Agreement is comprised of an amount equal to (a) the lesser of (i) eighty percent (80%) of Eligible Commissions Receivables (as defined in the Credit Agreement) we actually collected during the immediately preceding period of three months or (ii) eighty percent (80%) of our Eligible Commission Receivables for the immediately succeeding period of three months, plus (b) fifty percent (50%) of our Eligible Commission Receivables for the immediately succeeding period of six months (excluding the immediately succeeding period of three months), in each case subject to reserves established by RBC (the &#x201c;Borrowing Base&#x201d;). The proceeds of the loans under the Credit Agreement may be used for working capital and general corporate purposes. The borrowers have the right to prepay the loans under the Credit Agreement in whole or in part at any time without penalty. Subject to availability under the Borrowing Base, amounts repaid may be reborrowed. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts not borrowed under the Credit Agreement will be subject to a commitment fee of 0.5% per annum on the daily unused portion of the credit facility, to be paid in arrears on the first business day of each calendar quarter. At the closing of the Credit Agreement, we paid a one-time facility fee of 1.75% of the total commitments of $40.0&#160;million. We also paid a one-time closing fee of 0.5% of the new commitment of $75.0&#160;million in connection with the Amendment. The Company is also obligated to pay other customary administration fees for a credit facility of this size and type. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The availability under the credit facility was up to the lesser of $40.0 million or the Borrowing Base in the original credit agreement. The Amendment increased the availability up to the lesser of $75.0 million or the Borrowing Base, which may be reduced from time to time pursuant to the Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial covenants in the original Credit Agreement required that we maintain Excess Availability (as defined in the Credit Agreement) at or above $6.0 million at any time. The Amendment also changed the financial covenants to require us to maintain at least $6.0&#160;million of Excess Availability at all times or, if greater, up to $11.3&#160;million depending on our Borrowing Base as determined by eligible past and future commissions receivable. In addition, the Amendment also included changes in the payment conditions to, among other things, require us to have at least $10.0&#160;million of liquidity or, if greater, up to $18.8&#160;million depending on the Borrowing Base as determined by eligible past and future commissions receivable, in order for us to make certain permitted acquisitions, investments, distributions and payments of indebtedness. The Amendment also stated the seasonal amount thresholds used in connection with the cash dominion and field examination covenants in the Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We incurred $1.2 million of issuance costs in connection with the Credit Agreement, which were capitalized as part of other assets on our Consolidated Balance Sheet in the period we entered into the Credit Agreement. The Amendment did not change the interest rate. In connection with the Amendment, we incurred closing costs totaling $0.5&#160;million, which were capitalized and recorded as other assets on our Consolidated Balance Sheet as of December 31, 2019. The remaining balance of unamortized issuance costs was $0.5&#160;million and $0.7&#160;million as of September 30, 2021 and December 31, 2020, respectively. &lt;/span&gt;&lt;/div&gt;As of September 30, 2021, we had no outstanding borrowings under our revolving credit facility.</us-gaap:LongTermDebtTextBlock>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i1b88d930749840dda7fc079ab96c882a_I20180917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjE0_0e766f7e-90e3-4d30-9805-faaa9865f0b0"
      unitRef="usd">40000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i157113a553d840878f52e68b6c57d78d_I20180917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjcx_71e29f00-74ee-40d7-b1ce-001f47b3cc9d"
      unitRef="usd">5000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i1b88d930749840dda7fc079ab96c882a_I20180917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfNDQ3_128654c6-2770-4902-8bc2-acc425c81b2d"
      unitRef="usd">40000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="ifa14883525614cf79dab683249f898ec_I20191220"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfNDUz_2679f9f1-6acb-4ef5-801f-28b42b64c674"
      unitRef="usd">75000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <ehth:LineOfCreditFacilityBorrowingBasePercentage
      contextRef="i8887c4dc48dd49678b387048f0530ba7_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfNjM1_590a00c7-a6d5-4d3b-a771-1651593d38ee"
      unitRef="number">0.80</ehth:LineOfCreditFacilityBorrowingBasePercentage>
    <ehth:LineOfCreditFacilityBorrowingBasePercentage
      contextRef="i8ec55043cfb045c2aa1b9f8dd9a631ce_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfODE0_9ff01baa-02fb-4470-98fd-06a7168e662e"
      unitRef="number">0.80</ehth:LineOfCreditFacilityBorrowingBasePercentage>
    <ehth:LineOfCreditFacilityBorrowingBasePercentage
      contextRef="ieca95dd280a443e393ddf3ccbcca1f92_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfOTM2_95da6b4d-5d34-412c-a4bc-2aed85506085"
      unitRef="number">0.50</ehth:LineOfCreditFacilityBorrowingBasePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i724149df6b244d9cb6760b3d59438694_D20180917-20180917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMTU4NQ_1926be87-6f79-4715-83ce-56977e252dcb"
      unitRef="number">0.005</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <ehth:LineOfCreditFacilityFacilityFeePercentage
      contextRef="i724149df6b244d9cb6760b3d59438694_D20180917-20180917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMTc5OQ_a80845df-68ce-40a2-b713-f5bc5b97951c"
      unitRef="number">0.0175</ehth:LineOfCreditFacilityFacilityFeePercentage>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="i1b88d930749840dda7fc079ab96c882a_I20180917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMTgzMA_db375c42-5b4f-44be-bc97-93130eb426c3"
      unitRef="usd">40000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <ehth:LineOfCreditFacilityFacilityFeePercentage
      contextRef="iea337c22bd714443919d49600be45338_D20191220-20191220"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMTg3Mw_c393b9ac-dbcd-4982-9763-ef13b1a1a78c"
      unitRef="number">0.005</ehth:LineOfCreditFacilityFacilityFeePercentage>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="ifa14883525614cf79dab683249f898ec_I20191220"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMTkwMQ_d4603485-b7d5-43f5-a6c8-b8504de1c24b"
      unitRef="usd">75000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i1b88d930749840dda7fc079ab96c882a_I20180917"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjEyNQ_dcb1fcd4-bbf1-46fd-82a4-eec94611ca11"
      unitRef="usd">40000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ifa14883525614cf79dab683249f898ec_I20191220"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjI0NQ_1126ca19-7ccd-4c62-8558-3b4be088cd7c"
      unitRef="usd">75000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <ehth:LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents
      contextRef="i1b88d930749840dda7fc079ab96c882a_I20180917"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjQ5Mw_c7d1af62-2120-4227-b899-701cd4aeb168"
      unitRef="usd">6000000</ehth:LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents>
    <ehth:LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents
      contextRef="ifa14883525614cf79dab683249f898ec_I20191220"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjU5NQ_e5586ea8-3f1f-4179-b50c-84f977f421fb"
      unitRef="usd">6000000</ehth:LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents>
    <ehth:LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents
      contextRef="ifa14883525614cf79dab683249f898ec_I20191220"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjY1Ng_3981d935-da2f-4258-89b7-55117aa606cf"
      unitRef="usd">11300000</ehth:LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents>
    <ehth:LineOfCreditFacilityCovenantMinimumLiquidity
      contextRef="ifa14883525614cf79dab683249f898ec_I20191220"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjg4NA_744997be-8a7c-4a33-8aec-b401ecfb0c2d"
      unitRef="usd">10000000</ehth:LineOfCreditFacilityCovenantMinimumLiquidity>
    <ehth:LineOfCreditFacilityCovenantMaximumLiquidity
      contextRef="ifa14883525614cf79dab683249f898ec_I20191220"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMjkyMg_247ebc29-1bbe-4903-b184-3686595111e8"
      unitRef="usd">18800000</ehth:LineOfCreditFacilityCovenantMaximumLiquidity>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i1b88d930749840dda7fc079ab96c882a_I20180917"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMzMwNg_f2835f44-012c-4fd6-9094-53e1e2ad4b5e"
      unitRef="usd">1200000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ica1b5f7280934d02b7e7917401872662_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMzYxOA_df2f79ee-9740-436a-8039-8deb3e37f641"
      unitRef="usd">500000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="id8ba51940194417ebfd20f82ded0000b_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMzc4OQ_4f9b23b2-9b6f-44c2-ac5b-dbd68a8ef6e3"
      unitRef="usd">500000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i35b23d73e2ba484d8591b732fcc5f47c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMzc5Ng_7ac5d196-caea-4f3c-94ca-97ff570d5ac8"
      unitRef="usd">700000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LineOfCredit
      contextRef="i942081d424f34699add16e658f851ed1_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83MC9mcmFnOmIwNmFkNjRkZjAzNDQ1MTA4MGVhMjVmNGU1MTcyN2IyL3RleHRyZWdpb246YjA2YWQ2NGRmMDM0NDUxMDgwZWEyNWY0ZTUxNzI3YjJfMzg0OQ_f127a321-b09e-442c-b86f-96b6cea3e93f"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfMTg1Mw_49d415aa-d90a-4c4a-afee-6e22d879da0a">Income Taxes &lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes our benefit from income taxes and our effective tax rates for the periods presented below (in thousands, except effective tax rate):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before benefit from income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,848)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit from income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,834)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three and nine months ended September 30, 2021, we recognized a benefit from income taxes of $12.8&#160;million and $19.3&#160;million, representing an effective tax rate of 19.5% and 21.1%, respectively. These effective tax rates are higher than the statutory federal tax rate due primarily to stock-based compensation adjustments, non-deductible lobbying expenses and state taxes, partially offset by research and development credits. For the three and nine months ended September 30, 2020, we recognized benefits from income taxes of $6.4 million and $10.9&#160;million, representing an effective tax rate of 30.8% and 43.1%, respectively, which were higher than the statutory federal tax rate due primarily to stock-based compensation adjustments, non-deductible lobbying expenses and state taxes, partially offset by research and development credits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assessing the realizability of our deferred tax assets is dependent upon several factors, including the likelihood and amount, if any, of future taxable income in relevant jurisdictions during the periods in which those temporary differences become deductible. We forecast taxable income by considering all available positive and negative evidence, including our history of operating income and losses and our financial plans and estimates that we use to manage the business. These assumptions require significant judgment about future taxable income. As a result, the amount of deferred tax assets considered realizable is subject to adjustment in future periods if estimates of future taxable income change. We continue to recognize our deferred tax assets as of September 30, 2021, as we believe it is more likely than not that the net deferred tax assets will be realized, with the exception of certain net operating losses and credits that are expected to expire unutilized which have a valuation allowance.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfMTg2Mw_2734ec25-93f5-464e-9cde-bd6fd3302f5e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The following table summarizes our benefit from income taxes and our effective tax rates for the periods presented below (in thousands, except effective tax rate):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended September 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss before benefit from income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,848)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit from income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,834)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMi0xLTEtMS0w_542eea80-8b7c-489c-af04-5aecfc9e10fe"
      unitRef="usd">-65848000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMi0zLTEtMS0w_19752c18-a642-4ae0-bd72-02e835763bd2"
      unitRef="usd">-20948000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMi01LTEtMS0w_5c86eac6-0e07-414c-bfa0-ce11662fe818"
      unitRef="usd">-91501000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMi03LTEtMS0w_86d26888-1f2b-4d1e-b34e-843d499700af"
      unitRef="usd">-25346000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMy0xLTEtMS0w_1136af01-ddfd-4a1f-965c-16c440ee8d3c"
      unitRef="usd">-12834000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMy0zLTEtMS0w_b4506e28-7765-4eff-bbe8-687893eba8d4"
      unitRef="usd">-6443000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMy01LTEtMS0w_7a4592c1-3669-4035-ad7e-d07376c63453"
      unitRef="usd">-19278000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfMy03LTEtMS0w_20047725-20a4-428e-854c-66b18436e4e4"
      unitRef="usd">-10923000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfNC0xLTEtMS0w_18fcdef3-c708-4e22-be11-f91f5a644645"
      unitRef="number">0.195</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfNC0zLTEtMS0w_09c3034f-3ed5-4774-b879-aea37f9e47ed"
      unitRef="number">0.308</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfNC01LTEtMS0w_866b3145-e05f-4009-a68b-cfb1b09a91c5"
      unitRef="number">0.211</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RhYmxlOjZiMGExMTE3YTgyNzRlZjJiOGE4ZGJjNzMyZTYzMzNlL3RhYmxlcmFuZ2U6NmIwYTExMTdhODI3NGVmMmI4YThkYmM3MzJlNjMzM2VfNC03LTEtMS0w_edc8aa60-6df2-458a-b78e-3e47d741722e"
      unitRef="number">0.431</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfMjIw_0be0bea4-0a40-41f2-9272-10e03cdf1736"
      unitRef="usd">-12800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfMjI3_3382f98a-8c15-4321-93e2-e76a5df31bc3"
      unitRef="usd">-19300000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ica28973693e74e8cb672d581df69bbe6_D20210701-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfMjY5_18fcdef3-c708-4e22-be11-f91f5a644645"
      unitRef="number">0.195</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfMjc2_866b3145-e05f-4009-a68b-cfb1b09a91c5"
      unitRef="number">0.211</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfNTQ5NzU1ODE0MDc3MA_903e542a-d1a3-4bff-97f1-36258dc8065a"
      unitRef="usd">-6400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfNTgx_6da43a04-3c2d-493f-94dd-8a5b304e5a9d"
      unitRef="usd">-10900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i7f4b1dc7d2614e799fbbab7ff0c2b4f1_D20200701-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfNTQ5NzU1ODE0MDc4OA_09c3034f-3ed5-4774-b879-aea37f9e47ed"
      unitRef="number">0.308</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie60ee865d5c2445f890e399d7c10c4b9_D20200101-20200930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl83My9mcmFnOjYwYmNlMjFlN2I2ZDQyYmM4NmE1ZDhlNDVlZWE1ZjNmL3RleHRyZWdpb246NjBiY2UyMWU3YjZkNDJiYzg2YTVkOGU0NWVlYTVmM2ZfNjMw_edc8aa60-6df2-458a-b78e-3e47d741722e"
      unitRef="number">0.431</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDEtMy0xLTEtMA_518524af-b08d-469d-a46b-ad21ff86b3e8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDEtMy0xLTEtMA_518524af-b08d-469d-a46b-ad21ff86b3e8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjktMy0xLTEtMA_8dd10fb0-60d3-4cd0-8e67-50c5e4edd50e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjktMy0xLTEtMA_8dd10fb0-60d3-4cd0-8e67-50c5e4edd50e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjctMy0xLTEtMA_fc64627f-a1a3-4c25-9756-78e60e35dfff"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjctMy0xLTEtMA_fc64627f-a1a3-4c25-9756-78e60e35dfff"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDAtMy0xLTEtMA_a7d99179-ef04-42e8-812f-d02c653646e7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDAtMy0xLTEtMA_a7d99179-ef04-42e8-812f-d02c653646e7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjItMy0xLTEtMA_8a61d91c-006a-4d3f-aafe-517efebf3aec"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjItMy0xLTEtMA_8a61d91c-006a-4d3f-aafe-517efebf3aec"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjgtMy0xLTEtMA_c0b94042-c45c-4332-b7ce-89ffa7e675c5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjgtMy0xLTEtMA_c0b94042-c45c-4332-b7ce-89ffa7e675c5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOS0zLTEtMS0w_f9e8d5fc-5f1a-4394-a3ba-3b83620cc224"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOS0zLTEtMS0w_f9e8d5fc-5f1a-4394-a3ba-3b83620cc224"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzctMy0xLTEtMA_e5e15142-ba25-4497-9ae7-ec708f2f9259"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzctMy0xLTEtMA_e5e15142-ba25-4497-9ae7-ec708f2f9259"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzEtMy0xLTEtMA_f2c82846-1978-4782-ab46-14ced2a76dcd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzEtMy0xLTEtMA_f2c82846-1978-4782-ab46-14ced2a76dcd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjEtMy0xLTEtMA_93ce37c2-5e41-4572-ae76-22f89096d113"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjEtMy0xLTEtMA_93ce37c2-5e41-4572-ae76-22f89096d113"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNi0zLTEtMS0w_b0c470d1-5569-4b38-ba4c-549e9f2c8ba1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNi0zLTEtMS0w_b0c470d1-5569-4b38-ba4c-549e9f2c8ba1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNy0zLTEtMS0w_06f2a0e0-4c0f-4c3a-bd07-1da910ffb435"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNy0zLTEtMS0w_06f2a0e0-4c0f-4c3a-bd07-1da910ffb435"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNC0zLTEtMS0w_973cd248-37a9-408f-998f-7395871cea8e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNC0zLTEtMS0w_973cd248-37a9-408f-998f-7395871cea8e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTAtMy0xLTEtMA_07cb5ec8-79d1-418e-8f4d-63364b505854"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTAtMy0xLTEtMA_07cb5ec8-79d1-418e-8f4d-63364b505854"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjUtMy0xLTEtMA_8c1e456e-b4ff-4909-b9c0-d5ef37d91249"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjUtMy0xLTEtMA_8c1e456e-b4ff-4909-b9c0-d5ef37d91249"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNS0zLTEtMS0w_c7f0cd2d-e5b7-4572-8091-5f90beb9e305"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNS0zLTEtMS0w_c7f0cd2d-e5b7-4572-8091-5f90beb9e305"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTUtMy0xLTEtMA_3964d77d-fea3-4afe-8421-55c3cc3cde1b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTUtMy0xLTEtMA_3964d77d-fea3-4afe-8421-55c3cc3cde1b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzAtMy0xLTEtMA_895d489e-e29f-400b-a15e-e0bc1ac39f76"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzAtMy0xLTEtMA_895d489e-e29f-400b-a15e-e0bc1ac39f76"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzItMy0xLTEtMA_da23f0db-05c5-4d01-a973-6d1630dbc55b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzItMy0xLTEtMA_da23f0db-05c5-4d01-a973-6d1630dbc55b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzgtMy0xLTEtMA_e0767b25-f544-4f1a-ba74-87b6dadf7af4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzgtMy0xLTEtMA_e0767b25-f544-4f1a-ba74-87b6dadf7af4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjAtMy0xLTEtMA_d97efac3-28eb-4ea2-9676-9133521a2c9b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjAtMy0xLTEtMA_d97efac3-28eb-4ea2-9676-9133521a2c9b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMy0zLTEtMS0w_ac4a11bb-e4d7-486f-851d-d6c471a89fee"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMy0zLTEtMS0w_ac4a11bb-e4d7-486f-851d-d6c471a89fee"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTctMy0xLTEtMA_d4569728-416a-47a6-9953-462068b66f5c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTctMy0xLTEtMA_d4569728-416a-47a6-9953-462068b66f5c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTItMy0xLTEtMA_adf0cfc9-05b4-4267-8b84-5052befdd4dd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTItMy0xLTEtMA_adf0cfc9-05b4-4267-8b84-5052befdd4dd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjQtMy0xLTEtMA_294efc7c-77df-4766-84ab-0e37f25faaaf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjQtMy0xLTEtMA_294efc7c-77df-4766-84ab-0e37f25faaaf"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTMtMy0xLTEtMA_771b9f87-82e8-4711-9fb8-a744d7d9c306"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTMtMy0xLTEtMA_771b9f87-82e8-4711-9fb8-a744d7d9c306"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTQtMy0xLTEtMA_fb23a37a-2ca0-4833-b6c8-b309f76b307c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTQtMy0xLTEtMA_fb23a37a-2ca0-4833-b6c8-b309f76b307c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOC0zLTEtMS0w_a4ef4595-7fda-42b2-a40a-60640a12be13"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOC0zLTEtMS0w_a4ef4595-7fda-42b2-a40a-60640a12be13"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzMtMy0xLTEtMA_b7c1e801-3c04-4559-b6f4-b080c391953e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzMtMy0xLTEtMA_b7c1e801-3c04-4559-b6f4-b080c391953e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzYtMy0xLTEtMA_effeaa50-9e6e-4471-87b2-c397dfb10fde"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzYtMy0xLTEtMA_effeaa50-9e6e-4471-87b2-c397dfb10fde"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzktMy0xLTEtMA_23659aac-e96b-4ca6-9b5a-3e0277e23a69"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzktMy0xLTEtMA_23659aac-e96b-4ca6-9b5a-3e0277e23a69"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzUtMy0xLTEtMA_c1ed0323-1ba4-463e-8f80-6a886a540a12"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzUtMy0xLTEtMA_c1ed0323-1ba4-463e-8f80-6a886a540a12"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTYtMy0xLTEtMA_badf2027-c006-488e-a6d5-6961ba416881"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTYtMy0xLTEtMA_badf2027-c006-488e-a6d5-6961ba416881"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjYtMy0xLTEtMA_d9730304-e7ad-477a-a47f-77fb5f54d0a2"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjYtMy0xLTEtMA_d9730304-e7ad-477a-a47f-77fb5f54d0a2"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See Note 1 &#x2013; Summary of Business and Significant Accounting Policies</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDEtMy0xLTEtMA_518524af-b08d-469d-a46b-ad21ff86b3e8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjktMy0xLTEtMA_8dd10fb0-60d3-4cd0-8e67-50c5e4edd50e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjctMy0xLTEtMA_fc64627f-a1a3-4c25-9756-78e60e35dfff"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNDAtMy0xLTEtMA_a7d99179-ef04-42e8-812f-d02c653646e7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjItMy0xLTEtMA_8a61d91c-006a-4d3f-aafe-517efebf3aec"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjgtMy0xLTEtMA_c0b94042-c45c-4332-b7ce-89ffa7e675c5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOS0zLTEtMS0w_f9e8d5fc-5f1a-4394-a3ba-3b83620cc224"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzctMy0xLTEtMA_e5e15142-ba25-4497-9ae7-ec708f2f9259"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzEtMy0xLTEtMA_f2c82846-1978-4782-ab46-14ced2a76dcd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjEtMy0xLTEtMA_93ce37c2-5e41-4572-ae76-22f89096d113"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNi0zLTEtMS0w_b0c470d1-5569-4b38-ba4c-549e9f2c8ba1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNy0zLTEtMS0w_06f2a0e0-4c0f-4c3a-bd07-1da910ffb435"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNC0zLTEtMS0w_973cd248-37a9-408f-998f-7395871cea8e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTAtMy0xLTEtMA_07cb5ec8-79d1-418e-8f4d-63364b505854"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjUtMy0xLTEtMA_8c1e456e-b4ff-4909-b9c0-d5ef37d91249"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfNS0zLTEtMS0w_c7f0cd2d-e5b7-4572-8091-5f90beb9e305"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTUtMy0xLTEtMA_3964d77d-fea3-4afe-8421-55c3cc3cde1b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzAtMy0xLTEtMA_895d489e-e29f-400b-a15e-e0bc1ac39f76"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzItMy0xLTEtMA_da23f0db-05c5-4d01-a973-6d1630dbc55b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzgtMy0xLTEtMA_e0767b25-f544-4f1a-ba74-87b6dadf7af4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjAtMy0xLTEtMA_d97efac3-28eb-4ea2-9676-9133521a2c9b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMy0zLTEtMS0w_ac4a11bb-e4d7-486f-851d-d6c471a89fee"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTctMy0xLTEtMA_d4569728-416a-47a6-9953-462068b66f5c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTItMy0xLTEtMA_adf0cfc9-05b4-4267-8b84-5052befdd4dd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjQtMy0xLTEtMA_294efc7c-77df-4766-84ab-0e37f25faaaf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTMtMy0xLTEtMA_771b9f87-82e8-4711-9fb8-a744d7d9c306"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTQtMy0xLTEtMA_fb23a37a-2ca0-4833-b6c8-b309f76b307c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfOC0zLTEtMS0w_a4ef4595-7fda-42b2-a40a-60640a12be13"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzMtMy0xLTEtMA_b7c1e801-3c04-4559-b6f4-b080c391953e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzYtMy0xLTEtMA_effeaa50-9e6e-4471-87b2-c397dfb10fde"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzktMy0xLTEtMA_23659aac-e96b-4ca6-9b5a-3e0277e23a69"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMzUtMy0xLTEtMA_c1ed0323-1ba4-463e-8f80-6a886a540a12"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMTYtMy0xLTEtMA_badf2027-c006-488e-a6d5-6961ba416881"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RhYmxlOjEyOGI1ODhhNzc0NjQ5MjM4OGE2YWZmZTdlNjdiODcxL3RhYmxlcmFuZ2U6MTI4YjU4OGE3NzQ2NDkyMzg4YTZhZmZlN2U2N2I4NzFfMjYtMy0xLTEtMA_d9730304-e7ad-477a-a47f-77fb5f54d0a2"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmE2ZDdlOGJiMGY0ZjQ1Zjg4ZjY3N2Q2Y2YwNmMxYjhmL3NlYzphNmQ3ZThiYjBmNGY0NWY4OGY2NzdkNmNmMDZjMWI4Zl8xNi9mcmFnOjgxYTBmNjNkMDhlYTQ2MTc5NmY1NDBkNGZmZTM5ZjE5L3RleHRyZWdpb246ODFhMGY2M2QwOGVhNDYxNzk2ZjU0MGQ0ZmZlMzlmMTlfMjA2_5d04dc85-14a4-48e4-b103-44b563e6dc3d"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844337466344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Nov. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EHEALTH, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-2357876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2625 AUGUSTINE DRIVE, SECOND FLOOR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">SANTA CLARA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">584-2700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EHTH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,388,112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001333493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844332833912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 157,530<span></span>
</td>
<td colspan="2" class="nump">$ 43,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">70,212<span></span>
</td>
<td colspan="2" class="nump">49,620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">1,305<span></span>
</td>
<td colspan="2" class="nump">1,799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract assets &#8211; commissions receivable &#8211; current</a></td>
<td class="nump">194,197<span></span>
</td>
<td colspan="2" class="nump">219,153<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">36,653<span></span>
</td>
<td colspan="2" class="nump">16,661<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">459,897<span></span>
</td>
<td colspan="2" class="nump">330,992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetNoncurrent', window );">Contract assets &#8211; commissions receivable &#8211; non-current</a></td>
<td class="nump">563,171<span></span>
</td>
<td colspan="2" class="nump">573,252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">13,795<span></span>
</td>
<td colspan="2" class="nump">14,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">38,693<span></span>
</td>
<td colspan="2" class="nump">42,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">3,354<span></span>
</td>
<td colspan="2" class="nump">3,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">8,153<span></span>
</td>
<td colspan="2" class="nump">8,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">40,233<span></span>
</td>
<td colspan="2" class="nump">40,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">32,307<span></span>
</td>
<td colspan="2" class="nump">26,455<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,159,603<span></span>
</td>
<td colspan="2" class="nump">1,040,022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">10,084<span></span>
</td>
<td colspan="2" class="nump">36,921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">20,424<span></span>
</td>
<td colspan="2" class="nump">20,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_AccruedMarketingExpenses', window );">Accrued marketing expenses</a></td>
<td class="nump">11,263<span></span>
</td>
<td colspan="2" class="nump">17,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities &#8211; current</a></td>
<td class="nump">5,570<span></span>
</td>
<td colspan="2" class="nump">5,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">10,547<span></span>
</td>
<td colspan="2" class="nump">308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">4,546<span></span>
</td>
<td colspan="2" class="nump">3,657<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">62,434<span></span>
</td>
<td colspan="2" class="nump">84,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes &#8211; non-current</a></td>
<td class="nump">52,185<span></span>
</td>
<td colspan="2" class="nump">72,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities &#8211; non-current</a></td>
<td class="nump">37,138<span></span>
</td>
<td colspan="2" class="nump">41,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">4,747<span></span>
</td>
<td colspan="2" class="nump">4,370<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">156,504<span></span>
</td>
<td colspan="2" class="nump">202,464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td colspan="2" class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Convertible preferred stock</a></td>
<td class="nump">225,438<span></span>
</td>
<td colspan="2" class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">38<span></span>
</td>
<td colspan="2" class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">744,784<span></span>
</td>
<td colspan="2" class="nump">721,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost</a></td>
<td class="num">(199,998)<span></span>
</td>
<td colspan="2" class="num">(199,998)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">232,519<span></span>
</td>
<td colspan="2" class="nump">316,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">318<span></span>
</td>
<td colspan="2" class="nump">350<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">777,661<span></span>
</td>
<td colspan="2" class="nump">837,558<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, convertible preferred stock, and stockholders&#8217; equity</a></td>
<td class="nump">$ 1,159,603<span></span>
</td>
<td colspan="2" class="nump">$ 1,040,022<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 1 &#8211; Summary of Business and Significant Accounting Policies</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_AccruedMarketingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total carrying values as of the balance sheet date of liabilities incurred through that date and payable for obligations related to marketing and advertising services received from vendors. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_AccruedMarketingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844332742456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 63,914<span></span>
</td>
<td class="nump">$ 94,284<span></span>
</td>
<td class="nump">$ 294,685<span></span>
</td>
<td class="nump">$ 289,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="num">(25)<span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="nump">1,217<span></span>
</td>
<td class="nump">2,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Marketing and advertising</a></td>
<td class="nump">43,317<span></span>
</td>
<td class="nump">33,405<span></span>
</td>
<td class="nump">138,772<span></span>
</td>
<td class="nump">104,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CustomerCareAndEnrollmentExpense', window );">Customer care and enrollment</a></td>
<td class="nump">48,956<span></span>
</td>
<td class="nump">43,342<span></span>
</td>
<td class="nump">121,480<span></span>
</td>
<td class="nump">101,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_TechnologyAndContentExpense', window );">Technology and content</a></td>
<td class="nump">20,369<span></span>
</td>
<td class="nump">17,673<span></span>
</td>
<td class="nump">63,996<span></span>
</td>
<td class="nump">46,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">16,640<span></span>
</td>
<td class="nump">19,942<span></span>
</td>
<td class="nump">57,812<span></span>
</td>
<td class="nump">60,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="nump">416<span></span>
</td>
<td class="nump">1,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and reorganization charges</a></td>
<td class="nump">573<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,004<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">129,951<span></span>
</td>
<td class="nump">115,131<span></span>
</td>
<td class="nump">386,697<span></span>
</td>
<td class="nump">315,528<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(66,037)<span></span>
</td>
<td class="num">(20,847)<span></span>
</td>
<td class="num">(92,012)<span></span>
</td>
<td class="num">(26,070)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">189<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="nump">511<span></span>
</td>
<td class="nump">724<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before benefit from income taxes</a></td>
<td class="num">(65,848)<span></span>
</td>
<td class="num">(20,948)<span></span>
</td>
<td class="num">(91,501)<span></span>
</td>
<td class="num">(25,346)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="num">(12,834)<span></span>
</td>
<td class="num">(6,443)<span></span>
</td>
<td class="num">(19,278)<span></span>
</td>
<td class="num">(10,923)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(53,014)<span></span>
</td>
<td class="num">(14,505)<span></span>
</td>
<td class="num">(72,223)<span></span>
</td>
<td class="num">(14,423)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDividendsAdjustment', window );">Paid-in-kind dividends for preferred stock</a></td>
<td class="num">(4,561)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,643)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Change in preferred stock redemption value</a></td>
<td class="num">(2,373)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,770)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (59,948)<span></span>
</td>
<td class="num">$ (14,505)<span></span>
</td>
<td class="num">$ (83,636)<span></span>
</td>
<td class="num">$ (14,423)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net loss per share attributable to common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (2.24)<span></span>
</td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (3.13)<span></span>
</td>
<td class="num">$ (0.56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (2.24)<span></span>
</td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (3.13)<span></span>
</td>
<td class="num">$ (0.56)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average number of shares used in per share amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">26,786<span></span>
</td>
<td class="nump">26,487<span></span>
</td>
<td class="nump">26,688<span></span>
</td>
<td class="nump">25,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">26,786<span></span>
</td>
<td class="nump">26,487<span></span>
</td>
<td class="nump">26,688<span></span>
</td>
<td class="nump">25,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (53,014)<span></span>
</td>
<td class="num">$ (14,505)<span></span>
</td>
<td class="num">$ (72,223)<span></span>
</td>
<td class="num">$ (14,423)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized holding gain (loss) for available for sales debt securities, net of tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(97)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(26)<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">73<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">(53,037)<span></span>
</td>
<td class="num">(14,498)<span></span>
</td>
<td class="num">(72,255)<span></span>
</td>
<td class="num">(14,279)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMember', window );">Commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">59,191<span></span>
</td>
<td class="nump">73,544<span></span>
</td>
<td class="nump">276,066<span></span>
</td>
<td class="nump">253,986<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 4,723<span></span>
</td>
<td class="nump">$ 20,740<span></span>
</td>
<td class="nump">$ 18,619<span></span>
</td>
<td class="nump">$ 35,472<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_CustomerCareAndEnrollmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period related to providing customer care and enrollment services. These services include pre-sales assistance to applicants who call our customer care center and enrollment services to applicants during the underwriting process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_CustomerCareAndEnrollmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_TechnologyAndContentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for technology and content. Technology and content expenses consist primarily of compensation and benefits costs for personnel associated with developing and enhancing our website technology as well as maintaining our website.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_TechnologyAndContentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDividendsAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDividendsAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844330297928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Total</div></th>
<th class="th"><div>Cumulative effect from the adoption of ASU 2016-13</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative effect from the adoption of ASU 2016-13</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 527,164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (1,147)<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 455,159<span></span>
</td>
<td class="num">$ (199,998)<span></span>
</td>
<td class="nump">$ 271,852<span></span>
</td>
<td class="num">$ (1,147)<span></span>
</td>
<td class="nump">$ 116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock in connection with equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock in connection with equity incentive plans</a></td>
<td class="nump">1,577<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Repurchase of shares to satisfy employee tax withholding obligations</a></td>
<td class="num">(17,174)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,174)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Repurchase of shares to satisfy employee tax withholding obligations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">23,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">144<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(14,423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,423)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued in equity offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Shares issued in equity offering</a></td>
<td class="nump">228,024<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">228,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Settlement of earnout liability (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Settlement of earnout liability</a></td>
<td class="nump">28,521<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Sep. 30, 2020</a></td>
<td class="nump">775,686<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">719,104<span></span>
</td>
<td class="num">$ (199,998)<span></span>
</td>
<td class="nump">256,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Jun. 30, 2020</a></td>
<td class="nump">792,055<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">720,976<span></span>
</td>
<td class="num">$ (199,998)<span></span>
</td>
<td class="nump">270,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock in connection with equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock in connection with equity incentive plans</a></td>
<td class="nump">263<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Repurchase of shares to satisfy employee tax withholding obligations</a></td>
<td class="num">(9,014)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,014)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Repurchase of shares to satisfy employee tax withholding obligations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">6,880<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(14,505)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Sep. 30, 2020</a></td>
<td class="nump">775,686<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">719,104<span></span>
</td>
<td class="num">$ (199,998)<span></span>
</td>
<td class="nump">256,282<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2020</a></td>
<td class="nump">837,558<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">721,013<span></span>
</td>
<td class="num">$ (199,998)<span></span>
</td>
<td class="nump">316,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock in connection with equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock in connection with equity incentive plans</a></td>
<td class="nump">2,735<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Repurchase of shares to satisfy employee tax withholding obligations</a></td>
<td class="num">(7,968)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,968)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Repurchase of shares to satisfy employee tax withholding obligations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock', window );">Paid-in-kind dividend and accretion related to convertible preferred stock</a></td>
<td class="num">(11,413)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,413)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee stock purchase program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for employee stock purchase program</a></td>
<td class="nump">2,248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">26,756<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="num">(32)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(72,223)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72,223)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Sep. 30, 2021</a></td>
<td class="nump">777,661<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">744,784<span></span>
</td>
<td class="num">$ (199,998)<span></span>
</td>
<td class="nump">232,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">318<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Jun. 30, 2021</a></td>
<td class="nump">831,754<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">738,906<span></span>
</td>
<td class="num">$ (199,998)<span></span>
</td>
<td class="nump">292,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock in connection with equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock in connection with equity incentive plans</a></td>
<td class="nump">1,933<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Repurchase of shares to satisfy employee tax withholding obligations</a></td>
<td class="num">(2,061)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,061)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Repurchase of shares to satisfy employee tax withholding obligations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock', window );">Paid-in-kind dividend and accretion related to convertible preferred stock</a></td>
<td class="num">(6,934)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,934)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">6,006<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income, net of tax</a></td>
<td class="num">(23)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(53,014)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,014)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Sep. 30, 2021</a></td>
<td class="nump">$ 777,661<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 744,784<span></span>
</td>
<td class="num">$ (199,998)<span></span>
</td>
<td class="nump">$ 232,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 318<span></span>
</td>
</tr>
<tr><td colspan="10"></td></tr>
<tr><td colspan="10"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 1 &#8211; Summary of Business and Significant Accounting Policies</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to retained earnings for the increase in carrying amount of redeemable preferred stock that is classified as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 3.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177168-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844332578024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (72,223)<span></span>
</td>
<td class="num">$ (14,423)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="nump">2,604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Amortization of internally developed software</a></td>
<td class="nump">9,140<span></span>
</td>
<td class="nump">5,307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">416<span></span>
</td>
<td class="nump">1,207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">24,881<span></span>
</td>
<td class="nump">21,722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(20,134)<span></span>
</td>
<td class="num">(10,982)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">908<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">493<span></span>
</td>
<td class="num">(1,522)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_IncreaseDecreaseInCommissionsReceivable', window );">Contract assets &#8211; commissions receivable</a></td>
<td class="nump">35,244<span></span>
</td>
<td class="num">(16,772)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other assets</a></td>
<td class="num">(20,790)<span></span>
</td>
<td class="num">(9,398)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(26,913)<span></span>
</td>
<td class="num">(3,196)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="num">(118)<span></span>
</td>
<td class="num">(7,438)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_IncreaseDecreaseInAccruedMarketingExpenses', window );">Accrued marketing expenses</a></td>
<td class="num">(6,525)<span></span>
</td>
<td class="num">(5,449)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">10,240<span></span>
</td>
<td class="nump">23,901<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">1,360<span></span>
</td>
<td class="nump">3,059<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(60,321)<span></span>
</td>
<td class="num">(10,959)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopSoftware', window );">Capitalized internal-use software and website development costs</a></td>
<td class="num">(12,589)<span></span>
</td>
<td class="num">(12,082)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment and other assets</a></td>
<td class="num">(3,554)<span></span>
</td>
<td class="num">(6,454)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="num">(88,967)<span></span>
</td>
<td class="num">(180,505)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Proceeds from redemption and maturities of marketable securities</a></td>
<td class="nump">68,288<span></span>
</td>
<td class="nump">70,750<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(36,822)<span></span>
</td>
<td class="num">(128,291)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of preferred stock, net of issuance costs</a></td>
<td class="nump">214,025<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">228,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Net proceeds from exercise of common stock options and employee stock purchases</a></td>
<td class="nump">4,983<span></span>
</td>
<td class="nump">1,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards', window );">Repurchase of shares to satisfy employee tax withholding obligations</a></td>
<td class="num">(7,968)<span></span>
</td>
<td class="num">(17,174)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Acquisition-related contingent payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,751)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Principal payments in connection with leases</a></td>
<td class="num">(126)<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">210,914<span></span>
</td>
<td class="nump">203,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">113,771<span></span>
</td>
<td class="nump">64,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">47,113<span></span>
</td>
<td class="nump">26,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">$ 160,884<span></span>
</td>
<td class="nump">$ 91,187<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_IncreaseDecreaseInAccruedMarketingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in accrued marketing expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_IncreaseDecreaseInAccruedMarketingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_IncreaseDecreaseInCommissionsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Commissions Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_IncreaseDecreaseInCommissionsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash paid by the entity during the period to settle equity instruments granted under equity-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844332764632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Business and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Business and Significant Accounting Policies</a></td>
<td class="text">Summary of Business and Significant Accounting Policies<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eHealth, Inc. (the &#8220;Company,&#8221; &#8220;eHealth,&#8221; &#8220;we&#8221; or &#8220;us&#8221;) is a leading health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Our mission is to connect every person with the highest quality, most affordable health insurance and Medicare plans for their life circumstances. Our platform integrates proprietary and third-party developed educational content regarding health insurance plans with decision support tools to aid consumers in what has traditionally been a confusing and opaque health insurance purchasing process, and to help them obtain the health insurance products that meet their individual health and economic needs. Our omnichannel consumer engagement platform enables consumers to use our services online, through interactive chat, or by telephone with a licensed insurance agent. We have created a marketplace that offers consumers a broad choice of insurance products that includes thousands of Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business and other ancillary health insurance products from over 200 health insurance carriers across all fifty states and the District of Columbia.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Basis of Presentation &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The accompanying condensed consolidated balance sheet as of September 30, 2021, the condensed consolidated statements of comprehensive loss and stockholders&#8217; equity for the three and nine months ended September 30, 2021 and 2020, and the condensed consolidated statements of cash flows for the nine months ended September 30, 2021 and 2020 are unaudited. The condensed consolidated balance sheet data as of December 31, 2020 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission on February 26, 2021 and amended on April 29, 2021. The accompanying financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and reflect all normal recurring adjustments that are necessary to present fairly the results for the interim periods presented. The condensed consolidated financial statements include the accounts of eHealth, Inc. and its direct and indirect wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with those rules and regulations. Certain prior period amounts have been reclassified to conform with our current period presentation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020 and include all adjustments necessary for the fair presentation of our financial position as of September 30, 2021 and December 31, 2020, and our results of operations for the periods presented. The results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for any subsequent period or for the year ending December 31, 2021 and therefore should not be relied upon as an indicator of future results.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the issuance of our consolidated financial statements for the year ended December 31, 2020, we identified certain errors, including a $3.0&#160;million under-recognition of stock-based compensation expense and a $1.5&#160;million over-recognition of licensing costs for the year ended December 31, 2020. We adjusted for these items in the first quarter of 2021 and the adjustments reduced our net loss by approximately $1.5&#160;million, or $0.06 per basic and diluted share in our Condensed Consolidated Statement of Comprehensive Loss for the three months ended March 31, 2021. These items also reduced our net loss by approximately $1.5&#160;million, or $0.06 per basic and diluted share, on our Condensed Consolidated Statement of Comprehensive Loss for the nine months ended September 30, 2021. We evaluated the effects of these out-of-period adjustments, both qualitatively and quantitatively, and concluded that the errors and the correction thereof were immaterial both individually and in the aggregate to the current reporting period and the periods in which they originated, including quarterly reporting.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies, Estimates and Judgments &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates, including those related to, but not limited to, the useful lives of intangible assets, fair value of investments, recoverability of intangible assets, the commissions we expect to collect for each approved member cohort, valuation allowance for deferred income taxes, provision (benefit) for income taxes and the assumptions used in determining stock-based compensation. We base our estimates of the carrying value of certain assets and liabilities on historical experience and on various other assumptions that we believe to be reasonable. Actual results may differ from these estimates. There have been no material changes to our significant accounting policies discussed in our Annual Report on Form 10-K for the year ended December 31, 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Seasonality &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Open enrollment periods drive the seasonality of our business. A greater number of our Medicare-related health insurance plans are sold in our fourth quarter during the Medicare annual enrollment period when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, our Medicare plan-related commission revenue is highest in our fourth quarter. Our Medicare plan-related commission revenue is also elevated in the first quarter compared to the second and third quarters as a result of the reintroduction of the Medicare Advantage open enrollment period in the first quarter of 2019. Any changes to or adoption of open enrollment or special enrollment periods may change the seasonality of our business.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The majority of our individual and family health insurance plans is sold in the fourth quarter during the annual open enrollment period as defined under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act. In the states where the Federally Facilitated marketplace operates as the state health insurance exchange, individuals and families generally are not able to purchase individual and family health insurance outside of the annual enrollment period, unless they qualify for a special enrollment period as a result of certain qualifying events, such as losing employer-sponsored health insurance or moving to another state. Extended open enrollment or special enrollment periods may change the seasonality of our individual and family health insurance business.  For example, the COVID-related special enrollment period which ended on August 15, 2021 has caused increased commission revenue from the sale of individual and family health insurance plans outside of the open enrollment period. In addition, we may experience changes in seasonality due to the extension of the 2022 open enrollment period to January 15, 2022 for most states.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Income Taxes (Topic 740) &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2019, the Financial Accounting Standard Board (&#8220;FASB&#8221;) issued ASU No. 2019-12, Income Tax, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, which aims to simplify the accounting for income taxes. We adopted this guidance in the first quarter of 2021, and it did not have a material impact on our condensed consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">. ASU 2020-10 is intended to facilitate codification updates for technical corrections, such as conforming amendments, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements. It contains amendments that improve the consistency of the codification by including all disclosure guidance in the appropriate disclosure section and other updates that vary in nature. We adopted this guidance in the first quarter of 2021 with no material impact on our condensed consolidated financial statements and disclosures.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Debt with Conversion and Other Options (Topic 470) and Contracts in Entity's Own Equity (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> &#8211; In June 2020, the FASB issued ASU No. 2020-06 to simplify the accounting for convertible instruments and improve the usefulness and relevance of information regarding convertible instruments. This ASU reduces the number of accounting models for converting debt instruments and convertible preferred stock. ASU No. 2020-06 is effective for us in 2022, with early adoption permitted. We early adopted this guidance in the first quarter of 2021, and it did not have a material impact on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844328542024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below depicts the disaggregation of revenue by product and is consistent with how we evaluate our financial performance (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.694%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,953)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Individual and Family </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Qualified Health Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qualified Health Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Individual and Family</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ancillary</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Ancillary</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Small Business</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,975&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commission Bonus and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Commission Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,191&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,066&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,986&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsorship and Advertising Revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,723&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,740&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,619&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,472&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,914&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,284&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,685&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,458&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:11.65pt">We define our Individual and Family plan offerings as major medical individual and family health insurance plans, which does not include Medicare-related, small business or ancillary plans. Individual and family health insurance plans include both qualified and non-qualified plans. Qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are offered through the government-run health insurance exchange in the relevant jurisdiction. Non-qualified health plans are Individual and Family plans that meet the requirements of the Affordable Care Act and are not offered through the exchange in the relevant jurisdiction. Individuals that purchase non-qualified health plans cannot receive a subsidy in connection with the purchase of those plans.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commission revenue by segment is presented in the table below (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Members Approved During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Commission Revenue from Members Approved in Prior Periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare Segment Commission Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Individual, Family and Small Business</span></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Members Approved During the Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Renewals of Small Business Members During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Commission Revenue from Members Approved in Prior Periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total IFP/SMB Segment Commission Revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,664&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,792&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,690&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Commission Revenue from Members Approved During the Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Renewals of Small Business Members During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net Commission Revenue from Members Approved in Prior Periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Commission Revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,191&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,544&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,066&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,986&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These amounts include commission bonus revenue.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These amounts reflect our revised estimates of cash collections for certain members approved prior to the relevant reporting period that are recognized as adjustments to revenue within the relevant reporting period. The net adjustment revenue includes both increases in revenue for certain prior period cohorts as well as reductions in revenue for certain prior period cohorts. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, beginning in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">The impacts of total net commission revenue from members approved in prior periods were $0.37 and $0.62 per basic and diluted share for the three months ended September 30, 2021 and 2020, respectively. The impacts of total net commission revenue from members approved in prior periods were $0.65 and $1.14 per basic and diluted share, for the nine months ended September 30, 2021 and 2020, respectively. </span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The total reductions to revenue from members approved in prior periods were $3.2 million and $3.7 million for the three months ended September 30, 2021 and 2020, respectively, and $22.6 million and $5.3 million for the nine months ended September 30, 2021 and 2020, respectively. These reductions to revenue primarily related to the Medicare segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844328493784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Statement Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Supplemental Financial Statement Information</a></td>
<td class="text">Supplemental Financial Statement Information<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all investments with an original maturity of 90 days or less from the date of purchase to be cash equivalents. Cash and cash equivalents are stated at fair value. We also invest in marketable securities that are measured and recorded at fair value. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion about our marketable securities. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalent and restricted cash balances are summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.078%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,884&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021 and December 31, 2020, we had $3.4 million of restricted cash which was classified as a non-current asset on our Condensed Consolidated Balance Sheets. This amount collateralizes letters of credit related to certain lease commitments.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets and Accounts Receivable</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not require collateral or other security for our contract assets and accounts receivable. We believe the potential for collection issues with any of our customers was minimal as of September 30, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We estimate an allowance for credit losses using relevant available information from internal and external sources, related to past events, current conditions, and reasonable and supportable forecasts. Specifically, for the purpose of measuring the probability of default parameters, we utilize Capital IQ&#8217;s, Standard &amp; Poor&#8217;s and Moody&#8217;s analytics. Our estimates of loss given default are determined by using our historical collections data as well as historical information obtained through our research and review of other insurance related companies. Our estimated exposure at default is determined by applying these internal and external data sources to our commission receivable balances. As such, we apply an immediate reversion method and revert to historical loss information when computing our credit loss exposure. Credit loss expenses are assessed quarterly and included in general and administrative expense on our Condensed Consolidated Statement of Comprehensive Loss. There were no write-offs during any of the three or nine month periods ended September 30, 2021 and 2020.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We considered the impact of recent events and global economic conditions when evaluating the appropriate adjustments to our allowance for credit losses as of September 30, 2021. We also considered the current and expected future economic and market conditions surrounding the COVID-19 pandemic.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the allowance for credit losses for the nine months ended September 30, 2021 is summarized as follows (in thousands):&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.485%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract assets &#8211; commission receivable activities, net of credit loss allowances&#160;are summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.037%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFP/SMB Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from members approved during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from renewals of small business members during the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net commission revenue from members approved in prior periods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,485)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in credit loss allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687,274&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757,368&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFP/SMB Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from members approved during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from renewals of small business members during the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net commission revenue from members approved in prior periods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201,256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237,213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in credit loss allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,536)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562,426&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,919&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604,345&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments that are exposed to concentrations of credit risk principally consist of cash, cash equivalents, marketable securities, contract assets &#8211; commissions receivable, and accounts receivable. We invest our cash and cash equivalents with major banks and financial institutions and such investments are in excess of federally insured limits. We also have deposits with major banks in China that are denominated in both U.S. dollars and Chinese Yuan Renminbi and are not insured by the U.S. federal government. The deposits in China were $3.8&#160;million as of September 30, 2021. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more information regarding our marketable securities.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not require collateral or other security for either our contract assets or accounts receivable. Carriers that represented 10% or more of our total contract assets and accounts receivable balance are summarized as of the dates presented below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthCare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aetna</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Percentages include the carriers' subsidiaries.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the contract assets and accounts receivable of WellCare are included in the percentage calculation for September 30, 2021 and December 31, 2020.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prepaid Expenses and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our prepaid expenses and other current assets are summarized as of the periods presented as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.276%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid maintenance contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,448&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,653&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,661&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844327050184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define fair value as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques we use to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. We classify the inputs used to measure fair value into the following hierarchy:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:90.129%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unadjusted quoted prices in active markets for identical assets or liabilities.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs for the asset or liability.</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial assets measured at fair value on a recurring basis are summarized below by their classification within the fair value hierarchy as of the dates presented below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bond</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,977&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,371&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,977&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.366%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,620&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, our cash equivalents consisted of money market funds and commercial paper with original maturity of 90 days or less were classified as Level 1 and 2, respectively. We endeavor to utilize the best available information in measuring fair value. We used observable prices in active markets in determining the classification of our money market funds as Level 1. Our Level 2 assets consisted of available for sale marketable securities, which included commercial paper, agency bonds, and a corporate bond with maturities of less than one year. We classify our marketable debt securities within Level 2 in the fair value hierarchy, because we use quoted market prices to the extent available or alternative pricing sources and models utilizing market observable inputs to determine fair value. Our portfolio primarily consisted of financial instruments with a credit rating of AA or equivalent by S&amp;P Rating and Moody's Investor Services. There were no transfers between the hierarchy levels during either the nine months ended September 30, 2021 or the year ended December 31, 2020. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash equivalents and available-for-sale debt securities by contractual maturity (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,977&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gains and losses on available-for-sale debt securities that are not credit related are included in accumulated other comprehensive income and summarized as follows as of September 30, 2021 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bond</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,980&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,977&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>As of September 30, 2021, we had forty-one securities in net loss positions and their unrealized losses were immaterial individually and in aggregate. We did not record any credit losses regarding our available-for-sales debt securities during the nine months ended September 30, 2021. We do not intend to sell these securities and it is more likely than not that we will not be required to sell these securities before the recovery of their amortized cost basis.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844332215112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Equity</a></td>
<td class="text">Equity<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Inducement Plan &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 22, 2021, the Company adopted an inducement plan (the &#8220;2021 Inducement Plan&#8221;), pursuant to which the Company reserved 410,000 shares of its common stock (subject to customary adjustments in the event of a change in capital structure of the Company) to be used exclusively for grants of awards to individuals who were not previously employees or directors of the Company, other than following a bona fide period of non-employment, as an inducement material to the individual's entry into employment with the Company within the meaning of Rule 5635(c)(4) of the Nasdaq Listing Rules (&#8220;Nasdaq Rules&#8221;). The Inducement Plan was approved by the Company's board of directors (the &#8220;Board&#8221;) without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Rules, and the terms and conditions of the Inducement Plan and awards to be granted thereunder are substantially similar to the Company's stockholder-approved Amended and Restated 2014 Equity Incentive Plan.  As of September 30, 2021, no shares were issued under the 2021 Inducement Plan. Subsequently, 390,584 shares were issued under the 2021 Inducement Plan in October 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Programs &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no stock repurchase activity during the three and nine months ended September 30, 2021. In addition to 10.7 million shares repurchased under our previous repurchase programs, we have in treasury 1.3 million shares as of September 30, 2021 that were previously surrendered by employees to satisfy tax withholding due in connection with the vesting of certain restricted stock units. As of September 30, 2021 and December 31, 2020, we had a total of 12.0 million shares and 11.8 million shares, respectively, held in treasury. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For accounting purposes, common stock repurchased under our stock repurchase programs is recorded based upon the settlement date of the applicable trade. Such repurchased shares are held in treasury and are presented using the cost method.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our stock-based compensation expense is summarized as follows by award types (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,855&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,234&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,332&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,881&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,722&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Amounts include market-based and performance-based restricted stock units.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense by operating function for the periods presented below&#160;(in thousands):&#160;</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"/><td style="width:39.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.209%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing and advertising</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer care and enrollment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology and content</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount capitalized in internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,006&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,880&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Stock-based compensation expense for both three and nine months ended September 30, 2021 was impacted by a $4.1&#160;million credit related to forfeited equity awards due to our chief executive officer's separation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844327120440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Convertible Preferred Stock</a></td>
<td class="text">Convertible Preferred Stock<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 30, 2021 (the &#8220;Closing Date&#8221;), we issued and sold to Echelon Health SPV, LP (&#8220;H.I.G.&#8221;), an investment vehicle of H.I.G. Capital, in a private placement, 2,250,000 shares of our newly designated Series A convertible preferred stock (the &#8220;Series A preferred stock&#8221;), par value $0.001 per share, at an aggregate purchase price of $225.0&#160;million. We received $214.0&#160;million in net proceeds from the private placement with H.I.G., net of sales commissions and certain transaction fees totaling $11.0 million. The Series A preferred stock ranks senior to all other equity securities of the Company with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Dividends initially accrue on the Series A preferred stock daily at 8% per annum on the stated value of $100 per share (&#8220;Stated Value&#8221;) and compound semiannually, payable in kind (&#8220;PIK&#8221;) until the second anniversary of the Closing Date on June 30 and December 31 of each year (each, a &#8220;Dividend Payment Date&#8221;), beginning on June 30, 2021, and thereafter 6% PIK and 2% payable in cash in arrears on June 30 and December 31 of each year, beginning on June 30, 2023. PIK dividends are cumulative and are added to the Accrued Value (as defined below). &#8220;Accrued Value&#8221; means, as of any date, with respect to any share of Series A preferred stock, the sum of the Stated Value per share plus, on each Dividend Payment Date, on a cumulative basis, all accrued PIK dividends on such share that have not previously compounded and been added to the Accrued Value. The Series A preferred stock participates, on an as-converted basis in all dividends paid to the holders of our common stock.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Conversion Rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211; The Series A preferred stock is convertible at any time into common stock at a conversion rate equal to (i) the Accrued Value plus accrued PIK dividends that have not yet been added to the Accrued Value, (ii) divided by the conversion price as of the applicable conversion date (the &#8220;Conversion Price&#8221;). As of the date of this report, the Conversion Price is equal to $79.5861 per share. This Conversion Price is subject to further adjustment and the number of shares of common stock issuable upon conversion of the Series A preferred stock is subject to certain limitations, each as set forth in the Certificate of Designations of Series A preferred stock, as filed with the Secretary of State of the State of Delaware on April 30, 2021 (the &#8220;Certificate of Designations&#8221;).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption Put Right </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; At any time on or after the sixth anniversary of the Closing Date, holders of the Series A preferred stock will have the right to cause the Company to redeem all or any portion of the Series A preferred stock in cash at an amount equal to the greater of (i) 135% of the Accrued Value per share as of the redemption date, plus accrued PIK dividends that have not yet been added to the Accrued Value and (ii) the amount per share that would be payable on an as-converted basis on such Series A preferred stock at the then-current Accrued Value, plus accrued PIK dividends that have not yet been added to the Accrued Value, and in either case of (i) or (ii) plus any unpaid cash dividends that would have otherwise been settled in cash in connection with such conversion (the greater of (i) and (ii), the &#8220;Redemption Price&#8221;).</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Redemption Call Right </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; At any time on or after the sixth anniversary of the Closing Date, the Company will have the right (but not the obligation) to redeem out of legally available funds and for cash consideration all (but not less than all) of the Series A preferred stock upon at least 30 days prior written notice at an amount equal to the Redemption Price.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Board Nomination Rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211; H.I.G. is entitled to nominate one individual for election to the the Board so long as it continues to own at least 30% of the common stock issuable or issued upon conversion of the Series A preferred stock originally issued to it in the private placement. H.I.G. also has the right to nominate an additional individual to the Board if the Company fails to maintain certain levels of commissions receivable and liquidity.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Voting Rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211; The Series A preferred stock will vote together with the common stock as a single class on all matters submitted to a vote of the holders of the common stock (subject to certain voting limitations set forth in, and the terms and conditions of, the Certificate of Designations). Each holder of Series A preferred stock shall be entitled to the number of votes, rounded down to the nearest whole number, equal to the product of (i) the aggregate Accrued Value of the issued and outstanding shares of Series A preferred stock divided by the Minimum Price (as defined below), multiplied by (ii) a fraction, the numerator of which is the number of shares of Series A preferred stock held by such holder and the denominator of which is the aggregate number of issued and outstanding shares of Series A preferred stock. &#8220;Minimum Price&#8221; means the lower of: (i) the Nasdaq Official Closing Price per share of common stock on the Closing Date; or (ii) the average Nasdaq Official Closing Price per share of common stock for the five trading days immediately prior to the Closing Date. Holders of Series A preferred stock will have one vote per share on any matter on which the holders of the Series A preferred stock are entitled to vote separately as a class (subject to certain voting limitations set forth in, and the terms and conditions of, the Certificate of Designations).</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Mandatory Conversion of the Series A Preferred Stock  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211; At any time on or after the third anniversary of the Closing Date, if the volume-weighted average price per share of our common stock is greater than 167.5% of the then-current Conversion Price for 20 consecutive trading days in a 30-day trading day period, the Company will have the right to convert all, but not less than all, of the Series A preferred stock into common stock at a conversion rate with respect to each share of Series A preferred stock of (i) the Accrued Value plus accrued PIK dividends that have not yet been added to the Accrued Value, (ii) divided by the then applicable Conversion Price.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Covenants and Liquidity Requirements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211; As long as H.I.G. continues to own at least 30% of the Series A preferred stock originally issued to it in the private placement, the consent of H.I.G. will be required for the Company to incur certain indebtedness and to take certain other corporate actions as set forth in the Company's investment agreement with H.I.G. entered into on February 17, 2021 (the &#8220;Investment Agreement&#8221;).  In addition, the Company is required to maintain an asset coverage ratio (as defined in the Investment Agreement) of at least 2x, which increases to 2.5x thirty months after the date of the Investment Agreement.  Additionally, the Investment Agreement requires the Company to maintain a minimum liquidity amount (as defined in the Investment Agreement) for certain periods that ranges from $65&#160;million to $125&#160;million. If the Company fails to maintain the minimum asset coverage ratio or minimum liquidity amount as of a certain date or for a certain time period required by the Investment Agreement and H.I.G continues to own at least 30% of the Series A preferred stock originally issued to it in the private placement, H.I.G will have the right to nominate an additional director to the Board, and the consent of H.I.G. will be required to approve the Company's annual budget, hire or terminate certain key executives, and incur </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">certain indebtedness as outlined in the Investment Agreement. H.I.G. will no longer have these additional board nomination and consent rights if the Company is able to satisfy the minimum liquidity amount requirements in the Investment Agreement for any subsequent 12 consecutive months.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Series A preferred stock is considered temporary equity in our condensed consolidated financial statements. We have determined there are no material embedded features that require recognition as a derivative asset or liability. We recognized the Series A preferred stock at its stated amount less issuance costs of $11.0 million, or $214.0 million.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, the estimated Series A preferred stock redemption value equals 135% of the Accrued Value per share as of the redemption date, plus any accrued and unpaid dividends, which is significantly in excess of the fair value of the common stock into which the Series A preferred stock is convertible as of September 30, 2021. We have elected to apply the accretion method to adjust the carrying value of the Series A preferred stock to its redemption value at the earliest date of redemption, April 30, 2027. Amounts recognized to accrete the Series A preferred stock to its estimated redemption value are treated as a deemed dividend and are recorded as a reduction to retained earnings. The estimated redemption value will vary in subsequent periods due to the redemption put right described above and we have elected to recognize such changes prospectively.  No shares of Series A preferred stock have been converted and the Series A preferred stock was convertible into 2.9&#160;million shares of common stock as of September 30, 2021. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the proceeds and changes to our Series A preferred stock (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,025&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of Closing Date</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued paid-in-kind dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in preferred stock redemption value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,438&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844327139592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share Attributable to Common Stockholders</a></td>
<td class="text">Net Loss Per Share Attributable to Common Stockholders<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Series A preferred stock is considered a participating security which requires the use of two-class method for the computation of basic and diluted per share amounts. Under the two-class method, earnings available to common stockholders for the period are allocated between common stockholders and participating securities according to dividends accumulated and participation rights in undistributed earnings. Net loss attributable to common stockholders is not allocated to the convertible preferred stock as the holder of the Series A preferred stock does not have a contractual obligation to share in losses. Basic net loss attributable to common stockholders per share is computed by dividing net loss available to common stockholders by the weighted-average number of shares of common stock outstanding for the period. Diluted net loss attributable to common stockholders per share is computed by dividing the net loss available to common stockholders for the period by the weighted average number of common and common equivalent shares outstanding during the period. Diluted net loss attributable to common stockholders per share reflects all potential dilutive common stock equivalent shares, including conversion of preferred stock, stock options, restricted stock units and shares to be issued under our employee stock purchase program (&#8220;ESPP&#8221;).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss attributable to common stockholders per share (in thousands, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,948)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,423)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculation &#8211; basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in diluted share calculation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,487&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders per share &#8211; basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each of the three and nine months ended September 30, 2021 and 2020, we had securities outstanding that could potentially dilute per share amounts, but the shares from the assumed conversion or exercise of these securities were excluded in the computation of diluted net loss per share as their effect would have been anti-dilutive. The number of outstanding anti-dilutive shares that were excluded from the computation of diluted net income (loss) per share consisted of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,595&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,285&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844327138472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service and Licensing Obligations</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into service and licensing agreements with third party vendors to provide various services, including network access, equipment maintenance, and software licensing. As the benefits of these agreements are experienced uniformly over the applicable contractual periods, we record the related service and licensing expenses on a straight-line basis, although actual cash payment obligations under certain of these agreements fluctuate over the terms of the agreements. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future minimum payments under non-cancellable contractual service and licensing obligations as of September 30, 2021 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">For the Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,575&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for commitments related to our operating leases.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">From time to time, we receive inquiries from governmental bodies and also may be subject to various legal proceedings and claims arising in the ordinary course of business. We assess contingencies to determine the degree of probability and range of possible loss for potential accrual in our condensed consolidated financial statements. An estimated loss contingency is accrued in the condensed consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. There was no material litigation-related accrual during the three and nine months ended September 30, 2021. Legal proceedings or other contingencies could result in material costs, even if we ultimately prevail.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Securities Class Action </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211; On April 8, 2020 and April 30, 2020, two purported class action lawsuits were filed against us, our then-chief executive officer, Scott N. Flanders, our then-chief financial officer, Derek N. Yung, and our then-chief operating officer, David K. Francis (collectively, the &#8220;Defendants&#8221;), in the United States District Court for the Northern District of California. The cases are captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Patel v. eHealth, Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">., Case No. 5:20-cv-02395 (N.D. Cal.) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Bertrand v. eHealth, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Case No. 4:20-cv-02967 (N.D. Cal.). The complaints allege, among other things, that we and Messrs. Flanders, Yung and Francis made materially false and misleading statements and/or failed to disclose material information regarding our accounting and modeling assumptions, rate of member churn and our profitability during the alleged class period of March 19, 2018 to April 7, 2020. The complaints allege that we and Messrs. Flanders, Yung and Francis violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The complaints seek compensatory and (in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Patel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> lawsuit) punitive damages, attorneys&#8217; fees and costs, and such other relief as the court deems proper. On June 24, 2020, the court consolidated the above-referenced matters under the caption</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"> In re eHealth Securities Litig.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, Master File No. 4:20-cv-02395-JST (N.D. Cal.). The court also appointed a lead plaintiff and lead counsel for the consolidated matter. The lead plaintiff filed an amended complaint on August 25, 2020, which the Defendants moved to dismiss on October 23, 2020. The Defendants&#8217; motion, which the plaintiff opposed, was granted in part and denied in part on August 12, 2021.  The court dismissed the plaintiff's claims to the extent premised upon alleged misrepresentations or omissions relating to churn, but denied the Defendants motion with respect to alleged misstatements regarding purported operating costs.  On October 1, 2021, the Company filed an answer denying in part and admitting in part the remaining allegations, and denying any wrongdoing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Derivative Actions &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 7, 2020 and October 13, 2020, two derivative lawsuits were filed against our then-chief executive officer, Mr. Flanders, our then-chief financial officer, Mr. Yung, our then-chief operating officer, Mr. Francis, and the members of our Board  at the time of filing of the complaints (collectively, the &#8220;Individual Defendants&#8221;), in the United States District Court for the Northern District of California and the Superior Court of California, County of Santa Clara. The cases are captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet v. Flanders et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">., Case No. 3:20-cv-04477-SK (N.D. Cal.), and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire Police Pension Fund v. Flanders et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">, Case No. 20CV371555 (Cal. Super. Ct.), and also name the Company as a nominal defendant. A third derivative lawsuit was filed against the same defendants on October 5, 2021 in the United States District Court for the Northern District of California, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Badwal v. Flanders et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">., Case No. 4:21-cv-07795 (N.D. Cal.). The complaints allege, among </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">other things, that beginning on March 19, 2018, the Individual Defendants made or caused the Company to make materially false and misleading statements and/or failed to disclose material information regarding our accounting and modeling assumptions, rate of member churn, profitability, and internal controls. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> complaints purport to assert claims for breach of fiduciary duty, unjust enrichment and waste of corporate assets. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> lawsuit also alleges that the Individual Defendants violated Sections 14(a), 10(b), and 20(a) of the Securities Exchange Act of 1934, and asserts claims for abuse of control and gross mismanagement. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Badwal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> complaint purports to assert a claim for breach of fiduciary duty, an insider trading claim, and violations of Section 14(a), 10(b) and 20D of the Securities Exchange Act of 1934.  The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> complaints seek damages, restitution, attorneys&#8217; fees and costs, and certain measures with respect to our corporate governance and internal procedures, and (in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> lawsuit) equitable and/or injunctive relief. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Badwal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> complaint seeks damages, declaratory relief, corporate governance measures, equitable and injunctive relief, restitution and disgorgement, and attorneys' fees and costs.  On August 10, 2020, the parties filed a Stipulation and Proposed Order in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> matter to stay the action until and through the resolution of the Defendants' anticipated motion to dismiss the consolidated securities class action, and filed a similar stipulation in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> matter on December 11, 2020.  The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chernet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> stipulation was granted by the court on August 12, 2020 and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Lincolnshire</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> stipulation on December 11, 2020. The agreed-upon stays terminated with the filing of an answer in the securities class action and the parties are engaged in discussions regarding further proceedings. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The Gonzalez and Le</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Vias Complaints</span> &#8211; On April 6, 2018, a former employee, Lupita Gonzalez, filed a complaint against us in the Superior Court of the State of California for the County of Sacramento (the &#8220;Gonzalez Complaint&#8221;). On July 1, 2019, two other current or former employees, Michael Le&#8217;Vias and Ramona Meadows, filed a related complaint against us and eHealth Ins. Serv. Co., in the Superior Court of the State of California for the County of Santa Clara (the &#8220;Le&#8217;Vias Complaint&#8221;). Both complaints asserted claims under the California Private Attorney General Act on behalf of all current and former hourly-paid or non-exempt employees who work or have worked for us in California, based on alleged failures to comply with California wage and hour laws. The parties have entered into a court-approved settlement agreement that resolves both matters related to the Gonzalez and Le'Vias Complaints, and both the Gonzalez and Le'Vias Complaints have been dismissed with prejudice.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments, contingencies, and guarantees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI http://asc.fasb.org/topic&amp;trid=2155896<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844327107480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment and Geographic Information</a></td>
<td class="text">Segment and Geographic Information<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Segments</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report segment information based on how our chief executive officer, who is our chief operating decision maker ("CODM"), regularly reviews our operating results, allocates resources and makes decisions regarding our business operations. The performance measures of our segments include total revenue and profit. Our business structure is comprised of&#160;two&#160;operating segments: Medicare and Individual, Family and Small Business. Please refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Business and Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Part II, Item 8 of the Annual Report on Form 10-K for the year ended December 31, 2020 for our accounting policies relating to operating segments.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of our operating segments are summarized for the periods presented below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual, Family and Small Business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,284&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,685&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,458&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment profit (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare segment profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,882)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual, Family and Small Business segment profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total segment profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,383)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,665)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,146&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,827)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,581)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,376)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,881)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,899)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,995)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,840)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,911)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(416)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and reorganization charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,004)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before benefit from income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,848)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,948)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,501)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,346)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">During the first quarter of 2021, we revised the calculation of segment profit by excluding amortization of capitalized software development costs to enhance comparability of our financial metrics with peer companies. The amortization of capitalized software development costs were $3.4 million and $2.1 million for the three months ended September 30, 2021 and 2020, respectively, and $9.1 million and $5.3 million for the nine months ended September 30, 2021 and 2020, respectively.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Depreciation and amortization has been adjusted to include amortization of software development costs. </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no inter-segment revenue transactions for the periods presented. With the exception of contract assets &#8211; commissions receivable, which is presented by segment in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Financial Statement Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our CODM does not separately evaluate assets by segment, and therefore, assets by segment are not presented. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Information</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-lived assets primarily consist of property and equipment and internally-developed software. Our long-lived assets are attributed to the geographic location in which they are located. Long-lived assets by geographical area are summarized as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,102&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,065&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Customers</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all revenue for the three and nine months ended September 30, 2021 and 2020&#160;was generated from customers located in the United States. Carriers representing 10% or more of our total revenue are summarized as follows:&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthCare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aetna </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Percentages include the carriers' subsidiaries.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the revenue of WellCare is included in the percentage calculation for the three and nine months ended September 30, 2021 and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844327155064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases have remaining lease terms of 2 to 8 years. Certain of these leases have free or escalating rent payment provisions. We recognize lease expense on a straight-line basis over the terms of the leases, although actual cash payment obligations under certain of these agreements fluctuate over the terms of the agreements. Most leases include options to renew, and the exercise of these options is at our discretion.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating lease expenses were $1.9 million and $2.1 million for the three months ended September 30, 2021 and 2020, and $5.7 million and $6.4 million for the nine months ended September 30, 2021 and 2020, respectively and sublease income was immaterial for both periods.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases are as follows (dollars in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term of operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate used to recognize operating lease right-of-use-assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,411&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash outflows related to operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, maturities of operating lease liabilities are as follows (in thousands):</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,708&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Noncancellable sublease income for the remainder of 2021 and years ending December 31, 2022 and 2023 of $0.3 million, $0.4 million, and $0.4 million, respectively, is not included in the table above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844327174824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Reorganization<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Reorganization</a></td>
<td class="text">Restructuring and Reorganization<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our restructuring and reorganization costs and liabilities consist primarily of severance, transition and other related costs. The following table summarizes the cash-based restructuring and reorganization related liabilities (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and reorganization charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,466)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, we eliminated approximately 89 full-time positions, primarily in the United States, representing approximately 5% of our workforce, primarily within our customer care and enrollment group, and to a lesser extent, in our marketing and advertising, technology and content, and general and administrative groups. Total pre-tax restructuring charges  were $2.4&#160;million for the nine months ended September 30, 2021, which primarily related to employee termination benefits. Substantially all of the restructuring charges resulted in cash expenditures. The restructuring activities were completed by March&#160;31, 2021. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, we announced the transition of our chief executive officer. Mr. Scott Flanders resigned as a member of our Board and chief executive officer, effective October 31, 2021. We recognized $0.5&#160;million in severance costs related to his separation in September 2021 and we expect to recognize an additional $1.9&#160;million in the fourth quarter of 2021. Stock-based compensation expense for both three and nine months ended September 30, 2021 was impacted by a $4.1&#160;million credit related to forfeited equity awards due to Mr. Flanders' separation, which was included in general and administrative expenses on our Condensed Consolidated Statement of Comprehensive Loss.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844327056360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 17, 2018, we entered into a Credit Agreement with Royal Bank of Canada (&#8220;RBC&#8221;), as administrative agent and collateral agent (the &#8220;Credit Agreement&#8221;). The Credit Agreement provides for a $40.0 million secured asset-backed revolving credit facility with a $5.0 million letter of credit sub-facility. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2019, we amended our revolving credit facility agreement with RBC (the &#8220;Amendment&#8221;) and increased the borrowing amount from $40.0 million to $75.0&#160;million. The maturity date has been extended to December 20, 2022.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowing base under the Credit Agreement is comprised of an amount equal to (a) the lesser of (i) eighty percent (80%) of Eligible Commissions Receivables (as defined in the Credit Agreement) we actually collected during the immediately preceding period of three months or (ii) eighty percent (80%) of our Eligible Commission Receivables for the immediately succeeding period of three months, plus (b) fifty percent (50%) of our Eligible Commission Receivables for the immediately succeeding period of six months (excluding the immediately succeeding period of three months), in each case subject to reserves established by RBC (the &#8220;Borrowing Base&#8221;). The proceeds of the loans under the Credit Agreement may be used for working capital and general corporate purposes. The borrowers have the right to prepay the loans under the Credit Agreement in whole or in part at any time without penalty. Subject to availability under the Borrowing Base, amounts repaid may be reborrowed. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts not borrowed under the Credit Agreement will be subject to a commitment fee of 0.5% per annum on the daily unused portion of the credit facility, to be paid in arrears on the first business day of each calendar quarter. At the closing of the Credit Agreement, we paid a one-time facility fee of 1.75% of the total commitments of $40.0&#160;million. We also paid a one-time closing fee of 0.5% of the new commitment of $75.0&#160;million in connection with the Amendment. The Company is also obligated to pay other customary administration fees for a credit facility of this size and type. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability under the credit facility was up to the lesser of $40.0 million or the Borrowing Base in the original credit agreement. The Amendment increased the availability up to the lesser of $75.0 million or the Borrowing Base, which may be reduced from time to time pursuant to the Credit Agreement.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial covenants in the original Credit Agreement required that we maintain Excess Availability (as defined in the Credit Agreement) at or above $6.0 million at any time. The Amendment also changed the financial covenants to require us to maintain at least $6.0&#160;million of Excess Availability at all times or, if greater, up to $11.3&#160;million depending on our Borrowing Base as determined by eligible past and future commissions receivable. In addition, the Amendment also included changes in the payment conditions to, among other things, require us to have at least $10.0&#160;million of liquidity or, if greater, up to $18.8&#160;million depending on the Borrowing Base as determined by eligible past and future commissions receivable, in order for us to make certain permitted acquisitions, investments, distributions and payments of indebtedness. The Amendment also stated the seasonal amount thresholds used in connection with the cash dominion and field examination covenants in the Credit Agreement. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred $1.2 million of issuance costs in connection with the Credit Agreement, which were capitalized as part of other assets on our Consolidated Balance Sheet in the period we entered into the Credit Agreement. The Amendment did not change the interest rate. In connection with the Amendment, we incurred closing costs totaling $0.5&#160;million, which were capitalized and recorded as other assets on our Consolidated Balance Sheet as of December 31, 2019. The remaining balance of unamortized issuance costs was $0.5&#160;million and $0.7&#160;million as of September 30, 2021 and December 31, 2020, respectively. </span></div>As of September 30, 2021, we had no outstanding borrowings under our revolving credit facility.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844327076376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes our benefit from income taxes and our effective tax rates for the periods presented below (in thousands, except effective tax rate):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before benefit from income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,848)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,948)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,501)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,346)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,834)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,278)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three and nine months ended September 30, 2021, we recognized a benefit from income taxes of $12.8&#160;million and $19.3&#160;million, representing an effective tax rate of 19.5% and 21.1%, respectively. These effective tax rates are higher than the statutory federal tax rate due primarily to stock-based compensation adjustments, non-deductible lobbying expenses and state taxes, partially offset by research and development credits. For the three and nine months ended September 30, 2020, we recognized benefits from income taxes of $6.4 million and $10.9&#160;million, representing an effective tax rate of 30.8% and 43.1%, respectively, which were higher than the statutory federal tax rate due primarily to stock-based compensation adjustments, non-deductible lobbying expenses and state taxes, partially offset by research and development credits.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assessing the realizability of our deferred tax assets is dependent upon several factors, including the likelihood and amount, if any, of future taxable income in relevant jurisdictions during the periods in which those temporary differences become deductible. We forecast taxable income by considering all available positive and negative evidence, including our history of operating income and losses and our financial plans and estimates that we use to manage the business. These assumptions require significant judgment about future taxable income. As a result, the amount of deferred tax assets considered realizable is subject to adjustment in future periods if estimates of future taxable income change. We continue to recognize our deferred tax assets as of September 30, 2021, as we believe it is more likely than not that the net deferred tax assets will be realized, with the exception of certain net operating losses and credits that are expected to expire unutilized which have a valuation allowance.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844332039768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Business and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_DescriptionOfBusinessPolicyPolicyTextBlock', window );">Description of Business</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eHealth, Inc. (the &#8220;Company,&#8221; &#8220;eHealth,&#8221; &#8220;we&#8221; or &#8220;us&#8221;) is a leading health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. Our mission is to connect every person with the highest quality, most affordable health insurance and Medicare plans for their life circumstances. Our platform integrates proprietary and third-party developed educational content regarding health insurance plans with decision support tools to aid consumers in what has traditionally been a confusing and opaque health insurance purchasing process, and to help them obtain the health insurance products that meet their individual health and economic needs. Our omnichannel consumer engagement platform enables consumers to use our services online, through interactive chat, or by telephone with a licensed insurance agent. We have created a marketplace that offers consumers a broad choice of insurance products that includes thousands of Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business and other ancillary health insurance products from over 200 health insurance carriers across all fifty states and the District of Columbia.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Basis of Presentation &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The accompanying condensed consolidated balance sheet as of September 30, 2021, the condensed consolidated statements of comprehensive loss and stockholders&#8217; equity for the three and nine months ended September 30, 2021 and 2020, and the condensed consolidated statements of cash flows for the nine months ended September 30, 2021 and 2020 are unaudited. The condensed consolidated balance sheet data as of December 31, 2020 was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission on February 26, 2021 and amended on April 29, 2021. The accompanying financial statements and related notes should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information and reflect all normal recurring adjustments that are necessary to present fairly the results for the interim periods presented. The condensed consolidated financial statements include the accounts of eHealth, Inc. and its direct and indirect wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with those rules and regulations. Certain prior period amounts have been reclassified to conform with our current period presentation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020 and include all adjustments necessary for the fair presentation of our financial position as of September 30, 2021 and December 31, 2020, and our results of operations for the periods presented. The results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for any subsequent period or for the year ending December 31, 2021 and therefore should not be relied upon as an indicator of future results.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the issuance of our consolidated financial statements for the year ended December 31, 2020, we identified certain errors, including a $3.0&#160;million under-recognition of stock-based compensation expense and a $1.5&#160;million over-recognition of licensing costs for the year ended December 31, 2020. We adjusted for these items in the first quarter of 2021 and the adjustments reduced our net loss by approximately $1.5&#160;million, or $0.06 per basic and diluted share in our Condensed Consolidated Statement of Comprehensive Loss for the three months ended March 31, 2021. These items also reduced our net loss by approximately $1.5&#160;million, or $0.06 per basic and diluted share, on our Condensed Consolidated Statement of Comprehensive Loss for the nine months ended September 30, 2021. We evaluated the effects of these out-of-period adjustments, both qualitatively and quantitatively, and concluded that the errors and the correction thereof were immaterial both individually and in the aggregate to the current reporting period and the periods in which they originated, including quarterly reporting.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Significant Accounting Policies, Estimates and Judgments</a></td>
<td class="text">Significant Accounting Policies, Estimates and Judgments &#8211; The preparation of condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates, including those related to, but not limited to, the useful lives of intangible assets, fair value of investments, recoverability of intangible assets, the commissions we expect to collect for each approved member cohort, valuation allowance for deferred income taxes, provision (benefit) for income taxes and the assumptions used in determining stock-based compensation. We base our estimates of the carrying value of certain assets and liabilities on historical experience and on various other assumptions that we believe to be reasonable. Actual results may differ from these estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_SeasonalityPolicyPolicyTextBlock', window );">Seasonality</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Seasonality &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Open enrollment periods drive the seasonality of our business. A greater number of our Medicare-related health insurance plans are sold in our fourth quarter during the Medicare annual enrollment period when Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D prescription drug coverage for the following year. As a result, our Medicare plan-related commission revenue is highest in our fourth quarter. Our Medicare plan-related commission revenue is also elevated in the first quarter compared to the second and third quarters as a result of the reintroduction of the Medicare Advantage open enrollment period in the first quarter of 2019. Any changes to or adoption of open enrollment or special enrollment periods may change the seasonality of our business.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The majority of our individual and family health insurance plans is sold in the fourth quarter during the annual open enrollment period as defined under the federal Patient Protection and Affordable Care Act and related amendments in the Health Care and Education Reconciliation Act. In the states where the Federally Facilitated marketplace operates as the state health insurance exchange, individuals and families generally are not able to purchase individual and family health insurance outside of the annual enrollment period, unless they qualify for a special enrollment period as a result of certain qualifying events, such as losing employer-sponsored health insurance or moving to another state. Extended open enrollment or special enrollment periods may change the seasonality of our individual and family health insurance business.  For example, the COVID-related special enrollment period which ended on August 15, 2021 has caused increased commission revenue from the sale of individual and family health insurance plans outside of the open enrollment period. In addition, we may experience changes in seasonality due to the extension of the 2022 open enrollment period to January 15, 2022 for most states.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Income Taxes (Topic 740) &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2019, the Financial Accounting Standard Board (&#8220;FASB&#8221;) issued ASU No. 2019-12, Income Tax, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, which aims to simplify the accounting for income taxes. We adopted this guidance in the first quarter of 2021, and it did not have a material impact on our condensed consolidated financial statements.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> In October 2020, the FASB issued ASU No. 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">. ASU 2020-10 is intended to facilitate codification updates for technical corrections, such as conforming amendments, clarifications to guidance, simplifications to wording or structure of guidance, and other minor improvements. It contains amendments that improve the consistency of the codification by including all disclosure guidance in the appropriate disclosure section and other updates that vary in nature. We adopted this guidance in the first quarter of 2021 with no material impact on our condensed consolidated financial statements and disclosures.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Debt with Conversion and Other Options (Topic 470) and Contracts in Entity's Own Equity (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> &#8211; In June 2020, the FASB issued ASU No. 2020-06 to simplify the accounting for convertible instruments and improve the usefulness and relevance of information regarding convertible instruments. This ASU reduces the number of accounting models for converting debt instruments and convertible preferred stock. ASU No. 2020-06 is effective for us in 2022, with early adoption permitted. We early adopted this guidance in the first quarter of 2021, and it did not have a material impact on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DescriptionOfBusinessPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description Of Business, Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DescriptionOfBusinessPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_SeasonalityPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Seasonality Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_SeasonalityPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844332206312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue by Segment</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue &#8211; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below depicts the disaggregation of revenue by product and is consistent with how we evaluate our financial performance (in thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.694%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,557&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,357&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Part D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,953)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,551&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Individual and Family </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Qualified Health Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qualified Health Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Individual and Family</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,556&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ancillary</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dental</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Ancillary</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,436&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Small Business</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,975&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commission Bonus and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Commission Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,191&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,544&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,066&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,986&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sponsorship and Advertising Revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,855&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Other Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,723&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,740&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,619&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,472&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,914&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,284&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,685&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,458&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:11.65pt">We define our Individual and Family plan offerings as major medical individual and family health insurance plans, which does not include Medicare-related, small business or ancillary plans. Individual and family health insurance plans include both qualified and non-qualified plans. Qualified health plans are individual and family health insurance plans that meet the requirements of the Affordable Care Act and are offered through the government-run health insurance exchange in the relevant jurisdiction. Non-qualified health plans are Individual and Family plans that meet the requirements of the Affordable Care Act and are not offered through the exchange in the relevant jurisdiction. Individuals that purchase non-qualified health plans cannot receive a subsidy in connection with the purchase of those plans.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commission revenue by segment is presented in the table below (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Members Approved During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,698&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Commission Revenue from Members Approved in Prior Periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(698)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicare Segment Commission Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Individual, Family and Small Business</span></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Members Approved During the Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Renewals of Small Business Members During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Commission Revenue from Members Approved in Prior Periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,068&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total IFP/SMB Segment Commission Revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,664&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,792&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,690&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Commission Revenue from Members Approved During the Period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission Revenue from Renewals of Small Business Members During the Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net Commission Revenue from Members Approved in Prior Periods </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Commission Revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,191&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,544&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276,066&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,986&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These amounts include commission bonus revenue.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">These amounts reflect our revised estimates of cash collections for certain members approved prior to the relevant reporting period that are recognized as adjustments to revenue within the relevant reporting period. The net adjustment revenue includes both increases in revenue for certain prior period cohorts as well as reductions in revenue for certain prior period cohorts. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, beginning in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">The impacts of total net commission revenue from members approved in prior periods were $0.37 and $0.62 per basic and diluted share for the three months ended September 30, 2021 and 2020, respectively. The impacts of total net commission revenue from members approved in prior periods were $0.65 and $1.14 per basic and diluted share, for the nine months ended September 30, 2021 and 2020, respectively. </span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The total reductions to revenue from members approved in prior periods were $3.2 million and $3.7 million for the three months ended September 30, 2021 and 2020, respectively, and $22.6 million and $5.3 million for the nine months ended September 30, 2021 and 2020, respectively. These reductions to revenue primarily related to the Medicare segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844337855128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Statement Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule Of Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalent and restricted cash balances are summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.078%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,884&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalent and restricted cash balances are summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.078%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,765&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,552&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,884&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,113&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock', window );">Schedule of Change in Allowance for Credit Loss</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the allowance for credit losses for the nine months ended September 30, 2021 is summarized as follows (in thousands):&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.485%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,819&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Contract Assets - Commissions Receivable</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contract assets &#8211; commission receivable activities, net of credit loss allowances&#160;are summarized as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.037%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFP/SMB Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from members approved during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from renewals of small business members during the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net commission revenue from members approved in prior periods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,700)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,485)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311,310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in credit loss allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687,274&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,094&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757,368&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.037%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Medicare Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IFP/SMB Segment</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589,222&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from members approved during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission revenue from renewals of small business members during the period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net commission revenue from members approved in prior periods</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201,256)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237,213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in credit loss allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,536)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,650)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562,426&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,919&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604,345&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div>(1)Commission revenue from renewals of small business members during the period was previously included in net commission revenue from members approved in prior periods. However, starting in the first quarter of 2021, we enhanced our reporting by separately disclosing commission revenue from renewals of small business members during the period in a separate line item.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of Credit Risk</a></td>
<td class="text">Carriers that represented 10% or more of our total contract assets and accounts receivable balance are summarized as of the dates presented below:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthCare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aetna</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Percentages include the carriers' subsidiaries.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the contract assets and accounts receivable of WellCare are included in the percentage calculation for September 30, 2021 and December 31, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule Of Prepaid Expenses And Other Current Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our prepaid expenses and other current assets are summarized as of the periods presented as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.420%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.276%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid maintenance contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,448&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prepaid expenses and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,653&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,661&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844328603976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">We classify the inputs used to measure fair value into the following hierarchy:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:90.129%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unadjusted quoted prices in active markets for identical assets or liabilities.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unadjusted quoted prices in active markets for similar assets or liabilities; unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs for the asset or liability.</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Summary of Financial Assets Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial assets measured at fair value on a recurring basis are summarized below by their classification within the fair value hierarchy as of the dates presented below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bond</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,977&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,371&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,606&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,977&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.366%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,197&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,620&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>As of September 30, 2021, o<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Summary of Contractual Maturities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash equivalents and available-for-sale debt securities by contractual maturity (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,977&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Summary of Unrealized Gains and Losses</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gains and losses on available-for-sale debt securities that are not credit related are included in accumulated other comprehensive income and summarized as follows as of September 30, 2021 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bond</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,980&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,977&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique used to measure similar asset in prior period by class of asset or liability on non-recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844428814936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock', window );">Schedule Of Stock-Based Compensation Expense By Award Type</a></td>
<td class="text">Our stock-based compensation expense is summarized as follows by award types (in thousands):<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units*</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,078&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,855&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,234&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,332&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,881&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,722&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Amounts include market-based and performance-based restricted stock units.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock', window );">Schedule Of Stock-Based Compensation Expense By Operating Function</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense by operating function for the periods presented below&#160;(in thousands):&#160;</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"/><td style="width:39.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.209%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing and advertising</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,922&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer care and enrollment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology and content</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,881&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,722&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount capitalized in internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,006&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,880&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,756&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Stock-based compensation expense for both three and nine months ended September 30, 2021 was impacted by a $4.1&#160;million credit related to forfeited equity awards due to our chief executive officer's separation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Stock-Based Compensation Expense By Operating Function [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Stock-Based Compensation Expense [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844327075816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Summary of Convertible Preferred Stock</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the proceeds and changes to our Series A preferred stock (in thousands):</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,025&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of Closing Date</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued paid-in-kind dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in preferred stock redemption value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of September 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,438&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844428823864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net loss attributable to common stockholders per share (in thousands, except per share amounts):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,948)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83,636)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,423)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in per share calculation &#8211; basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in diluted share calculation</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,487&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders per share &#8211; basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text">The number of outstanding anti-dilutive shares that were excluded from the computation of diluted net income (loss) per share consisted of the following (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,595&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,285&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844327126616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock', window );">Schedule of Future Minimum Rental Payments for Contractual Obligations</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future minimum payments under non-cancellable contractual service and licensing obligations as of September 30, 2021 (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">For the Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,575&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 303<br> -Paragraph (a)<br> -Subparagraph (5)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844333451544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of our operating segments are summarized for the periods presented below (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual, Family and Small Business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,923&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,284&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,685&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,458&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment profit (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare segment profit (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,882)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual, Family and Small Business segment profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total segment profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,383)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,348&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,665)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,146&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,827)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,581)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,376)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,332)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,881)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,899)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,995)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,840)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,911)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(416)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and reorganization charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,004)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before benefit from income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,848)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,948)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,501)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,346)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">During the first quarter of 2021, we revised the calculation of segment profit by excluding amortization of capitalized software development costs to enhance comparability of our financial metrics with peer companies. The amortization of capitalized software development costs were $3.4 million and $2.1 million for the three months ended September 30, 2021 and 2020, respectively, and $9.1 million and $5.3 million for the nine months ended September 30, 2021 and 2020, respectively.</span></div>(2)Depreciation and amortization has been adjusted to include amortization of software development costs.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule Of Long Lived Assets By Geographical Areas</a></td>
<td class="text">Long-lived assets by geographical area are summarized as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,102&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,065&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule Of Revenue By Major Customers</a></td>
<td class="text">Carriers representing 10% or more of our total revenue are summarized as follows:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UnitedHealthCare </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aetna </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Centene </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Percentages include the carriers' subsidiaries.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Centene Corporation acquired WellCare Health Plans, Inc. in 2020, and the revenue of WellCare is included in the percentage calculation for the three and nine months ended September 30, 2021 and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Long Lived Assets By Geographical Areas [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844327147144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Supplemental Information</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental information related to leases are as follows (dollars in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term of operating leases</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate used to recognize operating lease right-of-use-assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,738&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,411&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash outflows related to operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Operating Lease Maturities</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2021, maturities of operating lease liabilities are as follows (in thousands):</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,708&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.94pt">Noncancellable sublease income for the remainder of 2021 and years ending December 31, 2022 and 2023 of $0.3 million, $0.4 million, and $0.4 million, respectively, is not included in the table above.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844430424664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Reorganization (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Summary of Restructuring and Other Related Liabilities</a></td>
<td class="text">The following table summarizes the cash-based restructuring and reorganization related liabilities (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and reorganization charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,466)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844332106584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule Of Components Of Income Tax Expense</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table summarizes our benefit from income taxes and our effective tax rates for the periods presented below (in thousands, except effective tax rate):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 4.37pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before benefit from income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,848)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,948)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,501)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,346)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit from income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,834)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,278)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844337423544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Business and Significant Accounting Policies - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>insurance_carrier </div>
<div>state </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>insurance_carrier </div>
<div>state </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_NumberOfHealthInsuranceCarriers', window );">Number of health insurance carriers (more than) | insurance_carrier</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which the Company is licensed to market and sell health insurance | state</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 5,234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,332<span></span>
</td>
<td class="nump">$ 24,881<span></span>
</td>
<td class="nump">$ 21,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="nump">1,217<span></span>
</td>
<td class="nump">2,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Change in net income (loss)</a></td>
<td class="nump">$ 53,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,505<span></span>
</td>
<td class="nump">$ 72,223<span></span>
</td>
<td class="nump">$ 14,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share) | $ / shares</a></td>
<td class="num">$ (2.24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (3.13)<span></span>
</td>
<td class="num">$ (0.56)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share) | $ / shares</a></td>
<td class="num">$ (2.24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (3.13)<span></span>
</td>
<td class="num">$ (0.56)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_UnderRecognitionOfStockBasedCompensationExpenseMember', window );">Under-Recognition Of Stock-Based Compensation Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_OutOfPeriodAdjustmentsMember', window );">Out-Of-Period Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Change in net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember', window );">License | Over-Recognition Of Licensing Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_NumberOfHealthInsuranceCarriers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Health Insurance Carriers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_NumberOfHealthInsuranceCarriers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_UnderRecognitionOfStockBasedCompensationExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_UnderRecognitionOfStockBasedCompensationExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_OutOfPeriodAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_OutOfPeriodAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_OverRecognitionOfLicensingCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=ehth_OverRecognitionOfLicensingCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844329456584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 63,914<span></span>
</td>
<td class="nump">$ 94,284<span></span>
</td>
<td class="nump">$ 294,685<span></span>
</td>
<td class="nump">$ 289,458<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_MedicareMember', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">41,109<span></span>
</td>
<td class="nump">49,551<span></span>
</td>
<td class="nump">221,628<span></span>
</td>
<td class="nump">208,366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_MedicareMember', window );">Medicare | Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">36,557<span></span>
</td>
<td class="nump">41,901<span></span>
</td>
<td class="nump">209,224<span></span>
</td>
<td class="nump">168,834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_MedicareMember', window );">Medicare | Medicare Supplement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,214<span></span>
</td>
<td class="nump">7,321<span></span>
</td>
<td class="nump">15,357<span></span>
</td>
<td class="nump">32,384<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_MedicareMember', window );">Medicare | Medicare Part D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,338<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="num">(2,953)<span></span>
</td>
<td class="nump">7,148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_IndividualandFamilyMember', window );">Individual and Family</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">8,175<span></span>
</td>
<td class="nump">11,381<span></span>
</td>
<td class="nump">27,556<span></span>
</td>
<td class="nump">16,144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_IndividualandFamilyMember', window );">Individual and Family | Non-Qualified Health Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">5,909<span></span>
</td>
<td class="nump">9,915<span></span>
</td>
<td class="nump">20,352<span></span>
</td>
<td class="nump">12,585<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_IndividualandFamilyMember', window );">Individual and Family | Qualified Health Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,266<span></span>
</td>
<td class="nump">1,466<span></span>
</td>
<td class="nump">7,204<span></span>
</td>
<td class="nump">3,559<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_AncillariesMember', window );">Ancillary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">6,795<span></span>
</td>
<td class="nump">9,535<span></span>
</td>
<td class="nump">17,647<span></span>
</td>
<td class="nump">17,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_AncillariesMember', window );">Ancillary | Short-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,370<span></span>
</td>
<td class="nump">2,438<span></span>
</td>
<td class="nump">4,639<span></span>
</td>
<td class="nump">6,724<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_AncillariesMember', window );">Ancillary | Dental</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,938<span></span>
</td>
<td class="nump">4,452<span></span>
</td>
<td class="nump">9,326<span></span>
</td>
<td class="nump">5,791<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_AncillariesMember', window );">Ancillary | Vision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">642<span></span>
</td>
<td class="nump">1,798<span></span>
</td>
<td class="nump">1,781<span></span>
</td>
<td class="nump">2,228<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_AncillariesMember', window );">Ancillary | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">845<span></span>
</td>
<td class="nump">847<span></span>
</td>
<td class="nump">1,901<span></span>
</td>
<td class="nump">2,693<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_SmallBusinessMember', window );">Small Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,190<span></span>
</td>
<td class="nump">1,723<span></span>
</td>
<td class="nump">7,703<span></span>
</td>
<td class="nump">6,975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionBonusMember', window );">Commission Bonus and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">922<span></span>
</td>
<td class="nump">1,354<span></span>
</td>
<td class="nump">1,532<span></span>
</td>
<td class="nump">5,065<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMember', window );">Commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">59,191<span></span>
</td>
<td class="nump">73,544<span></span>
</td>
<td class="nump">276,066<span></span>
</td>
<td class="nump">253,986<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">4,723<span></span>
</td>
<td class="nump">20,740<span></span>
</td>
<td class="nump">18,619<span></span>
</td>
<td class="nump">35,472<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Sponsorship and Advertising Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">4,165<span></span>
</td>
<td class="nump">18,855<span></span>
</td>
<td class="nump">16,002<span></span>
</td>
<td class="nump">32,114<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 558<span></span>
</td>
<td class="nump">$ 1,885<span></span>
</td>
<td class="nump">$ 2,617<span></span>
</td>
<td class="nump">$ 3,358<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedMedicareAxis=ehth_MedicareAdvantageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedMedicareAxis=ehth_MedicareAdvantageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedMedicareAxis=ehth_MedicareSupplementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedMedicareAxis=ehth_MedicareSupplementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedMedicareAxis=ehth_MedicarePartDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedMedicareAxis=ehth_MedicarePartDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_IndividualandFamilyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_IndividualandFamilyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedIndividualandFamilyAxis=ehth_NonQualifiedHealthPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedIndividualandFamilyAxis=ehth_NonQualifiedHealthPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedIndividualandFamilyAxis=ehth_QualifiedHealthPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedIndividualandFamilyAxis=ehth_QualifiedHealthPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_AncillariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_AncillariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedAncillariesAxis=ehth_ShorttermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedAncillariesAxis=ehth_ShorttermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedAncillariesAxis=ehth_DentalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedAncillariesAxis=ehth_DentalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedAncillariesAxis=ehth_VisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedAncillariesAxis=ehth_VisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedAncillariesAxis=ehth_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedAncillariesAxis=ehth_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_SmallBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_SmallBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionBonusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionBonusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedOtherAxis=ehth_SponsorshipAndAdvertisingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedOtherAxis=ehth_SponsorshipAndAdvertisingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DisaggregatedOtherAxis=ehth_MiscellaneousOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DisaggregatedOtherAxis=ehth_MiscellaneousOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844330361368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Commission Revenue by Segment (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 63,914<span></span>
</td>
<td class="nump">$ 94,284<span></span>
</td>
<td class="nump">$ 294,685<span></span>
</td>
<td class="nump">$ 289,458<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (2.24)<span></span>
</td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (3.13)<span></span>
</td>
<td class="num">$ (0.56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (2.24)<span></span>
</td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (3.13)<span></span>
</td>
<td class="num">$ (0.56)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMember', window );">Commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 59,191<span></span>
</td>
<td class="nump">$ 73,544<span></span>
</td>
<td class="nump">$ 276,066<span></span>
</td>
<td class="nump">$ 253,986<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember', window );">Commission Revenue from Members Approved During the Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">47,590<span></span>
</td>
<td class="nump">56,052<span></span>
</td>
<td class="nump">252,469<span></span>
</td>
<td class="nump">219,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember', window );">Commission Revenue from Renewals of Small Business Members During the Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,744<span></span>
</td>
<td class="nump">1,122<span></span>
</td>
<td class="nump">6,154<span></span>
</td>
<td class="nump">5,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember', window );">Net Commission Revenue from Members Approved in Prior Periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 9,857<span></span>
</td>
<td class="nump">$ 16,370<span></span>
</td>
<td class="nump">$ 17,443<span></span>
</td>
<td class="nump">$ 29,481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="nump">$ 1.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.37<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="nump">$ 1.14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax', window );">Change in revenue</a></td>
<td class="num">$ (3,200)<span></span>
</td>
<td class="num">$ (3,700)<span></span>
</td>
<td class="num">$ (22,600)<span></span>
</td>
<td class="num">$ (5,300)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember', window );">Medicare | Commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">42,527<span></span>
</td>
<td class="nump">51,342<span></span>
</td>
<td class="nump">224,274<span></span>
</td>
<td class="nump">214,296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember', window );">Medicare | Commission Revenue from Members Approved During the Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">42,698<span></span>
</td>
<td class="nump">52,040<span></span>
</td>
<td class="nump">235,974<span></span>
</td>
<td class="nump">205,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember', window );">Medicare | Commission Revenue from Renewals of Small Business Members During the Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember', window );">Medicare | Net Commission Revenue from Members Approved in Prior Periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="num">(171)<span></span>
</td>
<td class="num">(698)<span></span>
</td>
<td class="num">(11,700)<span></span>
</td>
<td class="nump">8,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember', window );">Individual, Family and Small Business | Commission</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">16,664<span></span>
</td>
<td class="nump">22,202<span></span>
</td>
<td class="nump">51,792<span></span>
</td>
<td class="nump">39,690<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember', window );">Individual, Family and Small Business | Commission Revenue from Members Approved During the Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">4,892<span></span>
</td>
<td class="nump">4,012<span></span>
</td>
<td class="nump">16,495<span></span>
</td>
<td class="nump">14,170<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember', window );">Individual, Family and Small Business | Commission Revenue from Renewals of Small Business Members During the Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,744<span></span>
</td>
<td class="nump">1,122<span></span>
</td>
<td class="nump">6,154<span></span>
</td>
<td class="nump">5,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember', window );">Individual, Family and Small Business | Net Commission Revenue from Members Approved in Prior Periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 10,028<span></span>
</td>
<td class="nump">$ 17,068<span></span>
</td>
<td class="nump">$ 29,143<span></span>
</td>
<td class="nump">$ 20,515<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844431234168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Financial Statement Information- Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 37,765<span></span>
</td>
<td class="nump">$ 39,552<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">119,765<span></span>
</td>
<td class="nump">4,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">157,530<span></span>
</td>
<td class="nump">43,759<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">3,354<span></span>
</td>
<td class="nump">3,354<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 160,884<span></span>
</td>
<td class="nump">$ 47,113<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 91,187<span></span>
</td>
<td class="nump">$ 26,820<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 1 &#8211; Summary of Business and Significant Accounting Policies</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844332865288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Statement Information - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">$ 3,354,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,354,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="nump">$ 3,354,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff', window );">Write-off</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Deposits', window );">Deposits</a></td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 1 &#8211; Summary of Business and Significant Accounting Policies</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of writeoff of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, charged against allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Deposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Deposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844328577496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Statement Information - Schedule of Allowance for Credit Loss (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward', window );"><strong>Contract with Customer, Asset, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss', window );">Beginning balance</a></td>
<td class="nump">$ 2,026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCreditLossExpense', window );">Change in allowance</a></td>
<td class="num">(207)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss', window );">Ending balance</a></td>
<td class="nump">$ 1,819<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844333707224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Statement Information - Schedule of Commissions Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 792,405<span></span>
</td>
<td class="nump">$ 589,222<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 63,914<span></span>
</td>
<td class="nump">$ 94,284<span></span>
</td>
<td class="nump">294,685<span></span>
</td>
<td class="nump">289,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCommissionsReceived', window );">Cash receipts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(311,310)<span></span>
</td>
<td class="num">(237,213)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease', window );">Net change in credit loss allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="num">(1,650)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Ending balance</a></td>
<td class="nump">757,368<span></span>
</td>
<td class="nump">604,345<span></span>
</td>
<td class="nump">757,368<span></span>
</td>
<td class="nump">604,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">739,637<span></span>
</td>
<td class="nump">550,922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCommissionsReceived', window );">Cash receipts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(276,825)<span></span>
</td>
<td class="num">(201,256)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease', window );">Net change in credit loss allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="num">(1,536)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Ending balance</a></td>
<td class="nump">687,274<span></span>
</td>
<td class="nump">562,426<span></span>
</td>
<td class="nump">687,274<span></span>
</td>
<td class="nump">562,426<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember', window );">Individual, Family and Small Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,768<span></span>
</td>
<td class="nump">38,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCommissionsReceived', window );">Cash receipts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,485)<span></span>
</td>
<td class="num">(35,957)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease', window );">Net change in credit loss allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="num">(114)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Ending balance</a></td>
<td class="nump">70,094<span></span>
</td>
<td class="nump">41,919<span></span>
</td>
<td class="nump">70,094<span></span>
</td>
<td class="nump">41,919<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember', window );">Commission Revenue from Members Approved During the Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">47,590<span></span>
</td>
<td class="nump">56,052<span></span>
</td>
<td class="nump">252,469<span></span>
</td>
<td class="nump">219,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember', window );">Commission Revenue from Members Approved During the Period | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">42,698<span></span>
</td>
<td class="nump">52,040<span></span>
</td>
<td class="nump">235,974<span></span>
</td>
<td class="nump">205,330<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember', window );">Commission Revenue from Members Approved During the Period | Individual, Family and Small Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">4,892<span></span>
</td>
<td class="nump">4,012<span></span>
</td>
<td class="nump">16,495<span></span>
</td>
<td class="nump">14,170<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember', window );">Commission Revenue from Renewals of Small Business Members During the Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,744<span></span>
</td>
<td class="nump">1,122<span></span>
</td>
<td class="nump">6,154<span></span>
</td>
<td class="nump">5,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember', window );">Commission Revenue from Renewals of Small Business Members During the Period | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember', window );">Commission Revenue from Renewals of Small Business Members During the Period | Individual, Family and Small Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,744<span></span>
</td>
<td class="nump">1,122<span></span>
</td>
<td class="nump">6,154<span></span>
</td>
<td class="nump">5,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember', window );">Net Commission Revenue from Members Approved in Prior Periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">9,857<span></span>
</td>
<td class="nump">16,370<span></span>
</td>
<td class="nump">17,443<span></span>
</td>
<td class="nump">29,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember', window );">Net Commission Revenue from Members Approved in Prior Periods | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="num">(171)<span></span>
</td>
<td class="num">(698)<span></span>
</td>
<td class="num">(11,700)<span></span>
</td>
<td class="nump">8,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember', window );">Net Commission Revenue from Members Approved in Prior Periods | Individual, Family and Small Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ChangeInContractWithCustomerAssetRollForward', window );"><strong>Change in Contract with Customer, Asset [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 10,028<span></span>
</td>
<td class="nump">$ 17,068<span></span>
</td>
<td class="nump">$ 29,143<span></span>
</td>
<td class="nump">$ 20,515<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ChangeInContractWithCustomerAssetRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Contract with Customer, Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ChangeInContractWithCustomerAssetRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in allowance for credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCommissionsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for commissions during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCommissionsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedDuringCurrentPeriodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionRevenueFromRenewalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ehth_CommissionMembersApprovedInPriorPeriodsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844332225640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Statement Information - Schedule of Credit Risk (Details) - Customer Concentration Risk - Accounts Receivable<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Humana</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">UnitedHealthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Aetna</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Centene</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_HumanaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_HumanaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_UnitedhealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_UnitedhealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_AetnaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_AetnaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_CenteneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_CenteneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844326836888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Supplemental Financial Statement Information - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_PrepaidMaintenanceContractsCurrent', window );">Prepaid maintenance contracts</a></td>
<td class="nump">$ 8,448<span></span>
</td>
<td class="nump">$ 7,715<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_PrepaidLicenses', window );">Prepaid licenses</a></td>
<td class="nump">3,302<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">23,828<span></span>
</td>
<td class="nump">6,628<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">672<span></span>
</td>
<td class="nump">1,672<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousCurrent', window );">Others</a></td>
<td class="nump">403<span></span>
</td>
<td class="nump">646<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">$ 36,653<span></span>
</td>
<td class="nump">$ 16,661<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 1 &#8211; Summary of Business and Significant Accounting Policies</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_PrepaidLicenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Licenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_PrepaidLicenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_PrepaidMaintenanceContractsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Maintenance Contracts (Current)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_PrepaidMaintenanceContractsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844332404264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Financial Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">$ 70,212<span></span>
</td>
<td class="nump">$ 49,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">19,371<span></span>
</td>
<td class="nump">4,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">170,606<span></span>
</td>
<td class="nump">49,620<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">189,977<span></span>
</td>
<td class="nump">53,827<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">189,977<span></span>
</td>
<td class="nump">53,827<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">1,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds | Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds | Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">1,276<span></span>
</td>
<td class="nump">35,423<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds | Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds | Carrying Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">1,276<span></span>
</td>
<td class="nump">35,423<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds | Fair Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">1,276<span></span>
</td>
<td class="nump">35,423<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">66,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">66,414<span></span>
</td>
<td class="nump">14,197<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Carrying Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">66,414<span></span>
</td>
<td class="nump">14,197<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Fair Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">66,414<span></span>
</td>
<td class="nump">14,197<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bond</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">2,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bond | Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bond | Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">2,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bond | Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bond | Carrying Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">2,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bond | Fair Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">2,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">19,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">19,371<span></span>
</td>
<td class="nump">4,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Carrying Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">19,371<span></span>
</td>
<td class="nump">4,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Fair Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">19,371<span></span>
</td>
<td class="nump">$ 4,207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">100,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">100,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Carrying Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">100,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Fair Value | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 100,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 1 &#8211; Summary of Business and Significant Accounting Policies</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844328644536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Contractual Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due in 1 year</a></td>
<td class="nump">$ 189,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in 1 year</a></td>
<td class="nump">$ 189,977<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844333611096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Unrealized Gains and Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 157,530<span></span>
</td>
<td colspan="2" class="nump">$ 43,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
<td class="nump">70,212<span></span>
</td>
<td colspan="2" class="nump">$ 49,620<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost', window );">Total</a></td>
<td class="nump">189,980<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">4<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(7)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities', window );">Fair Value</a></td>
<td class="nump">189,977<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">19,371<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">19,371<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash equivalents</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">100,398<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(4)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">100,394<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Amortized Cost</a></td>
<td class="nump">1,276<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
<td class="nump">1,276<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Amortized Cost</a></td>
<td class="nump">66,413<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">4<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(3)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
<td class="nump">66,414<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate bond</a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Short-term marketable securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent', window );">Amortized Cost</a></td>
<td class="nump">2,522<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
<td class="nump">$ 2,522<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 1 &#8211; Summary of Business and Significant Accounting Policies</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Accumulated Gross Unrealized Gains, before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents And Available-For-Sale Debt Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents And Available-For-Sale Debt Securities, Accumulated Gross Unrealized Gain, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents And Available-For-Sale Debt Securities, Accumulated Gross Unrealized Loss, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents And Available-For-Sale Debt Securities, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Gain, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Loss, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844332012168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>security</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of securities in net loss positions</a></td>
<td class="nump">41<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844331382856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Narrative (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 08, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 22, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Number of shares repurchased under share repurchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes', window );">Treasury shares that were previously surrendered by employees to satisfy tax withholdings (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">390,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=ehth_PreviousRepurchaseProgramsMember', window );">Previous share repurchase programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Number of shares repurchased under share repurchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares Outstanding, Shares Acquired, Previously Cancelled Vested Shares Withheld For Tax Purposes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=ehth_PreviousRepurchaseProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=ehth_PreviousRepurchaseProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844333616824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Schedule of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 5,234<span></span>
</td>
<td class="nump">$ 6,332<span></span>
</td>
<td class="nump">$ 24,881<span></span>
</td>
<td class="nump">$ 21,722<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Amount capitalized in internal-use software</a></td>
<td class="nump">772<span></span>
</td>
<td class="nump">548<span></span>
</td>
<td class="nump">1,875<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Total stock-based compensation</a></td>
<td class="nump">6,006<span></span>
</td>
<td class="nump">6,880<span></span>
</td>
<td class="nump">26,756<span></span>
</td>
<td class="nump">23,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">4,666<span></span>
</td>
<td class="nump">6,078<span></span>
</td>
<td class="nump">23,031<span></span>
</td>
<td class="nump">20,855<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Common stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="nump">402<span></span>
</td>
<td class="nump">867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">486<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,448<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Marketing and advertising</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">2,297<span></span>
</td>
<td class="nump">1,869<span></span>
</td>
<td class="nump">6,922<span></span>
</td>
<td class="nump">5,138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ehth_CustomerCareAndEnrollmentExpenseMember', window );">Customer care and enrollment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">740<span></span>
</td>
<td class="nump">527<span></span>
</td>
<td class="nump">1,901<span></span>
</td>
<td class="nump">1,762<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ehth_TechnologyAndContentExpenseMember', window );">Technology and content</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">2,380<span></span>
</td>
<td class="nump">1,430<span></span>
</td>
<td class="nump">7,483<span></span>
</td>
<td class="nump">2,965<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="num">(183)<span></span>
</td>
<td class="nump">$ 2,506<span></span>
</td>
<td class="nump">8,575<span></span>
</td>
<td class="nump">$ 11,857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="num">$ (4,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost expensed and capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ehth_CustomerCareAndEnrollmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ehth_CustomerCareAndEnrollmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ehth_TechnologyAndContentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ehth_TechnologyAndContentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844443349608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 30, 2024 </div>
<div>day</div>
</th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($) </div>
<div>state </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2027 </div>
<div>day</div>
</th>
<th class="th"><div>Aug. 17, 2023</div></th>
<th class="th">
<div>May 31, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Feb. 17, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_SaleOfStockConsiderationReceivedOnTransactionGross', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214,025<span></span>
</td>
<td class="nump">$ 225,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Dividend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_PreferredStockConvertibleStatedValue', window );">Stated value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionPrice', window );">Conversion rate (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79.5861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare', window );">Redemption put right, percentage of accrued value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ConvertiblePreferredStockVotesPerShare', window );">Number of votes per share | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio', window );">Asset coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Shares converted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis', window );">Accrued paid-in-kind dividends, common stock equivalent, as-converted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ehth_EchelonHealthSPCLPHIGMember', window );">H.I.G</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors', window );">Number of nominations to board of directors | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors', window );">Minimum common stock ownership percentage needed to nominate individual to board of directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt', window );">Minimum ownership percentage needed for consent to incur debt in excess of $175 million</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ConvertiblePreferredStockCovenantLiquidity', window );">Minimum liquidity amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ConvertiblePreferredStockCovenantLiquidity', window );">Minimum liquidity amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Scenario, Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_PreferredStockDividendRatePayableInKindPercentage', window );">Dividend rate, payable-in-kind</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_PreferredStockDividendRateCashPercentage', window );">Dividend rate, cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare', window );">Redemption put right, percentage of accrued value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice', window );">Redemption call right, number of days for written notice | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage of conversion price</a></td>
<td class="nump">167.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days | day</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ConvertiblePreferredStockThresholdTradingDays', window );">Threshold trading days | day</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio', window );">Asset coverage ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="11"></td></tr>
<tr><td colspan="11"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">See Note 1 &#8211; Summary of Business and Significant Accounting Policies</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Minimum Ownership Percentage Needed To Nominate Individual To Board Of Directors</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Accrued Paid-In-Kind Dividends, Common Stock Equivalent, As-Converted Basis</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Covenant, Asset Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ConvertiblePreferredStockCovenantLiquidity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Covenant, Liquidity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ConvertiblePreferredStockCovenantLiquidity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Minimum Ownership Percentage Needed For Consent To Incur Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Number Of Nominations To Board Of Directors</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Redemption Call Right, Written Notice</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Redemption Value, Percentage Of Accrued Value Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Threshold Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Threshold Percentage Of Stock Price Trigger</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ConvertiblePreferredStockThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ConvertiblePreferredStockThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ConvertiblePreferredStockVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Convertible Preferred Stock, Votes Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ConvertiblePreferredStockVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_PreferredStockConvertibleStatedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Convertible, Stated Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_PreferredStockConvertibleStatedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_PreferredStockDividendRateCashPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Dividend Rate, Cash, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_PreferredStockDividendRateCashPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_PreferredStockDividendRatePayableInKindPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Dividend Rate, Payable-In-Kind, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_PreferredStockDividendRatePayableInKindPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_SaleOfStockConsiderationReceivedOnTransactionGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Consideration Received On Transaction, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_SaleOfStockConsiderationReceivedOnTransactionGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share conversion price of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ehth_EchelonHealthSPCLPHIGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ehth_EchelonHealthSPCLPHIGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844329304328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Preferred Stock - Summary of Stock (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">5 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_SaleOfStockConsiderationReceivedOnTransactionGross', window );">Gross proceeds</a></td>
<td class="nump">$ 225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Less: issuance costs</a></td>
<td class="nump">10,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Net proceeds</a></td>
<td class="nump">214,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionOfDividends', window );">Accrued paid-in-kind dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Change in preferred stock redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,770<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance as of September 30, 2021</a></td>
<td class="nump">$ 214,025<span></span>
</td>
<td class="nump">$ 225,438<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_SaleOfStockConsiderationReceivedOnTransactionGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Consideration Received On Transaction, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_SaleOfStockConsiderationReceivedOnTransactionGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity during the period due to unpaid dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844333414680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (59,948)<span></span>
</td>
<td class="num">$ (14,505)<span></span>
</td>
<td class="num">$ (83,636)<span></span>
</td>
<td class="num">$ (14,423)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in per share calculation - basic (in shares)</a></td>
<td class="nump">26,786<span></span>
</td>
<td class="nump">26,487<span></span>
</td>
<td class="nump">26,688<span></span>
</td>
<td class="nump">25,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_IncrementalCommonSharesAttributableToOptions', window );">Dilutive effect of common stock (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in diluted share calculation (in shares)</a></td>
<td class="nump">26,786<span></span>
</td>
<td class="nump">26,487<span></span>
</td>
<td class="nump">26,688<span></span>
</td>
<td class="nump">25,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss attributable to common stockholders per share - basic (in usd per share)</a></td>
<td class="num">$ (2.24)<span></span>
</td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (3.13)<span></span>
</td>
<td class="num">$ (0.56)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss attributable to common stockholders per share - diluted (in usd per share)</a></td>
<td class="num">$ (2.24)<span></span>
</td>
<td class="num">$ (0.55)<span></span>
</td>
<td class="num">$ (3.13)<span></span>
</td>
<td class="num">$ (0.56)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_IncrementalCommonSharesAttributableToOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental Common Shares Attributable To Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_IncrementalCommonSharesAttributableToOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844337463672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share Attributable to Common Stockholders - Schedule of Anti-Dilutive Shares Excluded from Computation Of Net Income Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">4,285<span></span>
</td>
<td class="nump">1,013<span></span>
</td>
<td class="nump">2,992<span></span>
</td>
<td class="nump">1,201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">2,866<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,595<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">1,134<span></span>
</td>
<td class="nump">599<span></span>
</td>
<td class="nump">1,055<span></span>
</td>
<td class="nump">748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Common stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">278<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="nump">453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844426384360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2019 </div>
<div>plaintiff</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 13, 2020 </div>
<div>claim</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,845<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInNextTwelveMonths', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,407<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInSecondYear', window );">2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInThirdYear', window );">2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligationDueInFourthYear', window );">2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_ContractualObligationToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">New claims filed | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=ehth_LeViasCompliantMember', window );">Le'Vias Compliant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_ContractualObligationToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual Obligation, to be Paid, After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_ContractualObligationToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=ehth_LeViasCompliantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=ehth_LeViasCompliantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844329435560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information - Segment Operating Results (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 63,914<span></span>
</td>
<td class="nump">$ 94,284<span></span>
</td>
<td class="nump">$ 294,685<span></span>
</td>
<td class="nump">$ 289,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense', window );">Stock-based compensation expense</a></td>
<td class="num">(5,234)<span></span>
</td>
<td class="num">(6,332)<span></span>
</td>
<td class="num">(24,881)<span></span>
</td>
<td class="num">(21,722)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(4,899)<span></span>
</td>
<td class="num">(2,995)<span></span>
</td>
<td class="num">(12,840)<span></span>
</td>
<td class="num">(7,911)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="num">(121)<span></span>
</td>
<td class="num">(287)<span></span>
</td>
<td class="num">(416)<span></span>
</td>
<td class="num">(1,207)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and reorganization charges</a></td>
<td class="num">(573)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,004)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">189<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="nump">511<span></span>
</td>
<td class="nump">724<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before benefit from income taxes</a></td>
<td class="num">(65,848)<span></span>
</td>
<td class="num">(20,948)<span></span>
</td>
<td class="num">(91,501)<span></span>
</td>
<td class="num">(25,346)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Amortization of internally developed software</a></td>
<td class="nump">3,400<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
<td class="nump">9,140<span></span>
</td>
<td class="nump">5,307<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">63,914<span></span>
</td>
<td class="nump">94,284<span></span>
</td>
<td class="nump">294,685<span></span>
</td>
<td class="nump">289,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_SegmentOperatingIncomeLoss', window );">Segment profit (loss)</a></td>
<td class="num">(40,383)<span></span>
</td>
<td class="nump">4,348<span></span>
</td>
<td class="num">(7,665)<span></span>
</td>
<td class="nump">48,146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">46,381<span></span>
</td>
<td class="nump">70,361<span></span>
</td>
<td class="nump">240,633<span></span>
</td>
<td class="nump">246,891<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_SegmentOperatingIncomeLoss', window );">Segment profit (loss)</a></td>
<td class="num">(52,882)<span></span>
</td>
<td class="num">(14,139)<span></span>
</td>
<td class="num">(46,141)<span></span>
</td>
<td class="nump">23,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Individual, Family and Small Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">17,533<span></span>
</td>
<td class="nump">23,923<span></span>
</td>
<td class="nump">54,052<span></span>
</td>
<td class="nump">42,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_SegmentOperatingIncomeLoss', window );">Segment profit (loss)</a></td>
<td class="nump">12,499<span></span>
</td>
<td class="nump">18,487<span></span>
</td>
<td class="nump">38,476<span></span>
</td>
<td class="nump">24,153<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_SegmentOperatingIncomeLoss', window );">Segment profit (loss)</a></td>
<td class="num">$ (14,827)<span></span>
</td>
<td class="num">$ (15,581)<span></span>
</td>
<td class="num">$ (43,206)<span></span>
</td>
<td class="num">$ (43,376)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Allocated Share-based Compensation Expense, Net Of Restructuring Reversal Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_SegmentOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_SegmentOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ehth_MedicareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ehth_IndividualFamilyAndSmallBusinessSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844326964264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment and Geographic Information - Schedule Of Long-Lived Assets By Geographical Area (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 46,102<span></span>
</td>
<td class="nump">$ 41,065<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">45,465<span></span>
</td>
<td class="nump">40,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">China</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 637<span></span>
</td>
<td class="nump">$ 565<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844333540248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information - Schedule of Revenue by Major Customers (Details) - Customer Concentration Risk - Revenue<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">UnitedHealthcare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Aetna</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Humana</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Centene</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Major customer revenue, percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_UnitedhealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_UnitedhealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_AetnaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_AetnaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_HumanaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_HumanaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ehth_CenteneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ehth_CenteneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844326921112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="nump">$ 6.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844326866280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term of operating leases</a></td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate used to recognize operating lease right-of-use-assets</a></td>
<td class="nump">5.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 5,738<span></span>
</td>
<td class="nump">$ 6,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash outflows related to operating leases</a></td>
<td class="nump">$ 5,722<span></span>
</td>
<td class="nump">$ 5,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844332087048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="nump">$ 1,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">7,701<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">8,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">7,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">8,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">19,407<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">52,908<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(10,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">42,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear', window );">Sublease income, remainder of 2021</a></td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths', window );">Sublease income, 2022</a></td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears', window );">Sublease income, 2023</a></td>
<td class="nump">$ 400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844337443624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Reorganization - Restructuring and Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and reorganization charges</a></td>
<td class="nump">$ 573<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">3,004<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,466)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844337714600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring and Reorganization - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>employee</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Positions eliminated | employee</a></td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce', window );">Percentage of total workforce</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_RestructuringChargesPreTax', window );">Pre-tax restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Accrued restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Credit to stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,234<span></span>
</td>
<td class="nump">$ 6,332<span></span>
</td>
<td class="nump">24,881<span></span>
</td>
<td class="nump">$ 21,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Credit to stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(183)<span></span>
</td>
<td class="nump">$ 2,506<span></span>
</td>
<td class="nump">8,575<span></span>
</td>
<td class="nump">$ 11,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Credit to stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Scenario, Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1', window );">Expected cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring And Related Cost, Number Of Positions Eliminated, Percentage Of Total Workforce</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_RestructuringChargesPreTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges, Pre-Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_RestructuringChargesPreTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected cost remaining for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a result of restructuring activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844330685288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 20, 2019</div></th>
<th class="th"><div>Sep. 17, 2018</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Borrowings under line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=ehth_CreditAgreementAmendmentMember', window );">Credit Agreement Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Borrowing capacity</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityFacilityFeePercentage', window );">Facility fee percentage</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents', window );">Covenant, minimum cash and cash equivalents</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents', window );">Covenant, maximum cash and cash equivalents</a></td>
<td class="nump">11,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityCovenantMinimumLiquidity', window );">Minimum liquidity</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityCovenantMaximumLiquidity', window );">Maximum liquidity</a></td>
<td class="nump">$ 18,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Credit Agreement Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember', window );">Eligible Commissions Receivables, Preceding Three Months | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityBorrowingBasePercentage', window );">Borrowing base percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember', window );">Eligible Commissions Receivables, Succeeding Three Months | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityBorrowingBasePercentage', window );">Borrowing base percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember', window );">Eligible Commissions Receivables, Succeeding Six Months | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ehth_LineOfCreditFacilityBorrowingBasePercentage', window );">Borrowing base percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_LineOfCreditFacilityBorrowingBasePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Borrowing Base, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_LineOfCreditFacilityBorrowingBasePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Covenant, Maximum Cash And Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_LineOfCreditFacilityCovenantMaximumLiquidity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Covenant, Maximum Liquidity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_LineOfCreditFacilityCovenantMaximumLiquidity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Covenant, Minimum Cash And Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_LineOfCreditFacilityCovenantMinimumLiquidity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Covenant, Minimum Liquidity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_LineOfCreditFacilityCovenantMinimumLiquidity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_LineOfCreditFacilityFacilityFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Facility Fee Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_LineOfCreditFacilityFacilityFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ehth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ehth_CreditAgreementAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ehth_CreditAgreementAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ehth_BorrowingBasePercentageAxis=ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844329281400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Income Tax Benefit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before benefit from income taxes</a></td>
<td class="num">$ (65,848)<span></span>
</td>
<td class="num">$ (20,948)<span></span>
</td>
<td class="num">$ (91,501)<span></span>
</td>
<td class="num">$ (25,346)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="num">$ (12,834)<span></span>
</td>
<td class="num">$ (6,443)<span></span>
</td>
<td class="num">$ (19,278)<span></span>
</td>
<td class="num">$ (10,923)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">19.50%<span></span>
</td>
<td class="nump">30.80%<span></span>
</td>
<td class="nump">21.10%<span></span>
</td>
<td class="nump">43.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844329282344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit from income taxes</a></td>
<td class="nump">$ 12,834<span></span>
</td>
<td class="nump">$ 6,443<span></span>
</td>
<td class="nump">$ 19,278<span></span>
</td>
<td class="nump">$ 10,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">19.50%<span></span>
</td>
<td class="nump">30.80%<span></span>
</td>
<td class="nump">21.10%<span></span>
</td>
<td class="nump">43.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139844331872008">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
<td class="text">Accounting Standards Update 2016-13 [Member]<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>78
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M]\^Z7KT494D"(]3+ V$@.V=V"FU4.>Z6N?MNBW4$H*E= H0WW;<(,PC](+#
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MDTF"J1X!\'B:FQ%F$6#&:<$^B@RX1<:^R,[A-D5%1%S$4]RFF<^%+:V 47G
M73/UD7R$\6R,F"60'YG+CK 2D:6<AE'.X$<JI7,("3T+PL SPMBT P_\T))1
MPJAH<*Y4PI)(Z4JB+T%S+)U0(V25VQ [Q]-GKXMVE^7R>K9K9"N;9SF[8=3I
MU9\PT.D!TJB(PJV(6!X^8R75I=$X]K"06U7GW\A#)%/K  +?"'O"SA)$8M1#
MP9W)UE*#VM3E2C9MMTBCG[O:3[TZS])&]1)N]=+3CRF,W7="D@R_G3:GP(Y.
M^=RJ=;M:%3J[PB6DSTDNBPHKLEV!2XJ$:0I2Y/N1D1=2=L ];BDKQ"A=XHQT
M-;BG[IO7GLD+EBE<22VYB0I3D2YY@O\,7L\;GJ(=Q4NXQ>N+5!DVK9C,F@I7
M.WUV2I0X C!EFL(D*B8><ELM)$:9$FZ9PL1UO]V7F:[&AY,Q3+L;N=&?4I[E
MH+PD=$*GN$$O8138%NRH4<*M4?VNWUJ7+0G7%* HBHZ/Z@;$IETL(NNQAQBE
M2OQ!J;K0.F#;(R\ZH?B#+L;F23Q9MU*&KKI5:*4[/9\?=<!WZX#QB6,XA'?W
M6DK)/M=*,GY(FY;]ET!6K]G[?8OV;2^FR^*I*M9%GF&J,E2WNOYZJ,O"E-?>
MB?G1]ZFM;)ZZ[WPMZ_H.WAZ:^X^)=[!(NT]HTW:Q2 75[B]2GVH/%FE M8>+
M-*3:HT4:4>WQ(HVI]F21)E0[]Q8I]\@G')]P\@DZS4FO.;K-2;\Y.LY)SSFZ
MSDG?.3K/2>\YNL])_SD2P$D&.%+ 20X .0"2 T .@.0 ],23' !R "0'@!P
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MI$Z\P#;1BM2QF]7[8(%C24TH)/2(-LMC#+"GEKZV4,32+\6+F+G[):HJ%;(
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MENRB,P@Q0U1XJ4M&N \J8M>': I'+U55%<9BN5!U9RP5O?V4$S8_#/ ;^AS
MW2@<$.R)C=LP3&'"8S$H!E<\CC ]8CP$ TDTJ!SGWC388TJ;3=%8@XA@J5M0
M4J^G.8'CP9R'D U#6@'7Y122'L*T5Q:&Q%J"Y0<W'N(56,<PO&\NL&XC9.+
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MT^ '&Y0#G[J!6KYL(5]R91OLQ!A$"92;JM(^)Z>T'M<Q. /Z>->=Y3DMX1"
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M1?V/,GE@+8C=!;2U:DL'! CX&Q2BNJF@RIX>M1%[5"CUG5FO$2"?&%TAH?P
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M?4_?*ANEFIRUXH_)U#J#R?'G,SJ&C8XAZQC^>S2?%42E>&8+&<%E!VO-@EE
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M,@&)+[1$@,]G&ONN/Y""YI/;U3]02P,$%     @ I8MH4Y#)$^E-!P  >!$
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M&<PJR+F+MY\[Y>[/)@ZZ>&12]')702Y]0NZ4?M:-VUAZVY2R_%)^ @P[(.D
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MHVWVK9?[^<''$T3=UGTBHK<\O)_X[RCC[O@5ZLQ_?'D@]Y^PWF-HDJC7E=B
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M79NN1:@.QEYZK'&K92\'L%\Y%[<+<3#<DT__!%!+ P04    " "FBVA3O!A
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MZ,1&[JQMYD]N)K2M:R!-]X044RI!E1F 0XDM94Q:3SGJL,DWLR#FYHT6#KL
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M_+0 OR^<B^T-.>@^#E[]#5!+ P04    " "FBVA3+]J90%$%  !"#0  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6S=5UMOVS84_BN$T0 -H/HBVZE3
M) &27K "[1 TW?HP[(&2CBPV%*F25!SWU^\[E.RXF9UM?=R+Q=NY?A\/C\]6
MUMWZBBB(^UH;?SZH0FA>C48^KZB6?F@;,M@IK:MEP-0M1[YQ)(LH5.M1.AZ?
MC&JIS.#B+*Y=NXLSVP:M#%T[X=NZEFY]1=JNS@>3P6;ADUI6@1=&%V>-7-(-
MA=^::X?9:*NE4#49KZP1CLKSP>7DU=6,S\<#ORM:^9VQX$@R:V]Y\KXX'XS9
M(=*4!]8@\;FCUZ0U*X(;WWJ=@ZU)%MP=;[2_B[$CEDQZ>FWU%U6$ZGRP&(B"
M2MGJ\,FN?J$^GCGKRZWV\5>LNK/3Z4#DK0^V[H7A0:U,]Y7W?1YV!!;C P)I
M+Y!&OSM#T<LW,LB+,V=7PO%I:.-!##5*PSEE&)2;X+"K(!<NWIO<UB0^RWOR
M9Z, C;P^RGOIJTXZ/2!]*CY:$RHOWIJ"BA_E1_!DZTZZ<><J?5+A#35#,1TG
M(AVGDR?T3;?A3:.^Z3^&)]XHGVOK6T?BC\O,!P="_/F$B=G6Q"R:F/UD!O^]
MM/A<D2BMQD519BF"S#3UMT5]Q[9MP4 R5*H@2F=KH3KA$(6E*>()*DN*5.=U
MX63 'BZO"%#>D%.V\ +WUY,)5$ ?K(GGRF#?MAY*?"+H/J<F[-%T_ H^.J(?
M8!< +5"=D8O(_8H(G]IG9/EGO#/Z8+V'*W"3GHCPF7A^,D\6L\4Q#]-Q<MH/
M3R?)?#SI5N?)='9R+*X.:GD^29/%='8,9<EL-L5W<IJD+Q<\@,H4*V__%KB8
MG [GX@@!#!?XI)/A!)_9-'[>]=D-,36,@^$<U%T.Z$ .$K$BE+7<+@W0+81\
M(G);BF>3%*9KI74L9C#R##Y--RL)5/6H,G>DV8,>J^$XCJ(XQW#$8K[ISNGU
MD!GH:2^%)*"I4.*(8Y4F!NR##&VP;BU**LA)_6"J:,$VIYBZ>BV"Q5F;W[[@
M EH(1(9'Q<NN+A=?4>90YP.89ZQY@72UL,[DUS;+UAP/W;- SW(VVV<F$8UT
M04D-([8L/5ZQ;,TQD71Y%4\7A-!LPP9$[JA0>,1^#K+Q8\AZP/P!Q$Z&LT>
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M7\X'PG4=>S<)MHE=<F8#>NXXK/ GAQP?P'YI;=A,V,#V;]/%7U!+ P04
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MTP@#3""5+9F"T+5OG:P+!7=UGU5HC,3OE<8C*8(JEK4U=K%F;_/*76L\Q9I
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ME^0>DO"'%?NPC(K%%]4<U&3>JHD<]9ZTJI)UGN; NI7\#/?)_([$IXY91D1
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M*B5SF["^'3;R<#"\UB;R^W-V_4K<.V #D*;36&CD(S\^L"@3-:G5,I/H)IE
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M0;$E<@3UF.8.T[]>])X!A8Q<[UWU%[P4EESK"C:U)5/5$+?2G87U]N %@>
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M-#@!WE]K[88'!!CO[4[^!E!+ P04    " "FBVA3S<ACF2<%  ">#P  &0
M 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6RU5VU/ZS84_BM6-DT@!9JD:=-"
MJ53*N)MTT1 O]WZ8]L%)W,;#B8/MM+?[]3MV7II"""!M'Z"Q?5X>G_/X''NV
MY>)))H0H]"-EF;RP$J7RL\% 1@E)L3SE.<E@9<5%BA4,Q7H@<T%P;)12-O <
M9SQ(,<VL^<S,W8KYC!>*T8S<"B2+-,5B=TD8WUY8KE5/W-%UHO3$8#[+\9K<
M$_68WPH8#1HK,4U))BG/D""K"VOAGET&6MX(?*-D*UO?2.\DY/Q)#WZ/+RQ'
M R*,1$I;P/"S(4O"F#8$,)XKFU;C4BNVOVOKUV;OL)<02[+D[#N-57)A32P4
MDQ4NF+KCV]](M9^1MA=Q)LU_M"UE \]"42$53RME0)#2K/S%/ZHXM!0FSAL*
M7J7@&=RE(X/R"BL\GPF^14)+@S7]8;9JM $<S712[I6 50IZ:GZ-J4#?,"L(
MNB%8%H) Q)5$1P\X9$0>SP8*O&C90519O"PM>F]8G*(;GJE$HE^SF,2'^@-
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M#;X"G%CBLPN45<#U0DIS'-@-^H?<ZE]02P,$%     @ IHMH4Q:A +B^ @
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M--Z [@NMW5[Q ;K]O?@+4$L#!!0    ( *:+:%.ZB*1U/08  ,P.   9
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MYBC1:I5>>B&%MLB"TTPV"]$4TA>+,&*J*N7NUA@V4PTV%2JWELZHPF(TN@4
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MO6#&H#4P&@SAA^[YE5)Y(,1C+#VQ7]\@XS/=;_0^@U$XR:;T'H?#)($;9C9
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MQ?/[ ..@8QQXQL%S$32E#RJ'?\F_V0)U)^$+9PD77L-33W^0QW7RV%0LQ6E
MK6I0WV PNRH0<B6H#1VC=6EM>Y'?4Z#$#BDSQ6M7Y!DUW&-]>K\P="M4/ B%
M(RX)1]6&[,WQ&+Z2KKTJ ,JAQ3*A0+>)A 6NN92.)6&"R13A);QZ,8I[\;LG
M7NF1BK1@>DW,_9,H&L"2W=' L"0D/AF<G1T[TGW@87\$3R4RW&FA$@G2#0H#
MJ:JE;;JI.^UFT;QIP0?S9I!=D"(N#0C,R34Z?4.MKYOAT&RLJGQ#)LI2>_ME
M0?,4M3.@^UPIN]TX@FY"S_X"4$L#!!0    ( *:+:%,<[C3GQ0(  !@&   9
M    >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;(55;6_:0 S^*U:T246*R NA
MA0J02MMIE=:M:MGV8=J'(W'(J<E==G<9;+]^ODO(J%;8EYSMLQ\_QF<SVTKU
MK M$ [NJ%'KN%<;4ET&@TP(KIH>R1D$WN505,Z2J3:!KA2QS0549Q&%X'E2,
M"V\Q<[8'M9C)QI1<X(,"W5054[^66,KMW(N\O>&1;PIC#<%B5K,-/J'Y7#\H
MTH(>)>,5"LVE (7YW+N*+I>)]7<.7SAN]8$,MI*UE,]6N<OF7F@)88FIL0B,
MCI]XC65I@8C&CP[3ZU/:P$-YC_[.U4ZUK)G&:UE^Y9DIYM[$@PQSUI3F46[?
M8U?/V.*ELM3N"]O6-QE[D#;:R*H+)@85%^W)=MWO<! P"8\$Q%U ['BWB1S+
M&V;88J;D%I3U)C0KN%)=-)'CPC;ER2BZY11G%G<BE17"BNU0P]F*K4O4@UE@
M"-HZ!&D'LVQAXB,P4[B7PA0:;D6&V<OX@"CUO.(]KV5\$O )ZR&,0A_B,(Y.
MX(WZ.D<.;_3?.N&&Z[24NE$(WZ[6VBAZ&=]/I$CZ%(E+D1RC3 .3-27"IQRN
M955+@<)HJQTDO]W1.&E\[1<^C;XJ$')9TA!QL0%C&]5-$O]-K9,-O4X4F',#
MN9(5\#:G<8UE(G,>F.?HQL#:03%#=S388 B\1L5EIH%F6Q-QS B/LL$9%W0O
M&TT@V@?<I5B;5Y &E[ J%.*+EP#41X/5&I5KYD<JZM2];;;]A ?2!ZDU42&:
M>*+"-W!V/O8GR61@Q3CTIYTXC?QQ&+76L3]*S@>P/(IR%L7^9)0,",Q/DA&=
MT=2/+R96(,B8++?_% [1=#B&MU3 <$)'' TC.I*1/5Y[5L'!M%:H-FXG:4AE
M(TP[N+VU7WM7[;3_=6]WYCU3&RXTE)A3:#B\H"VCVCW4*D;6;O;7TM F<6)!
MJQN5=:#[7$JS5VR"_L]@\0=02P,$%     @ IHMH4Z+..%0'!0  @A0  !D
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MY,4#"P0<7K/,=[=$BRPK3K*L.-W-BO.VK+@_,JE&)C^X?./J)(&]_Z88W!;
MNWO8<P]58%P=*+#]1'&WT1=WRXNF#C:Z58''_H^6OBK#V%Z'_UZ2GN)F-<1^
MXU1TS&H_UJIF8GO1_)[4.BVP=_>SVW7[]<B/6.U'7E5";"^%WY< IP7ZL=B/
M6.W'7M4S;"]H'_)C)@1Y]]+,5?E;\Z%MCC2V_4&J<D'<'[P_2)6@B3U!'S^H
MW18(1U:[LW/CD3"YRBZS%,KN*?*/KK*WO#"[SJZ):OT3?#G#+?US?'F37X=5
M\/GM''Q6K^!+ ,5L"4.YW0&D)YE?>.4-+=;9?<N3T%HDV2-\0$!E,@;P?BF$
M?FV8 <IKQ_%?4$L#!!0    ( *:+:%/(E)^!J@8  !HE   9    >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;+5:76^<.!3]*VC4AU;:=O G.$HB)6&J5MKN
M9INV^[#:!SHX,ZB 9\&3M-+^^#7,!!/;..DB7A)@SO7%]^!SKR^<WHOZ6[/E
M7 ;?RZ)JSA9;*7<GRV6SWO(R;=Z(':_4+[>B+E.I3NO-LMG5/,TZH[)8PC"D
MRS+-J\7Y:7?MNCX_%7M9Y!6_KH-F7Y9I_>.2%^+^; $6#Q<^YINM;"\LST]W
MZ8;?</EY=UVKLV4_2I:7O&IR404UOSU;7("3%8E;@P[Q)>?WS> X:*?R58AO
M[<G[[&P1MG?$"[Z6[1"I^G?'KWA1M".I^_CG..BB]]D:#H\?1G_;35Y-YFO:
M\"M1_)EG<GNVB!=!QF_3?2$_BOMW_#@ATHZW%D73_0WN#]A(>5SO&RG*H[$Z
M+_/J\#_]?@S$P$"-XS: 1P-H&N 1 W0T0,_U@(\&^+D>R-&@F_KR,/<N<$DJ
MT_/36MP'=8M6H[4'7?0[:Q6OO&H?E!M9JU]S92?//_([7NUY\#I(\B;=;&J^
M23L&Q6WP\-O+A,LT+YI7"O7Y)@E>OG@5O CR*OBT%?LFK;+F="G5O;0C+M='
MOY<'OW#$+PH^B$INFV!593QSV"=^>^:Q7ZH8](& #X&XA-X!;_CN38#"7P(8
M0N"XGZOGFX>NZ4SSOOK?WA\% _5/!>K&0R/CC3\+?_VJH,%[R<OF;X\CW#O"
MG2,\XNB3D&FA!*<;W/44'<QI9]Z*WMTY10S@T^7=D!L;Q3",#51BHR##-":/
M82L'+&:8Q#WLT4Q)/U/BG>D'GN7KM.:>H-%^*#HO.U'O*)K&SL&<#$*% 0B9
MP8X#Q0@!!CLV"D) 86RPXX"%,:+4S4[<SS1^%CO!OT%_>)'=I954V=(32=:/
MS^:E#(1:T,-II!WMAR%$E)#(8,T!PX"%)FT.& P9A,;B6SEP@,8QPF[BP""!
M@9^F[F:_VQ5<U3/2%U*H7<"9V=/""]!$]I#-'K0$T8&*$+2XLU& (/-)6#E=
MHGB,.:W]P"_^+N:NTUH&B2^46G !F9DU+<B 3F2-VI%&*#99LU$(,I,T&_0:
M,H),TFQ8!/!($@,Z(P!_2GA?9?E=GNW5=%7A%[Q-R[SXX8NA5F 0STR7%F/
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M M3OMT+(AY/60?\YU/E_4$L#!!0    ( *:+:%,]!QF1, 8  .4A   9
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M\QY]PIQCW3SH[1HD)I5XI]#/NS5Z^^;=S);*(ZUK9YWU96O=NV#=1Q\9E:5
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M\C'?_<8;AUBE;Y$GHOX+=@T6#L!B*\H\;82E!6F<[?]'WYJ).!"0>NP"N!'
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M"SQL[]CO7?(FF151D CVC68ZGP;C &6P)A73"[%]@":A*\N7"J;<$VV;V"A
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ME;(N@NJ.%J6K(U9"FT5QS=P4CB!M@/F^%D+O.G:"MA2=_0%02P,$%     @
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ME&UPC_)0V8/[';=^+C>B2![)K71+DAF5,/A1=Q',B(.YQ7&98Y'Z/5I(I:W
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MVX_0"AH8>XDHE+V2;;LW\$A2*RW*%HP>E#EO_MES&X@C -KI!X0M(#P7$+6
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M[,2   ;$B0$!#(@3 V(7WHD! 0R($P,"&! G!@0P($X,"&! G!@0P( X,2"
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MU0,_?8/*G]#8BSF5]HM.U5G/07$A%<\JL%:0$5;^\6L5AS- ?] "\"N _[^
MH ($UM%2F75KA16>300_(6%.:VMF8&-CT=H;PDP6-TKH7:)Q:K;D[ A"D2T%
MM-81!"$@01O%XP.Z19LRMXCOJJ7K%2A,J+S1FT^;%;J^ND%7B##TF/)"8I;(
MB:NT+&/<C2L)BU*"WR)AGHL>"KQ/R/?\?@-\V0W?0-X&=W4PZHCX=41\:R]H
ML?<(6<Z%\?KS2T'4&UH1&5,N"P'H>;Z52NBK]Z>#**B) DLT:"'Z*KB4*!<\
M!FB.6XD?6KPIQ^/,]T//\R;NL8%W4/,..GF_@Y1WB$A98!8#BKE4C>REE?",
MO>^-H["9/*S)PT[RG[HQ=;D<7I#Z_8'GM[ .:]9A9T[O6:Q;G 1S?\O1C;VT
M'U/]_, I1;H_G+!(NG(<U<11I[OS.!:%+J@<D^26L-L#80E*R)$DT%PKR^@B
MY]%P$#2[/ZI5C#I5+%/,]F \SNL2E[:>]4C'P#;4(Z8%-"D:7:0DB**6.SBN
M%8T[%2TPM9</2]M;(%>0;4%TM8'%^+(:_KT:I=R&8WXX"$8?!+MG/=.\5S^P
MV!,F$86=!GJ]2#LLRC>@G"B>VS:ZY4HW93M,];,)PAS0^SO.U?O$=.;Z(9[]
M!5!+ P04    " "FBVA3M]OB$IT#  #^#   &0   'AL+W=O<FMS:&5E=',O
M<VAE970T."YX;6RU5VUOJS88_2L6ZH=6N@WOA%1)I"9DVJ3=J;I9M\\..,&J
MP<PVS=V_GVT()=0AV5L_--B<<^SG\/CA87ZD[(WG" GPO2 E7UBY$-63;?,T
M1P7D$UJA4M[94U9 (8?L8/.*(9AI4D%LSW$BNX"XM)9S/??"EG-:"X)+],(
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M&-CFD"'P+ 3#NUK '4% 4+"F12$?Z5;0]"VG)$.,@T<U6TF,?MIT#U:0XQ3
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MM0TA"5"VVE&EO@ VYWSG\AUS.+,#%X\R!5#H.<^8G#NI4L6UZ\HXA9S(*UX
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MPJ"0A!=(0#9S3OSC<S\T COBCL!6[K21267%^;WI?$EGCF<B @J),A98_SW
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M]5T*A!F@WV><JZ>..4N;V]G\'U!+ P04    " "FBVA3I^IDSL0%  !'&
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M";X6>0$POV^DU*>'8H'F?P?3_P%02P,$%     @ IHMH4R$UO8F+ @  8@<
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M:W-G FD#S/>E$'K7L0+5+6SX%U!+ P04    " "FBVA3.0\O??0"  !'"
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M[#"F3H_2&-#^2@B]FQ@']7^'R5]02P,$%     @ IHMH4S$PEH+3 @  [P@
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M*Z@MZO:),^UN5+E3%,JI37!L,2XLV@<641#$QT:3)IJCN#M5W)W&N*?T!7N
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MQ*TQH<YT;/9N^'3,-K(B%&XX$INZQOS7#"JVG3B^L]NX):M2Z@UW.E[C%2Q
MWJ]ON%JY'4M.:J"",(HX%!/GPC^?)]K>&'PEL!5[<Z25+!E[T(NK?.)X.B"H
M().: :OA$2ZAJC21"N-GR^ET+C5P?[YC_V2T*RU++."25=](+LN),W10#@7>
M5/*6;3]#JR?6?!FKA'FB;6OK.2C;",GJ%JPBJ EM1OS4YF$/H'CL@* %!(>
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M7QFR+#6Z)\9'.S:_";T):*>&*W^+6S3NE#L<9@\L!Y%2=%3>08L1=OLY;"W
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( *6+:%/4@)G\304  'L5   8
M          " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " "EBVA36L(27. '   \(0  &               @(&0#0  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ I8MH4X&<\_L+"   *2,
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M965T-RYX;6Q02P$"% ,4    " "EBVA3K<51^?@*   0'0  &
M    @($21P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
MI8MH4PKLY+;J!@  ?A,  !@              ("!0%(  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( *6+:%.0R1/I30<  '@1   9
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M970Q-"YX;6Q02P$"% ,4    " "EBVA3.',:@(0$  ")"@  &0
M    @($7B0  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M *:+:%.[XFB/V@0  #,+   9              " @=*-  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ IHMH4[P80+>F!P  *!0  !D
M             ("!XY(  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    " "FBVA3+]J90%$%  !"#0  &0              @(' F@  >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( *:+:%-Q'=#@XPX
M *DL   9              " @4B@  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ IHMH4V&;L.EU"   +Q<  !D              ("!
M8J\  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " "FBVA3
M?H& HX0&  ##$P  &0              @($.N   >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( *:+:%/-R&.9)P4  )X/   9
M      " @<F^  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ IHMH4ZU_TF1@!   70H  !D              ("!)\0  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " "FBVA3.C.5L,<"  #@!0
M&0              @(&^R   >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( *:+:%/@9]O*Z@,  -0)   9              " @;S+  !X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ IHMH4Q:A +B^
M @  RP4  !D              ("!W<\  'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    " "FBVA3NHBD=3T&  #,#@  &0
M@('2T@  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( *:+
M:%/3$+/SOP,  )T(   9              " @4;9  !X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ IHMH4S93"^*1 @  K04  !D
M         ("!/-T  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
M    " "FBVA3'.XTY\4"   8!@  &0              @($$X   >&PO=V]R
M:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( *:+:%.BSCA4!P4  ((4
M   9              " @0#C  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL
M4$L! A0#%     @ IHMH4\B4GX&J!@  &B4  !D              ("!/N@
M 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " "FBVA3/0<9
MD3 &  #E(0  &0              @($?[P  >&PO=V]R:W-H965T<R]S:&5E
M=#,S+GAM;%!+ 0(4 Q0    ( *:+:%,03%>*90,  %\*   9
M  " @8;U  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
MIHMH4];4L=U< P  , L  !D              ("!(OD  'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    " "FBVA3@!<G<'@"  "Q!0  &0
M            @(&U_   >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( *:+:%/Z%N+W?@8  .0B   9              " @63_  !X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ IHMH4U;R3O7G @
ME@H  !D              ("!&08! 'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    " "FBVA3K#WOK%P#  "5"0  &0              @($W
M"0$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( *:+:%/F
MF5>EH@<  *,S   9              " @<H, 0!X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ IHMH4ZN0'/@. @  F00  !D
M     ("!HQ0! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *:+:%/J;<P'50<  !4?   9              "
M@<,G 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ IHMH
M4T7,MAG> @  E <  !D              ("!3R\! 'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6Q02P$"% ,4    " "FBVA3M]OB$IT#  #^#   &0
M        @(%D,@$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0
M   ( *:+:%/)M?8JNP,   $/   9              " @3@V 0!X;"]W;W)K
M<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ IHMH4\(VV&W[ @  J0D
M !D              ("!*CH! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q0
M2P$"% ,4    " "FBVA3I^IDSL0%  !'&   &0              @(%</0$
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( *:+:%,A-;V)
MBP(  &('   9              " @5=# 0!X;"]W;W)K<VAE971S+W-H965T
M-3(N>&UL4$L! A0#%     @ IHMH4PH[-TDH P  =@T  !D
M ("!&48! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " "F
MBVA3ATJE*LL"  "1"0  &0              @(%X20$ >&PO=V]R:W-H965T
M<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( *:+:%,Y#R]]] (  $<(   9
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M970U.2YX;6Q02P$"% ,4    " "FBVA3L7K+X.("  #K"   &0
M    @(&77@$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    (
M *:+:%-G%4 TIP(  ,\'   9              " @;!A 0!X;"]W;W)K<VAE
M971S+W-H965T-C$N>&UL4$L! A0#%     @ IHMH4WS$,2OH 0  6@0  !D
M             ("!CF0! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"
M% ,4    " "FBVA3E_?$&"$#  ".$@  #0              @ &M9@$ >&PO
M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( *:+:%.7BKL<P    !,"   +
M      "  ?EI 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *:+:%,;7W,*\ 0
M  PI   /              "  >)J 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " "FBVA3=TMQA08"  #Q)   &@              @ '_;P$ >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "FBVA3_R>G=>,!  !L
M)   $P              @ $]<@$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    1@!& "$3  !1= $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>374</ContextCount>
  <ElementCount>357</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>80</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Summary of Business and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies</Role>
      <ShortName>Summary of Business and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Supplemental Financial Statement Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation</Role>
      <ShortName>Supplemental Financial Statement Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2116104 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2122105 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2126106 - Disclosure - Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/ConvertiblePreferredStock</Role>
      <ShortName>Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2130107 - Disclosure - Net Loss Per Share Attributable to Common Stockholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholders</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2134108 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2137109 - Disclosure - Segment and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SegmentandGeographicInformation</Role>
      <ShortName>Segment and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2142110 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2147111 - Disclosure - Restructuring and Reorganization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/RestructuringandReorganization</Role>
      <ShortName>Restructuring and Reorganization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2151112 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2153113 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Summary of Business and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Business and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/Revenue</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Supplemental Financial Statement Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables</Role>
      <ShortName>Supplemental Financial Statement Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2317303 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/FairValueMeasurements</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2323304 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/Equity</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2327305 - Disclosure - Convertible Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/ConvertiblePreferredStockTables</Role>
      <ShortName>Convertible Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/ConvertiblePreferredStock</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2331306 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersTables</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholders</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2335307 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/CommitmentsandContingencies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2338308 - Disclosure - Segment and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables</Role>
      <ShortName>Segment and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/SegmentandGeographicInformation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2343309 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/Leases</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2348310 - Disclosure - Restructuring and Reorganization (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/RestructuringandReorganizationTables</Role>
      <ShortName>Restructuring and Reorganization (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/RestructuringandReorganization</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2354311 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/IncomeTaxes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - Summary of Business and Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Business and Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Revenue - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails</Role>
      <ShortName>Revenue - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Revenue - Commission Revenue by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails</Role>
      <ShortName>Revenue - Commission Revenue by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Supplemental Financial Statement Information- Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Supplemental Financial Statement Information- Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Supplemental Financial Statement Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails</Role>
      <ShortName>Supplemental Financial Statement Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Supplemental Financial Statement Information - Schedule of Allowance for Credit Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails</Role>
      <ShortName>Supplemental Financial Statement Information - Schedule of Allowance for Credit Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Supplemental Financial Statement Information - Schedule of Commissions Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails</Role>
      <ShortName>Supplemental Financial Statement Information - Schedule of Commissions Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - Supplemental Financial Statement Information - Schedule of Credit Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails</Role>
      <ShortName>Supplemental Financial Statement Information - Schedule of Credit Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2415409 - Disclosure - Supplemental Financial Statement Information - Schedule of Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails</Role>
      <ShortName>Supplemental Financial Statement Information - Schedule of Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - Fair Value Measurements - Summary of Financial Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Financial Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - Fair Value Measurements - Contractual Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails</Role>
      <ShortName>Fair Value Measurements - Contractual Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - Fair Value Measurements - Unrealized Gains and Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails</Role>
      <ShortName>Fair Value Measurements - Unrealized Gains and Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2421413 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2424414 - Disclosure - Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/EquityNarrativeDetails</Role>
      <ShortName>Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2425415 - Disclosure - Equity - Schedule of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails</Role>
      <ShortName>Equity - Schedule of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2428416 - Disclosure - Convertible Preferred Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails</Role>
      <ShortName>Convertible Preferred Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2429417 - Disclosure - Convertible Preferred Stock - Summary of Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails</Role>
      <ShortName>Convertible Preferred Stock - Summary of Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2432418 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2433419 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Anti-Dilutive Shares Excluded from Computation Of Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails</Role>
      <ShortName>Net Loss Per Share Attributable to Common Stockholders - Schedule of Anti-Dilutive Shares Excluded from Computation Of Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2436420 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - Segment and Geographic Information - Segment Operating Results (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails</Role>
      <ShortName>Segment and Geographic Information - Segment Operating Results (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2440422 - Disclosure - Segment and Geographic Information - Schedule Of Long-Lived Assets By Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails</Role>
      <ShortName>Segment and Geographic Information - Schedule Of Long-Lived Assets By Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - Segment and Geographic Information - Schedule of Revenue by Major Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails</Role>
      <ShortName>Segment and Geographic Information - Schedule of Revenue by Major Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2444424 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2445425 - Disclosure - Leases - Supplemental Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails</Role>
      <ShortName>Leases - Supplemental Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2446426 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2449427 - Disclosure - Restructuring and Reorganization - Restructuring and Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/RestructuringandReorganizationRestructuringandOtherLiabilitiesDetails</Role>
      <ShortName>Restructuring and Reorganization - Restructuring and Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2450428 - Disclosure - Restructuring and Reorganization - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails</Role>
      <ShortName>Restructuring and Reorganization - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2452429 - Disclosure - Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/DebtDetails</Role>
      <ShortName>Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ehealthinsurance.com/role/Debt</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2455430 - Disclosure - Income Taxes - Summary of Income Tax Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails</Role>
      <ShortName>Income Taxes - Summary of Income Tax Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2456431 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ehth-20210930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - ehth-20210930.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - ehth-20210930.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="ehth-20210930.htm">ehth-20210930.htm</File>
    <File>a2021q3ex311.htm</File>
    <File>a2021q3ex312.htm</File>
    <File>a2021q3ex321.htm</File>
    <File>a2021q3ex322.htm</File>
    <File>ehth-20210930.xsd</File>
    <File>ehth-20210930_cal.xml</File>
    <File>ehth-20210930_def.xml</File>
    <File>ehth-20210930_lab.xml</File>
    <File>ehth-20210930_pre.xml</File>
    <File>exhibit106fransoistmanexec.htm</File>
    <File>exhibit107scottflanderssep.htm</File>
    <File>exhibit108christinejanofsk.htm</File>
    <File>exhibit109johnpierantonise.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2021</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>84
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ehth-20210930.htm": {
   "axisCustom": 5,
   "axisStandard": 27,
   "contextCount": 374,
   "dts": {
    "calculationLink": {
     "local": [
      "ehth-20210930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ehth-20210930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ehth-20210930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ehth-20210930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ehth-20210930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ehth-20210930.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 511,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 1,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 6
   },
   "keyCustom": 52,
   "keyStandard": 305,
   "memberCustom": 38,
   "memberStandard": 38,
   "nsprefix": "ehth",
   "nsuri": "http://www.ehealthinsurance.com/20210930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.ehealthinsurance.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122105 - Disclosure - Equity",
     "role": "http://www.ehealthinsurance.com/role/Equity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126106 - Disclosure - Convertible Preferred Stock",
     "role": "http://www.ehealthinsurance.com/role/ConvertiblePreferredStock",
     "shortName": "Convertible Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130107 - Disclosure - Net Loss Per Share Attributable to Common Stockholders",
     "role": "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholders",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134108 - Disclosure - Commitments and Contingencies",
     "role": "http://www.ehealthinsurance.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137109 - Disclosure - Segment and Geographic Information",
     "role": "http://www.ehealthinsurance.com/role/SegmentandGeographicInformation",
     "shortName": "Segment and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142110 - Disclosure - Leases",
     "role": "http://www.ehealthinsurance.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147111 - Disclosure - Restructuring and Reorganization",
     "role": "http://www.ehealthinsurance.com/role/RestructuringandReorganization",
     "shortName": "Restructuring and Reorganization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151112 - Disclosure - Debt",
     "role": "http://www.ehealthinsurance.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153113 - Disclosure - Income Taxes",
     "role": "http://www.ehealthinsurance.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ehth:DescriptionOfBusinessPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Summary of Business and Significant Accounting Policies (Policies)",
     "role": "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Business and Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ehth:DescriptionOfBusinessPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Revenue (Tables)",
     "role": "http://www.ehealthinsurance.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Supplemental Financial Statement Information (Tables)",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables",
     "shortName": "Supplemental Financial Statement Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317303 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.ehealthinsurance.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ehth:ScheduleOfStockBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323304 - Disclosure - Equity (Tables)",
     "role": "http://www.ehealthinsurance.com/role/EquityTables",
     "shortName": "Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ehth:ScheduleOfStockBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327305 - Disclosure - Convertible Preferred Stock (Tables)",
     "role": "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockTables",
     "shortName": "Convertible Preferred Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331306 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)",
     "role": "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersTables",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2335307 - Disclosure - Commitments and Contingencies (Tables)",
     "role": "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338308 - Disclosure - Segment and Geographic Information (Tables)",
     "role": "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables",
     "shortName": "Segment and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2343309 - Disclosure - Leases (Tables)",
     "role": "http://www.ehealthinsurance.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348310 - Disclosure - Restructuring and Reorganization (Tables)",
     "role": "http://www.ehealthinsurance.com/role/RestructuringandReorganizationTables",
     "shortName": "Restructuring and Reorganization (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "role": "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:MarketingAndAdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2354311 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.ehealthinsurance.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ehth:DescriptionOfBusinessPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ehth:NumberOfHealthInsuranceCarriers",
      "reportCount": 1,
      "unitRef": "insurance_carrier",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Summary of Business and Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Business and Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i53205ea49e0b458292f697b7a5c56a93_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Revenue - Disaggregation of Revenue (Details)",
     "role": "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails",
     "shortName": "Revenue - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i5bf2b0808d5d4b95ad14fb56678b89df_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Revenue - Commission Revenue by Segment (Details)",
     "role": "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
     "shortName": "Revenue - Commission Revenue by Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i7c18eadfc0c5443f8b7c31b736463ad6_D20210701-20210930",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Supplemental Financial Statement Information- Schedule of Cash, Cash Equivalents and Restricted Cash (Details)",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails",
     "shortName": "Supplemental Financial Statement Information- Schedule of Cash, Cash Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Supplemental Financial Statement Information - Narrative (Details)",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails",
     "shortName": "Supplemental Financial Statement Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAllowanceForCreditLossWriteoff",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i759d5300c26749239484a4f23e10ce0a_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Supplemental Financial Statement Information - Schedule of Allowance for Credit Loss (Details)",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails",
     "shortName": "Supplemental Financial Statement Information - Schedule of Allowance for Credit Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i759d5300c26749239484a4f23e10ce0a_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i759d5300c26749239484a4f23e10ce0a_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Supplemental Financial Statement Information - Schedule of Commissions Receivable (Details)",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails",
     "shortName": "Supplemental Financial Statement Information - Schedule of Commissions Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i759d5300c26749239484a4f23e10ce0a_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "id2046c7d044743ceaad71b60d4431854_D20210101-20210930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - Supplemental Financial Statement Information - Schedule of Credit Risk (Details)",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails",
     "shortName": "Supplemental Financial Statement Information - Schedule of Credit Risk (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "id2046c7d044743ceaad71b60d4431854_D20210101-20210930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "ehth:PrepaidMaintenanceContractsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415409 - Disclosure - Supplemental Financial Statement Information - Schedule of Prepaid Expenses and Other Current Assets (Details)",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails",
     "shortName": "Supplemental Financial Statement Information - Schedule of Prepaid Expenses and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "ehth:PrepaidMaintenanceContractsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ia776a591bb4d4eabab7db24eecef27c1_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "role": "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ia776a591bb4d4eabab7db24eecef27c1_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - Fair Value Measurements - Summary of Financial Assets (Details)",
     "role": "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
     "shortName": "Fair Value Measurements - Summary of Financial Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i491b5e834621498ca113938980a0be07_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - Fair Value Measurements - Contractual Maturities (Details)",
     "role": "http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails",
     "shortName": "Fair Value Measurements - Contractual Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - Fair Value Measurements - Unrealized Gains and Losses (Details)",
     "role": "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails",
     "shortName": "Fair Value Measurements - Unrealized Gains and Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "ehth:CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421413 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ie5b86e4a17824c849cfbd6758868c90c_I20210922",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424414 - Disclosure - Equity - Narrative (Details)",
     "role": "http://www.ehealthinsurance.com/role/EquityNarrativeDetails",
     "shortName": "Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ie5b86e4a17824c849cfbd6758868c90c_I20210922",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ehth:ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425415 - Disclosure - Equity - Schedule of Stock-Based Compensation Expense (Details)",
     "role": "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
     "shortName": "Equity - Schedule of Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ehth:ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i62bd92b031dc46ee938800c64916afe9_D20210430-20210430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428416 - Disclosure - Convertible Preferred Stock - Narrative (Details)",
     "role": "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails",
     "shortName": "Convertible Preferred Stock - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i62bd92b031dc46ee938800c64916afe9_D20210430-20210430",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i62bd92b031dc46ee938800c64916afe9_D20210430-20210430",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "ehth:SaleOfStockConsiderationReceivedOnTransactionGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429417 - Disclosure - Convertible Preferred Stock - Summary of Stock (Details)",
     "role": "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails",
     "shortName": "Convertible Preferred Stock - Summary of Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i62bd92b031dc46ee938800c64916afe9_D20210430-20210430",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432418 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss per Share (Details)",
     "role": "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "ehth:IncrementalCommonSharesAttributableToOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433419 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Anti-Dilutive Shares Excluded from Computation Of Net Income Per Share (Details)",
     "role": "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails",
     "shortName": "Net Loss Per Share Attributable to Common Stockholders - Schedule of Anti-Dilutive Shares Excluded from Computation Of Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436420 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - Segment and Geographic Information - Segment Operating Results (Details)",
     "role": "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails",
     "shortName": "Segment and Geographic Information - Segment Operating Results (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440422 - Disclosure - Segment and Geographic Information - Schedule Of Long-Lived Assets By Geographical Area (Details)",
     "role": "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails",
     "shortName": "Segment and Geographic Information - Schedule Of Long-Lived Assets By Geographical Area (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i807a2c2c69384b17a0895525b7e3edd3_D20210701-20210930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - Segment and Geographic Information - Schedule of Revenue by Major Customers (Details)",
     "role": "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
     "shortName": "Segment and Geographic Information - Schedule of Revenue by Major Customers (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i807a2c2c69384b17a0895525b7e3edd3_D20210701-20210930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444424 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445425 - Disclosure - Leases - Supplemental Information (Details)",
     "role": "http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails",
     "shortName": "Leases - Supplemental Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446426 - Disclosure - Leases - Maturities of Lease Liabilities (Details)",
     "role": "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i759d5300c26749239484a4f23e10ce0a_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449427 - Disclosure - Restructuring and Reorganization - Restructuring and Other Liabilities (Details)",
     "role": "http://www.ehealthinsurance.com/role/RestructuringandReorganizationRestructuringandOtherLiabilitiesDetails",
     "shortName": "Restructuring and Reorganization - Restructuring and Other Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsForRestructuring",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i2ce9e77371e64f6a8892196a9e45088f_D20210201-20210228",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated",
      "reportCount": 1,
      "unique": true,
      "unitRef": "employee",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450428 - Disclosure - Restructuring and Reorganization - Narrative (Details)",
     "role": "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails",
     "shortName": "Restructuring and Reorganization - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i2ce9e77371e64f6a8892196a9e45088f_D20210201-20210228",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated",
      "reportCount": 1,
      "unique": true,
      "unitRef": "employee",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452429 - Disclosure - Debt (Details)",
     "role": "http://www.ehealthinsurance.com/role/DebtDetails",
     "shortName": "Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i942081d424f34699add16e658f851ed1_I20210930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCredit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Summary of Business and Significant Accounting Policies",
     "role": "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies",
     "shortName": "Summary of Business and Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455430 - Disclosure - Income Taxes - Summary of Income Tax Benefit (Details)",
     "role": "http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails",
     "shortName": "Income Taxes - Summary of Income Tax Benefit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "ica28973693e74e8cb672d581df69bbe6_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456431 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Revenue",
     "role": "http://www.ehealthinsurance.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Supplemental Financial Statement Information",
     "role": "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation",
     "shortName": "Supplemental Financial Statement Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116104 - Disclosure - Fair Value Measurements",
     "role": "http://www.ehealthinsurance.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210930.htm",
      "contextRef": "i01bd7206e01f4628b0328f2fa25e2a73_D20210101-20210930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": null,
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - ehth-20210930.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - ehth-20210930.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 80,
   "tag": {
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA",
        "terseLabel": "China"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "ehth_AccruedMarketingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total carrying values as of the balance sheet date of liabilities incurred through that date and payable for obligations related to marketing and advertising services received from vendors. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Marketing Expenses.",
        "terseLabel": "Accrued marketing expenses"
       }
      }
     },
     "localname": "AccruedMarketingExpenses",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_AetnaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aetna [Member]",
        "label": "Aetna [Member]",
        "terseLabel": "Aetna"
       }
      }
     },
     "localname": "AetnaMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allocated Share-based Compensation Expense, Net Of Restructuring Reversal Expense",
        "label": "Allocated Share-based Compensation Expense, Net Of Restructuring Reversal Expense",
        "negatedTerseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedSharebasedCompensationExpenseNetOfRestructuringReversalExpense",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_AncillariesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ancillaries [Member]",
        "label": "Ancillaries [Member]",
        "terseLabel": "Ancillary"
       }
      }
     },
     "localname": "AncillariesMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_BorrowingBasePercentageAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing Base Percentage [Axis]",
        "label": "Borrowing Base Percentage [Axis]",
        "terseLabel": "Borrowing Base Percentage [Axis]"
       }
      }
     },
     "localname": "BorrowingBasePercentageAxis",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ehth_BorrowingBasePercentageDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Borrowing Base Percentage [Axis]",
        "label": "Borrowing Base Percentage [Domain]",
        "terseLabel": "Borrowing Base Percentage [Domain]"
       }
      }
     },
     "localname": "BorrowingBasePercentageDomain",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Accumulated Gross Unrealized Gains, before Tax",
        "label": "Cash And Cash Equivalents, Accumulated Gross Unrealized Gains, before Tax",
        "terseLabel": "Unrealized Gain"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAccumulatedGrossUnrealizedGainsBeforeTax",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, before Tax",
        "label": "Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Unrealized Loss"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1": {
       "order": 3.0,
       "parentTag": "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents And Available-For-Sale Debt Securities",
        "label": "Cash, Cash Equivalents And Available-For-Sale Debt Securities",
        "totalLabel": "Fair Value"
       }
      }
     },
     "localname": "CashCashEquivalentsAndAvailableForSaleDebtSecurities",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1": {
       "order": 2.0,
       "parentTag": "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents And Available-For-Sale Debt Securities, Accumulated Gross Unrealized Gain, Before Tax",
        "label": "Cash, Cash Equivalents And Available-For-Sale Debt Securities, Accumulated Gross Unrealized Gain, Before Tax",
        "totalLabel": "Unrealized Gain"
       }
      }
     },
     "localname": "CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1": {
       "order": 1.0,
       "parentTag": "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents And Available-For-Sale Debt Securities, Accumulated Gross Unrealized Loss, Before Tax",
        "label": "Cash, Cash Equivalents And Available-For-Sale Debt Securities, Accumulated Gross Unrealized Loss, Before Tax",
        "negatedTotalLabel": "Unrealized Loss"
       }
      }
     },
     "localname": "CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalents And Available-For-Sale Debt Securities, Amortized Cost",
        "label": "Cash, Cash Equivalents And Available-For-Sale Debt Securities, Amortized Cost",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_CenteneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Centene",
        "label": "Centene [Member]",
        "terseLabel": "Centene"
       }
      }
     },
     "localname": "CenteneMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_ChangeInContractWithCustomerAssetRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Contract with Customer, Asset",
        "label": "Change in Contract with Customer, Asset [Roll Forward]",
        "terseLabel": "Change in Contract with Customer, Asset [Roll Forward]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerAssetRollForward",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ehth_CommissionBonusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission Bonus [Member]",
        "label": "Commission Bonus [Member]",
        "terseLabel": "Commission Bonus and Other"
       }
      }
     },
     "localname": "CommissionBonusMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_CommissionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission [Member]",
        "label": "Commission [Member]",
        "terseLabel": "Commission"
       }
      }
     },
     "localname": "CommissionMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_CommissionMembersApprovedDuringCurrentPeriodMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission, Members Approved During Current Period [Member]",
        "label": "Commission, Members Approved During Current Period [Member]",
        "terseLabel": "Commission Revenue from Members Approved During the Period"
       }
      }
     },
     "localname": "CommissionMembersApprovedDuringCurrentPeriodMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_CommissionMembersApprovedInPriorPeriodsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission, Members Approved In Prior Periods [Member]",
        "label": "Commission, Members Approved In Prior Periods [Member]",
        "terseLabel": "Net Commission Revenue from Members Approved in Prior Periods"
       }
      }
     },
     "localname": "CommissionMembersApprovedInPriorPeriodsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_CommissionRevenueFromRenewalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission Revenue From Renewals",
        "label": "Commission Revenue From Renewals [Member]",
        "terseLabel": "Commission Revenue from Renewals of Small Business Members During the Period"
       }
      }
     },
     "localname": "CommissionRevenueFromRenewalsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Minimum Ownership Percentage Needed To Nominate Individual To Board Of Directors",
        "label": "Common Stock, Minimum Ownership Percentage Needed To Nominate Individual To Board Of Directors",
        "terseLabel": "Minimum common stock ownership percentage needed to nominate individual to board of directors"
       }
      }
     },
     "localname": "CommonStockMinimumOwnershipPercentageNeededToNominateIndividualToBoardOfDirectors",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ehth_ContractualObligationToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual Obligation, to be Paid, After Year Four",
        "label": "Contractual Obligation, to be Paid, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "ContractualObligationToBePaidAfterYearFour",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock, Accrued Paid-In-Kind Dividends, Common Stock Equivalent, As-Converted Basis",
        "label": "Convertible Preferred Stock, Accrued Paid-In-Kind Dividends, Common Stock Equivalent, As-Converted Basis",
        "terseLabel": "Accrued paid-in-kind dividends, common stock equivalent, as-converted (in shares)"
       }
      }
     },
     "localname": "ConvertiblePreferredStockAccruedPaidInKindDividendsCommonStockEquivalentAsConvertedBasis",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ehth_ConvertiblePreferredStockCovenantAssetCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock, Covenant, Asset Coverage Ratio",
        "label": "Convertible Preferred Stock, Covenant, Asset Coverage Ratio",
        "terseLabel": "Asset coverage ratio"
       }
      }
     },
     "localname": "ConvertiblePreferredStockCovenantAssetCoverageRatio",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ehth_ConvertiblePreferredStockCovenantLiquidity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock, Covenant, Liquidity",
        "label": "Convertible Preferred Stock, Covenant, Liquidity",
        "terseLabel": "Minimum liquidity amount"
       }
      }
     },
     "localname": "ConvertiblePreferredStockCovenantLiquidity",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock, Minimum Ownership Percentage Needed For Consent To Incur Debt",
        "label": "Convertible Preferred Stock, Minimum Ownership Percentage Needed For Consent To Incur Debt",
        "terseLabel": "Minimum ownership percentage needed for consent to incur debt in excess of $175 million"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMinimumOwnershipPercentageNeededForConsentToIncurDebt",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ehth_ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock, Number Of Nominations To Board Of Directors",
        "label": "Convertible Preferred Stock, Number Of Nominations To Board Of Directors",
        "terseLabel": "Number of nominations to board of directors"
       }
      }
     },
     "localname": "ConvertiblePreferredStockNumberOfNominationsToBoardOfDirectors",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ehth_ConvertiblePreferredStockRedemptionCallRightWrittenNotice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock, Redemption Call Right, Written Notice",
        "label": "Convertible Preferred Stock, Redemption Call Right, Written Notice",
        "terseLabel": "Redemption call right, number of days for written notice"
       }
      }
     },
     "localname": "ConvertiblePreferredStockRedemptionCallRightWrittenNotice",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ehth_ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock, Redemption Value, Percentage Of Accrued Value Per Share",
        "label": "Convertible Preferred Stock, Redemption Put Right, Percentage Of Accrued Value Per Share",
        "terseLabel": "Redemption put right, percentage of accrued value"
       }
      }
     },
     "localname": "ConvertiblePreferredStockRedemptionPutRightPercentageOfAccruedValuePerShare",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ehth_ConvertiblePreferredStockThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock, Threshold Consecutive Trading Days",
        "label": "Convertible Preferred Stock, Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days"
       }
      }
     },
     "localname": "ConvertiblePreferredStockThresholdConsecutiveTradingDays",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ehth_ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock, Threshold Percentage Of Stock Price Trigger",
        "label": "Convertible Preferred Stock, Threshold Percentage Of Stock Price Trigger",
        "terseLabel": "Threshold percentage of conversion price"
       }
      }
     },
     "localname": "ConvertiblePreferredStockThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ehth_ConvertiblePreferredStockThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock, Threshold Trading Days",
        "label": "Convertible Preferred Stock, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "ConvertiblePreferredStockThresholdTradingDays",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ehth_ConvertiblePreferredStockVotesPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Preferred Stock, Votes Per Share",
        "label": "Convertible Preferred Stock, Votes Per Share",
        "terseLabel": "Number of votes per share"
       }
      }
     },
     "localname": "ConvertiblePreferredStockVotesPerShare",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ehth_CreditAgreementAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement Amendment",
        "label": "Credit Agreement Amendment [Member]",
        "terseLabel": "Credit Agreement Amendment"
       }
      }
     },
     "localname": "CreditAgreementAmendmentMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_CustomerCareAndEnrollmentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total expense recognized in the period related to providing customer care and enrollment services. These services include pre-sales assistance to applicants who call our customer care center and enrollment services to applicants during the underwriting process.",
        "label": "Customer Care And Enrollment Expense",
        "terseLabel": "Customer care and enrollment"
       }
      }
     },
     "localname": "CustomerCareAndEnrollmentExpense",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_CustomerCareAndEnrollmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Care And Enrollment Expense [Member]",
        "label": "Customer Care And Enrollment Expense [Member]",
        "terseLabel": "Customer care and enrollment"
       }
      }
     },
     "localname": "CustomerCareAndEnrollmentExpenseMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 2.0,
       "parentTag": "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Gain, Before Tax",
        "label": "Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Gain, Before Tax",
        "terseLabel": "Unrealized Gain"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Loss, Before Tax",
        "label": "Debt Securities, Available-For-Sale, Current, Accumulated Gross Unrealized Loss, Before Tax",
        "negatedLabel": "Unrealized Loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_DentalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dental [Member]",
        "label": "Dental [Member]",
        "terseLabel": "Dental"
       }
      }
     },
     "localname": "DentalMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_DescriptionOfBusinessPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description Of Business, Policy",
        "label": "Description Of Business, Policy [Policy Text Block]",
        "terseLabel": "Description of Business"
       }
      }
     },
     "localname": "DescriptionOfBusinessPolicyPolicyTextBlock",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ehth_DisaggregatedAncillariesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disaggregated Ancillaries [Axis]",
        "label": "Disaggregated Ancillaries [Axis]",
        "terseLabel": "Disaggregated Ancillaries [Axis]"
       }
      }
     },
     "localname": "DisaggregatedAncillariesAxis",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ehth_DisaggregatedAncillariesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disaggregated Ancillaries [Axis]",
        "label": "Disaggregated Ancillaries [Domain]",
        "terseLabel": "Disaggregated Ancillaries [Domain]"
       }
      }
     },
     "localname": "DisaggregatedAncillariesDomain",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_DisaggregatedIndividualandFamilyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disaggregated Individual and Family [Axis]",
        "label": "Disaggregated Individual and Family [Axis]",
        "terseLabel": "Disaggregated Individual and Family [Axis]"
       }
      }
     },
     "localname": "DisaggregatedIndividualandFamilyAxis",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ehth_DisaggregatedIndividualandFamilyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disaggregated Individual and Family [Axis]",
        "label": "Disaggregated Individual and Family [Domain]",
        "terseLabel": "Disaggregated Individual and Family [Domain]"
       }
      }
     },
     "localname": "DisaggregatedIndividualandFamilyDomain",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_DisaggregatedMedicareAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disagregated Medicare [Axis]",
        "label": "Disaggregated Medicare [Axis]",
        "terseLabel": "Disaggregated Medicare [Axis]"
       }
      }
     },
     "localname": "DisaggregatedMedicareAxis",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ehth_DisaggregatedMedicareDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disaggregated Medicare [Axis]",
        "label": "Disaggregated Medicare [Domain]",
        "terseLabel": "Disaggregated Medicare [Domain]"
       }
      }
     },
     "localname": "DisaggregatedMedicareDomain",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_DisaggregatedOtherAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disaggregated Other",
        "label": "Disaggregated Other [Axis]",
        "terseLabel": "Disaggregated Other [Axis]"
       }
      }
     },
     "localname": "DisaggregatedOtherAxis",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ehth_DisaggregatedOtherDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disaggregated Other",
        "label": "Disaggregated Other [Domain]",
        "terseLabel": "Disaggregated Other [Domain]"
       }
      }
     },
     "localname": "DisaggregatedOtherDomain",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_EchelonHealthSPCLPHIGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Echelon Health SPC, LP (H.I.G)",
        "label": "Echelon Health SPC, LP (H.I.G) [Member]",
        "terseLabel": "H.I.G"
       }
      }
     },
     "localname": "EchelonHealthSPCLPHIGMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_EligibleCommissionsReceivablesPrecedingThreeMonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eligible Commissions Receivables, Preceding Three Months [Member]",
        "label": "Eligible Commissions Receivables, Preceding Three Months [Member]",
        "terseLabel": "Eligible Commissions Receivables, Preceding Three Months"
       }
      }
     },
     "localname": "EligibleCommissionsReceivablesPrecedingThreeMonthsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_EligibleCommissionsReceivablesSucceedingSixMonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eligible Commissions Receivables, Succeeding Six Months [Member]",
        "label": "Eligible Commissions Receivables, Succeeding Six Months [Member]",
        "terseLabel": "Eligible Commissions Receivables, Succeeding Six Months"
       }
      }
     },
     "localname": "EligibleCommissionsReceivablesSucceedingSixMonthsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_EligibleCommissionsReceivablesSucceedingThreeMonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eligible Commissions Receivables, Succeeding Three Months [Member]",
        "label": "Eligible Commissions Receivables, Succeeding Three Months [Member]",
        "terseLabel": "Eligible Commissions Receivables, Succeeding Three Months"
       }
      }
     },
     "localname": "EligibleCommissionsReceivablesSucceedingThreeMonthsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_HumanaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Humana [Member]",
        "label": "Humana [Member]",
        "terseLabel": "Humana"
       }
      }
     },
     "localname": "HumanaMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_IncreaseDecreaseInAccruedMarketingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in accrued marketing expenses.",
        "label": "Increase Decrease In Accrued Marketing Expenses",
        "terseLabel": "Accrued marketing expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedMarketingExpenses",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_IncreaseDecreaseInCommissionsReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Commissions Receivable",
        "label": "Increase (Decrease) In Commissions Receivable",
        "terseLabel": "Contract assets \u2013 commissions receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInCommissionsReceivable",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax",
        "label": "Increase (Decrease) In Revenue From Contract With Customer, Excluding Assessed Tax",
        "terseLabel": "Change in revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInRevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_IncrementalCommonSharesAttributableToOptions": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental Common Shares Attributable To Options",
        "label": "Incremental Common Shares Attributable To Options",
        "terseLabel": "Dilutive effect of common stock (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToOptions",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ehth_IndividualFamilyAndSmallBusinessSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual, Family, And Small Business Segments [Member]",
        "label": "Individual, Family, And Small Business Segments [Member]",
        "terseLabel": "Individual, Family and Small Business"
       }
      }
     },
     "localname": "IndividualFamilyAndSmallBusinessSegmentsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_IndividualandFamilyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual and Family [Member]",
        "label": "Individual and Family [Member]",
        "terseLabel": "Individual and Family"
       }
      }
     },
     "localname": "IndividualandFamilyMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_LeViasCompliantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Le'Vias Compliant [Member]",
        "label": "Le'Vias Compliant [Member]",
        "terseLabel": "Le'Vias Compliant"
       }
      }
     },
     "localname": "LeViasCompliantMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_LineOfCreditFacilityBorrowingBasePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Borrowing Base, Percentage",
        "label": "Line Of Credit Facility, Borrowing Base, Percentage",
        "terseLabel": "Borrowing base percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityBorrowingBasePercentage",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ehth_LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Covenant, Maximum Cash And Cash Equivalents",
        "label": "Line Of Credit Facility, Covenant, Maximum Cash And Cash Equivalents",
        "terseLabel": "Covenant, maximum cash and cash equivalents"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantMaximumCashAndCashEquivalents",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_LineOfCreditFacilityCovenantMaximumLiquidity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Covenant, Maximum Liquidity",
        "label": "Line Of Credit Facility, Covenant, Maximum Liquidity",
        "terseLabel": "Maximum liquidity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantMaximumLiquidity",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Covenant, Minimum Cash And Cash Equivalents",
        "label": "Line Of Credit Facility, Covenant, Minimum Cash And Cash Equivalents",
        "terseLabel": "Covenant, minimum cash and cash equivalents"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantMinimumCashAndCashEquivalents",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_LineOfCreditFacilityCovenantMinimumLiquidity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Covenant, Minimum Liquidity",
        "label": "Line Of Credit Facility, Covenant, Minimum Liquidity",
        "terseLabel": "Minimum liquidity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCovenantMinimumLiquidity",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_LineOfCreditFacilityFacilityFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Facility Fee Percentage",
        "label": "Line Of Credit Facility, Facility Fee Percentage",
        "terseLabel": "Facility fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityFacilityFeePercentage",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ehth_MedicareAdvantageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Advantage [Member]",
        "label": "Medicare Advantage [Member]",
        "terseLabel": "Medicare Advantage"
       }
      }
     },
     "localname": "MedicareAdvantageMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_MedicareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare [Member]",
        "label": "Medicare [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "MedicareMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_MedicarePartDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Part D [Member]",
        "label": "Medicare Part D [Member]",
        "terseLabel": "Medicare Part D"
       }
      }
     },
     "localname": "MedicarePartDMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_MedicareSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Segment [Member]",
        "label": "Medicare Segment [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "MedicareSegmentMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_MedicareSupplementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Supplement [Member]",
        "label": "Medicare Supplement [Member]",
        "terseLabel": "Medicare Supplement"
       }
      }
     },
     "localname": "MedicareSupplementMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_MiscellaneousOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Miscellaneous Other",
        "label": "Miscellaneous Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "MiscellaneousOtherMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_NonQualifiedHealthPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Qualified Health Plans [Member]",
        "label": "Non-Qualified Health Plans [Member]",
        "terseLabel": "Non-Qualified Health Plans"
       }
      }
     },
     "localname": "NonQualifiedHealthPlansMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_NumberOfHealthInsuranceCarriers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Health Insurance Carriers",
        "label": "Number Of Health Insurance Carriers",
        "terseLabel": "Number of health insurance carriers (more than)"
       }
      }
     },
     "localname": "NumberOfHealthInsuranceCarriers",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ehth_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other [Member]",
        "label": "Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_OutOfPeriodAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Out-Of-Period Adjustments",
        "label": "Out-Of-Period Adjustments [Member]",
        "terseLabel": "Out-Of-Period Adjustments"
       }
      }
     },
     "localname": "OutOfPeriodAdjustmentsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_OverRecognitionOfLicensingCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Over-Recognition Of Licensing Costs",
        "label": "Over-Recognition Of Licensing Costs [Member]",
        "terseLabel": "Over-Recognition Of Licensing Costs"
       }
      }
     },
     "localname": "OverRecognitionOfLicensingCostsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_PreferredStockConvertibleStatedValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred Stock, Convertible, Stated Value",
        "label": "Preferred Stock, Convertible, Stated Value",
        "terseLabel": "Stated value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockConvertibleStatedValue",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ehth_PreferredStockDividendRateCashPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred Stock, Dividend Rate, Cash, Percentage",
        "label": "Preferred Stock, Dividend Rate, Cash, Percentage",
        "terseLabel": "Dividend rate, cash"
       }
      }
     },
     "localname": "PreferredStockDividendRateCashPercentage",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ehth_PreferredStockDividendRatePayableInKindPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred Stock, Dividend Rate, Payable-In-Kind, Percentage",
        "label": "Preferred Stock, Dividend Rate, Payable-In-Kind, Percentage",
        "terseLabel": "Dividend rate, payable-in-kind"
       }
      }
     },
     "localname": "PreferredStockDividendRatePayableInKindPercentage",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ehth_PrepaidLicenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Licenses",
        "label": "Prepaid Licenses",
        "terseLabel": "Prepaid licenses"
       }
      }
     },
     "localname": "PrepaidLicenses",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_PrepaidMaintenanceContractsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Maintenance Contracts (Current)",
        "label": "Prepaid Maintenance Contracts Current",
        "terseLabel": "Prepaid maintenance contracts"
       }
      }
     },
     "localname": "PrepaidMaintenanceContractsCurrent",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_PreviousRepurchaseProgramsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previous Repurchase Programs",
        "label": "Previous Repurchase Programs [Member]",
        "terseLabel": "Previous share repurchase programs"
       }
      }
     },
     "localname": "PreviousRepurchaseProgramsMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_QualifiedHealthPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Qualified Health Plans [Member]",
        "label": "Qualified Health Plans [Member]",
        "terseLabel": "Qualified Health Plans"
       }
      }
     },
     "localname": "QualifiedHealthPlansMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring And Related Cost, Number Of Positions Eliminated, Percentage Of Total Workforce",
        "label": "Restructuring And Related Cost, Number Of Positions Eliminated, Percentage Of Total Workforce",
        "terseLabel": "Percentage of total workforce"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentageOfTotalWorkforce",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ehth_RestructuringChargesPreTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges, Pre-Tax",
        "label": "Restructuring Charges, Pre-Tax",
        "terseLabel": "Pre-tax restructuring charges"
       }
      }
     },
     "localname": "RestructuringChargesPreTax",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_SaleOfStockConsiderationReceivedOnTransactionGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_SaleOfStockConsiderationReceivedOnTransaction",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Consideration Received On Transaction, Gross",
        "label": "Sale Of Stock, Consideration Received On Transaction, Gross",
        "terseLabel": "Gross proceeds"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransactionGross",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails",
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Long Lived Assets By Geographical Areas [Table Text Block]",
        "label": "Schedule Of Long Lived Assets By Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule Of Long Lived Assets By Geographical Areas"
       }
      }
     },
     "localname": "ScheduleOfLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ehth_ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Stock-Based Compensation Expense By Operating Function [Table Text Block]",
        "label": "Schedule Of Stock-Based Compensation Expense By Operating Function [Table Text Block]",
        "terseLabel": "Schedule Of Stock-Based Compensation Expense By Operating Function"
       }
      }
     },
     "localname": "ScheduleOfStockBasedCompensationExpenseByOperatingFunctionTableTextBlock",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ehth_ScheduleOfStockBasedCompensationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Stock-Based Compensation Expense [Table Text Block]",
        "label": "Schedule Of Stock-Based Compensation Expense [Table Text Block]",
        "terseLabel": "Schedule Of Stock-Based Compensation Expense By Award Type"
       }
      }
     },
     "localname": "ScheduleOfStockBasedCompensationExpenseTableTextBlock",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ehth_SeasonalityPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Seasonality Policy [Policy Text Block]",
        "label": "Seasonality Policy [Policy Text Block]",
        "terseLabel": "Seasonality"
       }
      }
     },
     "localname": "SeasonalityPolicyPolicyTextBlock",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ehth_SegmentOperatingIncomeLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Operating Income (Loss)",
        "label": "Segment Operating Income (Loss)",
        "terseLabel": "Segment profit (loss)"
       }
      }
     },
     "localname": "SegmentOperatingIncomeLoss",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_ShorttermMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term [Member]",
        "label": "Short-term [Member]",
        "terseLabel": "Short-term"
       }
      }
     },
     "localname": "ShorttermMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_SmallBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Small Business [Member]",
        "label": "Small Business [Member]",
        "terseLabel": "Small Business"
       }
      }
     },
     "localname": "SmallBusinessMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_SponsorshipAndAdvertisingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sponsorship And Advertising",
        "label": "Sponsorship And Advertising [Member]",
        "terseLabel": "Sponsorship and Advertising Revenue"
       }
      }
     },
     "localname": "SponsorshipAndAdvertisingMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_TechnologyAndContentExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total expense recognized in the period for technology and content. Technology and content expenses consist primarily of compensation and benefits costs for personnel associated with developing and enhancing our website technology as well as maintaining our website.",
        "label": "Technology And Content Expense",
        "terseLabel": "Technology and content"
       }
      }
     },
     "localname": "TechnologyAndContentExpense",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ehth_TechnologyAndContentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology And Content Expense [Member]",
        "label": "Technology And Content Expense [Member]",
        "terseLabel": "Technology and content"
       }
      }
     },
     "localname": "TechnologyAndContentExpenseMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares Outstanding, Shares Acquired, Previously Cancelled Vested Shares Withheld For Tax Purposes",
        "label": "Treasury Stock, Shares Outstanding, Shares Acquired, Previously Cancelled Vested Shares Withheld For Tax Purposes",
        "terseLabel": "Treasury shares that were previously surrendered by employees to satisfy tax withholdings (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesOutstandingSharesAcquiredPreviouslyCancelledVestedSharesWithheldForTaxPurposes",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ehth_UnderRecognitionOfStockBasedCompensationExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Under-Recognition Of Stock-Based Compensation Expense",
        "label": "Under-Recognition Of Stock-Based Compensation Expense [Member]",
        "terseLabel": "Under-Recognition Of Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "UnderRecognitionOfStockBasedCompensationExpenseMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_UnitedhealthcareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UnitedHealthcare [Member]",
        "label": "Unitedhealthcare [Member]",
        "terseLabel": "UnitedHealthcare"
       }
      }
     },
     "localname": "UnitedhealthcareMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ehth_VisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vision [Member]",
        "label": "Vision [Member]",
        "terseLabel": "Vision"
       }
      }
     },
     "localname": "VisionMember",
     "nsuri": "http://www.ehealthinsurance.com/20210930",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Person with designation of chief executive officer.",
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r107",
      "r160",
      "r173",
      "r174",
      "r175",
      "r176",
      "r178",
      "r180",
      "r184",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r287",
      "r288",
      "r290",
      "r292",
      "r293",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r107",
      "r160",
      "r173",
      "r174",
      "r175",
      "r176",
      "r178",
      "r180",
      "r184",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r287",
      "r288",
      "r290",
      "r292",
      "r293",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.",
        "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Rental Payments for Contractual Obligations"
       }
      }
     },
     "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r50",
      "r52",
      "r105",
      "r106",
      "r299",
      "r324",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r112",
      "r120",
      "r126",
      "r215",
      "r392",
      "r393",
      "r394",
      "r409",
      "r410",
      "r433",
      "r436",
      "r438",
      "r439",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "verboseLabel": "Cumulative effect from the adoption of ASU 2016-13"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r112",
      "r120",
      "r126",
      "r215",
      "r392",
      "r393",
      "r394",
      "r409",
      "r410",
      "r433",
      "r436",
      "r438",
      "r439",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period Of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r112",
      "r120",
      "r126",
      "r215",
      "r392",
      "r393",
      "r394",
      "r409",
      "r410",
      "r433",
      "r436",
      "r438",
      "r439",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period Of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r191",
      "r352",
      "r357",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r298",
      "r323",
      "r372",
      "r374",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r534",
      "r571",
      "r575",
      "r603",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails",
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r298",
      "r323",
      "r372",
      "r374",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r534",
      "r571",
      "r575",
      "r603",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails",
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r191",
      "r352",
      "r357",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r187",
      "r352",
      "r355",
      "r536",
      "r570",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r187",
      "r352",
      "r355",
      "r536",
      "r570",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r298",
      "r323",
      "r363",
      "r372",
      "r374",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r534",
      "r571",
      "r575",
      "r603",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails",
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r298",
      "r323",
      "r363",
      "r372",
      "r374",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r534",
      "r571",
      "r575",
      "r603",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails",
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r51",
      "r52",
      "r105",
      "r106",
      "r299",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r121",
      "r373",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.",
        "label": "Forecast [Member]",
        "terseLabel": "Scenario, Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails",
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r121",
      "r126",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario, Unspecified [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails",
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r188",
      "r189",
      "r352",
      "r356",
      "r573",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r622",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r188",
      "r189",
      "r352",
      "r356",
      "r573",
      "r591",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r622",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r121",
      "r126",
      "r267",
      "r373",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails",
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r193",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals.",
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r113",
      "r114",
      "r115",
      "r116",
      "r197",
      "r198",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r279",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r409",
      "r410",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r497",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r38",
      "r501"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r8",
      "r27",
      "r194",
      "r195"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r56",
      "r57",
      "r58",
      "r559",
      "r583",
      "r587"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r55",
      "r58",
      "r65",
      "r66",
      "r67",
      "r109",
      "r110",
      "r111",
      "r426",
      "r578",
      "r579",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r28",
      "r395",
      "r501"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r392",
      "r393",
      "r394",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForErrorCorrectionDomain": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r122",
      "r123",
      "r124",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of error correction.",
        "label": "Error Correction, Type [Domain]",
        "terseLabel": "Error Correction, Type [Domain]"
       }
      }
     },
     "localname": "AdjustmentsForErrorCorrectionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Repurchase of shares to satisfy employee tax withholding obligations"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r375",
      "r377",
      "r397",
      "r398"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r377",
      "r383",
      "r396"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense",
        "verboseLabel": "Credit to stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails",
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r91",
      "r241",
      "r243"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedTerseLabel": "Amortization of intangible assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r100",
      "r168",
      "r175",
      "r182",
      "r211",
      "r280",
      "r281",
      "r282",
      "r284",
      "r285",
      "r286",
      "r287",
      "r289",
      "r291",
      "r293",
      "r294",
      "r423",
      "r427",
      "r458",
      "r499",
      "r501",
      "r540",
      "r557"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r11",
      "r13",
      "r49",
      "r100",
      "r211",
      "r280",
      "r281",
      "r282",
      "r284",
      "r285",
      "r286",
      "r287",
      "r289",
      "r291",
      "r293",
      "r294",
      "r423",
      "r427",
      "r458",
      "r499",
      "r501"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r441"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets measured at fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r203"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in 1 year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r202",
      "r203",
      "r553"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in 1 year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r200",
      "r228"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 2.0,
       "parentTag": "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Short-term marketable securities",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Short-term marketable securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r378",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "auth_ref": [
      "r605",
      "r606"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for amortization of capitalized computer software costs.",
        "label": "Capitalized Computer Software, Amortization",
        "terseLabel": "Amortization of internally developed software"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r453",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r36",
      "r501",
      "r589",
      "r590"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r36",
      "r93"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 1.0,
       "parentTag": "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Cash and Cash Equivalents [Line Items]",
        "terseLabel": "Cash and Cash Equivalents [Line Items]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r87",
      "r93",
      "r97"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r87",
      "r467"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r333",
      "r334",
      "r335",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r45",
      "r266",
      "r545",
      "r563"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock": {
     "auth_ref": [
      "r265",
      "r274",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments, contingencies, and guarantees.",
        "label": "Commitments Contingencies and Guarantees [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsContingenciesAndGuaranteesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r109",
      "r110",
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r26",
      "r501"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r61",
      "r63",
      "r64",
      "r72",
      "r549",
      "r566"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r149",
      "r150",
      "r191",
      "r455",
      "r456",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r149",
      "r150",
      "r191",
      "r455",
      "r456",
      "r588",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r149",
      "r150",
      "r191",
      "r455",
      "r456",
      "r588",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r149",
      "r150",
      "r191",
      "r455",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "verboseLabel": "Major customer revenue, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r147",
      "r149",
      "r150",
      "r151",
      "r455",
      "r457",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r149",
      "r150",
      "r191",
      "r455",
      "r456",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss": {
     "auth_ref": [
      "r218",
      "r220",
      "r223",
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in allowance for credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Allowance for Credit Loss, Period Increase (Decrease)",
        "terseLabel": "Net change in credit loss allowance"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAllowanceForCreditLossPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetAllowanceForCreditLossRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Contract with Customer, Asset, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Contract with Customer, Asset, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAllowanceForCreditLossRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Schedule of Change in Allowance for Credit Loss"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAllowanceForCreditLossWriteoff": {
     "auth_ref": [
      "r222"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of writeoff of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, charged against allowance for credit loss.",
        "label": "Contract with Customer, Asset, Allowance for Credit Loss, Writeoff",
        "terseLabel": "Write-off"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAllowanceForCreditLossWriteoff",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of Contract Assets - Commissions Receivable"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetCreditLossExpense": {
     "auth_ref": [
      "r221",
      "r341",
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)",
        "negatedTerseLabel": "Change in allowance"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCreditLossExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofAllowanceforCreditLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r338",
      "r340",
      "r353"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r338",
      "r340",
      "r353"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "terseLabel": "Contract assets \u2013 commissions receivable \u2013 current"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetNoncurrent": {
     "auth_ref": [
      "r338",
      "r340",
      "r353"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Contract assets \u2013 commissions receivable \u2013 non-current"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r338",
      "r339",
      "r353"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.",
        "label": "Contractual Obligation",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "ContractualObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationDueInFourthYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Contractual Obligation, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "ContractualObligationDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationDueInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Contractual Obligation, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "ContractualObligationDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationDueInSecondYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Contractual Obligation, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "ContractualObligationDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationDueInThirdYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Contractual Obligation, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "ContractualObligationDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_ContractualObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contractual obligation to be paid in remainder of current fiscal year.",
        "label": "Contractual Obligation, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r94",
      "r95",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Shares converted (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r320",
      "r321",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible preferred stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate bond"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r176",
      "r178",
      "r184",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r76",
      "r100",
      "r211",
      "r280",
      "r281",
      "r282",
      "r285",
      "r286",
      "r287",
      "r289",
      "r291",
      "r293",
      "r294",
      "r458"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r148",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCreditRiskDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r99",
      "r107",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r315",
      "r316",
      "r479",
      "r541",
      "r542",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r43",
      "r99",
      "r107",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r315",
      "r316",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r43",
      "r99",
      "r107",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r328",
      "r329",
      "r330",
      "r331",
      "r476",
      "r477",
      "r479",
      "r480",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent": {
     "auth_ref": [
      "r201",
      "r228"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails": {
       "order": 2.0,
       "parentTag": "ehth_CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Amortized Cost, Current",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Summary of Unrealized Gains and Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r206",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of securities in net loss positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r37",
      "r302",
      "r478"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r91",
      "r101",
      "r407",
      "r413",
      "r414",
      "r415"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r400",
      "r401"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes \u2013 non-current"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Deposits": {
     "auth_ref": [
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.",
        "label": "Deposits",
        "terseLabel": "Deposits"
       }
      }
     },
     "localname": "Deposits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r91",
      "r244"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r91",
      "r163"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "negatedNetLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r352",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue by Segment"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net loss per share attributable to common stockholders:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r73",
      "r117",
      "r118",
      "r120",
      "r121",
      "r122",
      "r127",
      "r130",
      "r133",
      "r134",
      "r135",
      "r139",
      "r140",
      "r439",
      "r440",
      "r550",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Net loss attributable to common stockholders per share - basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails",
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r73",
      "r117",
      "r118",
      "r120",
      "r121",
      "r122",
      "r130",
      "r133",
      "r134",
      "r135",
      "r139",
      "r140",
      "r439",
      "r440",
      "r550",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Net loss attributable to common stockholders per share - diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails",
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net Loss Per Share Attributable to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholders"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r467"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails",
      "http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "auth_ref": [
      "r384"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Amount Capitalized",
        "terseLabel": "Amount capitalized in internal-use software"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash paid by the entity during the period to settle equity instruments granted under equity-based payment arrangements.",
        "label": "Share-based Payment Arrangement, Cash Used to Settle Award",
        "terseLabel": "Repurchase of shares to satisfy employee tax withholding obligations"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Common stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Major Customer [Line Items]",
        "terseLabel": "Revenue, Major Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r65",
      "r66",
      "r67",
      "r109",
      "r110",
      "r111",
      "r114",
      "r123",
      "r125",
      "r142",
      "r215",
      "r327",
      "r332",
      "r392",
      "r393",
      "r394",
      "r409",
      "r410",
      "r438",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r578",
      "r579",
      "r580",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r122",
      "r123",
      "r124",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of error correction.",
        "label": "Error Correction, Type [Axis]",
        "terseLabel": "Error Correction, Type [Axis]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "terseLabel": "Error Corrections and Prior Period Adjustments Restatement [Line Items]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r304",
      "r313",
      "r314",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r441",
      "r442",
      "r443",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique used to measure similar asset in prior period by class of asset or liability on non-recurring basis.",
        "label": "Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r441",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of Financial Assets Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r304",
      "r313",
      "r314",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r442",
      "r507",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r304",
      "r313",
      "r314",
      "r441",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r441",
      "r442",
      "r445",
      "r446",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r304",
      "r313",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r304",
      "r364",
      "r365",
      "r370",
      "r371",
      "r442",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r304",
      "r313",
      "r314",
      "r364",
      "r365",
      "r370",
      "r371",
      "r442",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r304",
      "r313",
      "r314",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r442",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r304",
      "r313",
      "r314",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r507",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r447",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r484",
      "r489"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedLabel": "Principal payments in connection with leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r204",
      "r205",
      "r208",
      "r209",
      "r210",
      "r219",
      "r224",
      "r225",
      "r226",
      "r227",
      "r230",
      "r231",
      "r232",
      "r233",
      "r312",
      "r326",
      "r429",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r237",
      "r238",
      "r501",
      "r539"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r69",
      "r168",
      "r174",
      "r178",
      "r181",
      "r184",
      "r537",
      "r546",
      "r551",
      "r568"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Loss before benefit from income taxes",
        "totalLabel": "Loss before benefit from income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r246",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r102",
      "r404",
      "r405",
      "r406",
      "r411",
      "r416",
      "r418",
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r103",
      "r124",
      "r125",
      "r166",
      "r402",
      "r412",
      "r417",
      "r569"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Benefit from income taxes",
        "terseLabel": "Benefit from income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/IncomeTaxesNarrativeDetails",
      "http://www.ehealthinsurance.com/role/IncomeTaxesSummaryofIncomeTaxBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r90",
      "r535"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseInCarryingAmountOfRedeemablePreferredStock": {
     "auth_ref": [
      "r319"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to retained earnings for the increase in carrying amount of redeemable preferred stock that is classified as temporary equity.",
        "label": "Increase in Carrying Amount of Redeemable Preferred Stock",
        "negatedTerseLabel": "Paid-in-kind dividend and accretion related to convertible preferred stock"
       }
      }
     },
     "localname": "IncreaseInCarryingAmountOfRedeemablePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r240",
      "r242"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Summary of Contractual Maturities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "verboseLabel": "Schedule of Operating Lease Maturities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r493"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r493"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r493"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r493"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r493"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r493"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r493"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year One",
        "terseLabel": "Sublease income, 2022"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year",
        "terseLabel": "Sublease income, remainder of 2021"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Two",
        "terseLabel": "Sublease income, 2023"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r40",
      "r100",
      "r176",
      "r211",
      "r280",
      "r281",
      "r282",
      "r285",
      "r286",
      "r287",
      "r289",
      "r291",
      "r293",
      "r294",
      "r424",
      "r427",
      "r428",
      "r458",
      "r499",
      "r500"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r33",
      "r100",
      "r211",
      "r458",
      "r501",
      "r543",
      "r561"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, convertible preferred stock, and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, convertible preferred stock, and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r42",
      "r100",
      "r211",
      "r280",
      "r281",
      "r282",
      "r285",
      "r286",
      "r287",
      "r289",
      "r291",
      "r293",
      "r294",
      "r424",
      "r427",
      "r428",
      "r458",
      "r499",
      "r500",
      "r501"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicenseMember": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.",
        "label": "License [Member]",
        "terseLabel": "License"
       }
      }
     },
     "localname": "LicenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r24",
      "r542",
      "r556"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Borrowings under line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "New claims filed"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising.",
        "label": "Marketing and Advertising Expense",
        "terseLabel": "Marketing and advertising"
       }
      }
     },
     "localname": "MarketingAndAdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r87",
      "r89",
      "r92"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r6",
      "r59",
      "r62",
      "r67",
      "r70",
      "r92",
      "r100",
      "r113",
      "r117",
      "r118",
      "r120",
      "r121",
      "r124",
      "r125",
      "r131",
      "r168",
      "r174",
      "r178",
      "r181",
      "r184",
      "r211",
      "r280",
      "r281",
      "r282",
      "r285",
      "r286",
      "r287",
      "r289",
      "r291",
      "r293",
      "r294",
      "r440",
      "r458",
      "r547",
      "r564"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "negatedLabel": "Change in net income (loss)",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r117",
      "r118",
      "r120",
      "r121",
      "r127",
      "r128",
      "r132",
      "r135",
      "r168",
      "r174",
      "r178",
      "r181",
      "r184"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net loss attributable to common stockholders",
        "verboseLabel": "Net loss attributable to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r189"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states in which the Company is licensed to market and sell health insurance"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "terseLabel": "Operating costs and expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r168",
      "r174",
      "r178",
      "r181",
      "r184"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r488",
      "r494"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Lease liabilities \u2013 current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease liabilities \u2013 non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r485",
      "r489"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash outflows related to operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r481"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r491",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate used to recognize operating lease right-of-use-assets"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r490",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term of operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r173",
      "r174",
      "r175",
      "r176",
      "r178",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Current",
        "terseLabel": "Others"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r421",
      "r422",
      "r425"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Unrealized holding gain (loss) for available for sales debt securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r60",
      "r63",
      "r65",
      "r66",
      "r68",
      "r71",
      "r327",
      "r468",
      "r473",
      "r474",
      "r548",
      "r565"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r15",
      "r16",
      "r41",
      "r501"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Acquisition-related contingent payments"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r86",
      "r251"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationRestructuringandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_SaleOfStockConsiderationReceivedOnTransaction",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Issuance costs",
        "verboseLabel": "Less: issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails",
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r79",
      "r81",
      "r199"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment and other assets"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToDevelopSoftware": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Develop Software",
        "negatedTerseLabel": "Capitalized internal-use software and website development costs"
       }
      }
     },
     "localname": "PaymentsToDevelopSoftware",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockConvertibleConversionPrice": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share conversion price of preferred stock.",
        "label": "Preferred Stock, Convertible, Conversion Price",
        "terseLabel": "Conversion rate (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockConvertibleConversionPrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock.",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "terseLabel": "Dividend rate"
       }
      }
     },
     "localname": "PreferredStockDividendRatePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred Stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockTextBlock": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.",
        "label": "Preferred Stock [Text Block]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "PreferredStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r11",
      "r34",
      "r35"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r9",
      "r12",
      "r235",
      "r236"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidInsurance": {
     "auth_ref": [
      "r10",
      "r12",
      "r234",
      "r236"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Insurance",
        "terseLabel": "Prepaid insurance"
       }
      }
     },
     "localname": "PrepaidInsurance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCommissionsReceived": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for commissions during the current period.",
        "label": "Proceeds from Commissions Received",
        "negatedTerseLabel": "Cash receipts"
       }
      }
     },
     "localname": "ProceedsFromCommissionsReceived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "terseLabel": "Proceeds from issuance of preferred stock, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r79",
      "r80",
      "r199"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from redemption and maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r83",
      "r387"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Net proceeds from exercise of common stock options and employee stock purchases"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r19",
      "r20",
      "r245",
      "r501",
      "r554",
      "r562"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r14",
      "r21",
      "r97",
      "r592"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r249",
      "r251",
      "r254",
      "r263",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Reorganization"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RestructuringandReorganization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected cost remaining for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost Remaining",
        "terseLabel": "Expected cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCostRemaining1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of positions eliminated during the period as a result of restructuring activities.",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated",
        "terseLabel": "Positions eliminated"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminated",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r91",
      "r248",
      "r257",
      "r260"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "negatedTerseLabel": "Restructuring and reorganization charges",
        "terseLabel": "Restructuring and reorganization charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationRestructuringandOtherLiabilitiesDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r251",
      "r258"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Accrued restructuring charges"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails",
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationRestructuringandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationRestructuringandOtherLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r29",
      "r332",
      "r395",
      "r501",
      "r560",
      "r582",
      "r587"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r109",
      "r110",
      "r111",
      "r114",
      "r123",
      "r125",
      "r215",
      "r392",
      "r393",
      "r394",
      "r409",
      "r410",
      "r438",
      "r578",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r159",
      "r160",
      "r173",
      "r179",
      "r180",
      "r187",
      "r188",
      "r191",
      "r350",
      "r352",
      "r536"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r149",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r354",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/DebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "totalLabel": "Net proceeds"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Sale of stock, shares issued (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntiDilutiveSharesExcludedfromComputationOfNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances.",
        "label": "Schedule of Cash and Cash Equivalents [Table]",
        "terseLabel": "Schedule of Cash and Cash Equivalents [Table]"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule Of Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule Of Components Of Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Computation of Basic and Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleofRevenuebyMajorCustomersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r122",
      "r123",
      "r124",
      "r125",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.",
        "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]",
        "terseLabel": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]"
       }
      }
     },
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule Of Prepaid Expenses And Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r18",
      "r97",
      "r538",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r250",
      "r251",
      "r252",
      "r253",
      "r260",
      "r261",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r255",
      "r256",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Summary of Restructuring and Other Related Liabilities"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RestructuringandReorganizationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
        "terseLabel": "Schedule Of Revenue By Major Customers"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r168",
      "r171",
      "r177",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r168",
      "r171",
      "r177",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r378",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r147",
      "r149",
      "r150",
      "r151",
      "r455",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Schedule of Credit Risk"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r155",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r173",
      "r174",
      "r175",
      "r176",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r184",
      "r191",
      "r253",
      "r262",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r155",
      "r157",
      "r158",
      "r168",
      "r172",
      "r178",
      "r182",
      "r183",
      "r184",
      "r185",
      "r187",
      "r190",
      "r191",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationScheduleOfLongLivedAssetsByGeographicalAreaDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Marketing and advertising"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r376",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": {
     "auth_ref": [
      "r382"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount",
        "totalLabel": "Total stock-based compensation"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityScheduleofStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r337",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-based Payments [Text Block]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "terseLabel": "Repurchase of shares to satisfy employee tax withholding obligations (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r98",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Business and Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r5",
      "r155",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r173",
      "r174",
      "r175",
      "r176",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r184",
      "r191",
      "r239",
      "r247",
      "r253",
      "r262",
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/RevenueCommissionRevenuebySegmentDetails",
      "http://www.ehealthinsurance.com/role/SegmentandGeographicInformationSegmentOperatingResultsDetails",
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformationScheduleofCommissionsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r48",
      "r65",
      "r66",
      "r67",
      "r109",
      "r110",
      "r111",
      "r114",
      "r123",
      "r125",
      "r142",
      "r215",
      "r327",
      "r332",
      "r392",
      "r393",
      "r394",
      "r409",
      "r410",
      "r438",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r578",
      "r579",
      "r580",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Balance Sheet Impact"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Comprehensive loss:"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r109",
      "r110",
      "r111",
      "r142",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r25",
      "r26",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Settlement of earnout liability (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r25",
      "r26",
      "r327",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock for employee stock purchase program (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r25",
      "r26",
      "r327",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Shares issued in equity offering (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r26",
      "r327",
      "r332",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Issuance of common stock in connection with equity incentive plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r48",
      "r327",
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Settlement of earnout liability"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r25",
      "r26",
      "r327",
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock for employee stock purchase program"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r25",
      "r26",
      "r327",
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Shares issued in equity offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r48",
      "r327",
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock in connection with equity incentive plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r26",
      "r31",
      "r32",
      "r100",
      "r196",
      "r211",
      "r458",
      "r501"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r475",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r475",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r475",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Supplemental Financial Statement Information"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SupplementalFinancialStatementInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TemporaryEquityAccretionOfDividends": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity during the period due to unpaid dividends.",
        "label": "Temporary Equity, Accretion of Dividends",
        "verboseLabel": "Accrued paid-in-kind dividends"
       }
      }
     },
     "localname": "TemporaryEquityAccretionOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity to its redemption value during the period.",
        "label": "Temporary Equity, Accretion to Redemption Value",
        "terseLabel": "Change in preferred stock redemption value"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.",
        "label": "Temporary Equity, Accretion to Redemption Value, Adjustment",
        "negatedTerseLabel": "Change in preferred stock redemption value"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r17",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity, by Class of Stock [Table]",
        "terseLabel": "Temporary Equity, by Class of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r280",
      "r285",
      "r286",
      "r287",
      "r293",
      "r294"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Balance as of September 30, 2021",
        "periodStartLabel": "Balance as of Closing Date",
        "terseLabel": "Carrying amount",
        "verboseLabel": "Convertible preferred stock"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails",
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockSummaryofStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityDividendsAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accretion of temporary equity during the period due to cash, stock, and in-kind dividends. This item is an adjustment to net income necessary to derive net income apportioned to common stockholders and is to be distinguished from Temporary Equity, Accretion of Dividends (Temporary Equity, Accretion of Dividends).",
        "label": "Temporary Equity, Dividends, Adjustment",
        "negatedTerseLabel": "Paid-in-kind dividends for preferred stock"
       }
      }
     },
     "localname": "TemporaryEquityDividendsAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]",
        "terseLabel": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r17",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity [Table Text Block]",
        "terseLabel": "Summary of Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/ConvertiblePreferredStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r204",
      "r205",
      "r208",
      "r209",
      "r210",
      "r312",
      "r326",
      "r429",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r47",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r47",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r26",
      "r327",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Number of shares repurchased under share repurchase plan (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/EquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r47",
      "r333",
      "r336"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r104",
      "r364",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "Agency bonds"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsSummaryofFinancialAssetsDetails",
      "http://www.ehealthinsurance.com/role/FairValueMeasurementsUnrealizedGainsandLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r143",
      "r144",
      "r145",
      "r146",
      "r152",
      "r153",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Significant Accounting Policies, Estimates and Judgments"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/SummaryofBusinessandSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r129",
      "r135"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Shares used in diluted share calculation (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average number of shares used in per share amounts:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r127",
      "r135"
     ],
     "calculation": {
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Shares used in per share calculation - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.ehealthinsurance.com/role/NetLossPerShareAttributabletoCommonStockholdersComputationofBasicandDilutedNetLossperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "http://asc.fasb.org/topic&trid=2155896"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 3.C)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177168-122764"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(k)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.12)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756"
  },
  "r607": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r608": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r609": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r610": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r611": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r612": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r613": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r614": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r615": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r616": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r617": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r618": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r619": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "303",
   "Subparagraph": "(5)"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r620": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r621": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03"
  },
  "r622": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r623": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r624": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r625": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r626": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r627": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r628": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r629": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r630": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r631": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r632": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r633": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r634": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r635": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r636": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r637": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r638": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r639": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r640": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r641": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r642": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r643": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>85
<FILENAME>0001333493-21-000167-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001333493-21-000167-xbrl.zip
M4$L#!!0    ( *:+:%.YX.@;^P<  ' H   0    83(P,C%Q,V5X,S$Q+FAT
M;=U:77/;MA)]O[\"E>>FR8R^*,D?D1W/N+8SU4SKM(XZF?MT!R1 "6.08 %0
MLOKK[P% 69(EU_*UFRCV RT2B\4N]N#L N3)#Q>?SH?_^>V2C&TFR6]__/3+
MX)S4&JW6E^YYJW4QO" _#W_]A?2:[8@,-<V-L$+E5+9:EU<U4AM;6_1;K>ET
MVIQVFTJ/6L/KEE/5:TFE#&\RRVJG)^X)KIRRTW^=_-!HD N5E!G/+4DTIY8S
M4AJ1C\@7QLT-:30JJ7-5S+08C2WIM#L1^:+TC9C0T&Z%E?QTKN>D%>Y/6GZ0
MDUBQV>D)$Q,BV(>:2 \/63OJO8\[<=KK=/A1.^IV#@\/#CII='C0COX;P<@6
MQ$,?8V>2?ZAE(F^,N1N_?]@I[/%4,#ON1^WVOVLK<I;?V@:58I3WO;5H355N
M886&UO!S73G5(^BWJNCO0_=]'>&!R!F<\Z/_DTKGW1,EE>[OM?W?L6MII#03
M<M;_<2@R;L@5GY)KE='\Q[H!%AJ&:Y$&02/^XI@;C.IOI]6\08\4.9_/8]1Q
MDW=Y.Q:QL*0;-:-57Q[R*%;6JLP[];"/"=SB>E></+^\'@X^#L[/AH-/5X]%
MK/+OX"M8V]MH[:!./F)Y)\*0STH8"X5UDG!M13HC=DSMF[W]H^/MW3@N*&-8
MT@W)4XQQ5*R"K^&>?"-7H^;<C:\_^KUI:3?WW30,R)A..-%\(O@49&C'",/O
M)=6 LYR1:UXH;8G*R4>E,Q*U&[\3E1+^,Z?2CNMDD"=-A.?]ZPA/9^?"\Q,U
M" JF/YN1FUQ-)6<C7@]1TB$V3,&$7"&?800J<D+S&2ESJTL.#Y#A?+)#T"C)
M<*<%E22E"1YIHC)0H55!;DT@YPDWANJ9$\GH#<>X2SH-GC$8@R&ESY08PPDD
M0B,S0BQ'=UC"N";3L4C&Q)3NLN@_Y9I72IP#F3 2*=1EXZFP8SAH"IYX YW>
M J8I!C<GZ,9(/%N>AM<#PN[W T).4I$[Y@9B%F&M X$01[->:A=Y"@:AKH3#
M[T26##H!G:48U@$[X5BG0.0=:!V8I5R@L@*$N3<T@,]\;5AW$J6$ *"H@!<_
MG/'V)-2,22K5U,QQJOD(V0:9QQ+J'@:[865]"6YF;LR:M:\'<;V=0]QP)3QO
M]HXZT>&QJ3!5E0:.)E2:"MSZP T(U=Q#!"$7L>0NE(0#E[$49NS$G5@&BG0T
MZ>Z9,(E4ID0_1YY:R8"50JN$,SPVY"V@P3BP%N)_>9N,:3[BY R\=%U*2$1=
MVHCVW_)WOFNTS\)=N!6N+,P#1IU^XLAK";H!2LZ6K0=*5P9*,9#S\SZ@(>$2
M^[-*I^[!#H&4[@Y(HV;[T,W#!3>H_1$OG]<>!U/=I=R$EF;[+B[WQ1S J$8*
MV525&@I 4!-A/.U!BN=>CZN7%X2Y3+J:2^J15J73!5KJ%2&[1@'RA"U&2<'\
M[MB4L1%,4"V< R(D?9\&<J>I-"X1^X5I?-;V)(GM-PS"OMAW*E!-BJ24U'$[
MW/)&+!(Z>H3R8+FJP:^8.T'0+_IS]BRZW2DDQ[N#Y(IN5X&\-6>MX7E[MML:
MUE@*$\$<6JE1.76T3@V0[HI+!V&JV1Q. +B@L9#"SER*WS2L6UP>>1Y485VL
MB"X5ISY[W%8.%:4N &KC2Y(D49IY WR9.N(Y*@T);*.%%V[1.!&4X &_6%RB
M (&_'@0GNX/@.1=?3J@L/6&Y^/(T19TH)HB,V5#OW1446Q!PN-U< GK$HB/(
MTX1",U:E?=B";5($O9/FKHI.']_ZD'A>G_M%R,-,P!X/.#? JP =VQW0S6DS
MA',=%FX'7I5OOF4C]IY EBZGJR0IM0O^4@+=H#53QN*Y.X^$+I- T9_A-(>\
M?:!+"A2#QNY)5X9CV\3]X8$[5\C+.[O>!:O&U-Q5&XX />HY\YG!ST?%VC,B
MQ0V7U4G"/?GZLZ?HV4C?J?W8_LXA_?_;C_F3139?)/4%3SG:7 ;J@K(<U)Y0
M?ZR5LG>F492S5FESE_+] ZC,,F$MYW^3%&*%HL*U,P'[O)*W@#,XV#B.QW]7
M5,_7(/^S%##?K[<R3_R!P[MG;;OV>SN$Q1W<=IU)U&FH&P6PYO:Z;M><" YP
M5.GZ;OLSY?3&Y=]0M_D,["M.?_0Y/QYZ$N2JG4HX:=C ;92AH^%WU/8@/*LZ
M%5V ,923]5 $&%0 ILR $,R2=Z9**1L/TIY->SL%M=W;%YTACZ<:S%%'W+DG
M.R#''U57$*N'-"CRB9(3[G)A3D?5B;NN^)%GA50SCM;I6 52I"L !N!>I%!H
MKL'@"2]NER"R])HSO!6T?M]5R<= *]<-Q$72PO#^_,<QF+Z0=-87N9]=W^EX
M_27JQ*4+5!K5FU./OM"\>,O=;(<WW19V6S8?N6IN^J:69>MMO>91Y_V#K>UF
M]&#;WVF-#F'/T8NK[47-@Z.75]OM@"?WMU+;\O,;YAAA- 7-/]2ZM7F':DWT
M.\4MB5;?=[MELA9)5=2>BJROO-(]JBZP=C<DZ/ELO=1$? O7KD -60QV.*K[
M[U;N/'S<M[;SK/8ZIN'-7@_$Z:]O]J*#]H;KQ^NSJ_/!9_+YT^#S\->SJY69
MVG)=/&'*7E:THF"WC"!+_&$MF4_KO2@1_[_]>+C",OU&$;O_ <AW%8[O<L;/
MQX*GY/*6)Z4[IB*?PM9M?>);/I$_L:A8_G:M4.'+O7YX S'A#W[-5F6*]J(+
MC0'NTJYW>="(E6OX%L]_%7CZ/U!+ P04    " "FBVA3_J^]+0\(  ##*
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MK$N_,?F4D*(9D"S\:G)S8HI"KQ?:0Y-&M77:?K@Y3WF6Y.MTG=8_\/K!P^3
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MZDI$X>J!=JYQ\MXZ2E5=L&2#OJ+IN;/JQM:N;D;=D&735YGJ5S':'%MBTS)
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M735797%%BHG>,I#F@"FA+WWDKD](LKS57%^#7(\F/RA"LU-:;>1T&BX*<J0
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M3B-!!+"L+=?5$L0X(?(Y#$!K# ?AU0R0$0&3-:WR<O,2U*:KZ8E-Q?I<0AA
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MA,C$WN1D4H3HP&2+16)@YNPE]<W;!D7D;1IWK;A; P=B\0DL REW0W4E!D]
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M\\5,SWHM&QQV:]$L*/@$G@Q49[-(R>"32X5:\D.:Y3L B%<2?3-FX]!P*#F
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M%A%<=3FWTC/B!+42-%Y&#3C7&["NZ*Q/U( O5S]P:>JGEIR10]!&I?E'R]3
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MGV'H3^\;M%IAXYT?=?.I8/(RPH9FU">O10K+*+\UZ"<->G!!@69?I7<3CX*
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MZ^.'/^_OWMM[L_OVI7M^\)/9>?BCZ7;=>7MXM//LL(]^N'\%-L 5P\A"G]F
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MQVU]O74FI]58'!.!O+F0QWX<%B:Z Q,=SI@7-CF%(W=(>*$R$S%DB#0H@A1
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M.Y+.VTMUGL1((3U'2?%,.LXB$[% G"81079"2][<9+0%#DF-')$24UA#(Z&
M=RG@G5H,SH8$<E'(@YV/N-8161D$DD829SF16N=N7K+%19V: C^]YAK7FPYW
M/D#\F =2S??LCX5_5]@YI!#N7(3K9ZVE0$.2SDLD972YHEX@9[Q&%%NL+?4B
M29-[.!-A6A(ORTN['18>.-Y2R*R0V>H;HQ0RFY?,IM9CX$(:137PF+2(*RN1
M,0*<0$FQU$[*)'PF,\QQ"]-[[XJR"M-RK<:.OVI;U^Y4<YQ:&6#5K>5ZE]-^
M3!&<I[S8/?^IU:A.)5<_'_<ZL+J#J@^*^K4ZJ3P\FV]R.8.E#[U1_J(?CA)?
MYO3RVW[GXQM?WID*N<PP?_@94J?V[+H!4@O'ANKVP&5 \,K'8?TQ5JW2RNT.
MALO'2[T)A#4Z)B\0X4PA[KQ"+ELO%NR1Y*3V7 0P7,!JT0L7Y=8O9EVXZ%%R
MT4HG>Q4N6HR+9IPHHV*RGB&J<T0H6HJ,5.!)$<8$)99ZXZI&]8;6J?_:4QKK
M!4K?'^7SA;V3W.'=5DC,'I.+W9C:BS6[?M19P9781SLGIYW>68QO8L<.8YCQ
M>@L]W86>=B[5 /+HO, 1)4<EXC8J9)7QH%C4$J&X$CG&0W$+9%RCFJ)2 [B&
MQD4!\M*!/+4S#/.1*4^1B)R,IX<"F"6B-&F#C0PD-[ &( N^K$AMC8H#U\K.
M.+']3['JE70^P:O4##Z$@1&/A\?/)D+9.Y?)9,I/21S-QT676B*)J(D#,2%E
MG0"?QPBD0^ ()XN9%$&:I)N;A+2H+.<0'R]X[]6H*.!=*GBGAH2VD@1#/,(X
M9WT#2\CFHP:"J)BB2\S&G/55+:77J!72(V@*N<81EJI=V6PJL\Q&KX,!='U;
MN7._[*QX97<ATTL-&<#@<4(%BSS)T5\K([*, Z/Z1*GRDB8JFINB)12ND5-6
MHBMK9 @5$-\/B*<6$34\)J\\4BHDQ)64".3G$(Y, 7Z3!?LH@Y@L;3)8B:S,
MA\7M\WJW?OP<NZ,KY3G%)7OHF5Z%CQ;BHTM]&R@5GF/OD9%:(DZ50<X'B@18
M&@(KQHPD57F+X.5(YN/%\MVMB@+7^X?K3$ %;'\NP/)W/('Y8+#)9X(P"B(F
MIH(AE)OF)L-K%$UY5,&)<?,&?[7>N@0E'KR30\D1+\A$EWHYX) \4]J#^R(=
M& Y<(XV313+Z@'.X-TAP9#C8#;)&CDR)1M3%;BCH73UZ+U62,LPP1U'9@+A2
M%EFN$E(J.9$$#]C2W&E:BH6M_KJ&(=:BE\.R+(G)0MQZ2ORC(ZJ5F!F%HQ;D
MJ$O]#Q*U,BGMP,.A%#@J,F0U_*&)33'(8&7PS4U)6YPMZ^3-K?&Q1G&+IXOY
ME1@G!?.+8WZF4[677%(P1"S);2D]%<@H(9'24>+(1 !3HKFI>8LO+<1Q[YA_
M GVL+W(F[:[OG<3&T'Z=J<L &:%2FU$#^^1<3+N5E([LUQGR*N./YR6N#[/&
M2A3>D'SVQ6H/QHH38*=0KY%U@08F"9'>-3<%;1%=1I@_7ABOQ.0H,%XRC*?V
MA\?.<,PI\EQXQ!FCR"D?D38I616E$EXT-Q5M,?(( R-U-C%N+OM<U+QX"OG=
MARS]+.UW[\A,GV8-#!^I95%JY)/+W2"]0(YR 8JE&571TE!E?E6+L#HE?TNA
MQAH:& 7(2P?R3 D'4"].#B.)0PYQ!(PT&!9(8"\BCR& %]'<Y*3%RC2NARC>
MF#$G2@%';4R+[U+ A8KN1D7?+O4V8^#:**N!@+0EN1@]UW!(CJ3D/#))@(YX
MKN%0B]=^EIA%;0'\(#4<!<!W!_",+6%$X-I$%*E)"#3!(4L$_(J=)]:S/-TS
M YC5ZDC8TROCN._RC<=-4*NNW2B,-!<C7>H!1HG!A!"-%),1<1DI,BHQ)(PU
MC"@6M0.3@@C9$OC>JS;6-8+Q1'&^ZGJ-@O-Y<3Y3J$&]III+1(S2X#IHBJS+
MOW(? [5*!A]RBS#:XG(]</X$ AS/>R<G[>%)S,WG<T_2C#ZX]=CU/S),[N!C
MW<_>_G70?M9M=_ZW.>R/XM639Q?/MM4-SV>?K*#[%NB^U'2+JA %=10%:3#B
MD7FDE>%(Q@A;.G:8NZKWS'>POA___%[U;YX]I^C?_>K?S/$$2UG"P2$LO$ \
M8(*L40Q)( <&_^Z%<#?JWQ-(AC^_>4!/28$_I!=Y%$].>WW;/]NIAB$]M_W^
M&:SHUDGNA+\U'/;;;C3,W?"/>G_8$OV:FR7V9G<IPX+$4A"D=<ZD,8^1]MXC
M9Q6E'F/C% 8;E(H6+SGQ1XSLY?B-J?TU!O0M]GL%U"L']<R8:>5)U+#A YPY
MXD(8Y&3BR&&-/3/$" :F9U7[17^M$:@?S[2XPQMG^Y6A<0_JNO>ZQ<2[)Q/O
MJB_7ZU8X^,MVLJ]7^'P./K_48$JJQ%-B%G0C1C#2+$/:!HUD))82!Y0>;7.S
MV&>/&);+:RY58+D8+&<..@ ?8D89(LZ"F2591,"2&$FKM;2"8TMHS6#YE/I(
M;<$MY^6VG<:I;0?4[C:\/6T/;:?4(3[H?-4+N?P!8MGM/A\+I3#17$QTJ9&4
MM5)881S2U,;<2,HAIZU#3(*=8*STG)+FIN*\I1:?L%K*$&N+W]7,)"WX70Y^
MIY8$;._16H&1B;GBARN"M'(4@66O0G($IQ#SD4G2PF3A"3UUK4*LN3EQU(]V
M,.J?C>,'K88=PB,/GMAQR9_J9DR<2Z5X-'?DH4OMHJCU+ED>\T$JAS@S!-DD
M#)*88X^]Q\J;YB8QIF7,5;?FYQ)H> 2P78D-46"[.&QGS <1B2"<(F>I //!
M*&3RY.#H%=:))D-%W6#[E (1;^+0PC^&1K3]+MQ\.0?YH";#N3AV)M+8\GYT
M,JI&(&_'U/;MDGN>CXLN-7%RCG.!54!"48NXT0%90@DR3&-&C)0!YX(21EN"
M+'PVNX0B:@OEE9@1!<K+A_*,68&55 XLBB0X1SP1F\O"> Y-R&!#4C;QYB8C
MLD5$G1JR/:6HQ(S&-WKCP1F]D]-^/([=0?MSG#23?%I!B@>H=I@10W5*^_FL
M$,8]YE[U!KFSW$$ZLE\+*\W%2I\N#S-/CBCE$(@IYKKVF,?W$*13Y#Z)P%BL
M6*E.:=<2I*B+<5%@NU+8S@SM9%(8:SV*)L^Z\58BXX1%+&*J5*3,RMQ[32S<
M9*&N08JU:+(PN+%N=9&8Q=-MG[^2@,9LL?&XO+X0U1Q$M;]]N:$3>#8^>84(
M<[FJ2QID.%9(*B\593K$Y)N;2JF6E&1)7D]M9F8L,;KQ=$&_DM!' ?WBH)]:
M)U8%8X@R**9\8H9&C32A"05,O11,<AE5<U,SU1)B8<=B5:!?9AR$U?S S94>
M4:V,R9L.^+:JU@VW-W9NV55CO #/&*Q9Z(WR]YX_]V)D6+>@TW\_X/H\EDUB
MU0VYMKJA;!D+;AF7NG0YFZAB#J, XLM)]X <9PP)$37XN,J28)N;I$6$:4F\
M<-7>TI'TP+&L0JF%4M?1[BZ4NFQ*G5KA@FA!N4WYH'H UQLHU>;)V#90DI*6
MCD6=*15SW,*4/AI*K0SU7ZKV!_!W:'_>_%?UQU+AIL[A5GW@LURRW_8_!B#-
M 'P__N]B52_?WN:_7/^7S1M>7/Z]__!._V_FBM3K#;N]85Q+\'7B[V_.WOT=
M3AWE\F#[Q3'<&]VCK[\<O/SK>'_[[=?];Y_HNX]_XKV7KW$&T]ZWSLG>42?M
M?=RB[T7 /'@M$.'Y/**.'#F"&=@F3D@69? L9*X;+]";7A;-\7!X^NR77[Y\
M^;+QU?4[&[W^AU\HQNR7/KS\R_E[FYN',3;V\[*2BYE!AZ.3$]L_:_12X[?1
M *0Q&'?$.P0%;R=0]NZPL>5];O ! &G\ ; 9]\B;D=)-FO-#M;KAQ7-MF\&>
MC[ ]])>]<9D[(NGH.#:LS_EYV\W-3QIY!6#-^O#/W48;;O5#OSJLV!_F11T>
MQT',.UR(W4&L.@U6U%/E^E.[:[N^787LX1^JGFD;-R[)Y#8$ASL_[0VJXSO/
M^K%CA^W/\=<O[3 \/M]N9ZZ:,"*>7F(=W,%H>/,E][[V!-^*"MC<VG%'I;KN
MLMD_\T=43&1E4%$[AQ-/7"2MDU0J2)^P],3I])Z8YOE%Q_UISXX/$;E^M)^0
M3?"MSVSGBST;-'^Y=',G[>[YXRL*Z_.]=/[I5A]4@%?B.94 =W[?V7IU]'NK
ML;O_?..[?;VN]_S\ .R9_<.=[0;\='CP:G=[ZPA^.3R"O_9V]H\.&P<OX*6]
M/][ T^T?[OZUTWAU<'AXXW,!NWX R4Y@J"X[, _ZI#^UNT!/O1%\1ABT&O&K
MCV#ZG$;0V^.*SJJV3O#*J&M'H0V$=5%D7EDY4X:I+"NX[8X]'<1GYS_\&MJ#
MTXX]>];N5E]>7?3KY?40IU>LJFIYQB]/,;"!QSB8!$(GWSQY>:-ZZ3M+<?R:
M4!N:Z!M?QAODQM=^]+%Z0QIQIT_]\6M,\[6Y5W#2UN9>[VM=S:T^]98=L6[,
MTYG;-,\:4TFMHOG'?; W]^!]QX/&#AA 8%4"P\03!Q3#<*NQC"9::[HV^_ O
MMUZ:1?5G)L WAQ-<[P7,<?7;-.J^S0,_M87#R^U>]ZC6IBC54I1J'9I FEL]
MVIOX.79'\38='Y>E%\M6H0?XREH)]OJ<Q/5QYK(V-ZS-4L_C\ U1[P6HAA@,
M!NU>=Y&2Y0=.6M[N4>=.6M8A[7B[1YLC[8BI8E@9RY2C/!GF0C0^L1!E(D1;
M_7Z[JN10F*"EG%ZN-I47_=Y)'I"1[^_O]O#X^6@ :Q7[.U]]9Y37>&LPB/#_
MH4['%@X.S[,BX7C_V[\_P6>S@[_W\/ZW-Q_??0SMO8][>._CBY/]CV_:>W__
M^_CM-_]E)B5)WWW\].7@Y9N3MR=O/NU_?'WV;GM/P'VRO9-W[8.C+;;W\J]/
M;X_>G5Q-2;X[@=?YNY?OVN]>YI3DOS_M??OTY=U'?_;N9%?L;?LO[_Y^ \_R
M+EVD(P_QE_?86.DTU@@+QA%G3B#KM$=))Z,YYXY1U=P4ID7,PJ7 ]3MN5/CJ
M4?(5<UIRJR/!DG'OF9:!1NZ(DS(IYDW%5_B<KW#AJ[KSU;<+OB(*A$NB!\%)
MC'@(&CG*#'*>2:L]UEC(YJ9B+<&7-5"N\%7AJ_OEJ^2HI-J;((CEDC!CC$CP
M?S)A'H&V)O85*?;5FO 5N>"K +N,TIHA23D!OB(2:4X(,CH1 0)-@OKF)E6R
MA:4LA%4(:RT(2S#&K>2)4]AF=>#6BA"PD1)3EFP0$P.+% -K30B+71 6BTP2
M:QRBL \AK@)&)DB-J'9 95Q''",0EF MH^M$6$L]R5[[$%S5R^&Q--E;.CUY
MKZ2U/'JG+:>..:=9M,9&0[%Q.)5XU3K1T_[SF7@5"X8:YPRRAD3$#:=("X81
MMDZ9Q#BA3#4W>4O1.G41?^*M]Y8.<)XDX4FSQ!SAUD<'YD?PBAI%@Y=4E #/
MF@%\&N#1"3-MI41,1XMXU8V/*H>DCQ0\8A.BRO8';BF^<".=@O#:(IQXHN')
M)<?)<2:T4]P:V*L3>!V@(J:$1-8,X=.02"0RB&A@"\_@S@)&FEB"E&+6>VPI
MH8!PHENRM,]]Q C/"66PY!(-.<^(B0E:>L*5)X0[85*)(:P9PJ<Q!&N=2=Q(
MA%.0B#N<FV-[@H3E1JMDA*4A=\)K<;7P$=?Z==6M1]S@1TUD^F,P+-(S=VUZ
M7RT_N&"I-HI)PZ+B47LGP>D0FH0D@<ZB+,&%M>*MPYG@ O5&N&@I,M0$Q ,E
MR%',$!84B^AIA!VKN2E9RY!E)9?7I9E)X89;]>=(W)'@5:"2\*B,2<Y9IU+"
MGCJ>2(E+K!DWS,0E-,><28XL310!\1NDJ4_(PWY@*8X.:]O<-+Q%%Y\_^A2Y
MX7$3 R8N*(IEQ"1QF7-IC.:Y59:*2*UB)9RQ9L0P#6=0EP0SQ" L\V@R0S2R
M22D4M4LRUZ2Y"$8#!6:0>N$9(G.AZ#'0PJ-GABAQC%J*(#SEN6V&P9$9$Y0G
MV'-G2AADS9AAII3"2<V%EDBHG,J0.5<)LD7",L)U<!2('IA!FQ9?O.7NJFR&
M)=59U#E(<G :^[;JZ)3''X];/L6OI[E'T>!61QWO'!,NGU&?SWAJ9_H&54NN
M)80&UV^[GF=X\!+"?P-X7OCI^[TYB^ @37;HLNO.L^O.GF@+EM"@@T&1,G#4
M7<)(*TF0TDPF''E47N8"QGI,"7[B<[/J&($KJ%P:*J?A,V8B5CXHQ&($+SEQ
MCD!!%5C%.# F*:%2-S>Y7E;+VX+-^F%SM4&P MP%@#L-;ZGD07\<0]XEAKA.
M$5D%P!7&>H83C3*$W+&:$E6@^VBAN]HH58'N M"=QI^$CUX)F5"BQ").E$,&
MO!<DE;8B):T<XV )MP"D-8+NTSK(LV?[GV(5:\I1)ANJ6QO [^5P3RWJ;R[D
ML]4-6U/I[(S#@86;YN"F@]ES/)3&X*P$1G(*N"D8@D!X#('[YIBFV!H"7CIG
M+;:X75&*@&L+YM46S!0P+Q/,4^=>68]UT :1\9EA#\Z]4@()':CU)G*A?7.3
ML1;'"V? "YAK"^;5^O<%S,L$\]3A]\JDF(Q!3F:'GTJ&#&<!D9A8Q(8[+ PX
M_$RW5*VJ]PN:U]GE+VA>)IJG,0 :$J8I47#ZB4+<28*,, +1:+6/G(/;S@'-
MF+<PKQ.:GUCV?5)_U?#C45FA$;O]7J>3AUX]K51\[0(!\7AX_.Q</L]!/$!0
M.Q?"*?QT!WZ:/7+#A-/,4P'>O\_9^LB1EL0BF20/#'8@H5+."[:,J%.WH9)?
M6,<X0,'R/6!Y&@80V$ENJ$$!9(2XP 89PP-BX [ZP(7QBHQC>HN;&@7+M<7R
M:L( !<OW@.69* !5FEAID-?YN)LT@&42'7)4:J:"-S%CF5#2XKI.V<,"YG6,
M A0PWP.8IT& J),*B7#$(]$YI!<14'1"D7BL->%*R2H(0%KXFKK84@JP&E0>
M17_<A:_Z<%9% "H8WM']?PKQR16Z_U/) "\]'\NED-(=&@T?;65"&GO_6^\-
ME>#M48Z"SI7 UG)DN,&(&.+!4@37+[BJU1\(N4:AR9)H6%O?OP!YB4 ^NP!R
M(E((SDQ.%&+$4Y3(>8I1C)*R:*QU(M<(JY94I2OOXP7R"AW_ N3E 7E_NB.3
MX%SRR2$07$"<VX2,H!HQR22GQ,GDX[@!EEDX&E^ 7%L@K]#I+T!>(I"G.[+%
M-BHI)9*$>L0UL\@P\/BQ!SB;8,'[S^6ULJ46'^)1LOYW1.3+V(U]VYE4_I^T
MN^W!,#>>^/S$CM_7SND_+TJ:"*@J29H53R&HNQ#4SJSO[ZV35CF'C$P"<2H(
MT@D[%*SR43$J#<DN@VS)Q=O\E_1";?&\VOK_@N<EXWEJ< C!3"!5OC HQ!G7
M2!M&D<(Z!:JU"B;G"TW+E-S_(\;S:H\ %#PO%\\SD0#L'/'2,Q1A)T8\:(&,
ML191%CF)A%*G:7-3J)8F!<^/%\^K/010\+QD/,_LSY83SL#*EBE&L+<-!<M;
M"A253T2E0#S)D3W<8GA9K2A+!<"\P-PZZ<&]?+,5*GNIT>X.;?=#VW5BPPX&
M<3@HQ0#W%Q>X3$6SHCA(NQ>"V*KD4)AH+B;:G?7\%1&)""\1ML8CGE2N_3<:
M>>*]#<K1J'E565BCN&1),-3.[2]PO4^X3@T'0Z(2BE!$A#&(.YH0:&9$F$@K
M*9B!C*7<Q+ITZ7B\<%V"5U_@>H]PG?';E9*"&8Z1B/F\+W$,.:T"PB!!H:TB
MSN4^FZ1.6;\"UW5VV@N6EXOEZ=9+!7:$48$8EP%\=L"RIH&BI(S7WBN6**]:
M;^(Z;;[_X+*']N"T8\_RS<8?$T!YY^5W/JWBB#=Q,.R/_'#4/V^.V(^]_@?;
M/8^/^&/;_Q#O%A)Y"J';I8=$+DGD^7CU"[W/1>^O9P,AD4@?M8I(VN019Q$C
MV*/S"+'DM60))"5RBF7ADNF27ZDM2)=<_Y#:7V- WV*_5\!['^"=VF8*"RL$
M%@C<8/"S=+3(.(R1MQP3*2EEW#<!J)H2^FL!\*,%\*H'>Q84+XSBF6B)TYH(
M0"CR0G,$?$N15D8C!2Q,:/#&4MG<9"V,ES73MV"X?AA><KRD;,+W"]^9<X=2
M":4H0=P:"9LPI0APJU RRN(HF6,FUG$3+B&2NH1(KH][U3DN<M0;VDZC]X,1
MI8L4B3S=.<RK/5F2)]P,<I.;B<S*+C#7+O!V-HXBHA,I!9>S71IQYC4RDAI$
MM$U!":]L'K-,J&D9L:RBDGL?L_P .;&GB_W5GD(IV%\4^U,+D&GPL37FR.;N
M,1R'@#1W#M&DB>=*&*/!."!$M @KV+_#,SUNX*]^(F4!_@+ GXG<),*P"Q&V
M>I5;VH'/CG3F9XQ#,B!"> TV?:9E2YIE9<=O!Y+'@/I'#_S5S[,LP%\$^-,=
M'[9U[(2)2''%$#?.()<21Q$'RZBWW@D"P(<=7]"%3[*L:L=?4FE'/>(6ZEIP
MONH-!HW4[YV<QRYZW85J-QX9=_VTVE#% )X7?IJ+Q0[.8TZ[7=\[B5F@A<CF
M(C(_&[9P+ A!5$3>.R"R/ -#>T*1U"P$FF)T4C0WI6QA=M6 ^7G>L'5MG)8E
M)J6>, 4L(6)1*."!*&"F2Q=XF3XDBPS0..),:.0 _LA$S#2-7+@4J@:XFA<*
MF.^9'CG^EQ"X*/A_&/S/!C&HP$%CB206#G&< /\V*>09Q4I*D%X^6V=H"U_3
M9&-Y^']TX'_\^%]"_*+@_X'P/].4(SF=HA<(B)PC+DA C@F&B 0^3T+3H'(#
M?' !U-4F>/7;_Y] ]<7!\#CV&^U*^QL_32HN?FXUNK$,ZEC9091*"/N];N\R
M&Y4N07<AI ^72BF\B9Y(A;338)!$%>$GQ1%CX*=$)X3,,0FBRSB.-8/K0\46
M"G#O$[A32T)2)ER0#&EP&Q#GBB ;DT<2O,.@&7.)L&K"UP)F1,%L;;?8I3?H
M*$A=*E)G&VMZS0C6!@66!_*!$82T)10Y3 U+ACE'27-3D-+^ZO'"=0G>>X'K
M?<)UIMP 6^6MM4C2W->:2X>T)A@Q3I)CRH+$0G-3T87/AZVN \>CJ29P,?7Z
M$?[JQM0>CHL+)J[YT'Y=K#7$$XXM/E!YP32D^ ($F4<!M;LC6.6#BW*1WRIY
MC]]WE 6\\W78MR"H=M?VSW:'\60 ')B?)4\.KEAP&/MQ,"P$.!<!?KI4IH!9
M")$(Y P5B&N2$"B&0=%KDF,"V 73W)2BI?G5<JOZQ2A+FF)=0PF%2M:32F;*
M';A3V.D\3E"!+86Y1(9[AARU*2:)E:"F*G<PA4I*N4,-RAT*C]2'1_9G9X?I
MF"C5""O"$'<\=^T XX1Z D:(U312W]PTI"46BG>6LHE'QR,/5#91>*1&/#+3
MVEQJJKSCR),0P1[Q$CDE$[*&41$8MF-[1+08O]HNN7[VR!,HO_AMJ:&>M0TU
MKTTT!ZAL$H.>2*[0U3QT]7%K-A(CE9!$,8.2(09Q'L#LH9BCI(AG@O(T/NM.
M6YI=C4:7-.]C /.#QE,*F!<&\]3V\"XY"I8!PCJ7?@8KD;5"(L68H]'ZR'/S
M7]GB_&K[WX+EQX#E!XUI%"POBN798QS*L!2E0H%Z@;AT!!F#'7+<)*+ PY1Z
M//N8JD7BF@7,]07S@P86"I@7!O-,1ZFHA<<Q(*9R?PE!+=(Y78&54(+8P*0U
MN9*R96A-=N8G4.ZQ'X>-3F]P/Q4=CYR:'B@  "(KA\3N2$@[LVY_BLDG9B**
M/DG$:3+(!1&1,TX;Z61TU#8W!6MALHC;_^2R'8\<]@\4*BBP7PCV9S-UXD+X
M&,#ZX$(CD"5&VH-3P:3#SC-XR>43';PEL"BP+[!_V*A"@?TBL)^))<A@E!1:
MHJB3R%VA(M+1) 3B,TR#R\"#SO7F+;J0^U%@_[A@_T#QAP+[A6 _W>TCA\U=
M>H$8IA1QS 0RAN4B22VQ-<D3*ZK=GM<?]F6Z29EN<E?.^\.V VIWT:=V-S1"
M^W,[Q&X89$IJG/9CBOU^S.K=\Y]*Q4<])ID<Q9/37M_VSW;^,VH/S[;/9;85
M/HX&PY/8+='H^?:%O=G@CPG8XB@LDL)@Q%/(,V)E0%H[:6C WC';W 0G4):3
M_>N#YCH.B"TX7CZ.I_8=F&T\6&&0BE7M%F7(>:T190;\<^F#TVEID^H*G.N[
M.:]VXD@!]=)!/1.KL2QQ+X)&.$F!.%4"N1 %4A(\-AV4!$>\N:E:LM1PK1&:
MZS@XMN!X^3B>*?E(C*@4+#*)BWPN-2!GL$)@;DD+_A-/F-1Q<WY4A1_7@_'Y
ML>U^B(UV]WOWOP$_ 2@JA'ZVG5%<I#1D_4AJ;>(!6][W8[[#H]Z;"XG]E056
MN.N.W/5Z-D! F*0J F,9G4<(4!(SBTE$#29,&&MD\,U-VF)J"7'C-4T*K1^\
MUR! 4(!]'\">Z0UNHG)):P"V58AK'Y 5(A> \0SKI$BT=9QM7_#]F"(&!>7W
M@/+9<H^8I#-6(Z$C09S@D"> ""2PSKURF,$R-#=92RUC $"!=_VV[X<*(11@
MWP>PI]MW"@1'"[(0(4_WXU; 1BX2BH)((Q/6T2TOIK!$?)?BC5*\L>@IG88=
M#OMM-QI:UXF-80^>]^2DUQT';HY[G1#[5T[R_-,R+%#85[>8UG_?T[/7>DM<
MMQ-+6Y]MNY/U]ZCWO-+>PQGE_<T.VK[LCG/MCF]GHU8X.:RID<CZ8!%G+L?>
ML4641R%\U94)-S>%6; 3Y%SX>>"D6B' 0H!U.KM5"'#Y!#C3"M=8QJ2T2*>8
M$$_&(ZL-1U)@%< E])CP)9SN*@18"+ N#[UNI]@* 2Z= &<"GUHE01W%*"B&
M$><F(:.<0UY+[)+W&C:]YJ9F+<D6Z;U9"+ 08%T>>MW.\Q4"7#X!SDQL3+D\
M%!N4!/.(2V:08]HBFU2T1D@O;5S"B;^5$. _Q#;_,0DT0YK3^V1P,Z$WRB'$
M2S=ZBT\I7SC?%Z[!CG%-1N266E>KA_N'P/EI[#<&Q[8?;Q-"?W9CR>.=].0I
MO75)E;-C4XO51;ENZ)F>=^I%4HF/S**\[@G7UV[\(_8/,V$L-X5";QSAO6/[
M75BVP?GW7K8#<;$#;V$'7IJO)P6)A#.)DJ0I5_<1!,*@R%LE0P3QJ4B;FW3C
MF@FCZUP 5 CH<1/0@BF,0D#W3$ S$XX%%BPEB420% @H'TUVFB"M/+6$$4,E
M;V[B#;&$-G.%@ H!K8B %DPA% *Z7P*:205$I;TAU*#(.4><!($L$0GI*)1C
M.!)!67.3;9#'=8*I$-#C)J %0_B%@.Z9@*86D)/<2<,%2DXSQ.%'I)WFR"L5
M!*;1:"<J"V@)4P!K-.AO+:)7V^W.:!C#(L?K'QEY7O>$CXX\5Q:_FNA7H<]Y
MZ//;I;F$6%GJF<4(2R80CXXC*QQ%"OMD,4^,\,4C6/7K@E,HZ'%3T,HB6(6"
M[DA!,Z?M+-;>8H^,L!KQ@ .RU 3$)&P?6,"/)BP<PRH45"CHD<:P"@7=C8)F
MFP$&)IPR"H%:6L0))\BZR)'0R6,,OI^Q8>$H5J&@0D&/-(I5*.B.%#0S4SIZ
MS$V*" =%$,<T@CT4(HH"IX!Y3#0'TA>,8RV1@AY/ =_?U2\1K$ZX*?LA-KJC
M$Q?[C5X:E_,-&J-!#%4;PVF%WPDLZ[!4\94JOEM7\35L-17CVHCHQ0(\K8XZ
M8W@]:,?+<_!OC;&_7T'_(%6[VN!@-!P,06RPW.7(Q/S[V^YLH)$3+8B2L*MQ
M)1#7F6\Y\XA*C<')]]9IL9:J,K%]KFA,498%E,73Z!FEH"Q2(FX]@Y\213Y$
M;@1)++'<&%6VE+YJ#M6H(5-IN+;T[6')+5,+YA\6\S.)?!] HMPB23TX0,H"
M^@6QB-G 0Q"1>L'74EF*+;%L54DN6FY,1$PF4!6/&;($E(9%S:5BW-% JNV!
M:U6VAR>U/:RVX6[9'NX7\S,A>A94DBI*)%-@@'E'D%$"HRBYX212R;592V4I
MV\.R524RZ0)E!$G8#Q"722%KB$<X@025]]C&6&T/4E]M4%>VA\>\/2RY8W/9
M'AX6\S,=.;23FN8QJX1$!'M!0F#L"Q2=,]Q0ZPB7:ZDL97M8MJHD24!<SJ.
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MC;$-(<V-+^,-<N-K/_I8N<&4N-.G_O@UQN]VY>.Y5XWUVMSK.JWK.MWK.NG
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M6<,YB?>Y[91IED5*14J+5-&N-B@UG28Z>!.KGD!'O2/[]>\I [[H]:LTP6_
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MHAH[K94F7!).G+ T?6(4L5QARQ2LUC3:&_A<:P3V!J]L5>4ZJ$W>ZL/X%@+
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M1=3W9@7!EDVK(J4BI6?N5UHX W,\W$G#FIMG^_F<[][@E3WKC6V_]N^[[X_
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MJ7YF^Q?,))\]3&HZ@$9_LZ^NTX<[;QUNA(6^ M)R&:P:"(+?\KA?B&B69J>
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M"S(36!.KF4O6KD"@'(A:JR-!/,_.2@LQ^D)7M(7D5<0?KXB#<8YRZ[@R'E)
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M%'4??\0R;D(.D4?II:= '<Y[%M:SG%$CQ\V<55)AXV1\L8\+G%Q! R<XK8X
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M9KBJA*^OA&<=G9 \&6<#T.1M\%%GKP77VH:<*B6T81*^H(1*^AD/0A,N32(
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M9TGG/"C;PU,VLO9>OV=*&)%H"?<%3X#KXD7D,D'K2@5.=?0^G#>:'FS:%O;
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M66"&:!W1:@7'B>7)$>.3R2%9G"EYJUF_4TZ>.NL//.M9\^ -+6?ZE(!E@GC
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M[KF343$0P1KA4[ ZYT03]5'=$)UK/9^' N8S]7R2Y-1[:8D33!!P'('92$H
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M,A/ %2+>1" A>Z>M8M&7[ U Q0(I1=6>L3#R2Z72.Z32J<3B5; *@B"<,TY
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MJ+>"Z"*!Z-05D)V+VE!*.&,4A5!MB0=92O2JK, 7;[Y&$+7+JM1->& 4?39
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M6<TKW_Z#Z.7?J#S,5K1<<!5]8W+&?J*D3P]J=EWOAU3U9U&F/">M;4X^6,[
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MS-1S\Q_4=Z.(#BA)S7*=,PPBVGBDL9>!:LD3!_-?=X2ZM:70,O7Z,C7W(L0
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M+3/_V:6^DJD;YU+^@*?E]\#_^\A/ACF6Y;S^=K?:8)X>,&7L%I'J<Y18PWG
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MX6"Y2)XW]B4EZAO"AZ[RO_\R&!:1V1_O#[;[(/:WHAL_8T7J8RG3)[CF)(2
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M90F#2?9M+2W9TN.?ENR[$/]9D.MGVRM:?.TM7RQ_U+IA6C?,]PX,NYDP^_;
ML%:@72W0=A?]+Z"?A,@TV"@^2<0IQT@G^#,)+$VP22AK[UJ@M?Z7Z['E-"0I
M!Q2A;A^5]O.SP*+6$_,]<8Y;S9Q/@BNAN)7."*%9H S^*P#QTGGM_7S8P:T
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M%W1E&FD8Q/H=)1FM%+ ?9VTDU_.:=Y<N55?*UN7&A3#Z"#/YN>QP_R;SF9-
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M*DA"A,I<DSX'_2@1410I!D$UTQ)L!]ZA^H[3 6_%=^MRI-#"S&/I[-["S /
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M32%I2<!P8AVAGD)UAN64J%EX\F(NPR,*L[]AOL'><<S!,_V#ZK=H1_&)IA<
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M0><8EF=DI "=,&N;W68,1X,0>^6/T6AR5/?W[8 N/BZJ^%&M#OK#"7#T%&M
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MIS@P[/'Q(!='"=F@!CRL:J;KIE0G]N:/,JJ-0&9/%9&EC:WWL'[NN0<TFAO
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M,)3+!@USB99)K6O4L3A@CBR^8P3\Z4LGSNZH:"O#DAXV2$T4W6662O.^%W<
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MQ:$8U)X0=22*0W,SY\?+\,W>N?-CYDS>^OUO$?U:B*Z:+@] ]"3.,DZ '&.
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M:X@):4+ L%5$V(01;H(P9";,XH3-^X4>:=KDZ6G?&2! ROG (Q9RCPL< *^
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M)*[<\ONP_]T%03SYV.H</%%?DVKBE-)(Q'&$D[-YRBV@1,)EHN)4IURW5/.
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M9N%6(-#@%D6EU('QJY 78%/F.->XMI6+UT^#'W@]FC=.I74ZP53-72"FH[P
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MCIO\T1D'6^C1+U61^QQ+78P/N\N#V-U.>8+A_!DGK3<24 #U^TCBJ\_;!^Z
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M8RS>I1B"+3&:5=;P- H7!)S*G>K>%?\UU397\HAUL3D6WGT^RL&6/ZMS56O
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MFZF?IN"%GN29GY7_7$5Y"QLP?_=SD/@O]VP!#3PP'V0B_NK;G7[67I!/96+
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M-:N['^A)#(E4_]6'I98Z&U\8Q^^C[O>,O<98M2\] >@C>[MGVF\+*=0>TSZ
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MA0>/7A0&F ROBAP*!^?G^[)P M)L#T4>,:DYPN/"-#),_NT;V5!B29^GE>?
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M"]HI"VK4WUZ0!24+2A:TE@]JD07MK04=G@LJ0K??)@R$$?YVO<?O_B+^N.K
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MM(*<V].^3]!G/^E2FL@EN[!GF6=2Z4;(Y6O/45'SC[>V5?@BIO:U IO&)[!
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MFR$@ (SW5#R#*JL<VXJ0;'2]*$H;V^BEKI U)0DA:TK6],4V""&T)<!7NTF
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M=Y!U7I0/ 3\ 3MDJ6RF08J^5YRQ]'N$,/&C]F;-(>6)Q2;I9DD3>/)69ZM
M0\R2K<#!^%TOD1 .L@<8Y8)[^ _^1^HET,(3B]P"-071()R5QQ=;3 B42<_A
MT?^)E1A!&<2TVX%4,CPH-Y.@W%JY? ON?"@;2+#9/P4)"Y8>JN:'&,QZW#M3
M6:"%>-NI,IQJY6*A>'$]N)"]_?1V*T7('-U!#^C26#N&=-"9L79)!KHTUB[)
M "%S] )A@) Y")F#D#D(F8.0.2A'F;+>*>N]::H1,@?9*+)19*/:3+7!(7/L
M1\+WP\/QOAB]-'=*L.E#@HU>^XI<QU)L2(R'(,;&M(6%D$F,28QK)L7I8TIV
M[&.RHSUM%5L[<T&=K")9Q>^LVK5G.V8928R'(,:Z:FCDI9(@=UZ0[R8SO57N
M#'FIU^%KRS8?C7NIA,EQQ&7O9;*P2* RWE/&,*63DX103CFA<Y#&M$MC2$)(
M0KIARZZ+TY&WU=64/)&]_*$J^VXW<[B4$WQP.T/9I)&S$KG.R0KHN5R)Q&#F
M_)%Z,F4V'BF5?6QS_0^@,ZZ6$(WWL_)\90>4C7E!Q13F'+M?I)A5GR4COF94
M[4AX;FWJZV\\3J+4221YD:B_\3!:LB 7D(\K%BUYCS-@HP,*1+L4<"0%! *$
M%R<E582=< Q[X(@%#E>5!/Z62E8";,BU5< UC)1:'8(N4=KMSN,AI 9V::P=
M2V/LS%B[) -=&FN79(#2;GN1/DAIMY1V2VFWE'9+:;>4@$0I;932UC35*.V6
M;!39*+)1;:;:X-)N#Z/PU2%ARKX=XDU:>V+2A7 2XZZ+\65W.$B4291;)\J]
MM\AUVNB"WWD>6_^#LD_)(EPV;U/5-*O?-H$$>0B"3%X:B7)/1'D -IG\M OB
M@Y1_V>%,$*K52EE"E"5$64*4>4G6M#6ZTDO9(&O:,@O4OIS+6]^?%$E;_Y3_
MJTASDK\XF7B63>X>W7J1>?:^G(IVKT^OGXMVWJS^0Y&*=OCGKSS"+1A;<@4T
MQ4EE0ID7*T&8*&O. IC/(O6/)SJ>/^?69.V)%GM=Y?[<*Q^B/'&=.O8B21$>
MXC81DW#S!,524N*V '8Y/;&<62R_S(L&*RR*\#;V&ABO/'G)ZE2Y8<Q)W [L
MABFXS8MA]\K ORR%HLQX+H-GI8%O\V.O*(R[2;/)BB7P)/RB;'SF\+S:]L*+
MX,L_4A8E6"M](:5/^2E0?N3S"'[]+'ZC"O&=ARP2 W.]B#M)&,4*VVRB\!%3
M;;'=0/3-H[47P$A$!WR]\<-GH0;P89[#+G_+N4C'S7_IAP[+$^YC42A>$@'L
M-K:M*D_0G._)QEW9]9] N(0#X:8SD0!_GWB809]5NXY5H,(&" '="V[M?&*+
MP!!.["F,O@##,"5YRXJ,0O\3B!+BGQ+X*!:JG#UPTA@\+Z":@UG'R!T>1*'O
MB[FBF["![O'7HE:YSV.0/-#]!!ZKHJP]= Q=?>%)+DC,%<Y=G/][R0/@O9\]
M@WF#9$2BX'?6OF 4+E4X64$?X$NX#$3R\_F2$Y=%Y]RRZ)A<[?+8B;PY,F,.
M4C!2WGY!O5I#PRNH;E%!]58NA!)70>CG3X$#)D6Y^T%BC'RC0H=)0\N>&-9Q
MC6Z[(W(:Q4)0V\NHS0MJ!SQ1CZW&'DHXK*G99ZH2I["U8UCK7;:#9E9B/RB<
M10%^A=[ >NW%,2Y&:)RYAXOE(@K7RL_<]<32(1;.M7 )8@F)L>!1!@J39C P
MNE; T\ _#&7^#&O*/ J_H%&'E1(6"E7\X#%?P&PLL#+]_'D[ZARV!L:T@!44
MUP4Q^EB,V^7SI+1.S%GP15G ^MQ=1_1%%)/PN S@5O$"&)%"60@\I#L !UT:
M:\? &#HSUB[)0)?&VB49(/"07H @$'@(@8<0> B!AQ!X"*514V(^)>8W334"
M#R$;13:*;%2;J38X\) 3X7_""WFCZ;?Z)J,^G?4[ZXG$> AB?*=K_2T@22(\
M!!$V9EJ_+?%9&1 ]K8-J3">M,D^=R9D@TTBF\3M;KYM[UC'32&(\!#&>&#U'
MF" Q'H(8WQFZV2IGAIS4*_%UUBJV-NZC$EC,$8>=4M@IA9U #DA"N@I0T,8V
M&M&8F8'_-QB->>OIDDWMNH2036T?<$S>5MOS[D2+O<8A.7%[!'\;85:EJ[S3
M1J8"P_ Q5][-01C.!R59;UA40A9A"&L  P]=F1!J:- HQ\?KU$^\C8]IJ,!P
MSTU%!JBW1I2#R(-]C >-=SB1LZ9 =0]1Y)0\N;PD3T:5/)T%,'*N.&U3GP5H
M1=X[OK.7_GPM>>JLL(D\XK_R@"^\1"9T9\G[G]F?/-Y;R;NF<R\F3\_+$\]$
M-\&)*YC17BMWNGM)T^;(&E^6NMB7Q,XNC74\FEF7I;C36/LB UT::Y=D ,9J
MGS>>8203=C3YDY*F*6F:DJ8I:9J2IBE]C!(2*2&Q::I1TC39*+)19*/:3+7!
M)4W_]5C(EU*F!WG_63?4J6FUZJXLW>(G*:XIQ6/5LOI[CY^$>"!";,[ZF_@_
MX&2460MA23IS7Y!L(]E&<%-GJC&9]M8XDA0/0XHU=6:0GTI2W&DIGJJF;?=6
MB*_BIW;029V,K^RD=MY#'5;*] ^+!7=$G<"$_:E$+!E8RK0^&]F4N46Y?4=(
M9FJC*8E'UY/RVMA&+]7%T$=U8<Y(788C'I9)XM$>"]3>-.G=E# SE^H6Y]R)
M%ON=.)U&"C_8+"#@$KK07RN+,*J1(OW$8L4/G[  >RF[%;VM>BUII:S7+*5Z
M-_.5_^GP.!;CS=(>8X7%<>AXHF8ZEH0'DH;.E_NYR-3%X? @%E721\<F76^N
M.1L5F"Y75D!<CI\S68D^3EB2)F'TK"RX*RK&%]T<)/4>&ZC"W-_3.,'B]5G9
M^B ,[F$X*0P<$S/]<#Y_QJ3C+$%9U@W&KK-K0-7UAR,><Q8YJZS*\"/WPPUV
MH@!]7:#DB9KQ/5/8#B:F']57=-*V6G96"GJUNN)R7JNA9K7UK)GV6%FOFK[_
MPE>93-H6".TFC#V<^$/$?8:LV69Q8X9AZ:MLP=>VG[!Y'/II<OR3@VNF;V<R
M3N;56_9I"E8,\1S"G_E9^4]LPG/_[U<>&[L3/IW/M86UL.S%=+H83R;NV%EH
M8T>?3Q?_G%E?Y1^MHNTMZB6_GX-&?KEG"^CU@?E/[#G^ZMM=#PW<LVS^$P,(
MM,^>EX9:O/)V?*H&??C$ET(I?@K +*R%0K8=UN*DW/TO!\7?A%&BQ-G,O.W,
M%&E]X(=5^*2$8!Z=E<<78%BXDPHC">;#<WBD*D^K4/%B\<['7[[_6856EZG/
M(A\-RZ/'G^2S< -6+T'C!.8F]84%\_W0 =L4XZ_@'2<S6&OV!7X"Z^[%,!1\
MNF01[@1$0_,TAKF K<]:A#=&RN>5 #81XP\<,-:P+J30*JY:^%$V102A</S4
MY;M8GZ+7313B/><[/XSC;^224'05)Q'86&@09XHF.?($>19R3YH\A?*'[23S
M#A\NDY%LZW./07\A)#O[&'W:F-2@DV",WS?DJ, 0WN^01K=&-M+B9UBH'/ N
MWB,KB:I7HNI/!;24JOPH.A6:\FD-FJO\-5..[D),O0AW@_9,<4-H- C13(+S
M!.8*J, ?F9^B5P4N)@>K DY4IO"J=#71Y4.7=".,*1@A,!IK+\[MF<.]1XQ@
M2"\.@: XF*Z*Y@2N#G:^02<-UG+WNL[8K:F*=CK7U6*.#A#%BV'>6R]XCV+@
MG@9@;T4.BC#GS!<;DKRI>^$@PALKSGP@OQ> ]1<+P<:'T:J9V4?#7/3^P7UD
M00(^B[K]W:=TL_&Y)#PPIOC]K^ U*]\+)CB1)YGJ1NDR;UYP$;<D/B@$N/U
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M*[%DR7,2MM5$7)067H!N#W!BS<$Z.K'<9FYX?K 25/J@;Z)"%,#?"^"/VQ+
M;R 6WS)S^\M.I#G7U*-AWE.PQ=5PQ:7MW6V1BV?CD373+P(NUD<S\S)HT5/-
MSD;:F2"@]9Y9VGC08QU?S"T::U]DH$MC[9(,X%C/@T,^$]"S;]"F! E\G#8$
M"4R0P(U! M]F<H0*3(B;A+CY5K0AQ$U"!28;U0K"D8TB&]44*G K/+_SP']_
MDX'3AQL*Q;7EA[JD+CO<9:\0QJNWE_EEK;I 0OT' .L.QI<U5LUIW0S]:E%M
M,R =B5Q[IC;15'-,(D<B=[NIW1FF.IMJM:$,6R1N9\'$G"MZ[6/0!94IA@(0
M0W:H-W;(L#1U;)JT]I',W5#FQNIT1OX6R=P-E_.Q:MCU0?Q;)&U]=[<&YVU=
M">.YS0;EK+S%@6$]3U2[MK]U'0!*P@@]VT,QL5@&,:G53!)%RVI$4(@_MPYQ
M36[-G,;7=!*,,TAF6ZIF&V1=6\TDRU#M\828U&HFZ;IJ39LI'4),.MN9;$:+
M&E\+KW3?1,Q[/#):4\/H2+I3&7:!"MJ_T?1;+?YCV#7J5OOJ[=XRYDV2W =)
MGEFJ,1VX)/=?6+LCCW>FIIH3NBW38@89@SN_H1655M3S-X&PI(YK;]5[MJ22
M*/="E*<SU;+K5B3MF2CW7UJ[(Y"V:M2.L9&#>&.CT0A_&O<1>W7'ISKP60E+
M>U::[[')E]8($WCNABFB(UZ2%?Z6)46[,4IJHXM<Z\8H6]W&K;.=KU],KE[*
M\SZ6=(9*^R9UH.S1U#YC<!68S2C1]^9(K\"I18!O;.&K[^[T;2Q)0@234]XY
MI_S.-M3I].910=H##E3<=$O5S1F)6XMXTF=Q,Z?JQ+IYS@K%&\Z_='7A\777
M(PYDC(9GC*RQJEMZEXT1B5MWQ V3HV:$&$ B=T,+-]' N[\Y( NY6^?G>LV&
M=P'HUH<[3848ZU6?S>*/O0H\GJ6\G4U0T0W5FLTHBZC=3)JJUI3R\=K-I#M;
MG4UKH,P0?UI\3;DG:7@D&&>0S 3K.AF3=6TUDPQ+U6U"96DWDW1+-0DZI^5,
MLIOQ]AM?"X>8DEYY+^@BS+6K9'&T3D+N+$TUI_6/<KN2R3!@UL)29/4\3Z7G
M867+4B=FIT\V>\X@7=6,F]^Z:MR/(-/\^A,]=3RV:='M'V>MJ:I;=4,I/69O
M]SAX9]OJ5*=5M[T,TO7QX-;<7J525D_X8QAMPH@E!_AQ_8Y&X=W]Z>W!@BE<
M>#Z#;-6>UE@0B$&W9=#$KGO;G3AT:Y^*#IY)+JHB7*9J:#6\.5+<VS/(G!"#
M6LL@?:+1VM=J#OW[OTT-W7A/1\ZO.')N\[;U4Q(Z7^[Q&C5.<;WA0<SP]K7"
M_\2?+]O-=C<X8ZL&I:JTF#]CU;P]6BWQY^SU7-5F%Q[:$X]N%A"J$:WK2?R9
M!..L/$!+G=:)%)+FWII!NCHQ:/EK+X-,5;<[C6/4;_[H%V*X=WWY>V$?ZWKQ
MQF?/#T&(B;2GY(G>I#??\LVA9.5_SS<1=SP9:<%\?+8.883_DK_H9/J],<CT
M^SMPF6<U5GP*7]_:959GLYL?WQ)_:MQ!GVDU J[$G]OR9]S,W93&/682CK.4
MUU"G5HW*?J2]-T_4F-6Y"T[\N;GW.*N3@47\N?'J5[?R44]6OP'<>_A0WG"'
M"\4+$A8L/2S5PN*8)_' +C[H!AW\M)<[QO3F9[;$G;-/%<879DP2AVZE/W8-
M7+^>G/F08)SE@-\^&9.X4R,X:&BT\+66/Y.93@M?JSET-Z9<\]8?>M.;PWQS
M * (O_$XB5(G22,8L+CH$/$P6K(@C[PX*Q8M^67!ELZ&%>_L20W(0@KZWI8[
M36:\$9<&IT.O,_BMX\M_T#'Z!;?&-;H#TU[^T(+0!2[U2(MZO20,X&SYEV3%
M(\4+G'#-E;LLD?X;50EX,JQ397U:MU8!!0AO'6+7Z-R_M=PQ9G7A<8A#_;^9
MT7B$G23C#)+9.AV.M9M#$Z-N<@-QZ-;65:]?VX>X<S/N#*]XR)7.[#I2A.QO
M81PK<[X((PY_!1QKD"VB<)WO;1/VY^'9W4NDR.I$R'D]F$ ,-TSQWG4^G=?5
MU&A;,.!=@_1IM6+=C6UU:M4ON'P]^C0<[R-%(44Y;YW5U!DIRBL.*SHOZAT2
M5LM29QKE!+>6089.*?VT:M.J_>:&<*:K=IW#E:&MVJ0HI"C2O;55TZI?I&,P
MBM)_4>^0L(['JFX3H%@##-*U\_S;<=USMQ;ZMV?.M2(V_6W"P 9^EX$P7A_?
M<OK2P P<V#_E_W81(8O!?/>7>?3M=P</\S&N6;3T@I)ASUESCX;NP1SG(N@%
M+@^2AWM]*@2\@7G^AR)E[?#/7WGDP.#8DBL@+$[JLX2[BA<K09@H:\X"F,\B
M]4?MIH(],LZ@PS',4&,T/0D9NG6.;\ZZ76+J^FAF(?6^EXE*R8HK"R^*$^6/
ME$4)CQ AQM ,756>N!+Q1P_+Y>!;.6\S%)F8+]? #&43A7A6,G]6^)^.G[HB
M^VD/<<9A&R\!FOP+FHK#1?+$(JZX_)'[X48TXH1Q$BM)J/!@Q0*'B_H\+&)S
MS_>29VPB3",89P //>:#5"61Y\3*DY>LE V'48L/ H_'(^4S#/;"$3QQ^/4[
M<V0IP 4_1ZQ]9XSTXA>+,!+D2%81Y\H:B+^*8=@N-/R);Q*^GL-H3$T51!2?
MPP_PSXC'&^Z@Q/C/JOB][&Q6:EMT9H_,@\Y A2[M:Z0,6>^,]NG=23SD%<-3
M2 Y/W-_3&.TH*(47H&(="O5Q03ZTM6<M1V5F(_??;JT7+3X(E71.G\X:,KGR
MD0<IKSOP#DY7MV&ZGX5M^5GJ^P\OZ?N;2/C+;ID8J2(R1O3W2L8A>6:.QOIG
M[H)*@G#F"X7+'?P>S:DUTG(3IRI@XDSK:U5QMPO2>;95KA%21?"KF*TY+ :1
M%X+W$62F<!-Y8.:>%9; BC%/A<N('S#EG0ZFI["T,+J(@]W +^--&,1A%*^\
MC=105QB8&(<79?,4OP^4=]/1M+(-&-S:BV/\=?9)ZW7RI/MWP-^? ABDYZ;,
M5Y4?18^")I_6S/>5OZ9 +!['%<P?;Q=7P7MC\L:\%R,[Y/YD*X,[C MXDAE?
M,?"<><KWL*9Z"1>] 4MX$&=6&'_Q\9=__/3]O5B:T,'8<.&E\" *?5]Z27)H
M,+DP7:Z4#^D2.E!TNZ3*P%,P]%LA3.>QYX)#@^-U0/Z8AR_D1 =?914JFS1R
M5O@!.&^^M_"@\Q5G/CI%/C!;^' .D-*#*0A:A7/@_R/0*XG"8 D474O"1AQF
M)-:5"*80XP"0R7_[_ ^!$1C'.(NX\$?6[/<PRCPS01 6^1XTDTW3"5>P4L7"
M\<I&#FZBFSI)T7(M\1DI?Q55&T/Y+7]D?EJL@MA_NG$%Y7&\Z]#E0!Z9@9_/
M*HE E.+,IW7"92 \P7>Z5I*"H\RO+9[JCGR^TR<E'Z_4/71X1':/[Y4N6^DR
M5;8M]/$./*DGSTU6V3Z[_%7F&&K;3]@\#OTT.?Y)*8: >T(>-62NK,EI"E8,
M\1P[?.9GY3]74=["!G;(]W-0\"_W; $-/##_B3W'7WV[ZY2#1YY-98*>\3ZE
M7^JU"_[-WW$[TUOW9KS=P$GO9G>!.VLO]VK?9GRY;P,-,_@5&&*T[XN8B]T]
M.["6)YT=L0LOOW- L,./,&:T7;/="&Q3(+H.JEOZX#XR&7?"U4[)E]^*AF&9
M>&=I9<_CR!3!]$YJN 6P"'O.2GF"79N/Z"X5KL:.L/P*O2K?PR1Y[$3>1BQ-
M;I0NY7(M&9)+4KX\X)H&XR_:^)1N-CX7H\#WSVS[!$.V9*R@'$YMRPE3^UI9
M1O^?O7=M;MO*TH7_"MY4^IVD"M)(LB79G9JI4IRDVWV2=L9V=^I\F@+)31$Q
M"; !4 K[UY]UW7MM7'B19>MB39TSXX@DL*_K^JQGE==@8&S8B&P)VOX*=H*-
MB_OOC7Y*R_>R@F%\#>[_Z4:S][:EPH#5>VQ#6=NN\)/)^PA-WI.7T0D8$&QI
MM#<H/E\<G@7!>/OG]C!YL_?5RFN%ZN-HZ'[BTY>P?2B+9*$N%O"B,4SG+0A&
MN,>_HHBZ&#<DP3(X3#1&E(_PO+F[S.NY;PN?T8RR\1A?"X,'X;K(5XL$UF62
MP\XNL@_XZG!&:;@LAJ)C"4L$<C*;PFF:X'5,17/ O,IKV#E6'W":RJ7&V.%U
MEZ[A8P[';@P2M<)I-;.LH3-!)Q).,PKAN;P&E)FK;MM[N(]V)(GF=W(0?N4<
MQ#=8Q/'M%S#YAQHD?--G.,^Q\@;-C*]/3PY?]LF8'7WNML1Z]B+8<J)S,<YH
MA5$T!OS-\?.>5$^ON")Q@<,V%NM*U:R-<$9F9!0^I->]Z%7');PN([$FG!H@
MR$-^K6[*\8>#$2D(G Y\P8LL_#)8%ANS#.&9[91"IS=$*EIE-W+#KI79G0@M
MVJ*LFQX+17]).A-6]8.CGW)R#E\[!CU5+C#?AT<(_V(L#OE:W3$!\N(*)D &
MM9N[.H/_CQG!; R"-<4YNZI V7W)3UD5-.]+26^B$@?Q#C*X*4M1LS!05+-7
MN(9^3*ZXA!]YR]RKXM0.4N5Y7H#:RN01/!%*?;+5(8Y#X\:S F[IY1KE>P,'
M<D%+3&N+<^)O4R9QD4UHQ6'C,77:V!.<%<6JUSH3'V,*+P-5)2G@AVVO[V]'
M2 J;9! 8R*<?(X/";4=Q<M9.=)S\:3=C"*^1?U)+R@2_.(JF;Y(S1P-?>ZAB
MYO/H^'MSWA]]>&V+8?#\S&CE/9V/SIT\/PH/8[/@Y<F 62"" 7\5:?2;&P9G
MSXR)\P@4?LKJ%J1J5K,\>K9)'GVL?4"N\$9=2F/%KUG]^*05/U(K@BG=JQ5W
MO( MPQRLWCA"?OIR#[7H'[5!+=IP6W3<6GKQ9"![_T!OX_W0BU]>LO'%?4DV
MXB/RR7]]E6=GDW/W8C0ZFCZ?/C^=OG@Q/3L_GYR-IT=GX^/1B^G_OCS_Z@XS
ME)]ZG_K#13_G_UKE$U08>(5>,204PX(@Y\>!W>,NCE +Q__0#-2MJF><U;.4
M_G?B8!.NP 4O5+K5&#D_@..V$)>?M'WMQB#N&LP&D%&X6J"@QQ!VAD%YCIM^
M0YJZ7,'P)O6W?]:5D">H8*':*)CM/%O6[L_ZC^^T445>T)CI1]_%F-C3+KB4
M%I4_#B?_\(A/O]#ER)OEXT/ZJ%6;P9^='1\^.SD;_!@LU<'/-CWV^!P>._S3
M38_=_-GIL^&7?M1@G^WTV"V41'NP#6^@V&6!>Y^XB;HVU0[5WH]U,7YP8UF+
MXS1R8!\^Y?*.I5"O4(I2,+0E3O=E*!NL&KU/=9@[+LKNA9C[3?Y^5\4=GYZG
M()-OQNVXVPK<,:_@TQE^[&?X^;/T_/2&Y.F?]@@_Z*YE.Z[^NRW&]V-I5[;C
M<IP?I2?')T_]3^[W+CU_F9Z=[*OU;G&7'I>5V6]GOR\Q./(Q?OL-A7D_R\F3
MHO_HI;G?=_KDY#P]?[ZOZ+W%]7D8AN[3[?@B;\?+9^FS\X\SDN_D<O03M3R*
ML/9O2!0^S]V5HWPS:+V*X&-#T9E44,/)-!LSK06AOOY I@8G7\?8-!(WE 5R
M6\SG\(:D7DVG^3C'9S=E,EU)?EM2E/A-S&=G33)W60W?N7;S*\<G13*SE,L1
MIH\Y9A 1.<[PZ+Q._H?3V_-U\M8M0:,CY/RG$I3Z\='!_S L>[IJ5I53$HVD
MPEE5@E2C84[<TA4$5H=E7>,,F[*J4V$NP%>V,O=7Y7RU<*E6B,SR9=H&Y*<6
MK%<6<,SJ -;7+/\<F0\X<ZKI?H;Y*6XN-3#"5KU3VH,F+*6?F<<3'":OD8QA
MDC.0KY1<1J)92H0+SB>X3_EBF=%.CF !$#@ #\K&L%+\11XS;D+/F FRN,@^
M$,AAN:KJ%1^JNL'I7FXB\7C8=VB6@QRR%0JXU3AK*J7C6HR0M&\8B@<CP!JC
M.4@=6=G*^:(CV2-_D;0,0.Z75KG@4^O5/%0.^**EZ,F7KH!K1F5B8[CA=8(H
M_"1+BA7%H.'9:Y=5@GN5O#ZF[DM,_L/#B*"F]]%I,BNO86)5BG4,X3UP95"2
M3*+9PGO"Y3E,+A!KP^-/&8?A1/!,Y^7U;C.+7EJX2SKNBGP1W 6\5M=>-L@#
M&L)O1PX;)-1R(U :7HFTF>=3I\.G$AJZ['2C^ 6$N0XB0$K+Q-^ -[I\28#>
M>#D+.'LD8!GBB_.49\ 5PO' #<-RC5E6A)TO5\T\6Q.PEBYEY>@Y6J&6_.9$
M%-/*$N27ZV,&Y;E'";%P;"TZ'T+%(-N;CG4=,$_ZQDA -W!^RE!FU7"-1W:5
MY7/RJ5#H\RG/BZXZ^#1YZUU8>;[Z[^0ND^9E4$T90[0Q6XS@KA(6$OS0QK5X
MHU2>IBQOUZ!-<KRP(M_)X64=IV5KHZSX .IMU!!0:0EV4SZF?U5P#N#Y>""P
M**RB+^FK$!X5;6B]&L]HLP@_Q'@#%ENZR7"KYX1#5XHH&>'$C?,)Z04ZEFX_
M?1:D1FK!Y'I]Z.\P=E9['H&'""BT"O&ML$M8=317[,1A(@!T?TMJT8$TE!IK
M8%D5TMI78FJ86\[X)18K?.,?;L'2QO-Y0?*M#Q'GS8A>P=)@Z(7H*4[/ X[M
M,'G5MBC9RI-*LHI9TRHB;(/WAE.?HT9=J;F&"@GW-[_,\< O,H25<5WCRR,P
M#==TA4B$^I(Z-1BU^-)6F:+"SFM"R8*]Z=9R0%5H%5R0[2H:RC);H@9HHT"'
MUZ)R4U3D=?+UR?&1P<["V[S20_663\3R\A<PB(3^:N^OSXX,6-4^;U4S.4=
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M?SU\??B7PZ]@+RC+#!)#"+A#&I-R$%)[UU1P0C*NGYJZAXS8V7B6?T P,I6
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MA-4()%4%1JED<4!Z2"NF;E2$BK#6NPT V?AF)6P0L9503)>31FL.M6GP=NG
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M"_9@UV9CY=G[&1;^4/5/4;9;-N6Z-F.[-@$-7NG:B&@9"[ <1(@"K@MX8[*
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M^=*52[:P1VM[A_'Z573\HQ,L!</FJ!9K/:1V6XF1!$S>$?DPL'+HT2:K)0P
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M3_DT'V=@>PB@43",-S _R0 7&[,[ <PH-RN&26)0IDY;[^EY8MH/I>0!L.L
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MP2!"20H.CLO9BB4)&^<3U.(LV'4:LZ[=X@>2>8OL&DQLX- P%OV?8941I[G
M0<4@8<4%9L$';2N<M#WDP^2O@^_GJJ0QZB/"O&.6HMW#"J4#,WH%?]*7?4[
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MY,O>,F]0D2LN@4V/^AY24!T '$AS?VN'=5H<\-0$@(UZ!KH<9!)6OK4KZIW
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MY'_$:E*=;S"#724\%U@"*946>(79S>\A].?($I<BFT)7GY$VB6H<1N'F'2Y
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MJA88# M1EQ52K*[P^\)(!:W$5YZHX=UMW6UV>PGE0:E'+@#LC#9F&UC5)K+
M?0;,Q+R9$J<=VD0-,;?Y;W[=I+!!+"<N(*]KXDQ6& )R3:B4X9D$ZAE95MI-
M:@H'NP++>LWHE'7R.YP>2BPPX\0'9\PJ?SAFOJ\7/X_=*7"U<(U9-E$MDT>
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M99-:K@*XA=.\6L1KRZV$5?NU7FDN.7MHW FG1T-(G_M88V*?<O+#+S#+Z ,
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MSP((KW:!T0!,!9K;I -CPE<9L;'\?G-L"?N&M-;R);DJC9&#P15865JFK*7
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MA&(+U9B=QBQ2AT" IJK 9$0%MF8QD61M(PD%6(.MIXOD3G2TG@"CNY/UQ2(
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MH+BF/GNQ0.">4HJ2?]<3K$(JE$#,CPWKF$K_\US"&_I"G^[N]H?UWQ*2Y&V
M-?VLP+ZW09WN/HLA\LE[(\CVS'J\WUFOQZS,_0:+87(>MEWHF\'F8(L6^;+'
M+61H6751"\//N0VHUH-.OGSL5FY?86%][-J6A,'3WI0;1W Q02*(3%@>_9]_
MQ1K8'S"96X^KG+$WDVIU:4:\K+"<94G<< K1\NSKJ"4PP=Y76"9#A,GM-,)W
MX">+ [_MY4S)A(\_&*T/^#W<9&JTEM=.'$: I0?8-*@X2?KV@8QOQL#.M8/^
M5L8X[@#O1HPRC@CYZ[*JIX%FW_9+BJY>\8+C8J,6_KA-[:%_#\7)S.,R)T(G
M%A#S_ -#^S1UW\XQX9<9!=I=KMH2^+1\+P&?;SKXCQ#@3"BDX0+F:V+F;IVP
M:\=,^D+3U(HDM1C!$]YS19,L?*([[(XVY6*.1631U:I^L;#%[#.-,Z6/E-B@
MC+]I<_O76W-"F^SLN#[5HO:F^5SH.KP/H#.0M N?H$ID !TPN"M*NVC-ZAX2
MLFY_E&U9) O(82*DK&X,I(E:"$4<7B(5>3YD61<]R7BUOIG 388/WTZWR+3M
MQ?X1I+OT$EK(G_ 6R]%J@R,Y0>?]S%1NM6?,*?O.E58V*=]4,6D/@H!"LA6>
M!V=@3[QI[Q$]6JV=%TG;=&& 54SIANL-EV(%+X$[VFV@O>OM(V<!O[!YK1$[
MZ;B6!+%#= >HH8'%ZEX[C](4?F3$\QXFWVL=&R.(QE)AA/"B3#%4\.H-Q2S2
M&4T=F@V3]4>5$*1(<+CVI7R(FR.R9JV.I=_Z*CO#N\^^L&'?MU&N0+B?AH9Q
MW&,M#8DRIM'+0E4<MWJ,F^1M:G-.>.A6_^UN%="JIUS)=%7"BG=)$\A0\K9P
MX+)$O@-I2]T9'''_^2S9E>72"WQU6;)4"XO$QDG4T69J"+]R/1;MF0VO#*<R
M\EI\=E_F1&!!X7#C4DN!2_NF=4B>D";MLB@JKRRY[8;ML$P%*9D4:TM'&!85
MH9HB!,\_+D[R*FYPN=5Z;H=3A](ZC31EMU5V"N.'C2JHB:S$>QILGID1 RC!
M[B<Q1+'O)]>>T3,^568-AC$'!,,8&'=9!5#XJ,,9%!9V2.=I@R7IR41?Q7L@
M%;OSIKQT7%5T>[$N-36U]Z_E\S6:4S_OH.91II?5-KT8"B&[YJG7)DLL5R*4
MO[?8K4+I\10P5*>C\:K.3:C$6H"[P4,RA1\;>HYT;C!X(H+FCP46ML=Y@A)X
M*,'Y%PPEN!O?16I8XU-),+WUUAN6&DV"Z.W+S*O\/95#67T9G$G')]Q^Y1>X
M]D@XP 3;; ],B(;&DB8S.<Q(^6LIP2&^7 S5#/Z3J3O]N+ "VRZRU=D\ZD4B
M 75M-NW'3)R>0AB;@>V>A39/B.6"MZ/GAPTT?<,\](Q$K1#$N:T/>R?I/4)/
MUZ CD&-<)RX;S^S+O:\]Y8_0"9T,^3I4_$LG4YLC$BZ =0EWY2+O(69$,Z$1
M4+ #/KJ\6&<@7D@@Q_4<O'GCQP][@<FD-^.F1"!W.#<22L(%\.$EQJA$F1>P
M_#,X\UR'V:R7G 7I6UCOR[0*[<AEUS&W 3/&._/?56>0;)!\//RRRDUY@_!)
MTIN,49G,1] ;\K0QLRT13PQFTHN$^5M[%%,$<B$.S'!+R/^HDP)I0^A ^_[&
M^&C8D\B;N48?X9JO*ZT#';./NH/^_)H4M.=FCMV&K+7E5 1:&>C_P 84@1PQ
MA#Y\KXX61SA6(>G&#@:A:N4XD=AO_"WMGA:578-?)O;?AMZ<>"?)EB[X?&!M
M&-_I>L-@8)>D=E3V7S*E=$A;Q/&;)(TP" \[9O)X1NC+<<9[R03^AM2Y##6>
MBHTGL-%X;;>9_!&1COU3H][PK51-\- HZ#90[N[9CDV;J+!?..C2]D[I>W,(
M" P$*N.0YNU1 ,AFB@?5">P%7[W5CJ]-7KUKIGS#T4HW>6DQ;ZOUSOJ"ZJ8Z
M\/86JVXE*.#X4I\N<*.SM;;6M?$,3(/7MD&]'S-XOLB5V&TE(C9*GXCN[3WR
M< VZ/=/!&M.@ HA0;^,KS[N%6\5D53<5;0S#33])'O:A+/?6!&U<NM]93E["
MMJ5B(W^HAE*LE[/4F2';WL\.Q0:GQ#+"@MN8J@B,P"UMJAJEO%CCP99E1?6&
M>:\]-X?)3R24,Y0K:90]_A6. MZP7P/U&!Z'OOZ+W-7G2.(?"K#Q+V2(H>1#
M>@NZ3:<"?V!M0$R;J&+-HN&60G]9TA_O9X:'V7L3/4W?(R(/R^FDE,KZH2''
M$38=N6,[-@UA@9QJ$'5;%^!I:=N1M%I@J/W,"..),WI^0V-UTV?3)R=",_,M
M/P[T$ACAE9.^2*7G(O'CV$;(WO8 A;7(5PN)H=/4;0 XH/*XX7/-)HEV<R9K
MPW=QEER>U5RJ)G'%/T:"\3Q^=I=Y+<RC-%Y_9L=Q\+A]P[T0Q09-.>Q25DF8
MKM9;V G<\B7WW^H]G2UXG,@9ZI%E68#@!%#";6,;&S+U-6A+8=.X@TU,^Q['
M4\WTLM8$._,;+!H.$W^S>9?27KR?A$PE&BTI,[/_9(^V*NI])U]N7A.Z[H@8
M;.M,'K/=@5Z.YL>I[R+^-.W63L7='#'(KU#FU@[1LQI9V5$_\I4=U(*1ZMO;
MIA$[)G)X]5[V,O!$V2PCB*VTD0!-2Z3 T2TNRV#9VY.BF%N^6L+-(:TH%3$*
M=BJI;M.V29J 4RJ(ZTFL.2$-Y$ >LM, [A;Z0O!M K8??>?3W?#R@XOYG/Y\
M_!T1CI<U^P^1I7^%N-7JH,*X 17$+GS K1Y61T$-8\MT(M([3-XA3,2_2!(\
MM7/$]._F>4BL^M.SL)U!86!S2:/JKV6MLOX5*CER08='0@_+<BGY%8\$"??<
MDHT@TYH76=/>FQZX4PQFN:,"1-[%'%-1,SE+JDGZRHDE$5Z@673C/^H9Z:?D
M;"3#6VM(4**8J!.);I7UJ>R-?UB8L ?"E*25_2]@.E=91?%5LR9<-MW9??;T
M<M@C0DAL48IRF#@NV).LTHO;@>N;S#4]()NKS;LLKSDY^JHL+BMB":WZ'O!]
M3BW\)K!,.8Q<*1-O!6U/X11J>$6V5#>1C*8#M1F@S\-%"":0%Z9:JM%C<=GH
M(_U_)IAGJ[PEM7PZW@<*>H@O/X;?J]W&[)8UX)>7@7SQ!6<@[WU8Q;<P(M$F
M+8Q:,&P5F@P=L[E\JV_[N8<'2=P>DKG(VG8(@<&%KFC*$+<U!26&EXR@-U[C
M$Y&9;ZMDR/.H5PB5XA I [>]%'=C/,]R1!KR_TW:O95"/+0,D)BVS$V3_J8M
M\DP*#O0_OHW_$&YP=-89R8Y\E?J8&E:<!/(ETI$WU.M1*RB4U'R!+'5ID.?4
M4,LG 5/3$XDJC9N&FW)*>MP))0J2II@^'Y[G.&L45!<\/U !K(V4 5>'BS%^
M'H<>?\[>6P\4YBY1)NHFF2VRR[8-;1G4WI"7ZH&\9&R 2BMXQ30G1 8Q-5^6
MH7"ME3 [=U?1\G>VR_F8D6A*37[YI-:N>Q!MKP\!: EX1J?$" (\EYR-(#X9
MW!?'?GCE\+.Z*9<A4A+Y%0&7]__:^]+F-HXLV[^"</1$VQ-%B(M6>UY'T)1D
MJY_;UICJGOGVH@ 4B++ *K@64NA?__*N>3.KL) B15+$BWC3%@'4DLO-NYQ[
M3A#9&[!#D.:X FKJ:P,WW PAW'KN,I,JQ3*=""%,UW9D&]]7P(U]G2'T _'>
M&1J)M@=S&6ZSS2!%UIMNZY]V"QGU,_]PIWAC_OVFQ]6()]#,QHH)B86B2L@7
MDLF+S?=)@2!I[D)3%YOLH6 #UZ*9Q JZB@&58CJ&?+.3)F9'+F#(H%)>4U(R
ME6)7V=;QK6$QD](<O%PWXRO)5_1=LD; A5*%]$@? A[2TVC,2^!6 JQ.\T\<
M0H!E)LPG9-UL8UIV5C:YXE\G>3V&E"Z"PI?!VG812<$J'P1C=^>C%LA!1#IX
M$)ISO:-HC5@EAC-/[8WP\UJ%+UF'Q!M&YT[ T8<U4"Q4(@AG1-ARBF3S2H5T
M^[NX5SH0PPY8@POVSANHN!J.%80L1-[XA$//J_@$',7 O0D:[C%&[3KM!.#2
MN.@BU^&0RH*W]65_Z/E(E4\M&LQ,!LL_LA_1U?DC>CP7G'D84C]L^=8ZXU.U
MZ"C7@K,^IBE9@"\Q$: 0([M@^<Y+R.+%H/5%FK/^D&0^Q.1@6K0^!X_%/_!Y
M^@>TNV H;^6E;6X>3=&LK)H]R/&L&#Z!ROG4S53.'LKKX<XLL0Z@B@-N%!JP
M$JWSHK/4+0EX20,W5^T:O,+E#+J3X"I9;:^2(,!)D2!4[UE=(P+* $S4L&LL
MR,*JJ_C)RXP<1*Q-?(7=>WB<&;$%68G&HR!%1TCQ])]YRKN\XA *XZ15%S 3
MKP"]'M^#>8V8;&0NS9LUM*LR?X,TM2AG)UHL!M;U]G6R/P9)/.71T)RX8.A5
M)@0REEU3&-&!=LSOU[ERHCQKKX0I+Y %M,KRTN@T?JRLS"%@"*"GW+4KW!G<
M0-Z;3%7KV93E1U8\H*8Y6,FF@M__N+&\6M])VVVQ]*O=M]6)DW9#TB_];XL4
M]*BW6DP8FDL;"HTKXA"8KFT:UXI[$!)BE$%K%H!3C2U67"H=.DN:]#X0##**
M](G,2^\HQVD*61)!"U>()B DZXT.ZX/=E5>,0"G[ (+LZSC#R*M'#_?N6*F^
M^=O@EF]^Q;%38W278T)3<[\&9H,WT"&?6)W;W)Q(V(U]^$P;56T>BB';(I$?
M-&)X&M3!A1NKB?05PFF##0<4H%M,'@J'@G.Y$O=#9S:@;U"-$S+(U!$]*<>M
MQ^D1CB<X['ROI?9&X&J'%A1X$,](H0^^MCLR(",1Q]1XI2%5B;!<!(W+:S68
MHM 31TQXI($M0 >K!S+CY2\9^Y7-TODT>KN>:8&X#^),<.-JEF[_,:-(C?(0
M5H,-0M1G^_Q%=<5?YR0&BQJKT$P_RM.D4]N('UE+,%P)[_5$ F^'6P%0GM96
M$;@9)Y(Z&KR!\?NCK?)Z0DJU6L?PP^:;>2&RX<:;&>,:$34 )#N@Q"ZTB)3O
M;\J=-L6]8\<\<W/:)"2]!%FZ&F'-M*0N7"08;&0U/-T]M*-#OLU9$EH"WV./
M&2/"1,>VP5(#8*S/E 9!F __"52VNWF[S7F3'FQCHC.;[ER7\R9V*" <[J#J
M=<YWH@4&Y_-JA_/9[=G/W[-IV\S*RET$U.D3J*>1X^V5D6%GM@7@+"F!E%?.
MJ88B) F1=DJ"8TBG98,_VU*P@8MV-,_K&?\K+>RO8,LOL7ZSL\VW.L_,'T"S
M"V4U/#)YLK#RU E#M.PB;GPX][(HM-^7J]EPL=UDWNY!RX<K3DI)8LB6:<A[
M1RQOE76HT"ZST0 ,=FV4)()&=XZ,=S/Y);8EVT$F-11'2I,22BQABF$L>!]Z
M6VR%J2"ZF[K;G#K*,Q!HSVPA%U$ZKQ5C#?CC;@9N?09$4!?ZO5SL)U5$0[D9
MIH"_KB3KZU8S](P_0W%JXBL YAJK6$G@78&/AM2"6+.7]*LF-GN*!(IE!5@(
M$S2#GX\4M$P[Z[^@GR6#'GY4Z/4=XE#TW7D]"3E430W+"Z*_&J0WW0BG\JI'
M[V ,BJP1B+1BR2-V0H$1$<,L,BD&K#0 _EX%#&60S=LTG[=5%I?PKO#*BHS:
M@B\\*,K$M)F]".O$DLF8M&= 84@),BKM^!V6^"1_GT*J$=E<R<1FBML(X!+^
M%J.!55:6^1=!1I#(2RD93MD\(1I[@CU1%V7X()K>PU2WIQ<)DL!)A_'TBB2G
M )?OX23EIZ)&:L.=@ WS_8OF!D%K9 /_4589K'W8IHKXL5KC8V$@@+2_'97.
M&M*#KK=!V@XW[NW6:J"7%K6/=\-E;>]7BT9,AZ(+2Y2K'KWN??81?!-@%%2%
MZKG;</ &H"DY01B@$_;,-V$"<-[<R6,JF:Y"&P58(Z"$2TV=@<H(=._FM"I;
M0NT6>&%P^2 J'L,:,$@( 4-9-E\A_5[#J@V_FP*:@]1#VP@+%W)K4<<!+21W
ME9[JXST[_ZZ!U[<X9BL!0=TS2R ]_H@+-^$^?B._FMKFV?%R!#NL2<<? >JI
M%QAAGS,"C:O,L$7Z'N$ZG;HEDU83B=)P@H!/!'Y/K2E-=E9YWFHW,TV*A&;E
M?!(T:X-=HT6#:1F$>ZIR9%2 EPY@+BT/XN&(93'<KJK.*.3++]+QD@Z7449+
M#P&L#-<R&A^T"\<HB>3>.?^SS>S9[HRYVT%@S[_2TO9OMO.&6]%XGK'+2YRM
MVAD,W&S38 506HSG$EII\>_3/"6! B\*2K\C?*2F8; P)=!7^ 9SVO4M#H\\
M'P.HK5AS;'&%.B0)CGH0+O4-D5>P1I^A0E[]!);#A.#S$\[GXQFD>X988 )I
M0/ND IJW?_-]ZCH,?^VR#2KM,>#(JYBG?76+)2UH"YQ5QPJ""G!.VHB^/^J<
M3]%0)$@M2,ZU!7?W30BQ"2"]'8#60[X5XJI9]=-N<R"!_P?<L0W<]:HJ/1R\
MSNI%WI"A;]*/M,6A<.^]>'=3Q'8[,^5NGS'[)OQ@FH[!09'CG15D+3R2':-F
MEE>3/3BCEK(C_$PD:HVF588_B0PH+AMO8N$&['1?N#LY4UF?$TZ@A9ZXB[QJ
M:Z*Z=U$%](BZ78"<#Q-VNAJTH8DP!9RSQPE^UZP]!^U==Q+;M@CAG,&^>VB_
MBOLM.TN$S60$3@BHZ@J-9^9"_&/6-ZR;$_=J;L:*/ 7" 5S8@_=L?X_'C<C+
M&R6$JAP!4D,9$[ -"'::CNC4O7!V658?^0SPKAK 'Y0Y21TKRL0S0Y5[9B:^
ME6/ F_,$PZ4:F2BP*;<L0#\2VT7%)AE"%9@]PVE+/CW!_5OM(,W<11"&8\\-
MPLG25VMB96C88$9D?Z,ERR?@\ANL7'[8TTN4^"3%/.;%#X&C'R _#(04B>,G
M"K7$84WG>+@.!]PWP<>FF6KGNT_J<;K IL J7>03U+)PIP3&BBOEHLRI6IM#
M%.=%'D901A$(U TX=9V6SJVTOBOO7?>7L=O5+GX!&Q08]7_EX   (N<$CL]T
M4N(+FS5*72 XI]V7)9@O4:V=!STB</_#_</#'Z"XE&'8T:C0$EW49R/$P#O?
MS"VT.@P4S4LEYC?V7>$L /\)+3><47S2^&_;A7">0<#IS(MV)9L1] PL$>3\
MTOTSTDT(U@A\W?0E<_OL-!#C^-JPS)L@@%P5LBA [#&?])Q\-I&J;>.$84=R
M0 VU9!U2 TATI*!=*-W98%K6X?B>Y)0B=ZLFPT)E6U-[HEP-DSC1Q=SR@ P$
M>+CU '^ DD7H<#EG7\JG$W8%^-YU.BJ11U2DU[L:9QTGA0?*L(D5Q(G3B!!6
MXY^$;F,TYB?NPEP!N"#(H]M=2A?E_NH\ ^(KCGLB]11?949I%R#@KSO68)H4
MJ^G.9,HS&+&A':7+9^ZA%_L[J,<]L&>H-G',^DA5>0[1?HEZ5"09$_Q]RMP,
MO%M$"T'_/258+7W-[=<).*64K#'I&>]R)+S_A*W+9"=#+3AT" S'6=7VA'S9
MI['APL.6.FI+[DD[1>%:5^!K"[J[;>@]T%,C(63+'MK-3<(7P7]HL1_PYIIZ
MP9<[^>U?[U[O';QR+P^T(<YC\NWA>6T<<@K^,&:![)Z+EN*NQ@K)N8 FS[V%
MRB]0>SKSDB@'*SCM<$*Y,XY[=GU""3\CW;OA[13@#K=:^;?=UK/VYA CR<%)
MF7](X"'(D\)'W5D@SXH$' '_+@;='.Q*NWE:\UJN?=0;')[,NYC0[C4AK^S7
MLEH7\?HD8A^YFRVU@-?:YX)0,J(RA,/ TL8;;!T#/%>B90,':HM<- TY_2%E
M'&07@F>2!PH*?T97@=GI;4B"L6ZL&]#]XYKRG<UO:"3)]"C"?>,CS(#.R&B:
M>*N"JEW4&:]E.'YP[T6IDQHV*?I \2K%F[5%)E&P#[ZP;DY#&QK2(H7!<2_1
MCTWZ7[MZ]!:YHPG_M4G_,!1D&ODPOZ'Y-1M %[SD-(S0*[C!;A\MFB"[:)-B
M!%73)&E'4M$N2W/3W@C"/P#L@=(FU4FP$7;N?-Y-$VVX6BX'&62'(*=>*REX
M7ZD\'BM.OM/%+!E51]5QU1:]TA@FZA9<I>JYCB$2+*CH84YN\-!^L$'S]B4M
M=3LI-V&J]<8UTEIL8M0[42.C6VT4*I6@S!#0NM"!1[W;WA&1<_,S&:3NV42L
M=3O^Q[_UZM%* N(9%9%%;@&*KA!WN5YN2"K@: !\B:&'+ED\4LV\KCA\+H43
M64DR;$5Q556AB^=.#'VTI^$0?\<ML 93SD <Z"Y>4X;.XS+ F)!?S*N6A*'@
ML'>'H23$8@ZGY8"6$91R5A1(7$#O['GK!EOUS-Q\H\P+^FUD<WLZ3[D:6\/C
MHWGTUPS'<,V<^R*.!&7VNSPX,5M2Y-AS'8TR4"RF24!YQBJ XP;OSCDSA+9E
MUDISC0:S/KB]W0^ 0DG\'/V4B:B#,FY0]8+DO9 Y!:]RZ7? S:YZ\5)Q*-Q4
MX?D'"C[,9YS7^*9-!0)Q$$'E->CQ8<V!M*P\!Q;1:=+)FE.-))"W,)ESJ)(2
MIU+?]DI\'+R^3,K4XDS%VC206T.)0"CI 1$I57(M966_U'-'Y)DI;GJ"^BU.
M7G_&XABYG82KWP#%RKZG#EU+<Y9@NERB=F">;&MQO;TX5H]&(%!1=H7M >N7
M2*-E@,:RS9:K^Y;78[:XRF>2,++6V[H#_]KZACU(H9AFRH8& ON*Z:F,.,;G
M)2D>K,.S25 4"1?AT$LK!$15'&[KT(1#9O3J5P9-&O\&RL[605(BHGZ3-T$V
MM]@R70;6Z/.EH]>DUNY855K>S&.C)F'-F(9D:H>4Y$$G.5@UB;K@-?!5O50-
M.A)N<>,PD,R:'H2T2P!/XRQDH;@^)'A K F.ZI\M :EXMWFI-@6RY.<LF6H/
M*/\N=Y9-.[S+;-HAT0E93MI+&FDY3:VR)>=V,>'6G6MF6]!!KC(A?V8^OFN'
MD 0B[@:. 7&7,;"*0&60L1A<SJB3BE$0;[M%#%EJXUIR\KE6IFRWR.?YOR79
M>Y'.6\T YL5%5N->?+RK2/"R"J^RK-BX<&3HNDN'4E2!;@DO0K/+_7+J,#IZ
M/;%XW[NS$K$J_:20GW?X'CN'/S%"I0!GVL2M*5(>XX_<D'!N9(+A) E(/%=<
M@Q>L%V/#[+>$Z(9&1G;F%8\$@[3VB)LI>E.,R0#P(@9W[N&;R\S-_+HWIP-P
MW8M%1#9<WA;F2&9E7\%1'R9U26UKF@&4E[<[L=/3FU^-H=[J]%'!+350?@NQ
MMC6NN)3/LCR8F%4Y:H4%ZSY!^UH+<E1Y\9D;>4>/MW5V+$ X1]1:O3)M !%*
M&;\39(XY8X*GH\E::!.09S:DV%<;-*%>4&3S-7#GQP=;.-C!%N[]3ML$W@(3
MF)T#\20ZU=D\6\Q*=*4,Y94L_H3R;+B% @P 9!7T7!$&=/39:F$@/X>X[SPC
MKG%T[=H"N\B@55WJ@5[4FZY!1?LMJ/Q;BB9[W@15[PC%9* /;44<8I:M#>&;
M[$1:,4OM3Z/"M!&B&]@3=%%E0*&.]68XSR%^E$,7Z9F%G-B7J/#%O%QHSA)@
MYN9A!R>^H@Q1SX\QPX<PQYX+!TI@5D"]O]<0Z7SXYN2G,[IRDI@JLWD9=U@A
M!9Q@-2,!X1H @30_Z//+]+CE7*>F+U!6#R!OXB6UJOCE5Y/I.J5T$L!]]S3B
MX<[.P#G!:BN67N(WB!=6XIM)>V !V1Z^7!=<9_*))B<WFI?L,L;='FW!/$G9
M1.X++U@6SI_X6)27D',3$4=G-<Z'HMSX#_"Y]1'1B5KU3)S0Z.0@R^HL+?)_
M\R*X),D_VBS,6(S>&$$U"Y1TR*?+L-%V[8W1HV=N$LW.V+N*B@5U=F744Q<,
M"5Z:"];O0)XPZ/%=<6?MP(%T!'X#$Q;8!VP'4\8R4@:4A#W^B)RY<*ALNELZ
M+Y KA9L7"KH<KB_H*8 TML=5TV) "WC.),#K]L%7F":TYY$:A[IW<TNJ1YN"
M, .- 5+P20U@]5+T*\R)([CO4= S! OQ@YHET[2AJN78M^'FX\/)^V-+J@+/
MZ\\64NV"<PN^9[Y&?22FZ4\57)*@1!=>3A9-;$_Y&&X5K.9-*@ &.#L/,%U(
MSU-#@(=V-/)XHHD"T&?9$A2"2>T-*%/UTA/H;H1G)P%.? ZH<O#MXE/7LO]K
MVL4Y WC\+"IRYU$!RR<CD2DEYU(.GK(]W1#1T/;-P,_2D7#)%^9L[2*MFQ49
M7)*>"Z1]C'R87.<B+^?,XTX/8F:;S0WY&UB;P/*]UHBF@[\\V]_'3[&]E*XE
MP>I?#I+@4[ -D&_1;_4!S2Z!I15T=J !&6M4O0^97#?*C .N.+(W4V[006S1
MG/%J&^\C7:;HLN'I2BNDK/(SQ+J"U YQ4D&?"148A[H-+303M(- +:W@OD?W
M28EI [2==9_[9[<=YJ!Q#>-%:-.5_#MY0.U[PLIJMM$S4:_$;60H#2XU::-&
MO>[W>T+IN3Z/QN9KW</W^%#J/UO7N\<A#\\TT^*3T'PA!L ,BWB^>18?</=4
M#?8S?O5% ^K^-,?OV+/^.[<=NE7P%D?0#??Q6 6Q8&0_I)^<L]? %MG^I7ZX
M[Z[!-9)"W84GX%Q%IKD=,TW'6!>W0C:X+5W\<\ZI:P&-.&<\!T#&+Q_^U5%O
M D((T3RC/?6PT4]O-"SZ.P!KW#EUD P.]P]>4OF58D6[]DX5[_C/Q00&SGWY
MZ=[^J^3.)"'Z7^QWK@[A@7+"C=X<X9RHC_CM\>G)X/G^\^_N$O@>I)9E(=IT
M 3]DPH6 \JP +D^I?TV),H?(@6AE3MI*7$+BB((M@/(^\F>P+\X'DN4_B1>^
MJ+&EC21$Z2 .O@+GE5R!<ST5=KE*M.-+. #$/U\$V HZCC,2C1&@*X+*T/(E
MYM)^<P9U'[QPN!N91GJ1+DT*"4$NV=@Y?5#<9GTJ1']-VLJ[7N9+L>R8L(>0
M1RCG>H\U^&N-%Y9^4_/:X=C,<F"-P+))4[D(5[(OS EH2I9_M),SQ*V[*0S+
M'4%RB"868G1S/4A_V%G728Y$2!%BT7FBN,$\)&^*+:6?+?===J9I\=61([5&
MW-J":+SO((8=/77DXPLN'Y5F% X[#E56Y0AH%Z51GM #(-X 5N 1:I)!V;%O
MX?4L.X^BZ"WZV2XOTK.D>PEA$K%?33/N=_"5<.ZC[5V44\-2A@8 ;U2Z:]-C
M^=Z1F]2^,HL)%D/8>6_P)/26*'6<UBR0X:<\):P<M)4R@M7_ROXF@%W!:X//
M' MG4%'(/0+.KW''S:_=A%%9635QYH0]25G2EV"C9IU,2.;06N+07-#KH*TF
M3Q=)%]Q#7U8(NYY.F>T*P*K4$]_S,LY2S!GK;W#T,>I^TWPECPADIJJ_B$2
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M+8'Z^BO=SKUCP+:T9J U((:<Y<N16 '+)#S9-AWF5T HK,!)7W3%TD^!PE[
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M.Y:Z;8\TO30%T.'82#T3MA(RR,(I3WUFGA/C>C'N0SUH6>\][-#IC T)^@P
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MFYREU9-)VJ1/W.,='!T=/7UU9/[S\ #^^^G3)QG)Z@$K'FF1@%3><-8X>P/
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M\.[7DV%H*ZXP?G<7?6PV+RI5^?T5!%#O_0O]ZF(IC'9>]E R/O!W>U(_P;:
ML3/1TAEPG55YL[OZ*KJM _S?IW">WM]A[@PQ[/X5_1?XV;?OJ]S]8I'.NU_X
M;F<V'L(+?>UFHXN WQF.&Q_HGD'VIJ/3:1";CLX7>DQ')\&D(5['*>:_P.C>
MG_3 =E'QDU$Y6;K_F37G\[_]?U!+ P04    " "FBVA3QSE03M83   ,X
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M*KN$"C)>P2:KH ]Q#YN "KOEY=VPC@FJ<VA3E_]5V_#X\.9:9^?Y-?#<V@R
M90DMHI2^)L&3XMI$+%B_N;DY?^,FN5N/G;8ERM?XKS6]44QLFI'FE\W^JH5T
MA]!ATQV+Z1#2[:G#SHZ79A%9E.)O-Z<:NSMRSD8("7CM+XH(=*'Y889?SDWL
M.92LA#EG=(%=).$?POC+R+<@*B([+,Y_V2$3. ZF@IX_"9XME\B98O\!>\0-
MYC:TFB&<ANXU$2YV=$WQXQ80DV [HQ^?+PE>0D(1=*.A1C"8$SB].^,!IQ9Z
MS]]L,/G - F+) 3$39^_/F<DT.YM:A+2<NN[.W,9 #;TVT;EBB\)+%IQ1N*R
M$": _M/7WP1VT?HS$M.S_S^J;\%IT>HS$N2@$K7GU&/V7D/6W5D;LSQY &9,
M._[\\_ Q.]<1XC>$(?>0_T:QCW66DK+_M-HFQ:YI@E+CI#^=;Q-LL?)<:/6=
MC^+W;7,/B(,B$L(M.\E-%V_@G63!P[!%9>W<?^YTGT?=#OMEU.\]=EKC;N>^
MU6L]M[NC3]WN>%08@&R.$F1T@4R#P3%B30I#:$*>6I2I%G#5?+951VTT9O\^
M=9_'H_Y#N_\T&'8_L3*/7[J]_N@P*,HER%'E#B(?JALI6O]!B\G1N* 3SAL4
M1N-^^]^?^KU.=SCJ_O+Y<?R?@P.]0X0<Z6:];I1!.BKH;W^];NA7_]1\@2?$
M(_VN-?KTT.M_/4*/7G.6XVNPP4RIGLSX:T) A? <>8L%("L\O?=<Y$#7!8XU
M0C,'39$)'-HRQ1 -.;,!MI')TK*BL!87($&797VZ[N=%R#5MS*1!#K4O0\-3
M+92B,3%:1(ZV$:2%DDXPIZ/P;G#G@IWE^XV#P:[]&/[V]Y,%I /S# AA.K_
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M%Z:G-0#(>G3^C?B)^1=D,5_D1@XP;[ILRPTX08L?82\1\/<6^+V3QC)^K+7
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MWWV?YJ-C\FW*L /]GX].84=4A(6JZT0]^ 4!\04,&X$LTTXIK()IKS>262]
MN,)\G3117*6ZY*N"2IHG>\3.Y<("/2J%7M7NE&,$T6;YF!A"?"6(4N@\8\KB
MWSYCDC2.WWO2.VLW2(&L74*M@MU'-B &&SO[KPXD[APM-\G9,V2(66,<[/^!
MFSH5VEUT<$DJ#%2+'X]4_6SD]C7E_KEI?O)"<FXAG60/AW?<L4V!J[;=PM.K
MQ5DJ,L>:=[?,"+T=<O--@IT*/>&S8VV=])7.FLM;HB0S%=IAY\&' C%PFT2%
M.J7L'9'M$962_ FVAG[!%*Z_W%8\;=LB_]XY6OK,T@"LN&+^48N]YJA2.2DQ
M627&'/Y-R4%RY1]0CGS@;HS[(M'.F K(S>1/>1!ESR.K1Y6IZ+QAT6U:^5MR
M#ZZ*MM4G;P%VW;$0JWJ\D H!<#W;N[YP/>?L<**\"K5I0[Z%/R,%VRJD@M[2
MDY;@[0#'-1-,%.U&.2IQR(LIY!P5;:/D+&/P<9T'\0W=Y-DU_RNU+&_DPU#V
MGR5SSP?BKNR /W:K;HM?VRN"#C]%&F[#'6!7#,Y<-F[U9Z!B6W_&F*5)7S'Y
MQF*29.;S\(*4R#=CU6JSE&TF+C"3F92,1-69\,@^BXR+DY(%50@I8: > $([
M^6)ZK*@*=4@9:LOG'#*(5*C79AHLXEJ'+"=Y9;TF[^YE":D*=0POQAK"I4?,
M.<>"\+G/148%L^E4J!T?ZP53=WR' +(@"3X#P&<U^66<8P(<%YB!8-FL>0E6
MJCK-7;G6^B<L>\ KA8,2T;#O41;&A<R6]5^6$>78Y2:G4<&\MT^"K^<"1Y3G
M*&*G:,Z)M#3BHZ[:B=FK_!N]G@"?<'3$D:L@P76#<R!9>[^DI(J.'T9S3"B%
M9)&QE7J[F J6^81<?LLB<""+$3E.P::75Z$VF9<OB'5#_@=A+F_(M2E_D<,N
M7BJLG:<JGK5!X $3L3W/H6/,1JT>\;\'4K1]2HI1H>E&2Z88%EKSR6A+5)!?
M09S1L[/(%.D;0G4/V/V)C6;^9[0*G?@OPD+5O=<MV\8F""^4G:2L$S]#EE+$
MAME\>$!<8&==$7(P_JKFI!VQJB7O$/$R*EA_VIF/W+<7)6C469J6W+I3YJ8>
M!4Q/?$S!->=P 3[^\#]02P,$%     @ IHMH4]689G@,)0  !7(! !4   !E
M:'1H+3(P,C$P.3,P7V-A;"YX;6SM?5ES6SF2[GO_"M^:UYMM[$O'=$^HO'0[
MPE5R6*[IN4\,+ F;MRA20U)>YM??!"G)DJR%% 'JJ/I&5:BTL,[Y@/R0&Q*)
M?_^/K\>39Y]QOAC/IG_]B?^9_?0,IVF6Q]./?_WIMP^OP?WT'W_[TY_^_7\!
M_-?/[]\^>SE+I\<X73Y[,<>PQ/SLRWCYZ=D_,RY^?U;FL^-G_YS-?Q]_#@!_
M6_U/+V8GW^;CCY^6SP03_/I?YW]AC"-R%D'$G$!Q:\$Q98&QY"-+(D:,__OC
M7R3Z%)C0$(SCH)A*$)75D+BW)F43G8FKAT[&T]__4K_$L,!G-+CI8O7C7W_Z
MM%R>_.7Y\R]?OOSY:YQ/_CR;?WPN&)//SS_]T]G'O_[P^2]R]6GNO7^^^NO%
M1Q?CFSY(C^7/_^N7MT?I$QX'&$\7RS!-]06+\5\6JU^^G:6P7,WYO;B>W?J)
M^A.<?PSJKX +D/S/7Q?YI[_]Z=FS]73,9Q-\C^59_>]O[]]<>25^PC!9?B*(
MI_.*\<]I=OR\?O#YB\-?7[[Z]>C52_KFZ/#MFY<''UZ]_/G@[<&O+UX=_>/5
MJP]'-)[5\Y??3O"O/RW&QR<3//_=ISF6O_Z$GY:?H J>><DJJG_;X*G/OR-/
M89).)ZN)>DL_GSV[PNLT"/RZQ&G&]>R=HYC,TI4/3:KL9O/S_W,2(DY6OQV=
M+N!C"">CH^4L_?YI-LFTL%[]]^EX^6V$TENI$@,IN0.E$X)7+ #+/%L10Z95
M<'7RZ@ 7-,*5S$M8Q)7@SU[QO,[J<YPL%^>_6<TS,'XF_W^['<MZAA\^NA>S
MX^/9=/7<_PR34QQEDX4+W@&F$D'%("$$+<!9YKE%:TQ47<9V'<G5D5UBS\$\
M/9O-:0I(Q_WT[ M6C72F[M:PPCS]0*NKB^WL$\\7I\?'JV?">(G'Y_]_U7U-
M.;"<-9STM61I!+N*_B#G<1U[F+P+X_QF^B*<C)=A,N+"&N%\ O3*$QB7(/B
MP((W/#GOL.@N#+@%T"9$$$^3""U$T(P/'\@+(*7[[1(OD1GGI$@@DB93G9*'
MH*P'7ZPMMJ C$]Z%"C]BV80%\CL+X"G18,>9;\: ][@,XRGF5V$^):=Q<9#(
M0:S3C/DEEG$:+T>^\.P9C:O$;$"1IP<Q%%)<GIM 6DP;&[LPXGYLFS!$/4T]
MT5@P[4S(=QR'RT\X)\-V,B</;KH8?\8W%'L<X]O98O$K+@_+A_!U) 33B%:
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M_ '0ECY/WR:]K?FTV_3W4=L7!NC#[%)3\;/C63^'Q3B-E,%@HZ:!6TF$#4R
M\\77SAHB&X/>BCZ%U%L";6O.C$X:I=40LZ7(GX0!P84,KB 3WDB>.QT>'VQ
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M)D'SEY]I1ZK^%=?]8C)>0/H'FGPOYM/9Y!*:5]_B:%ZLQ6?3*>#_TB?_;6"
M.QIT(DDQC9"C(#8;3J@Q5BNF K Z3#\ ;/^$.4[#V^E233UW&<6.9=0[M)S0
MH!U_?C&9SJ;/QNG5MR]XU-\0B(7(=.1 G#$H$*70[@_6H7PB#5R!<)I5X<^#
MT)[\]M*M\"NPH^!ZEU>T'IAHI!*1$2V%)%(B7QV ($Y&*FBR,5I9A0FW8/2O
M]8[5-.E*QA44_IMO_@EEJ;C*9^DK-+/A%+];+7@0>-#6!X'^?E1$NA2)H\(2
MFM&P2\YR)^HPX'Y<YT:)#K5PER/\4(X4MV6P/LM>^ ;*LL<HM5'9$=?@LDXN
M,4%)EMKC?L@%\<:C!&2@GND<#-B'W*%63SH7I7<OUKLZ%T?I_!/$B_%D-/E\
MA="*87,#%VY+7+B@B8G4$DD%XF*X::6HDM4^"JI"*W7?\Y"STG17PKRK9'GL
MYO]7&..R1XM-YQ)E7)8Z&WZ%-3PFN';,,!*C1%/54DT"I(!KIDI1KZ*0M,KN
M_P"P<^%'#3W<I8DZEB;/+B=X(/WW(@S^+K\>S_SX\S",H'@UL^D@9V%9DI(
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MPF9%8XX6?U)%[0]C>_)<Z%C\%3S:#83/8FR@B/C3Y ,D_+OR]=_]: XW(*=
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M#^!7GAM#BKU$K4@AIGZV@!6@,^7 (>*N$(G]!Y0B+TC/OD+C/\/;>1'-N[R
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M$1"N ,6RSD:'Q9T6C*>+>\I!3IQ%'DJ;0,:+8:B(IX*5HB=CN38Q"UZ%=$>
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M6DXD0&3HV2(^52G6?A^L<R!"=W*OL M\*O[PO+FZR=.8G%%42L)DF1SB2H&
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MKTRHRB8P64<8!X#M?\/KE$MW2V+KJJM"[&N'/%:E??A_H$IK$*!HDD7A2!#
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M+?6.P^VK^[Z;D-9ST5J ZOS*92><_J]<.E+7I):L>R."ICI''Q0)GB>TJ\O
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M%DB'> K=*Z$&0VYUCV@#YL=N@;27NNYMA7.(K*NW0,+G\AR=(2YF/+2LQJ^
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MD!2K,_-K!Z SLR$ZD'J%O*(ML%;\;P.LKO6P"]J)3(<N%/@P*8Z0?@VC82=
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M7Y:\$<W_JI_G:UXL[M[^8'5^TQ>E_ELI!5O-,AF)7) 42JG/ P.L$\$(AVF
M2"8B%(9Q;M-;9USUK<ALI.8]1:N^3B)CRKZ;^K] ;,VL3_3+#0CUWRV/$<;]
MDA@>.4QVZ'T?3]2CK/\+=BS21Q*;(:[_V(1%[_]N[X&V;D"' OBIP^&/-V #
M!>BP !H,T*#A\)3C14;1[8G(N":,>WKR(L-S=-+R,EH,K$3/_[ZNFENW;\M;
MSNOH9C+7QX;O%Z_)8Z'6A=KUIX?;@R^BB8867T7Y5##1:/Y%L.7=HGY+70]\
MQO,LHR&-U<I)4X@2'D/,*8%!A%&,$A9+9M5=U[?"D]L"K);L]W8;OUNGV++0
MNN]A-EL%IS1XGM>]V\_O7]^</H39[JMOMLM9$]->K<".30Y+O(\$O-N:\+Z5
M'K>(_$A#<%1U?BRY@TK/+9Y$N2KH7'Q6WQQ1EH+7A-=>27SZOE 4>U\\*M%,
M64#NQ$<AN.!-B'^E?O5M^5Y?$>L*^C,FDQ#':H5)L400Y0)!$J81E @C%B0<
M2\8LRM*YU&UJRTIK!%AV5H#'C1E@4=M14Q)K+-&WB86V!7#=HD+MWL0/IJL\
M+B7X/\,L 0_%?&Z\*OD8^_X%Z(5'U/\5<&<8V%@&:M-N0#?2&^O UCS0V ?>
M-0E5]4A_6X+:1J"-?+GQM"JA]U+C.EIYO=''U[;ZGH\1N%"9SZG(,:OV^<#J
MH**?%Q'#=IC[O6T.>^ <% ^0%..<)BDD7'=3#&,!L0@XE)324&"1YJ%5E0<;
MX5-;HK^N'QY(^:R7V%\7:I,P+_ZIIO)?2+%H#DEU(2';L'*KP3#;T_F"V/.:
M:=!JRVMMAB&P.=U=62DPZDYI"#2'NYY![[#/_'W3.@#;**EWZC?53.TX@D3$
M <1$4L5CD6(TQ6"0J^T(92$286B4*=@C8VITU:FY&U\(:DW-TX#/P=G/1(Y
M\DTX]OA8Y01?0&!07O"Y=XZ6&WS!J-W\X$L?'>:]?%";7"$^-(?Q%2N+QZ:.
MP$*\7XF':I;%,<TE4A.="=T,E""(<4H@38,@HC*@*35*\S>4-[5)WZA[TZ6A
M[J@,?M-*@UIKR\"52YB;^24.D?3,#->":.U[&$+CU-VX)'-4#\,0@$.GPO2Q
M@7%P:UJ)?ZP5A;U]TCLP]9:F'](LE[G:G>6A8I6<0Y1* 4D4)) 0'@@48AGE
MV"H&[IRDJ='+5E%0:PJTJI9-LR[#:\8G3D#SS"0#\;*/BKN$A=N(N+/2QHV&
MNV3T423<Q0<&)J^6=V11_+,^=-3'-<MYP9N(W07_K+Y.W8&D3MZHRQR1^28H
MK[(L1>M$UH1FR*X]=7W&K47UH<JN34VR5&O5MA%EY:62K5.@W::/.M%LW'13
MEV >I:<Z??G L)V'9;EJ=?@DWRN)BSM]W-MDS<Y8E$8A(AE,%'H0\0@I7R%+
M(,)I1-(,T21 5D$WO>*FYC7L:JOG<+'1=U":^P6L,4(QX9C!A$KMG-7M$1&#
M-,@5\"Q3+EH\H("F \A?H$+FJ,B;K6#NOKN>EZ9#\+:JMG4('(8#&6'B-IBG
M7^2XH3A&YA\%TI@]=6UV[-NZSMW?"B[:8NROGG\A?U^673'AZM7S%_&H55G<
M=:D538*DY$&<X32$(B**]26C,$=)#O.$(183?;66#\N+':S3U):&W4S*KF<!
M?0:U,9LZWM6-_MW&(+!-+KHN 7;XR!KN4,<=+]][6:]#=46.Z]7@>LIN':[7
M"^6U7@WD^8S6ZU_MH:3HFZ)BR_5BI8/WV\B+&:,DSW+E,V)%SQ"QA$*2<PQ%
M$"8)#I@DQ*J GJT"4R/HHY*BO-49E#JA9ZT#J5=+4#9!J/\4AZ5%0:F?ATL)
MU4?AH*I6MD-H>)#B<6!\GYE<K#;:Z5]G7=UT 6@CU1OM 6^\>J.GE)A.O=$>
MB*SJC?:]9^!!AB)J7LS7J^));.,UWO[0^4Z"-WV('A[7W8G*6U+J<J<Z3:J.
M65<^N5)GEN(@1(12B*50GF^2<YBG-(2)^D.,8Q%&(;4Z[W"AU=2H==<H4&VL
M C\5"U!IM:OSW04]CIWA+G[L$?&]V=\=C*U!H+.HZZ2VL4F[P9U5FF";U*(;
MT%CF\&C )=!N3Q"<:#;N08-+,(_.(YR^?!A]?USK?N"?9'W 7;U?_.V^8/>-
M\]TL)**:A4A1<!RF,!%) E&DR)G&8:(8.L\#F001DE;EN@QD3HUZ&Y7U%*YJ
MI74"S7>M-EC=BWJ6D\4S*"HP+YAN#%K[N ^D_%VLZENI2LSGX%Z0^>I>/5JM
M2_O>NR8C94;%CO'W3+1;Z+\>0-^H##J=W5&H!4!."=)$[JCT9P'$(;G9/&I'
M756YFGTK5OJ4X/V"%T\%7Y.Y[M;V1;?TTNT2[XO';\M&5ALA$C(>IIARF%!,
M%(4%!.*41S!*:(1QF+ H,CI9'2![:E16J]]<3W0&6 ;D#!F ?F;R#*MGAAJ$
MJ#$I78%-'SFIU^X0D_KID)2&R!V%G*X I".I:UXQL,=CN61"\$I[=;^05>OK
M?2Y%UW3P=L%?D_F\^B0/<QVVKN&,I#$-A4P@SG,!$8HY)&F$8$PX#;-(8!)9
M]2]RHM74"*XSJMF!E8*+A\=->-##QDH]81L/K<X1VNZG+=L_.AE8,\=M].'R
M3)S[([6UZ ;LV-0T8M%6Z1$SR/IRV"#2)=YN&T4ZT6S<AI$NP3QJ'.GTY<,H
MOJL$HXMRE.6S[DU9[] _R2^*@\0#.<KFG04<DU3*#.8A5WQ.,(8TB1,8,,JR
M2/(@2[,!H4?VFDPT'$G7.('% OY>* ZHUVFA_J$)@3!E8LWJ72-?M>%F.VGV
MCYLT^TH;:$?J X;2C,$]C<PX=/U^I_9CIWY[?-G<\7<6'-8X<,?(P_%S2K\#
MU!B5:X?#=$BL5[QI8!S5X%+633UK)56'\:HO[D?U56YWGSQE2<YE"CD-)$0I
M36%.> JIHEB4(1%DN=7UD@\EI^9&ZYJ&J^>NXORPC!T?8VE&M"\]0KYOG^I1
M\94<Y!$[MZ%3/A0=-Y;*(]1'P54^95U!]E_$HYH6]TJH\N+O2O+03O0DQS+A
MH6)IH:@:<<7<A' )I4SC),D#F<56F=E]PJ9&OK6N8*LL:+6]AHC/X6Q!J [0
M\TR,PX$;1I,7$'%/=^<$CD];%TP_23^7GAG854#YGL7J'6'%?'OC$$<LDV'$
M(<HE4_2A_H-1F, 8"\E%@H,PL^OV=T+(U&BCT1%T2@YDBY-PFK'$M2!Y9@=K
M?.P+S/< X+8,_"E!XQ9K[S'UJ*1ZWV<'!A[6H<&;;&B6B4 0BF%"4:K;#"%(
M T)@%LN(QI)E";<J/+?_^JE-] OY9": F4WHX3#XW@'5BGG)Y#YML]M0N'T1
MX\:TG33O*#CM]*<&U(C^14U]IM;^K^O'QWF]T?A%Z-B06802F4094QX]B2%"
MF$.:A!@RFE(9Q^H;@(R2G'NE3&WF=GJ"K:(6-7K/8MD_FYTAY'E2GP '_-9H
M:>C#]*-D49/8!5HC51<>A)I=?>!+:/16^CW[\'@U>R_IOU=]]^*'A]X//HFV
MCO_K.:FJ0A:"OWK>Z>O;WEP^OR&KPU*N/"(9CC"#@@2**W-=CS+,"(S3+,(A
M#H,46T5^7*/,U"AUI\[N;B_M[3VP[>7?%>-D>@TX#OK>+P0W9H"M'3JA]\0X
M/ -MB]>2O"Y@=7Q/>(5"(]\87@_=\=VA@W<.<#A_710KP9MH>\WC[>*/!,M0
M%!*8ZQ +%"A/DPB>0!$'C,@@Y4G&C=W-TS*FQHR-EO^YT=+"ASH#HH&?>3TT
MGFGK4,$A+N89>"P<S.MA&LF]//P2N?8M^X'H]2S//#J>7]FO^YY7>>&C WBN
MJ6:ZG^_[H2"T/F/[MGPE=/C4K51$TQ137NLM=XI9JCQ($J6!VG)+"O-44:*0
M82"X)"$E1H?B ^5/C1^_W8M2$*VAQ=0? +L!:_H%TS.C=@60CPH-;"RXT?%Y
M5 !MQ0VH(>\*J*\]@V_!R7X'822^]C48=JP^',I>QA_PVO%6@^$V[ZT45[QF
MX/VIMDT[Y773P*+Z?=M6*)Q%(I$Y4]L;EI(4HHA+2*,4PX"':2XSM9@$R>Q)
ME'1I?)/:(\YF/NT*]7BZ5M>K8FW=(5 VY8AN=MKM6=ZN]H%M>,OJ"$#?MZV[
M:@*MY\U.:S.'=ZX&<+B]>^T3..X=K('I1W>Q)L_8=])IDN5N.5=?H>JU3O,M
MORV_+V:,9S+)402%X)GB#Z:<3YH1F"0\S%*6!8P9I=[VR)B:6]DFIK=ZW@"M
MJ<(1:%W->^F< [2?(QS!Y)D:!B%DU4WG @:#NNF<>^=HW70N&+7;3>?21X=Y
M"E_$BA0+P;M:).VQ!XZR@,B80$DYUT=K <0HEC#)L* RS?.,6MU.G!8SM6G>
M:;DIZV/G")S!TLP%N!XASS/\"!R'QT9F(#A=\L^(&G6Q[S?W<)F_\.GAO4#?
M+ZI566]D;W\4U4PD&95)C&"8Q1BBC#*8QXS!D"<X8PI-'ED5P#P6,;5Y7^<@
M;U4$OVDE+6,L3P!I-O&O@\?SI+=$9E#/S=/&.^^L>2!F]/Z9I\T\U27SS"<'
M'"B?;3M\RUBYUCDA!7^_^'^+!7_3YN)6KY</#\M%_2&=,/9$YEJ/JGV3X*](
MI;[:<<)8E"BG'^6**'3W"ICS1$+$LPA%<8K"W"B5PZN64Z.9UASP>"H)6OG,
MK#:J26\&8F/6#2 59)UE]L4A_7X3#$["IS"^_D]&SO>#[\:]3GY_OX#:4O!F
M.^Z-L<VGP=N=<;^MX,9B4)L\A1&W.'Z?PLB/=$C_XM\ N]-\WR/3>^;O3?AX
M-P.^\=N[/_ N;.C>X7%9%:MJ)A-))<,IC'45480$@7D:"Y@&:2:2F&=I:M4-
MLWOQU!;P3B_;G4$+D^E^P-YX[[N "W8/\/OWC73L[;<O']G'WS?IV+,_^+O=
MI*NKO)?/L]<?9\KUCF2<AY#$+(0H0!G$-">0R5#F*!0R-DN$W+YR:A/M]7VQ
M(&:S; >7_ODUS%K??N-_OO]X>_VT.K:MYSB\_7 SG]H?ML?B.Z\:9?H<J]Y-
MG!-_&;9._5(7!=25;A;\EM<K::5^>OM#UTP0LYS$),.$08P9AR@.(ICKNMBQ
M3+(,LUC&PJH:=K^XJ4VUC;9-%:ZMOG:+W 6,S98^=\AYGK;[H.VH"EI=W:V4
M9I@X73\OB!QU534S_W"M-7QJ&)U\$P^/RY*4STU!I8W+?<O_OFZBXV<TI[HB
M00(#C'09P$BMT%P$NJPK)BB484J2 64 +TLVFB,3*?M7 ;DLKROK9S 49LSC
M"-F1RE-WRH)&VYO=HX2MQNXXR!P=ISQD('94+C*'X9"/+)Z\MEGIE3U(FNZ6
M.!(T$4$*\U!*W;TIAD21%LP"EI,DB#&EX;"^I2[4FYH+M=L7TU$7H6L;FSKY
M%IA1Y\N-K6>:?8EAO:()JDOT/?5#=:+B"[5&=0GO^2ZI3J4,N#!^.R_J#MKZ
M^+BH*MTXX8M@HGC2+ZZ^KIDNRJTD?E/?$/'+<K&Z[Z*<*$]RF?$,QIBE$(D4
M0YHK#YBEG!.$,D2Y^8WP8#6FMC1TAH =2\".*3=@:PRHK0&-.187?</'S.#N
M=I21\$SD@P=A2![I\-&PN%<=951&NCCU.#IV5Z)7@]I[YSG\[>-=:EZ-P-ZM
MY?5ONZYMPQO153J_9?59\H[X69:0D(<\@''*8HAH*" 540:C6*J12W#,T\T)
MC=D>QT3L@.,9SPM4IZ/NW]TJ.:RS0B_:9CL)9PB.W#WAIT[A/^I&"AM$OUQ&
M='"[!!.(O#1(Z!7\(BT13* XUP3!Z%DGI\0'584D88ID&(-$,!T_&:60IIE.
MQ,QY+/(LC$.C2GE&TJ;F%.^7=SH7-7752?"@(D[.0!SY_-=K"28C4'P>^[YD
M$24CXR\<]KHK@_2FJ,C=7=GX!=LVAV3!WY&'8MX5=LX3@C'+(X@1HVHGSBG,
M,R%@'"491SEB46)4.-="YM089D_KW2Z>^KJV4=RRE+;- !ALJ]W#ZIES7A91
MBZVQ>V1'V@<;(>PH_68 4KV;6\-7C;>3M;-M;]MJ^>@ 'M\>]]:.SE$'ES9,
MX<"'P2@DJ<0Q3$(40I0HOY'01,(TB@2AC AL%O4W7(6IL?SF@N:3;%Q&6-L!
M=@WI G+ JZ[SE6Y[8\%0PP;+8 GP/@1C78^9H&_AH;H: HLUP_M0C+2$^!H2
MNW7E*C1[EYEA;QYOU;G*\KU%Z+HW#5B37BW+<OF]6-QI4=OZ,74><YZ(,,IU
MIQT>$H@RS"&FNF<Y)2R.!4NH63&(2X*FMKYL5-695V*GTI%5@OA%> W6"D>@
M>5X11L++@M@=X382?0_&SXZ?#4#I9>&^Y\?C6@,K]AC5Y/,#>//C<O$_U>Z@
MKH3=5-35_12[*]TT1'G <P1E$ O%G+KWH=0-44)!HYQ*$9NUJ;TL:FK<J92%
M&VU!HRZH];5@@7YP#7C3&62>F?,\6D-"$/IALZ!/9_"-1*#7P&C'H4;(]+)H
M_QO&XU$C2_:8U.R)*_K'5CI=X-VR_$9^_*U8W=\OYSI,0/WB=,/;69YQ&254
MP%RYHQ#%.8$T)Z$B71ICR3(92:N"14.4F!K_[C1,7<JV7H@N$JRUK>0S$ ^/
M\^6S$&!%?H#O6P/!DLZ+N]JDRK[4R%7#:'9)YWMP?)^:: 4AK;?E;4=FL-.Q
M^::)$ZY ;9:8\SI'1ID)=NP$GS9CY+CY[4!<W3?%M55D_&:Y Z$ZV41WZ+N&
M%H=^>"B:+BZW"ZZ;MRAA8L$*4;TI*C9?5NM2;+I*)FD2AB+@D-,L@DC($!),
M4IBRC$0D0UD2644J6$F?&JON*%]?R^RI#[;ZFW2Q=# V9HSI#7'/5.D2[ $E
MJ > YK@FM8T&(Q>I'@#.<=7J(2\91GEO6V_GJRB?"B9.T^KMO/Y:U(D57P1;
MWBV*?PK^693%4GVN6E6OR6.Q4HZO^NWM@XX6FV5Y&(59&$',)(((<46.>9;#
M%#&F-O<IBF.KPC>>])P:C39: ;;54P=.%@LE>T'F<*V<UFHI5]^-&USY'F<S
MHIW Z+VT]]J.[(X-[BC9,[Q.R=N7KJ/2O&? #Q<$W^*NS:S^*N[TEUSMK)>E
M7JO>+]3>[*'6Y=5S^\<F<9:*),LQCV#" PF1Y 12Q#@4G'/*!(\"L^JH5^@P
M-<K?3:9M]00;*\".&3>ZVVCWB2NSH,U'S/#LP>\XC!6PX70(KLA8M@;14UJR
MN1XOE'ML#=3Y!&/[5PVCS7?%@B@KZU97G\M"N?6/9-ZZ#-6,!AE)!5/#PL(
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M!B2'2.W>="9%"H,$<4QR+"+";7C!6H.I<8;Z=B$[@K 'W8P\O$+IF5@:W6_
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MNV@XJ-H899G)=.5@F;'3B$/@F<..-[6;C:]L-[Y[?1?5VK"Q"VC#;@"1:O#
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MX^I[_[H9TLZ^NN&?'LK3&7LW8&L6V%RC'OYNYP&'FV!_(^%V#^Q!SW&WP/Z
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MOEEE#Z!F_JP[F#RO#HVB1XTG%<UXV3V;X>*\E62/R-$;1EXV_U1;2(.G!I=
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MC6-IL.^KFSY;[2]K=HQS>T&C7SSNI<R.*4<7,;M_&S:9/I?BD13=5<[MHDF
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MHR>H%;7LK=(+:3^%N +*,VT,PLB8+$Q Z",(]?P..:B?#HFA5\ H9&!B8D<
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M",<\X_Y@0#S8UR?K0UJN'J9/9N1[V222V9HZF\!$7DFJ.+-1KPH@5$M *E@
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M+MGC28;UN5Y0\<2I>NESD>Z+/B^MJ;=^L1'0:\L>YJ=/335&#E6-65-/'!8
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MAM[4GNB3#I?QDPJO@T2@9)/<T/'E7OY@S>!=UG0M.*HJ:=.#;$LX0G-[C:$
M)!!I40M9$J=#2=\D8]M.M^T^MG(&M$$Y!M)A*XP 3^(=[1296SK%'$,4T#+F
M!JB&[AWC 5E8%YD+6#BUDSE^=OB^,A>D/]M@YM)GPSPUG2_RZX-2ZXZ"WTU7
M8K98/2_W<@>T)IH370"F$#5,**U[!I>@+AG/!:RYJKSJ0KM-.S9N[*3.&K&W
MALZ>X"[)!+<L@YN?)CZXB9DU"J[>'AD_F**Z81RG'M3WX@?'L</%\^G8M4?:
M B<?I__U/)7V:J1F@D-$*X!UB6PFA08$YA@(1*626-=5[I1SYCWSV"AK4SYG
MMA$P5MV*8\0=3+Q4."9FIX\.U2@ZE#^F1CE609 ;T!Y1#1!GU"/6_+B 7'B9
MC^,!1U+9XX*>[L4\+@T06":@M^G8+J7@ZW3^?:8V@<_OS#ZT-9XPRC'B7(&J
MPA5 R(8G%J(&!82Z0B6B>>65AWR[2&/;+-ZSZ3+[WVSV[!F;$&%QW"S;82%/
MO*\X=$O<)6Z8WVX[2MG;RU;#75Z'U?$NVRU@$HLY'OQQZR_<+M:P11NBP7A2
MZ2'>R+$B$K=O>%DC6 J2 TQ8#9"6$-"<2<"+6JI*D9QCX143?G&JL='JUXNQ
MB9Y%'WK0=>//.)@EYD6/F+ D+'<=I,1A8J_#2M?5OAXVENJ<_V:Q7"[^,*3U
MAJW4[@[(AN92R:"PB6<%0)!0P&JM@68(*BA+R/!MQ_P+$X^-8;9B9C9).GO:
M"GKC.?02[H&'_0AHOM99?X?PFR:W]G-JB&\\Z4> ^K4/^@&0WW[.OX*;]S'_
MTGBO>\J_HN750_ZUY\.,QW8/>3MCJ]4G_6VIV.IY^=)L,E:&)KUQ4N)*(F:.
M[KFQ& '"-C2N*"ISDF<44UEAA(B/%>DPY]C(OA7Y+FN$MC%O&[&S1N[L]^:-
M:D3WO(5R60 W0S,RK(E9/PJBWG:F!T91#4Z7>0>U/#V .#9!?1X-[#USOK3"
M;T:UKE\*KR736 F0(WO7A.LFY4X#IH3."1=F&0JO+C379AP;(;5E7?:*#&?-
M*1?^)9LOYD!<Z;D2B+H;#T7%,C$+]=5OV0D<L7>-*S9QN]A<G778?C:N()QT
MMG%^,(QWK"NW\>3^VI!:4PCK_5+]U[.:BY=W"YNW,-%$Z KF""@I&$!U;IB'
MB!HH3B0N2B9SHGV8QV'.L7'/GJ395M3L]U983_/'!7(WVHD,9&+B"<30FW \
M4(E*.2[S#DHZ'D <TX[/HV'$\V$NK!VEWJGVOQ_FOSP^S18O2G5Q/?M- 5!%
M"JX9!Q7%UJE/"T!1(4$I(*><&'"85Z$7G\G'1D7W0BR?CVJ2-G=U7,V5GOHV
M#O5:!S=:2H5N8G[:B)W]M!'\YVPZSS:R;P,&DW1Y",$L*GMY"3 HC85 <\QG
M06/X$9M4T\E;>SEA)GB[D&H"*R&+ DD@*DH!DDH"6M<U, :3IDJJ2FNGMJ''
M X^-D-XV%V=&N,Q*Y\8^)V#U,\LM$"1F#4?MG0GADJIG7O:5$O_Q??'C?YI'
MVO?<_*5YO9L7^V2@05[:2^)O7LB+OP^XPGN[F/]0R_64S]1G@XXRYR'9.&4V
MP6&[@$:D:H((4Z!FME)<63/ <E*#0FJ8LR+77'+G&SSW><?VJF[:F6W#=#/6
M7Q[[)M =KN_20)GZE=\)G6VE;GVX^W&C(5&Z'NAZW-RE07F@B[MH:/O=VOEC
MUGMIYS'<<'=V_CH>7-D%/!Y:YV=M#IQ*_L*6MHK&RAR!GA^?V^P/<^01T_5$
M8EX4HLJ!398%B$L!S/\HH(+)LD9Y7BNO$^+U*<?&[1N),]6)[%O-YRK&;J>_
MN,@EIO(M:!MILY_VY,TZ@7^.69_'%9W(!7FN3CMP!1Y7&$Y+[C@_>>--W*:6
MYB9+7Y5:5"4%NF;8'.=*#3B&&M2\TEP8]D',*Z[_PCQCHY7===%&SL KMB,X
M/2_6PD$:[#IM5ZTW6NZY(PQI;LZ.YGJ=^[+S"E^\);OP<?\6!!^GZ^GWMN4+
M6RG;U;"[F2$4EXHJ"8AYYP$2,@>,P!Q47 NNREKF.7)M0G!IDK%QP$Y.V_9.
M>=Y[]<+93P.Q0$K, =[X>+4AN ; S8T(+DXP6"N":RKN-R.X^MG0SMVG\8=_
MFS_;=E',+'N3<OCX.%TW-V%J/X36T &O2E6#LBY+&YA3 8:-=8"8KDFN-.&Y
M5V!.L"1CHXV=F)E6_N'BMZ^,FXTQ"-[)&6C>U"4\B6YN%<DVFEB/R791C#)1
MHYVC 1JYOWFH- -W0[\1M-/>Z;<.>$-1YJDM?=KX@OXVGZY77[[^;5-_"M(Z
MIZH -:H%0 IS0$6% *VJ*B\4KJ3T2L_KG6ULA+@3MFTDD#W/O>_K^^%U==%$
M BVY=V:+5QLAW4B:_61D7?V<X)CEA$O\0LD79QR^*/(UY<\60+[Z4!B1O%W,
MFRR_OT_7#YM>)_>KE5KON7QLMOH?MB+0^\6RI;J/B]5JPE"M<VQH!>E" 506
M'##;+LZ88W6-<%%B3?U[:80+Y/-.O4;/#1[2*N*&]=%(PEIQ!20K;"]J2@%%
M90U(P1',<ZE*C7U[<PRY.H/U\!AZ8=SVCV&@3G^+VRB1_6&TV';@NLL:1=HZ
M&(W\F;8-NEJ[VJH0;[NY'<:H>]$-X@RZ4=T.V_$N%F'$T#H69FAK@'_2/447
M6(FAPGD%2E$8FQECV\0(:E RQ)@T>QJFV*^DA<.L8[.=MT+;8^[9V@VA13'=
M%L&-&:-#FY@$HZ :4/K" Z7(53!<9AZX((8'&*>U,7P>OJ'8SH?5ZEG)=TT9
M]<^MA?K S#=Q$T;;?.BS^5H^V%1M\QU;392@L.*, 2+*"J B5X!*#('D0E=U
M22#&?MU9P^08&Y%9#1J[PKQQ8O'XN)AWS@!K9ZA-L'G[HZ=.D>QIN?B^9(_9
M3U/SZ4;ARS$)41?1E?:2+TUR(K1XMRIDK0Y9J\1=UJIQM\L$:#^\425K=(E<
M&"@<S/A5@P)D&;ZD4#A@9^L-W3!<X/V3,@:G.DSWW/:-:O[U32T?)S+GD%".
M08F8 BCG)>"22%#12G)H_J^6N==ED].T8^/0K839K,G8,7,^>EXJN<'M>(,4
M'<34UT6-P'?922[X#M@VV_Y;'[#^%T->.,6]!7*;>M@K'R\X3NYW_)X.M/TL
MZ7U1&SOD<VN&W/\Y74T$E^;<F0N@<W,T15!(0(5BQL8C!5>P9+5;2L7UJ<;&
M/HVDV4[4K)/5G)6,M+ZGS\L(.]I>47!+;5X%0N9O/%U%(ZY]='FZ84V@JVJ?
M6#G7GPBDC+UV]9O+H;=L]7 _;_YCCZ8_V*QI4K_I3S^1J! 8$0ZT%@0@9+E$
M$@H@0Z(2$/&2^Q5M]9=A="33J=!$=1B9[YH_LSW1N_:RVRM2^WM/[@E8*D=2
M2KL  ]T[-VT$VZ"^AP;MDR7X_5M3*=8JD35:Q*2R< SC<ER ',.27SA0)ZQX
MPU#!=3 6CVKKQ]OZF[FL-:TE 5QK"A"'"A#.!5"\%!AS1(W!Y5GRXMP\8Z.]
M5LQLYY<.]>I?PM6-OR*@E9BC0H *J4K1!T/L A1GYQJZUD2?PF?*2O1^W+^"
MQ+T91S8A>3/V?8(D$74A*.!5SHU=!$O ;$%2)BL&18UR43DE&YR,/+;7?BM<
M9J5SKR%Q"%?_NWT3"(G?9D?]O:I(G-4UJ(S$X4B#U9$XJ\!^(8GS'PB.-K/Q
MK\LFL^#+=/7/QK*;,$B5* L-ZLIZ.6I-S#9,:Z")PE6!2%41KZR_\].,[74\
MD#*S8G:6KN<F? %4MSWX=J@2O[0!*(7$"/6 $#O^Y]Q40\?V]*A[)FZG[].!
MY<%7Z^FCV= _Z6T1O.U?=KTFNWCKJH12%%0"6F!M'1<:\-R8Z@4K<JQDR2ON
MU+H[9/*QD49H6R\OP-VH(Q6,B0EE([;U^>SUV-HOG!D_Z#T$J[B%PGT$&+9B
M>  T)Z7#0\8(*(;UM[GYX!<E%M_G4TN'74"0[9P@W^Z5BOSE3_O7S>N$D*RH
MMDUMB#EEH)P1P&") 810Y16O"P1KY[I802*,C<4:)<">%K9I2*,':!3)]C7)
M.E4\*CR%K5,_[0V#?F+R"P+^.A_&6@&/<EO)5V*@REMQ7P6_\ELW8=A;B2ML
MY.&*<MVD^4%]KMM&"K.>CPN!;2N$M7]=F>D^+Z="34J,\]HV9A2Y+:<#B\)F
M_]0@KVM"%*^)E$ZN+=^)Q[;?[,3+EM;TLQ&><C&;L>7*9LRWT9Z>P9[.B^!F
M3:> -O%F<J90X%;JS3\:S!O!XQG3OE!%-:2=)Q_4B/:%Y-B ]GX^E+@60BFY
M>F\4:&;Z]-3<__[RIUJ*J6',2<XU95#G0$#( >):&\8JS5F_@@(6D,B:5'Z,
M=67&L5'5;VIM ]$;H3.[T)GJ1#V)95^TJC27YA=BVCWSWJ^OCRN9140].8OM
M@]U&G7?B9EMY8Y*7(S216>O:K /3E2,(ISSE^N M@0+?V)^=N?:F;?<P@56M
M*X$IP-2>XSD4@+):V;@!38601&+H'RAP,L_8R*@3JWTUINUE^)K]Z4LKEU!%
MQ.PZ"A6 U[D 2*@",)E3P/.RK&J"<ZF+R5Q];WH'),>5MKCNS_??%EDWFH[P
M+4Q,SET AA%QZXSXJ9,R8KW8*S@DB, XG>L5(C N*GP^ N/RQ\.X]EX(6Q9_
M90[/:OK#7BH9V^=MUQ*PDK*J2@B!*+ AW)(B0+'  $,N!#*GV5QXM4/KFVQL
MK+N1-5MNA?5CA5YDW:@A%EZ)^6$+U4[.NXQILTJ7:TN8HVGL]HLN:$5ED=X)
M!Z42%]6/^<3IF8#KF?NYF%JGSE1M"B CA247N :BYA@@54' 95T S9@N2DQ$
M)9S: YT??G3$T0GHTPSC%#.':Y";D$A-"3O90BXN3O'PN)2X"9>!+AR\\/&[
M3[BH?N]=P>E3P]T#7)3XP,=_^5,W5J3I6EXO'I\6<QOOWF2DH;J6!;%G(5I#
M8,Y(%!"J!2 YIY7*JTHB)\YRFFUL%-851-D)&9;OUPNPFP44#;;$?.>-6'@E
MF3XDTE20.3OCZU2.Z5/^8L68WH=N;":]"VQ9;1,OD#D?02H,;0@H :(Y :QF
M&G!>(Z0U)GGN5<6J;[*Q4<=>,->>M,&Y+;TXNU%(+/02,T@X<.%MHWL02=,O
M^MR$K],HND?UBQVB^YX)]+[,UU,YG3VOIS_45R6>ETU;UE_^%+-GJ:3UKUO6
M>FZMT4]ZTPGHLUHV2<UO7LX/T&RP94&$R!4!JA "H,(Z;[3M:B_,GQB:7]5>
M]5,2RCHV$MN7--N)&F0%I5QB1R_2.!8N^8DS:,W\O4SIT8SKI$HH[[ ^KO3
MG[C(!I@RI!OPV33MO0JN?UTN5JN_S9>*S:;_4M+Z6]\HO5C:VX,)H4*ALM9
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MU.(X1U.,MSK.>2QN*H]S84B_;6VU7-N^6_)9K#\MOZKECZE030W(6C(!)65
M%J0&R':XYE6A 2LP*67.(;(E<J[O59<F&-L&U,G8G(X[,;WJ<EX$LG^#B0%/
MXETC !EG7KFF?I^M:Y[=LW/-OXYMW(N##T(3UU3;O/M7/Q=Z"6(;.RV?%FT"
M66,9O[6IJ,N7MPNI)AAC!G-=@(J7!* ZMY4:\PI4A->JK@D3TNF4[#C?V%[W
M[H+@0.:[K)$ZL]&MK>29%=WW#J4?=]=KE6AH#G/3<A.0 5<P3O#<<"O3/_[
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M3H%SH0*,C;:^/C\^LN5+TV>JK>?%9EU=V$V(B[3EI_8".>PI/=NJU_1>#XV
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M"0PQ1UQB1Y/VSCET1*D+ &>B2IT>"^:6IACVWZ?KA\VU3^/GM,64-<.RAK@
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M(I\]RQ5;_KPEV)U^N$5H/8#KY<]9"+L77GAP!WZCG2@5 FY7*WV);$H8O;N
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MSCRUU\2;@^H#[I4&[  7B$O]_I6P0 77[V-*30Y@ C/!1)$4B;;',[=F+X-
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MP<=,2+E._X,LE2L'"UH;NS;LWST\SI<O4M;7?-'?W6_Z'?E%?Q%G**$LIEC
M-&<)Q"EBD.(D@5FLWU)Q@3A#5DVTKI)B:F^FLQ6R3>]KV6K1_NFQU0,\KI;W
M*_H0I![VA46S,\\'7XJ!WUFU;*!1H,O\;%2XZ:JQ=&HTA DZ18#19/"JUW9
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MVRY \BQG4L%J^]OKZ1SYQ"1$HPT#ZXJK!I+":\,%**^=L5)H%?D  +EGZ9W
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MWG_"V>R*>J\]^<462C!TVBD1(*JL@.)EXP0AG)DA7B>NK[D;&CJ^<SQ2C%V
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MDHR8UBSH)!N5M#U!V+A)9&V/K"%UT@'$GITMZ-#][XURWI3;7>@GI4C'LU*
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MS=G(_6Y'BO'&!TD'F^:QPO6K"F'CR2G+3!,3RE=#4)ONU ;].AK-@[;T[2;
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MTCKPRFY>@UL;+/V,!Y=J3[B:..\Q(S"5A$DA:]OHO:NCV0FM=?[H.\0^"N@
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M.VJSFBY (3X$YC.4%)3#+)AU["EWZ[L:'3.@MH\<(;./Z/M!UL/33D)R.H:
M( J6:J(#A%3GGF1%,4YBWMXNL/W>1L@TQ\XPPNT'++M,.$&CA%(6H3 7005!
M8N/2 4LJ<ZX5\_'(X57]C)(YM?$Y6N =/%H\/JW8")FY31QXRK&V9+?D%PH%
M&8-0,MF@&UV0'3\7?)RYFX<XTL.KH@=<W1AI2_2)DKP%GPI956?H*Q0"=,A"
M9:=BTHUP]+W,!=]+O8_.!=]'UF.?9?>/MS8VIZBR!Y."K.::@6-*@E8I%K1!
M9FUW.K.ZGPN^EZZ>G@N^C^#&5OV>PZJ%$CD:JX$I3QY:=@6<%P$T4N3I0U$E
M[.;'?+]SP0\&2T-1=W#2/#DX)&>&(?I0)PBFFK,OP<7$P/):_B-"LVRK[W@H
MWC%^S* *&=M,/?\4YA_QU?S!)\CK;YPB%2>1$Q8T$Z"*"G7G6! 6M4U(^T;O
M&&SML6J7U\H'*GMQ"LEW8+,>Y.E77&]:(DH,""S$FO9L#43K#!CFF"8GT<38
MIEW<8U2-.8FZ&1!V33/85RO=Y&\=,NB**RYS3@)RD8XB$41PVGI0UA;' Y?I
M]JSJP<JWVHPL:S3K^E2H;*W##LSAV^4B(>;5!8^WLC$P3Y0T4B7R1EBRLB:F
M::#_9\A9>(?(C-CMZ79O2#Y!V)@3LT\%OR%U\STD#=Z;1G9QQ7M[D.#$LQAR
MU!Q0LAHI%8K("H_@)4^1R6+QU#FO^Y _3E^X3H[T9GKNP)P^ZL=$%WUQV0/Y
M,L1+H$WKE$RU/4_=R-E$?>)2@UV]R\&[P'4"Q7VU\D=-4]WLPCJLX,2YJ7?6
M'3TA]7%)G'@XGV3*91& Y1!!F< AQB* K!XW*$26\7L>67IC8D85^<7]ES H
M748&S#JD74C1GA<Q@4#:J"8($[%1,\U[Z?DN,D_W0<H]QO%8-?1Q\-[DXJ>O
M'^B?7CSP23+P7-?&VK[V(**OO+<.T(3,<DHLYF:W.@\1-7H-W]$Z?PI&!RJ@
M1RQ51K8O04QK;IUP(*6CH!X-!\<B@T1NB=)22NN:^7 /$=49E@Y5_)-VZ3 M
M] "HK<]YAZ7+QV.5BE2<0<B>'$^O',4W68+T*M<@IXXQ;0.JQPGK#%B' N V
ML ;41@_@NKO_?L)Y^G06EO_8;,)2A,9@*&@RQE (C20K91Q)+6!(M=-/X:<Z
M_FY0-GI1\ G.P,-5T26T+KFYS(O@P:60$NCZ0JU,)+]3,0/.>1MDU-:*9DU!
M'J6L,\MU% Z>!-D12ND 9,_2IM_GM0+0K1U.QFK)O0$A3<T'U\1"JEG#,42>
M4DE9MVF6^1!%O8'J&+TO&BAAY(JR7\+_62PO#_>+U,ZL./H2(VAM-B\D$:()
M$FHVE4@I2NUV&I:Z4RG9W?5'[Q@PU $W@'A'!L>OX0S?E!L\;+>-=T4S7<@6
MLZA 6<D@2J;(Y].89!W(I78ZPW;"R(-DC%<S=JQ>%T,+>>R\L[^>GX5YN"Q/
MJD],SB*X(&OIBE<0Z7O A=6B<*&"WRVO[/JGCJ?L@32T&$)<8^OY;_/I&O/%
MZT%-Z-ZRP!(+AM6$N7J"*ILJ^)VM?5."CTF;A+L5CM[_^>,5^#70_0 B'!L%
MSW!]A=YHBM=:(7!T1'Q4];K*:PB:M*NC$.1=[:3Z:Q\Z7CU> WT?*JRQE?R<
M1(7S2WAR\I2YS@&<+G2\4;A%/C(*X$8*DX*2/NV8*WS]8\?)Z6BDZ,,%UD%$
M><?Q?7V5$LTTUR8H!<5)75.B16V%E2%S&4I&PZ-ODV'Y,$WCSH@\Q2W88>+O
M$4AO<5F_$3XBG_#BK6;*@O9D!!4:1TX/MY"DS$I(31SITT#I&E6=75$<J/FG
M '6H&@Z&U!=<QD6GO<K?+O%SF.9M)\E5F.<WZT^XW#;FV*0YG;AS^3X4C9WP
M<[#T3IL*9(JRQ2@&G (L4$H1RK5.4*R77&*(0GV/<R$WOL96!;^0PT(BK:M=
MYNNMMFJ8,!>LR'0(N4)>B/+,0U16@$21I-+.&A]V\MB>7NN[R/?9!PXW_+J!
M93VV7[]EY_4T;7;O1-4A%24A),L]*,$TN;J8P$;EC/)1*6/VP<GE!X_[4GDB
M4!PDQ0Z\M)LF_!+&61856? @-*_2\!P"?8>< ^6SURXQUB:GXEYRQGT): B@
MX930#Y)>77H6$YD0>2D(+&8*HKGBX(3E@%:'XB/C0NWT?G0HB*XH&3=(/!U^
M#A-]!]#9>(T7[N(O)!J<D<1P<7YUJA:OHPP4^CAG*$RI:;HA%^))*E,O1'5J
M%"T^0=@XY1\G!-:0BND 9S?M[+-MN'+!WR5+AD)BEH(%9J*I%2T%7!U#F(*R
M7*8ZB=6>X.B[E[B=\&:^8[P-K:##,;>@*+C]C<7/8;K\CS [QU\P5"ENVMD<
M<M%P_P<->C^P ZT#A?57*]T'+Y<9R]QDT,EF.MI$G>F$&CB+R1>,WJ8VM:N/
M476L8;KOLS^0-'^B'_K'1(N2C"T%M(\UC2@E""@S>.8L6FXMN8DG8_F*K'%C
M_<$P<ML$#:>*WD<[WKNA-R\8PYF@[<>U-T3WT7T*<Q251):R@6"Q#M;6!:(/
M&@0A023IO2O?L3G:NGX7<LYOYK\NYDNLLYJG\X\_A=5T57]JH\H/F#[-I_]U
M?GVS.)))\,'5,N,Z3)4QB"EJT,R@"<*C$6U<J6'H[]C [8.Z!PW<Z93;@>O_
M(-?O;K#\C3]?+$86)7">'"C+'/AZF9>-I<C&>F\;)5#O2^FXUZNGA^D0"NL
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M)5I7<\$:34 _NGCF5%Y@3V#K71L'(XLL?ISW7W7_\NJ9D-2*UMR U#4>]T%
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M;1(?GR2G$Y[LF>"I/\&/H+G0?=G\^H!_OKD(T\OE[],+S)M.2I,D>>!:(<7
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MZ>"7A;A*9BJ-ZV<W59'$<<Q83\5097.E^)KR)<DX+-\.?+40<PTCPV\@]$9
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MGA%,H(PPSB@C+P&F^"%4>Z@CS5][$'9NW9B)2$^T;1'9^#B8Y%J#"Q#8Z&R
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M9=H0;FN)"&Q49TV.! P;6;:-I(Z.@EK>2JP7NLW%USF6$:]X?MF?;HQY_/C
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M3\@;I&>@=(LF%>L8B#LX;N7#R?K%XS<: 2NX_"8Y"N/<M?F9H/G-Y'M!+\I
M'C1VQC#\&#97%+JCX F>&<WH(%#CP">Q P-?"31S[YAUI&0Q/("@%>5?+Y#!
MJ0X.H\8 &B6?^);UBF<^1F'7=.:[-3KS]T_/5AS[+A@$ R6(UGSN-ZT@F\Y@
M:TRM,8[+G489#$3\@=P-#/M?AW;C\,Q^=_INOW$(_'SOX['JLCA@96 D6/F4
M$GKBQV!BP"5QA!8.GM-%;T;N4*4?BX:']2U,PC5RYJA&G+E2&R6=SK,XRF:=
MR[-OS1PZJ)+:@L)*P%!2KV.%8!SAIKI3A['R:T6!SP=N;QKZ(]  SS/O3J3
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M 0:_GSY9+@JRI*8FC\-C)&%;"^G!B@3YE5D:%YUS6KN!#0K*,XP2#XQZTG9
M$Z@%41=;48<'C6.V+"0KM$,LPD ^O@:=48O22D>P7!MW-@.*D'9(S,ZAT"FI
MCW>XG"&M)XK; K^5DEGK>\;2I%3E32U6%.41&ZD@0?G(>RH1%\\YX[!U,?6
M):J0$A537W.Q5=]HR=Q14(<58)T0M) TR)4.#RPHX'>=^L&Z@\62H!Q;*2X7
M^5NB\3CCA(XQG(D>J:RDJ]+F,?;9'$G8PY)?4.+9_;\:EEA7ZD:4XOR3%*:G
M_".@]8F[B')F_()7)KP# S21Z1U>AI1&@Q=S/5(_Q:0@JT6QHH)W38M"T]VS
M8Z3JF)F;2V.0N[H&2'MIB \J==/*J&M8<,%ADE&>-+TTH0=G1',KYS$26V%:
MT4CDYCU<S=?I7V7(53%U.:);U+8YX@;BVX5=L#/B(I:=\:Z>[4#R9&-#*@@.
MWXS67!M]3BK,*F./DZ-H.R*KSK)X%B6LW7F">5QM[S!3&><OT #IR<6$@I *
M9"E/!EXWOL=(6#G)K> $GS]"Z:ETCM)+HIE,#BQMKY'0^63\/LH,E+(_"D&U
MR69*Z%?G':/1F87RCCCWA_![,_2'*#."O7TP,I851?MU5P\(J#P1E$?(3FY=
M&+!O-1?%XPNSI'E+V]?T%8Z_@!4/=$5)R_31*[0LR>D^"KR$B9'>P])C_J*6
MZB7%I21NZIT?W5IK?G0I"ZI2^IO<*$-",Z"MF=0UOP S,?8G/M^Q78!G+X 4
M>P5Z&EF^4F,7\=A/1/4F5&)#[4*I+O#$*:EF('V2\WF#L._9WLK+VI;9;66)
M6M(9==!NJ=Y9=J66-5M)$1#WZ9ZI86DJY F%"P.$1<%DJ#1WR,^1%6>A$78#
MK<W%+(FG?)Z%:A1.AY!A$,\&T?2("H_-X@R>&$86?$'!O2#@4<U8QR8"C?02
MLLF+L2NYL#._F%%,-Q04S W1B([>C$94DY2+>::>BUSGRC9O;,K=*19(LJ>&
M7>)+<VD91 2SXY1X +W\[W\[?O<K:@]SKV;_$$7Y*\>*^7#^V)\Q<Z-]2EJ&
M$0D$$>?KD&5NF*RL<)A[<K63ZO! 6ER@17*0Z%KI=.BFLK6<!,,YIBS"B36*
M0C13;.O!Y1QBOFKF^A[G1$23B5T@]F)59D.V[?&;V;8]4G.UV;SN[0M'R#B+
M8QA)\*1R/N;,>K1L9)3**"Y9$JA:5E7"?$EX.'"C3H3=A)+"\S4O9AODE\>Z
MD/U,\X57 ]0<V-1L1:XOS:8"A>D[X2954_0:L[T.MQD_+TNOQNPZN=3)/& "
M':DIN8Q!E/AN[(N"'5'"GL!;1Q$9;^A14<7Y<YGMH:<J^8L/-IP*97T>!9:7
MD1.GF ):ED,;<D2>O)DC\EJFC,.*#MS C9\D@M=8^#/Z%AT]=5-_BPXD'' L
M,"F55$<TP K,^!=.TWLJXP!5#]V-TM8CM34A6MG6HTO%OUI+),T14U&DMDC:
M<DE95!FPMA4(]P'ONH\8R,_%#$Y96 S"7E:MP> 3KH<":0>&O9W[UFWT@,T"
M=\R'N+QP(O@!_G24Q6Q?@E4I0AHA>CS])&$?)-G$=MDS*?-H[-QVE]Y%)FI!
M92\4#'KL02A 5%34!6[&'C]],WN\&UG7@IVDP,>769K%PNJXCTE6ISU=VL+
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M348\/ZO-(>(M+#&6#II2V)-YTD @I-B^W"KLM<B?2W$SRM+&AS&D;> ^3K)
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M(&)8,.NZ55VY<!=%GC5QJ;6"+/\'/O=0?Y.?*9X;;Q--EI?4Y6IP\\)ILK^
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MQZ+1&5"V(%9R"*R8'0LTY,C_]A#YGEV-2Z&;7V"A$VQQB^XT-[(J*TT0Y[=
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M!KB.:1 _E"%E-^4L>CN%<1\H#P.7L.,^UHOIM(Y5[GB*K284XPQ2V82]!9P
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M0%2VV:26.]<"TV:8G)%O45N7&!<KC+D=JH1%4^CQLN[M"QP6V,M+J'X5*!V
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MXBCD\X<>Y#<X?^#A=@W*)OR<?WV)/-]Q1T"" 5JQ;NPE%5>T0',$.[$O"/<
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M"6=S,H?YL[LIY>=O)IV@6>J>/K%N&<PN3Y9A,8.8;;5)-9@K12\775M<Y(;
M?%3M36>1KOU&8%<V@N\Y^D?Q.0.?[@7>E)KVBEWW<A6;6$BU0:Z(B(T%H77"
MU5/KI' "GIX-/K#HP5HN8HCF29W <N5S[&QZ!G(!:LZB!%-HD;7"L5F%KE$9
MFWTA?\XGR*#P#NF 7T(H/ \]!J.7\X&+\4R8("AE1CT]'N]]$+7Y8![QT ZP
M(O])XQU6-I]ZUJ[2%>RN]^ G"M4'!RRQI#3F 39UPCN2^R@+O(5 SS7-HR9P
MN+7B9::12@<@JN:LQD<SMK4RD+731UC;)SA?K9W#!C:\>F+'-#:&(8:06-N^
M!LDL/FVLGY8@X)ZU\TX^9!(% >].O&D>AD EI)&.\1!]$55/]W:+%[.5(+7+
M?&/)M B]Y?"!4J^> 14C!@0'2]>/58@,&75'[.*S:"<H;&WU)L3^I/PQ"D()
M5%7%G)[R>F"P^<XMPYV:FCWWA6'%7C67H-$)CW1$HUE;I)K&3.A^4J4BA%FF
M[F\%@'%#,QT]F?'DQ0 EE8WV#*I/0:\B8VY,1IJ?W"N0:-SN8&HAW7/C1UIK
M'Z0=UY)P%$IUUIX#1EZ45Q?EZL;TO:D1@.$*'=#PTG-HC/J&J69$C9/CP]HH
M?L\[DLIM!8K@*!1E3SC#S@<;6=M>Q6X!2ZG"KB DC8W=IZ0E3P/*;7EX'GE.
MDX+'))JH%#7=7I %M,R0):<("]WDQ1E=A74_/MHWOXN9R/QE;5Q,3>N#TW7Z
MU+BXXS0'CG71<P;4%YE:DE/W[5:GV;Y"U(9VZR.WN^X[%VUL*0W_X_OREM[Z
M_G]U>[=XP>"&^EA3*^[?VX,AM@W&9K[P$[8&OFQ^PF;*W*UZV+ZBGMK.[T[K
M9JA:.,NAV7($[4MZ-G4Q_MB^4@^ZI1[&U%#ZJCET^NUFI_/9:EY>PLNQ\W'^
MRH$S'':X=S#U*>;FZ.>%"<$=-)_%)O%FA2->4%!TN"D1AS4>3T;2\DB0LJ.@
M8*C5PAB%7<+"SC;:TLI4)>Q%Z3)*K&%+:WP9;5,7^D2":B2PK6!B>"ZENS)W
MA8*>,8VX;1%H">'8GP4RZ4^Z-%E=V!!'T?'",,.\YPTSO8%,L$B$-&-@/R9%
M'#L1&RH9DYH52M)109'&-*@YW#Z&;8/G8^D0:N>>PI3FW'5:*#\5TV1!'^BB
MYQO[#S_ .&>R_>$H[[N;WU*!;F_.I(P87GA\P6V.%&'U72J5^C+510AMC2_8
M%H*5[IDO5"?FR3?BI0TJC[IA$P%L']O*/8:PFA1WX.")9PVCU\Y ?S8UZTJZ
MEX$R_%FDF3H"8KQV\7B]UJXW3JVCAFT='APVOF$Y?#V86(%(K!L(Z:7_75K'
M^Y*P>[7L^;.__?#J^U$]U?=Z5';GA?KG&UFH_],_6[WNX*9#MG7S0]\A,_A;
M 6W\<'OK^#6P-MZ]!M9&X]L ;92!X.K"U<\#?:OKZ+_'GJR-RY$RH%KL(*;T
M<PTWL$,!G%H&]//QKC4H62^BU*))@DIUP* "=UI%N';<S(3MCF%Z<F"!S1"-
M1(QV ^NG:#P@R]449L'1<3E3D5XGA6U+0ARHEG7KK$L2'X4;I/=R+=OA>(WQ
MOI_^B6&H"U!NR(EK('S4F+^DBZX>C(5<M4YN6@B.NQ8I7\^<-GD$NC41]SM4
M["VS7V,Q$91=3B@IG@1%QZ0,S)BN)3FI%>Y:998D)8=]<N@ARONOJ]22S0+J
MP('[EM7$SD<$\S9V9S0'S/Y!88;QCD)VD"=1X0IU&KKOV%2X5)+J8M;KB/D8
MOI^NJ):0%:V<V5 ZG!?WD_4H+QZ>EQ*\D75X^#8THF7%;VMEA#]C;];,Q4P=
M.9H#N\ VGDC\F //LD51?@;(IG@X\IF@X6O "<XMFXD8P=PL^"ID7XX%8WM
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MB %713#9X^VLV4VF+[E?N;^(1)_%T6^#$-_#$5-6<GX\1\QP\:E)7#ZW[0H
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MELM#*K5;[O)5M',+?L S:2ZY+.LK<BME=@^A]5:7X%=RMS??W! M__+.P6D
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M8O=KVCGNM^;5H!:VLFDGH]/,5#T,(K/1Q*36#HM!C?T12& >=1W(C"&V-AR
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MS IW9PT*:1&1%A44)&#+X9U[3*G@E;O\YRVRX_VG[;X;NC5WX_#7?3)-3Y)
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M"]M#SC/VLC"S>S&E/E^I8R6X9Q&O@:MYO!/H9*#4H.8SE&C<QD,418,O)PT
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M'KZY[< &^H-];U&V?,[$LIG)_&RY8#WJD;*-1L5$<<AFRD1+ 6D<,3!,D)
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MSPK.+A.N>9]=7K"SD\')<9,(]&,-@:K/OC4!_K>$-9WTD1,'3V&Z:I:Q#U+
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M5 *&YV%)CT?DW5<;D?35\:O!R>GI;Z/#6$6W;;D5^W.F:S&<BH.Q%OSS 9^
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M'N[,OB]L.XL"-M0C@DQEHCH-NH;;40D4L@#[V:($,"X*7#,+3IRV8*_:8Z
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MVQ#:HW^+\!-.8('L'=9PP6XXO.^:41,W.*UOSY7E2GM+1H^-ZX/3U!N\9IN
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M^_]02P$"% ,4    " "FBVA3N>#H&_L'  !P*   $               @ $
M    83(P,C%Q,V5X,S$Q+FAT;5!+ 0(4 Q0    ( *:+:%/^K[TM#P@  ,,H
M   0              "  2D(  !A,C R,7$S97@S,3(N:'1M4$L! A0#%
M  @ IHMH4S%'.Y0Y!0  "A8  !               ( !9A   &$R,#(Q<3-E
M>#,R,2YH=&U02P$"% ,4    " "FBVA3Y7 0B34%  #U%0  $
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M,#(Q,#DS,%]D968N>&UL4$L! A0#%     @ IHMH4QHZSUNU[   Z<X) !4
M             ( !;P $ &5H=&@M,C R,3 Y,S!?;&%B+GAM;%!+ 0(4 Q0
M   ( *:+:%/]RB: KX\  &=>!@ 5              "  5?M! !E:'1H+3(P
M,C$P.3,P7W!R92YX;6Q02P$"% ,4    " "FBVA3!I+L8/\A   J'@$ '@
M            @ $Y?04 97AH:6)I=#$P-F9R86YS;VES=&UA;F5X96,N:'1M
M4$L! A0#%     @ IHMH4^"D'!&S80  O\H" !X              ( !=)\%
M &5X:&EB:70Q,#=S8V]T=&9L86YD97)S<V5P+FAT;5!+ 0(4 Q0    ( *:+
M:%/X"M,]IS@  ,YL 0 >              "  6,!!@!E>&AI8FET,3 X8VAR
M:7-T:6YE:F%N;V9S:RYH=&U02P$"% ,4    " "FBVA3L&\'K+X7  "&GP
M'@              @ %&.@8 97AH:6)I=#$P.6IO:&YP:65R86YT;VYI<V4N
9:'1M4$L%!@     .  X L@,  $!2!@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
